data_5mye_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5mye _Structure_validation_residue.Date_analyzed 2017-03-17 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtp . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 119.67 -0.205 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.29 178.49 0.06 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.147 1.779 . . . . 0.0 113.285 -161.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.7 99.82 0.35 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.171 -0.955 . . . . 0.0 110.57 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -99.27 92.96 5.68 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.125 0.97 . . . . 0.0 109.717 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.0 mt -78.94 119.37 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -114.91 109.06 17.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.104 0.865 . . . . 0.0 109.929 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.55 141.01 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.512 -0.742 . . . . 0.0 111.534 -153.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HZ2' ' CG ' ' A' ' 19' ' ' ASP . 10.9 ttpp -66.43 124.73 23.56 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.957 167.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.6 -174.81 3.1 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.583 1.953 . . . . 0.0 111.357 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 149.04 12.23 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.376 0.671 . . . . 0.0 112.058 158.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.7 t -57.09 130.96 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.145 0.498 . . . . 0.0 110.266 162.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.97 -19.75 5.06 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.044 1.306 . . . . 0.0 115.921 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.65 89.41 43.68 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 119.624 1.712 . . . . 0.0 112.507 -170.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.71 32.1 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.149 1 C-N-CA 125.42 4.08 . . . . 0.0 115.105 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -136.71 0.38 2.45 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.77 1.628 . . . . 0.0 113.366 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.3 pt -142.51 157.67 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.992 1.317 . . . . 0.0 111.565 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.9 mt -85.35 -20.25 30.22 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -158.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 39.28 -135.98 1.4 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 127.381 2.419 . . . . 0.0 118.294 167.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' CG ' ' HZ2' ' A' ' 8' ' ' LYS . 7.7 p-10 -71.95 7.46 1.59 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.679 1.992 . . . . 0.0 115.233 -167.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.787 ' HB2' ' HG ' ' A' ' 23' ' ' CYS . 69.1 m -117.86 91.01 38.13 Favored Pre-proline 0 CA--C 1.51 -0.563 0 O-C-N 120.429 -1.419 . . . . 0.0 110.956 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.425 ' HD3' ' CD2' ' A' ' 159' ' ' HIS . 78.5 Cg_endo -63.98 -24.21 67.35 Favored 'Trans proline' 0 C--N 1.391 2.801 0 O-C-N 116.555 -2.392 . . . . 0.0 111.268 166.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -54.31 -42.31 69.97 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.902 2.481 . . . . 0.0 114.564 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.787 ' HG ' ' HB2' ' A' ' 20' ' ' SER . 30.8 p -79.9 -32.02 40.24 Favored 'General case' 0 C--N 1.372 1.578 0 CA-C-N 120.768 1.622 . . . . 0.0 111.014 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.71 -27.35 68.85 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.15 1.38 . . . . 0.0 112.984 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 74' ' ' ASP . 86.8 mtt180 -56.18 -42.8 77.67 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.476 1.111 . . . . 0.0 113.917 169.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.19 -34.59 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.792 0.837 . . . . 0.0 110.454 -170.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.5 mt -66.98 -44.86 79.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.272 1.029 . . . . 0.0 110.828 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 tp -56.48 -51.58 67.92 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.216 1.406 . . . . 0.0 113.196 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.08 -19.64 63.25 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.868 1.213 . . . . 0.0 113.981 -176.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -93.01 -37.2 12.32 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.201 1.0 . . . . 0.0 112.716 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -68.93 -27.76 66.04 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.088 -1.008 . . . . 0.0 113.51 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -66.87 -41.83 86.62 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.953 -1.092 . . . . 0.0 111.78 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HZ2' ' CD ' ' A' ' 81' ' ' GLU . 37.9 mttp -71.21 -11.61 61.02 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.283 1.433 . . . . 0.0 114.853 169.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm 63.67 7.43 3.13 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.253 1.821 . . . . 0.0 115.22 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.8 tt -74.54 130.7 81.32 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.086 0.954 . . . . 0.0 111.483 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.49 152.64 38.74 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.909 2.406 . . . . 0.0 113.698 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -152.39 176.02 12.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.929 1.692 . . . . 0.0 111.175 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -127.73 141.88 51.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.794 1.238 . . . . 0.0 110.864 164.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t -108.75 99.1 8.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.459 1.104 . . . . 0.0 111.499 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -78.0 86.62 4.18 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.154 1.381 . . . . 0.0 110.01 172.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.55 126.91 31.62 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.424 1.089 . . . . 0.0 112.439 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -114.26 121.76 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.091 1.756 . . . . 0.0 110.235 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -82.88 95.89 8.09 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.229 -0.919 . . . . 0.0 109.306 162.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 mt 60.56 -12.79 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.986 2.587 . . . . 0.0 117.986 168.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.43 5.71 0.19 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.842 1.687 . . . . 0.0 114.149 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.01 -5.23 20.45 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.528 1.664 . . . . 0.0 115.052 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -109.3 137.23 20.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 124.411 1.084 . . . . 0.0 109.269 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.26 175.93 6.17 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.453 2.768 . . . . 0.0 113.643 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -47.41 -31.74 4.37 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.84 -23.36 52.4 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -93.29 -6.9 46.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.558 1.543 . . . . 0.0 114.079 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.7 mt -114.47 -36.46 4.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.786 2.034 . . . . 0.0 112.383 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -64.59 -5.38 5.44 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.954 2.901 . . . . 0.0 114.614 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.15 -22.19 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 126.492 1.917 . . . . 0.0 110.97 168.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -92.34 139.71 24.09 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.297 1.439 . . . . 0.0 111.615 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.96 -19.04 40.49 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.646 2.23 . . . . 0.0 112.883 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.518 ' CD ' ' HZ2' ' A' ' 59' ' ' LYS . 3.0 mm-40 -95.11 -6.74 41.26 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.898 1.679 . . . . 0.0 112.884 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.39 2.3 26.22 Favored Glycine 0 CA--C 1.54 1.647 0 O-C-N 120.844 -1.16 . . . . 0.0 114.736 -163.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 73.8 mttt -89.46 129.12 36.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.712 1.605 . . . . 0.0 110.56 -175.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.3 m -82.98 148.74 57.64 Favored Pre-proline 0 N--CA 1.474 0.741 0 O-C-N 121.316 -0.865 . . . . 0.0 109.496 154.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.29 134.14 20.67 Favored 'Cis proline' 0 CA--C 1.543 0.97 0 N-CA-C 116.511 1.697 . . . . 0.0 116.511 9.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 m -147.56 175.09 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 127.506 2.322 . . . . 0.0 111.615 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.4 m -138.17 148.65 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 120.767 -1.208 . . . . 0.0 113.664 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -93.33 132.05 37.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.209 1.003 . . . . 0.0 109.787 153.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.4 79.69 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.863 1.265 . . . . 0.0 108.452 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.6 t70 60.38 61.57 1.75 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.0 0.92 . . . . 0.0 112.385 -170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 61.93 -10.94 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -170.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -79.36 105.2 10.51 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.626 -1.296 . . . . 0.0 109.718 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -70.6 156.09 39.89 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -166.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.0 t -147.58 136.2 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.633 2.373 . . . . 0.0 109.359 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.93 -171.33 0.53 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.403 1.881 . . . . 0.0 114.337 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.96 166.56 9.06 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -154.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.3 p -50.82 -16.2 0.38 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' HH11 ' A' ' 25' ' ' ARG . 7.9 m-20 -103.42 -15.44 15.9 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.105 1.762 . . . . 0.0 111.636 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -108.58 -14.1 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.307 1.443 . . . . 0.0 113.437 165.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.72 -33.45 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.434 1.493 . . . . 0.0 112.564 164.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.6 -15.5 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.761 1.224 . . . . 0.0 113.185 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.85 -56.54 0.8 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.314 0.959 . . . . 0.0 113.224 158.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 mt -73.12 -29.67 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.64 1.22 . . . . 0.0 113.45 -161.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.0 tp -77.48 -14.37 59.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.622 -1.299 . . . . 0.0 112.694 173.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.469 ' CD ' ' HZ2' ' A' ' 33' ' ' LYS . 47.7 mm-40 -91.99 -42.71 9.84 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.705 1.602 . . . . 0.0 110.773 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 11.7 tt0 -50.89 -45.37 60.1 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.065 2.546 . . . . 0.0 112.977 170.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.423 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 98.5 mttt -98.91 9.99 42.33 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.728 1.211 . . . . 0.0 113.496 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.22 139.53 34.32 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.876 0.87 . . . . 0.0 111.511 -175.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.63 -27.58 8.9 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.097 1.864 . . . . 0.0 112.998 166.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -88.18 158.96 48.85 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.129 0.972 . . . . 0.0 111.453 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -50.85 125.36 15.73 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.538 2.825 . . . . 0.0 115.849 -168.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -59.95 142.13 97.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.57 2.847 . . . . 0.0 113.764 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.0 mt -114.89 8.18 15.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.696 1.599 . . . . 0.0 112.948 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.46 -12.15 59.59 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.7 m -57.85 117.3 18.31 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 123.971 0.908 . . . . 0.0 111.999 -169.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -86.03 115.0 1.4 Allowed 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.415 2.743 . . . . 0.0 111.248 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -78.18 -177.41 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.328 2.685 . . . . 0.0 111.151 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -55.48 -34.75 64.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.182 1.793 . . . . 0.0 112.372 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -60.97 -19.56 61.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.259 1.424 . . . . 0.0 114.284 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.29 68.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.168 0.894 . . . . 0.0 112.766 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.4 p -63.41 -59.2 5.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.969 0.804 . . . . 0.0 111.838 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.1 -37.07 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.542 1.137 . . . . 0.0 111.595 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.48 -31.27 79.03 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.069 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.2 p -71.15 -19.03 62.47 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.597 1.198 . . . . 0.0 114.193 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -86.27 -39.51 16.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.792 1.237 . . . . 0.0 112.471 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.5 -39.38 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.447 1.499 . . . . 0.0 111.45 173.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.3 -55.42 31.73 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.659 1.584 . . . . 0.0 114.202 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.99 -33.33 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.276 2.651 . . . . 0.0 113.117 172.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.5 p -65.99 -30.81 71.43 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.365 1.438 . . . . 0.0 112.352 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -79.91 -19.6 47.75 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.116 -1.615 . . . . 0.0 113.794 172.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.428 HG23 ' HZ3' ' A' ' 156' ' ' LYS . 88.4 t -72.63 -42.26 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.448 -1.408 . . . . 0.0 110.23 163.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -68.42 -27.47 66.23 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.61 -40.72 84.07 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.279 1.432 . . . . 0.0 111.873 170.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.15 8.64 10.39 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.057 1.743 . . . . 0.0 114.688 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -142.21 35.62 1.52 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.494 2.718 . . . . 0.0 110.911 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 p -81.24 58.92 3.73 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.651 1.98 . . . . 0.0 113.487 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.32 -45.23 94.17 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.3 1.04 . . . . 0.0 110.061 161.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.91 119.88 67.3 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 128.349 2.66 . . . . 0.0 107.694 155.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.7 133.65 59.37 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.41 2.073 . . . . 0.0 115.833 -160.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -68.06 -31.61 71.37 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.018 -0.991 . . . . 0.0 112.103 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.78 -31.92 68.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.388 1.475 . . . . 0.0 113.993 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.66 -34.66 9.02 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 123.981 0.801 . . . . 0.0 113.279 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -64.1 -42.59 96.84 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.155 1.382 . . . . 0.0 112.078 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -58.97 -27.86 65.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.84 2.056 . . . . 0.0 113.128 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -68.36 -19.9 64.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.032 0.933 . . . . 0.0 112.804 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.24 -35.96 14.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.76 0.824 . . . . 0.0 112.427 166.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.9 mt -65.66 -34.49 78.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -62.64 -37.22 85.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.747 0.703 . . . . 0.0 112.072 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.98 -30.74 34.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.132 0.573 . . . . 0.0 112.527 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.08 -46.08 90.69 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.966 0.906 . . . . 0.0 111.944 166.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.95 -40.46 95.05 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.023 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -63.2 -42.05 99.25 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 120.343 1.429 . . . . 0.0 112.585 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.78 -35.07 79.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.274 0.63 . . . . 0.0 112.243 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.62 -54.86 7.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.772 0.829 . . . . 0.0 111.49 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.25 -35.69 81.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.692 1.997 . . . . 0.0 114.055 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.54 -33.44 81.72 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.913 0.768 . . . . 0.0 113.706 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -95.14 -29.08 14.74 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.9 mt -65.47 -32.8 74.61 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.543 -1.348 . . . . 0.0 113.259 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -66.06 -11.23 47.0 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 t -85.29 -28.69 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.948 0.899 . . . . 0.0 111.953 169.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -94.31 -37.35 11.55 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.756 1.222 . . . . 0.0 113.313 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.17 -72.34 0.22 Allowed Glycine 0 CA--C 1.541 1.712 0 CA-C-O 116.537 -2.257 . . . . 0.0 116.464 167.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -100.44 -35.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.969 0 N-CA-C 117.633 2.128 . . . . 0.0 117.633 -155.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -134.06 157.66 45.55 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.259 1.39 . . . . 0.0 112.856 -167.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.8 mt -71.09 -13.29 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.09 2.78 53.5 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 165.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 112.92 -134.28 11.85 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.062 1.315 . . . . 0.0 113.258 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -65.29 -25.45 67.64 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -139.67 163.89 31.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.77 1.228 . . . . 0.0 110.729 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.34 120.49 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.622 0.769 . . . . 0.0 110.637 170.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.7 p -144.39 -164.69 1.96 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.211 2.205 . . . . 0.0 109.321 163.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.57 -30.62 3.72 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 -160.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.96 -38.35 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.657 1.571 . . . . 0.0 112.771 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -62.76 -40.37 97.04 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.454 -0.779 . . . . 0.0 111.339 166.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.1 mt -64.94 -33.17 75.4 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.736 -0.602 . . . . 0.0 111.945 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.8 m -69.89 -38.37 76.31 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 120.179 -1.575 . . . . 0.0 113.237 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.5 mt -118.49 -32.18 4.69 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -159.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.3 -53.95 56.21 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 120.595 1.543 . . . . 0.0 115.084 -162.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.02 -19.8 29.69 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.577 1.518 . . . . 0.0 113.359 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.428 ' HZ3' HG23 ' A' ' 107' ' ' VAL . 22.4 ttmm -72.07 -30.97 65.66 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.593 -1.317 . . . . 0.0 111.849 175.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.81 -42.69 76.93 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.684 0.794 . . . . 0.0 111.895 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -64.88 -39.32 93.35 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 171.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.425 ' CD2' ' HD3' ' A' ' 21' ' ' PRO . 17.4 t-80 -65.04 -32.72 74.59 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 119.857 -1.777 . . . . 0.0 112.154 172.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.0 tp -68.4 -48.44 64.67 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.925 1.239 . . . . 0.0 111.072 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -51.61 -46.73 63.69 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.766 1.626 . . . . 0.0 112.195 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 82.9 t -74.13 -57.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.807 0.843 . . . . 0.0 113.261 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.93 -35.6 28.93 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.963 -1.086 . . . . 0.0 113.507 -167.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 tp -72.36 -32.33 66.37 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.681 -0.637 . . . . 0.0 111.205 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.75 -27.65 36.39 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.91 1.243 . . . . 0.0 114.855 171.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -68.04 -18.69 64.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -141.59 -27.3 0.67 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -149.69 81.61 1.4 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.512 1.525 . . . . 0.0 109.317 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.88 74.66 0.11 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.287 1.435 . . . . 0.0 112.282 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -70.58 112.93 14.69 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.334 1.854 . . . . 0.0 112.173 -169.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.11 142.02 27.01 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.546 2.164 . . . . 0.0 111.749 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.6 mm -92.25 112.82 57.01 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.371 1.068 . . . . 0.0 108.897 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -67.55 155.09 71.62 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.474 2.116 . . . . 0.0 112.116 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.78 -14.49 53.18 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -61.76 -31.37 71.56 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.216 -0.928 . . . . 0.0 112.724 167.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.92 56.68 3.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.477 1.911 . . . . 0.0 110.814 168.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -24.06 64.96 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.336 1.055 . . . . 0.0 113.277 -160.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -74.64 -51.74 13.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.413 1.006 . . . . 0.0 110.305 165.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 24.5 t -57.37 -46.91 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.288 0.949 . . . . 0.0 112.675 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 58.6 tp -64.3 -29.24 70.33 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -91.42 -30.6 16.41 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.149 -0.969 . . . . 0.0 113.328 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -63.65 -36.59 84.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.23 1.412 . . . . 0.0 112.933 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.84 -37.19 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.376 -0.827 . . . . 0.0 111.582 172.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -66.62 -30.16 70.37 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.044 -1.66 . . . . 0.0 112.654 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.3 mt -70.84 -20.18 62.57 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.412 -1.28 . . . . 0.0 113.219 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.1 mt -65.85 -22.62 66.55 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.117 1.326 . . . . 0.0 112.715 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -83.7 17.36 2.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.541 1.536 . . . . 0.0 113.486 171.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 p -142.33 178.57 7.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.126 2.17 . . . . 0.0 113.045 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 58.82 174.42 0.07 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.064 1.746 . . . . 0.0 113.609 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 5.1 mp0 -74.56 -44.51 50.68 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.791 1.236 . . . . 0.0 109.563 166.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -20.68 66.33 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.578 1.951 . . . . 0.0 116.042 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -116.24 -48.08 2.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.132 1.333 . . . . 0.0 113.59 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -63.13 -30.08 71.31 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.37 -1.456 . . . . 0.0 114.529 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -74.2 -18.74 60.72 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.5 p -97.82 -1.49 43.05 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.698 1.199 . . . . 0.0 112.757 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -59.43 123.51 17.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.543 1.537 . . . . 0.0 111.429 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.63 165.45 24.25 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.572 1.149 . . . . 0.0 113.162 170.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.8 125.56 29.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.028 0.531 . . . . 0.0 110.14 161.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.03 -34.07 57.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -150.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -36.94 79.05 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.168 1.387 . . . . 0.0 110.853 169.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -84.74 -7.47 59.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.978 1.711 . . . . 0.0 113.07 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 31.3 t -77.06 -51.04 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.472 -0.768 . . . . 0.0 109.413 158.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.05 -50.5 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.721 1.208 . . . . 0.0 111.669 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.14 -15.28 63.38 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.74 -25.26 18.35 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.471 -0.768 . . . . 0.0 113.862 168.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -78.24 -31.44 49.25 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.033 1.333 . . . . 0.0 113.732 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -48.02 -56.63 12.93 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -69.65 -20.72 34.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 120.652 1.269 . . . . 0.0 112.022 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -84.86 3.84 36.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.242 1.817 . . . . 0.0 114.005 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 65.5 t -68.62 -28.79 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.127 0.876 . . . . 0.0 110.312 153.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -96.96 -51.99 4.04 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.34 -1.314 . . . . 0.0 113.832 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 C-N-CA 126.954 2.102 . . . . 0.0 113.234 -177.138 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 ttm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 118.373 -0.823 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.47 -169.37 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.21 1.004 . . . . 0.0 112.233 -168.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.2 mt -71.78 116.09 11.75 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.916 -1.115 . . . . 0.0 110.597 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -125.71 111.29 14.75 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.9 mt -92.15 135.29 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HG ' ' HB2' ' A' ' 40' ' ' HIS . 6.6 m -112.0 137.75 49.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.227 0.611 . . . . 0.0 109.621 163.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.69 140.95 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.03 -1.044 . . . . 0.0 110.153 -162.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.785 ' H ' ' HG ' ' A' ' 23' ' ' CYS . 31.7 tttm -66.45 124.68 23.43 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 170.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.87 172.73 12.97 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.256 1.423 . . . . 0.0 111.524 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.39 140.84 32.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.055 0.942 . . . . 0.0 111.624 169.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.4 t -54.57 119.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.19 0.519 . . . . 0.0 109.949 171.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.04 -13.86 41.86 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 116.425 1.33 . . . . 0.0 116.425 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.04 84.39 63.42 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 120.128 1.964 . . . . 0.0 112.044 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.23 7.56 0.63 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 125.149 3.899 . . . . 0.0 117.658 -167.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -120.74 6.27 10.48 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.876 1.271 . . . . 0.0 113.509 -172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.5 pt -142.09 160.28 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.176 1.79 . . . . 0.0 110.44 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.35 -48.73 31.82 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.75 -125.83 12.16 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.657 1.122 . . . . 0.0 114.601 -174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.79 18.04 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.348 2.659 . . . . 0.0 117.154 -171.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.49 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.9 p -118.45 75.39 12.17 Favored Pre-proline 0 C--O 1.25 1.12 0 O-C-N 120.344 -1.472 . . . . 0.0 110.955 -159.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.65 -31.91 39.5 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.936 2.424 . . . . 0.0 111.865 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -62.45 -37.16 84.81 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.962 0.905 . . . . 0.0 113.061 171.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.785 ' HG ' ' H ' ' A' ' 8' ' ' LYS . 83.3 m -63.99 -46.27 85.28 Favored 'General case' 0 C--N 1.379 1.863 0 O-C-N 119.924 -1.735 . . . . 0.0 110.994 171.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -56.92 -37.16 71.07 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.198 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.484 HH12 ' CG ' ' A' ' 74' ' ' ASP . 69.9 mtp180 -52.59 -44.05 65.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.187 0.995 . . . . 0.0 112.714 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -78.63 -28.85 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.019 1.328 . . . . 0.0 112.441 -168.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.9 mt -71.79 -41.11 68.7 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.245 -0.285 . . . . 0.0 111.278 166.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -60.47 -35.72 76.57 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -162.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.7 p -69.59 -48.28 60.7 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.325 0.966 . . . . 0.0 112.569 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.52 -31.77 67.43 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.703 0.801 . . . . 0.0 112.167 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -77.69 -23.49 49.51 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -77.42 -40.38 43.66 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.146 0.885 . . . . 0.0 112.507 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -67.91 -9.58 46.21 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.859 1.264 . . . . 0.0 112.92 165.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 mttt 58.29 17.72 4.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.034 2.534 . . . . 0.0 114.676 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.84 124.93 91.61 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.035 0.934 . . . . 0.0 108.806 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.29 140.25 57.9 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.804 1.669 . . . . 0.0 111.001 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -138.4 160.72 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.468 1.507 . . . . 0.0 109.709 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -93.41 122.77 36.18 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.385 1.074 . . . . 0.0 110.05 172.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.7 t -87.93 134.13 33.78 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.422 ' HB2' ' HG ' ' A' ' 6' ' ' CYS . 67.9 m-70 -127.5 76.61 1.68 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.279 1.832 . . . . 0.0 109.912 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.0 mt -68.49 133.2 48.24 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.923 0.889 . . . . 0.0 111.253 170.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 mt -134.98 122.72 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.66 1.584 . . . . 0.0 110.512 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -83.34 98.85 9.67 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.278 -0.889 . . . . 0.0 109.602 169.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.6 mt 60.03 -6.87 0.07 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.6 11.84 0.83 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.751 1.644 . . . . 0.0 115.074 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.81 -5.5 12.47 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.045 1.923 . . . . 0.0 115.169 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -134.44 145.14 53.95 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 126.442 1.897 . . . . 0.0 109.164 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.12 158.85 41.73 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.794 2.329 . . . . 0.0 114.184 -153.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -63.64 -10.73 20.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -56.5 -19.18 14.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.117 1.767 . . . . 0.0 114.641 165.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.32 9.0 21.6 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.082 2.153 . . . . 0.0 113.098 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.2 mt -126.67 -41.28 1.86 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.525 2.33 . . . . 0.0 111.833 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -65.73 -7.15 14.12 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 128.207 2.603 . . . . 0.0 114.042 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.0 mt -60.57 -19.44 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 126.598 1.959 . . . . 0.0 110.95 163.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.2 p -113.96 143.13 29.03 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 126.87 2.068 . . . . 0.0 111.477 160.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.4 -24.86 36.38 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.477 2.118 . . . . 0.0 113.195 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -77.51 3.94 12.33 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.217 1.407 . . . . 0.0 114.724 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.61 47.23 91.26 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.217 0.913 . . . . 0.0 112.642 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -125.75 176.67 6.75 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 -167.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.82 148.03 40.97 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 126.875 2.07 . . . . 0.0 107.155 168.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.5 158.23 98.97 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 N-CA-C 115.293 1.228 . . . . 0.0 115.293 5.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -156.97 161.53 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.044 2.538 . . . . 0.0 108.659 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.14 148.01 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 120.486 -1.384 . . . . 0.0 114.617 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -98.55 126.79 44.24 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.711 1.604 . . . . 0.0 109.855 162.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.2 mt -103.14 69.76 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.348 1.459 . . . . 0.0 108.701 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.257 23.3 t70 58.87 58.92 3.02 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.477 1.132 . . . . 0.0 112.102 -162.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.57 13.64 2.66 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -175.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -90.92 112.17 23.92 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.889 -1.132 . . . . 0.0 108.77 164.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -83.06 149.77 26.72 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -162.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -144.61 135.42 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.766 2.026 . . . . 0.0 109.956 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.93 -149.49 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.006 2.122 . . . . 0.0 113.95 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -51.84 161.0 0.61 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.3 p -38.71 -43.05 0.86 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.901 2.481 . . . . 0.0 116.088 166.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.484 ' CG ' HH12 ' A' ' 25' ' ' ARG . 3.2 m-20 -73.75 -13.84 61.03 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.362 1.437 . . . . 0.0 114.778 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.78 -24.49 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.555 1.071 . . . . 0.0 113.157 162.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.31 -40.72 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 119.527 1.058 . . . . 0.0 111.994 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -63.59 -5.28 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.44 -61.47 0.5 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.276 0.941 . . . . 0.0 112.923 158.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.0 mt -70.79 -28.32 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.048 1.339 . . . . 0.0 113.672 -163.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.28 -46.6 55.14 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.768 -1.207 . . . . 0.0 110.929 170.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -69.25 -27.36 65.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.576 1.15 . . . . 0.0 113.34 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 38.2 tt0 -63.61 -32.66 74.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.893 2.077 . . . . 0.0 113.203 167.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.525 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 91.1 mttt -114.07 3.13 15.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.249 1.42 . . . . 0.0 113.131 -168.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -86.61 142.63 35.02 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.671 1.588 . . . . 0.0 110.157 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.59 -24.74 18.37 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.947 1.765 . . . . 0.0 113.898 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -80.89 146.53 59.78 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 118.779 0.718 . . . . 0.0 109.921 169.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -54.66 149.8 38.57 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.137 2.558 . . . . 0.0 115.585 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.21 121.97 8.99 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.712 2.274 . . . . 0.0 112.591 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 mt -63.07 -17.7 62.56 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.187 1.395 . . . . 0.0 111.577 157.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.78 -8.38 14.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.136 1.774 . . . . 0.0 114.959 169.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.8 m -59.69 114.74 10.31 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 119.195 0.907 . . . . 0.0 109.532 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.92 125.18 10.21 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.854 1.703 . . . . 0.0 111.937 -165.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.53 159.24 53.49 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.681 2.254 . . . . 0.0 110.79 163.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -50.52 -34.07 23.92 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.561 1.544 . . . . 0.0 113.102 159.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -63.01 -13.97 42.03 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.03 71.5 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.372 -1.455 . . . . 0.0 113.14 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.7 p -71.15 -7.25 45.41 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.44 -40.88 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.422 1.489 . . . . 0.0 111.387 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.99 -31.89 80.22 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.268 0.937 . . . . 0.0 114.429 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.1 p -66.91 -13.08 61.35 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 172.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -90.67 -43.75 9.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.915 1.286 . . . . 0.0 112.073 169.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.37 -34.2 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.31 1.044 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 152' ' ' SER . 88.4 t80 -59.65 -49.29 92.66 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -77.91 -21.04 11.28 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.339 2.693 . . . . 0.0 113.975 167.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.492 ' HA ' ' CE ' ' A' ' 108' ' ' LYS . 58.3 m -69.52 -31.28 69.41 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.703 1.592 . . . . 0.0 114.802 173.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -67.17 -28.46 68.13 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.042 -1.036 . . . . 0.0 113.734 162.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.18 -47.72 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 120.57 1.532 . . . . 0.0 110.926 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.492 ' CE ' ' HA ' ' A' ' 105' ' ' SER . 51.0 mtmt -59.81 -45.4 92.47 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.087 0.955 . . . . 0.0 111.683 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.77 -20.56 61.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.569 0.747 . . . . 0.0 112.98 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.59 20.19 9.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.722 1.609 . . . . 0.0 113.207 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -132.07 62.08 1.65 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.133 1.373 . . . . 0.0 110.52 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -59.81 5.26 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -165.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -64.23 -34.11 77.34 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.822 -1.174 . . . . 0.0 111.561 155.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.28 149.46 94.12 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.802 1.241 . . . . 0.0 110.98 166.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.0 88.99 0.9 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.582 2.188 . . . . 0.0 110.484 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -51.57 -40.43 59.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.84 -10.94 60.58 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -96.93 -33.88 5.9 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.868 1.223 . . . . 0.0 113.63 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.4 m -61.79 -33.37 73.99 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.482 -1.011 . . . . 0.0 112.227 168.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -54.4 -44.41 72.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 128.284 2.633 . . . . 0.0 111.707 170.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -71.18 -38.76 72.1 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.228 -0.92 . . . . 0.0 112.451 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.67 -41.4 92.54 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.327 -0.858 . . . . 0.0 112.461 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.9 tp -64.68 -37.31 87.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.42 1.088 . . . . 0.0 112.347 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.88 -39.59 94.92 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.082 0.856 . . . . 0.0 112.629 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.494 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 26.6 mm-40 -69.38 -34.88 75.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.655 1.116 . . . . 0.0 112.743 175.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -67.45 -37.72 83.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.351 -0.843 . . . . 0.0 112.631 172.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.51 -33.15 62.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 113.49 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.494 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 82.1 mttt -60.19 -36.87 78.59 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.68 1.127 . . . . 0.0 112.553 173.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.81 -19.2 65.8 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.5 tp -96.86 -54.42 3.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.242 1.417 . . . . 0.0 112.618 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.8 -43.06 99.81 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -154.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.49 -25.75 73.75 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 121.632 -0.668 . . . . 0.0 113.806 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -89.15 -28.49 20.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.58 1.152 . . . . 0.0 112.995 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.82 -41.62 82.63 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.456 0.702 . . . . 0.0 112.2 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -59.46 -20.3 54.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.231 1.812 . . . . 0.0 114.362 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.4 t -84.82 -26.1 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.584 1.153 . . . . 0.0 112.244 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -105.13 -36.44 7.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.941 1.296 . . . . 0.0 113.535 -171.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.04 -176.23 35.11 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.287 -0.883 . . . . 0.0 114.197 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.03 -2.24 10.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.424 3.416 . . . . 0.0 115.498 -166.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -94.95 168.47 10.77 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.576 -1.328 . . . . 0.0 112.619 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.27 7.4 tt -77.41 9.66 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.678 -1.264 . . . . 0.0 112.93 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.84 31.69 3.3 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.001 2.12 . . . . 0.0 113.319 159.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.61 -115.59 4.05 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.202 -1.561 . . . . 0.0 113.613 172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -62.12 -25.77 67.92 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -166.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -152.65 170.62 19.78 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.649 1.179 . . . . 0.0 112.153 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.09 138.86 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.536 1.134 . . . . 0.0 109.708 164.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.5 p -139.91 -179.55 6.02 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.308 1.843 . . . . 0.0 110.743 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.77 -16.02 46.14 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.285 -1.509 . . . . 0.0 114.708 167.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.15 -42.98 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 119.634 1.106 . . . . 0.0 110.905 167.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.03 -40.94 99.23 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.88 -1.138 . . . . 0.0 112.798 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.0 mt -67.61 6.94 0.55 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.683 1.193 . . . . 0.0 113.93 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 13.2 p -124.62 -40.93 2.17 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.618 -1.301 . . . . 0.0 111.682 174.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.8 mt -93.06 -39.7 10.93 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.73 1.212 . . . . 0.0 113.977 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.72 99.33 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.79 -26.27 13.67 Favored 'Trans proline' 0 C--N 1.35 0.637 0 CA-C-N 121.027 1.402 . . . . 0.0 113.266 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -71.83 -32.22 67.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 117.551 -1.214 . . . . 0.0 112.581 172.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.01 -40.95 91.56 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.124 0.875 . . . . 0.0 112.694 167.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -62.5 -45.48 92.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.85 0.75 . . . . 0.0 112.112 175.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -64.95 -27.75 69.05 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.314 0.646 . . . . 0.0 112.443 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 tp -75.85 -45.68 34.4 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.298 1.039 . . . . 0.0 113.576 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -60.54 -37.88 82.65 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.018 0.826 . . . . 0.0 111.238 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.76 -57.97 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.32 -49.56 12.23 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.118 -0.989 . . . . 0.0 113.57 -165.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 54.5 tp -68.49 -37.67 80.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.266 0.485 . . . . 0.0 110.908 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.96 -26.99 61.56 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.271 0.938 . . . . 0.0 115.375 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -63.79 -32.59 74.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.562 1.145 . . . . 0.0 113.98 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -107.89 -31.93 7.8 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.108 0.963 . . . . 0.0 113.416 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -145.87 102.76 3.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.037 1.735 . . . . 0.0 107.936 167.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -68.62 85.71 0.3 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.622 0.769 . . . . 0.0 110.455 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -85.72 110.35 29.33 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.005 1.322 . . . . 0.0 110.133 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.09 139.22 32.29 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.698 1.599 . . . . 0.0 109.852 171.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.5 mt -65.09 121.47 74.4 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 159.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -60.46 158.47 31.56 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.335 2.023 . . . . 0.0 113.563 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.21 -28.57 69.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.469 1.108 . . . . 0.0 113.642 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -61.5 -23.59 66.01 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.347 -1.47 . . . . 0.0 113.287 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 79.8 mt -104.24 43.25 1.11 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.956 2.503 . . . . 0.0 111.527 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -46.24 -39.55 10.07 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.075 2.15 . . . . 0.0 113.909 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -73.45 -44.66 57.66 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.855 -1.153 . . . . 0.0 111.698 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 23.8 t -69.89 -33.52 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.634 -0.666 . . . . 0.0 110.963 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.48 -43.92 98.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.417 1.087 . . . . 0.0 112.939 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -70.66 -31.75 68.78 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.145 -0.972 . . . . 0.0 113.331 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -63.9 -25.99 68.4 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.875 0.762 . . . . 0.0 112.9 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.3 mt -52.74 -38.58 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.269 -0.894 . . . . 0.0 111.461 166.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -79.95 -9.57 59.69 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.204 -1.56 . . . . 0.0 114.07 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.81 -19.05 55.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 116.791 -1.576 . . . . 0.0 113.402 162.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.0 mt -64.64 -20.35 66.23 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.441 1.473 . . . . 0.0 113.231 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -92.23 4.2 53.77 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.9 p -123.78 -177.88 3.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.257 1.823 . . . . 0.0 114.475 -159.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 56.8 -168.45 0.11 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.232 1.813 . . . . 0.0 111.37 -173.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -73.97 -43.36 58.43 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.73 162.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.4 p -63.68 -78.6 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.397 2.279 . . . . 0.0 113.713 -172.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -57.93 -38.76 76.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.531 -0.731 . . . . 0.0 112.366 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -60.81 -34.98 75.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -75.16 -36.71 61.51 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.164 1.347 . . . . 0.0 112.317 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 23.7 p -69.54 -15.4 63.23 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -54.12 101.65 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.345 1.458 . . . . 0.0 111.43 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.92 135.6 37.02 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.353 0.661 . . . . 0.0 111.352 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.9 121.47 9.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.214 1.006 . . . . 0.0 111.792 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 -69.46 -40.65 77.02 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.574 1.149 . . . . 0.0 113.811 -148.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -61.35 -33.44 73.64 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.377 1.071 . . . . 0.0 112.563 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -81.66 -10.32 59.43 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.75 -46.91 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.092 0.86 . . . . 0.0 109.713 162.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 mt -64.36 -53.48 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.869 1.268 . . . . 0.0 111.606 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.75 -27.38 68.26 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.93 -14.46 60.8 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.478 -1.179 . . . . 0.0 113.985 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -82.89 -22.9 33.82 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.789 1.794 . . . . 0.0 113.826 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -48.85 -47.88 72.23 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.57 -19.51 18.9 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 122.009 1.806 . . . . 0.0 114.426 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -79.7 -2.43 42.86 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.537 1.535 . . . . 0.0 115.0 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.1 m -58.4 -20.51 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.396 -0.815 . . . . 0.0 112.428 157.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -118.23 -31.17 5.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.645 1.578 . . . . 0.0 114.75 168.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.754 1.222 . . . . 0.0 114.123 -179.533 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtp . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.8 -175.17 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.821 1.248 . . . . 0.0 112.604 -158.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.45 105.62 0.79 Allowed 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.637 -1.289 . . . . 0.0 110.576 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -106.91 90.04 3.19 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.601 1.16 . . . . 0.0 109.432 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.32 129.01 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.125 0.97 . . . . 0.0 108.481 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.9 m -120.02 111.44 17.89 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.084 0.954 . . . . 0.0 109.361 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.1 139.32 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.622 0.769 . . . . 0.0 111.657 -154.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -64.5 126.77 28.89 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.25 0.548 . . . . 0.0 110.131 168.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.64 -171.44 2.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.156 2.183 . . . . 0.0 111.834 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.33 147.21 13.92 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.33 -0.857 . . . . 0.0 111.486 154.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.01 128.88 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.279 0.562 . . . . 0.0 109.792 159.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.95 -23.64 5.78 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.105 1.336 . . . . 0.0 116.214 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.64 87.64 54.35 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 119.868 1.834 . . . . 0.0 112.818 -168.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.24 17.8 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 125.254 3.969 . . . . 0.0 115.444 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -114.9 -5.2 12.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.345 1.858 . . . . 0.0 113.476 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.3 pt -143.29 160.3 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.213 1.405 . . . . 0.0 111.722 -173.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.1 mt -79.65 -32.1 41.56 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -168.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.72 -129.59 7.62 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.645 1.593 . . . . 0.0 115.874 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -64.55 2.38 0.65 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.705 2.002 . . . . 0.0 115.474 -172.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.91 ' CB ' ' HG ' ' A' ' 23' ' ' CYS . 68.7 m -108.54 80.68 1.23 Allowed Pre-proline 0 C--O 1.255 1.347 0 C-N-CA 125.021 1.328 . . . . 0.0 111.015 -164.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.72 -24.51 68.94 Favored 'Trans proline' 0 C--N 1.373 1.817 0 O-C-N 116.433 -2.456 . . . . 0.0 111.284 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.08 -38.05 87.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.923 1.689 . . . . 0.0 114.313 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.91 ' HG ' ' CB ' ' A' ' 20' ' ' SER . 30.9 p -78.62 -30.93 46.75 Favored 'General case' 0 C--N 1.376 1.735 0 O-C-N 119.906 -1.746 . . . . 0.0 110.964 171.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -64.19 -27.36 69.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.52 1.128 . . . . 0.0 113.198 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -53.8 -44.19 69.95 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.423 1.089 . . . . 0.0 112.164 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 t -76.72 -32.02 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.598 1.159 . . . . 0.0 111.542 -171.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.1 mt -65.08 -47.48 77.12 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 122.1 -0.375 . . . . 0.0 111.154 167.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.02 -47.76 80.11 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.999 1.32 . . . . 0.0 113.233 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -23.13 64.14 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.2 mt -90.62 -39.42 12.51 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.285 1.034 . . . . 0.0 112.339 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -69.04 -24.06 64.14 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.435 ' CD ' HH22 ' A' ' 189' ' ' ARG . 10.5 tp10 -74.37 -37.98 63.3 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.598 -1.313 . . . . 0.0 113.123 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HZ2' ' CD ' ' A' ' 81' ' ' GLU . 36.7 mttp -70.45 -12.06 61.33 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 168.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HE3' ' OE1' ' A' ' 190' ' ' GLU . 33.0 mmtm 62.51 8.55 2.93 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.681 1.992 . . . . 0.0 114.481 -173.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 tt -71.33 130.43 87.73 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.887 1.275 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.67 151.13 51.76 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.627 2.218 . . . . 0.0 112.795 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -148.93 165.61 31.06 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.136 1.374 . . . . 0.0 111.339 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -110.3 131.85 54.69 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.23 1.812 . . . . 0.0 109.247 168.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.5 t -107.79 123.78 49.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.508 0.723 . . . . 0.0 111.756 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.62 86.22 2.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.863 1.665 . . . . 0.0 109.597 174.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.6 mt -73.02 124.11 24.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.849 1.26 . . . . 0.0 111.444 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mt -123.19 117.53 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 126.313 1.845 . . . . 0.0 109.483 -167.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -83.45 94.04 7.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.777 0.831 . . . . 0.0 109.392 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.2 mt 57.67 11.51 1.32 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 166.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.06 22.8 5.49 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 119.084 0.856 . . . . 0.0 114.9 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -62.47 -7.14 4.05 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.169 1.485 . . . . 0.0 114.017 168.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -122.15 145.44 44.05 Favored Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 125.319 1.448 . . . . 0.0 111.122 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.59 176.38 5.08 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.413 2.742 . . . . 0.0 113.359 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -51.37 -26.69 8.2 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.617 1.967 . . . . 0.0 115.728 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -57.13 -20.79 28.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.153 1.781 . . . . 0.0 115.778 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -100.64 -0.82 36.78 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.265 1.426 . . . . 0.0 113.725 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.4 mt -128.28 -37.96 1.81 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.94 2.096 . . . . 0.0 112.15 -166.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.42 -18.58 51.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.554 2.342 . . . . 0.0 114.868 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.4 mt -57.86 -29.38 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 126.784 2.033 . . . . 0.0 111.283 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.8 t -93.76 135.68 24.74 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.008 1.723 . . . . 0.0 112.358 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -69.8 -16.05 37.2 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.371 2.047 . . . . 0.0 113.234 167.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 59' ' ' LYS . 35.6 mt-10 -88.18 -14.21 39.18 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.316 1.046 . . . . 0.0 112.862 170.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.2 -19.43 0.35 Allowed Glycine 0 CA--C 1.546 1.972 0 O-C-N 119.923 -1.735 . . . . 0.0 114.929 -159.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.581 ' HZ3' ' CG ' ' A' ' 72' ' ' ASP . 41.2 tttt -59.83 130.01 44.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.722 2.409 . . . . 0.0 111.22 169.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.74 146.37 38.93 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.977 1.311 . . . . 0.0 108.936 152.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.31 139.87 32.54 Favored 'Cis proline' 0 CA--C 1.539 0.762 0 N-CA-C 117.264 1.986 . . . . 0.0 117.264 19.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.1 m -151.69 178.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 127.176 2.191 . . . . 0.0 111.447 175.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.16 153.88 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 121.039 -1.038 . . . . 0.0 112.454 170.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -96.96 132.03 43.15 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.334 148.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.2 mt -96.94 86.35 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.261 1.024 . . . . 0.0 108.441 168.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.3 t0 57.17 58.23 4.06 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.926 0.89 . . . . 0.0 112.924 -169.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.291 80.5 m-20 62.27 -0.75 0.46 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -174.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -88.89 108.42 19.53 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.508 -1.37 . . . . 0.0 109.496 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -66.79 153.51 43.16 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -166.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -141.23 142.87 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.988 2.115 . . . . 0.0 108.722 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.69 -163.57 0.1 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.537 1.535 . . . . 0.0 113.959 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.581 ' CG ' ' HZ3' ' A' ' 59' ' ' LYS . 38.9 t70 -50.44 160.75 0.37 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.042 2.137 . . . . 0.0 116.134 -167.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.6 p -48.83 -33.33 10.31 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.978 1.311 . . . . 0.0 114.042 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.53 -1.97 58.34 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.33 -13.48 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.043 1.337 . . . . 0.0 113.773 161.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.45 -32.81 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.005 1.722 . . . . 0.0 112.416 166.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.6 -15.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.5 -58.8 0.8 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.115 0.864 . . . . 0.0 112.571 157.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.2 mt -72.67 -27.52 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 118.273 1.037 . . . . 0.0 113.78 -160.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.6 tp -77.94 -24.96 48.06 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.293 -1.505 . . . . 0.0 112.281 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' CD ' ' HZ2' ' A' ' 33' ' ' LYS . 52.8 mm-40 -80.82 -43.14 20.49 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.892 1.277 . . . . 0.0 110.887 176.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.43 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 12.5 tt0 -50.13 -39.59 43.66 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.224 2.61 . . . . 0.0 113.258 170.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.43 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 98.8 mttt -105.59 4.79 30.69 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.007 1.323 . . . . 0.0 113.949 -171.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.69 140.09 54.88 Favored Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 121.499 -0.751 . . . . 0.0 111.015 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.54 -31.57 6.91 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.342 2.028 . . . . 0.0 112.328 168.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -81.38 161.25 62.81 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.75 1.22 . . . . 0.0 111.276 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.94 125.81 19.95 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.839 2.359 . . . . 0.0 115.654 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -64.94 129.5 23.39 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.602 2.868 . . . . 0.0 113.666 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 mt -103.48 10.36 37.23 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.264 1.426 . . . . 0.0 113.265 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.78 -11.2 54.17 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.2 m -58.31 117.86 23.3 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.437 -171.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.63 117.42 3.35 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.049 2.499 . . . . 0.0 110.918 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -75.57 177.82 8.18 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.717 2.278 . . . . 0.0 110.953 165.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -55.37 -33.0 63.05 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.793 -1.192 . . . . 0.0 113.166 167.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -59.5 -20.66 57.0 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.683 1.593 . . . . 0.0 114.818 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.3 -26.12 68.24 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.786 -1.196 . . . . 0.0 112.808 171.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.4 m -65.5 -17.31 64.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.793 1.637 . . . . 0.0 114.181 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.5 t -124.16 -36.82 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.273 1.429 . . . . 0.0 111.279 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.11 -31.12 77.72 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 120.483 -1.386 . . . . 0.0 114.23 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.6 p -68.65 -25.94 65.07 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.164 -1.198 . . . . 0.0 113.999 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -75.77 -41.7 52.38 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.591 1.156 . . . . 0.0 111.611 170.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.38 -35.54 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.776 1.63 . . . . 0.0 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -55.6 -49.62 91.64 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.7 -33.17 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.091 2.527 . . . . 0.0 113.137 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -71.72 -30.87 66.11 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.142 -0.974 . . . . 0.0 113.351 -170.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -75.67 -21.0 58.05 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.409 -1.432 . . . . 0.0 114.501 167.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.4 t -72.89 -34.22 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.464 -1.397 . . . . 0.0 110.941 167.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.53 -35.43 80.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.035 0.934 . . . . 0.0 112.482 168.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -63.6 -20.3 65.55 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.241 1.417 . . . . 0.0 113.457 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 mt -95.44 -2.01 49.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.649 1.58 . . . . 0.0 114.254 172.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -127.65 54.89 1.65 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.849 1.66 . . . . 0.0 110.779 164.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.8 p -62.9 29.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 131.699 4.0 . . . . 0.0 117.95 -167.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.38 -28.5 69.31 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.961 1.304 . . . . 0.0 112.471 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.3 110.5 44.97 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-O 117.074 -1.441 . . . . 0.0 107.351 159.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.71 141.65 97.92 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.495 2.13 . . . . 0.0 116.02 -152.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -64.61 -35.74 81.98 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.86 171.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.09 -18.33 63.97 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.38 -44.36 3.5 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.066 0.841 . . . . 0.0 112.954 163.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 88.1 m -61.87 -33.17 73.71 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.46 -28.15 68.1 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.912 1.285 . . . . 0.0 113.201 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -70.53 -32.84 70.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.1 0.96 . . . . 0.0 111.406 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.04 -41.2 59.64 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.317 -0.864 . . . . 0.0 112.201 168.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.29 -33.3 75.66 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 39.5 mt -65.26 -41.21 94.49 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.826 0.739 . . . . 0.0 112.616 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -74.88 -33.61 62.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.146 0.885 . . . . 0.0 112.694 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.68 -38.08 76.91 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.806 -1.183 . . . . 0.0 112.605 169.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.6 mt -63.94 -39.35 93.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.49 -1.381 . . . . 0.0 111.813 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.45 -41.02 93.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.415 1.007 . . . . 0.0 112.275 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.39 -35.78 81.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.526 0.73 . . . . 0.0 112.044 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 tp -71.2 -54.92 9.3 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.841 0.856 . . . . 0.0 111.784 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -64.74 -34.78 79.13 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.89 1.676 . . . . 0.0 113.793 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.34 -33.21 69.94 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.414 1.006 . . . . 0.0 113.772 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -101.06 -24.58 14.28 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.7 mt -66.88 -32.59 73.96 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.44 -1.412 . . . . 0.0 113.075 171.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -63.66 -18.86 64.4 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.26 -32.23 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.854 0.862 . . . . 0.0 111.71 172.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -85.11 -30.88 23.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.275 1.03 . . . . 0.0 113.464 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.31 -99.74 1.98 Allowed Glycine 0 CA--C 1.539 1.564 0 CA-C-O 117.616 -1.658 . . . . 0.0 114.288 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.71 -34.27 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.554 2.169 . . . . 0.0 116.798 -144.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -129.58 156.14 44.68 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.364 1.438 . . . . 0.0 112.439 -168.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.9 tt -78.94 -4.17 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -163.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.57 -6.14 41.02 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.68 1.592 . . . . 0.0 114.931 160.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.69 -123.82 5.49 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.309 1.433 . . . . 0.0 113.543 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -62.7 -26.53 68.71 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -155.29 164.97 38.05 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.715 2.006 . . . . 0.0 110.083 -169.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.1 mt -69.43 113.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.493 1.117 . . . . 0.0 109.876 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.1 p -136.98 -163.89 1.49 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.107 0.963 . . . . 0.0 111.01 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.97 -24.75 1.62 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -166.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.48 -42.98 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.77 1.168 . . . . 0.0 112.235 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.82 -45.53 92.07 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.077 -1.014 . . . . 0.0 111.936 166.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.81 -12.11 15.74 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 62.5 m -106.19 -39.32 5.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.461 1.504 . . . . 0.0 112.914 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.5 -32.04 9.17 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -169.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.07 84.41 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -163.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.11 -22.84 18.83 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 120.885 1.352 . . . . 0.0 113.298 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -67.05 -31.05 71.3 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 118.146 -0.931 . . . . 0.0 111.823 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.77 -42.69 73.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 118.2 -0.905 . . . . 0.0 113.252 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -65.9 -39.11 90.31 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.052 0.842 . . . . 0.0 112.447 171.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -64.15 -33.42 75.74 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.736 -1.227 . . . . 0.0 112.743 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.78 -50.89 61.24 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.598 1.09 . . . . 0.0 112.046 169.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -51.31 -39.98 58.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.941 1.297 . . . . 0.0 112.124 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.2 t -81.83 -61.85 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.253 1.021 . . . . 0.0 113.242 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.9 37.41 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.949 -1.094 . . . . 0.0 113.645 -165.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.38 -35.21 73.37 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.693 -0.629 . . . . 0.0 110.57 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.4 -27.85 42.03 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.115 1.34 . . . . 0.0 115.237 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -65.97 -20.61 66.26 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -136.74 -25.02 1.13 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -154.79 85.07 1.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.904 1.681 . . . . 0.0 109.181 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -64.79 89.05 0.07 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.259 0.624 . . . . 0.0 110.332 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -90.36 112.82 54.95 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.371 1.468 . . . . 0.0 110.632 -169.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.07 136.09 24.13 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.377 2.051 . . . . 0.0 112.226 -166.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.3 mm -80.94 109.96 15.6 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.275 1.03 . . . . 0.0 108.233 159.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -71.44 159.36 51.72 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.036 1.824 . . . . 0.0 111.342 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.67 -14.94 56.61 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -63.2 -31.12 72.19 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.207 -0.933 . . . . 0.0 113.027 166.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.53 54.62 2.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.01 1.724 . . . . 0.0 111.139 168.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -21.22 63.8 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.333 1.053 . . . . 0.0 113.628 -162.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -74.55 -54.66 7.06 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.697 1.135 . . . . 0.0 109.637 164.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.0 -40.17 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.092 0.86 . . . . 0.0 112.505 -171.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.3 tp -63.38 -30.12 71.3 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.353 1.061 . . . . 0.0 113.322 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -94.37 -24.93 17.17 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.089 -1.007 . . . . 0.0 113.172 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.29 -37.22 86.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.403 1.081 . . . . 0.0 112.485 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 71.4 mt -63.91 -35.31 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.172 -0.955 . . . . 0.0 111.917 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -66.09 -32.51 74.02 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 119.854 -1.779 . . . . 0.0 112.462 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.85 -17.21 62.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.892 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.34 -24.07 67.52 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.422 1.465 . . . . 0.0 112.982 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -83.83 12.61 5.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.927 1.291 . . . . 0.0 113.238 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.9 p -135.87 174.95 10.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.286 1.834 . . . . 0.0 112.724 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.435 HH22 ' CD ' ' A' ' 32' ' ' GLU . 69.0 mtp85 58.59 173.52 0.06 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.612 1.965 . . . . 0.0 113.785 -172.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.425 ' OE1' ' HE3' ' A' ' 34' ' ' LYS . 18.4 mp0 -71.71 -37.91 70.58 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.205 1.002 . . . . 0.0 109.834 165.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 97.3 p -61.42 -30.56 70.64 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.377 1.871 . . . . 0.0 114.739 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -121.12 -46.69 2.3 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.114 0.87 . . . . 0.0 113.31 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.73 -33.22 71.35 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.732 -1.23 . . . . 0.0 113.351 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -70.96 -23.56 62.24 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.1 p -89.03 -3.55 58.66 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.767 0.827 . . . . 0.0 112.993 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.15 106.32 0.5 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.344 1.058 . . . . 0.0 110.574 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.54 141.48 48.47 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.396 0.678 . . . . 0.0 111.864 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.4 125.22 24.97 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.038 0.935 . . . . 0.0 111.575 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.51 -43.1 99.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -152.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.3 -35.38 75.44 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.882 0.873 . . . . 0.0 112.041 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -81.79 -10.49 59.33 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.917 1.287 . . . . 0.0 113.82 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.62 -46.85 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.595 -0.691 . . . . 0.0 109.909 164.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.51 -49.83 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.712 1.205 . . . . 0.0 111.258 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.15 66.58 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.5 -26.28 15.95 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.817 -0.991 . . . . 0.0 114.097 170.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -71.8 -35.55 70.01 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.119 1.46 . . . . 0.0 113.181 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -53.65 -51.99 71.27 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.57 -22.85 57.9 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.442 1.428 . . . . 0.0 112.832 172.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -83.9 3.99 31.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.814 1.645 . . . . 0.0 115.342 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.17 -23.82 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.198 -0.939 . . . . 0.0 110.678 152.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -102.37 -43.24 5.73 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.261 1.425 . . . . 0.0 112.802 172.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.338 0 C-N-CA 126.338 1.855 . . . . 0.0 113.864 -172.856 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtp . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.06 -170.28 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.479 1.112 . . . . 0.0 112.702 -162.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.2 mt -67.48 109.83 3.38 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.656 -1.277 . . . . 0.0 110.628 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -112.02 89.87 3.18 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.769 1.228 . . . . 0.0 109.953 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.9 mt -70.61 128.0 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -119.62 99.72 6.83 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.282 1.033 . . . . 0.0 109.122 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.21 143.19 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.025 1.33 . . . . 0.0 111.061 -157.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.517 ' N ' ' HG ' ' A' ' 23' ' ' CYS . 31.8 tttm -64.97 126.16 27.13 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.592 -0.692 . . . . 0.0 109.567 167.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.07 176.7 9.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.872 1.669 . . . . 0.0 111.868 169.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.4 141.9 18.63 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.409 -0.807 . . . . 0.0 112.037 163.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.8 t -55.79 122.09 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.852 -0.53 . . . . 0.0 109.94 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.91 -15.62 19.97 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.213 -1.326 . . . . 0.0 116.155 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.03 79.82 72.42 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 119.792 1.796 . . . . 0.0 112.003 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.61 -5.41 10.15 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.274 3.316 . . . . 0.0 115.735 -174.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -87.56 -6.67 58.22 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.413 1.485 . . . . 0.0 114.437 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.2 pt -142.04 163.84 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.766 1.167 . . . . 0.0 113.355 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.2 mt -82.88 -23.19 33.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -170.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 32.74 -126.63 0.3 Allowed Glycine 0 N--CA 1.477 1.392 0 C-N-CA 127.104 2.287 . . . . 0.0 117.331 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -62.75 5.84 0.11 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.306 2.642 . . . . 0.0 116.434 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.423 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 68.5 m -111.87 74.55 1.34 Allowed Pre-proline 0 C--O 1.253 1.276 0 O-C-N 119.836 -1.79 . . . . 0.0 110.959 -163.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.5 -28.04 45.97 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.189 2.593 . . . . 0.0 111.432 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -58.38 -42.22 86.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.098 1.759 . . . . 0.0 113.5 168.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.517 ' HG ' ' N ' ' A' ' 8' ' ' LYS . 83.7 m -65.98 -41.81 90.67 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.875 -1.766 . . . . 0.0 111.008 171.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -65.86 -27.11 67.99 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.26 1.024 . . . . 0.0 112.585 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -54.06 -45.27 71.66 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.51 1.124 . . . . 0.0 112.322 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.0 t -74.87 -27.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.431 1.092 . . . . 0.0 111.824 -170.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.8 mt -71.82 -45.8 60.25 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.847 -0.533 . . . . 0.0 111.113 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.58 -47.44 76.44 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.563 1.545 . . . . 0.0 113.489 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -68.22 -24.9 64.98 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.043 1.292 . . . . 0.0 113.973 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.75 -35.85 16.46 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.731 1.213 . . . . 0.0 112.63 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -70.98 -29.04 64.91 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' CD ' HH21 ' A' ' 189' ' ' ARG . 44.3 tp10 -66.0 -42.05 90.26 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.904 -1.123 . . . . 0.0 111.885 168.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -71.7 -11.28 60.75 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.715 1.606 . . . . 0.0 114.609 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm 64.76 3.24 1.94 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.565 1.946 . . . . 0.0 115.419 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.87 122.9 88.2 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 119.344 0.975 . . . . 0.0 111.035 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.45 151.43 53.43 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.374 2.05 . . . . 0.0 112.261 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -144.23 161.66 38.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.186 1.394 . . . . 0.0 111.04 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -99.11 126.21 44.82 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.302 1.041 . . . . 0.0 109.576 165.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 t -100.7 120.37 39.98 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.611 0.764 . . . . 0.0 111.655 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -103.37 85.98 2.57 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.158 1.783 . . . . 0.0 109.483 171.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.51 121.44 19.65 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.724 1.21 . . . . 0.0 111.653 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.4 mt -119.69 113.69 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.451 1.9 . . . . 0.0 109.838 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -81.21 98.08 7.92 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.218 -0.927 . . . . 0.0 109.865 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.6 mt 55.26 17.45 2.06 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 168.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.45 21.36 7.29 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.027 0.822 . . . . 0.0 114.901 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -65.12 12.09 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.488 1.644 . . . . 0.0 115.385 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -139.94 149.25 58.22 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.283 1.833 . . . . 0.0 110.339 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.4 174.08 5.63 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.086 2.524 . . . . 0.0 113.329 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -54.61 -21.22 9.82 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -55.17 -20.77 11.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.116 2.166 . . . . 0.0 115.798 171.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -104.73 -2.52 24.8 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.053 1.341 . . . . 0.0 113.447 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.62 -36.35 3.51 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.79 2.036 . . . . 0.0 112.252 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.47 -16.15 53.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.844 2.057 . . . . 0.0 114.921 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 31.0 mt -60.89 -32.14 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.232 1.813 . . . . 0.0 111.29 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.86 136.5 27.62 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 126.973 2.109 . . . . 0.0 110.322 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.07 -11.28 30.14 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.871 2.381 . . . . 0.0 114.797 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 12.04 6.65 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.259 2.224 . . . . 0.0 112.76 174.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.13 4.18 88.72 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 125.409 1.481 . . . . 0.0 116.39 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -88.1 91.82 8.92 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.396 1.598 . . . . 0.0 113.201 -172.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -59.93 144.1 86.74 Favored Pre-proline 0 N--CA 1.479 0.999 0 O-C-N 120.264 -1.523 . . . . 0.0 110.379 154.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 85.8 Cg_endo -75.78 139.77 62.69 Favored 'Cis proline' 0 CA--C 1.542 0.902 0 N-CA-C 116.858 1.83 . . . . 0.0 116.858 8.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -148.75 -178.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 128.282 2.633 . . . . 0.0 111.077 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.6 m -136.57 156.22 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.714 -1.241 . . . . 0.0 112.624 166.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -95.98 137.48 34.99 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.537 -0.727 . . . . 0.0 109.912 146.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.1 mt -101.0 95.73 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 163.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 55.67 52.97 10.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.822 1.249 . . . . 0.0 114.094 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 61.23 -5.06 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -169.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -80.41 113.81 18.86 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.389 1.449 . . . . 0.0 108.789 171.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -67.96 153.92 42.7 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -168.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -143.16 143.33 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 127.2 2.2 . . . . 0.0 108.503 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.6 -160.25 0.08 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.251 1.421 . . . . 0.0 113.75 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -62.22 166.99 4.37 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.995 2.118 . . . . 0.0 114.828 -163.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.8 p -55.81 -20.05 13.75 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -104.49 -19.37 14.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.298 -1.334 . . . . 0.0 113.514 -168.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.3 m -92.15 -16.52 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 155.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.09 -32.28 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.714 1.206 . . . . 0.0 112.712 175.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 p -65.6 -10.48 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.34 -58.57 0.91 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.391 0.996 . . . . 0.0 112.673 157.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.5 mt -75.83 -35.66 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.878 1.339 . . . . 0.0 113.775 -162.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 tp -75.65 -24.3 56.37 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.407 -1.433 . . . . 0.0 111.885 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -76.51 -42.04 44.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.066 0.946 . . . . 0.0 111.821 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 15.6 tt0 -56.36 -47.96 77.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.084 2.154 . . . . 0.0 112.69 171.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 99.3 mttt -90.85 6.04 46.0 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -171.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.66 140.94 59.6 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 121.367 -0.833 . . . . 0.0 111.324 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.63 -28.38 8.22 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.317 2.011 . . . . 0.0 112.33 168.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -80.2 160.6 67.78 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.529 1.132 . . . . 0.0 111.379 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -55.92 126.49 22.57 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.53 2.153 . . . . 0.0 114.349 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -59.81 139.38 88.12 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.45 2.767 . . . . 0.0 112.837 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.64 9.23 17.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.284 1.433 . . . . 0.0 112.744 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.08 -16.7 64.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.4 m -58.38 120.79 47.29 Favored Pre-proline 0 N--CA 1.472 0.675 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.169 -170.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.6 121.89 5.3 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.373 2.049 . . . . 0.0 111.121 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.32 177.42 7.32 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.919 2.412 . . . . 0.0 111.236 162.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.19 -27.47 65.73 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.289 -1.507 . . . . 0.0 112.954 163.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -60.94 -19.64 61.11 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.554 -1.341 . . . . 0.0 113.722 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.77 78.81 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.956 -1.09 . . . . 0.0 113.095 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.4 p -76.84 3.24 12.41 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.111 1.323 . . . . 0.0 114.349 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.4 t -120.61 -39.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.956 1.303 . . . . 0.0 110.798 170.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.89 -30.54 69.92 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.961 1.267 . . . . 0.0 114.329 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 62.6 p -68.11 -19.46 64.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.778 1.289 . . . . 0.0 114.044 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -89.97 -41.37 11.78 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.785 1.234 . . . . 0.0 111.895 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.96 -38.79 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.95 1.7 . . . . 0.0 111.079 174.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.54 -45.37 99.86 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -85.73 -34.46 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.306 2.671 . . . . 0.0 114.696 166.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -68.0 -33.2 74.15 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 121.304 1.865 . . . . 0.0 113.051 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -77.37 -27.73 52.64 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.208 -1.557 . . . . 0.0 113.098 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.7 t -71.95 -32.7 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 120.586 -1.321 . . . . 0.0 111.473 170.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -65.35 -38.1 89.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.413 1.085 . . . . 0.0 111.992 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -64.04 -25.01 67.92 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.955 1.302 . . . . 0.0 113.62 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.5 mt -87.94 10.54 18.47 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.558 1.543 . . . . 0.0 113.996 171.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -141.03 58.41 1.54 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.784 2.034 . . . . 0.0 109.357 165.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.6 p -58.98 27.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 1 C-N-CA 132.884 4.474 . . . . 0.0 118.461 -164.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.59 -26.2 57.66 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.16 1.784 . . . . 0.0 113.028 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -88.85 114.6 60.66 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 116.983 -1.484 . . . . 0.0 107.038 155.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -55.09 133.18 56.64 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.642 2.228 . . . . 0.0 115.011 -157.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -62.92 -34.68 77.96 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.359 -0.829 . . . . 0.0 112.437 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.17 -18.92 65.48 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.237 1.015 . . . . 0.0 113.684 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -96.13 -42.76 3.43 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.518 1.056 . . . . 0.0 112.844 165.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 86.0 m -62.8 -33.26 74.84 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.784 -0.833 . . . . 0.0 113.082 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.46 -26.37 68.48 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -70.24 -33.47 71.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.625 0.77 . . . . 0.0 110.765 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.9 -41.47 67.89 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.153 -0.967 . . . . 0.0 112.445 165.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 mt -62.2 -36.82 83.1 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.809 0.731 . . . . 0.0 112.923 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.3 mt -68.66 -38.77 80.69 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.251 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.95 -32.31 65.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.628 1.104 . . . . 0.0 112.535 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.5 -45.05 88.96 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.151 -0.968 . . . . 0.0 112.305 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -67.63 -36.11 80.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.894 -1.051 . . . . 0.0 112.952 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.05 -41.89 94.74 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.728 1.604 . . . . 0.0 112.134 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.11 -32.66 74.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.18 0.592 . . . . 0.0 112.346 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -73.07 -56.7 4.76 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.323 1.049 . . . . 0.0 111.533 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.06 -35.92 82.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.029 1.732 . . . . 0.0 114.131 -171.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.51 -32.93 74.47 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.947 0.784 . . . . 0.0 113.56 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -96.62 -28.14 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 47.1 mt -64.52 -32.47 74.12 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.114 1.324 . . . . 0.0 113.043 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -64.99 -14.69 60.97 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.55 -35.33 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.14 0.976 . . . . 0.0 111.856 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -83.58 -26.89 29.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.132 0.973 . . . . 0.0 113.458 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 107.08 -99.27 1.4 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-O 117.339 -1.812 . . . . 0.0 114.746 163.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.51 -33.4 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.004 3.136 . . . . 0.0 117.257 -151.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -129.8 158.83 38.36 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.669 1.577 . . . . 0.0 112.98 -169.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.0 tp -71.56 -8.13 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.34 -4.89 28.23 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 166.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.5 -135.05 8.2 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 120.093 1.315 . . . . 0.0 113.948 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -18.99 62.26 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.407 1.483 . . . . 0.0 113.928 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -136.39 153.94 50.96 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.723 1.609 . . . . 0.0 110.953 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.61 109.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.5 1.12 . . . . 0.0 109.508 162.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.3 p -137.65 -164.19 1.56 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.564 1.546 . . . . 0.0 110.44 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.16 -25.19 4.94 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -164.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.7 t -77.29 -40.73 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.789 1.177 . . . . 0.0 112.661 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -57.55 -48.4 79.43 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.868 -1.145 . . . . 0.0 111.685 165.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.4 mt -63.7 -9.07 12.23 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.22 1.008 . . . . 0.0 113.533 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 56.5 m -108.94 -34.18 6.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.469 1.507 . . . . 0.0 113.181 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 48.2 mt -108.91 -30.91 7.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.07 89.45 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -164.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.2 -20.09 16.81 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.333 1.355 . . . . 0.0 113.752 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -70.24 -31.86 69.44 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.998 -1.064 . . . . 0.0 112.075 172.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.99 -39.93 79.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.737 0.699 . . . . 0.0 112.303 171.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -64.82 -41.79 95.48 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.446 -0.784 . . . . 0.0 113.067 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -66.04 -32.13 73.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.869 -1.144 . . . . 0.0 112.428 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.6 tp -64.55 -50.83 65.75 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.379 0.99 . . . . 0.0 111.103 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -55.52 -54.51 43.11 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.399 1.479 . . . . 0.0 111.823 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.56 -51.1 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.8 -50.9 13.84 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.564 -0.71 . . . . 0.0 111.953 -169.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 7.0 tp -66.32 -28.42 68.67 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.888 -0.508 . . . . 0.0 111.598 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.82 -23.45 22.36 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.524 1.535 . . . . 0.0 115.677 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -67.13 -21.22 65.84 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -134.95 -28.15 1.21 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -152.21 84.78 1.26 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.227 1.811 . . . . 0.0 109.566 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -63.65 95.89 0.11 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.125 0.57 . . . . 0.0 109.985 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -91.15 109.35 34.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.874 1.27 . . . . 0.0 110.816 -167.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.62 135.8 22.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.456 2.104 . . . . 0.0 112.046 -167.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.3 mm -81.53 112.14 31.42 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.449 1.1 . . . . 0.0 108.576 162.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -69.27 157.37 61.6 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.09 1.86 . . . . 0.0 112.152 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -59.09 -23.15 61.82 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -64.95 -26.43 68.3 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 171.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.22 53.75 2.57 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.935 1.694 . . . . 0.0 111.006 167.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -21.64 63.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.147 0.979 . . . . 0.0 113.464 -160.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -76.39 -52.17 10.41 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.81 1.186 . . . . 0.0 110.355 165.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.58 -40.72 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 119.816 1.189 . . . . 0.0 112.068 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.35 -32.4 73.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.379 1.071 . . . . 0.0 113.004 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -82.17 -33.49 29.48 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.973 -1.079 . . . . 0.0 113.133 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -64.47 -36.62 84.78 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.291 1.036 . . . . 0.0 112.641 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.19 -29.13 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 120.931 -1.105 . . . . 0.0 112.29 173.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -69.05 -31.12 69.67 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 119.755 -1.841 . . . . 0.0 112.274 170.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.38 -21.59 64.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 117.914 -1.041 . . . . 0.0 113.148 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.5 -23.18 65.73 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.447 1.021 . . . . 0.0 112.797 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -91.33 17.59 8.21 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.485 1.514 . . . . 0.0 113.636 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 p -140.89 177.25 8.17 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.136 2.174 . . . . 0.0 112.779 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.432 HH21 ' CD ' ' A' ' 32' ' ' GLU . 68.6 mtp85 57.87 177.42 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.407 1.883 . . . . 0.0 113.448 -172.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -75.02 -40.3 60.59 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.341 1.056 . . . . 0.0 110.084 162.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 92.2 p -57.43 -30.43 64.99 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.431 1.892 . . . . 0.0 114.531 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -122.97 -45.61 2.13 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -61.76 -32.43 72.68 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.675 -1.266 . . . . 0.0 113.356 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.12 -24.08 63.14 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.4 p -91.64 -2.36 57.1 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.367 1.067 . . . . 0.0 113.272 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -60.7 103.16 0.23 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.945 1.298 . . . . 0.0 110.268 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.72 144.23 51.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.591 0.756 . . . . 0.0 112.008 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.47 131.34 49.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.714 0.806 . . . . 0.0 111.529 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -71.78 -44.01 64.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.251 1.42 . . . . 0.0 113.469 -149.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -60.76 -32.9 72.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.628 1.171 . . . . 0.0 112.039 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -84.99 -6.85 59.33 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.3 t -75.99 -48.76 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 119.155 0.889 . . . . 0.0 109.417 159.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 70.4 mt -63.76 -52.79 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.496 1.118 . . . . 0.0 111.872 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.23 -26.4 68.1 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.17 -22.68 40.52 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.654 -1.081 . . . . 0.0 113.845 172.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -76.37 -35.66 58.57 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.058 1.429 . . . . 0.0 113.524 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -50.29 -51.9 59.16 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.29 -21.46 54.55 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.58 1.52 . . . . 0.0 113.182 174.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -87.04 6.04 34.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.345 1.858 . . . . 0.0 115.461 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.26 -15.83 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 120.917 -1.114 . . . . 0.0 110.815 149.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -115.74 -24.56 8.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.944 1.698 . . . . 0.0 114.946 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.143 -1.884 . . . . 0.0 115.91 -170.347 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtp . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.87 -168.89 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.516 1.127 . . . . 0.0 112.408 -163.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.5 mt -66.9 104.28 1.33 Allowed 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.557 -1.34 . . . . 0.0 111.204 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -104.34 91.08 3.76 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.496 1.118 . . . . 0.0 109.587 168.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.4 mt -69.55 131.98 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -121.39 113.67 20.2 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.778 0.831 . . . . 0.0 108.785 173.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.6 142.26 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.033 -1.042 . . . . 0.0 110.696 -156.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.633 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 32.7 tttm -63.73 127.32 30.84 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.737 -0.602 . . . . 0.0 109.472 169.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.83 175.54 9.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.204 1.801 . . . . 0.0 111.882 169.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.53 140.65 33.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.617 0.767 . . . . 0.0 111.32 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.4 t -55.77 120.17 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 120.979 0.419 . . . . 0.0 110.012 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.37 -13.01 29.83 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 118.167 -1.352 . . . . 0.0 116.297 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.26 77.35 75.68 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 119.838 1.819 . . . . 0.0 112.004 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.16 -11.99 24.61 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.239 3.293 . . . . 0.0 115.859 -173.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -80.22 -8.46 59.46 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.623 1.569 . . . . 0.0 114.52 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 pt -141.92 165.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.595 1.158 . . . . 0.0 112.591 -172.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.5 mt -75.46 -44.36 44.65 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.08 -129.93 12.96 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.75 1.167 . . . . 0.0 114.882 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.12 17.29 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.928 3.291 . . . . 0.0 117.087 -173.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.416 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 90.4 p -116.59 71.52 5.03 Favored Pre-proline 0 C--O 1.25 1.11 0 O-C-N 119.925 -1.734 . . . . 0.0 110.99 -161.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.0 -26.96 30.65 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.411 2.741 . . . . 0.0 111.931 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -60.19 -41.22 92.48 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.324 1.45 . . . . 0.0 112.797 167.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.633 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.2 m -66.11 -41.07 91.06 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.713 -1.867 . . . . 0.0 111.011 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -62.81 -29.33 70.64 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 117.489 -1.244 . . . . 0.0 112.633 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -52.43 -46.65 66.47 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.6 1.091 . . . . 0.0 112.842 172.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 t -75.43 -35.01 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.536 1.135 . . . . 0.0 111.592 -169.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.01 -44.17 80.98 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.477 0.711 . . . . 0.0 111.161 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 tp -57.14 -48.96 77.39 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.368 1.467 . . . . 0.0 112.993 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.14 -24.98 65.05 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.4 mt -90.7 -35.51 14.88 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.723 1.209 . . . . 0.0 112.95 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.57 -25.27 63.0 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.976 -1.077 . . . . 0.0 113.712 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' CD ' HH22 ' A' ' 189' ' ' ARG . 42.1 tp10 -69.97 -39.78 75.76 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.696 -1.252 . . . . 0.0 112.384 167.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -69.13 -15.71 63.48 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.999 1.32 . . . . 0.0 114.229 171.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HE3' ' OE1' ' A' ' 190' ' ' GLU . 32.0 mmtm 65.0 0.91 1.32 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.572 1.949 . . . . 0.0 115.326 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.8 tt -68.03 126.67 92.93 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.026 0.93 . . . . 0.0 111.001 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.54 150.71 57.88 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.311 2.007 . . . . 0.0 112.411 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -145.27 163.94 32.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.592 1.557 . . . . 0.0 110.483 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -101.77 132.29 47.59 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.622 1.169 . . . . 0.0 109.608 163.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -106.11 115.76 30.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.751 0.82 . . . . 0.0 111.356 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -99.37 84.27 2.97 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.758 1.623 . . . . 0.0 109.757 171.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.93 130.53 43.58 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.638 0.775 . . . . 0.0 110.734 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 mt -128.97 114.84 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.642 1.977 . . . . 0.0 109.709 -170.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -83.27 96.95 8.63 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.527 -0.733 . . . . 0.0 109.53 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.0 mt 53.82 26.74 6.36 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 168.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.73 23.6 9.91 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 115.419 0.928 . . . . 0.0 115.419 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.31 12.29 0.05 Allowed 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -143.13 149.94 50.58 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.904 2.082 . . . . 0.0 110.077 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.82 168.84 8.04 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.866 2.377 . . . . 0.0 112.936 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -60.78 -14.6 22.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 116.455 -1.736 . . . . 0.0 115.319 -172.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -53.82 -20.24 5.5 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.327 2.251 . . . . 0.0 116.026 165.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -106.26 0.53 25.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.861 1.664 . . . . 0.0 113.275 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.5 mt -124.01 -40.09 2.32 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.495 2.318 . . . . 0.0 112.378 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.21 -14.27 16.74 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.333 2.253 . . . . 0.0 114.631 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.6 mt -64.31 -29.45 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 126.829 2.052 . . . . 0.0 111.434 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.8 t -91.28 139.28 25.43 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 123.661 0.784 . . . . 0.0 109.831 160.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -65.84 -14.51 44.94 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.709 2.273 . . . . 0.0 113.459 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.28 7.74 44.21 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.528 1.131 . . . . 0.0 113.212 173.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.95 11.21 73.99 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 120.704 -1.247 . . . . 0.0 114.844 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.28 162.71 23.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.625 1.57 . . . . 0.0 112.995 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.88 149.52 70.77 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 126.365 1.866 . . . . 0.0 107.653 156.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.13 144.32 72.75 Favored 'Cis proline' 0 CA--C 1.54 0.802 0 N-CA-C 117.202 1.962 . . . . 0.0 117.202 12.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 m -153.97 178.35 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 129.168 2.987 . . . . 0.0 110.82 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.0 m -139.34 153.02 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 120.827 -1.171 . . . . 0.0 112.739 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -96.83 130.36 44.11 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.6 -0.688 . . . . 0.0 109.246 148.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.17 85.51 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.5 t70 58.18 57.7 3.86 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.056 0.932 . . . . 0.0 113.027 -170.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.281 75.1 m-20 62.15 -4.35 0.21 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -83.5 108.83 16.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.959 1.304 . . . . 0.0 109.697 170.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -65.0 152.81 42.45 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.9 t -143.8 132.79 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.728 2.011 . . . . 0.0 108.955 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.77 -166.48 0.11 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.093 1.757 . . . . 0.0 113.774 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.31 157.48 0.97 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -158.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.2 p -52.22 -22.88 4.79 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.81 -10.64 44.69 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.73 -16.9 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.324 1.05 . . . . 0.0 113.205 162.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mt -55.1 -34.35 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.227 1.411 . . . . 0.0 112.828 168.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.95 -12.64 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.1 -57.9 0.71 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.829 0.728 . . . . 0.0 112.401 158.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.75 -34.83 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.235 -1.156 . . . . 0.0 113.577 -162.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.9 tp -76.86 -30.37 56.25 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.804 -1.185 . . . . 0.0 111.881 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.63 -41.71 68.51 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.689 0.796 . . . . 0.0 111.587 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -66.72 -42.78 85.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.273 1.829 . . . . 0.0 112.972 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.5 3.64 35.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.98 145.34 80.92 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 121.054 -1.029 . . . . 0.0 111.011 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.83 -26.87 12.96 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.318 2.012 . . . . 0.0 112.596 165.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -82.88 166.76 33.88 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.545 1.538 . . . . 0.0 111.864 173.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.84 132.84 52.25 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.522 2.148 . . . . 0.0 114.785 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -65.96 127.31 17.46 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.363 2.709 . . . . 0.0 112.968 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.7 mt -96.59 11.23 35.99 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.174 1.39 . . . . 0.0 112.621 174.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.16 -20.64 66.55 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.2 m -59.33 118.92 34.68 Favored Pre-proline 0 N--CA 1.474 0.774 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.377 -166.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.63 120.49 5.57 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.721 2.281 . . . . 0.0 110.827 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.81 -179.45 4.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.713 2.275 . . . . 0.0 111.056 166.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -53.74 -36.85 62.77 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.663 -1.273 . . . . 0.0 112.919 166.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.76 -18.91 57.66 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.881 1.672 . . . . 0.0 114.441 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.92 -30.4 70.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.71 1.141 . . . . 0.0 112.485 173.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -66.93 -14.31 62.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.937 1.295 . . . . 0.0 114.461 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.35 -37.95 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.013 1.325 . . . . 0.0 111.242 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.62 -31.42 74.97 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.194 1.378 . . . . 0.0 113.904 171.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.8 p -68.82 -16.94 63.92 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.944 1.372 . . . . 0.0 113.921 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -91.7 -44.89 8.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.088 1.355 . . . . 0.0 111.727 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.74 -41.17 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.629 1.572 . . . . 0.0 111.035 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.96 -42.73 92.01 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -85.93 -33.76 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.069 2.513 . . . . 0.0 114.845 166.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 77.1 p -68.58 -33.86 74.81 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.172 1.805 . . . . 0.0 112.867 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -75.84 -25.3 56.13 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.394 -1.441 . . . . 0.0 112.767 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.27 -34.48 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.49 -1.381 . . . . 0.0 111.312 167.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -64.9 -38.88 92.45 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.16 0.891 . . . . 0.0 111.99 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -63.73 -25.85 68.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.673 1.589 . . . . 0.0 113.749 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 mt -87.41 11.02 15.61 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.455 1.502 . . . . 0.0 113.966 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -141.9 65.81 1.36 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.728 1.611 . . . . 0.0 110.058 167.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -63.0 25.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 130.602 3.561 . . . . 0.0 118.026 -160.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -75.72 -27.36 58.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.718 1.607 . . . . 0.0 112.143 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.21 113.07 20.08 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-O 117.002 -1.475 . . . . 0.0 107.123 147.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -62.53 120.57 8.17 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 120.764 1.309 . . . . 0.0 112.674 -165.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -54.2 -35.05 61.95 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.71 -18.78 65.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.173 0.989 . . . . 0.0 113.325 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.81 -46.06 4.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.331 0.967 . . . . 0.0 112.561 163.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 m -59.64 -36.68 76.85 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.003 0.921 . . . . 0.0 112.783 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -60.99 -28.5 69.06 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.726 1.21 . . . . 0.0 113.506 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -67.31 -40.15 85.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.678 0.791 . . . . 0.0 110.354 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.12 75.09 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.319 -0.863 . . . . 0.0 112.859 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.4 mt -62.27 -37.85 87.06 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.838 0.744 . . . . 0.0 112.336 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -69.16 -36.75 77.71 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.419 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.31 -35.06 73.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.952 1.251 . . . . 0.0 112.729 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -64.25 -44.83 90.56 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.213 -0.929 . . . . 0.0 112.302 171.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.1 mt -68.37 -35.88 78.36 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.093 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -64.24 -45.1 89.64 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.822 1.646 . . . . 0.0 112.18 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.1 79.17 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.436 0.695 . . . . 0.0 112.258 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.0 tp -70.78 -58.02 4.06 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.509 1.124 . . . . 0.0 111.927 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.32 -35.06 79.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.496 1.518 . . . . 0.0 113.99 -169.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.46 87.14 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.433 -0.648 . . . . 0.0 113.509 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -91.74 -25.7 18.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.824 0.85 . . . . 0.0 113.176 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.6 mt -66.42 -33.5 75.85 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.729 -1.232 . . . . 0.0 113.281 172.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -63.88 -16.61 61.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 173.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.55 -36.38 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.122 0.969 . . . . 0.0 111.898 170.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -77.8 -25.57 49.03 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.7 -106.42 3.18 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 117.343 -1.809 . . . . 0.0 114.952 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.41 -30.58 1.11 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.437 2.758 . . . . 0.0 116.773 -144.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -133.09 160.1 38.16 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.976 1.262 . . . . 0.0 112.443 -169.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.2 tt -78.15 -5.07 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -167.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.02 -3.57 44.66 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.917 1.687 . . . . 0.0 114.776 160.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 119.34 -125.61 6.43 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.58 1.562 . . . . 0.0 113.359 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -58.6 -29.31 66.36 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -141.89 155.12 45.52 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.67 1.588 . . . . 0.0 109.825 -160.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.2 mt -70.48 105.26 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 167.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.8 p -134.87 -164.95 1.59 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.261 1.024 . . . . 0.0 110.764 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.67 -24.62 1.43 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.1 t -78.22 -42.12 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 120.012 1.278 . . . . 0.0 112.578 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.11 -47.38 83.44 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.199 1.363 . . . . 0.0 112.164 166.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.7 mt -61.21 -19.59 61.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.607 0.763 . . . . 0.0 112.773 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.9 m -93.74 -48.49 6.29 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.013 1.325 . . . . 0.0 112.47 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.4 mt -94.89 -34.56 12.38 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -162.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.3 -49.98 85.13 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -170.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.1 -21.75 17.72 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 120.649 1.268 . . . . 0.0 113.835 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -77.64 -27.75 51.14 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.002 -1.061 . . . . 0.0 112.697 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.21 -38.14 75.22 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.549 0.74 . . . . 0.0 112.243 166.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -63.29 -42.84 99.11 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.496 -0.752 . . . . 0.0 112.556 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -69.61 -28.65 66.12 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.907 -1.121 . . . . 0.0 113.352 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.2 tp -66.08 -52.56 47.62 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.105 0.962 . . . . 0.0 110.895 171.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -59.1 -51.12 71.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.571 1.548 . . . . 0.0 111.968 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.1 t -79.08 -53.79 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.55 -50.88 14.29 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.478 -0.764 . . . . 0.0 111.97 -167.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.29 -25.6 66.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 119.194 -0.431 . . . . 0.0 111.873 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.25 -23.43 25.65 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.52 1.533 . . . . 0.0 115.753 174.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -66.67 -19.6 65.8 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -135.52 -31.97 0.94 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -147.02 82.81 1.57 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.949 1.699 . . . . 0.0 109.391 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -63.87 90.9 0.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.758 0.823 . . . . 0.0 110.053 168.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -86.58 115.04 60.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.378 1.071 . . . . 0.0 111.164 -164.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.76 135.94 24.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.385 2.057 . . . . 0.0 112.128 -168.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.08 110.88 41.43 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.46 1.104 . . . . 0.0 108.413 161.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -66.19 156.64 63.88 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.888 1.725 . . . . 0.0 112.183 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.36 -22.08 52.27 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.761 1.624 . . . . 0.0 114.516 174.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -61.5 -29.46 70.0 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.038 -1.039 . . . . 0.0 112.859 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 89.8 mt -85.23 54.9 3.27 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.974 1.71 . . . . 0.0 111.286 170.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.17 -23.59 63.01 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.209 1.003 . . . . 0.0 113.532 -160.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -74.78 -53.68 8.72 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.173 0.897 . . . . 0.0 109.606 167.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.74 -39.15 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 119.777 1.171 . . . . 0.0 112.189 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.44 -35.22 79.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.8 0.84 . . . . 0.0 112.729 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.91 -28.55 35.83 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.046 -1.034 . . . . 0.0 113.179 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -68.08 -34.02 75.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.157 0.983 . . . . 0.0 112.744 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.21 -33.54 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.031 -1.043 . . . . 0.0 111.784 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -70.01 -28.94 65.9 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 119.751 -1.843 . . . . 0.0 112.498 172.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.34 -21.74 64.73 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.338 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.7 mt -60.84 -25.73 66.84 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.809 1.186 . . . . 0.0 112.855 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -89.43 13.66 13.17 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.271 1.428 . . . . 0.0 113.564 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.5 p -136.52 174.74 10.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.733 2.013 . . . . 0.0 112.638 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.443 HH22 ' CD ' ' A' ' 32' ' ' GLU . 70.9 mtp85 57.92 175.36 0.06 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.614 1.966 . . . . 0.0 113.73 -173.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.427 ' OE1' ' HE3' ' A' ' 34' ' ' LYS . 18.3 mp0 -72.96 -38.22 66.81 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 124.587 1.155 . . . . 0.0 109.902 164.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.7 p -60.56 -32.51 71.59 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.165 1.786 . . . . 0.0 114.486 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -121.39 -43.87 2.39 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.88 1.066 . . . . 0.0 113.88 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -60.63 -31.56 70.74 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.626 -1.296 . . . . 0.0 112.899 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -73.51 -21.59 60.36 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.1 p -93.59 -1.59 55.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.015 1.326 . . . . 0.0 113.425 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -59.33 98.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.81 1.644 . . . . 0.0 110.45 172.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.36 140.89 45.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.76 0.824 . . . . 0.0 111.711 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.26 125.04 20.96 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.805 0.842 . . . . 0.0 111.896 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -68.51 -44.9 73.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.06 1.344 . . . . 0.0 113.612 -149.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -63.43 -29.18 70.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.532 1.133 . . . . 0.0 112.331 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -82.87 -13.18 56.62 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.5 t -73.49 -45.89 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.298 0.954 . . . . 0.0 109.503 163.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.57 -53.15 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.332 1.053 . . . . 0.0 111.572 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.33 -29.98 70.29 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.91 -24.49 57.86 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.709 -1.245 . . . . 0.0 113.619 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -78.33 -32.4 49.15 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.283 1.433 . . . . 0.0 113.98 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -47.7 -53.6 29.62 Favored Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.39 -19.41 49.48 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.656 1.571 . . . . 0.0 113.54 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -85.06 5.49 29.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.348 1.859 . . . . 0.0 115.052 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.76 -20.59 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.55 -0.719 . . . . 0.0 110.997 152.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -101.95 -31.74 10.53 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.807 1.243 . . . . 0.0 114.296 168.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.167 0 C-N-CA 126.726 2.01 . . . . 0.0 113.696 -176.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.6 -167.08 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.154 0.981 . . . . 0.0 112.055 -162.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.6 mt -65.69 109.16 2.32 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.555 -1.34 . . . . 0.0 111.003 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -111.46 92.96 4.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.212 1.006 . . . . 0.0 109.471 167.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.4 mt -69.92 132.7 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.107 0.963 . . . . 0.0 108.459 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.5 m -120.13 114.94 22.7 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.96 141.25 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.073 -1.017 . . . . 0.0 110.863 -157.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.614 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 31.8 tttm -63.16 126.18 26.52 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 169.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.87 174.71 10.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.022 1.729 . . . . 0.0 111.733 168.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.94 140.58 30.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.681 0.792 . . . . 0.0 111.48 167.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.33 122.14 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 122.003 -0.435 . . . . 0.0 110.053 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.83 -17.82 10.47 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.389 -1.228 . . . . 0.0 115.995 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.8 79.99 67.55 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 119.587 1.694 . . . . 0.0 112.2 -172.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.87 -12.98 34.48 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.639 2.892 . . . . 0.0 116.362 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -78.25 -9.04 59.05 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.3 pt -142.89 163.68 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.927 1.291 . . . . 0.0 112.132 -167.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 mt -78.56 -41.93 30.62 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.08 -126.42 7.17 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.876 1.227 . . . . 0.0 114.494 -174.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -60.35 12.08 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 129.468 3.107 . . . . 0.0 117.455 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -113.57 71.56 1.74 Allowed Pre-proline 0 C--O 1.262 1.716 0 O-C-N 119.61 -1.931 . . . . 0.0 110.954 -161.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -69.47 -23.07 32.53 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 123.77 2.98 . . . . 0.0 112.296 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -67.34 -38.51 84.96 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.799 1.239 . . . . 0.0 112.757 169.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.2 m -64.85 -42.47 94.87 Favored 'General case' 0 C--N 1.374 1.658 0 O-C-N 119.931 -1.731 . . . . 0.0 110.99 169.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -62.16 -26.28 68.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 117.627 -1.178 . . . . 0.0 112.817 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -53.6 -47.6 70.04 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.58 1.082 . . . . 0.0 112.899 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.54 -33.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.465 1.106 . . . . 0.0 111.498 -167.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.7 mt -69.41 -40.59 77.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.739 0.815 . . . . 0.0 111.351 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.77 -48.11 82.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.321 1.449 . . . . 0.0 113.246 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 96.9 p -65.25 -38.5 90.51 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.649 1.113 . . . . 0.0 112.884 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.18 -33.19 38.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.782 0.833 . . . . 0.0 112.769 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -73.41 -30.04 62.98 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 171.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 189' ' ' ARG . 38.7 tp10 -66.14 -41.38 90.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.837 -1.164 . . . . 0.0 111.747 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -70.85 -9.85 58.41 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm 62.33 1.8 0.77 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.186 1.794 . . . . 0.0 115.288 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.52 127.15 92.28 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.362 1.065 . . . . 0.0 110.618 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.45 147.21 64.39 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.118 1.878 . . . . 0.0 112.026 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.37 162.56 36.99 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.604 1.561 . . . . 0.0 110.322 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -101.11 137.28 39.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.609 1.564 . . . . 0.0 109.139 165.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -112.35 122.11 46.79 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.559 0.744 . . . . 0.0 111.323 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -107.77 86.26 2.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.804 1.642 . . . . 0.0 109.573 174.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.1 mt -70.4 126.69 30.35 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.381 1.073 . . . . 0.0 111.395 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.0 mt -126.75 112.2 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.444 1.898 . . . . 0.0 109.698 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -81.36 104.87 12.1 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.425 -0.797 . . . . 0.0 109.813 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.9 mt 52.29 23.67 2.51 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.79 23.78 10.52 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.224 0.85 . . . . 0.0 115.224 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -65.01 20.16 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -140.49 155.55 69.78 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 126.268 1.827 . . . . 0.0 110.679 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -60.16 167.51 7.44 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.121 1.881 . . . . 0.0 112.304 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -58.42 -15.75 12.07 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -56.37 -12.91 1.86 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.882 2.473 . . . . 0.0 116.015 171.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -117.24 -1.48 11.81 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.344 2.258 . . . . 0.0 113.416 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.0 mt -123.29 -38.68 2.54 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.557 2.343 . . . . 0.0 112.497 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.89 -13.99 7.83 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.575 2.35 . . . . 0.0 114.568 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -64.98 -29.67 48.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.453 2.301 . . . . 0.0 111.594 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.3 t -99.27 136.32 20.5 Favored Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 123.468 0.707 . . . . 0.0 109.224 160.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.31 -14.15 42.98 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.629 2.219 . . . . 0.0 113.233 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -89.55 1.55 55.8 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.872 1.269 . . . . 0.0 113.241 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.66 11.96 82.86 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.016 1.293 . . . . 0.0 115.354 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -84.81 162.52 19.53 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.096 1.358 . . . . 0.0 112.887 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.34 148.19 66.69 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 126.484 1.914 . . . . 0.0 107.898 157.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -78.27 145.18 77.23 Favored 'Cis proline' 0 CA--C 1.539 0.768 0 N-CA-C 116.877 1.837 . . . . 0.0 116.877 12.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.3 m -154.97 176.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 128.809 2.843 . . . . 0.0 110.564 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.45 149.58 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 O-C-N 120.565 -1.334 . . . . 0.0 113.761 172.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -95.54 126.06 40.56 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.364 1.065 . . . . 0.0 109.553 153.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.1 mt -100.17 76.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.277 1.431 . . . . 0.0 108.952 175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 58.45 60.53 2.56 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.19 0.995 . . . . 0.0 111.867 -163.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.307 61.3 m-20 64.64 -7.8 0.24 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -76.32 117.59 18.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.873 1.669 . . . . 0.0 109.884 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -69.53 143.19 53.49 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.6 t -138.3 131.34 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.832 1.653 . . . . 0.0 108.878 160.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.01 -154.83 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.222 1.809 . . . . 0.0 113.205 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.4 157.06 0.54 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -158.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.0 p -49.81 -25.55 3.19 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.879 1.671 . . . . 0.0 114.917 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -97.44 -10.15 25.96 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.8 1.24 . . . . 0.0 113.671 -171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.57 -21.82 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.159 0.984 . . . . 0.0 112.698 158.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.12 -37.98 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.965 1.706 . . . . 0.0 112.838 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.48 -16.93 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.0 -53.27 0.75 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.062 0.839 . . . . 0.0 113.268 160.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -71.33 -36.88 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.477 1.138 . . . . 0.0 113.312 -163.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.2 tp -73.89 -35.83 64.73 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.246 0.93 . . . . 0.0 111.391 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -71.68 -36.06 70.49 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.66 -32.37 73.83 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.566 1.546 . . . . 0.0 112.843 168.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -98.96 8.87 44.58 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.795 1.238 . . . . 0.0 113.085 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.43 137.03 34.64 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.92 0.888 . . . . 0.0 110.621 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.09 -29.8 17.15 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 121.669 1.58 . . . . 0.0 112.376 168.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -85.91 141.19 35.46 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 118.567 0.622 . . . . 0.0 111.76 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.2 128.89 26.75 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.778 2.985 . . . . 0.0 115.792 -160.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -57.81 143.45 95.55 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.206 2.604 . . . . 0.0 114.966 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.4 mt -110.49 0.94 17.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.989 2.116 . . . . 0.0 112.516 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.14 -13.11 62.23 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.964 1.705 . . . . 0.0 115.33 -176.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.2 m -65.2 122.14 78.23 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-O 118.287 -0.864 . . . . 0.0 109.749 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.89 126.39 8.72 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.932 1.755 . . . . 0.0 110.788 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.18 167.44 23.67 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.1 1.866 . . . . 0.0 110.191 155.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -57.91 -26.15 61.8 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.725 -1.234 . . . . 0.0 113.665 165.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -55.44 -22.92 22.57 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.371 -1.455 . . . . 0.0 113.97 167.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.7 -24.19 67.49 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.509 -1.369 . . . . 0.0 113.903 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 p -73.56 -3.7 29.44 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.304 1.411 . . . . 0.0 113.988 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.92 -38.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.986 1.315 . . . . 0.0 111.042 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.36 75.69 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.084 -1.01 . . . . 0.0 114.497 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.8 p -68.2 -15.52 63.61 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -90.41 -42.44 10.9 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.935 1.294 . . . . 0.0 112.356 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.32 -32.43 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.134 1.374 . . . . 0.0 110.94 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.74 -55.57 44.44 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.292 -1.337 . . . . 0.0 113.929 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.2 -31.78 3.45 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.581 2.188 . . . . 0.0 113.983 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.2 p -68.13 -36.54 79.89 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.006 1.73 . . . . 0.0 112.934 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -76.33 -24.46 54.27 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.57 -1.331 . . . . 0.0 114.047 170.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.24 -34.7 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.381 -1.45 . . . . 0.0 111.305 169.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -67.01 -39.22 87.03 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.589 1.155 . . . . 0.0 112.069 171.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -61.78 -24.65 66.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.131 1.372 . . . . 0.0 114.145 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.4 mt -90.18 7.98 35.34 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.813 1.645 . . . . 0.0 114.103 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -137.83 66.66 1.44 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.351 1.46 . . . . 0.0 110.692 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -62.15 23.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 130.903 3.681 . . . . 0.0 118.324 -162.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.03 -29.57 65.53 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.379 1.472 . . . . 0.0 111.597 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -80.61 114.62 49.27 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 152.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -58.41 128.5 28.69 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.405 2.07 . . . . 0.0 114.271 -164.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -57.19 -42.45 81.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.449 1.1 . . . . 0.0 112.753 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -61.93 -24.35 66.92 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.54 -40.17 5.75 Favored Glycine 0 N--CA 1.474 1.209 0 O-C-N 121.156 -0.965 . . . . 0.0 112.494 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.2 m -61.56 -36.74 81.48 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.07 -27.26 68.23 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -68.97 -38.76 79.58 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.676 -0.64 . . . . 0.0 111.332 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.05 -37.39 78.53 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.873 -1.142 . . . . 0.0 112.659 171.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 mt -62.5 -39.64 94.15 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.508 0.595 . . . . 0.0 112.17 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.71 -44.12 87.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.44 -0.791 . . . . 0.0 112.042 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.56 -32.7 70.22 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.862 1.21 . . . . 0.0 112.842 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -64.44 -49.63 70.71 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.222 -0.924 . . . . 0.0 112.319 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.3 mt -68.25 -32.1 72.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.939 -1.029 . . . . 0.0 113.051 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -64.36 -45.55 87.27 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.627 1.558 . . . . 0.0 112.191 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.75 -31.49 72.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.113 0.565 . . . . 0.0 112.395 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 tp -75.71 -59.85 2.57 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.93 1.292 . . . . 0.0 111.822 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.25 -33.92 76.54 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.499 1.52 . . . . 0.0 114.148 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.74 -29.99 62.16 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.935 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -101.05 -26.9 13.54 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.18 -31.68 72.88 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.471 1.487 . . . . 0.0 113.328 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -64.57 -12.76 48.37 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.7 t -98.97 -35.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.911 1.284 . . . . 0.0 111.95 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -82.41 -22.05 35.5 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.04 -109.28 3.24 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-O 117.603 -1.665 . . . . 0.0 114.883 162.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.76 -30.26 3.93 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.151 3.234 . . . . 0.0 116.781 -149.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -132.45 160.23 37.04 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.201 1.364 . . . . 0.0 112.697 -169.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.8 tt -73.08 -8.21 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -171.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.92 -5.83 40.53 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 164.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 123.01 -129.97 7.64 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.966 1.257 . . . . 0.0 113.781 -175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -71.81 -20.41 61.85 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.589 1.556 . . . . 0.0 114.005 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -139.31 153.0 47.67 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.983 1.713 . . . . 0.0 109.973 -175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.91 105.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.771 0.828 . . . . 0.0 108.952 162.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.2 p -133.33 -164.86 1.54 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.722 1.209 . . . . 0.0 110.767 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.07 -24.26 3.75 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -165.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.27 -43.5 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.189 1.359 . . . . 0.0 112.663 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.78 -47.98 78.92 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.772 1.169 . . . . 0.0 111.834 167.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.39 -15.51 49.31 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.9 m -100.32 -36.11 9.37 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.642 1.577 . . . . 0.0 113.094 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.54 -32.85 6.55 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -165.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.26 97.81 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -167.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.69 -18.71 19.35 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.251 1.301 . . . . 0.0 114.464 175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -70.81 -32.99 70.25 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.712 -1.242 . . . . 0.0 111.773 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.4 -34.43 72.53 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -64.93 -44.6 88.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.518 0.675 . . . . 0.0 112.362 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -69.07 -28.76 66.8 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.082 -1.011 . . . . 0.0 113.197 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.93 -56.41 19.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.686 1.194 . . . . 0.0 110.835 168.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -61.39 -46.39 90.36 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.702 1.201 . . . . 0.0 111.753 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.2 t -80.0 -53.32 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.83 -52.79 9.6 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.544 -0.723 . . . . 0.0 112.106 -167.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 9.1 tp -69.28 -21.57 63.87 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.893 -0.504 . . . . 0.0 111.942 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -51.75 -28.41 23.01 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.579 1.561 . . . . 0.0 115.388 169.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -71.73 -15.65 62.2 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -136.92 -36.65 0.68 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -150.82 77.85 1.29 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.545 1.538 . . . . 0.0 109.199 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -59.18 103.24 0.16 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.873 0.469 . . . . 0.0 110.471 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -91.87 108.37 29.49 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.194 0.997 . . . . 0.0 110.964 -168.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.34 133.77 21.55 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.256 1.97 . . . . 0.0 111.39 -171.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 42.1 mm -74.18 114.8 36.74 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 159.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -69.73 158.8 55.73 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.058 1.839 . . . . 0.0 111.435 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.36 -22.54 61.49 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -64.29 -28.63 69.85 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.97 54.3 3.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.165 1.786 . . . . 0.0 110.964 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -22.11 62.82 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.491 1.116 . . . . 0.0 113.796 -161.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -75.29 -52.8 9.97 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.663 1.119 . . . . 0.0 109.92 166.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 92.3 t -60.72 -37.85 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 119.257 0.935 . . . . 0.0 112.345 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.411 ' O ' ' HE3' ' A' ' 184' ' ' LYS . 63.4 tp -62.6 -31.9 72.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.327 1.051 . . . . 0.0 113.059 174.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -89.16 -26.02 21.51 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.018 -1.051 . . . . 0.0 113.258 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -67.23 -35.06 78.79 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.244 1.017 . . . . 0.0 112.759 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.7 mt -61.14 -32.93 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 120.911 -1.118 . . . . 0.0 111.998 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 180' ' ' LEU . 70.1 mttt -69.84 -26.55 64.28 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.718 -1.863 . . . . 0.0 112.627 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.1 mt -70.02 -20.72 63.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.281 171.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.22 -24.67 67.98 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.666 1.121 . . . . 0.0 112.877 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -88.31 13.9 10.63 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.471 1.509 . . . . 0.0 113.024 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.7 p -137.56 176.71 8.46 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.116 1.766 . . . . 0.0 113.827 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 32' ' ' GLU . 68.5 mtp85 55.48 -173.1 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.211 1.804 . . . . 0.0 112.286 -169.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -79.03 -41.18 29.49 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.161 1.384 . . . . 0.0 109.866 162.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 92.7 p -57.41 -35.9 70.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.948 2.099 . . . . 0.0 114.586 -171.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -114.11 -43.44 3.23 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.06 -30.08 70.12 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.614 -1.304 . . . . 0.0 113.812 -177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.87 -17.5 55.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 20.0 p -100.37 -6.43 25.76 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.499 1.12 . . . . 0.0 113.42 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -51.24 104.03 0.07 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.258 1.823 . . . . 0.0 110.959 163.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -81.56 145.56 30.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.24 1.016 . . . . 0.0 112.142 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.55 120.55 8.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.312 1.045 . . . . 0.0 111.884 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -65.54 -42.44 91.94 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.61 1.564 . . . . 0.0 113.873 -151.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -31.63 72.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.127 0.971 . . . . 0.0 113.014 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -81.17 -11.99 59.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.1 t -70.74 -48.99 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.834 1.197 . . . . 0.0 109.43 162.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.5 mt -64.14 -53.93 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.447 1.099 . . . . 0.0 111.81 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.84 71.74 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -77.67 -23.95 66.1 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.92 -1.113 . . . . 0.0 113.477 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -79.67 -31.11 41.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.141 1.376 . . . . 0.0 114.144 174.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -47.97 -51.11 50.17 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.58 -20.08 47.61 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 121.846 1.697 . . . . 0.0 113.937 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -88.07 4.26 45.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.185 1.794 . . . . 0.0 114.923 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.02 -25.67 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 122.6 0.36 . . . . 0.0 110.572 151.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -91.88 -38.07 12.53 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 116.804 -1.569 . . . . 0.0 114.697 168.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.797 2.039 . . . . 0.0 113.49 -179.487 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.47 -174.63 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.069 1.348 . . . . 0.0 113.618 -168.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.05 116.92 17.22 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.908 -1.12 . . . . 0.0 110.871 -170.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -127.61 122.82 34.13 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.071 0.948 . . . . 0.0 110.98 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.8 mt -102.66 132.67 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.591 1.557 . . . . 0.0 108.731 -172.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.9 m -114.26 105.15 12.82 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.56 143.75 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.881 1.272 . . . . 0.0 110.785 -162.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.665 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.0 tttm -63.55 127.86 33.22 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.534 169.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.94 173.91 10.2 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.85 1.66 . . . . 0.0 112.117 168.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.28 138.72 20.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.324 1.049 . . . . 0.0 111.512 163.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.8 t -56.18 123.47 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 121.056 0.455 . . . . 0.0 109.942 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.87 -11.71 26.52 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 116.446 1.338 . . . . 0.0 116.446 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.81 78.38 73.78 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.978 1.889 . . . . 0.0 112.138 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.03 -13.13 38.05 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.6 2.867 . . . . 0.0 116.693 -168.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.02 -11.19 59.89 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.2 pt -141.06 162.32 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.598 1.159 . . . . 0.0 112.346 -164.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 mt -76.56 -44.53 34.33 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.31 -128.57 13.37 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.315 0.96 . . . . 0.0 114.774 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -63.04 16.88 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.392 3.077 . . . . 0.0 116.896 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -115.56 70.45 3.25 Favored Pre-proline 0 C--O 1.256 1.396 0 O-C-N 119.717 -1.864 . . . . 0.0 110.991 -162.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -68.5 -23.83 36.89 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 123.336 2.691 . . . . 0.0 112.046 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -65.09 -41.0 95.39 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.358 1.463 . . . . 0.0 112.935 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.5 m -64.29 -41.81 96.71 Favored 'General case' 0 C--N 1.373 1.611 0 O-C-N 119.762 -1.836 . . . . 0.0 110.991 170.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -62.75 -28.32 69.89 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 117.567 -1.206 . . . . 0.0 112.641 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -53.26 -46.5 69.25 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.507 1.049 . . . . 0.0 112.88 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.13 -40.77 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.345 1.058 . . . . 0.0 111.059 -170.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.6 mt -69.2 -37.34 78.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.825 0.85 . . . . 0.0 111.789 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.3 tp -59.4 -46.01 89.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.456 1.502 . . . . 0.0 113.209 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.41 -37.87 77.67 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.702 1.137 . . . . 0.0 113.03 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -75.35 -37.28 60.76 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.86 0.864 . . . . 0.0 113.11 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -72.87 -27.29 61.82 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -68.63 -41.18 79.81 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.745 -1.222 . . . . 0.0 111.522 169.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -68.74 -11.03 59.82 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.158 1.783 . . . . 0.0 115.058 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm 62.32 3.01 0.94 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 126.394 1.878 . . . . 0.0 115.331 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.8 tt -72.06 131.13 85.67 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.805 0.842 . . . . 0.0 110.786 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.93 147.02 73.54 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.192 1.928 . . . . 0.0 112.158 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -146.19 160.94 41.28 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.095 1.758 . . . . 0.0 109.526 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -101.17 128.69 47.15 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.955 0.902 . . . . 0.0 109.551 166.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.9 t -104.7 128.19 52.7 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.207 0.603 . . . . 0.0 111.941 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -113.97 93.11 4.22 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.803 1.641 . . . . 0.0 109.925 167.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.29 136.96 50.31 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.28 1.032 . . . . 0.0 111.134 168.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.8 mt -133.58 115.04 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.808 2.043 . . . . 0.0 110.198 -167.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -82.46 111.23 18.29 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.553 -0.717 . . . . 0.0 109.736 169.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.9 mt 52.73 19.63 1.32 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 168.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.64 25.26 10.06 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.135 0.879 . . . . 0.0 115.035 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -61.89 13.41 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -138.7 152.5 70.83 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 126.187 1.795 . . . . 0.0 110.524 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -59.74 167.68 6.52 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.351 2.034 . . . . 0.0 111.868 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -61.16 -12.84 14.05 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 116.595 -1.669 . . . . 0.0 114.962 -172.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -56.95 -13.1 2.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.09 2.556 . . . . 0.0 116.433 168.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -115.96 2.12 13.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.746 2.019 . . . . 0.0 112.978 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.7 mt -127.29 -40.9 1.78 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.587 2.355 . . . . 0.0 112.266 -172.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.19 -14.92 12.18 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 127.881 2.472 . . . . 0.0 114.807 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.0 mt -63.88 -24.35 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 127.26 2.224 . . . . 0.0 111.298 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.5 t -102.82 139.23 19.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.467 1.107 . . . . 0.0 109.992 157.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -62.91 -25.37 74.23 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.433 2.089 . . . . 0.0 112.811 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -80.82 -0.88 40.79 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.312 1.445 . . . . 0.0 113.361 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.3 9.18 57.21 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 120.075 -1.641 . . . . 0.0 114.992 -170.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -69.62 158.18 35.81 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.754 1.222 . . . . 0.0 112.398 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.15 150.24 73.35 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 126.408 1.883 . . . . 0.0 107.965 154.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.31 148.26 77.25 Favored 'Cis proline' 0 CA--C 1.541 0.859 0 N-CA-C 116.264 1.602 . . . . 0.0 116.264 8.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.0 m -155.52 170.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 127.85 2.46 . . . . 0.0 111.127 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.03 149.35 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -96.54 123.53 40.24 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.759 2.024 . . . . 0.0 109.346 158.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.08 80.93 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.325 1.45 . . . . 0.0 108.966 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 t70 58.32 60.95 2.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.786 0.835 . . . . 0.0 111.712 -163.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 64.63 -16.76 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -75.28 123.12 24.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.059 1.344 . . . . 0.0 110.626 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -72.14 144.27 48.66 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.8 t -140.29 131.27 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 126.367 1.867 . . . . 0.0 108.723 162.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.42 -149.79 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.967 1.707 . . . . 0.0 113.342 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -37.42 154.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.643 1.977 . . . . 0.0 116.084 -165.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -50.25 -23.43 2.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.663 1.585 . . . . 0.0 114.689 163.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -98.91 -8.69 25.21 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 113.825 -171.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.5 m -104.79 -22.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.277 1.031 . . . . 0.0 112.605 158.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mt -52.02 -35.51 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.472 1.909 . . . . 0.0 113.127 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.61 -18.4 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.555 1.142 . . . . 0.0 114.018 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.62 -56.34 0.64 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.125 0.869 . . . . 0.0 112.565 158.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.48 -31.74 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.024 -1.28 . . . . 0.0 113.688 -161.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 tp -79.9 -40.78 27.51 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.315 0.962 . . . . 0.0 111.57 169.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.45 -30.64 71.39 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.29 -32.56 74.04 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.209 1.804 . . . . 0.0 114.519 168.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -115.82 -10.9 11.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.901 1.281 . . . . 0.0 113.659 -159.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -71.64 139.62 83.68 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.213 1.005 . . . . 0.0 109.701 165.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.71 -26.89 32.5 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 121.88 1.72 . . . . 0.0 113.488 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -79.74 142.64 57.19 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 118.918 0.781 . . . . 0.0 111.305 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -55.02 143.47 73.11 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.106 2.537 . . . . 0.0 116.454 -160.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.93 130.2 28.45 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.856 3.037 . . . . 0.0 113.313 -175.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.3 mt -94.55 1.65 55.67 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.867 2.067 . . . . 0.0 112.791 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.41 -25.13 68.14 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.2 m -62.8 119.14 48.66 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.114 -168.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.4 124.93 7.37 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.502 2.135 . . . . 0.0 111.349 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -75.36 177.31 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.899 2.399 . . . . 0.0 110.709 162.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -58.79 -29.08 66.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.689 -1.257 . . . . 0.0 113.535 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -57.71 -24.16 55.44 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.85 -24.53 67.78 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.805 -1.184 . . . . 0.0 113.002 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.0 p -67.12 -14.62 63.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.152 1.381 . . . . 0.0 114.096 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.59 -36.68 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.913 1.285 . . . . 0.0 111.239 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 -26.89 70.46 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 120.964 -1.085 . . . . 0.0 114.591 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 p -69.61 -15.69 63.25 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 170.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -88.51 -40.83 13.14 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.454 1.501 . . . . 0.0 111.936 169.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.84 -31.97 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.034 1.334 . . . . 0.0 111.531 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.72 -55.8 42.37 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.374 -1.298 . . . . 0.0 113.575 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.55 -32.28 3.82 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.342 2.028 . . . . 0.0 113.647 170.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 p -67.48 -32.74 73.77 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 121.17 1.805 . . . . 0.0 113.349 -170.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.15 -28.82 42.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.25 -35.76 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 120.696 -1.252 . . . . 0.0 111.262 170.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -66.43 -45.09 81.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.829 1.652 . . . . 0.0 111.7 170.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -59.33 -40.77 87.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.146 0.978 . . . . 0.0 112.721 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.2 -21.9 64.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.165 1.386 . . . . 0.0 114.501 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -98.84 71.29 1.9 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.658 1.572 . . . . 0.0 109.867 165.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.7 m -60.2 18.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.513 3.125 . . . . 0.0 118.743 -159.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -74.54 -23.09 58.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.489 1.916 . . . . 0.0 113.046 173.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -76.2 113.11 25.13 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.279 158.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.63 117.26 3.64 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.005 2.47 . . . . 0.0 112.802 -164.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.3 -39.61 94.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.914 -161.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.15 -25.74 68.49 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.367 -1.458 . . . . 0.0 114.165 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.58 -39.58 6.65 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.288 0.947 . . . . 0.0 113.507 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.6 m -57.16 -38.85 74.18 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.559 1.144 . . . . 0.0 111.922 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.71 -26.7 68.21 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.248 1.419 . . . . 0.0 114.0 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -71.28 -35.98 71.53 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.469 -0.77 . . . . 0.0 112.173 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.68 84.26 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.94 -1.1 . . . . 0.0 112.177 171.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.5 mt -62.55 -40.2 96.08 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.89 0.476 . . . . 0.0 111.769 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.9 -43.9 86.86 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.324 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.41 ' CD ' ' HZ2' ' A' ' 128' ' ' LYS . 8.3 mm-40 -69.49 -34.43 74.32 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.052 1.296 . . . . 0.0 112.855 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -63.72 -47.63 80.3 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.233 -0.917 . . . . 0.0 112.419 170.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.52 -35.2 77.15 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.123 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HZ2' ' CD ' ' A' ' 125' ' ' GLU . 75.9 mttt -63.47 -44.3 94.82 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.352 1.433 . . . . 0.0 112.018 175.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.52 72.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.346 0.658 . . . . 0.0 112.689 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.82 -56.24 4.87 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.93 0.892 . . . . 0.0 111.953 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.49 -32.96 74.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.054 1.341 . . . . 0.0 114.0 -168.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.74 -34.41 60.88 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.585 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -93.38 -30.54 15.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.241 1.016 . . . . 0.0 113.202 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.74 -28.76 70.1 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.379 -1.451 . . . . 0.0 113.489 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -67.67 -11.24 57.82 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 171.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.8 t -101.29 -44.19 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.977 1.311 . . . . 0.0 111.455 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -75.48 -17.51 60.11 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.0 -110.21 3.84 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 117.772 -1.571 . . . . 0.0 115.506 159.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.83 -28.23 4.22 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.677 2.918 . . . . 0.0 116.487 -148.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -134.81 164.36 27.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.887 1.221 . . . . 0.0 112.391 -170.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.4 tt -78.55 -7.13 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.327 -0.858 . . . . 0.0 113.183 -166.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.35 -1.48 53.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.684 1.594 . . . . 0.0 114.568 161.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 111.31 -127.72 8.33 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.303 1.43 . . . . 0.0 113.334 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -64.81 -19.37 65.81 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.31 1.844 . . . . 0.0 114.238 -171.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -147.68 150.47 34.41 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.932 1.693 . . . . 0.0 109.429 -172.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.83 112.94 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.365 0.666 . . . . 0.0 109.484 164.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.3 p -140.25 -164.66 1.75 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.362 1.065 . . . . 0.0 110.9 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.63 -24.2 2.09 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -167.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.83 -43.11 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 120.234 1.379 . . . . 0.0 112.142 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.83 -44.81 96.45 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.031 -1.043 . . . . 0.0 112.187 169.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.4 -19.36 61.82 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.533 0.733 . . . . 0.0 112.841 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.9 m -95.44 -36.26 11.4 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.339 1.456 . . . . 0.0 113.115 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 48.5 mt -111.8 -36.07 5.54 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -165.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.48 -46.13 98.24 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -168.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.02 -20.38 19.41 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 120.662 1.272 . . . . 0.0 114.371 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -70.51 -32.77 70.38 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.834 -1.166 . . . . 0.0 111.77 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.91 -35.67 74.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.346 0.659 . . . . 0.0 112.597 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -65.39 -43.12 91.66 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.729 0.776 . . . . 0.0 112.378 169.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -68.0 -28.8 67.74 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.15 -0.969 . . . . 0.0 113.184 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.42 -56.3 15.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.482 1.113 . . . . 0.0 110.935 169.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -58.31 -46.18 86.62 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.511 1.124 . . . . 0.0 111.93 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.3 t -82.88 -52.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.13 -55.28 5.58 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.527 -0.733 . . . . 0.0 111.789 -167.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.36 -29.45 69.63 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.034 -0.416 . . . . 0.0 111.691 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.08 -21.31 38.19 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.04 1.305 . . . . 0.0 116.046 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -68.62 -19.34 64.43 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -131.17 -34.24 1.45 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -146.88 91.08 1.97 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.745 1.618 . . . . 0.0 109.335 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -66.58 90.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.666 0.786 . . . . 0.0 110.198 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -84.73 113.64 50.6 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.621 1.168 . . . . 0.0 111.143 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.36 136.82 22.38 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.295 1.997 . . . . 0.0 111.523 -175.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 97.0 mt -86.16 101.06 1.63 Allowed Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 161.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -70.16 160.86 48.09 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.014 1.81 . . . . 0.0 112.522 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.95 -21.54 58.55 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -172.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -61.4 -29.48 69.95 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.398 -0.814 . . . . 0.0 113.15 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.45 53.22 2.25 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.877 2.071 . . . . 0.0 111.064 171.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -21.67 63.34 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.318 1.047 . . . . 0.0 113.589 -160.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -75.05 -54.88 6.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.816 1.189 . . . . 0.0 109.823 165.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.82 -36.63 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 119.022 0.828 . . . . 0.0 112.476 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.9 tp -64.47 -32.42 74.04 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.879 -1.138 . . . . 0.0 112.957 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -81.09 -24.92 37.4 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.752 -1.218 . . . . 0.0 113.219 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -67.16 -31.62 72.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.12 0.968 . . . . 0.0 112.908 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 36.4 mm -56.28 -40.1 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 120.996 -1.065 . . . . 0.0 111.705 168.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -71.39 -22.4 61.88 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.473 -1.392 . . . . 0.0 112.288 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.76 -22.5 59.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 117.795 -1.098 . . . . 0.0 113.458 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.82 -27.03 68.48 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 120.212 1.369 . . . . 0.0 112.907 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.73 12.51 8.8 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.181 1.792 . . . . 0.0 113.463 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.9 p -137.78 178.24 7.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.832 1.653 . . . . 0.0 113.821 -167.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 56.61 -171.41 0.08 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.402 1.481 . . . . 0.0 111.351 -163.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -78.28 -44.01 26.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.009 0.924 . . . . 0.0 109.435 156.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 59.5 p -70.01 -36.05 74.82 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 126.018 1.727 . . . . 0.0 115.456 -161.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -85.06 -50.57 7.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.278 0.945 . . . . 0.0 111.547 165.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -59.76 -34.84 73.51 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -73.09 -19.5 61.15 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.387 0.994 . . . . 0.0 113.181 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.1 p -94.7 -8.8 36.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -53.18 107.64 0.25 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.108 1.363 . . . . 0.0 110.188 167.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.62 145.4 34.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.565 0.746 . . . . 0.0 111.826 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.54 127.1 30.36 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.732 0.813 . . . . 0.0 111.158 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -69.26 -42.19 75.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.473 1.109 . . . . 0.0 113.889 -149.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -61.41 -33.67 74.08 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.693 1.197 . . . . 0.0 112.328 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -79.81 -12.78 59.75 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.21 -48.52 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 119.247 0.931 . . . . 0.0 109.591 163.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.0 mt -63.5 -55.31 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.703 1.201 . . . . 0.0 111.8 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.67 -29.14 67.53 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -78.74 -27.8 56.12 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.709 -1.244 . . . . 0.0 113.211 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -75.43 -33.41 60.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.194 1.398 . . . . 0.0 113.929 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -48.21 -52.01 45.14 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.8 -20.41 58.73 Favored 'Trans proline' 0 C--N 1.354 0.823 0 CA-C-N 121.57 1.596 . . . . 0.0 113.552 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -93.65 9.88 35.07 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.575 1.95 . . . . 0.0 114.408 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 50.0 t -68.27 -25.12 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.681 -0.637 . . . . 0.0 110.364 148.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -96.59 -50.01 4.89 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 117.833 -1.08 . . . . 0.0 113.762 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.894 0 C-N-CA 125.843 1.657 . . . . 0.0 114.539 -175.625 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.5 mtp . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 118.372 -0.823 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.94 -167.3 0.06 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.346 1.058 . . . . 0.0 112.704 -170.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.8 mt -73.16 118.31 15.95 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.945 -1.097 . . . . 0.0 111.521 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -122.3 122.21 38.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.635 1.174 . . . . 0.0 109.806 166.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mt -109.43 129.23 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.004 1.322 . . . . 0.0 108.29 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.3 m -113.27 117.52 32.09 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.79 142.76 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.222 1.009 . . . . 0.0 110.198 -161.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.699 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.8 tttm -64.32 128.78 37.25 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.451 170.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.07 174.08 9.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.996 1.719 . . . . 0.0 112.176 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.24 136.1 43.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.9 0.88 . . . . 0.0 111.107 164.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 68.1 t -57.85 122.85 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.75 -0.594 . . . . 0.0 109.763 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.04 -10.81 61.94 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 118.21 -1.328 . . . . 0.0 116.07 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.46 83.89 24.69 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 120.078 1.939 . . . . 0.0 112.293 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.83 -14.05 42.77 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.552 2.835 . . . . 0.0 116.525 -171.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -81.8 -7.03 59.56 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.2 pt -141.83 161.88 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.868 1.267 . . . . 0.0 111.957 -166.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.5 mt -77.37 -46.13 23.8 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.37 -123.89 7.39 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.829 1.204 . . . . 0.0 114.398 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -63.4 16.97 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.802 2.841 . . . . 0.0 116.894 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -116.26 71.16 4.41 Favored Pre-proline 0 C--O 1.26 1.635 0 O-C-N 119.494 -2.004 . . . . 0.0 110.945 -162.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -69.28 -21.38 35.8 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.425 2.75 . . . . 0.0 112.42 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -69.1 -42.51 76.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.441 1.496 . . . . 0.0 112.627 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.699 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -60.74 -42.48 97.46 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 119.364 -2.085 . . . . 0.0 111.014 168.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -63.1 -27.46 69.4 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 117.59 -1.195 . . . . 0.0 113.106 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -55.75 -44.96 78.12 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 120.139 1.336 . . . . 0.0 112.536 172.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -72.03 -40.09 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.904 1.281 . . . . 0.0 111.422 -171.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.43 -36.4 71.29 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.453 0.701 . . . . 0.0 111.493 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.71 -41.79 95.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.603 1.161 . . . . 0.0 113.698 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -70.42 -40.84 73.58 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.011 1.278 . . . . 0.0 112.527 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.2 -34.5 65.99 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.684 0.794 . . . . 0.0 113.036 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -78.28 -19.77 52.96 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -72.69 -40.88 65.88 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 120.709 -1.244 . . . . 0.0 112.008 162.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -74.07 -4.53 36.1 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.59 1.556 . . . . 0.0 114.775 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt 58.7 16.81 4.63 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.99 2.116 . . . . 0.0 115.197 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.5 mm -76.99 129.55 78.26 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.858 0.863 . . . . 0.0 110.317 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.95 145.76 45.88 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.462 2.108 . . . . 0.0 111.953 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -148.31 158.65 44.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.339 1.456 . . . . 0.0 110.489 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -96.8 100.93 12.44 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.387 1.075 . . . . 0.0 110.268 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -81.73 136.26 35.46 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -127.51 96.74 4.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.289 1.836 . . . . 0.0 110.165 168.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.7 mt -72.15 142.26 49.11 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.634 1.174 . . . . 0.0 111.433 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.4 mt -133.07 119.52 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.592 1.557 . . . . 0.0 110.683 -170.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -89.37 112.05 23.06 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.708 -0.62 . . . . 0.0 110.064 170.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.3 mt 51.29 22.18 1.32 Allowed 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.02 24.97 15.44 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 119.061 -0.855 . . . . 0.0 115.207 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -65.34 16.73 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -141.02 147.61 48.53 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 126.203 1.801 . . . . 0.0 110.517 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -62.99 171.66 5.84 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.475 2.116 . . . . 0.0 112.094 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -58.89 -17.67 26.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 116.919 -1.515 . . . . 0.0 115.045 -174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -57.35 -11.84 2.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.692 1.997 . . . . 0.0 116.261 169.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -116.32 3.4 13.35 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.352 1.861 . . . . 0.0 113.091 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.6 mt -131.96 -40.26 1.06 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.127 2.171 . . . . 0.0 112.594 -170.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.49 -8.78 2.02 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 128.531 2.732 . . . . 0.0 115.137 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.3 mt -68.31 -19.64 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 127.989 2.516 . . . . 0.0 111.16 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.7 p -110.56 148.07 37.71 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 124.671 1.188 . . . . 0.0 111.069 161.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.71 -20.94 59.18 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.907 2.405 . . . . 0.0 113.985 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -101.14 1.48 39.22 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.135 1.374 . . . . 0.0 114.038 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.54 11.69 80.24 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 119.219 0.918 . . . . 0.0 114.971 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.55 ' HZ3' ' CG ' ' A' ' 72' ' ' ASP . 82.5 tttt -62.62 150.87 39.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.061 1.344 . . . . 0.0 110.673 171.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.42 150.33 75.3 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.224 1.41 . . . . 0.0 108.843 155.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.5 153.78 97.11 Favored 'Cis proline' 0 CA--C 1.542 0.888 0 N-CA-C 116.721 1.777 . . . . 0.0 116.721 14.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.8 m -157.13 167.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 127.964 2.506 . . . . 0.0 110.92 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.41 147.19 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.964 -1.085 . . . . 0.0 113.797 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -100.09 115.55 30.04 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.063 1.745 . . . . 0.0 108.932 164.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.3 mt -95.05 77.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.645 1.178 . . . . 0.0 109.173 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.7 t70 58.39 60.41 2.62 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.418 -164.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.263 56.0 m-20 64.9 -10.84 0.15 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.591 2.356 . . . . 0.0 117.33 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -73.33 117.75 15.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.347 1.459 . . . . 0.0 109.928 171.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -68.75 144.49 54.35 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.0 t -141.83 131.84 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.278 1.831 . . . . 0.0 109.173 166.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.87 -149.58 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.27 1.828 . . . . 0.0 113.732 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.55 ' CG ' ' HZ3' ' A' ' 59' ' ' LYS . 27.0 t0 -46.01 158.51 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.097 2.159 . . . . 0.0 116.766 -163.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.6 p -51.93 -30.52 24.83 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.624 -1.298 . . . . 0.0 113.83 168.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.65 -7.37 52.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -170.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.8 -22.13 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.282 1.033 . . . . 0.0 113.094 160.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mt -53.78 -37.79 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.694 1.598 . . . . 0.0 112.946 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.92 -11.08 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.7 -58.81 0.71 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.781 0.705 . . . . 0.0 112.341 154.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.15 -32.58 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.388 -1.066 . . . . 0.0 113.839 -161.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -77.28 -45.73 25.38 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.258 0.936 . . . . 0.0 111.752 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.31 -26.28 68.41 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.11 0.964 . . . . 0.0 113.511 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.51 -33.57 75.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.903 1.681 . . . . 0.0 114.264 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -116.28 -20.03 9.94 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.789 1.236 . . . . 0.0 113.629 -158.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -73.83 126.35 89.59 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.15 0.98 . . . . 0.0 108.701 158.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.18 -12.98 25.81 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.822 2.348 . . . . 0.0 115.333 -168.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -72.03 142.2 84.92 Favored Pre-proline 0 CA--C 1.547 0.864 0 CA-C-N 119.073 0.851 . . . . 0.0 109.637 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -57.83 134.6 63.67 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 CA-C-N 121.886 1.709 . . . . 0.0 114.939 -163.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.38 132.92 46.21 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.173 3.249 . . . . 0.0 113.578 -166.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 mt -86.45 2.61 47.15 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.171 1.388 . . . . 0.0 112.819 166.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.79 -31.85 73.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.75 1.62 . . . . 0.0 115.094 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.6 m -64.93 120.57 67.82 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.848 -164.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.34 125.98 10.06 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.192 1.928 . . . . 0.0 111.026 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -73.71 176.86 8.8 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.146 2.564 . . . . 0.0 110.765 164.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -58.56 -29.63 66.52 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.605 -1.309 . . . . 0.0 113.323 171.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -57.6 -23.96 53.78 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.022 1.329 . . . . 0.0 114.144 172.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.97 67.04 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.905 -1.122 . . . . 0.0 113.705 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.6 p -65.94 -14.23 61.18 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 171.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.61 -37.54 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.943 1.297 . . . . 0.0 111.343 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.18 -26.06 68.89 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.333 0.968 . . . . 0.0 114.897 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 p -70.15 -15.64 62.98 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -88.0 -41.07 13.37 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.281 1.432 . . . . 0.0 111.731 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.7 -31.34 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.599 1.159 . . . . 0.0 111.895 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.53 -54.65 53.85 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.612 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.66 -29.61 4.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.608 2.205 . . . . 0.0 113.874 170.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 p -70.4 -31.19 68.31 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 121.384 1.902 . . . . 0.0 113.356 -173.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.6 -34.8 74.63 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.077 -1.639 . . . . 0.0 113.517 165.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.2 t -67.02 -32.47 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.941 -1.1 . . . . 0.0 111.315 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -68.4 -44.87 74.14 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.521 1.529 . . . . 0.0 111.868 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -63.07 -37.98 89.37 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.89 1.276 . . . . 0.0 112.737 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 73.1 mt -74.82 13.67 0.61 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.815 1.646 . . . . 0.0 114.633 170.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -141.07 71.17 1.36 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.94 1.296 . . . . 0.0 111.047 160.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 m -61.15 23.26 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 130.46 3.504 . . . . 0.0 118.279 -163.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.73 -32.66 72.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.72 1.608 . . . . 0.0 111.498 167.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -79.04 113.78 38.77 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 117.821 -1.085 . . . . 0.0 108.547 160.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -58.16 128.5 28.93 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.777 1.651 . . . . 0.0 114.141 -160.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -55.24 -51.89 65.14 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.594 1.158 . . . . 0.0 113.677 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.16 -27.23 66.93 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.11 -40.18 8.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.551 1.072 . . . . 0.0 113.414 172.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.7 m -59.58 -35.11 73.64 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.988 0.915 . . . . 0.0 112.652 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.16 -29.5 70.4 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.975 1.31 . . . . 0.0 113.26 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -71.02 -38.79 72.61 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.31 -0.869 . . . . 0.0 111.705 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.84 -39.72 87.73 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.39 -0.819 . . . . 0.0 112.499 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.46 -41.13 93.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.977 0.511 . . . . 0.0 111.8 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.23 -37.09 74.92 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.885 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -65.85 -42.16 90.81 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.654 1.57 . . . . 0.0 112.525 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -62.91 -47.39 83.46 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.573 -0.704 . . . . 0.0 112.029 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.0 mt -70.68 -33.34 70.82 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.988 -1.07 . . . . 0.0 113.166 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -64.08 -43.28 95.9 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.294 1.406 . . . . 0.0 111.967 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.66 -32.58 74.31 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.75 -57.94 3.6 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.994 0.918 . . . . 0.0 112.17 174.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.88 -30.7 69.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.741 1.216 . . . . 0.0 113.946 -168.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.89 -30.93 57.84 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.081 -0.844 . . . . 0.0 113.787 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -100.0 -27.2 13.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.114 0.966 . . . . 0.0 113.526 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.43 -31.17 72.25 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.096 -1.627 . . . . 0.0 113.008 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -66.93 -9.83 42.38 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.3 t -97.31 -42.92 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.864 1.266 . . . . 0.0 111.362 171.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -80.88 -15.57 55.97 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.72 -107.21 2.86 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-O 117.398 -1.779 . . . . 0.0 115.719 157.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.41 -25.26 3.92 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.442 2.761 . . . . 0.0 116.832 -150.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -138.72 162.58 34.33 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.52 1.055 . . . . 0.0 112.225 -166.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.0 tt -77.74 -4.4 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.727 -1.233 . . . . 0.0 113.854 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.65 -4.01 38.27 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.435 1.494 . . . . 0.0 114.882 161.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.2 -127.88 7.98 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.12 1.343 . . . . 0.0 112.976 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -67.21 -21.49 65.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.187 1.795 . . . . 0.0 114.187 -170.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -144.82 150.08 36.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.236 1.815 . . . . 0.0 109.27 -173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 77.9 mt -60.33 111.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.682 0.793 . . . . 0.0 109.488 163.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 p -141.77 -159.86 1.02 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.623 1.169 . . . . 0.0 110.592 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.98 -24.89 7.21 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -166.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.04 -40.27 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 120.113 1.324 . . . . 0.0 112.409 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 -45.63 93.6 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.848 -1.157 . . . . 0.0 111.916 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.9 mt -61.41 -24.96 66.88 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.856 0.462 . . . . 0.0 112.154 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.0 m -85.63 -43.96 13.01 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.214 1.405 . . . . 0.0 113.337 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.6 mt -110.73 -33.07 6.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -161.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.51 99.67 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.22 -23.47 17.9 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 CA-C-N 120.578 1.242 . . . . 0.0 113.881 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.27 -35.29 73.66 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.032 -1.043 . . . . 0.0 111.85 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.39 -36.66 81.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.494 0.718 . . . . 0.0 112.743 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -66.84 -45.82 77.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.648 0.658 . . . . 0.0 112.427 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -62.76 -24.43 67.71 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.534 0.733 . . . . 0.0 112.633 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.8 tp -77.23 -52.51 9.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.401 1.08 . . . . 0.0 112.654 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.27 -34.3 76.28 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.319 0.648 . . . . 0.0 111.869 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.67 -61.32 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.01 -52.26 15.1 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.077 -1.014 . . . . 0.0 112.372 -164.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.9 tp -70.27 -26.91 64.03 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.888 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.83 -26.95 48.88 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.05 1.31 . . . . 0.0 115.408 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -65.23 -20.14 66.29 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -126.32 -33.95 2.55 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.226 1.01 . . . . 0.0 113.67 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -152.64 97.52 2.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.824 1.65 . . . . 0.0 109.009 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -68.44 82.17 0.26 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.42 0.688 . . . . 0.0 110.773 168.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -73.25 120.56 81.67 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.357 1.063 . . . . 0.0 111.059 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.9 128.48 12.43 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.065 1.843 . . . . 0.0 111.189 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 95.3 mt -75.94 103.21 0.96 Allowed Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 155.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -70.61 161.93 44.32 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.744 1.63 . . . . 0.0 112.521 -163.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.19 -24.78 63.4 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.901 1.68 . . . . 0.0 115.477 -170.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -62.13 -25.67 67.87 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.217 1.007 . . . . 0.0 113.367 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.8 mt -83.9 51.77 2.12 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.449 1.9 . . . . 0.0 111.06 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.48 -22.86 62.62 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.376 1.071 . . . . 0.0 113.654 -156.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -74.0 -53.49 9.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.108 1.322 . . . . 0.0 109.833 164.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.28 -37.17 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.204 0.911 . . . . 0.0 112.291 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.57 -35.2 79.65 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -74.9 -31.8 61.67 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.461 -0.774 . . . . 0.0 112.745 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -65.62 -28.74 69.34 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.616 1.167 . . . . 0.0 112.9 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.3 mm -53.86 -39.27 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.086 -1.008 . . . . 0.0 111.719 166.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -82.82 -14.56 54.14 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.658 -1.276 . . . . 0.0 112.625 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.94 -20.34 61.08 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 161.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -61.76 -23.99 66.54 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.366 1.439 . . . . 0.0 113.428 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -85.71 3.56 40.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.796 1.238 . . . . 0.0 112.501 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 p -121.9 177.14 5.41 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -162.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 56.08 -161.34 0.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.531 1.532 . . . . 0.0 110.576 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -87.08 -38.13 16.79 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 125.392 1.477 . . . . 0.0 108.902 156.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -51.62 63.29 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 129.258 3.023 . . . . 0.0 113.274 -168.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -91.31 -44.26 9.29 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -58.19 -32.6 68.41 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -77.9 -21.28 51.47 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 29.3 p -89.34 -15.59 33.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.388 1.075 . . . . 0.0 113.311 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -53.03 132.99 38.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.315 1.046 . . . . 0.0 109.414 163.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -127.56 149.65 50.05 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.53 1.132 . . . . 0.0 111.436 -171.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -54.5 124.84 17.38 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.971 0.908 . . . . 0.0 111.615 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -83.86 -34.3 24.65 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.751 -143.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -37.62 74.81 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.776 1.631 . . . . 0.0 113.022 161.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -79.55 -10.98 59.89 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.6 t -75.15 -48.2 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 120.21 1.368 . . . . 0.0 110.039 161.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.2 mt -63.03 -54.1 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.294 1.038 . . . . 0.0 111.622 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.93 -33.07 73.98 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -173.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -75.22 -23.91 72.67 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 120.843 -1.161 . . . . 0.0 113.399 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -82.61 -25.56 33.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -48.63 -51.47 52.57 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.52 -19.92 54.37 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.817 1.678 . . . . 0.0 113.594 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -87.0 -0.59 56.87 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.653 1.581 . . . . 0.0 114.746 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.14 -21.89 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.361 -0.837 . . . . 0.0 110.879 152.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -96.9 -23.46 16.33 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.863 2.065 . . . . 0.0 113.531 -173.464 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 118.288 -0.863 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.33 -166.19 0.09 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.88 0.872 . . . . 0.0 112.631 -168.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.2 mt -75.4 121.17 21.87 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.068 -1.02 . . . . 0.0 111.18 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.27 118.16 25.39 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.856 1.262 . . . . 0.0 109.64 168.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 mt -107.89 128.33 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.092 1.357 . . . . 0.0 108.626 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.4 m -113.24 116.61 30.04 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.29 142.2 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.705 1.202 . . . . 0.0 110.151 -162.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.689 ' N ' ' HG ' ' A' ' 23' ' ' CYS . 33.1 tttm -63.13 127.69 32.42 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.078 169.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.71 176.16 9.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.431 1.892 . . . . 0.0 111.916 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.88 140.17 37.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.902 0.881 . . . . 0.0 111.436 164.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.97 124.61 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.07 0.462 . . . . 0.0 110.11 169.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.43 -13.4 22.1 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.03 1.3 . . . . 0.0 116.133 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.69 80.34 66.44 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 119.771 1.786 . . . . 0.0 112.203 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.22 -8.79 15.26 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.943 3.095 . . . . 0.0 116.087 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -79.48 -12.33 59.88 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.0 pt -142.03 162.17 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.675 1.19 . . . . 0.0 112.224 -167.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 mt -76.05 -43.18 45.05 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.59 -120.71 4.45 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.091 1.329 . . . . 0.0 114.211 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -66.03 12.85 0.05 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.579 2.351 . . . . 0.0 117.158 -170.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -115.68 77.07 6.03 Favored Pre-proline 0 C--O 1.27 2.179 0 O-C-N 119.634 -1.916 . . . . 0.0 110.938 -155.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.74 -24.2 25.48 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 124.483 3.455 . . . . 0.0 113.713 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -66.01 -42.62 89.47 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.433 1.093 . . . . 0.0 112.641 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.689 ' HG ' ' N ' ' A' ' 8' ' ' LYS . 83.0 m -62.55 -42.92 99.84 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 119.144 -2.223 . . . . 0.0 111.022 170.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -65.06 -23.59 67.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 117.084 -1.436 . . . . 0.0 113.004 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -56.19 -47.23 78.74 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.36 1.436 . . . . 0.0 112.412 170.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.98 -41.13 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.09 1.356 . . . . 0.0 111.284 -171.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.88 -36.24 72.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.375 0.67 . . . . 0.0 111.289 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.21 -41.35 98.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.156 0.982 . . . . 0.0 113.63 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 p -69.1 -40.52 78.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.338 1.426 . . . . 0.0 112.487 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -75.84 -33.69 60.05 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -76.64 -19.77 57.43 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.416 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 38.7 tp10 -76.18 -35.93 58.9 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.516 -1.365 . . . . 0.0 112.961 163.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -74.05 -2.27 23.6 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 167.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 32' ' ' GLU . 19.0 mmtt 60.28 13.61 4.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 127.309 2.243 . . . . 0.0 115.286 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.413 ' CD1' HD21 ' A' ' 84' ' ' ASN . 34.2 mt -80.3 129.12 70.68 Favored Pre-proline 0 CA--C 1.541 0.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.963 -172.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.0 148.71 51.62 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.555 2.17 . . . . 0.0 112.331 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -147.04 157.55 43.65 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.172 1.389 . . . . 0.0 111.428 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 32.1 tttt -90.85 97.59 11.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.424 1.09 . . . . 0.0 110.152 173.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.6 t -80.61 137.79 36.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.433 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 78.9 m-70 -129.75 93.06 3.44 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.297 1.839 . . . . 0.0 110.563 171.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.1 mt -70.14 133.35 47.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.323 1.449 . . . . 0.0 111.015 170.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.39 118.74 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.884 1.673 . . . . 0.0 110.235 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -93.29 107.53 19.34 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.738 0.815 . . . . 0.0 109.92 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.6 mt 53.64 20.26 2.1 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 171.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.15 25.7 12.33 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 119.123 -0.821 . . . . 0.0 115.037 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.99 9.05 0.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.39 1.595 . . . . 0.0 115.19 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -140.19 143.6 34.32 Favored Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 126.518 1.927 . . . . 0.0 109.781 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.59 175.9 3.94 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.383 2.722 . . . . 0.0 113.129 -170.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -57.75 -20.64 36.36 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -174.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -59.19 -12.32 5.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.607 1.963 . . . . 0.0 116.099 171.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.83 -0.93 15.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.891 2.076 . . . . 0.0 113.029 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 mt -127.29 -39.27 1.9 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.241 2.217 . . . . 0.0 112.689 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -59.83 -12.0 6.54 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.328 2.651 . . . . 0.0 114.888 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.0 mt -65.51 -21.19 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 127.566 2.347 . . . . 0.0 111.43 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.1 p -106.54 147.63 35.32 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 121.626 -0.671 . . . . 0.0 110.606 157.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.78 -11.59 32.59 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.848 2.365 . . . . 0.0 113.856 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -103.42 7.17 38.02 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.014 1.326 . . . . 0.0 112.97 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.13 14.03 67.89 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.047 -1.033 . . . . 0.0 114.924 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -76.43 162.86 27.5 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.786 1.634 . . . . 0.0 112.141 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.23 151.29 73.12 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.775 2.03 . . . . 0.0 108.075 154.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.77 146.75 79.66 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 N-CA-C 116.848 1.826 . . . . 0.0 116.848 11.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -156.77 169.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 128.717 2.807 . . . . 0.0 110.735 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.5 150.39 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.635 -1.291 . . . . 0.0 114.267 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -102.79 123.78 47.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.976 1.71 . . . . 0.0 109.085 162.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.5 mt -104.8 84.87 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.182 1.393 . . . . 0.0 108.744 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 56.04 57.89 4.76 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.743 -164.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.267 61.7 m-20 64.55 -7.03 0.26 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 117.333 2.346 . . . . 0.0 117.333 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -79.86 119.23 22.45 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.684 -1.26 . . . . 0.0 110.16 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -70.98 146.59 49.34 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.0 t -142.68 130.74 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.484 1.913 . . . . 0.0 109.531 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.57 -155.92 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.692 1.997 . . . . 0.0 114.119 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -44.16 153.12 0.15 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.908 2.083 . . . . 0.0 115.707 -161.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.1 p -50.88 -26.48 5.89 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -86.95 -12.52 47.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.06 -19.82 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.128 0.971 . . . . 0.0 113.137 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -54.34 -38.11 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.201 1.4 . . . . 0.0 112.651 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.65 -8.23 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.32 -55.24 0.64 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.914 0.769 . . . . 0.0 113.005 156.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.0 mt -74.19 -30.26 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.402 1.101 . . . . 0.0 113.631 -163.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.1 tp -73.25 -44.49 59.32 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.743 -1.223 . . . . 0.0 110.611 167.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -67.47 -26.53 66.42 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 26.1 tt0 -67.66 -46.03 73.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.819 2.048 . . . . 0.0 112.978 167.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.499 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 94.3 mttt -93.82 -13.12 27.66 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.461 1.105 . . . . 0.0 113.507 -167.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.413 HD21 ' CD1' ' A' ' 35' ' ' ILE . 28.3 t-20 -86.72 133.11 40.43 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.789 1.636 . . . . 0.0 109.907 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.1 -15.26 25.89 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.244 1.962 . . . . 0.0 115.602 -168.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -76.27 143.9 73.87 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 119.666 1.121 . . . . 0.0 111.341 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -55.85 130.42 40.24 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.787 2.325 . . . . 0.0 114.336 -171.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -61.13 134.41 52.48 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.592 2.861 . . . . 0.0 113.574 -165.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.4 mt -81.86 -0.12 42.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.724 1.61 . . . . 0.0 112.513 165.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.48 -27.53 67.1 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.858 1.663 . . . . 0.0 114.935 -174.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.3 m -66.05 122.16 79.73 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.325 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.53 133.77 14.67 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.106 1.871 . . . . 0.0 111.451 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.93 175.14 11.22 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.924 2.416 . . . . 0.0 110.58 160.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -57.07 -31.56 65.33 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.552 -1.342 . . . . 0.0 113.344 171.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -63.18 -17.6 62.58 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.268 1.427 . . . . 0.0 113.812 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.64 -21.99 66.86 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.665 -1.272 . . . . 0.0 113.503 171.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.1 p -64.24 -12.65 43.01 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.9 t -119.27 -36.67 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.143 1.377 . . . . 0.0 111.475 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.8 -27.47 70.13 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 120.828 -1.17 . . . . 0.0 114.718 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.8 p -69.54 -18.76 63.68 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 170.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -84.22 -43.22 15.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.86 1.264 . . . . 0.0 111.501 168.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -66.9 -33.71 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.907 0.883 . . . . 0.0 111.855 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -59.46 -53.08 69.5 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.278 -1.344 . . . . 0.0 113.654 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.21 -29.86 4.69 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.8 2.333 . . . . 0.0 114.214 170.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 p -69.1 -29.93 68.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.992 1.724 . . . . 0.0 112.771 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -67.28 -38.64 85.38 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.798 -1.189 . . . . 0.0 113.739 164.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.39 -40.75 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-N 120.108 1.322 . . . . 0.0 110.806 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -65.8 -42.3 90.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.531 1.132 . . . . 0.0 112.416 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -65.94 -36.45 83.39 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.192 0.997 . . . . 0.0 113.09 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.0 mt -76.62 9.26 2.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.675 1.59 . . . . 0.0 113.7 168.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -130.5 55.74 1.8 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.402 1.881 . . . . 0.0 109.688 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 m -65.45 26.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 129.674 3.19 . . . . 0.0 117.532 -151.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.02 -22.65 39.22 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.516 1.526 . . . . 0.0 112.285 164.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.5 123.02 85.66 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 117.512 -1.232 . . . . 0.0 107.725 151.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -63.33 110.94 1.31 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 CA-C-N 121.126 1.438 . . . . 0.0 112.374 -171.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -50.08 -44.31 51.77 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -173.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -63.86 -20.62 65.96 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.42 -38.96 6.1 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.312 1.434 . . . . 0.0 113.356 167.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 m -57.44 -41.7 81.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.401 1.08 . . . . 0.0 111.956 174.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -62.37 -30.94 71.55 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.182 1.793 . . . . 0.0 113.251 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -67.5 -41.52 84.36 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.512 -0.743 . . . . 0.0 111.25 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.45 80.8 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.37 -0.832 . . . . 0.0 112.872 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.47 -36.42 83.7 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.72 -0.613 . . . . 0.0 112.468 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.3 -38.48 81.67 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.448 1.022 . . . . 0.0 112.223 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -64.97 -41.3 95.56 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.194 1.361 . . . . 0.0 112.732 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -64.47 -50.48 67.32 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.585 -0.697 . . . . 0.0 112.066 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.03 -30.91 68.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.823 -1.173 . . . . 0.0 113.236 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -63.24 -43.98 96.51 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.613 1.551 . . . . 0.0 112.053 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.85 72.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -73.84 -57.97 3.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.218 1.007 . . . . 0.0 112.05 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -66.97 -33.73 76.21 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.493 1.517 . . . . 0.0 113.856 -169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -56.26 -30.18 57.67 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.956 -0.913 . . . . 0.0 114.042 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 100.0 m-70 -104.15 -24.09 13.2 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.53 -34.04 76.9 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.264 1.393 . . . . 0.0 113.025 171.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -62.6 -13.75 34.98 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.34 -30.98 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.863 1.265 . . . . 0.0 112.057 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -97.96 -11.46 23.06 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.02 -123.59 6.03 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 117.27 -1.85 . . . . 0.0 115.473 155.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.5 -20.4 8.18 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.876 3.051 . . . . 0.0 117.282 -153.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -131.42 160.04 36.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.915 1.234 . . . . 0.0 112.465 -167.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.9 tt -76.18 -1.43 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.814 -1.179 . . . . 0.0 113.486 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -105.13 -0.65 26.39 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 162.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 117.58 -127.61 7.44 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 120.163 1.347 . . . . 0.0 113.487 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.3 -26.06 62.7 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.488 1.515 . . . . 0.0 113.84 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -131.12 151.48 51.4 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.238 1.815 . . . . 0.0 109.947 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.74 113.36 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.713 0.805 . . . . 0.0 108.948 163.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -141.57 -158.52 0.87 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.843 0.857 . . . . 0.0 110.959 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.32 -23.6 24.55 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -165.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.23 -39.0 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.595 1.089 . . . . 0.0 112.234 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.77 -45.84 92.17 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.575 1.08 . . . . 0.0 112.177 167.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.89 -26.15 67.23 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.5 m -82.21 -54.68 5.06 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.613 1.165 . . . . 0.0 112.326 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 34.0 mt -98.54 -33.09 11.13 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -160.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.08 -47.99 97.69 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.14 -26.47 14.84 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 120.908 1.36 . . . . 0.0 113.272 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -69.7 -34.95 74.64 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.289 172.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.11 -39.29 89.84 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.955 0.902 . . . . 0.0 112.418 171.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -64.95 -45.61 85.01 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.596 0.634 . . . . 0.0 112.201 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -61.61 -27.5 68.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.444 0.697 . . . . 0.0 112.346 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.8 tp -79.44 -46.71 16.98 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.28 -32.19 72.02 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.817 0.735 . . . . 0.0 111.593 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.5 t -90.07 -61.84 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.9 -50.33 20.66 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.22 -0.925 . . . . 0.0 112.809 -164.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 40.7 tp -71.93 -30.68 65.59 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 119.219 -0.42 . . . . 0.0 111.574 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.6 -26.76 60.31 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -64.13 -18.85 64.83 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.229 1.412 . . . . 0.0 114.58 171.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -124.8 -36.95 2.52 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.67 1.188 . . . . 0.0 113.42 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -151.91 94.24 1.94 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.255 1.822 . . . . 0.0 108.834 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -68.08 88.65 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.996 -0.44 . . . . 0.0 111.048 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -69.37 117.54 53.52 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.59 1.156 . . . . 0.0 111.269 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.86 111.79 3.38 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.012 1.808 . . . . 0.0 110.878 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.6 108.6 2.26 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 159.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -69.17 161.52 45.51 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.601 1.534 . . . . 0.0 112.246 -169.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.94 -26.47 64.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.549 1.539 . . . . 0.0 114.236 -176.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -65.32 -23.6 67.06 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.3 mt -85.65 50.08 1.89 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.879 1.671 . . . . 0.0 111.342 171.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -27.23 65.3 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -156.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -73.01 -50.95 20.17 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.829 1.195 . . . . 0.0 110.198 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.37 -40.22 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.883 0.765 . . . . 0.0 111.985 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.5 -41.72 96.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.475 1.11 . . . . 0.0 113.227 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -69.28 -35.14 75.73 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.373 -0.829 . . . . 0.0 112.395 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -65.47 -25.5 67.52 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.497 1.119 . . . . 0.0 112.984 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.8 mm -55.26 -37.53 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.016 -1.052 . . . . 0.0 111.785 166.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -84.52 -15.04 47.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.418 -1.426 . . . . 0.0 113.161 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 94.2 mt -73.13 -16.59 61.45 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 163.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 54.5 mt -63.47 -21.09 66.11 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.652 1.114 . . . . 0.0 113.476 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -94.95 4.97 53.2 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.424 1.49 . . . . 0.0 111.966 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -108.31 172.71 6.68 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.154 1.382 . . . . 0.0 114.627 -168.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 53.57 -157.47 0.17 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.819 1.648 . . . . 0.0 110.8 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -88.4 -38.98 14.63 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 127.573 2.349 . . . . 0.0 108.551 161.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.86 -53.63 52.82 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 129.216 3.007 . . . . 0.0 113.432 -167.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -90.27 -42.15 11.15 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -57.75 -34.86 69.98 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -76.32 -22.79 54.53 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 30.1 p -85.38 -16.35 40.14 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.287 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 199' ' ' GLU . 51.2 ttt180 -49.73 137.89 15.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.318 1.047 . . . . 0.0 109.767 165.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -135.97 146.43 47.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.678 0.791 . . . . 0.0 111.701 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -49.26 114.45 1.03 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.358 1.463 . . . . 0.0 111.809 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 196' ' ' ARG . 2.0 mp0 -63.82 -32.58 74.14 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -153.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -59.19 -38.99 81.19 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.98 1.312 . . . . 0.0 113.053 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -81.74 -10.17 59.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.7 t -76.01 -43.85 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.07 0.85 . . . . 0.0 109.796 163.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.8 mt -66.97 -57.12 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.207 1.403 . . . . 0.0 111.819 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.27 67.98 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.47 -24.16 59.31 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.736 -1.227 . . . . 0.0 113.627 171.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -75.22 -34.73 61.5 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.096 1.448 . . . . 0.0 113.225 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -43.6 -53.04 12.78 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -174.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.34 -28.1 55.04 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 121.838 1.692 . . . . 0.0 113.811 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -82.38 0.59 41.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.476 1.91 . . . . 0.0 114.504 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.81 -25.79 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.523 0.729 . . . . 0.0 110.776 156.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -115.68 -41.27 3.25 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.165 1.386 . . . . 0.0 114.273 174.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 CA-C-O 115.924 -1.988 . . . . 0.0 114.361 -173.596 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.73 -170.07 0.05 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.083 1.353 . . . . 0.0 112.934 -169.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.8 mt -71.28 117.07 12.34 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.047 -1.033 . . . . 0.0 111.126 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -120.36 121.91 39.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.852 1.261 . . . . 0.0 109.592 167.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.0 mt -109.52 131.98 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.921 1.288 . . . . 0.0 108.126 -174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.6 m -112.53 128.49 56.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 166.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.55 142.14 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.509 1.123 . . . . 0.0 109.697 -164.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.758 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 32.1 tttm -63.91 128.19 34.72 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.616 170.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.66 175.85 9.82 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.904 2.082 . . . . 0.0 112.041 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.48 141.49 30.79 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.818 0.847 . . . . 0.0 111.555 164.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.39 124.5 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 120.995 0.426 . . . . 0.0 110.157 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.19 -16.68 15.57 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.984 1.278 . . . . 0.0 116.056 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.53 84.57 61.32 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.834 1.817 . . . . 0.0 112.245 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.71 -11.57 27.2 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.008 3.139 . . . . 0.0 115.755 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -79.72 -13.61 59.34 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.1 pt -141.05 160.28 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.513 1.125 . . . . 0.0 112.22 -164.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.4 mt -72.22 -47.83 47.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.2 -124.82 5.54 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.967 1.27 . . . . 0.0 114.716 -171.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.04 10.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.67 2.788 . . . . 0.0 117.964 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -112.8 76.66 2.25 Favored Pre-proline 0 C--O 1.268 2.041 0 CA-C-N 121.182 1.81 . . . . 0.0 111.02 -155.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.69 -24.91 34.55 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 124.13 3.22 . . . . 0.0 113.193 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -67.34 -40.98 85.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.262 1.025 . . . . 0.0 112.746 171.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.758 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.4 m -59.75 -43.54 94.22 Favored 'General case' 0 C--N 1.376 1.729 0 O-C-N 119.688 -1.882 . . . . 0.0 111.031 168.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -66.26 -23.5 66.41 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 117.147 -1.406 . . . . 0.0 113.009 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -56.11 -46.06 79.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 120.359 1.436 . . . . 0.0 112.288 170.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.8 t -72.99 -40.45 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.164 1.386 . . . . 0.0 111.586 -172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.9 -37.95 72.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.681 0.792 . . . . 0.0 111.314 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.1 -43.52 95.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.808 1.243 . . . . 0.0 113.175 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 p -70.44 -40.64 73.64 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.533 1.06 . . . . 0.0 112.751 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.26 -32.04 64.46 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -78.23 -25.73 47.07 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 172.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -68.47 -39.02 81.56 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.569 -1.332 . . . . 0.0 111.829 165.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -74.04 -2.12 22.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.257 1.423 . . . . 0.0 114.826 168.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HE3' ' OE1' ' A' ' 190' ' ' GLU . 28.6 mmtm 61.57 10.42 3.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 127.447 2.299 . . . . 0.0 115.798 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.48 ' CD1' HD21 ' A' ' 84' ' ' ASN . 42.4 mt -79.61 129.85 69.94 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 121.332 -0.855 . . . . 0.0 109.943 -170.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.67 145.21 51.3 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.371 2.047 . . . . 0.0 112.04 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -144.93 155.61 43.52 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.808 1.243 . . . . 0.0 111.492 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.461 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 46.0 tttt -89.63 94.1 9.73 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.065 1.346 . . . . 0.0 110.242 175.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.2 t -80.99 138.47 36.06 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.461 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 75.6 m-70 -129.47 94.15 3.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.328 1.851 . . . . 0.0 110.746 172.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.0 mt -70.5 134.98 48.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.733 1.213 . . . . 0.0 111.061 170.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.1 mt -130.89 117.54 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.973 1.709 . . . . 0.0 110.467 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -88.83 101.96 14.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.542 0.737 . . . . 0.0 109.638 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.8 mt 54.54 23.48 4.63 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 166.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.51 24.37 10.19 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.291 0.876 . . . . 0.0 115.291 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.48 -0.1 1.23 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.437 1.619 . . . . 0.0 114.868 171.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -130.55 142.21 44.69 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 125.57 1.548 . . . . 0.0 110.024 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.78 176.1 3.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.358 2.705 . . . . 0.0 112.967 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -57.96 -19.83 33.42 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 116.509 -1.71 . . . . 0.0 114.917 -174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -57.61 -16.46 10.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.117 2.167 . . . . 0.0 116.022 170.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -111.93 1.01 16.27 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.738 2.015 . . . . 0.0 112.871 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.8 mt -126.24 -39.85 2.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.2 2.2 . . . . 0.0 112.626 -171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -57.12 -15.85 6.39 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 128.57 2.748 . . . . 0.0 114.725 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.424 ' CD1' ' HE3' ' A' ' 64' ' ' LYS . 8.8 mt -63.01 -21.54 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 127.696 2.398 . . . . 0.0 111.233 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.5 p -106.8 145.76 31.72 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.323 0.649 . . . . 0.0 110.736 153.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.73 -15.28 44.03 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.768 2.312 . . . . 0.0 113.467 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -89.85 -6.04 56.25 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.674 1.59 . . . . 0.0 113.263 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.61 11.11 72.35 Favored Glycine 0 CA--C 1.539 1.588 0 O-C-N 120.842 -1.161 . . . . 0.0 115.021 -175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -73.96 160.39 31.41 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.862 1.665 . . . . 0.0 111.641 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.39 148.31 63.6 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 126.604 1.962 . . . . 0.0 107.899 160.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.5 152.12 93.14 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 N-CA-C 116.717 1.776 . . . . 0.0 116.717 13.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.1 m -158.63 165.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 128.444 2.698 . . . . 0.0 110.289 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.19 150.82 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 120.661 -1.274 . . . . 0.0 114.229 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 54' ' ' ILE . 85.4 mttt -104.55 113.78 27.58 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.118 1.767 . . . . 0.0 109.092 164.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.1 mt -88.16 80.84 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.858 1.263 . . . . 0.0 108.654 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t70 58.59 58.83 3.16 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.753 0.787 . . . . 0.0 111.584 -168.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.256 49.0 m-20 65.69 -5.72 0.47 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.874 2.175 . . . . 0.0 116.874 -175.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -84.61 114.54 22.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.931 1.292 . . . . 0.0 110.047 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -71.07 150.65 45.31 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -166.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.0 t -142.02 134.03 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.916 2.086 . . . . 0.0 109.132 165.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.78 -153.23 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.143 1.777 . . . . 0.0 113.467 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -33.91 156.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.826 2.05 . . . . 0.0 116.233 -170.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 p -48.95 -26.83 2.72 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.007 1.323 . . . . 0.0 114.224 160.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -94.35 -8.55 38.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.026 1.33 . . . . 0.0 113.142 -170.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.15 -21.32 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.43 1.092 . . . . 0.0 113.013 159.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mt -54.74 -38.82 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.598 1.559 . . . . 0.0 112.315 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.33 -6.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.45 -59.81 0.52 Allowed Glycine 0 CA--C 1.534 1.227 0 CA-C-N 119.037 0.835 . . . . 0.0 112.303 155.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.91 -35.76 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.443 -1.033 . . . . 0.0 113.648 -163.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.9 tp -72.64 -46.04 55.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.979 0.809 . . . . 0.0 111.075 172.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.94 -28.47 69.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.92 -36.33 81.99 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.133 1.373 . . . . 0.0 114.245 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -111.19 -15.42 13.66 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.866 1.266 . . . . 0.0 113.168 -160.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.48 HD21 ' CD1' ' A' ' 35' ' ' ILE . 27.9 t-20 -75.19 136.99 72.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.026 1.73 . . . . 0.0 109.698 164.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.04 -20.37 21.9 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.345 2.03 . . . . 0.0 115.113 -169.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -72.34 150.02 91.66 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.11 0.868 . . . . 0.0 111.246 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -55.52 130.86 42.81 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.681 2.254 . . . . 0.0 113.478 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.99 137.97 83.59 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.742 2.961 . . . . 0.0 112.775 -167.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -86.88 -3.61 59.09 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.689 0.795 . . . . 0.0 112.731 164.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.07 81.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.041 1.336 . . . . 0.0 114.042 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.4 m -63.14 114.53 12.93 Favored Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 123.447 0.699 . . . . 0.0 110.876 -166.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.3 136.81 14.55 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.009 1.806 . . . . 0.0 111.561 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.95 174.41 12.82 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.951 2.434 . . . . 0.0 110.43 156.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -27.0 62.86 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 168.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -54.57 -24.88 22.97 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.457 -1.402 . . . . 0.0 114.03 169.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.79 68.75 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.854 -1.154 . . . . 0.0 113.664 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.2 p -72.66 -3.42 24.86 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.007 1.276 . . . . 0.0 114.025 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.1 -38.46 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.166 1.386 . . . . 0.0 110.788 170.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.64 -28.55 68.06 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.254 0.93 . . . . 0.0 114.971 173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.6 p -67.79 -17.24 64.46 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.721 1.26 . . . . 0.0 114.144 173.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -91.44 -40.65 11.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.744 1.618 . . . . 0.0 111.758 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.4 mt -65.14 -32.28 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.251 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -57.06 -55.65 41.8 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.131 -1.414 . . . . 0.0 113.845 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -77.87 -29.62 4.24 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.626 2.217 . . . . 0.0 113.989 170.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.9 p -68.94 -32.65 72.41 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.723 1.602 . . . . 0.0 112.893 -173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -66.48 -37.78 85.86 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.901 -1.125 . . . . 0.0 113.619 166.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.57 -39.03 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.583 1.083 . . . . 0.0 110.982 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -68.13 -40.86 82.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.563 1.145 . . . . 0.0 112.542 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -66.5 -36.93 83.93 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.994 0.918 . . . . 0.0 112.626 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.3 mt -75.46 21.35 0.14 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.46 1.504 . . . . 0.0 113.621 166.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.8 tttt -144.43 54.71 1.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.599 2.36 . . . . 0.0 110.159 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.8 p -62.0 26.96 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 130.396 3.478 . . . . 0.0 118.203 -160.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -75.43 -25.56 57.62 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.295 -1.503 . . . . 0.0 112.093 157.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.04 120.84 79.12 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 117.485 -1.245 . . . . 0.0 107.88 155.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -63.06 115.56 3.03 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 121.029 1.403 . . . . 0.0 112.574 -169.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -46.45 -51.38 15.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.381 1.472 . . . . 0.0 114.351 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.07 -15.06 61.95 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -93.96 -42.77 4.0 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.456 1.503 . . . . 0.0 113.403 166.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.9 m -57.6 -40.3 78.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.617 1.167 . . . . 0.0 112.025 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.21 -30.25 70.32 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.498 1.919 . . . . 0.0 113.388 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -68.59 -39.72 80.79 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.366 -0.834 . . . . 0.0 111.343 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.72 -36.31 78.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.505 -0.747 . . . . 0.0 112.781 172.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.18 -38.27 88.45 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.776 -0.577 . . . . 0.0 112.197 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.38 -35.51 79.47 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.176 0.898 . . . . 0.0 112.667 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.495 ' CD ' ' HZ1' ' A' ' 128' ' ' LYS . 60.0 mm-40 -66.67 -43.47 84.43 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.294 1.406 . . . . 0.0 112.559 172.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -64.82 -45.28 86.84 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.628 -0.67 . . . . 0.0 112.43 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.0 mt -72.42 -31.71 65.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.369 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.495 ' HZ1' ' CD ' ' A' ' 125' ' ' GLU . 45.4 mtmt -62.54 -42.85 99.79 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 120.771 1.623 . . . . 0.0 111.875 171.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.34 -26.81 68.2 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 tp -81.06 -54.53 5.47 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.203 1.001 . . . . 0.0 111.763 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.37 -33.85 75.0 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.869 1.268 . . . . 0.0 114.053 -168.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.19 -28.38 66.64 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.723 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -96.89 -29.83 13.48 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.176 0.991 . . . . 0.0 113.381 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.4 mt -62.65 -33.59 75.35 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.289 -1.507 . . . . 0.0 112.841 175.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -68.57 -1.25 6.33 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.82 -44.94 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.269 1.428 . . . . 0.0 111.458 165.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -93.99 5.48 51.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -168.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.11 -165.18 26.46 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 116.191 1.236 . . . . 0.0 116.191 158.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.35 -8.73 19.9 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.768 3.645 . . . . 0.0 117.808 -136.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -118.07 165.42 13.77 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.858 -1.151 . . . . 0.0 110.746 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.253 0.9 OUTLIER -75.75 -0.18 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 120.225 -1.547 . . . . 0.0 112.898 -172.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.54 9.43 29.49 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 128.006 2.522 . . . . 0.0 114.567 162.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.24 -128.36 9.36 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.939 1.256 . . . . 0.0 113.589 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -62.07 -23.93 66.79 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -136.61 148.06 47.27 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.393 1.477 . . . . 0.0 109.743 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.59 118.13 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.321 1.048 . . . . 0.0 109.555 163.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.5 p -142.55 -161.79 1.31 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.157 0.983 . . . . 0.0 111.544 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.4 -23.32 3.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.126 1.77 . . . . 0.0 115.319 -172.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.78 -43.79 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.824 1.193 . . . . 0.0 111.506 174.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.18 -43.21 98.87 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.92 -1.112 . . . . 0.0 111.97 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.3 mt -61.74 -24.61 66.92 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.1 m -85.76 -39.78 16.78 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.689 1.195 . . . . 0.0 113.174 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.0 mt -114.04 -34.6 5.34 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -164.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.34 -46.77 99.76 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -168.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.03 -21.88 15.34 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 120.723 1.294 . . . . 0.0 113.752 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -68.72 -36.45 78.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.926 -1.109 . . . . 0.0 111.628 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.11 -38.85 92.55 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.648 0.658 . . . . 0.0 112.343 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -65.21 -46.57 80.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 173.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -61.55 -31.12 71.14 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.267 0.627 . . . . 0.0 112.173 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.1 tp -76.66 -45.55 29.37 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.316 1.046 . . . . 0.0 113.418 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.62 -35.11 75.34 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.238 0.615 . . . . 0.0 111.635 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.4 t -89.08 -59.86 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.44 -48.55 22.26 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.294 -0.879 . . . . 0.0 113.11 -166.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.6 tp -73.74 -33.73 64.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.428 172.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.98 -26.05 60.34 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.888 -0.951 . . . . 0.0 115.345 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -62.92 -20.75 65.48 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.375 1.47 . . . . 0.0 114.599 170.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -123.87 -35.77 2.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.614 1.166 . . . . 0.0 113.432 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -150.79 98.91 2.67 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.444 1.898 . . . . 0.0 108.714 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -68.81 88.16 0.37 Allowed 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.972 -0.455 . . . . 0.0 110.504 168.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -70.04 116.64 46.22 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.194 0.997 . . . . 0.0 110.747 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.93 120.58 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.008 1.805 . . . . 0.0 111.035 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.25 109.21 4.46 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 155.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -69.24 166.01 28.42 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.676 1.584 . . . . 0.0 112.444 -170.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -26.89 63.75 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.736 1.615 . . . . 0.0 113.676 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -64.79 -26.46 68.36 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.615 1.166 . . . . 0.0 113.779 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.9 mt -89.86 50.24 1.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.293 1.837 . . . . 0.0 111.169 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -30.22 70.73 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.533 1.133 . . . . 0.0 113.504 -157.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -76.82 -45.39 28.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.535 1.061 . . . . 0.0 111.525 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 62.4 t -60.61 -38.76 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 118.851 0.75 . . . . 0.0 111.588 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.3 tp -64.65 -43.44 93.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.756 1.222 . . . . 0.0 113.187 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -68.48 -34.47 75.99 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.392 -0.817 . . . . 0.0 112.703 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.2 -28.4 70.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.174 0.99 . . . . 0.0 112.949 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 43.5 mm -54.21 -37.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.123 -0.985 . . . . 0.0 111.905 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -86.07 -11.79 51.86 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.565 -1.334 . . . . 0.0 113.831 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.5 mt -72.27 -21.6 61.34 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 117.89 -1.053 . . . . 0.0 113.35 162.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 58.4 mt -62.19 -23.16 66.46 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.566 1.076 . . . . 0.0 113.232 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -90.61 13.24 16.49 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.581 1.552 . . . . 0.0 112.83 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.1 p -132.64 176.59 8.32 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.228 1.411 . . . . 0.0 114.511 -167.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 53.62 -167.87 0.06 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.919 1.688 . . . . 0.0 110.846 -166.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.411 ' OE1' ' HE3' ' A' ' 34' ' ' LYS . 23.4 mp0 -76.03 -42.83 46.63 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.085 1.354 . . . . 0.0 109.622 153.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -52.08 46.62 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 128.308 2.643 . . . . 0.0 113.081 -165.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -91.9 -44.84 8.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.746 0.419 . . . . 0.0 112.015 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -61.94 -28.12 69.31 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -172.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.86 -22.35 50.01 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.645 1.111 . . . . 0.0 113.619 171.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 26.8 p -89.32 -14.48 35.61 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.601 1.16 . . . . 0.0 113.595 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -51.86 130.92 30.3 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.573 1.149 . . . . 0.0 109.315 163.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -126.08 142.51 51.49 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.095 0.958 . . . . 0.0 111.418 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -52.43 120.27 5.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.537 1.135 . . . . 0.0 111.994 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.7 mp0 -67.91 -34.89 77.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.647 1.179 . . . . 0.0 113.883 -148.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -60.34 -37.18 79.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.832 1.253 . . . . 0.0 112.853 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -79.41 -9.82 59.68 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.604 -1.31 . . . . 0.0 114.03 174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.8 t -79.94 -44.0 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 118.912 0.778 . . . . 0.0 110.068 164.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.3 mt -65.93 -57.7 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.332 1.453 . . . . 0.0 111.633 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.72 69.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.715 0.806 . . . . 0.0 112.994 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.53 -22.67 59.8 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 120.781 -1.199 . . . . 0.0 113.96 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -72.86 -35.95 67.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.654 1.727 . . . . 0.0 112.619 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -44.34 -53.12 14.95 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -171.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.77 -27.55 59.79 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 122.085 1.78 . . . . 0.0 113.691 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -85.16 1.12 49.39 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.247 1.819 . . . . 0.0 114.416 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.3 -24.44 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.428 0.691 . . . . 0.0 110.31 156.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -120.7 -37.15 3.04 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.928 1.291 . . . . 0.0 113.861 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 115.135 -2.364 . . . . 0.0 114.5 -179.716 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.45 -169.49 0.06 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.991 1.316 . . . . 0.0 112.815 -167.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.42 116.04 10.3 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.938 -1.101 . . . . 0.0 110.956 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -120.19 115.37 23.51 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.849 1.26 . . . . 0.0 109.756 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 mt -103.35 136.75 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.094 1.358 . . . . 0.0 108.378 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.8 m -117.15 126.31 52.61 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 166.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.12 140.06 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.483 1.113 . . . . 0.0 109.98 -164.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.699 ' N ' ' HG ' ' A' ' 23' ' ' CYS . 33.5 tttm -64.69 127.49 31.75 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.684 -0.635 . . . . 0.0 109.465 171.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.49 176.78 8.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.641 1.977 . . . . 0.0 112.223 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.72 140.49 29.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.924 0.89 . . . . 0.0 111.737 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.24 121.76 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.018 0.437 . . . . 0.0 109.952 167.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.54 -9.41 50.23 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.005 1.288 . . . . 0.0 116.307 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.31 84.36 24.15 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 119.999 1.899 . . . . 0.0 112.392 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.69 -10.68 27.47 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.237 2.625 . . . . 0.0 116.437 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -77.38 -11.51 59.85 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.2 pt -143.2 161.21 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.867 1.267 . . . . 0.0 112.197 -165.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.4 mt -76.19 -43.94 40.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.3 -126.18 8.93 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.761 1.172 . . . . 0.0 114.764 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.25 13.38 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.747 2.819 . . . . 0.0 117.461 -172.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -116.9 71.42 5.43 Favored Pre-proline 0 C--O 1.266 1.937 0 O-C-N 119.808 -1.808 . . . . 0.0 110.998 -156.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.0 -22.03 31.57 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.843 3.029 . . . . 0.0 113.365 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -67.64 -39.66 84.61 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.361 -0.837 . . . . 0.0 112.63 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.699 ' HG ' ' N ' ' A' ' 8' ' ' LYS . 83.9 m -60.3 -42.72 96.1 Favored 'General case' 0 C--N 1.379 1.869 0 O-C-N 119.8 -1.812 . . . . 0.0 110.98 168.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -64.63 -25.7 68.08 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.182 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -55.3 -45.03 76.25 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 120.212 1.369 . . . . 0.0 112.545 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.5 t -73.22 -38.69 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.344 1.458 . . . . 0.0 111.727 -172.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.19 -38.46 69.07 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.663 0.785 . . . . 0.0 111.307 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.77 -43.32 98.19 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.146 1.379 . . . . 0.0 113.18 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 p -70.31 -40.58 74.12 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.627 1.103 . . . . 0.0 112.727 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.49 -32.64 68.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -78.74 -23.94 45.14 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -69.84 -37.77 76.27 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.404 -1.435 . . . . 0.0 112.184 164.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HE3' ' HG ' ' A' ' 89' ' ' LEU . 76.7 mttt -74.58 -4.34 36.47 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.79 1.636 . . . . 0.0 114.46 168.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm 60.23 15.97 5.73 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 127.063 2.145 . . . . 0.0 115.356 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -81.56 132.08 56.24 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.142 -0.973 . . . . 0.0 110.31 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.58 142.22 43.8 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.513 2.142 . . . . 0.0 112.138 171.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -143.72 156.28 44.47 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.041 1.336 . . . . 0.0 111.559 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 43.6 tttt -90.76 99.72 12.7 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.807 1.243 . . . . 0.0 110.004 173.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -83.57 129.29 34.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.432 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 86.8 m-70 -111.87 98.86 7.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.945 1.698 . . . . 0.0 110.353 164.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.1 mt -74.02 132.54 42.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.099 0.96 . . . . 0.0 111.533 166.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 93.6 mt -129.45 115.87 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.117 1.767 . . . . 0.0 109.866 -170.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -82.4 109.0 16.25 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.428 -0.795 . . . . 0.0 109.765 169.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.7 mt 51.4 26.1 2.95 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 168.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.76 22.51 15.8 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.232 0.853 . . . . 0.0 115.232 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -66.44 18.78 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -138.8 148.82 59.72 Favored Pre-proline 0 N--CA 1.474 0.758 0 C-N-CA 126.005 1.722 . . . . 0.0 110.32 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.18 173.48 5.05 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.785 2.323 . . . . 0.0 112.472 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -57.1 -18.95 16.84 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -55.59 -15.49 2.97 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.241 2.217 . . . . 0.0 116.248 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -116.46 3.51 13.24 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.737 2.015 . . . . 0.0 113.375 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.1 mt -128.83 -39.26 1.61 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.558 2.343 . . . . 0.0 112.423 -171.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.76 -14.55 5.98 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 128.89 2.876 . . . . 0.0 114.769 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.5 mt -61.78 -21.7 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 128.016 2.526 . . . . 0.0 111.229 172.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.3 p -109.84 149.52 40.08 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 111.011 157.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.94 -9.85 26.98 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.264 2.643 . . . . 0.0 114.177 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 39.3 mt-10 -107.69 -1.33 21.16 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.84 1.656 . . . . 0.0 112.881 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.66 13.93 75.0 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 120.983 -1.073 . . . . 0.0 114.922 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 57' ' ' GLU . 52.4 mtmt -69.45 160.76 30.78 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.932 1.293 . . . . 0.0 111.941 173.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 m -136.96 149.33 66.23 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 126.491 1.916 . . . . 0.0 107.949 155.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.58 150.83 91.27 Favored 'Cis proline' 0 CA--C 1.538 0.722 0 N-CA-C 116.559 1.715 . . . . 0.0 116.559 13.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 m -158.05 167.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 128.231 2.613 . . . . 0.0 110.499 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.35 152.93 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.654 -1.279 . . . . 0.0 114.101 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -108.1 120.71 43.1 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.703 1.601 . . . . 0.0 109.377 162.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 54.8 mt -93.96 82.25 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.542 1.537 . . . . 0.0 108.6 175.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.3 t70 58.01 57.18 4.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.595 0.758 . . . . 0.0 111.941 -167.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.254 48.4 m-20 65.42 0.41 1.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -94.01 111.83 23.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.119 1.368 . . . . 0.0 110.21 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -73.76 152.22 40.41 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -161.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -140.67 134.09 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 127.038 2.135 . . . . 0.0 108.782 164.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.21 -149.57 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.29 1.836 . . . . 0.0 113.166 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -41.31 157.09 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.516 1.926 . . . . 0.0 115.232 -166.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.3 p -48.38 -29.75 4.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.421 1.488 . . . . 0.0 114.426 166.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.37 -7.41 50.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.336 1.054 . . . . 0.0 113.566 -170.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.08 -20.92 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.477 1.111 . . . . 0.0 112.974 159.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.6 mt -54.99 -39.87 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.849 1.26 . . . . 0.0 112.202 171.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 m -63.04 -3.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -117.36 -53.15 0.32 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.215 0.912 . . . . 0.0 113.111 156.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.4 mt -71.16 -30.81 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 121.238 -1.154 . . . . 0.0 113.263 -166.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 tp -74.42 -45.92 43.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.657 1.117 . . . . 0.0 110.646 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -61.23 -35.26 76.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.274 1.03 . . . . 0.0 113.679 -171.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -73.1 -31.11 64.14 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.257 1.423 . . . . 0.0 114.3 172.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -94.64 -11.96 28.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.803 1.241 . . . . 0.0 112.988 -171.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.24 144.08 53.43 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.12 1.768 . . . . 0.0 110.382 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.58 -19.23 19.17 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.281 1.987 . . . . 0.0 115.043 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 33' ' ' LYS . 3.2 mm-40 -75.66 147.78 81.88 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.569 1.077 . . . . 0.0 109.942 165.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.21 145.84 63.5 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.519 2.813 . . . . 0.0 114.146 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -64.05 125.7 15.78 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.922 2.415 . . . . 0.0 112.212 -172.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.44 ' HG ' ' HE3' ' A' ' 33' ' ' LYS . 21.1 mt -73.31 -1.02 16.28 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.861 -1.15 . . . . 0.0 112.918 164.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.15 73.62 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.621 1.568 . . . . 0.0 113.654 174.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.5 m -61.54 113.12 7.3 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.434 0.693 . . . . 0.0 110.864 -169.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.11 135.62 11.1 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.97 1.78 . . . . 0.0 111.825 -166.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -75.06 172.43 16.38 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.809 2.339 . . . . 0.0 110.728 160.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -60.03 -26.51 66.16 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.647 -1.283 . . . . 0.0 113.399 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -58.05 -22.91 52.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.958 1.303 . . . . 0.0 114.021 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.59 -23.32 67.23 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.942 -1.099 . . . . 0.0 113.694 173.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.4 p -65.87 -14.5 61.58 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.4 t -116.33 -38.87 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.004 1.322 . . . . 0.0 111.663 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.47 -27.14 69.04 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.513 1.054 . . . . 0.0 114.892 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.1 p -67.97 -20.43 65.04 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 171.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -86.63 -39.88 15.68 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.307 1.443 . . . . 0.0 111.793 171.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.2 mt -66.88 -32.81 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.614 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.87 -51.67 80.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-O 117.438 -1.267 . . . . 0.0 113.987 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.81 -28.29 3.42 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.117 2.545 . . . . 0.0 114.333 169.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.6 p -69.24 -29.89 67.91 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.305 1.866 . . . . 0.0 112.841 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -65.39 -39.88 92.77 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.7 -1.25 . . . . 0.0 113.401 164.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.21 -38.76 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 119.974 1.261 . . . . 0.0 111.035 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -66.7 -42.67 86.03 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.418 1.087 . . . . 0.0 112.454 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -64.57 -39.95 94.66 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.839 0.856 . . . . 0.0 112.879 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.5 mt -70.99 5.95 1.79 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.475 1.51 . . . . 0.0 114.195 168.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -128.93 55.81 1.71 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.036 2.134 . . . . 0.0 109.577 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -61.77 20.94 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 129.733 3.213 . . . . 0.0 117.474 -159.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -73.07 -22.02 60.67 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.745 -1.222 . . . . 0.0 111.966 158.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -72.18 122.81 88.39 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.687 -1.149 . . . . 0.0 108.166 152.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -64.31 115.27 3.07 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.547 1.498 . . . . 0.0 112.656 -170.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -50.08 -44.62 51.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.48 -16.02 63.23 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -98.03 -38.23 4.15 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.259 1.409 . . . . 0.0 113.098 167.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.0 m -59.31 -39.48 83.21 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.34 1.07 . . . . 0.0 112.252 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -63.07 -26.35 68.79 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.009 1.724 . . . . 0.0 113.21 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -69.83 -41.04 75.48 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.316 -0.865 . . . . 0.0 111.269 173.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.4 87.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.336 -0.852 . . . . 0.0 112.503 171.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.65 -40.37 96.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.273 0.488 . . . . 0.0 112.286 172.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.87 -42.3 94.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.221 0.919 . . . . 0.0 112.118 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.486 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 7.4 mm-40 -69.39 -36.19 76.54 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.892 1.224 . . . . 0.0 112.839 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -66.16 -46.25 78.11 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.298 -0.877 . . . . 0.0 112.326 171.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.69 -31.45 69.5 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.692 -1.147 . . . . 0.0 113.29 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.486 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 74.1 mttt -62.27 -45.99 90.82 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.591 1.541 . . . . 0.0 111.72 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.85 -29.62 70.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.501 0.72 . . . . 0.0 112.667 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -77.24 -57.66 3.71 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.117 0.967 . . . . 0.0 112.048 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.81 -33.0 74.64 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.425 1.49 . . . . 0.0 113.796 -170.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.03 -27.7 57.46 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.123 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -105.94 -20.15 13.52 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.34 -35.04 79.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.386 1.448 . . . . 0.0 112.376 171.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -65.21 -7.26 12.08 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.27 -38.53 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.796 1.238 . . . . 0.0 111.78 170.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -102.02 7.14 41.36 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.51 -141.27 15.51 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-O 117.41 -1.772 . . . . 0.0 115.891 157.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.84 -7.74 9.36 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.368 2.712 . . . . 0.0 118.072 -143.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -130.37 162.12 29.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.539 1.518 . . . . 0.0 111.633 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 tt -75.45 -4.42 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.428 -1.42 . . . . 0.0 113.541 -171.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.39 2.06 47.52 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 126.458 1.903 . . . . 0.0 115.206 161.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.47 -127.53 9.12 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.647 1.594 . . . . 0.0 113.133 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -62.2 -27.48 69.0 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -138.42 149.07 45.14 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.997 1.719 . . . . 0.0 109.598 -173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.9 mt -60.39 114.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.55 1.14 . . . . 0.0 109.936 164.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.9 p -143.38 -157.91 0.82 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.366 1.066 . . . . 0.0 111.044 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.71 -25.6 4.52 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -169.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.4 t -75.16 -40.83 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.863 1.21 . . . . 0.0 111.954 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.8 -44.54 96.65 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.047 -1.033 . . . . 0.0 112.179 167.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.35 -27.14 67.13 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.701 0.4 . . . . 0.0 112.068 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.4 m -83.67 -49.64 8.95 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.765 1.226 . . . . 0.0 112.638 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.5 mt -103.08 -33.85 9.1 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -162.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.4 99.02 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -171.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.24 -26.74 12.23 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 CA-C-N 120.758 1.306 . . . . 0.0 113.228 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -68.52 -34.82 76.55 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.14 -0.975 . . . . 0.0 112.235 172.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.51 -41.33 96.49 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.857 0.863 . . . . 0.0 112.571 172.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -65.26 -43.78 90.22 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.822 0.737 . . . . 0.0 112.508 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -63.2 -31.22 72.31 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.551 -0.718 . . . . 0.0 112.631 176.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.54 -49.5 26.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.482 1.513 . . . . 0.0 112.53 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -57.97 -35.81 71.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.338 1.055 . . . . 0.0 111.974 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.0 t -90.46 -63.33 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.625 0.77 . . . . 0.0 113.001 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.16 -47.74 23.1 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.055 -1.028 . . . . 0.0 113.558 -164.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.9 tt -76.35 -33.8 58.94 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.82 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.74 -27.31 66.29 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 118.681 -1.066 . . . . 0.0 115.702 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.03 -23.89 65.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.818 1.247 . . . . 0.0 114.218 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -116.73 -30.19 5.85 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.322 1.049 . . . . 0.0 113.34 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -150.7 96.38 2.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.755 1.622 . . . . 0.0 109.449 168.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.38 99.02 0.52 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.812 -0.555 . . . . 0.0 110.414 169.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.3 t90 -77.42 113.13 28.8 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.616 1.166 . . . . 0.0 110.991 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.9 112.56 3.59 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.107 1.871 . . . . 0.0 110.905 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 85.3 mt -65.49 114.06 14.18 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 164.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -67.43 159.04 54.24 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.801 1.667 . . . . 0.0 112.714 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.66 -27.48 64.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.016 1.727 . . . . 0.0 113.679 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -63.76 -24.89 67.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.677 1.191 . . . . 0.0 113.82 173.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.49 51.28 2.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.75 1.62 . . . . 0.0 111.183 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.41 -27.69 67.28 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.454 1.101 . . . . 0.0 113.781 -156.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -74.63 -51.68 13.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.883 1.22 . . . . 0.0 110.428 168.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.5 t -59.21 -37.79 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 118.959 0.8 . . . . 0.0 112.087 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.0 tp -62.34 -44.23 96.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.906 1.283 . . . . 0.0 113.136 174.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -71.44 -32.45 68.36 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.572 -0.705 . . . . 0.0 112.842 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.07 -29.63 70.75 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.445 1.098 . . . . 0.0 112.99 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.3 mm -54.18 -39.43 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.323 -0.861 . . . . 0.0 111.429 168.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -85.47 -5.35 59.3 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.472 -1.392 . . . . 0.0 114.238 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.3 mt -76.56 -18.51 58.63 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.609 159.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.68 -21.45 66.4 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.116 1.325 . . . . 0.0 113.318 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -89.34 8.59 29.84 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.631 1.572 . . . . 0.0 113.102 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.2 p -128.94 175.27 8.79 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -165.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 53.88 -164.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.265 1.826 . . . . 0.0 110.795 -166.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -80.62 -39.0 28.21 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.34 1.456 . . . . 0.0 109.426 158.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -49.67 75.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.151 2.58 . . . . 0.0 112.948 -165.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -96.0 -42.54 8.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -59.5 -33.82 71.82 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.03 -25.38 55.61 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.4 p -89.43 -10.57 45.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -55.32 122.83 12.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.407 1.083 . . . . 0.0 110.221 167.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -93.46 153.99 18.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.046 0.938 . . . . 0.0 112.56 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.8 128.95 38.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.893 0.877 . . . . 0.0 111.051 166.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -79.39 -35.18 41.1 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.455 1.502 . . . . 0.0 113.47 -147.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -39.09 80.86 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.608 1.563 . . . . 0.0 112.982 168.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -81.45 -8.16 59.69 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.12 -46.77 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 120.078 1.308 . . . . 0.0 110.205 160.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.6 mt -63.14 -56.34 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.776 1.23 . . . . 0.0 111.4 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.84 68.88 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -84.48 -19.84 59.55 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 120.95 -1.094 . . . . 0.0 114.017 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -75.82 -31.98 59.62 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.554 1.677 . . . . 0.0 113.199 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -43.27 -56.15 7.06 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.59 -29.51 52.3 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 121.968 1.739 . . . . 0.0 113.421 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -82.12 -3.24 54.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.941 1.696 . . . . 0.0 114.482 -175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.2 p -69.95 -13.93 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 118.707 0.685 . . . . 0.0 112.299 162.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -122.2 -40.63 2.48 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.451 1.5 . . . . 0.0 114.093 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.141 0 CA-C-O 116.215 -1.85 . . . . 0.0 114.362 -175.698 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.29 -164.05 0.07 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.973 0.909 . . . . 0.0 111.845 -163.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.96 105.04 5.03 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.074 -1.016 . . . . 0.0 111.231 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -112.91 118.75 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.056 0.942 . . . . 0.0 109.832 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.4 mt -102.67 142.35 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.322 1.449 . . . . 0.0 108.333 -176.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.9 m -121.93 135.16 54.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.841 0.746 . . . . 0.0 109.72 162.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.92 142.6 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.28 1.032 . . . . 0.0 110.06 -163.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.715 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 31.1 tttm -64.25 127.51 31.77 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.71 176.24 9.11 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.394 1.878 . . . . 0.0 111.916 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.82 140.32 30.52 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.542 -0.724 . . . . 0.0 111.934 167.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.5 t -54.12 121.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 121.061 0.457 . . . . 0.0 109.966 168.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.56 -9.12 51.96 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 118.26 -1.3 . . . . 0.0 116.265 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.3 84.27 24.43 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 120.106 1.953 . . . . 0.0 112.459 -172.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.59 -12.79 35.32 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.206 2.604 . . . . 0.0 116.476 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -74.51 -11.23 60.16 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 pt -145.74 163.37 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.117 1.367 . . . . 0.0 112.243 -164.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.8 mt -75.83 -43.64 44.9 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.84 -127.12 8.78 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.702 1.144 . . . . 0.0 115.001 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' OD2' ' HE3' ' A' ' 209' ' ' LYS . 7.9 p-10 -65.23 16.42 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.525 2.73 . . . . 0.0 117.026 -170.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.4 p -115.2 73.49 3.56 Favored Pre-proline 0 C--O 1.262 1.733 0 O-C-N 119.755 -1.841 . . . . 0.0 110.967 -158.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.81 -26.88 31.88 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.593 2.862 . . . . 0.0 112.76 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -63.03 -42.02 99.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.649 1.18 . . . . 0.0 112.661 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.715 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.4 m -61.34 -42.61 98.97 Favored 'General case' 0 C--N 1.376 1.746 0 O-C-N 119.543 -1.973 . . . . 0.0 111.02 170.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -65.5 -26.9 68.12 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 117.284 -1.341 . . . . 0.0 112.797 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -54.45 -44.12 72.23 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.772 1.169 . . . . 0.0 112.776 171.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.4 t -73.38 -38.39 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.261 1.424 . . . . 0.0 112.043 -172.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -74.85 -36.73 62.34 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.691 0.796 . . . . 0.0 111.432 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -59.25 -44.29 92.4 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.501 1.52 . . . . 0.0 113.271 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 p -70.06 -39.5 75.64 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.609 1.095 . . . . 0.0 112.998 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.78 -33.44 66.3 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -77.85 -25.37 48.69 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 173.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -67.04 -39.92 87.06 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.776 -1.202 . . . . 0.0 111.948 163.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -75.02 -1.79 24.33 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 169.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm 62.68 10.17 4.0 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.943 2.097 . . . . 0.0 115.6 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.42 ' CD1' HD22 ' A' ' 84' ' ' ASN . 59.8 mt -80.47 130.54 64.64 Favored Pre-proline 0 N--CA 1.472 0.648 0 O-C-N 121.159 -0.963 . . . . 0.0 110.374 -168.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.63 145.85 53.24 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.577 2.185 . . . . 0.0 112.195 171.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -146.64 161.17 41.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.956 1.702 . . . . 0.0 109.957 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -99.75 103.17 14.8 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.393 -0.817 . . . . 0.0 110.133 170.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.4 t -82.99 136.08 34.64 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.612 0.765 . . . . 0.0 112.364 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -119.63 95.12 4.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.557 1.543 . . . . 0.0 109.525 172.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.2 mt -70.94 136.46 48.53 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.56 0.744 . . . . 0.0 110.919 172.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.12 117.43 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.471 1.508 . . . . 0.0 110.23 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -83.05 107.56 15.72 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.452 -0.78 . . . . 0.0 109.546 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.0 mt 52.13 23.59 2.36 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 169.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.4 21.08 11.94 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -66.41 23.17 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -140.93 150.84 60.79 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 125.729 1.612 . . . . 0.0 111.276 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -60.53 162.41 17.97 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.445 2.096 . . . . 0.0 111.674 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.67 -10.62 20.04 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -167.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -55.84 -24.25 35.39 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.106 2.162 . . . . 0.0 114.882 170.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -102.96 3.47 36.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.654 1.582 . . . . 0.0 113.454 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.6 mt -128.77 -39.55 1.61 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.204 2.202 . . . . 0.0 112.539 -169.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.22 -11.98 4.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 128.509 2.723 . . . . 0.0 114.669 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.7 mt -63.04 -21.0 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 127.039 2.136 . . . . 0.0 111.162 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -109.93 148.43 38.24 Favored Pre-proline 0 N--CA 1.472 0.647 0 C-N-CA 124.123 0.969 . . . . 0.0 111.104 157.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.61 -15.96 45.85 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.843 2.362 . . . . 0.0 113.426 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.71 -0.28 54.43 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.422 1.489 . . . . 0.0 113.01 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 12.57 63.86 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 120.907 -1.121 . . . . 0.0 114.847 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -76.62 164.29 26.05 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.931 1.692 . . . . 0.0 112.089 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.17 150.24 74.85 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.439 1.895 . . . . 0.0 108.129 154.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.94 151.89 94.54 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 N-CA-C 116.723 1.778 . . . . 0.0 116.723 13.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.4 m -158.09 165.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 128.528 2.731 . . . . 0.0 110.603 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.36 145.35 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 120.92 -1.113 . . . . 0.0 113.938 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -97.95 111.04 23.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.885 1.674 . . . . 0.0 109.067 161.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.34 83.99 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.619 1.168 . . . . 0.0 108.384 174.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 55.94 51.38 12.21 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.276 1.03 . . . . 0.0 113.244 -166.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.68 25.2 14.12 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -175.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -113.93 111.74 22.19 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.034 1.333 . . . . 0.0 108.517 169.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -84.73 149.96 25.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.254 -151.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.05 132.36 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.761 1.624 . . . . 0.0 109.357 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.44 -149.45 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.054 1.742 . . . . 0.0 113.149 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -35.08 155.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.805 2.042 . . . . 0.0 116.411 -171.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 p -47.51 -30.47 3.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.181 1.392 . . . . 0.0 113.934 160.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -90.6 -8.44 50.15 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.623 1.169 . . . . 0.0 113.303 -171.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.75 -23.33 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.085 0.954 . . . . 0.0 113.01 158.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.4 mt -56.48 -40.06 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.023 1.329 . . . . 0.0 112.184 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -61.43 -9.39 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.82 -58.52 0.57 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.482 1.039 . . . . 0.0 112.935 158.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.0 -35.59 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.229 -1.16 . . . . 0.0 113.366 -164.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.63 -43.21 63.55 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.346 0.976 . . . . 0.0 110.922 171.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -64.9 -28.24 69.4 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -68.5 -37.19 79.85 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.249 1.419 . . . . 0.0 114.57 167.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -108.28 -12.35 15.08 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.959 1.303 . . . . 0.0 113.259 -161.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.42 HD22 ' CD1' ' A' ' 35' ' ' ILE . 25.6 t-20 -73.21 142.55 82.25 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.122 1.769 . . . . 0.0 109.99 163.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.05 -21.94 20.05 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.149 1.9 . . . . 0.0 114.656 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -74.58 146.67 83.84 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 119.154 0.888 . . . . 0.0 110.476 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -55.24 144.81 69.3 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.845 2.363 . . . . 0.0 114.08 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.83 133.6 51.91 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.315 2.676 . . . . 0.0 112.765 -171.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.4 mt -80.37 -0.92 39.0 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.533 -0.729 . . . . 0.0 112.915 160.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.06 -32.09 73.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.316 1.447 . . . . 0.0 114.057 175.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.0 m -62.71 115.38 16.55 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 123.577 0.751 . . . . 0.0 110.777 -168.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -80.17 134.72 10.52 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 121.889 1.726 . . . . 0.0 112.099 -168.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -75.63 175.13 11.69 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.971 2.447 . . . . 0.0 110.61 156.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -58.19 -29.18 65.45 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.578 -1.326 . . . . 0.0 113.458 173.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -57.69 -25.25 60.03 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.316 1.446 . . . . 0.0 114.4 173.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.38 -28.25 69.86 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.91 0.777 . . . . 0.0 113.05 175.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.3 p -61.91 -42.54 99.21 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.296 0.638 . . . . 0.0 112.226 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.57 -38.33 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.946 0.898 . . . . 0.0 112.11 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.11 -23.77 64.35 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.957 1.265 . . . . 0.0 114.368 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 p -62.66 -25.25 68.04 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 172.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -84.17 -41.57 16.88 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.853 1.261 . . . . 0.0 112.368 173.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.3 mt -68.34 -34.9 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.098 0.959 . . . . 0.0 111.316 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.32 -48.56 93.66 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 120.519 -1.363 . . . . 0.0 114.301 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.99 -31.5 2.27 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.289 2.659 . . . . 0.0 114.129 170.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.2 p -69.25 -26.41 64.77 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 121.207 1.821 . . . . 0.0 112.987 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -62.38 -42.03 99.1 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.358 -1.464 . . . . 0.0 113.531 161.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.48 -36.73 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 119.856 1.207 . . . . 0.0 110.821 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -66.65 -44.23 82.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.415 1.486 . . . . 0.0 112.306 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -66.78 -37.29 84.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.046 1.338 . . . . 0.0 113.295 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.6 mt -75.95 13.9 0.78 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.862 1.265 . . . . 0.0 113.627 168.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -140.02 60.25 1.56 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.02 2.128 . . . . 0.0 110.12 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -57.0 17.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 130.799 3.64 . . . . 0.0 119.237 -160.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.59 -30.42 64.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.294 1.838 . . . . 0.0 111.835 169.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -81.13 121.78 80.9 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 117.726 -1.13 . . . . 0.0 108.324 159.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -56.72 124.75 16.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.3 2.0 . . . . 0.0 114.056 -167.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -60.35 -43.69 96.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 117.791 -1.099 . . . . 0.0 113.538 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.86 -20.78 66.08 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.49 -39.76 6.63 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.025 -1.047 . . . . 0.0 113.227 170.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.5 m -67.89 -26.8 66.18 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.445 -1.032 . . . . 0.0 113.524 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -65.19 -36.9 85.64 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.93 1.292 . . . . 0.0 112.219 170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -68.11 -39.43 82.79 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.225 -0.922 . . . . 0.0 111.73 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.41 -42.95 92.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.075 0.55 . . . . 0.0 112.472 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -62.49 -39.3 93.04 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.014 0.926 . . . . 0.0 112.475 174.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.76 -37.23 86.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.756 1.162 . . . . 0.0 112.2 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.451 ' HA ' ' HE3' ' A' ' 128' ' ' LYS . 10.5 tp10 -69.9 -33.83 72.72 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.723 1.147 . . . . 0.0 113.11 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -70.88 -44.94 65.28 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.837 -1.165 . . . . 0.0 112.692 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.5 mt -73.52 -31.34 63.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.666 -1.159 . . . . 0.0 113.389 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 125' ' ' GLU . 39.5 mtmt -59.03 -43.06 91.57 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.381 1.446 . . . . 0.0 112.214 173.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.07 72.81 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.07 -54.23 8.28 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.66 0.784 . . . . 0.0 111.454 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.03 -35.79 81.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.688 1.595 . . . . 0.0 113.661 -172.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.14 -34.5 73.49 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.708 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -93.15 -27.55 16.84 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.7 mt -64.54 -36.89 85.67 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.306 1.412 . . . . 0.0 112.3 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -64.06 -9.21 14.91 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 172.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.5 t -98.48 -33.48 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.871 1.268 . . . . 0.0 112.334 171.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -95.42 -25.08 16.4 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.99 -167.83 16.43 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-O 118.478 -1.179 . . . . 0.0 114.751 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -81.77 -5.75 12.37 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.607 2.871 . . . . 0.0 117.107 -122.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -107.47 160.17 15.85 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.77 -1.206 . . . . 0.0 110.685 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.261 8.7 tt -76.71 -3.72 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 119.915 -1.741 . . . . 0.0 112.907 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.5 -1.29 44.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.158 1.783 . . . . 0.0 115.377 159.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.64 -125.87 7.79 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 120.411 1.46 . . . . 0.0 113.917 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -69.44 -20.7 63.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.687 1.195 . . . . 0.0 113.972 -171.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -138.87 150.68 46.26 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.312 1.845 . . . . 0.0 109.825 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.8 mt -66.67 111.71 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.613 0.765 . . . . 0.0 109.264 165.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.9 p -140.57 -162.64 1.39 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.476 1.11 . . . . 0.0 110.845 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.02 -25.52 3.46 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.37 -40.63 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 119.812 1.187 . . . . 0.0 112.101 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.67 -45.02 95.78 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.768 -1.207 . . . . 0.0 112.475 166.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.97 -24.99 64.86 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.9 m -86.61 -55.44 3.87 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.789 1.235 . . . . 0.0 112.35 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.15 -31.5 14.76 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -161.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.94 -50.74 84.99 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -169.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.86 -23.83 18.48 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 120.842 1.337 . . . . 0.0 112.799 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -72.82 -35.69 67.36 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.414 172.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 41.4 mt -63.7 -37.85 88.92 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.249 0.931 . . . . 0.0 112.726 169.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -64.34 -42.89 96.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.412 0.551 . . . . 0.0 112.27 172.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -68.19 -27.07 66.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.815 0.846 . . . . 0.0 113.117 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.03 -55.91 12.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.549 1.14 . . . . 0.0 111.466 166.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -60.0 -36.62 77.59 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.723 0.692 . . . . 0.0 112.042 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 78.2 t -86.78 -66.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.06 -50.32 15.05 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.125 -0.984 . . . . 0.0 113.251 -161.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 52.6 tp -79.65 -32.74 41.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.846 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.11 -25.88 65.05 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.554 1.073 . . . . 0.0 114.999 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -63.14 -24.17 67.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -115.46 -28.36 6.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.143 0.977 . . . . 0.0 113.553 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -148.76 101.87 3.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.211 1.404 . . . . 0.0 109.109 164.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -71.63 85.5 0.89 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.505 0.722 . . . . 0.0 110.092 170.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -68.55 113.86 18.39 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.802 1.241 . . . . 0.0 110.302 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.97 120.62 6.45 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.974 1.783 . . . . 0.0 110.907 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 52.9 mt -68.36 117.26 48.07 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 163.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -64.39 157.72 53.05 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.208 1.938 . . . . 0.0 112.826 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -27.94 66.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.599 1.56 . . . . 0.0 113.196 174.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -65.82 -27.01 67.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.473 1.109 . . . . 0.0 113.659 173.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.3 mt -85.79 52.32 2.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.073 1.349 . . . . 0.0 110.793 168.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.15 -29.71 71.01 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.46 1.104 . . . . 0.0 112.63 -161.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -76.66 -47.23 22.8 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.597 0.635 . . . . 0.0 111.604 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.03 -40.51 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.231 0.612 . . . . 0.0 111.16 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.67 -45.17 91.33 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.768 1.227 . . . . 0.0 113.245 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -67.1 -36.65 82.39 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.49 -0.756 . . . . 0.0 112.517 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -63.84 -27.46 69.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.943 0.897 . . . . 0.0 113.365 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 44.0 mm -54.14 -36.17 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 120.997 -1.064 . . . . 0.0 111.962 168.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -89.03 -8.69 53.52 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.537 -1.352 . . . . 0.0 114.054 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 78.3 mt -74.08 -19.08 60.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 116.645 -1.645 . . . . 0.0 113.611 158.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 56.2 mt -62.96 -22.41 66.79 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.369 1.44 . . . . 0.0 113.055 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -93.56 9.04 38.41 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.364 1.466 . . . . 0.0 112.982 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.3 p -123.44 176.46 6.15 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.008 1.723 . . . . 0.0 114.424 -166.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 52.7 -163.87 0.08 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.81 1.644 . . . . 0.0 110.763 -170.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -78.68 -43.58 25.67 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 125.947 1.699 . . . . 0.0 110.275 154.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.02 -49.58 71.19 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 128.013 2.525 . . . . 0.0 112.916 -164.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -91.13 -44.92 8.97 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.79 -34.03 71.01 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -75.03 -24.53 58.32 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.419 1.009 . . . . 0.0 113.424 174.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 35.9 p -88.48 -12.29 43.44 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -53.56 110.55 0.58 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.14 1.376 . . . . 0.0 110.041 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.44 141.52 28.65 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.684 0.793 . . . . 0.0 112.005 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.61 119.47 5.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.703 1.201 . . . . 0.0 111.837 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -67.81 -38.01 82.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -149.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -59.15 -36.57 75.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.131 1.372 . . . . 0.0 112.502 174.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -82.35 -11.17 58.75 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.88 -43.97 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.921 0.782 . . . . 0.0 109.912 164.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.8 mt -62.28 -57.0 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.281 1.432 . . . . 0.0 111.364 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.53 70.38 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.37 -19.9 65.57 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.947 -1.096 . . . . 0.0 114.11 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -80.13 -27.57 39.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.586 1.193 . . . . 0.0 113.578 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -50.65 -49.94 75.8 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.47 -25.18 30.18 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 CA-C-N 121.881 1.707 . . . . 0.0 113.293 173.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HE3' ' OD2' ' A' ' 19' ' ' ASP . 57.1 mttm -84.58 -12.92 53.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.989 1.716 . . . . 0.0 114.984 -175.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -22.29 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 118.634 0.652 . . . . 0.0 111.372 161.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -97.76 -53.18 3.5 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 117.414 -1.279 . . . . 0.0 114.01 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 C-N-CA 126.712 2.005 . . . . 0.0 114.026 -168.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.0 mtp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 119.113 -0.47 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.31 -164.73 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.51 1.124 . . . . 0.0 112.004 -169.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.4 mt -71.1 103.7 2.82 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.92 -1.112 . . . . 0.0 110.847 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -109.59 118.76 37.42 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.793 0.837 . . . . 0.0 109.654 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.1 mt -100.1 142.66 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.399 1.08 . . . . 0.0 108.17 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.1 m -123.6 132.32 53.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.634 0.652 . . . . 0.0 109.406 163.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.1 142.06 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.701 1.201 . . . . 0.0 109.775 -162.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.67 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 32.0 tttm -65.58 127.48 32.04 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.352 -0.843 . . . . 0.0 109.377 171.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.53 176.36 9.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.7 2.0 . . . . 0.0 111.767 170.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.25 141.79 34.08 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.434 -0.791 . . . . 0.0 111.621 166.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 81.5 t -54.46 121.36 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.941 -0.474 . . . . 0.0 109.88 168.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.31 -15.39 34.63 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.073 1.321 . . . . 0.0 116.085 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -132.53 90.35 33.59 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 119.768 1.784 . . . . 0.0 112.211 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.36 -13.44 39.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.396 2.731 . . . . 0.0 115.249 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -76.14 -12.38 60.1 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.6 pt -142.93 162.64 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.796 1.238 . . . . 0.0 112.113 -165.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.1 mt -74.4 -43.05 58.06 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.23 -125.94 7.17 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.907 1.241 . . . . 0.0 114.622 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.96 18.51 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 128.774 2.83 . . . . 0.0 117.178 -172.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.421 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 68.7 m -119.23 68.78 9.99 Favored Pre-proline 0 C--O 1.262 1.749 0 O-C-N 120.558 -1.339 . . . . 0.0 110.965 -160.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.37 -22.11 39.97 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.975 3.117 . . . . 0.0 113.12 174.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -62.93 -42.22 99.73 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.405 -0.809 . . . . 0.0 112.786 167.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.2 m -61.57 -41.82 97.95 Favored 'General case' 0 C--N 1.369 1.447 0 O-C-N 120.015 -1.678 . . . . 0.0 111.006 170.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.04 -29.46 70.83 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 117.192 -1.385 . . . . 0.0 113.014 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -54.1 -43.19 70.2 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.141 1.337 . . . . 0.0 112.718 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.78 -36.72 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.369 1.468 . . . . 0.0 111.941 -173.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.31 -39.7 65.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.756 0.822 . . . . 0.0 111.279 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.7 tp -57.58 -44.79 85.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.975 1.71 . . . . 0.0 112.977 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -68.91 -43.13 75.82 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.48 1.037 . . . . 0.0 112.799 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.04 -32.44 69.17 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -77.73 -25.52 49.33 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 173.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.427 ' CD ' HH22 ' A' ' 189' ' ' ARG . 23.4 tp10 -70.68 -36.04 73.11 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.441 -1.412 . . . . 0.0 112.106 164.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE3' ' HG ' ' A' ' 89' ' ' LEU . 65.2 mttt -73.21 -3.49 27.02 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 167.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm 60.93 12.55 3.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.241 2.217 . . . . 0.0 115.024 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.8 mt -80.14 131.01 63.99 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 124.223 1.009 . . . . 0.0 110.307 -172.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.75 147.06 44.12 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.791 2.328 . . . . 0.0 112.483 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -147.33 159.28 43.86 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.489 1.516 . . . . 0.0 110.972 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -96.89 95.08 7.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.368 1.067 . . . . 0.0 110.289 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.7 t -82.06 136.54 35.2 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -118.7 100.6 7.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.758 1.623 . . . . 0.0 109.5 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.0 mt -73.14 135.9 44.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.375 0.67 . . . . 0.0 110.717 170.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mt -129.5 117.35 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.41 1.484 . . . . 0.0 110.532 -172.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -86.77 101.16 13.06 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.697 -0.627 . . . . 0.0 109.964 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.2 mt 53.67 21.52 2.66 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 170.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.06 23.54 9.1 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-O 118.884 -0.954 . . . . 0.0 115.246 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -64.15 10.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -140.15 145.34 41.42 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 126.0 1.72 . . . . 0.0 110.305 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -63.5 167.67 12.78 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.084 2.523 . . . . 0.0 112.238 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.53 -13.95 36.5 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 116.268 -1.825 . . . . 0.0 115.627 -168.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -56.64 -17.68 9.56 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 167.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -108.58 6.43 25.95 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.82 1.648 . . . . 0.0 113.517 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.1 mt -130.8 -41.07 1.17 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.461 2.304 . . . . 0.0 112.702 -170.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.93 -6.58 3.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.286 2.635 . . . . 0.0 114.961 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.1 mt -63.39 -17.87 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 126.961 2.104 . . . . 0.0 111.123 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 p -115.43 149.95 43.74 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.426 1.09 . . . . 0.0 111.446 156.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.25 -27.0 56.27 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.801 2.334 . . . . 0.0 113.043 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -75.27 -10.36 59.39 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.504 1.522 . . . . 0.0 113.626 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.62 12.5 59.24 Favored Glycine 0 CA--C 1.54 1.608 0 O-C-N 120.431 -1.418 . . . . 0.0 114.39 -166.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.4 ' HZ2' ' CG ' ' A' ' 72' ' ' ASP . 47.2 mtpt -70.57 160.1 33.12 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.148 1.379 . . . . 0.0 111.295 175.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.4 m -135.09 149.39 70.09 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 125.965 1.706 . . . . 0.0 108.465 155.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -75.91 151.7 95.88 Favored 'Cis proline' 0 CA--C 1.541 0.855 0 N-CA-C 117.192 1.959 . . . . 0.0 117.192 15.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.8 m -157.44 166.77 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 128.399 2.68 . . . . 0.0 111.023 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.78 144.83 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 171.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -96.14 111.0 23.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.703 2.001 . . . . 0.0 109.063 162.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.3 mt -89.55 79.75 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.052 0.941 . . . . 0.0 108.935 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.87 52.35 10.84 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.039 0.936 . . . . 0.0 112.207 -163.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.77 18.8 7.62 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -174.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -102.71 105.89 16.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.035 -1.041 . . . . 0.0 108.452 167.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -75.94 150.56 37.47 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -157.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.0 t -141.88 133.19 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.483 1.913 . . . . 0.0 108.829 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.63 -145.24 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.214 1.806 . . . . 0.0 113.341 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' CG ' ' HZ2' ' A' ' 59' ' ' LYS . 77.4 m-20 -38.3 154.19 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.395 1.878 . . . . 0.0 116.026 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.0 p -48.9 -30.29 5.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.099 1.36 . . . . 0.0 113.831 164.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -92.13 -6.23 51.2 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.221 1.008 . . . . 0.0 113.341 -171.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.8 m -106.04 -22.07 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.195 0.998 . . . . 0.0 113.082 158.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.4 mt -56.24 -40.15 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.043 1.337 . . . . 0.0 112.136 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 m -62.12 -9.89 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 114.509 1.299 . . . . 0.0 114.509 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.05 -57.76 0.68 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.275 0.94 . . . . 0.0 113.038 159.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.2 mt -75.0 -30.3 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -163.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 tp -72.83 -43.31 62.82 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.671 -1.268 . . . . 0.0 110.612 167.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -65.96 -30.37 70.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.493 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 21.9 tt0 -65.09 -45.89 83.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.449 1.9 . . . . 0.0 113.013 168.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 94.8 mttt -92.73 -9.44 40.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.58 1.152 . . . . 0.0 113.728 -168.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.16 142.73 55.56 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.568 1.547 . . . . 0.0 110.494 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.12 -16.49 28.58 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.254 1.969 . . . . 0.0 115.263 -173.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -81.97 149.03 62.21 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 119.812 1.187 . . . . 0.0 110.957 165.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -53.03 146.16 38.76 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.262 2.641 . . . . 0.0 115.042 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.03 124.33 12.09 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.533 2.822 . . . . 0.0 113.57 -167.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.439 ' HG ' ' HE3' ' A' ' 33' ' ' LYS . 19.4 mt -70.81 -5.72 32.36 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.328 -0.857 . . . . 0.0 113.186 163.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.26 -28.44 64.92 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.134 1.374 . . . . 0.0 113.513 170.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.3 m -61.88 113.59 8.87 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.134 0.973 . . . . 0.0 110.893 -166.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -80.21 125.08 5.66 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.156 1.904 . . . . 0.0 111.88 -171.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.49 170.97 18.69 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.378 2.052 . . . . 0.0 110.071 154.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.37 -23.98 64.72 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.847 -1.158 . . . . 0.0 113.79 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -54.9 -27.43 42.89 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.423 1.489 . . . . 0.0 114.247 170.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.04 -27.53 69.17 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.4 p -64.08 -42.38 96.98 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.861 0.755 . . . . 0.0 112.1 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 t -79.63 -38.82 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.52 1.128 . . . . 0.0 111.681 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.11 -23.28 61.63 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.038 1.304 . . . . 0.0 114.483 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.5 p -63.63 -24.85 67.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.868 1.267 . . . . 0.0 113.75 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -84.01 -45.32 13.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.688 1.195 . . . . 0.0 111.873 170.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.6 mt -68.23 -36.66 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.723 0.809 . . . . 0.0 111.466 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -61.17 -47.65 94.11 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 120.43 -1.419 . . . . 0.0 113.984 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.52 -31.78 2.49 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.087 2.525 . . . . 0.0 114.28 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.7 p -70.08 -24.0 63.15 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.147 1.794 . . . . 0.0 113.292 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -62.84 -40.2 96.71 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.057 -1.652 . . . . 0.0 113.575 161.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.8 t -66.12 -37.6 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.875 -1.141 . . . . 0.0 110.649 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -63.76 -45.56 89.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.317 1.447 . . . . 0.0 111.934 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -63.42 -41.37 98.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.178 1.391 . . . . 0.0 112.839 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.1 mt -69.89 -20.5 63.37 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 173.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -104.04 68.93 0.92 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.357 1.463 . . . . 0.0 110.436 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 m -64.91 27.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.61 2.764 . . . . 0.0 117.793 -162.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 211' ' ' ASN . 93.3 mttt -70.63 -35.24 72.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.908 1.283 . . . . 0.0 112.447 163.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -78.08 116.71 60.94 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 117.494 -1.241 . . . . 0.0 107.793 164.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -53.43 125.27 17.94 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.674 2.25 . . . . 0.0 113.602 -164.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -55.92 -46.57 78.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.137 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.99 -27.68 68.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.54 -34.05 12.49 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.095 -1.003 . . . . 0.0 113.584 173.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.9 m -71.34 -26.72 62.95 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.451 -1.029 . . . . 0.0 113.103 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -64.01 -45.48 88.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.585 1.554 . . . . 0.0 111.57 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -63.72 -40.35 96.55 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.773 -0.58 . . . . 0.0 112.092 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.25 96.2 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.379 -0.826 . . . . 0.0 112.851 172.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.23 -32.05 73.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 117.891 -1.052 . . . . 0.0 112.873 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.25 -40.58 96.67 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.476 1.489 . . . . 0.0 111.718 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.78 -31.19 64.7 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.79 -47.59 62.3 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.205 -0.934 . . . . 0.0 112.28 169.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.8 mt -70.45 -31.11 68.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 117.957 -1.021 . . . . 0.0 113.122 -176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -56.72 -45.31 81.97 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.945 1.248 . . . . 0.0 112.264 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.7 -28.03 66.47 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.98 0.734 . . . . 0.0 112.98 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -78.01 -56.97 4.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.148 0.979 . . . . 0.0 111.222 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.85 -35.05 79.87 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.145 1.778 . . . . 0.0 113.794 -172.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.6 -33.34 66.78 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.895 -0.947 . . . . 0.0 113.903 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -97.08 -26.52 14.96 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.2 mt -61.46 -37.62 84.25 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.467 1.485 . . . . 0.0 112.217 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.93 -12.78 40.36 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.61 -33.66 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.039 1.335 . . . . 0.0 111.679 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -89.03 -50.21 6.3 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.95 -172.81 45.43 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 -167.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -96.34 -8.09 1.13 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.311 3.341 . . . . 0.0 114.487 -171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -100.6 156.71 17.15 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.07 0.948 . . . . 0.0 110.404 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.273 9.8 tt -77.49 0.73 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 120.517 -1.365 . . . . 0.0 113.407 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.26 5.68 37.66 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.626 1.97 . . . . 0.0 114.957 159.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.88 -122.0 7.44 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.56 1.552 . . . . 0.0 113.562 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -66.66 -25.15 66.43 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.751 2.02 . . . . 0.0 114.055 -170.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -143.53 151.54 40.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.021 1.728 . . . . 0.0 109.077 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.6 mt -57.84 112.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.248 1.019 . . . . 0.0 109.802 160.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.7 p -140.23 -162.88 1.41 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.924 1.69 . . . . 0.0 110.773 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.26 -25.42 2.32 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.39 -37.78 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 117.543 -1.217 . . . . 0.0 112.514 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.86 -44.34 96.38 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.753 -1.217 . . . . 0.0 112.296 163.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.0 mt -58.54 -27.61 64.71 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 175.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.5 m -83.97 -60.99 1.93 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.939 1.296 . . . . 0.0 112.55 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.96 -33.2 17.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -160.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.01 90.4 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -171.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -71.97 -27.6 17.25 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 CA-C-N 120.887 1.352 . . . . 0.0 112.676 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -72.6 -33.09 66.46 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 117.629 -1.177 . . . . 0.0 112.641 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.6 mt -64.6 -40.11 94.93 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.075 0.852 . . . . 0.0 112.604 168.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -63.33 -45.07 92.99 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.805 0.729 . . . . 0.0 112.245 173.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -65.24 -27.7 68.84 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.486 -0.758 . . . . 0.0 112.939 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.41 -50.06 20.01 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.772 1.229 . . . . 0.0 113.173 171.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -58.5 -36.76 74.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.231 0.923 . . . . 0.0 111.437 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -81.78 -70.05 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.512 0.725 . . . . 0.0 112.73 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.44 -43.79 31.27 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.957 -1.09 . . . . 0.0 113.623 -163.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.6 tp -79.48 -36.04 39.3 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.983 0.356 . . . . 0.0 111.387 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.56 -29.77 70.38 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.758 1.17 . . . . 0.0 114.638 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -60.81 -33.95 73.79 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 172.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -103.56 -26.31 12.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -152.69 103.69 2.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.048 1.339 . . . . 0.0 109.486 165.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -72.79 76.65 1.13 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.038 0.935 . . . . 0.0 111.754 173.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 41.0 t90 -64.4 111.49 5.69 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.245 1.418 . . . . 0.0 110.631 174.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.7 126.72 9.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.764 1.643 . . . . 0.0 110.21 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.92 117.44 45.51 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 166.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -64.64 159.35 45.4 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.074 1.85 . . . . 0.0 112.868 -174.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -27.31 65.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.68 1.592 . . . . 0.0 113.505 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -68.43 -24.55 64.75 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 73.2 mt -88.53 51.82 2.28 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.417 1.487 . . . . 0.0 110.922 168.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.65 -29.23 69.2 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.805 1.242 . . . . 0.0 113.235 -159.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -72.94 -53.02 12.35 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 119.384 0.993 . . . . 0.0 110.295 171.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.22 -35.15 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 118.909 0.777 . . . . 0.0 111.884 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.4 tp -61.68 -46.09 91.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.704 1.202 . . . . 0.0 113.269 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -69.11 -37.33 78.33 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.537 -0.727 . . . . 0.0 112.601 174.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -62.05 -27.48 68.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.194 1.398 . . . . 0.0 113.479 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 43.8 mm -50.99 -36.35 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.801 0.84 . . . . 0.0 112.163 168.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -85.08 -6.38 59.31 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.322 -1.487 . . . . 0.0 113.859 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 26.2 mt -75.5 -21.8 57.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 117.646 -1.169 . . . . 0.0 113.758 159.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 61.1 mt -62.65 -21.14 65.47 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.947 1.248 . . . . 0.0 113.331 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -95.0 11.28 32.52 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.457 1.503 . . . . 0.0 112.979 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.1 p -130.58 178.57 6.52 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -164.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.427 HH22 ' CD ' ' A' ' 32' ' ' GLU . 66.4 mtp85 54.03 -161.68 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.925 1.69 . . . . 0.0 110.823 -170.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -82.28 -45.01 15.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 125.675 1.59 . . . . 0.0 109.312 157.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.4 p -55.34 -33.33 63.28 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.669 2.388 . . . . 0.0 115.78 -168.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -110.83 -40.24 4.6 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.299 0.954 . . . . 0.0 112.865 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -62.22 -29.36 70.33 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.447 -1.408 . . . . 0.0 113.817 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.75 -26.46 44.61 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 171.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 35.3 p -89.58 -9.04 51.25 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -50.65 114.99 1.29 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.781 1.633 . . . . 0.0 110.099 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -96.36 139.93 31.76 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.677 0.791 . . . . 0.0 111.934 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.35 117.29 3.41 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.785 1.234 . . . . 0.0 111.924 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -67.42 -36.92 82.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.98 1.312 . . . . 0.0 114.052 -149.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -62.06 -36.28 81.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.008 1.323 . . . . 0.0 112.454 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -83.15 -7.56 59.61 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.3 t -78.03 -43.31 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 119.352 0.978 . . . . 0.0 110.033 161.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.0 mt -63.49 -57.67 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.27 1.428 . . . . 0.0 111.394 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.14 69.31 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.27 -14.51 62.02 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 120.934 -1.104 . . . . 0.0 114.324 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -76.67 -37.72 55.72 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.15 1.475 . . . . 0.0 111.838 166.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -46.71 -56.43 11.53 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -168.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.44 -24.91 63.63 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 CA-C-N 122.116 1.791 . . . . 0.0 113.359 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -82.07 -3.66 55.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.225 1.41 . . . . 0.0 114.324 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.0 -20.03 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.248 0.931 . . . . 0.0 110.973 159.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.589 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 23.8 m-80 -105.91 -12.25 15.9 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 175.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.442 0 CA-C-O 115.505 -2.188 . . . . 0.0 115.264 -162.12 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.43 -166.36 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.841 0.856 . . . . 0.0 111.89 -166.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 mt -68.53 112.81 5.56 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.788 -1.195 . . . . 0.0 110.771 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -117.41 101.89 8.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.566 1.146 . . . . 0.0 109.049 167.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.9 mt -81.31 137.52 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.647 1.179 . . . . 0.0 108.656 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.6 m -121.29 132.55 54.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.315 0.507 . . . . 0.0 109.634 166.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.55 142.87 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.097 -1.002 . . . . 0.0 111.079 -158.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.704 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.8 tttm -66.28 128.49 36.33 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.623 -0.673 . . . . 0.0 109.331 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.25 176.13 8.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.017 1.727 . . . . 0.0 112.08 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.08 142.59 19.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.751 0.82 . . . . 0.0 111.951 167.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.4 t -54.45 121.59 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 120.965 0.412 . . . . 0.0 110.15 167.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.8 -8.6 42.22 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.042 1.306 . . . . 0.0 116.357 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.54 83.84 29.72 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 119.929 1.864 . . . . 0.0 112.278 -170.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.8 -13.7 40.8 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.582 2.855 . . . . 0.0 116.613 -172.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -81.84 -6.24 58.91 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.2 pt -142.97 160.01 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.179 1.392 . . . . 0.0 111.762 -167.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.5 mt -73.84 -43.28 59.18 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.83 -128.22 9.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.548 1.071 . . . . 0.0 114.593 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.04 15.56 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.426 2.69 . . . . 0.0 117.266 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.41 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 69.1 m -116.31 73.12 5.23 Favored Pre-proline 0 C--O 1.26 1.622 0 O-C-N 119.928 -1.732 . . . . 0.0 110.948 -158.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.23 -25.01 37.24 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 123.966 3.111 . . . . 0.0 113.098 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -66.97 -33.46 75.62 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.93 -1.106 . . . . 0.0 112.712 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.704 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.4 m -68.02 -43.47 78.7 Favored 'General case' 0 C--N 1.374 1.671 0 O-C-N 119.342 -2.099 . . . . 0.0 110.957 169.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.98 -36.12 76.47 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.799 0.84 . . . . 0.0 112.28 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -54.43 -39.8 67.7 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.582 1.553 . . . . 0.0 113.743 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.78 -36.93 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.843 0.857 . . . . 0.0 112.571 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.25 -39.11 82.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.157 0.583 . . . . 0.0 111.524 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.87 -41.41 95.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.358 1.463 . . . . 0.0 113.78 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 p -72.54 -38.8 67.89 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 119.822 1.192 . . . . 0.0 112.835 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -71.77 -36.8 70.47 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.94 0.896 . . . . 0.0 112.738 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -73.52 -28.81 62.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -69.58 -40.64 76.62 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.711 -1.243 . . . . 0.0 112.215 168.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -71.26 -4.2 24.5 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.23 1.412 . . . . 0.0 114.372 169.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 190' ' ' GLU . 30.6 mmtm 60.58 14.91 5.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.891 2.076 . . . . 0.0 114.876 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.57 128.65 74.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.169 0.988 . . . . 0.0 109.964 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.7 149.4 54.64 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.709 2.273 . . . . 0.0 112.203 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -147.91 158.5 44.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.405 1.482 . . . . 0.0 110.246 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -85.29 146.72 26.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.076 0.951 . . . . 0.0 108.957 160.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 t -132.47 137.98 47.43 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.412 0.685 . . . . 0.0 112.008 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -126.08 88.18 2.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.531 1.932 . . . . 0.0 109.449 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.18 135.39 49.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.719 0.807 . . . . 0.0 110.889 171.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.8 mt -131.73 121.27 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.456 1.502 . . . . 0.0 110.048 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -87.85 111.78 21.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 168.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.7 mt 51.7 27.45 4.08 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 167.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.28 17.54 39.49 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -67.23 12.3 0.09 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -138.69 138.52 21.99 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 126.114 1.766 . . . . 0.0 108.503 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.75 170.11 7.65 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.817 2.345 . . . . 0.0 112.793 -165.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -57.87 -17.24 15.2 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -173.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -58.71 -16.19 15.38 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.295 -2.128 . . . . 0.0 116.235 166.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -107.97 7.01 27.7 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.597 1.559 . . . . 0.0 113.1 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.4 mt -132.36 -38.59 1.05 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.441 2.297 . . . . 0.0 112.941 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -57.58 -16.17 9.49 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 128.389 2.676 . . . . 0.0 113.932 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.6 mt -59.9 -19.7 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 126.804 2.042 . . . . 0.0 110.942 172.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -109.05 147.94 36.93 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.369 1.068 . . . . 0.0 110.723 153.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -66.57 -14.03 42.34 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.55 2.167 . . . . 0.0 112.939 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' CB ' ' HE2' ' A' ' 59' ' ' LYS . 1.6 mm-40 -84.05 -12.68 54.76 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.544 1.938 . . . . 0.0 112.717 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.5 15.06 65.58 Favored Glycine 0 CA--C 1.538 1.518 0 O-C-N 121.014 -1.054 . . . . 0.0 114.447 -168.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.4 ' HE2' ' CB ' ' A' ' 57' ' ' GLU . 40.2 mtmt -82.63 167.47 18.24 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.407 1.483 . . . . 0.0 111.896 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.13 149.46 71.52 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 126.197 1.799 . . . . 0.0 108.504 152.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.16 151.29 95.02 Favored 'Cis proline' 0 CA--C 1.539 0.734 0 N-CA-C 116.765 1.794 . . . . 0.0 116.765 14.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.3 m -157.45 168.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 128.16 2.584 . . . . 0.0 110.622 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.0 m -137.22 143.9 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 120.907 -1.121 . . . . 0.0 113.995 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -91.31 117.24 29.49 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.416 156.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.0 mt -92.33 76.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.25 1.02 . . . . 0.0 109.185 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 56.88 55.77 5.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.905 0.882 . . . . 0.0 112.089 -163.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.15 16.56 4.93 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -175.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -98.6 103.58 15.55 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.519 -1.363 . . . . 0.0 108.77 167.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -74.57 148.03 41.19 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -159.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.68 133.2 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.511 1.924 . . . . 0.0 109.074 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.99 -147.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.296 1.839 . . . . 0.0 113.202 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -38.85 153.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.891 2.077 . . . . 0.0 116.291 -168.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.3 p -49.73 -27.69 5.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.761 1.624 . . . . 0.0 114.22 168.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -95.11 -8.42 36.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.591 1.156 . . . . 0.0 113.422 -170.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -105.0 -20.5 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.235 1.014 . . . . 0.0 112.748 159.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.0 mt -55.46 -39.55 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.334 1.454 . . . . 0.0 112.286 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.83 -6.53 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.03 -55.62 0.56 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-N 119.034 0.834 . . . . 0.0 112.803 158.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.0 mt -74.38 -32.36 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 121.657 -0.908 . . . . 0.0 113.155 -164.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.5 tp -73.79 -43.62 58.36 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.54 167.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -64.31 -29.17 70.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 30.0 tt0 -69.38 -44.8 70.76 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.054 1.742 . . . . 0.0 113.425 168.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.474 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 92.0 mttt -96.76 -8.67 30.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.435 1.094 . . . . 0.0 113.545 -165.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -80.7 141.02 51.39 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 126.35 1.86 . . . . 0.0 109.862 170.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.26 -19.35 25.84 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.153 1.902 . . . . 0.0 115.03 -171.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -79.95 145.34 61.25 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.169 0.895 . . . . 0.0 110.804 171.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -54.86 145.61 60.85 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.939 2.426 . . . . 0.0 115.114 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.6 123.73 11.82 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.779 2.986 . . . . 0.0 113.28 -167.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.56 -5.67 30.82 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.359 -0.838 . . . . 0.0 113.246 164.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.23 -26.49 64.92 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.557 1.543 . . . . 0.0 113.742 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -63.04 114.25 11.89 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.044 0.938 . . . . 0.0 110.923 -169.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.5 127.35 6.47 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.084 1.856 . . . . 0.0 112.115 -169.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -73.58 171.94 16.75 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.945 1.763 . . . . 0.0 110.146 152.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -57.7 -28.29 63.7 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.931 -1.106 . . . . 0.0 113.627 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -55.74 -26.38 45.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.651 1.58 . . . . 0.0 114.511 173.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.96 72.01 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.479 1.036 . . . . 0.0 112.671 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.6 p -64.9 -34.93 79.56 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.45 0.7 . . . . 0.0 112.453 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 31.4 t -86.76 -39.63 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.158 0.983 . . . . 0.0 112.055 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.79 60.45 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.142 1.353 . . . . 0.0 114.017 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.3 p -63.96 -24.44 67.72 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 171.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -82.44 -45.55 14.63 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.775 1.23 . . . . 0.0 111.873 170.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.9 mt -68.34 -35.16 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.123 0.969 . . . . 0.0 111.401 -172.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.6 -46.71 93.82 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.394 -1.441 . . . . 0.0 114.407 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.14 -31.24 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.193 2.595 . . . . 0.0 114.218 168.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.4 p -70.61 -23.54 62.58 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.279 1.854 . . . . 0.0 113.315 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -64.5 -39.09 93.14 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 119.97 -1.706 . . . . 0.0 113.544 161.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.81 -34.85 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 120.878 -1.139 . . . . 0.0 111.253 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.4 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 30.3 tttt -59.63 -52.2 66.54 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.024 1.33 . . . . 0.0 111.262 167.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -60.47 -38.29 83.73 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.703 1.201 . . . . 0.0 112.99 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.27 -24.23 57.53 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -94.48 61.11 2.7 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.325 1.45 . . . . 0.0 110.098 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.8 m -65.1 30.07 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.92 2.488 . . . . 0.0 117.517 -158.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -67.0 -38.28 85.72 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.147 1.379 . . . . 0.0 111.538 159.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.4 ' OD2' ' HE3' ' A' ' 108' ' ' LYS . 7.9 t0 -83.09 117.78 69.65 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.563 175.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -54.09 123.29 13.15 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.362 2.041 . . . . 0.0 114.419 -159.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -58.2 -46.62 85.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.276 1.03 . . . . 0.0 112.874 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.6 -23.79 67.53 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.43 -31.41 13.67 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 121.054 -1.029 . . . . 0.0 113.51 170.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 74.1 m -72.06 -28.89 63.63 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.45 1.1 . . . . 0.0 113.09 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -61.65 -43.78 98.22 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.301 1.441 . . . . 0.0 111.817 168.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -66.3 -38.77 88.51 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.581 -0.699 . . . . 0.0 112.171 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.24 -41.84 93.94 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.44 -0.787 . . . . 0.0 112.684 171.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -66.49 -29.9 70.11 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 117.813 -1.089 . . . . 0.0 113.159 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.69 -43.53 97.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.562 1.528 . . . . 0.0 111.623 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -74.07 -31.78 62.99 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -67.97 -46.36 71.58 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.119 -0.988 . . . . 0.0 112.585 170.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.66 -29.73 62.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.845 -1.074 . . . . 0.0 113.026 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -57.21 -46.1 83.22 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.243 1.383 . . . . 0.0 112.195 171.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.1 70.65 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.375 0.67 . . . . 0.0 112.551 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.4 tp -75.73 -54.85 6.3 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.102 0.961 . . . . 0.0 111.278 173.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.63 -37.66 85.3 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.604 1.561 . . . . 0.0 113.94 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.38 -35.5 88.72 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.533 -0.593 . . . . 0.0 113.406 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -89.44 -29.42 19.03 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 173.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 21.5 mt -61.63 -38.67 88.51 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.409 1.459 . . . . 0.0 112.475 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -65.48 -5.65 8.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.26 -23.17 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.403 1.481 . . . . 0.0 112.292 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -108.45 -22.4 12.32 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -167.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.75 -163.63 34.78 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 121.023 1.738 . . . . 0.0 116.062 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -102.19 -11.0 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.493 3.462 . . . . 0.0 114.518 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -101.76 158.23 16.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.353 1.061 . . . . 0.0 110.833 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.272 6.1 tt -78.27 5.54 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.418 -1.426 . . . . 0.0 113.294 -171.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -106.95 3.46 26.15 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.01 2.124 . . . . 0.0 115.038 159.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.05 -129.77 9.98 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.683 1.611 . . . . 0.0 113.289 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.01 -34.98 72.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.542 1.537 . . . . 0.0 113.712 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -129.55 151.48 50.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.255 1.822 . . . . 0.0 109.603 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.46 118.7 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.697 0.799 . . . . 0.0 109.848 162.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.3 p -140.89 -164.44 1.74 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.134 0.974 . . . . 0.0 111.42 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.34 -22.25 1.75 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.77 -36.49 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 120.125 1.329 . . . . 0.0 112.594 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.65 -43.22 97.42 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.383 -1.448 . . . . 0.0 112.468 164.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.2 mt -59.82 -31.74 70.0 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.22 -0.3 . . . . 0.0 111.334 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.1 m -74.57 -57.57 3.84 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.786 0.834 . . . . 0.0 111.979 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.0 mt -96.37 -33.6 11.86 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -159.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.89 -49.93 89.03 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.78 -26.87 18.69 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 120.944 1.373 . . . . 0.0 112.492 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.66 -33.9 64.68 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.772 173.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.52 -40.5 95.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.034 0.933 . . . . 0.0 112.388 169.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -63.98 -44.58 92.28 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.438 0.563 . . . . 0.0 112.183 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -63.5 -28.36 69.9 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.486 -0.759 . . . . 0.0 112.804 174.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.5 mt -75.61 -48.76 20.86 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.794 1.238 . . . . 0.0 113.631 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -58.86 -34.5 71.68 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.744 1.156 . . . . 0.0 111.232 177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -86.27 -68.59 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.148 0.979 . . . . 0.0 113.112 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.75 -45.59 35.6 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.056 -1.027 . . . . 0.0 113.229 -166.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 10.8 tp -79.82 -35.36 38.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.167 0.44 . . . . 0.0 111.587 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.19 -25.96 65.31 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.856 1.217 . . . . 0.0 114.992 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -63.0 -34.94 78.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.385 1.074 . . . . 0.0 113.697 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -100.52 -28.88 12.67 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -152.77 102.87 2.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.183 1.393 . . . . 0.0 109.641 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -72.19 85.56 1.05 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.584 0.754 . . . . 0.0 110.579 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.2 t90 -76.12 110.8 12.13 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.637 1.175 . . . . 0.0 110.477 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.45 130.35 14.88 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.008 1.805 . . . . 0.0 110.795 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.9 mt -68.87 119.03 66.74 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.93 157.68 55.53 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.129 1.886 . . . . 0.0 112.843 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.78 -25.59 65.03 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -65.85 -27.71 68.44 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.173 -0.955 . . . . 0.0 113.484 172.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.27 51.29 2.0 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.028 1.731 . . . . 0.0 110.932 170.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -31.93 73.4 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.148 1.379 . . . . 0.0 113.359 -160.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -74.98 -45.13 44.18 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.325 -0.86 . . . . 0.0 110.749 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.74 -39.43 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.358 0.981 . . . . 0.0 111.116 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.08 -49.4 74.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.294 1.437 . . . . 0.0 112.99 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -65.92 -37.09 85.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.513 -0.742 . . . . 0.0 112.826 177.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -63.06 -26.96 69.08 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.385 1.074 . . . . 0.0 113.294 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 42.8 mm -52.41 -37.86 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.794 0.838 . . . . 0.0 112.105 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -82.87 -6.04 59.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.361 -1.462 . . . . 0.0 113.497 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.47 -22.05 51.95 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 161.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.5 mt -62.73 -20.2 64.68 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.054 1.297 . . . . 0.0 113.466 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -91.52 7.25 42.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.05 1.34 . . . . 0.0 112.993 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.3 p -130.42 179.15 6.09 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -159.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 54.5 -160.25 0.16 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.152 1.781 . . . . 0.0 110.622 -167.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.453 ' OE1' ' HE3' ' A' ' 34' ' ' LYS . 16.1 mp0 -81.28 -40.19 24.08 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 125.92 1.688 . . . . 0.0 108.733 156.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -45.04 78.38 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 129.5 3.12 . . . . 0.0 113.908 -164.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -102.97 -38.45 7.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.475 0.71 . . . . 0.0 112.809 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -60.8 -31.33 70.72 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.472 -1.393 . . . . 0.0 113.389 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -78.22 -25.65 47.06 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 44.7 p -89.49 -8.37 53.01 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -52.71 115.65 1.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.252 1.421 . . . . 0.0 110.189 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -99.88 131.94 45.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.083 0.953 . . . . 0.0 111.421 -175.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -49.37 114.29 1.0 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.344 1.058 . . . . 0.0 112.354 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -62.46 -36.35 82.16 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -151.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -61.75 -36.2 80.3 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.073 1.349 . . . . 0.0 112.616 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -80.15 -11.65 59.73 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.42 -44.19 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.173 0.897 . . . . 0.0 109.812 165.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.3 mt -63.92 -57.16 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.146 1.379 . . . . 0.0 111.457 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.31 -28.14 67.74 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.32 -25.33 48.19 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 120.854 -1.154 . . . . 0.0 113.786 174.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -68.01 -37.96 82.05 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.13 1.465 . . . . 0.0 112.395 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -47.61 -55.07 18.26 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -166.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.34 -21.97 66.49 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 CA-C-N 122.352 1.876 . . . . 0.0 113.652 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -88.59 5.34 43.32 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.219 1.808 . . . . 0.0 114.383 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.11 -27.36 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.85 -0.531 . . . . 0.0 110.711 151.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -104.31 -40.4 6.12 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.622 -1.656 . . . . 0.0 113.926 -177.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 118.833 -0.603 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.25 -167.19 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.465 1.106 . . . . 0.0 112.036 -165.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.19 119.59 13.71 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.022 -1.049 . . . . 0.0 111.164 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.08 97.29 3.96 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.147 0.979 . . . . 0.0 109.328 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 mt -76.63 140.18 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.959 1.304 . . . . 0.0 108.715 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.6 m -118.01 137.39 52.91 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 159.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.81 142.38 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.36 1.064 . . . . 0.0 110.577 -161.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.723 ' N ' ' HG ' ' A' ' 23' ' ' CYS . 34.9 tttm -66.54 129.14 38.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.62 -0.675 . . . . 0.0 109.271 169.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.63 173.62 8.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.54 1.936 . . . . 0.0 112.058 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.09 142.2 31.59 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.075 0.95 . . . . 0.0 111.847 169.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.36 120.98 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 121.007 0.432 . . . . 0.0 110.355 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.14 -10.08 22.59 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.945 1.26 . . . . 0.0 116.229 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.45 79.64 71.93 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 119.694 1.747 . . . . 0.0 111.66 -172.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.39 -11.65 29.31 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.849 3.033 . . . . 0.0 116.531 -170.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -84.69 -4.15 58.89 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.6 pt -143.08 161.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.325 1.45 . . . . 0.0 111.793 -169.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.4 -44.61 51.24 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.09 -123.67 5.84 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.849 1.214 . . . . 0.0 114.577 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.97 13.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.701 2.4 . . . . 0.0 117.192 -173.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.43 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.8 p -114.68 72.75 2.76 Favored Pre-proline 0 C--O 1.261 1.706 0 O-C-N 120.108 -1.62 . . . . 0.0 110.983 -159.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.18 -27.81 41.14 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.824 3.016 . . . . 0.0 112.303 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -63.64 -37.06 85.9 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.791 -1.193 . . . . 0.0 113.114 172.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.723 ' HG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -62.97 -41.78 99.64 Favored 'General case' 0 C--N 1.37 1.497 0 O-C-N 120.576 -1.327 . . . . 0.0 110.991 173.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -63.12 -27.99 69.76 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.453 1.101 . . . . 0.0 113.011 -176.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.525 HH11 ' CG ' ' A' ' 74' ' ' ASP . 75.4 mtp180 -58.13 -42.95 86.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.48 1.112 . . . . 0.0 113.145 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.1 t -74.04 -37.09 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.289 1.036 . . . . 0.0 111.441 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.09 -40.01 86.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.756 0.822 . . . . 0.0 111.141 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.23 -42.58 99.44 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -69.98 -41.81 73.94 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.312 1.415 . . . . 0.0 112.476 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.96 -36.19 69.78 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -76.13 -26.55 56.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -68.92 -41.95 77.48 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.585 -1.322 . . . . 0.0 111.87 167.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -70.73 -7.77 47.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.87 1.668 . . . . 0.0 114.243 170.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm 58.88 18.02 5.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.964 2.106 . . . . 0.0 114.707 -177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.7 mt -77.64 133.66 66.52 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.249 1.02 . . . . 0.0 110.13 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.31 146.15 44.81 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.801 2.334 . . . . 0.0 112.666 173.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -148.65 160.24 43.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.931 1.693 . . . . 0.0 110.335 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -85.24 151.6 23.95 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.24 -0.913 . . . . 0.0 109.576 158.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.2 t -134.15 130.53 37.45 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.76 0.824 . . . . 0.0 110.902 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -121.9 87.39 2.74 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.488 1.515 . . . . 0.0 109.508 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.48 135.0 50.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.939 0.895 . . . . 0.0 111.072 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.8 mt -131.62 121.83 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.355 1.462 . . . . 0.0 110.262 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -88.1 111.12 21.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 168.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.2 mt 52.21 24.1 2.65 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 168.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.28 19.3 28.49 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.743 -1.032 . . . . 0.0 115.586 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -64.75 11.39 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -140.21 143.56 34.13 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 126.171 1.788 . . . . 0.0 110.504 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.04 161.48 22.33 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.081 2.521 . . . . 0.0 113.135 -167.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.14 -12.51 28.01 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -166.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -50.11 -31.42 13.29 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.107 1.763 . . . . 0.0 115.527 161.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -94.26 3.13 55.65 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.919 1.288 . . . . 0.0 113.901 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.4 mt -128.62 -40.2 1.59 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.121 2.168 . . . . 0.0 113.168 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.72 -16.66 11.69 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 127.961 2.504 . . . . 0.0 113.623 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.9 mt -58.92 -20.78 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 126.974 2.109 . . . . 0.0 111.063 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.5 p -109.56 147.8 36.82 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.921 1.288 . . . . 0.0 110.894 155.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -67.38 -17.62 49.39 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.592 2.195 . . . . 0.0 112.948 171.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.8 -8.91 59.12 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.527 1.531 . . . . 0.0 113.312 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.29 70.35 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 120.73 -1.231 . . . . 0.0 114.73 -172.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -83.46 174.52 10.56 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.405 1.882 . . . . 0.0 112.522 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.3 m -138.09 152.51 72.01 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 126.565 1.946 . . . . 0.0 109.098 154.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.85 153.27 99.08 Favored 'Cis proline' 0 C--N 1.35 0.624 0 N-CA-C 116.535 1.706 . . . . 0.0 116.535 9.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -156.5 167.67 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 128.783 2.833 . . . . 0.0 109.811 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -137.01 140.65 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 O-C-N 120.667 -1.271 . . . . 0.0 114.051 170.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -86.33 108.26 18.35 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.101 1.36 . . . . 0.0 108.739 156.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.9 mt -86.75 76.69 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.304 1.042 . . . . 0.0 109.151 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.6 t70 55.32 53.48 9.89 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.053 0.93 . . . . 0.0 111.819 -162.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.25 15.12 5.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -95.72 107.03 19.21 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.674 -1.266 . . . . 0.0 108.785 167.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -75.5 147.25 39.94 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -159.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -141.14 132.25 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.938 1.695 . . . . 0.0 109.816 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.2 -150.52 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.066 2.146 . . . . 0.0 114.295 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.12 154.1 0.61 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.757 2.023 . . . . 0.0 114.362 -171.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.6 p -54.72 -27.19 38.93 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.525 ' CG ' HH11 ' A' ' 25' ' ' ARG . 39.5 m-20 -70.27 -20.19 63.06 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -97.58 -20.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.266 0.939 . . . . 0.0 112.973 167.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.22 -42.9 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 O-C-N 121.121 -0.987 . . . . 0.0 111.652 170.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -63.48 -6.91 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.53 -58.43 0.55 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.515 1.055 . . . . 0.0 113.382 160.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.32 -31.61 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.404 1.082 . . . . 0.0 113.2 -165.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.05 -43.66 61.67 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.037 -1.039 . . . . 0.0 110.5 167.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -66.09 -27.83 68.36 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 25.0 tt0 -69.7 -45.83 67.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.84 1.656 . . . . 0.0 112.976 167.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.9 mttt -94.21 -8.36 39.51 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.354 1.062 . . . . 0.0 113.605 -166.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -80.45 141.25 52.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.071 1.748 . . . . 0.0 109.7 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.69 -15.45 27.05 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.018 1.812 . . . . 0.0 114.849 -172.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -84.06 141.15 40.2 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.901 171.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -49.98 142.27 27.31 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.921 3.081 . . . . 0.0 115.208 -173.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.89 118.09 5.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.29 2.66 . . . . 0.0 112.351 -169.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.56 -11.99 48.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.062 0.945 . . . . 0.0 112.774 165.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.01 -24.66 40.43 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.678 1.591 . . . . 0.0 113.645 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.2 m -65.29 116.13 27.91 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.821 0.848 . . . . 0.0 110.532 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.48 125.23 6.81 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.124 1.883 . . . . 0.0 112.513 -170.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.58 174.27 12.91 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.568 2.179 . . . . 0.0 110.288 154.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.23 -34.51 60.85 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.784 -1.198 . . . . 0.0 113.315 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -59.34 -22.88 61.96 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.894 1.678 . . . . 0.0 114.862 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.58 70.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.151 0.887 . . . . 0.0 112.899 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 85.4 p -64.57 -43.77 92.84 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.622 -0.673 . . . . 0.0 112.048 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.44 -39.8 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.265 1.026 . . . . 0.0 111.44 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.44 -24.51 67.7 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.52 1.533 . . . . 0.0 114.332 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.3 p -61.46 -26.02 67.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.451 1.125 . . . . 0.0 113.558 172.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -89.95 -39.98 12.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.638 1.175 . . . . 0.0 113.021 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.29 -32.74 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.587 0.755 . . . . 0.0 111.165 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.53 -49.26 93.09 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 120.551 -1.343 . . . . 0.0 114.015 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.31 -32.37 3.07 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.865 2.377 . . . . 0.0 113.699 168.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.8 p -71.96 -23.84 61.5 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 121.502 1.955 . . . . 0.0 114.043 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -64.94 -41.71 95.27 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 119.75 -1.844 . . . . 0.0 113.272 161.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.45 -33.88 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 121.063 -1.023 . . . . 0.0 111.126 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -61.37 -49.17 78.0 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.555 1.142 . . . . 0.0 111.634 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.13 -38.92 88.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.203 1.001 . . . . 0.0 112.156 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.2 mt -73.03 -7.61 52.03 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -116.91 58.73 0.77 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.797 2.039 . . . . 0.0 110.362 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.3 m -65.72 29.14 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.086 2.954 . . . . 0.0 117.572 -158.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 211' ' ' ASN . 93.0 mttt -64.98 -38.04 89.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.39 1.076 . . . . 0.0 111.959 161.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -90.4 131.27 38.85 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.772 -1.108 . . . . 0.0 108.324 170.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -58.13 135.52 68.94 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.263 1.975 . . . . 0.0 114.668 -161.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -61.72 -51.31 68.9 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.475 1.11 . . . . 0.0 112.591 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -23.24 64.71 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.97 -35.55 8.96 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 121.41 -0.806 . . . . 0.0 113.589 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.1 m -74.1 -26.22 60.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.404 -1.056 . . . . 0.0 112.847 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.425 ' CD ' ' HZ2' ' A' ' 168' ' ' LYS . 54.5 mt-10 -62.19 -44.89 95.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.634 1.574 . . . . 0.0 111.545 164.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.41 -33.05 73.54 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.522 -0.737 . . . . 0.0 112.821 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.71 85.88 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.559 -0.713 . . . . 0.0 112.308 168.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.2 mt -64.64 -30.39 71.41 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.022 -0.989 . . . . 0.0 112.886 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.23 -35.19 76.55 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.336 1.425 . . . . 0.0 112.411 170.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -77.88 -38.87 44.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.484 1.038 . . . . 0.0 112.388 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -70.67 -41.44 72.07 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.602 -1.311 . . . . 0.0 113.167 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.5 mt -74.26 -25.94 59.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 117.416 -1.278 . . . . 0.0 112.532 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -58.84 -47.08 86.13 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 120.875 1.671 . . . . 0.0 112.262 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.92 66.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.838 0.855 . . . . 0.0 113.056 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 tp -83.8 -56.12 3.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.693 1.197 . . . . 0.0 111.445 174.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.07 -36.03 81.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.875 1.67 . . . . 0.0 113.992 -165.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.91 -34.64 89.49 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.681 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -90.36 -26.66 19.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.839 0.856 . . . . 0.0 113.15 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.2 mt -62.5 -38.86 91.56 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.245 0.93 . . . . 0.0 111.926 174.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -65.75 -2.05 3.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.13 -28.41 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.105 1.362 . . . . 0.0 112.491 171.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -86.6 -54.83 4.17 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 164.3 175.37 35.07 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.238 -0.914 . . . . 0.0 115.274 -169.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.89 -7.84 14.41 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.581 3.521 . . . . 0.0 115.783 -160.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -98.98 164.52 12.15 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.891 -1.131 . . . . 0.0 111.306 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.252 9.2 tt -78.78 -0.95 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 120.292 -1.505 . . . . 0.0 113.081 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -99.67 -4.92 29.81 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.49 1.916 . . . . 0.0 115.078 160.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.98 -129.76 9.55 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 120.287 1.403 . . . . 0.0 113.785 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.06 -24.23 65.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.65 1.58 . . . . 0.0 114.58 -172.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -130.73 151.77 50.81 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 126.588 1.955 . . . . 0.0 109.554 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 76.5 mt -67.38 119.66 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.997 0.919 . . . . 0.0 109.541 162.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.1 p -137.45 -166.66 1.98 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.168 1.387 . . . . 0.0 112.667 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.75 -20.34 3.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.834 1.654 . . . . 0.0 114.65 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.56 -38.1 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.062 1.301 . . . . 0.0 111.898 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.0 -42.58 94.36 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.332 -1.48 . . . . 0.0 112.045 165.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.9 mt -64.18 -15.81 60.64 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.0 m -95.53 -50.38 5.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.503 1.521 . . . . 0.0 112.491 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.5 mt -100.26 -34.15 10.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.299 1.44 . . . . 0.0 114.159 -164.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.63 90.08 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -170.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.93 -24.32 17.71 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 CA-C-N 120.714 1.291 . . . . 0.0 112.942 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.77 -33.46 66.32 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 117.775 -1.107 . . . . 0.0 112.334 173.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.78 -41.9 95.49 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.517 0.727 . . . . 0.0 112.637 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.66 -46.7 87.0 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.766 0.794 . . . . 0.0 111.929 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -64.81 -27.74 69.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.787 0.835 . . . . 0.0 112.889 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.31 -49.97 24.65 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.311 1.044 . . . . 0.0 113.33 170.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.96 -34.28 71.61 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.949 0.795 . . . . 0.0 111.694 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.32 -68.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.69 0.796 . . . . 0.0 112.86 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.73 -46.49 37.06 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.106 -0.996 . . . . 0.0 113.195 -161.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 19.5 tp -79.84 -32.34 40.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 119.247 -0.406 . . . . 0.0 111.649 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.89 -28.29 65.74 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.641 1.115 . . . . 0.0 114.946 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -61.11 -32.11 71.79 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.88 -28.91 11.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.975 0.91 . . . . 0.0 113.087 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.425 ' HZ2' ' CD ' ' A' ' 120' ' ' GLU . 81.3 tttt -153.23 98.51 2.28 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.667 1.587 . . . . 0.0 109.612 169.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.41 84.14 0.8 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.548 0.739 . . . . 0.0 110.706 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 44.1 t90 -77.2 106.73 3.9 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.972 1.309 . . . . 0.0 110.169 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.23 134.6 25.25 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.649 1.566 . . . . 0.0 109.959 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.8 mm -65.49 117.2 38.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.078 -0.963 . . . . 0.0 108.652 166.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.69 159.35 45.64 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.068 1.846 . . . . 0.0 112.782 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -23.96 65.8 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.361 1.465 . . . . 0.0 114.439 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -66.12 -33.58 76.1 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.012 -1.055 . . . . 0.0 113.019 171.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.8 mt -86.85 48.42 1.64 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.595 1.958 . . . . 0.0 111.025 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -31.5 70.04 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.238 1.415 . . . . 0.0 112.613 -167.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -77.93 -42.04 34.4 Favored 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.643 -0.661 . . . . 0.0 112.366 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.1 -38.89 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.615 0.766 . . . . 0.0 110.734 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.7 tp -61.19 -47.96 83.75 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.771 1.228 . . . . 0.0 113.182 172.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -68.86 -40.31 79.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.571 -0.706 . . . . 0.0 112.794 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -64.0 -31.21 72.32 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.589 1.156 . . . . 0.0 112.892 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.6 mt -55.47 -32.03 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 O-C-N 121.515 -0.74 . . . . 0.0 112.014 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -83.4 -10.61 58.32 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.089 -1.632 . . . . 0.0 114.243 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.79 -20.07 60.58 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.058 -1.026 . . . . 0.0 113.596 161.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.46 -16.41 62.38 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.623 1.102 . . . . 0.0 113.836 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -92.94 6.54 47.45 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.634 1.574 . . . . 0.0 112.577 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 p -131.7 -179.04 5.14 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -159.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 55.61 -162.01 0.16 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.066 1.746 . . . . 0.0 109.889 -166.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -80.48 -36.52 33.31 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.386 153.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -42.36 83.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 128.633 2.773 . . . . 0.0 114.327 -164.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -105.05 -34.97 7.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -55.51 -34.75 64.91 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.128 1.371 . . . . 0.0 113.359 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -79.75 -21.22 44.74 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 60.0 p -93.42 -12.67 29.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -51.05 117.67 2.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.883 1.273 . . . . 0.0 109.926 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -99.41 140.83 33.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.046 0.938 . . . . 0.0 111.59 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.4 119.92 6.34 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.978 1.311 . . . . 0.0 111.792 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -68.1 -41.57 81.61 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.265 1.426 . . . . 0.0 114.082 -149.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.1 -36.62 80.17 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.837 1.255 . . . . 0.0 112.926 171.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -78.2 -10.48 59.66 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.3 -47.28 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.9 1.227 . . . . 0.0 110.452 160.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.63 -57.15 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.017 1.327 . . . . 0.0 111.737 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.72 -25.7 64.89 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.75 -27.72 37.5 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.006 -1.059 . . . . 0.0 113.477 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 40.6 t90 -68.91 -39.8 79.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.901 1.351 . . . . 0.0 112.371 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -44.11 -56.32 7.97 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -166.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.35 -21.72 60.84 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 CA-C-N 122.206 1.823 . . . . 0.0 113.781 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -84.18 3.33 35.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.693 1.597 . . . . 0.0 114.187 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 2.2 p -60.22 -25.44 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.4 0.546 . . . . 0.0 111.226 154.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.458 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 17.5 m-80 -104.01 -37.0 7.54 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.359 -1.782 . . . . 0.0 115.277 -159.382 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.08 -160.61 0.1 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.564 0.745 . . . . 0.0 111.718 -168.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.1 123.56 22.4 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.327 -0.858 . . . . 0.0 110.629 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -130.78 103.2 6.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.375 1.07 . . . . 0.0 108.369 168.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.4 mt -75.03 139.83 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 m -118.37 137.33 53.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 158.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.25 142.39 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.911 -1.118 . . . . 0.0 110.542 -159.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.763 ' N ' ' HG ' ' A' ' 23' ' ' CYS . 35.0 tttm -67.83 126.61 29.96 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.357 170.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.02 175.61 8.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.003 1.721 . . . . 0.0 111.845 170.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.39 141.96 28.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.852 0.861 . . . . 0.0 111.673 167.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.9 t -54.35 119.8 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.073 0.463 . . . . 0.0 110.15 168.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.65 -13.06 31.27 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.35 83.15 63.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.902 1.851 . . . . 0.0 112.011 -172.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.21 -10.65 26.65 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.713 2.942 . . . . 0.0 116.266 -171.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -83.1 -6.9 59.66 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 pt -142.92 161.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.186 1.394 . . . . 0.0 111.578 -167.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.42 -41.0 61.63 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.01 -125.51 6.63 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.729 1.157 . . . . 0.0 114.622 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.43 14.29 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.118 2.567 . . . . 0.0 116.92 -171.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.492 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 68.7 m -115.02 76.39 4.44 Favored Pre-proline 0 C--O 1.257 1.476 0 O-C-N 120.052 -1.655 . . . . 0.0 110.974 -158.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.23 -28.15 40.5 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.535 2.824 . . . . 0.0 112.113 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -64.83 -37.36 87.34 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.231 -0.918 . . . . 0.0 113.159 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.763 ' HG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -62.45 -40.03 95.3 Favored 'General case' 0 C--N 1.364 1.205 0 O-C-N 119.659 -1.901 . . . . 0.0 110.986 172.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -66.01 -27.7 68.32 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.199 1.0 . . . . 0.0 112.753 -176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -58.01 -43.51 86.73 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.509 1.123 . . . . 0.0 112.761 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 t -73.92 -38.5 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.808 1.243 . . . . 0.0 111.826 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.0 mt -66.91 -39.59 87.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.57 0.748 . . . . 0.0 111.405 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.85 -41.45 99.37 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.052 0.941 . . . . 0.0 113.268 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 p -70.26 -43.66 70.04 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.772 1.169 . . . . 0.0 112.397 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.69 -35.01 72.57 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -77.59 -23.25 49.96 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 172.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -71.2 -43.04 68.19 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.472 -1.393 . . . . 0.0 112.005 166.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -70.69 -8.15 49.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.702 1.601 . . . . 0.0 114.291 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 59.09 16.14 4.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 127.065 2.146 . . . . 0.0 114.64 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.58 128.81 73.65 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.397 1.079 . . . . 0.0 109.799 -176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.58 155.74 44.97 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.981 2.454 . . . . 0.0 113.258 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -152.32 159.16 43.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.128 1.771 . . . . 0.0 110.165 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -77.41 151.06 34.95 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.991 -1.068 . . . . 0.0 109.482 152.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 t -127.81 126.61 42.03 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.772 0.829 . . . . 0.0 110.713 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -117.91 83.38 1.99 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.521 1.529 . . . . 0.0 109.161 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.7 mt -65.6 135.51 55.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.506 0.723 . . . . 0.0 110.804 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 mt -130.12 120.13 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.533 1.533 . . . . 0.0 110.004 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -84.47 103.58 13.74 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.606 -0.684 . . . . 0.0 109.394 167.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt 54.89 15.18 1.06 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 168.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.67 17.23 8.72 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.779 1.18 . . . . 0.0 115.343 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -65.4 12.19 0.05 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 120.036 1.918 . . . . 0.0 116.167 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.93 143.95 36.45 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 126.084 1.753 . . . . 0.0 109.909 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.88 163.29 19.49 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.889 2.393 . . . . 0.0 112.516 -167.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -64.43 -11.84 37.32 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 116.798 -1.572 . . . . 0.0 115.077 -167.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -55.53 -22.35 21.06 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 163.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -101.93 2.63 38.2 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.443 1.497 . . . . 0.0 113.302 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.8 mt -126.81 -38.08 2.08 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.112 2.165 . . . . 0.0 112.843 -171.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.25 -17.57 20.29 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.865 2.466 . . . . 0.0 113.324 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.78 -20.5 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 127.156 2.182 . . . . 0.0 111.322 171.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 93.9 p -116.14 137.41 23.42 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.142 1.377 . . . . 0.0 111.499 158.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.99 -25.22 38.49 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.582 2.188 . . . . 0.0 113.039 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.7 pm0 -71.99 -8.27 53.54 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.295 1.038 . . . . 0.0 113.7 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.64 51.29 48.65 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.832 1.196 . . . . 0.0 112.973 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -131.64 174.22 10.34 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.251 2.22 . . . . 0.0 110.877 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 m -140.57 152.6 66.68 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.752 1.621 . . . . 0.0 108.284 163.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -66.09 156.21 80.38 Favored 'Cis proline' 0 C--N 1.348 0.511 0 N-CA-C 116.845 1.825 . . . . 0.0 116.845 11.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.2 m -158.08 167.49 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 128.577 2.751 . . . . 0.0 109.027 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.05 148.67 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 120.92 -1.113 . . . . 0.0 113.293 166.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -90.54 140.86 29.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.476 153.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.9 mt -116.93 72.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 126.734 2.014 . . . . 0.0 108.039 170.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.2 t70 57.31 61.12 2.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.112 1.365 . . . . 0.0 112.19 -165.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.307 5.2 m-20 57.96 9.82 1.01 Allowed 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 -175.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -88.85 120.86 30.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.578 1.151 . . . . 0.0 108.316 163.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -87.99 152.18 22.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -164.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -143.34 133.84 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.888 2.075 . . . . 0.0 109.206 171.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.07 -147.9 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.857 2.063 . . . . 0.0 113.641 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -50.29 159.37 0.47 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -170.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 p -39.42 -40.71 0.86 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.849 2.06 . . . . 0.0 115.341 166.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -15.14 60.75 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.1 m -103.33 -22.52 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.75 0.704 . . . . 0.0 112.86 165.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.7 mt -59.55 -42.38 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.483 1.113 . . . . 0.0 111.872 170.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.2 m -62.68 -8.16 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.04 -58.38 0.56 Allowed Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.4 1.0 . . . . 0.0 113.297 159.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.55 -32.25 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.777 1.231 . . . . 0.0 113.313 -164.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.39 -45.36 55.24 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.998 -1.064 . . . . 0.0 110.315 167.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.92 -30.33 71.43 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.488 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 18.8 tt0 -66.11 -46.2 78.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.128 1.771 . . . . 0.0 112.943 168.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.8 mttt -90.73 -9.35 47.02 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.716 1.206 . . . . 0.0 113.336 -169.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -76.06 140.59 70.14 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.011 1.724 . . . . 0.0 110.106 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.68 -11.99 22.17 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.946 1.764 . . . . 0.0 115.057 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -87.6 151.18 50.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.825 1.193 . . . . 0.0 111.056 164.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.48 144.42 18.67 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.652 2.902 . . . . 0.0 114.904 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.44 126.35 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.054 2.503 . . . . 0.0 112.285 -172.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.1 mt -67.02 -10.43 49.69 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 163.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.14 -21.57 47.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.697 1.599 . . . . 0.0 114.092 169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.9 m -63.75 114.56 13.83 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 123.846 0.858 . . . . 0.0 110.245 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.17 127.44 7.58 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.014 1.809 . . . . 0.0 112.226 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.2 175.16 11.62 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.43 2.087 . . . . 0.0 110.143 154.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -56.12 -31.91 63.73 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.568 -1.333 . . . . 0.0 113.507 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -59.31 -21.09 59.21 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.445 1.498 . . . . 0.0 114.648 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.99 73.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.843 1.201 . . . . 0.0 112.593 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 79.9 p -64.48 -41.33 96.53 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.607 -0.683 . . . . 0.0 112.098 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.96 -42.0 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.812 1.245 . . . . 0.0 111.557 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.04 -23.29 65.78 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.725 1.631 . . . . 0.0 114.522 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -61.99 -24.55 67.1 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -85.8 -44.28 12.61 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.571 1.148 . . . . 0.0 112.427 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.1 mt -67.12 -37.75 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 111.262 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -58.94 -46.64 99.52 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.533 -1.223 . . . . 0.0 114.023 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.94 -29.96 1.9 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.8 2.333 . . . . 0.0 114.172 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.2 p -70.86 -28.65 64.73 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 121.673 2.033 . . . . 0.0 113.542 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -58.6 -39.64 80.97 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.58 -1.325 . . . . 0.0 112.847 162.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.3 -29.81 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.188 -0.945 . . . . 0.0 111.627 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -68.04 -43.8 77.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.768 0.827 . . . . 0.0 111.84 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -65.34 -31.44 72.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.286 1.034 . . . . 0.0 112.843 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.9 mt -82.21 6.79 15.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.44 1.896 . . . . 0.0 114.113 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -132.8 54.81 1.93 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.6 1.96 . . . . 0.0 110.422 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -61.65 16.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 129.768 3.227 . . . . 0.0 118.405 -155.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -62.32 -42.69 99.59 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.765 -1.209 . . . . 0.0 110.911 166.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -84.6 128.7 60.19 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.93 -1.033 . . . . 0.0 108.469 174.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -60.92 129.99 31.08 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 120.911 1.361 . . . . 0.0 115.511 -153.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -68.91 -39.7 79.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 117.542 -1.218 . . . . 0.0 113.785 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -59.72 -30.45 68.83 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.66 -34.22 11.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.145 0.879 . . . . 0.0 113.666 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 51.0 m -68.65 -27.58 66.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.216 1.006 . . . . 0.0 112.139 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -62.49 -41.17 98.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.136 1.374 . . . . 0.0 112.29 167.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -69.8 -36.09 75.39 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.268 -0.895 . . . . 0.0 112.261 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.2 97.71 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.244 -0.91 . . . . 0.0 112.149 171.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.0 mt -67.71 -31.88 72.13 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.728 -1.129 . . . . 0.0 113.001 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.27 -45.26 95.23 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.664 1.574 . . . . 0.0 111.553 172.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -72.12 -34.71 68.8 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.766 1.166 . . . . 0.0 113.086 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -68.71 -40.41 79.99 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.264 -0.898 . . . . 0.0 112.655 173.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.9 -27.6 39.96 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.061 -1.024 . . . . 0.0 113.47 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -59.29 -41.88 89.98 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.373 1.442 . . . . 0.0 111.935 171.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.78 -24.79 67.01 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -82.35 -54.54 5.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.032 1.333 . . . . 0.0 111.587 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.44 -36.42 76.62 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -158.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.28 -35.65 92.23 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.017 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -83.6 -27.44 29.19 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.816 0.846 . . . . 0.0 112.959 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.04 -40.55 98.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.007 0.822 . . . . 0.0 111.767 172.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -62.97 -9.53 10.27 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.62 -35.33 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.347 1.059 . . . . 0.0 112.328 171.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -86.54 -55.26 3.96 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.76 177.56 34.93 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 -171.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.69 -7.72 17.75 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.919 3.746 . . . . 0.0 116.172 -158.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.47 167.46 11.14 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.637 1.108 . . . . 0.0 111.506 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.25 9.6 tt -78.22 4.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.359 -1.463 . . . . 0.0 112.792 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.594 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -108.83 -0.1 20.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.316 2.246 . . . . 0.0 114.721 163.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.15 -130.94 10.39 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.915 1.234 . . . . 0.0 113.751 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -26.61 67.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.67 1.588 . . . . 0.0 114.395 -170.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -127.41 151.83 48.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.178 1.791 . . . . 0.0 110.142 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.75 129.39 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.676 -0.64 . . . . 0.0 109.908 161.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.594 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 14.6 p -137.8 -170.76 2.84 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.821 1.248 . . . . 0.0 112.005 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.13 -16.95 3.47 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 173.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.1 t -72.78 -41.01 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.598 1.09 . . . . 0.0 111.819 171.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.59 -42.51 95.53 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.589 -1.319 . . . . 0.0 112.392 166.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.0 mt -61.26 -18.0 56.25 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 175.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.2 m -99.44 -46.32 5.53 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.445 1.098 . . . . 0.0 112.371 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.3 mt -96.55 -36.01 10.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.17 -47.64 94.15 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -171.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.21 -24.75 16.53 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 121.024 1.401 . . . . 0.0 112.954 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -72.14 -33.85 68.08 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 117.905 -1.045 . . . . 0.0 112.308 172.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.7 mt -65.65 -41.27 92.75 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.803 0.841 . . . . 0.0 112.912 168.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -62.19 -47.02 86.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.867 0.758 . . . . 0.0 112.101 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -64.61 -27.58 69.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.86 0.864 . . . . 0.0 112.817 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.45 -51.02 22.06 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.535 1.134 . . . . 0.0 113.479 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.3 -32.16 70.96 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.269 0.94 . . . . 0.0 111.744 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.5 -68.76 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.633 0.773 . . . . 0.0 112.913 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.19 -47.05 38.17 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.098 -1.001 . . . . 0.0 113.435 -161.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 52.4 tp -81.82 -33.31 30.8 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.721 175.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.38 -26.81 64.67 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.41 1.005 . . . . 0.0 114.555 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -59.86 -33.73 72.19 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 169.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -102.93 -29.42 11.43 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.029 0.932 . . . . 0.0 113.394 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -152.03 98.77 2.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.286 1.434 . . . . 0.0 109.266 168.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -72.81 78.55 1.13 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.646 0.778 . . . . 0.0 110.78 171.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -70.4 115.55 36.02 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.012 0.925 . . . . 0.0 110.109 175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.53 124.6 10.45 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.639 1.559 . . . . 0.0 110.048 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.1 mt -62.27 115.15 14.38 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 163.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.28 157.23 55.23 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.547 1.498 . . . . 0.0 112.676 -170.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -25.1 62.22 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.714 1.606 . . . . 0.0 113.707 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -67.29 -36.38 81.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.19 1.396 . . . . 0.0 113.101 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.71 49.56 1.21 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.135 1.774 . . . . 0.0 110.824 164.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -37.12 70.53 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.032 1.733 . . . . 0.0 112.339 -166.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -80.73 -41.01 24.28 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.803 0.841 . . . . 0.0 111.961 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.67 -40.62 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.595 0.758 . . . . 0.0 110.753 171.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.85 -49.13 76.08 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.872 1.269 . . . . 0.0 112.997 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -65.92 -37.12 85.23 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.545 -0.722 . . . . 0.0 112.715 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -62.17 -27.59 69.07 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.122 0.969 . . . . 0.0 113.266 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 42.0 mm -53.15 -37.61 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.319 -0.863 . . . . 0.0 111.994 170.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -83.24 -7.13 59.65 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.701 -1.249 . . . . 0.0 113.48 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 47.7 mt -75.67 -22.46 56.7 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 117.874 -1.06 . . . . 0.0 113.454 160.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.89 -19.76 66.08 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.956 1.253 . . . . 0.0 113.654 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -88.25 4.94 43.99 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.807 -1.183 . . . . 0.0 113.906 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -134.33 -176.63 4.27 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -158.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.4 mtp85 54.78 -161.64 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.637 1.575 . . . . 0.0 109.914 -162.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.42 -38.42 24.08 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.783 1.233 . . . . 0.0 108.468 156.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.89 -52.93 58.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 129.542 3.137 . . . . 0.0 113.531 -167.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -97.48 -35.03 10.78 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -57.63 -32.43 67.24 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.69 -1.256 . . . . 0.0 113.105 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -80.81 -21.68 40.67 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.1 p -89.08 -13.23 39.09 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -52.64 110.11 0.48 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.923 1.289 . . . . 0.0 110.523 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -92.45 136.41 33.23 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.866 0.866 . . . . 0.0 111.763 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.5 121.28 8.67 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.712 1.205 . . . . 0.0 112.36 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.5 mp0 -70.21 -39.95 74.84 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -144.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -60.91 -35.31 76.35 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.625 1.17 . . . . 0.0 112.355 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -79.58 -12.65 59.84 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.19 -44.09 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.897 166.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.1 mt -63.63 -57.68 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.955 1.302 . . . . 0.0 111.182 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.05 -24.85 66.03 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -86.34 -27.78 29.46 Favored Glycine 0 CA--C 1.536 1.356 0 O-C-N 120.938 -1.101 . . . . 0.0 113.562 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 50.5 t90 -69.97 -41.4 74.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.242 1.521 . . . . 0.0 112.471 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -43.05 -56.86 5.78 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -167.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.75 -23.07 56.25 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 CA-C-N 122.21 1.825 . . . . 0.0 113.92 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -81.87 4.47 22.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.344 1.458 . . . . 0.0 113.895 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.9 p -63.08 -19.5 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.253 0.478 . . . . 0.0 111.905 159.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -125.63 -31.06 3.0 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.083 1.353 . . . . 0.0 113.878 170.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 CA-C-O 115.75 -2.071 . . . . 0.0 114.321 176.158 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.72 -164.06 0.08 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.025 0.93 . . . . 0.0 111.872 -169.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 78.5 mt -69.67 119.27 13.66 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.723 -1.236 . . . . 0.0 111.132 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -128.5 91.58 3.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.539 1.161 . . . . 0.0 109.159 173.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.9 mt -68.38 138.37 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 124.945 1.298 . . . . 0.0 108.312 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.0 m -123.98 133.47 53.68 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 165.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.53 141.93 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 121.011 -1.056 . . . . 0.0 110.977 -158.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.733 ' N ' ' HG ' ' A' ' 23' ' ' CYS . 34.4 tttm -65.55 126.36 28.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 170.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.03 173.77 10.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.851 1.661 . . . . 0.0 111.663 169.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.07 142.48 19.95 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.616 0.766 . . . . 0.0 111.604 168.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.07 120.88 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 166.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.89 -16.62 31.2 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.069 1.319 . . . . 0.0 116.144 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.22 87.51 50.78 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 119.757 1.779 . . . . 0.0 112.095 -171.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.03 -4.78 10.84 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.022 3.148 . . . . 0.0 115.715 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -92.23 -6.84 49.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.929 1.291 . . . . 0.0 114.286 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.44 163.84 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.111 1.365 . . . . 0.0 111.701 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.11 -40.44 31.07 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -175.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.88 -124.59 6.07 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.912 1.244 . . . . 0.0 114.725 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -65.56 15.43 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.115 2.566 . . . . 0.0 116.67 -173.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.468 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 68.7 m -116.36 72.76 5.16 Favored Pre-proline 0 C--O 1.259 1.562 0 O-C-N 120.207 -1.558 . . . . 0.0 110.972 -160.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -66.08 -30.66 47.01 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.474 2.783 . . . . 0.0 111.935 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -61.81 -35.96 79.74 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.233 -0.917 . . . . 0.0 113.27 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.733 ' HG ' ' N ' ' A' ' 8' ' ' LYS . 83.6 m -65.24 -41.9 93.86 Favored 'General case' 0 C--N 1.37 1.47 0 O-C-N 120.101 -1.624 . . . . 0.0 111.003 172.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -63.91 -27.88 69.45 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.274 1.03 . . . . 0.0 112.687 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.57 HH12 ' CG ' ' A' ' 74' ' ' ASP . 72.4 mtp180 -56.52 -43.2 79.59 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.717 1.207 . . . . 0.0 112.779 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 t -74.99 -35.78 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.889 1.276 . . . . 0.0 112.005 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.81 -40.35 83.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.306 0.642 . . . . 0.0 111.236 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.09 -44.56 96.4 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.5 p -71.66 -37.84 70.74 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.284 1.402 . . . . 0.0 112.877 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.5 mt -71.8 -32.16 67.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.629 0.772 . . . . 0.0 112.853 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -76.6 -29.8 56.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -42.79 77.64 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.285 -1.51 . . . . 0.0 111.652 167.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -69.68 -9.2 53.38 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.925 -1.109 . . . . 0.0 113.408 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 mttp 58.14 26.36 13.62 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.286 2.234 . . . . 0.0 113.107 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -85.51 133.96 41.09 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.823 1.649 . . . . 0.0 110.159 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.15 148.25 49.83 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.943 2.428 . . . . 0.0 113.161 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -148.59 162.78 38.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.371 1.468 . . . . 0.0 111.724 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -86.0 150.87 24.17 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.906 -1.121 . . . . 0.0 109.639 152.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.1 t -135.39 111.27 9.42 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.862 0.865 . . . . 0.0 110.558 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -100.69 86.72 3.17 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.033 1.733 . . . . 0.0 109.111 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.97 132.8 49.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.339 0.656 . . . . 0.0 110.664 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 mt -128.0 117.49 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.588 1.555 . . . . 0.0 110.119 -174.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -81.97 99.85 9.35 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.493 -0.754 . . . . 0.0 109.217 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.9 mt 53.85 25.8 5.58 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 168.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.09 15.01 21.2 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-O 118.614 -1.103 . . . . 0.0 115.744 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.32 12.18 0.05 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -140.17 146.08 44.55 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 125.842 1.657 . . . . 0.0 110.609 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -60.78 157.58 37.18 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.975 2.45 . . . . 0.0 112.799 -168.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -64.12 -12.85 43.44 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -168.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -51.6 -26.77 9.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.61 1.964 . . . . 0.0 115.863 161.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -100.24 3.53 43.64 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.694 1.598 . . . . 0.0 113.874 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.5 mt -124.81 -41.07 2.14 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.304 2.242 . . . . 0.0 112.887 -171.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -58.76 -16.33 16.3 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.526 2.33 . . . . 0.0 113.608 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.8 mt -58.05 -21.65 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 127.044 2.137 . . . . 0.0 111.173 171.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.1 p -111.52 147.41 36.66 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.037 0.935 . . . . 0.0 111.338 155.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.26 -12.68 35.71 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.887 2.391 . . . . 0.0 113.065 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.572 ' CD ' ' HZ2' ' A' ' 59' ' ' LYS . 1.4 mm-40 -79.4 -13.97 59.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.412 1.485 . . . . 0.0 113.339 174.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.38 13.86 61.14 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.002 -1.062 . . . . 0.0 114.195 -166.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.572 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 84.9 mttt -88.4 167.43 13.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.506 1.522 . . . . 0.0 111.402 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.0 m -133.49 152.33 78.97 Favored Pre-proline 0 N--CA 1.469 0.498 0 C-N-CA 125.915 1.686 . . . . 0.0 109.207 157.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.32 151.83 63.99 Favored 'Cis proline' 0 C--N 1.35 0.632 0 N-CA-C 117.378 2.03 . . . . 0.0 117.378 10.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.1 m -158.87 171.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 129.264 3.026 . . . . 0.0 110.196 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.61 141.64 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 120.791 -1.193 . . . . 0.0 113.514 165.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -84.58 121.38 27.53 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.903 0.881 . . . . 0.0 108.74 153.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.2 mt -98.82 79.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.737 1.215 . . . . 0.0 108.652 170.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 55.55 53.41 9.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.279 1.032 . . . . 0.0 112.152 -165.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.81 14.09 3.06 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -174.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -94.99 109.93 21.89 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.428 -1.42 . . . . 0.0 108.56 166.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -77.8 147.31 35.32 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -160.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.35 132.28 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.902 1.681 . . . . 0.0 108.846 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.57 -142.15 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.972 1.709 . . . . 0.0 113.029 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.43 169.05 2.43 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -164.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.0 p -50.45 -39.73 48.53 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.57 ' CG ' HH12 ' A' ' 25' ' ' ARG . 7.4 m-20 -72.87 -22.38 60.78 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.51 1.505 . . . . 0.0 113.156 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -92.49 -24.03 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.962 -1.086 . . . . 0.0 113.818 165.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.1 mt -61.8 -42.87 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.123 1.329 . . . . 0.0 111.487 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.93 -7.08 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.66 -59.56 0.63 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.637 1.113 . . . . 0.0 113.36 159.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.0 mt -75.18 -33.34 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.677 1.191 . . . . 0.0 113.476 -164.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.08 -42.58 66.01 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.827 -1.171 . . . . 0.0 110.207 168.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -65.28 -28.88 69.64 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 22.4 tt0 -69.41 -43.86 72.57 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.995 2.118 . . . . 0.0 113.088 168.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.508 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 95.5 mttt -94.03 -7.15 43.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.481 1.112 . . . . 0.0 113.695 -168.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -77.22 141.38 66.63 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.978 1.311 . . . . 0.0 110.082 171.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -68.21 -26.34 36.09 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 121.918 1.746 . . . . 0.0 113.815 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -82.24 142.64 47.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.941 0.791 . . . . 0.0 110.79 172.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -53.74 150.84 27.59 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.561 2.841 . . . . 0.0 116.325 -166.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.08 118.95 5.89 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.087 2.524 . . . . 0.0 112.523 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.1 mt -67.61 -10.91 56.34 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.85 1.26 . . . . 0.0 112.504 162.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.99 -21.87 33.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.75 1.62 . . . . 0.0 113.922 165.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -61.17 114.47 10.75 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 124.01 0.924 . . . . 0.0 110.226 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.05 125.58 7.33 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.159 1.906 . . . . 0.0 112.304 -168.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -76.34 174.64 12.49 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.505 2.137 . . . . 0.0 110.216 156.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -54.52 -34.93 62.59 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.862 -1.149 . . . . 0.0 113.235 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -58.26 -21.06 46.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.099 1.759 . . . . 0.0 114.844 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.82 -30.37 71.43 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 120.263 1.392 . . . . 0.0 112.87 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.9 p -67.5 -15.65 63.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.622 1.169 . . . . 0.0 114.061 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.0 t -111.91 -39.84 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.222 1.409 . . . . 0.0 111.679 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.82 -24.01 67.88 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.198 1.38 . . . . 0.0 114.434 175.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.5 p -66.11 -19.6 65.89 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -85.99 -43.03 13.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.478 1.111 . . . . 0.0 112.329 166.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.2 mt -68.55 -34.68 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.375 0.67 . . . . 0.0 111.544 -174.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.41 -45.77 97.46 Favored Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 120.319 -1.488 . . . . 0.0 114.068 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.59 -22.23 4.68 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.161 2.574 . . . . 0.0 114.712 168.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.1 p -75.6 -26.53 57.93 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.856 2.116 . . . . 0.0 114.289 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -60.65 -39.33 87.92 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.136 -0.978 . . . . 0.0 112.582 159.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.37 -38.86 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 119.516 1.053 . . . . 0.0 111.752 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -62.85 -45.77 91.01 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.159 0.891 . . . . 0.0 112.042 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -68.66 -30.12 68.74 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.251 1.02 . . . . 0.0 113.307 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.7 mt -82.82 -2.34 54.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.381 1.873 . . . . 0.0 114.082 168.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -122.32 56.95 1.09 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.937 1.695 . . . . 0.0 109.687 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 m -66.43 24.49 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.042 2.937 . . . . 0.0 116.301 -161.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -68.09 -29.78 68.8 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.282 1.033 . . . . 0.0 111.377 152.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.36 141.16 93.26 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.785 160.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -68.11 98.22 0.52 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.015 1.81 . . . . 0.0 112.687 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -51.85 -42.34 62.53 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -171.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -22.36 66.74 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.978 1.263 . . . . 0.0 114.189 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.01 -32.6 9.69 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.52 1.057 . . . . 0.0 113.599 168.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.8 m -62.25 -31.63 72.22 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.097 0.959 . . . . 0.0 112.182 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.7 -44.29 96.61 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.117 1.767 . . . . 0.0 112.128 172.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -66.41 -36.81 83.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.509 -0.745 . . . . 0.0 112.157 175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.8 94.98 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.283 -0.885 . . . . 0.0 112.393 172.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.72 -33.07 75.04 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.065 -0.969 . . . . 0.0 112.874 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.7 mt -61.65 -43.37 98.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.458 1.481 . . . . 0.0 111.911 174.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -73.01 -31.87 64.75 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.516 1.053 . . . . 0.0 113.186 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -66.86 -43.78 82.72 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.264 -0.897 . . . . 0.0 112.279 170.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.44 -28.77 52.6 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.255 1.022 . . . . 0.0 113.525 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -59.85 -39.59 85.7 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 120.081 1.31 . . . . 0.0 112.51 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.99 -24.1 66.71 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 tp -85.15 -54.89 4.33 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.39 1.476 . . . . 0.0 111.635 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.27 -37.88 81.16 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -158.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.52 -34.32 88.79 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.217 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -84.5 -27.24 27.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.82 0.848 . . . . 0.0 112.883 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.48 -39.54 94.74 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.451 -0.781 . . . . 0.0 112.05 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -64.08 -6.07 5.8 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.41 -35.36 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.54 1.136 . . . . 0.0 112.368 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -82.64 -53.81 5.65 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 159.16 178.68 33.39 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 -170.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.63 -13.24 18.19 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.781 3.654 . . . . 0.0 115.986 -159.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -86.27 169.16 13.26 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.668 1.122 . . . . 0.0 111.559 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.255 9.9 tt -77.95 9.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.307 -1.496 . . . . 0.0 112.572 176.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.6 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -121.29 2.27 10.29 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.818 2.447 . . . . 0.0 114.173 168.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.15 -128.99 9.75 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 119.399 1.0 . . . . 0.0 113.86 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -67.12 -24.4 65.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.222 1.409 . . . . 0.0 114.119 -168.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -136.32 157.13 47.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.004 1.722 . . . . 0.0 110.274 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 81.1 mt -65.37 136.24 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.751 0.821 . . . . 0.0 109.597 164.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.6 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 19.4 p -138.9 -174.16 3.77 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.496 1.119 . . . . 0.0 111.77 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.71 -16.02 5.63 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 170.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.3 t -71.25 -43.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.499 1.045 . . . . 0.0 111.616 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.4 -42.44 96.1 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.227 -1.546 . . . . 0.0 112.643 166.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 37.4 mt -62.41 -16.6 55.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.6 m -98.27 -48.57 5.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.939 1.296 . . . . 0.0 112.331 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 28.3 mt -92.68 -37.35 12.45 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.77 1.228 . . . . 0.0 114.083 -168.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.73 -48.53 89.41 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -169.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.62 -27.11 15.69 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 120.859 1.342 . . . . 0.0 112.83 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.1 -33.98 74.35 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 117.3 -1.333 . . . . 0.0 112.39 171.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.06 -42.21 94.43 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.379 0.991 . . . . 0.0 112.641 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -64.83 -44.69 88.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.311 0.959 . . . . 0.0 112.174 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -62.3 -32.19 72.89 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.665 -0.647 . . . . 0.0 112.496 175.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.3 tp -74.01 -45.31 50.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.421 1.488 . . . . 0.0 113.427 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.6 -37.7 73.68 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.937 1.295 . . . . 0.0 111.44 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.65 -59.4 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.8 -51.03 17.72 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.169 -0.957 . . . . 0.0 113.507 -166.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.0 tp -75.9 -36.3 59.5 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.202 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.17 -26.53 63.79 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.972 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -60.11 -32.69 71.23 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 170.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.21 -30.22 9.34 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.141 0.977 . . . . 0.0 113.626 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -150.58 96.72 2.41 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.534 1.534 . . . . 0.0 109.548 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.9 75.13 0.89 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.862 0.865 . . . . 0.0 111.008 168.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -67.55 117.46 47.59 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 123.926 0.89 . . . . 0.0 110.339 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.83 121.8 8.24 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.744 1.629 . . . . 0.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 37.6 mt -61.3 112.76 6.42 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 161.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.8 156.28 62.67 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.567 1.512 . . . . 0.0 112.528 -169.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -21.77 63.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.125 1.37 . . . . 0.0 114.258 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -64.89 -37.47 87.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.182 0.993 . . . . 0.0 112.847 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.7 mt -81.23 49.09 1.21 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.288 1.835 . . . . 0.0 111.253 166.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -32.84 70.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.313 1.445 . . . . 0.0 112.306 -166.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -81.41 -39.54 24.8 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.499 0.72 . . . . 0.0 112.18 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.93 -40.86 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.427 0.691 . . . . 0.0 110.647 170.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 67.7 tp -64.59 -43.69 93.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.678 1.191 . . . . 0.0 113.333 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -69.33 -36.49 77.0 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.457 -0.777 . . . . 0.0 112.943 175.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -62.4 -26.68 68.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.964 0.906 . . . . 0.0 113.21 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 43.0 mm -51.36 -37.6 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.147 0.979 . . . . 0.0 112.16 168.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -78.8 -13.25 59.91 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.411 -1.431 . . . . 0.0 113.279 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 33.9 mt -74.81 -24.7 58.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.984 -1.007 . . . . 0.0 113.172 165.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.49 -23.78 67.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.361 0.982 . . . . 0.0 112.797 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -88.47 3.55 49.73 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.996 -1.065 . . . . 0.0 113.829 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.5 p -130.27 178.03 6.88 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -157.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 56.71 -170.36 0.09 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.154 1.781 . . . . 0.0 110.993 -173.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -72.8 -37.88 67.39 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.829 -1.17 . . . . 0.0 111.645 156.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -48.83 74.57 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.535 1.134 . . . . 0.0 113.679 -162.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -95.83 -35.03 11.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.01 -30.06 70.08 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.692 -1.255 . . . . 0.0 113.205 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.13 -24.87 51.64 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 63.3 p -90.25 -11.22 41.56 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -56.25 105.43 0.2 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.083 1.353 . . . . 0.0 110.512 171.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -76.12 151.63 36.95 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.998 0.919 . . . . 0.0 112.37 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.62 130.31 45.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.18 0.992 . . . . 0.0 111.303 166.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.56 -37.47 21.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.326 1.45 . . . . 0.0 112.902 -144.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -39.95 82.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.826 1.65 . . . . 0.0 113.037 167.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -79.99 -8.89 59.59 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.78 -47.77 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 120.103 1.319 . . . . 0.0 109.939 160.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.1 mt -65.14 -56.65 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.5 1.12 . . . . 0.0 111.204 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.45 -24.61 65.64 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.092 0.957 . . . . 0.0 113.45 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -85.13 -30.4 25.63 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.08 -1.012 . . . . 0.0 113.424 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -70.69 -36.56 73.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.127 1.464 . . . . 0.0 113.01 174.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -42.37 -56.51 5.5 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -164.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.64 -23.57 42.53 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 CA-C-N 122.359 1.878 . . . . 0.0 114.12 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -77.17 2.68 14.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.226 1.81 . . . . 0.0 113.904 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.38 -19.77 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.856 0.862 . . . . 0.0 112.377 156.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.44 -30.68 2.1 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 174.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 116.073 -1.918 . . . . 0.0 113.799 -179.616 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.02 -157.53 0.11 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.717 0.807 . . . . 0.0 112.002 -173.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.4 mt -73.07 119.51 17.42 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.358 -0.839 . . . . 0.0 111.182 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -123.94 98.51 5.83 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.833 1.253 . . . . 0.0 108.127 166.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mt -74.22 135.02 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.2 m -120.53 129.89 54.0 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.1 140.2 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.99 -1.069 . . . . 0.0 110.737 -156.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.731 ' N ' ' HG ' ' A' ' 23' ' ' CYS . 33.8 tttm -65.74 125.53 25.58 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 170.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.76 174.65 10.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.914 1.686 . . . . 0.0 111.76 169.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.55 140.85 21.8 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.884 0.874 . . . . 0.0 111.691 166.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.5 t -53.76 121.07 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.943 0.401 . . . . 0.0 110.091 167.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.3 -11.95 34.88 Favored Glycine 0 CA--C 1.536 1.403 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.91 83.93 55.37 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.979 1.89 . . . . 0.0 111.93 -172.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.24 -8.75 19.55 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.765 2.976 . . . . 0.0 116.742 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -91.63 -1.91 57.28 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.4 pt -142.56 163.09 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.253 1.421 . . . . 0.0 111.566 -170.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 mt -77.39 -41.75 38.95 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.28 -125.06 6.79 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.74 1.162 . . . . 0.0 114.961 -176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -65.1 13.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.318 2.647 . . . . 0.0 116.605 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.503 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 69.2 m -115.4 73.91 4.05 Favored Pre-proline 0 C--O 1.256 1.417 0 O-C-N 120.559 -1.338 . . . . 0.0 110.942 -160.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.77 -29.49 42.41 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 123.549 2.833 . . . . 0.0 111.804 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -61.19 -39.44 90.19 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.217 -0.927 . . . . 0.0 112.789 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.731 ' HG ' ' N ' ' A' ' 8' ' ' LYS . 83.8 m -63.34 -42.43 98.94 Favored 'General case' 0 C--N 1.373 1.612 0 O-C-N 120.343 -1.473 . . . . 0.0 110.987 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -60.86 -32.92 72.32 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.878 0.871 . . . . 0.0 112.776 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.498 HH12 ' CG ' ' A' ' 74' ' ' ASP . 73.0 mtp180 -52.5 -43.55 65.12 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.783 1.233 . . . . 0.0 113.027 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -77.61 -32.2 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.058 1.343 . . . . 0.0 112.364 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.83 -37.47 76.21 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.074 -0.391 . . . . 0.0 111.27 168.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.59 -42.18 98.29 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.574 0.954 . . . . 0.0 113.574 -163.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.9 p -74.92 -38.57 61.77 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.953 0.797 . . . . 0.0 112.937 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.89 -34.8 77.36 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.235 0.614 . . . . 0.0 112.609 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -77.66 -24.5 49.4 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -73.86 -42.65 60.48 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.691 -1.256 . . . . 0.0 112.283 169.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -66.52 -13.3 60.75 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.66 1.984 . . . . 0.0 112.846 167.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.8 mttm 61.86 21.47 12.28 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 127.827 2.451 . . . . 0.0 113.905 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.51 127.04 72.19 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.152 1.381 . . . . 0.0 109.66 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.3 152.46 49.93 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.93 2.42 . . . . 0.0 113.033 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -146.93 166.42 26.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.866 1.666 . . . . 0.0 111.13 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -89.8 148.87 22.96 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.04 -1.037 . . . . 0.0 109.813 156.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.1 t -131.98 108.73 9.55 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.868 0.867 . . . . 0.0 110.493 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -100.11 83.34 2.67 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.855 1.662 . . . . 0.0 108.494 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -69.23 130.5 42.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.418 0.687 . . . . 0.0 110.449 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 mt -127.75 119.13 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.603 1.561 . . . . 0.0 110.266 -172.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -82.63 98.14 8.86 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 168.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt 53.72 30.11 10.58 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 167.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.55 16.19 29.91 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.79 8.53 0.18 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.089 1.945 . . . . 0.0 115.812 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -140.88 145.44 39.59 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 126.522 1.929 . . . . 0.0 110.02 -177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -62.46 161.26 28.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.153 2.569 . . . . 0.0 113.497 -164.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.95 -10.66 41.17 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -170.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -52.13 -21.71 3.54 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.284 1.834 . . . . 0.0 115.745 158.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -108.56 5.22 24.88 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.365 1.466 . . . . 0.0 113.516 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.7 mt -125.59 -40.76 2.05 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.969 2.108 . . . . 0.0 113.034 -171.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -61.09 -13.81 19.71 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 126.811 2.044 . . . . 0.0 113.641 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.5 mt -58.62 -21.39 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 126.816 2.046 . . . . 0.0 111.167 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 84.1 p -110.84 147.16 35.91 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.616 1.166 . . . . 0.0 111.203 155.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.05 -17.13 40.91 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.542 2.161 . . . . 0.0 113.025 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.12 -10.35 59.58 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.688 1.595 . . . . 0.0 112.997 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.91 13.69 62.03 Favored Glycine 0 CA--C 1.537 1.469 0 O-C-N 120.658 -1.276 . . . . 0.0 114.358 -169.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -81.35 168.72 18.09 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.465 1.906 . . . . 0.0 112.109 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.71 151.05 71.87 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 113.211 -1.813 . . . . 0.0 108.769 153.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.9 151.07 91.46 Favored 'Cis proline' 0 C--N 1.349 0.562 0 N-CA-C 117.245 1.979 . . . . 0.0 117.245 11.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.8 m -154.58 170.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 128.779 2.832 . . . . 0.0 109.468 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.35 145.42 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 120.777 -1.202 . . . . 0.0 113.085 165.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -86.94 139.78 30.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.882 151.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.4 mt -118.52 81.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.249 1.42 . . . . 0.0 108.222 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.3 t70 55.53 55.38 7.35 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.171 1.388 . . . . 0.0 112.807 -164.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.72 20.29 3.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.746 2.018 . . . . 0.0 116.098 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -100.77 112.42 24.83 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.987 -1.071 . . . . 0.0 108.649 165.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -80.24 150.59 29.99 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -160.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.67 127.9 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.556 1.943 . . . . 0.0 109.029 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.93 -150.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.58 1.952 . . . . 0.0 113.825 -174.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.16 157.55 0.44 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -169.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.4 p -54.97 -28.26 50.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -173.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.498 ' CG ' HH12 ' A' ' 25' ' ' ARG . 3.3 m-20 -72.56 -21.41 61.16 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.076 1.351 . . . . 0.0 114.076 177.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 m -93.94 -23.59 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.729 1.149 . . . . 0.0 112.925 165.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.3 -42.34 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.276 0.944 . . . . 0.0 112.077 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -63.9 -6.17 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.43 -58.21 0.62 Allowed Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.602 1.096 . . . . 0.0 113.311 158.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -76.46 -31.08 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.602 1.161 . . . . 0.0 113.584 -163.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.6 tp -73.66 -40.28 63.83 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.526 -1.359 . . . . 0.0 110.746 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -65.14 -30.68 71.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.797 0.839 . . . . 0.0 113.11 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.506 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 25.3 tt0 -67.43 -42.26 83.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.384 1.874 . . . . 0.0 113.071 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.506 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.0 mttt -97.4 -7.33 32.01 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.537 1.135 . . . . 0.0 113.879 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.03 141.68 58.86 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.782 1.233 . . . . 0.0 110.015 169.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.23 -23.84 32.76 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.922 1.748 . . . . 0.0 114.252 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.33 139.57 60.09 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 117.734 -1.127 . . . . 0.0 110.343 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.53 146.73 18.87 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.869 3.046 . . . . 0.0 115.812 -171.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.47 120.24 7.4 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.875 2.383 . . . . 0.0 112.246 -173.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.4 mt -68.68 -8.6 43.97 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.042 0.937 . . . . 0.0 112.786 165.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.52 53.08 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.697 1.599 . . . . 0.0 113.717 164.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -61.58 112.11 5.49 Favored Pre-proline 0 N--CA 1.472 0.637 0 C-N-CA 124.072 0.949 . . . . 0.0 110.182 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.01 129.23 12.13 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.977 1.785 . . . . 0.0 112.246 -165.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -76.97 175.67 11.1 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.675 2.25 . . . . 0.0 110.401 157.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -53.56 -36.86 62.31 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.904 -1.123 . . . . 0.0 112.88 171.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -60.95 -15.93 36.9 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.063 1.745 . . . . 0.0 114.815 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.92 -30.29 70.11 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 120.321 1.419 . . . . 0.0 112.73 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.1 p -71.35 -8.62 54.96 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.179 1.392 . . . . 0.0 114.561 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.59 -41.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.735 1.214 . . . . 0.0 111.651 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.57 -22.92 68.31 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.106 1.336 . . . . 0.0 114.308 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.1 p -67.39 -18.16 65.02 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 168.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -87.91 -43.03 12.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.658 1.183 . . . . 0.0 112.15 165.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.57 -33.83 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.261 0.625 . . . . 0.0 111.721 -173.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.41 -48.78 92.86 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 120.387 -1.445 . . . . 0.0 113.743 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -79.89 -22.09 7.77 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.937 2.425 . . . . 0.0 114.998 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.0 p -73.85 -29.97 62.41 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 121.882 2.128 . . . . 0.0 113.363 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -62.85 -34.23 76.91 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.903 -1.123 . . . . 0.0 113.168 161.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.412 ' CG2' ' HZ3' ' A' ' 156' ' ' LYS . 79.6 t -65.35 -41.93 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.056 1.298 . . . . 0.0 111.484 173.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -64.32 -43.66 93.99 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.337 0.971 . . . . 0.0 112.313 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.5 -30.19 70.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.053 0.941 . . . . 0.0 112.345 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.5 mt -91.97 20.94 5.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.79 1.636 . . . . 0.0 113.583 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -138.03 62.85 1.56 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.013 1.725 . . . . 0.0 110.33 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -60.46 13.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 129.158 2.983 . . . . 0.0 117.636 -164.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -68.3 -35.93 78.58 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.007 -1.058 . . . . 0.0 111.364 160.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -76.63 148.96 80.48 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.68 0.392 . . . . 0.0 110.128 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.23 106.48 1.57 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.083 1.856 . . . . 0.0 110.77 -175.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -62.04 -38.11 87.49 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.537 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.96 -27.65 68.99 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.383 -1.448 . . . . 0.0 114.455 173.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.27 -31.16 20.39 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.023 -1.048 . . . . 0.0 113.521 171.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.2 m -69.31 -29.91 67.86 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.626 1.171 . . . . 0.0 112.091 173.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.53 -44.21 96.92 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.177 1.791 . . . . 0.0 111.802 169.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -66.69 -37.14 84.14 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.3 -0.875 . . . . 0.0 112.534 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.38 93.73 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.381 -0.824 . . . . 0.0 112.461 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.5 tp -64.88 -36.49 84.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.916 1.286 . . . . 0.0 112.382 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -60.3 -40.2 89.65 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.521 1.055 . . . . 0.0 112.473 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.478 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 14.5 mm-40 -74.06 -27.7 61.04 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.953 0.797 . . . . 0.0 112.899 177.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -69.65 -44.66 70.12 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.186 -0.947 . . . . 0.0 112.097 168.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -72.18 -28.65 63.35 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.478 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 81.4 mttt -60.9 -38.09 84.51 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.911 1.232 . . . . 0.0 112.937 173.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.25 64.96 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 174.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 tp -87.53 -57.76 2.83 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.477 1.511 . . . . 0.0 112.011 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.36 -37.55 85.55 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -159.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.74 -34.05 88.9 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.708 -0.62 . . . . 0.0 113.657 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -89.78 -24.29 21.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.845 0.858 . . . . 0.0 112.997 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.6 -39.76 95.2 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.23 -0.919 . . . . 0.0 111.924 166.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -64.81 -5.54 6.16 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 172.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.2 t -101.15 -37.13 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.841 1.256 . . . . 0.0 112.31 168.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -82.13 -49.24 10.39 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 155.26 177.22 28.31 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 121.05 -1.031 . . . . 0.0 115.642 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.29 -13.65 20.76 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.933 3.755 . . . . 0.0 116.132 -161.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -82.93 170.02 15.39 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.515 1.052 . . . . 0.0 111.7 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.6 tt -78.74 10.85 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.503 -1.373 . . . . 0.0 112.532 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.514 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -127.65 5.32 6.14 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.798 2.439 . . . . 0.0 114.08 169.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.46 -120.87 6.97 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 119.08 0.855 . . . . 0.0 113.892 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -70.1 -22.31 63.04 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.229 1.012 . . . . 0.0 113.631 -164.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.0 pttt -144.2 168.54 19.79 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.542 1.937 . . . . 0.0 111.858 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.5 mt -67.77 131.72 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 161.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.514 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 25.2 p -130.3 -176.97 4.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.984 1.313 . . . . 0.0 111.219 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.19 -16.93 6.03 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 170.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.51 -46.58 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.714 0.806 . . . . 0.0 111.442 168.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.97 -41.25 99.49 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.442 -1.411 . . . . 0.0 112.936 168.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.8 mt -64.78 0.33 1.2 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.3 m -121.8 -43.0 2.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.625 1.17 . . . . 0.0 112.012 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.37 -40.09 13.82 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.778 1.231 . . . . 0.0 113.977 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.58 97.65 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -170.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.67 -25.43 12.6 Favored 'Trans proline' 0 C--N 1.35 0.632 0 CA-C-N 120.752 1.304 . . . . 0.0 112.8 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.412 ' HZ3' ' CG2' ' A' ' 107' ' ' VAL . 65.2 mttm -68.88 -35.33 76.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 117.526 -1.226 . . . . 0.0 112.172 170.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.4 mt -64.84 -41.4 95.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 118.358 -0.829 . . . . 0.0 112.821 170.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -65.38 -42.08 93.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.321 0.964 . . . . 0.0 112.509 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -64.64 -30.07 71.09 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.304 -0.873 . . . . 0.0 112.435 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.2 tp -75.29 -44.48 45.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.001 1.321 . . . . 0.0 113.292 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -58.87 -36.41 74.57 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.696 1.198 . . . . 0.0 111.52 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.69 -57.07 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.69 -51.64 15.96 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.197 -0.939 . . . . 0.0 113.235 -166.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 60.6 tp -75.79 -33.4 60.16 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.564 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.22 -27.84 60.79 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.964 -0.909 . . . . 0.0 114.967 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -60.87 -27.27 68.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.182 1.393 . . . . 0.0 114.539 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -114.35 -33.07 5.74 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.604 1.162 . . . . 0.0 113.236 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -149.77 94.95 2.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.014 1.726 . . . . 0.0 109.091 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -71.17 76.53 0.7 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.65 0.78 . . . . 0.0 111.096 168.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -68.44 118.75 62.86 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 123.729 0.812 . . . . 0.0 110.234 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.96 128.63 14.27 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.644 1.563 . . . . 0.0 110.226 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.52 114.77 14.25 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 158.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -64.1 154.34 71.1 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.424 1.416 . . . . 0.0 113.29 -169.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -26.27 61.82 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.65 1.98 . . . . 0.0 113.489 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -62.95 -36.95 85.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.962 1.305 . . . . 0.0 112.607 172.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 87.2 mt -88.48 49.66 1.83 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.106 1.762 . . . . 0.0 111.239 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -28.96 69.62 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.283 1.433 . . . . 0.0 112.225 -166.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -80.15 -38.21 31.88 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.43 -0.794 . . . . 0.0 112.492 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.8 t -65.44 -39.17 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.773 0.829 . . . . 0.0 110.828 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 68.4 tp -65.02 -44.54 88.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.094 0.957 . . . . 0.0 113.117 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -67.3 -34.44 77.38 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.289 -0.882 . . . . 0.0 112.999 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -62.68 -26.94 68.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.838 0.855 . . . . 0.0 113.246 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.3 mm -53.7 -36.53 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 121.331 -0.856 . . . . 0.0 111.789 168.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -82.76 -7.43 59.65 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.418 -1.426 . . . . 0.0 113.713 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.27 -18.51 52.59 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 117.658 -1.163 . . . . 0.0 113.787 160.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.77 -17.49 63.11 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.117 1.326 . . . . 0.0 113.602 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -93.11 3.79 55.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.707 1.603 . . . . 0.0 113.749 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.6 p -123.17 178.77 4.95 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -159.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.7 mtp85 57.54 -165.57 0.16 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.335 1.854 . . . . 0.0 112.022 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -80.6 -38.31 29.62 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.62 1.168 . . . . 0.0 110.146 165.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.5 p -62.97 -81.13 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.484 2.314 . . . . 0.0 113.673 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -61.11 -39.82 91.44 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.172 -0.955 . . . . 0.0 113.507 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.35 -31.1 68.88 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.184 1.394 . . . . 0.0 113.736 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.31 -29.39 31.13 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.101 0.864 . . . . 0.0 113.22 172.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 81.5 p -75.8 -16.91 60.03 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 174.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -60.46 99.36 0.08 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.3 1.44 . . . . 0.0 112.125 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.61 150.42 41.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.37 123.16 18.02 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.008 1.323 . . . . 0.0 111.849 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -64.11 -47.04 81.57 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.956 1.702 . . . . 0.0 115.326 -153.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -61.71 -35.01 76.79 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.851 0.86 . . . . 0.0 112.258 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -77.97 -12.33 59.98 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.59 -45.54 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.406 1.003 . . . . 0.0 109.946 165.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.7 mt -67.16 -58.0 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.985 1.314 . . . . 0.0 111.585 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.06 -27.94 67.79 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.72 -21.01 62.47 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 120.848 -1.157 . . . . 0.0 113.782 171.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -80.2 -25.45 39.66 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.409 1.605 . . . . 0.0 113.841 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -47.27 -53.99 24.62 Favored Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -173.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.64 -18.5 37.53 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 122.295 1.855 . . . . 0.0 114.024 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -81.73 4.96 20.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.006 1.723 . . . . 0.0 114.11 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.32 -18.61 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 120.972 -1.08 . . . . 0.0 112.012 154.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -124.08 -35.64 2.8 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.12 1.368 . . . . 0.0 113.695 174.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 115.713 -2.089 . . . . 0.0 113.904 177.736 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.8 ttm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.63 -159.77 0.1 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.94 0.896 . . . . 0.0 111.514 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.0 mt -69.92 119.9 14.83 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.302 -0.873 . . . . 0.0 110.94 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -130.4 93.09 3.38 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.6 mt -74.05 139.14 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.599 1.159 . . . . 0.0 108.642 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.8 m -119.98 135.86 54.75 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 167.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.32 141.72 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.936 -1.103 . . . . 0.0 110.292 -162.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.774 ' N ' ' HG ' ' A' ' 23' ' ' CYS . 34.2 tttm -66.4 127.66 33.16 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 170.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.24 172.92 12.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.488 1.515 . . . . 0.0 111.732 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.54 139.82 36.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.186 0.994 . . . . 0.0 111.438 168.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 120.44 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.191 0.52 . . . . 0.0 110.05 169.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.66 -12.1 42.77 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 118.274 -1.292 . . . . 0.0 116.254 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.85 85.16 58.74 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 120.011 1.906 . . . . 0.0 111.891 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.82 -6.37 13.97 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.429 3.419 . . . . 0.0 117.179 -168.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -101.78 0.75 36.33 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.9 pt -141.81 162.59 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.61 1.564 . . . . 0.0 111.118 -172.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.07 -48.28 30.85 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.71 -126.71 13.42 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.338 0.97 . . . . 0.0 114.398 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.95 23.25 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 128.189 2.596 . . . . 0.0 117.009 -172.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.517 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.8 p -121.63 71.09 27.11 Favored Pre-proline 0 C--O 1.257 1.459 0 O-C-N 120.191 -1.568 . . . . 0.0 110.962 -159.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.75 -29.4 42.68 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.754 2.969 . . . . 0.0 112.424 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -61.96 -39.13 91.07 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.774 ' HG ' ' N ' ' A' ' 8' ' ' LYS . 83.6 m -63.09 -45.81 90.37 Favored 'General case' 0 C--N 1.376 1.739 0 CA-C-N 120.2 1.364 . . . . 0.0 111.018 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -57.56 -33.09 67.77 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.712 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.484 HH12 ' CG ' ' A' ' 74' ' ' ASP . 74.7 mtp180 -53.72 -43.82 69.35 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.756 1.223 . . . . 0.0 112.883 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -76.74 -27.25 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.394 1.477 . . . . 0.0 112.098 -170.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.59 -42.36 52.18 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.704 0.802 . . . . 0.0 111.076 169.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.64 -39.07 83.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -161.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 p -72.8 -43.45 62.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.121 0.873 . . . . 0.0 112.661 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.4 mt -66.32 -32.39 73.77 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.058 0.943 . . . . 0.0 112.08 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -79.55 -26.98 41.27 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -75.29 -39.05 60.04 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.064 0.847 . . . . 0.0 112.33 168.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -68.99 -9.62 53.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.931 1.693 . . . . 0.0 113.063 167.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 83.4 mttt 58.62 21.52 8.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.812 2.445 . . . . 0.0 114.746 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.98 123.53 83.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.497 1.119 . . . . 0.0 109.31 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.54 152.64 54.38 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.77 2.313 . . . . 0.0 112.519 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -150.78 160.32 43.95 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.462 1.505 . . . . 0.0 110.94 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -81.74 146.78 29.79 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.136 -0.978 . . . . 0.0 109.636 159.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -123.2 126.84 47.71 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.715 0.806 . . . . 0.0 111.319 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -115.09 80.72 1.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.748 1.619 . . . . 0.0 108.972 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.04 130.66 43.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.136 0.974 . . . . 0.0 110.368 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -129.74 120.34 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.772 1.229 . . . . 0.0 110.587 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -86.86 101.09 13.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.46 0.704 . . . . 0.0 109.246 168.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.5 mt 53.21 28.17 6.81 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 167.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.41 16.64 24.26 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -65.97 3.49 0.82 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 120.227 2.014 . . . . 0.0 115.698 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -140.15 146.92 48.25 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 126.541 1.936 . . . . 0.0 110.029 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.25 160.23 31.75 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.013 2.475 . . . . 0.0 113.772 -163.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.29 -10.38 23.57 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -55.35 -20.08 10.69 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.41 1.884 . . . . 0.0 114.902 164.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -108.39 9.84 27.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.37 1.868 . . . . 0.0 113.173 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.3 mt -132.68 -41.57 0.94 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.406 2.282 . . . . 0.0 112.637 -171.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.41 -13.53 20.88 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.905 2.482 . . . . 0.0 113.578 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mt -59.81 -21.93 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 127.162 2.185 . . . . 0.0 111.045 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.6 p -106.85 149.67 38.79 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.403 1.481 . . . . 0.0 110.998 156.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -68.52 -17.4 43.5 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.519 2.146 . . . . 0.0 112.975 170.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -82.09 -9.78 59.42 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.515 1.526 . . . . 0.0 113.443 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.5 23.09 73.56 Favored Glycine 0 CA--C 1.539 1.565 0 O-C-N 121.041 -1.037 . . . . 0.0 114.118 -171.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -89.63 172.69 8.77 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.497 1.919 . . . . 0.0 113.598 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.08 153.53 81.78 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 112.945 -1.934 . . . . 0.0 108.619 152.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.15 152.14 80.06 Favored 'Cis proline' 0 CA--C 1.536 0.587 0 N-CA-C 115.108 1.157 . . . . 0.0 115.108 5.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.1 m -155.19 164.65 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 128.141 2.577 . . . . 0.0 109.06 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.59 144.42 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 120.157 -1.589 . . . . 0.0 114.028 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -88.88 132.14 34.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.899 155.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.7 mt -109.27 79.64 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.829 1.252 . . . . 0.0 108.326 168.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 55.76 57.09 5.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.718 1.207 . . . . 0.0 112.865 -165.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.8 14.19 3.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -98.37 107.23 19.64 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.409 -1.432 . . . . 0.0 108.36 168.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -76.73 148.81 36.5 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.532 1.133 . . . . 0.0 113.712 -160.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -141.8 127.94 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.415 1.886 . . . . 0.0 109.34 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.53 -152.46 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.393 1.877 . . . . 0.0 113.828 -174.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.92 159.25 0.59 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.398 1.879 . . . . 0.0 115.211 -167.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.0 p -54.48 -29.06 48.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.484 ' CG ' HH12 ' A' ' 25' ' ' ARG . 41.6 m-20 -73.41 -15.53 61.35 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 m -100.2 -22.23 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.296 0.953 . . . . 0.0 113.007 163.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.1 mt -61.01 -40.82 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.449 1.022 . . . . 0.0 111.928 173.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.1 m -62.01 -7.39 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.17 -56.73 0.52 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.679 1.133 . . . . 0.0 113.346 161.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.1 mt -75.77 -31.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.648 1.179 . . . . 0.0 113.327 -164.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.5 tp -71.7 -42.7 67.07 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.83 -1.169 . . . . 0.0 110.51 168.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -65.26 -30.69 71.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 33.2 tt0 -66.25 -42.61 88.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.245 1.818 . . . . 0.0 112.996 169.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.511 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 94.5 mttt -99.78 -4.8 29.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.675 1.19 . . . . 0.0 113.621 -167.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -79.2 142.34 59.0 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.49 1.516 . . . . 0.0 110.188 170.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.7 -22.26 20.83 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.875 1.717 . . . . 0.0 114.004 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -80.08 145.43 60.88 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.043 169.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.52 149.09 24.89 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.632 2.888 . . . . 0.0 115.684 -172.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.13 120.47 7.62 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.939 2.426 . . . . 0.0 112.334 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.5 -10.13 53.55 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.436 -0.79 . . . . 0.0 112.593 164.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.58 -19.48 49.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.957 1.703 . . . . 0.0 114.211 166.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.5 m -59.91 112.88 6.02 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 123.712 0.805 . . . . 0.0 109.909 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.63 126.34 10.76 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.718 1.612 . . . . 0.0 111.852 -165.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.74 164.5 33.06 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.457 2.105 . . . . 0.0 110.788 159.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -51.97 -33.84 39.67 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.289 1.436 . . . . 0.0 112.961 160.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -60.63 -18.6 54.37 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 172.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.45 -29.9 70.85 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.505 -1.372 . . . . 0.0 113.182 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 94.3 p -67.61 -15.16 63.51 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.73 -38.79 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.419 1.488 . . . . 0.0 111.271 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.18 -27.8 71.16 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.31 0.957 . . . . 0.0 114.151 173.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.6 p -66.87 -19.49 65.74 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 171.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -87.91 -43.93 11.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.301 1.04 . . . . 0.0 112.837 167.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.8 mt -65.28 -32.79 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 122.605 0.362 . . . . 0.0 110.827 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.17 -49.57 90.16 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.238 -1.363 . . . . 0.0 114.449 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.32 -23.19 10.37 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.56 2.84 . . . . 0.0 114.128 167.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.473 ' HA ' ' CE ' ' A' ' 108' ' ' LYS . 17.2 m -66.88 -31.78 72.61 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.955 1.707 . . . . 0.0 114.147 171.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -67.73 -27.78 67.09 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 164.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.29 -42.27 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.313 1.415 . . . . 0.0 111.331 173.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.473 ' CE ' ' HA ' ' A' ' 105' ' ' SER . 53.3 mtmt -59.94 -47.87 84.03 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.035 0.834 . . . . 0.0 111.473 171.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -32.5 73.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.48 0.712 . . . . 0.0 112.333 -173.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.6 mt -88.01 17.03 5.26 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.537 1.535 . . . . 0.0 113.423 170.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -134.68 64.04 1.61 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.948 1.699 . . . . 0.0 110.335 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -60.39 10.22 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.351 2.66 . . . . 0.0 117.262 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -63.72 -33.33 75.42 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.012 -1.055 . . . . 0.0 111.605 156.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -82.23 149.1 61.38 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.044 0.938 . . . . 0.0 110.637 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.24 98.37 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.622 2.214 . . . . 0.0 110.913 -174.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -61.79 -31.81 72.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 116.925 -1.512 . . . . 0.0 114.394 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.34 -29.03 70.17 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.666 -1.272 . . . . 0.0 113.695 172.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.54 -27.63 32.07 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 120.891 -1.131 . . . . 0.0 113.656 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.1 m -70.93 -31.39 67.97 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.548 -0.972 . . . . 0.0 112.336 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.28 -44.09 96.08 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.879 1.672 . . . . 0.0 111.486 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -64.23 -41.46 97.0 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.466 -0.771 . . . . 0.0 112.788 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.4 95.02 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.382 -0.824 . . . . 0.0 112.66 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.9 tp -66.84 -36.58 82.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.738 1.215 . . . . 0.0 112.068 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.59 -38.1 83.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.809 1.186 . . . . 0.0 112.743 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.91 -29.22 62.97 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.063 0.847 . . . . 0.0 112.681 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -74.85 -37.6 62.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.201 1.0 . . . . 0.0 112.311 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.4 mt -71.9 -32.89 67.86 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.794 -1.191 . . . . 0.0 113.104 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -61.51 -39.45 91.03 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 120.014 1.279 . . . . 0.0 112.54 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.8 -25.46 67.25 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 174.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -86.29 -57.7 2.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.207 1.403 . . . . 0.0 112.46 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.71 -44.54 89.93 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -157.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.49 -24.79 69.64 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.637 -0.535 . . . . 0.0 113.312 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -89.23 -29.78 19.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.06 -0.972 . . . . 0.0 112.91 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.13 -39.4 86.14 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.32 1.418 . . . . 0.0 111.826 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.77 -12.42 10.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.692 1.597 . . . . 0.0 114.778 173.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 99.4 t -96.58 -31.02 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.087 1.355 . . . . 0.0 112.663 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -103.93 -27.72 12.0 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -167.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.22 177.43 19.09 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 120.095 1.316 . . . . 0.0 115.459 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.11 -11.39 23.23 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.761 3.64 . . . . 0.0 116.131 -163.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -84.6 173.29 10.9 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.522 1.055 . . . . 0.0 112.222 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.2 tt -79.65 13.15 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 120.874 -1.141 . . . . 0.0 112.411 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.72 24.87 2.4 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.161 2.584 . . . . 0.0 112.783 169.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.94 -117.55 4.44 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.733 -1.229 . . . . 0.0 113.408 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -64.56 -23.92 67.43 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -165.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -152.84 166.4 32.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.929 1.291 . . . . 0.0 112.617 -168.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.1 mt -66.16 128.95 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.5 0.72 . . . . 0.0 109.193 161.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.9 p -127.74 -178.69 4.59 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.069 1.748 . . . . 0.0 110.55 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.14 -15.31 13.76 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.374 -1.454 . . . . 0.0 114.823 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.37 -45.94 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.971 0.805 . . . . 0.0 111.178 167.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.98 -41.85 98.48 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.745 -1.222 . . . . 0.0 112.678 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.9 -0.88 1.69 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 172.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.1 m -121.53 -37.79 2.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.652 1.181 . . . . 0.0 112.061 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.8 mt -94.16 -38.22 11.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.854 1.262 . . . . 0.0 114.042 -176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.56 -47.7 92.25 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -169.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -74.27 -23.82 15.09 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.967 1.381 . . . . 0.0 113.046 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -70.3 -35.19 73.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.469 -1.253 . . . . 0.0 112.28 170.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 24.3 mt -64.7 -40.97 96.29 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.347 0.976 . . . . 0.0 112.585 168.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -62.21 -48.54 79.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.723 0.773 . . . . 0.0 112.188 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -64.6 -25.16 67.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.867 0.867 . . . . 0.0 112.573 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 32.1 tp -79.41 -43.28 23.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.802 1.241 . . . . 0.0 113.793 175.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -60.72 -32.86 72.1 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.739 0.815 . . . . 0.0 111.544 174.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 80.5 t -92.93 -62.44 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.029 0.931 . . . . 0.0 113.243 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.29 -51.89 27.03 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.323 0.965 . . . . 0.0 113.19 -166.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 53.8 tp -76.3 -35.69 58.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.542 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.87 -26.54 60.7 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.024 -0.876 . . . . 0.0 114.897 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -60.11 -32.07 70.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.962 1.305 . . . . 0.0 114.332 169.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -107.38 -32.0 7.93 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.439 1.095 . . . . 0.0 113.311 -178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -149.58 96.34 2.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.79 1.636 . . . . 0.0 108.963 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -71.81 77.33 0.87 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.858 0.863 . . . . 0.0 110.712 169.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 87.0 t90 -75.83 114.85 40.78 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.91 0.884 . . . . 0.0 109.947 172.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -72.74 138.92 29.87 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.731 1.62 . . . . 0.0 110.4 177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.6 mt -65.48 120.1 65.27 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 155.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -60.88 154.86 53.1 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.235 1.956 . . . . 0.0 113.154 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -22.35 64.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.446 1.499 . . . . 0.0 114.188 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -59.91 -42.74 94.53 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 112.157 168.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 78.4 mt -87.91 45.78 1.31 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.382 2.273 . . . . 0.0 111.326 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -29.26 67.72 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.658 1.583 . . . . 0.0 113.331 -168.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -79.69 -38.42 33.54 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.417 -0.802 . . . . 0.0 112.138 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.7 t -69.87 -36.08 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.888 -0.508 . . . . 0.0 111.077 170.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.6 tp -61.55 -42.93 99.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.116 0.966 . . . . 0.0 112.926 170.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -70.82 -32.2 69.18 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.284 -0.885 . . . . 0.0 113.264 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -63.02 -29.9 71.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.017 0.826 . . . . 0.0 112.932 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.47 -36.25 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.553 0.741 . . . . 0.0 111.503 169.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -81.78 -5.41 58.15 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.302 -1.499 . . . . 0.0 114.179 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.47 -22.74 54.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 117.989 -1.005 . . . . 0.0 113.357 159.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.34 -16.35 63.51 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.893 1.224 . . . . 0.0 114.17 -170.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -93.11 4.97 53.1 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.844 -1.16 . . . . 0.0 114.125 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.4 p -131.82 -174.68 3.49 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -158.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 59.31 -172.92 0.11 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.343 1.857 . . . . 0.0 111.809 -170.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -71.55 -34.87 70.38 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.918 163.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.4 p -76.7 -80.85 0.09 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.723 2.009 . . . . 0.0 112.558 -172.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -55.64 -40.49 72.26 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.206 -0.934 . . . . 0.0 113.258 -168.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.99 -38.52 67.95 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.105 1.762 . . . . 0.0 114.57 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -79.96 -33.36 39.58 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.178 0.899 . . . . 0.0 112.295 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 12.2 p -72.2 -7.44 49.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 171.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.435 HH22 ' CD ' ' A' ' 199' ' ' GLU . 33.5 ttt180 -60.4 109.84 1.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.072 1.305 . . . . 0.0 110.162 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -84.77 142.1 30.05 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.616 0.766 . . . . 0.0 111.833 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.11 125.95 25.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.722 1.209 . . . . 0.0 111.995 177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.435 ' CD ' HH22 ' A' ' 196' ' ' ARG . 1.0 OUTLIER -75.79 -34.96 60.22 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -151.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -39.02 92.8 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.85 -1.156 . . . . 0.0 112.757 169.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -76.86 -19.52 57.38 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.943 -1.098 . . . . 0.0 113.92 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 45.8 t -69.15 -46.11 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.082 0.855 . . . . 0.0 110.657 166.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mt -67.49 -55.63 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.028 0.931 . . . . 0.0 111.275 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.92 76.71 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -78.68 -18.18 75.98 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.846 -1.158 . . . . 0.0 113.721 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 58.2 t90 -82.43 -21.24 35.78 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.681 1.74 . . . . 0.0 114.069 173.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -45.83 -51.29 30.98 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.96 -18.39 24.32 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.179 1.919 . . . . 0.0 114.467 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -77.87 0.24 24.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.452 1.501 . . . . 0.0 114.345 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.3 m -60.48 -20.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.244 -0.91 . . . . 0.0 112.426 155.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -122.54 -33.48 3.42 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.592 1.557 . . . . 0.0 113.18 173.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -178.663 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 98.2 mtp . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.15 -161.14 0.08 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.178 0.991 . . . . 0.0 111.826 -169.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.5 mt -72.5 124.93 26.21 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.938 -1.102 . . . . 0.0 111.45 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -137.41 101.03 4.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.136 0.975 . . . . 0.0 108.777 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.3 mt -87.04 130.6 36.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 125.125 1.37 . . . . 0.0 108.605 -173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m -110.59 134.44 52.41 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.658 0.783 . . . . 0.0 109.418 169.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.04 140.66 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 121.114 -0.991 . . . . 0.0 110.8 -164.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.828 ' H ' ' HG ' ' A' ' 23' ' ' CYS . 33.6 tttm -66.53 126.84 30.14 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 170.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.21 173.15 11.26 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.776 1.63 . . . . 0.0 111.657 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.07 139.56 34.52 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.245 1.018 . . . . 0.0 111.372 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.4 t -54.67 118.3 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.006 0.431 . . . . 0.0 109.976 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.55 -10.22 65.25 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.471 1.349 . . . . 0.0 116.471 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.7 84.93 43.39 Favored Pre-proline 0 CA--C 1.552 1.019 0 CA-C-N 120.325 2.063 . . . . 0.0 112.397 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.5 5.24 1.01 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 125.281 3.987 . . . . 0.0 117.82 -168.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.74 6.11 10.98 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.704 1.201 . . . . 0.0 113.551 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.1 pt -140.36 160.84 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.906 1.682 . . . . 0.0 110.563 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 mt -74.64 -48.68 24.9 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.29 -125.44 10.21 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.318 0.961 . . . . 0.0 114.539 -174.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.2 21.16 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.084 2.554 . . . . 0.0 116.886 -171.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.485 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.4 p -121.13 70.18 20.3 Favored Pre-proline 0 C--O 1.255 1.36 0 O-C-N 120.241 -1.537 . . . . 0.0 111.006 -158.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -68.42 -29.24 31.61 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.431 2.754 . . . . 0.0 112.067 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -59.85 -38.65 82.71 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.704 0.802 . . . . 0.0 113.109 168.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.828 ' HG ' ' H ' ' A' ' 8' ' ' LYS . 83.6 m -64.87 -45.96 83.82 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 119.995 1.271 . . . . 0.0 111.0 173.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -55.85 -36.09 67.17 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.089 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.521 HH11 ' CG ' ' A' ' 74' ' ' ASP . 76.1 mtp180 -52.02 -45.94 64.79 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.689 1.196 . . . . 0.0 113.305 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.77 -32.57 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.337 1.455 . . . . 0.0 111.792 -169.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.14 -42.15 72.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.731 0.813 . . . . 0.0 111.027 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.0 tp -60.16 -39.26 85.78 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 p -71.63 -44.47 64.32 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.187 0.903 . . . . 0.0 112.753 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -72.76 -31.46 64.94 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.917 0.887 . . . . 0.0 112.251 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -79.08 -23.51 44.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -74.85 -41.23 60.25 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.218 0.917 . . . . 0.0 112.066 167.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -69.22 -8.58 47.16 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.135 1.374 . . . . 0.0 113.372 167.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.9 mttt 58.88 18.37 6.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.783 2.433 . . . . 0.0 115.22 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.8 mt -76.04 125.74 87.66 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.062 0.945 . . . . 0.0 109.462 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.7 150.01 68.02 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.617 2.211 . . . . 0.0 112.463 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -150.5 160.13 43.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.585 1.554 . . . . 0.0 110.718 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -84.95 131.46 34.48 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.957 -1.089 . . . . 0.0 110.085 163.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.2 t -93.25 131.65 38.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.29 0.636 . . . . 0.0 112.136 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -125.77 74.33 1.41 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.853 1.661 . . . . 0.0 109.665 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.8 mt -65.94 134.36 52.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.912 0.885 . . . . 0.0 110.561 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 mt -135.27 125.89 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.001 1.32 . . . . 0.0 110.667 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -88.26 100.27 12.86 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.328 -0.857 . . . . 0.0 109.684 166.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.3 mt 54.88 24.52 5.86 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 165.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.71 17.43 21.33 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.731 1.052 . . . . 0.0 115.731 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.421 ' OD2' ' HE3' ' A' ' 47' ' ' LYS . 4.1 p-10 -65.4 -7.31 13.25 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.852 1.826 . . . . 0.0 114.661 174.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HE3' ' OD2' ' A' ' 46' ' ' ASP . 71.9 mttt -133.9 143.04 45.78 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.944 2.098 . . . . 0.0 108.565 -178.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.69 165.05 21.89 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.359 2.706 . . . . 0.0 114.657 -155.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -59.14 -15.09 12.56 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -56.29 -18.01 9.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.322 1.849 . . . . 0.0 115.199 168.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -112.66 11.54 19.57 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.103 2.161 . . . . 0.0 113.026 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.9 mt -137.86 -38.62 0.57 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.274 2.23 . . . . 0.0 112.507 -169.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.32 -14.71 19.87 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 128.165 2.586 . . . . 0.0 113.61 171.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.83 -21.15 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 127.022 2.129 . . . . 0.0 111.074 168.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.2 p -105.83 149.25 37.77 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.167 1.387 . . . . 0.0 110.9 153.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.92 -12.46 35.38 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.569 2.179 . . . . 0.0 113.213 169.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -87.02 -10.88 52.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.204 1.802 . . . . 0.0 113.369 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.03 27.88 72.44 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-N 119.061 0.846 . . . . 0.0 114.335 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -102.08 169.98 8.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.827 1.651 . . . . 0.0 113.297 -174.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.49 155.61 68.74 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 126.535 1.934 . . . . 0.0 108.719 154.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -82.2 148.87 69.77 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 119.995 1.034 . . . . 0.0 114.754 2.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.6 m -156.13 159.79 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 128.081 2.552 . . . . 0.0 109.391 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.34 147.05 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.172 -1.58 . . . . 0.0 114.691 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -95.41 124.03 39.23 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.344 1.458 . . . . 0.0 109.771 162.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.1 mt -100.31 79.02 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.989 1.315 . . . . 0.0 108.353 168.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 30.9 t70 56.97 54.67 6.79 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.475 1.11 . . . . 0.0 112.755 -165.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.264 0.5 OUTLIER 58.67 17.56 5.18 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.171 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -100.37 114.51 28.09 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.061 1.344 . . . . 0.0 108.178 167.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -83.36 148.28 27.41 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -157.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -140.12 129.16 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.402 1.881 . . . . 0.0 109.392 172.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.45 -148.06 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.4 1.88 . . . . 0.0 113.533 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -44.09 159.29 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 -168.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.4 p -54.34 -32.22 56.23 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' HH11 ' A' ' 25' ' ' ARG . 41.1 m-20 -74.51 -17.81 60.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 176.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 m -96.27 -25.02 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.46 1.027 . . . . 0.0 112.687 164.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.5 mt -60.62 -41.96 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.973 0.909 . . . . 0.0 112.076 173.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -62.28 -8.76 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.92 -62.03 0.58 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.392 0.996 . . . . 0.0 112.888 159.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.96 -32.94 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.035 1.334 . . . . 0.0 113.613 -163.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.8 tp -70.61 -46.18 63.87 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.955 -1.09 . . . . 0.0 110.55 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -65.31 -34.79 79.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.504 1.121 . . . . 0.0 113.086 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 5.4 tt0 -58.88 -41.38 86.97 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.033 2.133 . . . . 0.0 112.785 169.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.411 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.7 mttt -101.93 6.24 41.23 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.925 1.29 . . . . 0.0 113.358 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -89.77 144.34 31.56 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.19 1.396 . . . . 0.0 111.014 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.88 -22.34 23.51 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.027 1.818 . . . . 0.0 114.385 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -82.66 144.08 48.23 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 119.223 0.92 . . . . 0.0 109.806 164.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -54.36 149.47 37.59 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.221 2.614 . . . . 0.0 115.18 -175.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.13 124.22 13.12 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.43 2.753 . . . . 0.0 112.849 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.2 mt -68.63 -11.48 60.13 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.309 -0.87 . . . . 0.0 112.293 161.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.24 -13.19 35.17 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.784 1.634 . . . . 0.0 114.73 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 m -60.49 116.63 18.88 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.859 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.17 123.86 7.5 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 121.927 1.751 . . . . 0.0 112.132 -166.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.04 172.06 17.11 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.757 2.305 . . . . 0.0 110.499 161.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.58 -33.4 68.14 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.458 -1.401 . . . . 0.0 112.682 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -60.99 -13.82 18.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.042 1.737 . . . . 0.0 114.983 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.67 69.99 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.111 1.323 . . . . 0.0 112.547 172.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.5 p -70.88 -13.18 61.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.15 -42.63 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.807 1.243 . . . . 0.0 111.267 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.34 -26.53 72.66 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 121.014 -1.054 . . . . 0.0 114.292 174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.7 p -68.84 -17.38 63.99 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.59 -47.03 10.96 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.541 1.064 . . . . 0.0 112.646 163.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 75.9 mt -65.78 -30.16 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.689 0.396 . . . . 0.0 111.12 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.09 -50.64 85.29 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 117.117 -1.42 . . . . 0.0 114.139 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.76 -27.38 8.87 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.301 2.667 . . . . 0.0 114.559 168.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.6 m -63.95 -35.09 79.54 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.035 1.743 . . . . 0.0 112.825 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -65.57 -29.03 69.58 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.723 -1.235 . . . . 0.0 113.912 166.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.9 t -66.68 -42.43 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.324 1.42 . . . . 0.0 110.539 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.73 -44.95 92.04 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.397 0.679 . . . . 0.0 112.78 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.81 -21.8 63.36 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.2 0.524 . . . . 0.0 112.104 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.7 mt -96.22 20.46 10.3 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.257 1.823 . . . . 0.0 113.402 167.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -140.23 69.21 1.35 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.512 1.525 . . . . 0.0 109.608 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.26 8.6 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.976 2.51 . . . . 0.0 116.608 -169.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -70.11 -33.6 72.05 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.82 1.248 . . . . 0.0 112.494 158.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -69.52 149.71 97.01 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.217 0.607 . . . . 0.0 109.971 159.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.17 101.43 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.339 2.026 . . . . 0.0 110.3 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.18 -39.65 79.47 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.64 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.49 -18.11 63.66 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.7 -28.99 14.38 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 121.196 -0.94 . . . . 0.0 113.355 168.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 60.8 m -69.53 -32.55 71.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.494 1.118 . . . . 0.0 111.907 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -58.23 -45.23 88.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.016 2.126 . . . . 0.0 111.887 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.19 -41.47 97.08 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.497 -0.752 . . . . 0.0 112.513 175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.87 -42.71 94.61 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.706 -0.621 . . . . 0.0 112.646 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.18 -37.4 87.23 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.548 1.139 . . . . 0.0 112.582 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.6 mt -60.88 -37.41 82.08 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.96 0.8 . . . . 0.0 112.658 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -71.22 -33.44 69.89 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.295 0.952 . . . . 0.0 112.605 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -71.19 -35.3 71.52 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.262 -0.899 . . . . 0.0 112.389 174.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -71.73 -31.64 66.91 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.855 0.862 . . . . 0.0 113.315 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -63.69 -36.3 83.38 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.029 1.286 . . . . 0.0 112.697 173.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.6 -28.69 68.7 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.02 -58.12 3.0 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.257 1.423 . . . . 0.0 112.911 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.16 -40.88 90.86 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -155.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.58 -26.68 72.03 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.679 -0.512 . . . . 0.0 113.729 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -89.98 -25.91 20.63 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.005 0.922 . . . . 0.0 113.06 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.67 -40.53 97.35 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.123 -0.986 . . . . 0.0 112.099 165.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -61.12 -14.19 22.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.018 1.327 . . . . 0.0 114.455 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.4 -34.48 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.733 1.213 . . . . 0.0 112.461 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -88.49 -53.49 4.63 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -174.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.54 177.41 34.6 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.646 1.019 . . . . 0.0 115.646 -169.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.07 -8.94 19.15 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.902 3.735 . . . . 0.0 116.503 -160.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -92.01 173.47 7.82 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.846 1.203 . . . . 0.0 112.199 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.258 8.5 tt -80.04 12.59 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.525 -1.36 . . . . 0.0 112.677 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.22 11.12 3.86 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.312 2.245 . . . . 0.0 113.543 168.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.99 -128.95 9.73 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 119.14 0.882 . . . . 0.0 113.748 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.92 -22.71 65.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.365 1.466 . . . . 0.0 114.541 -168.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -136.11 157.08 47.68 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.217 1.407 . . . . 0.0 112.04 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.35 131.64 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.875 1.27 . . . . 0.0 109.893 159.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.1 p -130.75 -176.08 3.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.304 1.842 . . . . 0.0 111.335 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.92 -14.52 22.97 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.125 -1.609 . . . . 0.0 114.787 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.66 -46.53 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.953 0.797 . . . . 0.0 110.874 167.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.7 -42.22 98.64 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.71 -1.244 . . . . 0.0 112.931 169.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.0 mt -64.48 -3.54 3.13 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.8 m -117.85 -39.46 3.11 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 120.892 -1.13 . . . . 0.0 112.055 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 21.8 mt -91.26 -38.97 12.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.593 1.157 . . . . 0.0 114.044 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.2 98.4 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.8 -22.66 13.25 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 121.07 1.418 . . . . 0.0 113.269 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -72.27 -33.92 67.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 117.544 -1.217 . . . . 0.0 112.319 170.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 30.2 mt -63.85 -41.27 97.85 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.036 0.835 . . . . 0.0 112.524 167.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -62.36 -45.31 93.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.575 0.625 . . . . 0.0 112.369 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -66.23 -25.91 67.12 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.536 0.734 . . . . 0.0 112.604 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.5 tp -77.37 -44.99 27.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.661 1.184 . . . . 0.0 113.137 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -61.39 -36.28 79.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.912 0.885 . . . . 0.0 111.498 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.71 -60.89 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.09 -47.98 15.16 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.148 -0.97 . . . . 0.0 113.332 -165.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.51 -37.13 79.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.382 0.537 . . . . 0.0 111.029 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.13 -27.86 60.56 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 115.636 1.014 . . . . 0.0 115.636 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -62.52 -30.25 71.15 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 171.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.41 -30.55 7.62 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.364 1.066 . . . . 0.0 113.149 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -149.43 101.07 3.07 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.243 1.817 . . . . 0.0 108.806 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -69.04 88.94 0.41 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.143 0.577 . . . . 0.0 110.495 168.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -82.78 111.33 28.69 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.605 1.162 . . . . 0.0 110.395 172.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.99 136.82 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.72 1.613 . . . . 0.0 109.812 170.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.1 mt -65.39 119.42 59.42 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 161.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -59.5 152.69 59.86 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.305 2.003 . . . . 0.0 113.339 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -23.1 64.79 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -63.72 -40.6 97.15 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.924 -1.11 . . . . 0.0 112.358 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.08 44.82 1.11 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.698 2.399 . . . . 0.0 111.187 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -28.39 69.23 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.356 1.462 . . . . 0.0 113.063 -167.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -77.28 -41.61 40.22 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.348 -0.845 . . . . 0.0 112.103 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 20.2 t -71.0 -32.9 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 118.908 -0.567 . . . . 0.0 111.368 171.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.39 -43.83 98.2 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.882 0.873 . . . . 0.0 112.826 168.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -69.1 -32.78 72.43 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.284 -0.885 . . . . 0.0 112.85 173.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -63.87 -27.5 69.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.721 0.809 . . . . 0.0 113.066 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.3 mt -53.16 -39.77 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.269 -0.895 . . . . 0.0 111.243 167.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -79.37 -10.27 59.77 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.262 -1.524 . . . . 0.0 113.488 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.22 -21.75 53.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 117.602 -1.19 . . . . 0.0 113.594 162.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.57 -21.77 65.85 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.115 1.325 . . . . 0.0 113.687 -177.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -89.3 5.13 46.37 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.803 -1.186 . . . . 0.0 114.071 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.2 p -129.68 -175.22 3.53 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -159.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 59.52 -169.8 0.14 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.339 1.856 . . . . 0.0 112.164 -172.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -70.28 -49.79 46.1 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.086 160.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -61.5 -78.19 0.04 OUTLIER 'General case' 0 C--O 1.231 0.113 0 C-N-CA 127.572 2.349 . . . . 0.0 113.267 -169.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -57.41 -40.39 78.19 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.737 0.699 . . . . 0.0 112.362 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.56 -40.38 91.4 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.14 1.376 . . . . 0.0 114.458 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.25 -35.95 74.15 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 120.114 1.324 . . . . 0.0 111.868 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.1 p -76.16 -1.61 27.08 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -64.71 99.14 0.3 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.273 1.397 . . . . 0.0 110.772 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.72 134.56 45.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.363 0.665 . . . . 0.0 111.736 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.65 122.78 13.6 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.026 0.93 . . . . 0.0 111.931 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.0 mp0 -68.51 -40.68 80.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.013 1.325 . . . . 0.0 113.962 -148.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -61.7 -33.98 74.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.339 1.056 . . . . 0.0 112.442 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -79.01 -15.05 58.78 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.973 -1.079 . . . . 0.0 113.778 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.44 -46.11 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 119.038 0.836 . . . . 0.0 109.829 166.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -63.83 -54.5 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.81 1.244 . . . . 0.0 111.272 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.52 -34.33 77.99 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.58 -15.74 72.72 Favored Glycine 0 CA--C 1.537 1.406 0 O-C-N 120.975 -1.078 . . . . 0.0 114.116 173.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -82.22 -21.96 36.13 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.804 1.802 . . . . 0.0 113.891 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -48.68 -47.36 71.58 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.98 -23.77 15.82 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 CA-C-N 122.16 1.807 . . . . 0.0 114.168 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.0 -1.82 30.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.862 1.665 . . . . 0.0 114.557 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 m -61.2 -20.47 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.48 -0.763 . . . . 0.0 112.239 158.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -118.86 -32.33 4.53 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.057 1.343 . . . . 0.0 114.461 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.25 0 CA-C-O 116.447 -1.74 . . . . 0.0 114.689 -174.855 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtp . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 119.67 -0.205 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.29 178.49 0.06 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.147 1.779 . . . . 0.0 113.285 -161.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.7 99.82 0.35 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.171 -0.955 . . . . 0.0 110.57 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -99.27 92.96 5.68 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.125 0.97 . . . . 0.0 109.717 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.442 HD11 HD12 ' A' ' 30' ' ' LEU . 90.0 mt -78.94 119.37 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -114.91 109.06 17.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.104 0.865 . . . . 0.0 109.929 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.55 141.01 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.512 -0.742 . . . . 0.0 111.534 -153.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 19' ' ' ASP . 10.9 ttpp -66.43 124.73 23.56 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.957 167.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.6 -174.81 3.1 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.583 1.953 . . . . 0.0 111.357 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 149.04 12.23 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.376 0.671 . . . . 0.0 112.058 158.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.7 t -57.09 130.96 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.145 0.498 . . . . 0.0 110.266 162.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.97 -19.75 5.06 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.044 1.306 . . . . 0.0 115.921 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.65 89.41 43.68 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 119.624 1.712 . . . . 0.0 112.507 -170.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.71 32.1 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.149 1 C-N-CA 125.42 4.08 . . . . 0.0 115.105 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -136.71 0.38 2.45 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.77 1.628 . . . . 0.0 113.366 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.3 pt -142.51 157.67 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.992 1.317 . . . . 0.0 111.565 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.9 mt -85.35 -20.25 30.22 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -158.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 39.28 -135.98 1.4 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 127.381 2.419 . . . . 0.0 118.294 167.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 8' ' ' LYS . 7.7 p-10 -71.95 7.46 1.59 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.679 1.992 . . . . 0.0 115.233 -167.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.424 ' OG ' ' HE3' ' A' ' 8' ' ' LYS . 69.1 m -117.86 91.01 38.13 Favored Pre-proline 0 CA--C 1.51 -0.563 0 O-C-N 120.429 -1.419 . . . . 0.0 110.956 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.422 ' HD3' ' CD2' ' A' ' 159' ' ' HIS . 78.5 Cg_endo -63.98 -24.21 67.35 Favored 'Trans proline' 0 C--N 1.391 2.801 0 O-C-N 116.555 -2.392 . . . . 0.0 111.268 166.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -54.31 -42.31 69.97 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.902 2.481 . . . . 0.0 114.564 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.8 p -79.9 -32.02 40.24 Favored 'General case' 0 C--N 1.372 1.578 0 CA-C-N 120.768 1.622 . . . . 0.0 111.014 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.71 -27.35 68.85 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.15 1.38 . . . . 0.0 112.984 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.532 HH12 ' CG ' ' A' ' 74' ' ' ASP . 86.8 mtt180 -56.18 -42.8 77.67 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.476 1.111 . . . . 0.0 113.917 169.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.19 -34.59 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.792 0.837 . . . . 0.0 110.454 -170.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.5 mt -66.98 -44.86 79.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.272 1.029 . . . . 0.0 110.828 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 tp -56.48 -51.58 67.92 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.216 1.406 . . . . 0.0 113.196 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.08 -19.64 63.25 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.868 1.213 . . . . 0.0 113.981 -176.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.442 HD12 HD11 ' A' ' 5' ' ' ILE . 89.1 mt -93.01 -37.2 12.32 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.201 1.0 . . . . 0.0 112.716 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -68.93 -27.76 66.04 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.088 -1.008 . . . . 0.0 113.51 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -66.87 -41.83 86.62 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.953 -1.092 . . . . 0.0 111.78 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 81' ' ' GLU . 37.9 mttp -71.21 -11.61 61.02 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.283 1.433 . . . . 0.0 114.853 169.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm 63.67 7.43 3.13 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.253 1.821 . . . . 0.0 115.22 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.8 tt -74.54 130.7 81.32 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.086 0.954 . . . . 0.0 111.483 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.49 152.64 38.74 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.909 2.406 . . . . 0.0 113.698 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -152.39 176.02 12.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.929 1.692 . . . . 0.0 111.175 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -127.73 141.88 51.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.794 1.238 . . . . 0.0 110.864 164.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t -108.75 99.1 8.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.459 1.104 . . . . 0.0 111.499 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -78.0 86.62 4.18 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.154 1.381 . . . . 0.0 110.01 172.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.55 126.91 31.62 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.424 1.089 . . . . 0.0 112.439 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.458 HD12 HG11 ' A' ' 60' ' ' VAL . 5.2 mt -114.26 121.76 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.091 1.756 . . . . 0.0 110.235 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -82.88 95.89 8.09 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.229 -0.919 . . . . 0.0 109.306 162.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 mt 60.56 -12.79 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.986 2.587 . . . . 0.0 117.986 168.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.43 5.71 0.19 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.842 1.687 . . . . 0.0 114.149 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.01 -5.23 20.45 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.528 1.664 . . . . 0.0 115.052 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -109.3 137.23 20.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 124.411 1.084 . . . . 0.0 109.269 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.26 175.93 6.17 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.453 2.768 . . . . 0.0 113.643 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -47.41 -31.74 4.37 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.84 -23.36 52.4 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -93.29 -6.9 46.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.558 1.543 . . . . 0.0 114.079 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.7 mt -114.47 -36.46 4.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.786 2.034 . . . . 0.0 112.383 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -64.59 -5.38 5.44 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.954 2.901 . . . . 0.0 114.614 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.15 -22.19 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 126.492 1.917 . . . . 0.0 110.97 168.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -92.34 139.71 24.09 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.297 1.439 . . . . 0.0 111.615 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.96 -19.04 40.49 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.646 2.23 . . . . 0.0 112.883 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.11 -6.74 41.26 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.898 1.679 . . . . 0.0 112.884 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.39 2.3 26.22 Favored Glycine 0 CA--C 1.54 1.647 0 O-C-N 120.844 -1.16 . . . . 0.0 114.736 -163.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -89.46 129.12 36.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.712 1.605 . . . . 0.0 110.56 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.458 HG11 HD12 ' A' ' 42' ' ' ILE . 15.3 m -82.98 148.74 57.64 Favored Pre-proline 0 N--CA 1.474 0.741 0 O-C-N 121.316 -0.865 . . . . 0.0 109.496 154.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.29 134.14 20.67 Favored 'Cis proline' 0 CA--C 1.543 0.97 0 N-CA-C 116.511 1.697 . . . . 0.0 116.511 9.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 m -147.56 175.09 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 127.506 2.322 . . . . 0.0 111.615 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.4 m -138.17 148.65 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 120.767 -1.208 . . . . 0.0 113.664 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -93.33 132.05 37.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.209 1.003 . . . . 0.0 109.787 153.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.4 79.69 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.863 1.265 . . . . 0.0 108.452 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.6 t70 60.38 61.57 1.75 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.0 0.92 . . . . 0.0 112.385 -170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 61.93 -10.94 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -170.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -79.36 105.2 10.51 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.626 -1.296 . . . . 0.0 109.718 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -70.6 156.09 39.89 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -166.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.0 t -147.58 136.2 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.633 2.373 . . . . 0.0 109.359 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.93 -171.33 0.53 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.403 1.881 . . . . 0.0 114.337 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.96 166.56 9.06 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -154.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.3 p -50.82 -16.2 0.38 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.532 ' CG ' HH12 ' A' ' 25' ' ' ARG . 7.9 m-20 -103.42 -15.44 15.9 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.105 1.762 . . . . 0.0 111.636 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -108.58 -14.1 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.307 1.443 . . . . 0.0 113.437 165.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.72 -33.45 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.434 1.493 . . . . 0.0 112.564 164.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.6 -15.5 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.761 1.224 . . . . 0.0 113.185 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.85 -56.54 0.8 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.314 0.959 . . . . 0.0 113.224 158.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 mt -73.12 -29.67 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.64 1.22 . . . . 0.0 113.45 -161.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.0 tp -77.48 -14.37 59.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.622 -1.299 . . . . 0.0 112.694 173.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 33' ' ' LYS . 47.7 mm-40 -91.99 -42.71 9.84 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.705 1.602 . . . . 0.0 110.773 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 11.7 tt0 -50.89 -45.37 60.1 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.065 2.546 . . . . 0.0 112.977 170.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.442 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 98.5 mttt -98.91 9.99 42.33 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.728 1.211 . . . . 0.0 113.496 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.22 139.53 34.32 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.876 0.87 . . . . 0.0 111.511 -175.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.63 -27.58 8.9 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.097 1.864 . . . . 0.0 112.998 166.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -88.18 158.96 48.85 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.129 0.972 . . . . 0.0 111.453 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -50.85 125.36 15.73 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.538 2.825 . . . . 0.0 115.849 -168.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -59.95 142.13 97.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.57 2.847 . . . . 0.0 113.764 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.0 mt -114.89 8.18 15.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.696 1.599 . . . . 0.0 112.948 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.46 -12.15 59.59 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.7 m -57.85 117.3 18.31 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 123.971 0.908 . . . . 0.0 111.999 -169.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -86.03 115.0 1.4 Allowed 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.415 2.743 . . . . 0.0 111.248 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -78.18 -177.41 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.328 2.685 . . . . 0.0 111.151 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -55.48 -34.75 64.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.182 1.793 . . . . 0.0 112.372 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -60.97 -19.56 61.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.259 1.424 . . . . 0.0 114.284 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.29 68.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.168 0.894 . . . . 0.0 112.766 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.4 p -63.41 -59.2 5.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.969 0.804 . . . . 0.0 111.838 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.1 -37.07 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.542 1.137 . . . . 0.0 111.595 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.48 -31.27 79.03 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.069 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.2 p -71.15 -19.03 62.47 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.597 1.198 . . . . 0.0 114.193 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -86.27 -39.51 16.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.792 1.237 . . . . 0.0 112.471 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.5 -39.38 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.447 1.499 . . . . 0.0 111.45 173.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.3 -55.42 31.73 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.659 1.584 . . . . 0.0 114.202 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.99 -33.33 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.276 2.651 . . . . 0.0 113.117 172.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.5 p -65.99 -30.81 71.43 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.365 1.438 . . . . 0.0 112.352 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -79.91 -19.6 47.75 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.116 -1.615 . . . . 0.0 113.794 172.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.63 -42.26 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.448 -1.408 . . . . 0.0 110.23 163.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -68.42 -27.47 66.23 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.61 -40.72 84.07 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.279 1.432 . . . . 0.0 111.873 170.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.15 8.64 10.39 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.057 1.743 . . . . 0.0 114.688 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -142.21 35.62 1.52 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.494 2.718 . . . . 0.0 110.911 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 p -81.24 58.92 3.73 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.651 1.98 . . . . 0.0 113.487 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.32 -45.23 94.17 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.3 1.04 . . . . 0.0 110.061 161.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.91 119.88 67.3 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 128.349 2.66 . . . . 0.0 107.694 155.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.7 133.65 59.37 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.41 2.073 . . . . 0.0 115.833 -160.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -68.06 -31.61 71.37 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.018 -0.991 . . . . 0.0 112.103 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.78 -31.92 68.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.388 1.475 . . . . 0.0 113.993 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.66 -34.66 9.02 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 123.981 0.801 . . . . 0.0 113.279 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -64.1 -42.59 96.84 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.155 1.382 . . . . 0.0 112.078 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -58.97 -27.86 65.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.84 2.056 . . . . 0.0 113.128 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -68.36 -19.9 64.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.032 0.933 . . . . 0.0 112.804 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.24 -35.96 14.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.76 0.824 . . . . 0.0 112.427 166.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.9 mt -65.66 -34.49 78.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -62.64 -37.22 85.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.747 0.703 . . . . 0.0 112.072 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.98 -30.74 34.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.132 0.573 . . . . 0.0 112.527 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.08 -46.08 90.69 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.966 0.906 . . . . 0.0 111.944 166.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.95 -40.46 95.05 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.023 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -63.2 -42.05 99.25 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 120.343 1.429 . . . . 0.0 112.585 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.78 -35.07 79.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.274 0.63 . . . . 0.0 112.243 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.62 -54.86 7.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.772 0.829 . . . . 0.0 111.49 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.25 -35.69 81.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.692 1.997 . . . . 0.0 114.055 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.54 -33.44 81.72 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.913 0.768 . . . . 0.0 113.706 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -95.14 -29.08 14.74 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.9 mt -65.47 -32.8 74.61 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.543 -1.348 . . . . 0.0 113.259 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -66.06 -11.23 47.0 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 t -85.29 -28.69 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.948 0.899 . . . . 0.0 111.953 169.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -94.31 -37.35 11.55 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.756 1.222 . . . . 0.0 113.313 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.17 -72.34 0.22 Allowed Glycine 0 CA--C 1.541 1.712 0 CA-C-O 116.537 -2.257 . . . . 0.0 116.464 167.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -100.44 -35.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.969 0 N-CA-C 117.633 2.128 . . . . 0.0 117.633 -155.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -134.06 157.66 45.55 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.259 1.39 . . . . 0.0 112.856 -167.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.8 mt -71.09 -13.29 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.09 2.78 53.5 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 165.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 112.92 -134.28 11.85 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.062 1.315 . . . . 0.0 113.258 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -65.29 -25.45 67.64 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -139.67 163.89 31.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.77 1.228 . . . . 0.0 110.729 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.34 120.49 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.622 0.769 . . . . 0.0 110.637 170.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.7 p -144.39 -164.69 1.96 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.211 2.205 . . . . 0.0 109.321 163.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.57 -30.62 3.72 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 -160.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.96 -38.35 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.657 1.571 . . . . 0.0 112.771 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -62.76 -40.37 97.04 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.454 -0.779 . . . . 0.0 111.339 166.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.1 mt -64.94 -33.17 75.4 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.736 -0.602 . . . . 0.0 111.945 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.8 m -69.89 -38.37 76.31 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 120.179 -1.575 . . . . 0.0 113.237 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.5 mt -118.49 -32.18 4.69 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -159.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.3 -53.95 56.21 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 120.595 1.543 . . . . 0.0 115.084 -162.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.02 -19.8 29.69 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.577 1.518 . . . . 0.0 113.359 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -72.07 -30.97 65.66 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.593 -1.317 . . . . 0.0 111.849 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.81 -42.69 76.93 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.684 0.794 . . . . 0.0 111.895 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -64.88 -39.32 93.35 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 171.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.422 ' CD2' ' HD3' ' A' ' 21' ' ' PRO . 17.4 t-80 -65.04 -32.72 74.59 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 119.857 -1.777 . . . . 0.0 112.154 172.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.0 tp -68.4 -48.44 64.67 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.925 1.239 . . . . 0.0 111.072 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -51.61 -46.73 63.69 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.766 1.626 . . . . 0.0 112.195 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 82.9 t -74.13 -57.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.807 0.843 . . . . 0.0 113.261 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.93 -35.6 28.93 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.963 -1.086 . . . . 0.0 113.507 -167.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 tp -72.36 -32.33 66.37 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.681 -0.637 . . . . 0.0 111.205 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.75 -27.65 36.39 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.91 1.243 . . . . 0.0 114.855 171.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -68.04 -18.69 64.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -141.59 -27.3 0.67 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -149.69 81.61 1.4 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.512 1.525 . . . . 0.0 109.317 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.88 74.66 0.11 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.287 1.435 . . . . 0.0 112.282 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -70.58 112.93 14.69 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.334 1.854 . . . . 0.0 112.173 -169.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.11 142.02 27.01 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.546 2.164 . . . . 0.0 111.749 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.6 mm -92.25 112.82 57.01 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.371 1.068 . . . . 0.0 108.897 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -67.55 155.09 71.62 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.474 2.116 . . . . 0.0 112.116 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.78 -14.49 53.18 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -61.76 -31.37 71.56 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.216 -0.928 . . . . 0.0 112.724 167.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.92 56.68 3.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.477 1.911 . . . . 0.0 110.814 168.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -24.06 64.96 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.336 1.055 . . . . 0.0 113.277 -160.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -74.64 -51.74 13.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.413 1.006 . . . . 0.0 110.305 165.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 24.5 t -57.37 -46.91 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.288 0.949 . . . . 0.0 112.675 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 58.6 tp -64.3 -29.24 70.33 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -91.42 -30.6 16.41 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.149 -0.969 . . . . 0.0 113.328 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -63.65 -36.59 84.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.23 1.412 . . . . 0.0 112.933 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.84 -37.19 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.376 -0.827 . . . . 0.0 111.582 172.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -66.62 -30.16 70.37 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.044 -1.66 . . . . 0.0 112.654 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.3 mt -70.84 -20.18 62.57 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.412 -1.28 . . . . 0.0 113.219 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.1 mt -65.85 -22.62 66.55 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.117 1.326 . . . . 0.0 112.715 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -83.7 17.36 2.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.541 1.536 . . . . 0.0 113.486 171.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 p -142.33 178.57 7.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.126 2.17 . . . . 0.0 113.045 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 58.82 174.42 0.07 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.064 1.746 . . . . 0.0 113.609 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 5.1 mp0 -74.56 -44.51 50.68 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.791 1.236 . . . . 0.0 109.563 166.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -20.68 66.33 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.578 1.951 . . . . 0.0 116.042 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -116.24 -48.08 2.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.132 1.333 . . . . 0.0 113.59 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -63.13 -30.08 71.31 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.37 -1.456 . . . . 0.0 114.529 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -74.2 -18.74 60.72 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.5 p -97.82 -1.49 43.05 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.698 1.199 . . . . 0.0 112.757 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -59.43 123.51 17.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.543 1.537 . . . . 0.0 111.429 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.63 165.45 24.25 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.572 1.149 . . . . 0.0 113.162 170.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.8 125.56 29.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.028 0.531 . . . . 0.0 110.14 161.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.03 -34.07 57.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -150.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -36.94 79.05 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.168 1.387 . . . . 0.0 110.853 169.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -84.74 -7.47 59.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.978 1.711 . . . . 0.0 113.07 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 31.3 t -77.06 -51.04 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.472 -0.768 . . . . 0.0 109.413 158.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.05 -50.5 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.721 1.208 . . . . 0.0 111.669 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.14 -15.28 63.38 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.74 -25.26 18.35 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.471 -0.768 . . . . 0.0 113.862 168.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -78.24 -31.44 49.25 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.033 1.333 . . . . 0.0 113.732 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -48.02 -56.63 12.93 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -69.65 -20.72 34.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 120.652 1.269 . . . . 0.0 112.022 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -84.86 3.84 36.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.242 1.817 . . . . 0.0 114.005 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 65.5 t -68.62 -28.79 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.127 0.876 . . . . 0.0 110.312 153.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -96.96 -51.99 4.04 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.34 -1.314 . . . . 0.0 113.832 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 C-N-CA 126.954 2.102 . . . . 0.0 113.234 -177.138 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 ttm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 118.373 -0.823 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.47 -169.37 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.21 1.004 . . . . 0.0 112.233 -168.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.2 mt -71.78 116.09 11.75 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.916 -1.115 . . . . 0.0 110.597 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -125.71 111.29 14.75 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 30' ' ' LEU . 52.9 mt -92.15 135.29 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 m -112.0 137.75 49.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.227 0.611 . . . . 0.0 109.621 163.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.69 140.95 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.03 -1.044 . . . . 0.0 110.153 -162.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 31.7 tttm -66.45 124.68 23.43 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 170.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.87 172.73 12.97 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.256 1.423 . . . . 0.0 111.524 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.39 140.84 32.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.055 0.942 . . . . 0.0 111.624 169.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.4 t -54.57 119.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.19 0.519 . . . . 0.0 109.949 171.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.04 -13.86 41.86 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 116.425 1.33 . . . . 0.0 116.425 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.04 84.39 63.42 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 120.128 1.964 . . . . 0.0 112.044 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.23 7.56 0.63 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 125.149 3.899 . . . . 0.0 117.658 -167.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -120.74 6.27 10.48 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.876 1.271 . . . . 0.0 113.509 -172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.5 pt -142.09 160.28 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.176 1.79 . . . . 0.0 110.44 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.35 -48.73 31.82 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.75 -125.83 12.16 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.657 1.122 . . . . 0.0 114.601 -174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.79 18.04 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.348 2.659 . . . . 0.0 117.154 -171.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.467 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.9 p -118.45 75.39 12.17 Favored Pre-proline 0 C--O 1.25 1.12 0 O-C-N 120.344 -1.472 . . . . 0.0 110.955 -159.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.65 -31.91 39.5 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.936 2.424 . . . . 0.0 111.865 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -62.45 -37.16 84.81 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.962 0.905 . . . . 0.0 113.061 171.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -63.99 -46.27 85.28 Favored 'General case' 0 C--N 1.379 1.863 0 O-C-N 119.924 -1.735 . . . . 0.0 110.994 171.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -56.92 -37.16 71.07 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.198 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.5 HH12 ' CG ' ' A' ' 74' ' ' ASP . 69.9 mtp180 -52.59 -44.05 65.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.187 0.995 . . . . 0.0 112.714 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -78.63 -28.85 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.019 1.328 . . . . 0.0 112.441 -168.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.9 mt -71.79 -41.11 68.7 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.245 -0.285 . . . . 0.0 111.278 166.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -60.47 -35.72 76.57 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -162.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.7 p -69.59 -48.28 60.7 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.325 0.966 . . . . 0.0 112.569 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.503 HD12 HD11 ' A' ' 5' ' ' ILE . 96.3 mt -71.52 -31.77 67.43 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.703 0.801 . . . . 0.0 112.167 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -77.69 -23.49 49.51 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -77.42 -40.38 43.66 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.146 0.885 . . . . 0.0 112.507 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -67.91 -9.58 46.21 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.859 1.264 . . . . 0.0 112.92 165.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 mttt 58.29 17.72 4.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.034 2.534 . . . . 0.0 114.676 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.84 124.93 91.61 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.035 0.934 . . . . 0.0 108.806 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.29 140.25 57.9 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.804 1.669 . . . . 0.0 111.001 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CD1' HD12 ' A' ' 5' ' ' ILE . 45.3 p90 -138.4 160.72 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.468 1.507 . . . . 0.0 109.709 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -93.41 122.77 36.18 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.385 1.074 . . . . 0.0 110.05 172.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.7 t -87.93 134.13 33.78 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -127.5 76.61 1.68 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.279 1.832 . . . . 0.0 109.912 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.0 mt -68.49 133.2 48.24 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.923 0.889 . . . . 0.0 111.253 170.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 mt -134.98 122.72 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.66 1.584 . . . . 0.0 110.512 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -83.34 98.85 9.67 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.278 -0.889 . . . . 0.0 109.602 169.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.6 mt 60.03 -6.87 0.07 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.6 11.84 0.83 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.751 1.644 . . . . 0.0 115.074 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.81 -5.5 12.47 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.045 1.923 . . . . 0.0 115.169 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -134.44 145.14 53.95 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 126.442 1.897 . . . . 0.0 109.164 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.12 158.85 41.73 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.794 2.329 . . . . 0.0 114.184 -153.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -63.64 -10.73 20.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -56.5 -19.18 14.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.117 1.767 . . . . 0.0 114.641 165.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.32 9.0 21.6 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.082 2.153 . . . . 0.0 113.098 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.2 mt -126.67 -41.28 1.86 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.525 2.33 . . . . 0.0 111.833 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -65.73 -7.15 14.12 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 128.207 2.603 . . . . 0.0 114.042 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.0 mt -60.57 -19.44 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 126.598 1.959 . . . . 0.0 110.95 163.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.2 p -113.96 143.13 29.03 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 126.87 2.068 . . . . 0.0 111.477 160.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.4 -24.86 36.38 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.477 2.118 . . . . 0.0 113.195 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -77.51 3.94 12.33 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.217 1.407 . . . . 0.0 114.724 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.61 47.23 91.26 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.217 0.913 . . . . 0.0 112.642 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -125.75 176.67 6.75 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 -167.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.82 148.03 40.97 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 126.875 2.07 . . . . 0.0 107.155 168.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.5 158.23 98.97 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 N-CA-C 115.293 1.228 . . . . 0.0 115.293 5.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -156.97 161.53 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.044 2.538 . . . . 0.0 108.659 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.14 148.01 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 120.486 -1.384 . . . . 0.0 114.617 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -98.55 126.79 44.24 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.711 1.604 . . . . 0.0 109.855 162.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.2 mt -103.14 69.76 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.348 1.459 . . . . 0.0 108.701 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.257 23.3 t70 58.87 58.92 3.02 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.477 1.132 . . . . 0.0 112.102 -162.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.57 13.64 2.66 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -175.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -90.92 112.17 23.92 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.889 -1.132 . . . . 0.0 108.77 164.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -83.06 149.77 26.72 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -162.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -144.61 135.42 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.766 2.026 . . . . 0.0 109.956 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.93 -149.49 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.006 2.122 . . . . 0.0 113.95 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -51.84 161.0 0.61 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.3 p -38.71 -43.05 0.86 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.901 2.481 . . . . 0.0 116.088 166.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.5 ' CG ' HH12 ' A' ' 25' ' ' ARG . 3.2 m-20 -73.75 -13.84 61.03 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.362 1.437 . . . . 0.0 114.778 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.78 -24.49 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.555 1.071 . . . . 0.0 113.157 162.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.31 -40.72 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 119.527 1.058 . . . . 0.0 111.994 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -63.59 -5.28 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.44 -61.47 0.5 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.276 0.941 . . . . 0.0 112.923 158.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.0 mt -70.79 -28.32 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.048 1.339 . . . . 0.0 113.672 -163.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.28 -46.6 55.14 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.768 -1.207 . . . . 0.0 110.929 170.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -69.25 -27.36 65.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.576 1.15 . . . . 0.0 113.34 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.55 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 38.2 tt0 -63.61 -32.66 74.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.893 2.077 . . . . 0.0 113.203 167.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 91.1 mttt -114.07 3.13 15.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.249 1.42 . . . . 0.0 113.131 -168.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -86.61 142.63 35.02 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.671 1.588 . . . . 0.0 110.157 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.59 -24.74 18.37 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.947 1.765 . . . . 0.0 113.898 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -80.89 146.53 59.78 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 118.779 0.718 . . . . 0.0 109.921 169.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -54.66 149.8 38.57 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.137 2.558 . . . . 0.0 115.585 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.21 121.97 8.99 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.712 2.274 . . . . 0.0 112.591 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 mt -63.07 -17.7 62.56 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.187 1.395 . . . . 0.0 111.577 157.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.78 -8.38 14.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.136 1.774 . . . . 0.0 114.959 169.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.8 m -59.69 114.74 10.31 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 119.195 0.907 . . . . 0.0 109.532 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.92 125.18 10.21 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.854 1.703 . . . . 0.0 111.937 -165.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.53 159.24 53.49 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.681 2.254 . . . . 0.0 110.79 163.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.52 -34.07 23.92 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.561 1.544 . . . . 0.0 113.102 159.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -63.01 -13.97 42.03 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.03 71.5 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.372 -1.455 . . . . 0.0 113.14 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.7 p -71.15 -7.25 45.41 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.44 -40.88 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.422 1.489 . . . . 0.0 111.387 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.99 -31.89 80.22 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.268 0.937 . . . . 0.0 114.429 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.1 p -66.91 -13.08 61.35 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 172.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -90.67 -43.75 9.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.915 1.286 . . . . 0.0 112.073 169.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.37 -34.2 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.31 1.044 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 152' ' ' SER . 88.4 t80 -59.65 -49.29 92.66 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -77.91 -21.04 11.28 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.339 2.693 . . . . 0.0 113.975 167.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.512 ' HA ' ' CE ' ' A' ' 108' ' ' LYS . 58.3 m -69.52 -31.28 69.41 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.703 1.592 . . . . 0.0 114.802 173.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -67.17 -28.46 68.13 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.042 -1.036 . . . . 0.0 113.734 162.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.18 -47.72 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 120.57 1.532 . . . . 0.0 110.926 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.512 ' CE ' ' HA ' ' A' ' 105' ' ' SER . 51.0 mtmt -59.81 -45.4 92.47 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.087 0.955 . . . . 0.0 111.683 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.77 -20.56 61.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.569 0.747 . . . . 0.0 112.98 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.59 20.19 9.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.722 1.609 . . . . 0.0 113.207 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -132.07 62.08 1.65 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.133 1.373 . . . . 0.0 110.52 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -59.81 5.26 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -165.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -64.23 -34.11 77.34 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.822 -1.174 . . . . 0.0 111.561 155.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.28 149.46 94.12 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.802 1.241 . . . . 0.0 110.98 166.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.0 88.99 0.9 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.582 2.188 . . . . 0.0 110.484 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -51.57 -40.43 59.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.84 -10.94 60.58 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -96.93 -33.88 5.9 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.868 1.223 . . . . 0.0 113.63 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.4 m -61.79 -33.37 73.99 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.482 -1.011 . . . . 0.0 112.227 168.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -54.4 -44.41 72.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 128.284 2.633 . . . . 0.0 111.707 170.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -71.18 -38.76 72.1 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.228 -0.92 . . . . 0.0 112.451 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.67 -41.4 92.54 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.327 -0.858 . . . . 0.0 112.461 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.9 tp -64.68 -37.31 87.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.42 1.088 . . . . 0.0 112.347 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.88 -39.59 94.92 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.082 0.856 . . . . 0.0 112.629 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -69.38 -34.88 75.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.655 1.116 . . . . 0.0 112.743 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -67.45 -37.72 83.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.351 -0.843 . . . . 0.0 112.631 172.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.51 -33.15 62.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 113.49 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -60.19 -36.87 78.59 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.68 1.127 . . . . 0.0 112.553 173.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.81 -19.2 65.8 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.5 tp -96.86 -54.42 3.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.242 1.417 . . . . 0.0 112.618 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.8 -43.06 99.81 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -154.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.49 -25.75 73.75 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 121.632 -0.668 . . . . 0.0 113.806 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -89.15 -28.49 20.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.58 1.152 . . . . 0.0 112.995 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.82 -41.62 82.63 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.456 0.702 . . . . 0.0 112.2 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -59.46 -20.3 54.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.231 1.812 . . . . 0.0 114.362 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.4 t -84.82 -26.1 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.584 1.153 . . . . 0.0 112.244 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -105.13 -36.44 7.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.941 1.296 . . . . 0.0 113.535 -171.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.04 -176.23 35.11 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.287 -0.883 . . . . 0.0 114.197 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.03 -2.24 10.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.424 3.416 . . . . 0.0 115.498 -166.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -94.95 168.47 10.77 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.576 -1.328 . . . . 0.0 112.619 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.27 7.4 tt -77.41 9.66 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.678 -1.264 . . . . 0.0 112.93 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.84 31.69 3.3 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.001 2.12 . . . . 0.0 113.319 159.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.61 -115.59 4.05 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.202 -1.561 . . . . 0.0 113.613 172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -62.12 -25.77 67.92 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -166.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -152.65 170.62 19.78 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.649 1.179 . . . . 0.0 112.153 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.09 138.86 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.536 1.134 . . . . 0.0 109.708 164.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.5 p -139.91 -179.55 6.02 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.308 1.843 . . . . 0.0 110.743 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.77 -16.02 46.14 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.285 -1.509 . . . . 0.0 114.708 167.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.15 -42.98 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 119.634 1.106 . . . . 0.0 110.905 167.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.03 -40.94 99.23 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.88 -1.138 . . . . 0.0 112.798 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.0 mt -67.61 6.94 0.55 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.683 1.193 . . . . 0.0 113.93 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.409 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 13.2 p -124.62 -40.93 2.17 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.618 -1.301 . . . . 0.0 111.682 174.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.8 mt -93.06 -39.7 10.93 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.73 1.212 . . . . 0.0 113.977 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.72 99.33 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.79 -26.27 13.67 Favored 'Trans proline' 0 C--N 1.35 0.637 0 CA-C-N 121.027 1.402 . . . . 0.0 113.266 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -71.83 -32.22 67.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 117.551 -1.214 . . . . 0.0 112.581 172.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.01 -40.95 91.56 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.124 0.875 . . . . 0.0 112.694 167.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -62.5 -45.48 92.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.85 0.75 . . . . 0.0 112.112 175.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -64.95 -27.75 69.05 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.314 0.646 . . . . 0.0 112.443 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 tp -75.85 -45.68 34.4 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.298 1.039 . . . . 0.0 113.576 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -60.54 -37.88 82.65 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.018 0.826 . . . . 0.0 111.238 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.76 -57.97 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.32 -49.56 12.23 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.118 -0.989 . . . . 0.0 113.57 -165.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 54.5 tp -68.49 -37.67 80.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.266 0.485 . . . . 0.0 110.908 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.96 -26.99 61.56 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.271 0.938 . . . . 0.0 115.375 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -63.79 -32.59 74.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.562 1.145 . . . . 0.0 113.98 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -107.89 -31.93 7.8 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.108 0.963 . . . . 0.0 113.416 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -145.87 102.76 3.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.037 1.735 . . . . 0.0 107.936 167.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -68.62 85.71 0.3 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.622 0.769 . . . . 0.0 110.455 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -85.72 110.35 29.33 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.005 1.322 . . . . 0.0 110.133 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.09 139.22 32.29 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.698 1.599 . . . . 0.0 109.852 171.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.5 mt -65.09 121.47 74.4 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 159.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -60.46 158.47 31.56 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.335 2.023 . . . . 0.0 113.563 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.21 -28.57 69.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.469 1.108 . . . . 0.0 113.642 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -61.5 -23.59 66.01 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.347 -1.47 . . . . 0.0 113.287 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 79.8 mt -104.24 43.25 1.11 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.956 2.503 . . . . 0.0 111.527 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -46.24 -39.55 10.07 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.075 2.15 . . . . 0.0 113.909 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -73.45 -44.66 57.66 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.855 -1.153 . . . . 0.0 111.698 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 23.8 t -69.89 -33.52 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.634 -0.666 . . . . 0.0 110.963 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.48 -43.92 98.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.417 1.087 . . . . 0.0 112.939 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -70.66 -31.75 68.78 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.145 -0.972 . . . . 0.0 113.331 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -63.9 -25.99 68.4 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.875 0.762 . . . . 0.0 112.9 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.3 mt -52.74 -38.58 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.269 -0.894 . . . . 0.0 111.461 166.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -79.95 -9.57 59.69 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.204 -1.56 . . . . 0.0 114.07 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.81 -19.05 55.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 116.791 -1.576 . . . . 0.0 113.402 162.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.0 mt -64.64 -20.35 66.23 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.441 1.473 . . . . 0.0 113.231 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -92.23 4.2 53.77 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.9 p -123.78 -177.88 3.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.257 1.823 . . . . 0.0 114.475 -159.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 56.8 -168.45 0.11 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.232 1.813 . . . . 0.0 111.37 -173.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -73.97 -43.36 58.43 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.73 162.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.4 p -63.68 -78.6 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.397 2.279 . . . . 0.0 113.713 -172.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -57.93 -38.76 76.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.531 -0.731 . . . . 0.0 112.366 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -60.81 -34.98 75.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -75.16 -36.71 61.51 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.164 1.347 . . . . 0.0 112.317 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 23.7 p -69.54 -15.4 63.23 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -54.12 101.65 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.345 1.458 . . . . 0.0 111.43 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.92 135.6 37.02 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.353 0.661 . . . . 0.0 111.352 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.9 121.47 9.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.214 1.006 . . . . 0.0 111.792 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 -69.46 -40.65 77.02 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.574 1.149 . . . . 0.0 113.811 -148.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -61.35 -33.44 73.64 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.377 1.071 . . . . 0.0 112.563 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -81.66 -10.32 59.43 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.75 -46.91 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.092 0.86 . . . . 0.0 109.713 162.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 mt -64.36 -53.48 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.869 1.268 . . . . 0.0 111.606 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.75 -27.38 68.26 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.93 -14.46 60.8 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.478 -1.179 . . . . 0.0 113.985 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -82.89 -22.9 33.82 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.789 1.794 . . . . 0.0 113.826 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -48.85 -47.88 72.23 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.57 -19.51 18.9 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 122.009 1.806 . . . . 0.0 114.426 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -79.7 -2.43 42.86 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.537 1.535 . . . . 0.0 115.0 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.1 m -58.4 -20.51 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.396 -0.815 . . . . 0.0 112.428 157.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -118.23 -31.17 5.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.645 1.578 . . . . 0.0 114.75 168.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.754 1.222 . . . . 0.0 114.123 -179.533 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtp . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.8 -175.17 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.821 1.248 . . . . 0.0 112.604 -158.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.45 105.62 0.79 Allowed 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.637 -1.289 . . . . 0.0 110.576 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -106.91 90.04 3.19 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.601 1.16 . . . . 0.0 109.432 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.424 HG22 HG13 ' A' ' 7' ' ' VAL . 39.8 mt -70.32 129.01 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.125 0.97 . . . . 0.0 108.481 174.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.9 m -120.02 111.44 17.89 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.084 0.954 . . . . 0.0 109.361 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.424 HG13 HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -137.1 139.32 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.622 0.769 . . . . 0.0 111.657 -154.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -64.5 126.77 28.89 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.25 0.548 . . . . 0.0 110.131 168.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.64 -171.44 2.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.156 2.183 . . . . 0.0 111.834 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.33 147.21 13.92 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.33 -0.857 . . . . 0.0 111.486 154.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.01 128.88 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.279 0.562 . . . . 0.0 109.792 159.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.95 -23.64 5.78 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.105 1.336 . . . . 0.0 116.214 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.64 87.64 54.35 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 119.868 1.834 . . . . 0.0 112.818 -168.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.24 17.8 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 125.254 3.969 . . . . 0.0 115.444 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -114.9 -5.2 12.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.345 1.858 . . . . 0.0 113.476 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.3 pt -143.29 160.3 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.213 1.405 . . . . 0.0 111.722 -173.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.1 mt -79.65 -32.1 41.56 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -168.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.72 -129.59 7.62 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.645 1.593 . . . . 0.0 115.874 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -64.55 2.38 0.65 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.705 2.002 . . . . 0.0 115.474 -172.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.589 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 68.7 m -108.54 80.68 1.23 Allowed Pre-proline 0 C--O 1.255 1.347 0 C-N-CA 125.021 1.328 . . . . 0.0 111.015 -164.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.72 -24.51 68.94 Favored 'Trans proline' 0 C--N 1.373 1.817 0 O-C-N 116.433 -2.456 . . . . 0.0 111.284 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.08 -38.05 87.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.923 1.689 . . . . 0.0 114.313 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 20' ' ' SER . 30.9 p -78.62 -30.93 46.75 Favored 'General case' 0 C--N 1.376 1.735 0 O-C-N 119.906 -1.746 . . . . 0.0 110.964 171.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -64.19 -27.36 69.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.52 1.128 . . . . 0.0 113.198 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -53.8 -44.19 69.95 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.423 1.089 . . . . 0.0 112.164 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 t -76.72 -32.02 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.598 1.159 . . . . 0.0 111.542 -171.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.1 mt -65.08 -47.48 77.12 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 122.1 -0.375 . . . . 0.0 111.154 167.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.02 -47.76 80.11 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.999 1.32 . . . . 0.0 113.233 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -23.13 64.14 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.2 mt -90.62 -39.42 12.51 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.285 1.034 . . . . 0.0 112.339 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -69.04 -24.06 64.14 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.37 -37.98 63.3 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.598 -1.313 . . . . 0.0 113.123 167.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -70.45 -12.06 61.33 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 168.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 190' ' ' GLU . 33.0 mmtm 62.51 8.55 2.93 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.681 1.992 . . . . 0.0 114.481 -173.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 tt -71.33 130.43 87.73 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.887 1.275 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.67 151.13 51.76 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.627 2.218 . . . . 0.0 112.795 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -148.93 165.61 31.06 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.136 1.374 . . . . 0.0 111.339 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -110.3 131.85 54.69 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.23 1.812 . . . . 0.0 109.247 168.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.5 t -107.79 123.78 49.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.508 0.723 . . . . 0.0 111.756 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.62 86.22 2.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.863 1.665 . . . . 0.0 109.597 174.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.6 mt -73.02 124.11 24.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.849 1.26 . . . . 0.0 111.444 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mt -123.19 117.53 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 126.313 1.845 . . . . 0.0 109.483 -167.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -83.45 94.04 7.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.777 0.831 . . . . 0.0 109.392 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.2 mt 57.67 11.51 1.32 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 166.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.06 22.8 5.49 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 119.084 0.856 . . . . 0.0 114.9 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -62.47 -7.14 4.05 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.169 1.485 . . . . 0.0 114.017 168.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -122.15 145.44 44.05 Favored Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 125.319 1.448 . . . . 0.0 111.122 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.59 176.38 5.08 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.413 2.742 . . . . 0.0 113.359 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -51.37 -26.69 8.2 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.617 1.967 . . . . 0.0 115.728 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -57.13 -20.79 28.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.153 1.781 . . . . 0.0 115.778 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -100.64 -0.82 36.78 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.265 1.426 . . . . 0.0 113.725 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.4 mt -128.28 -37.96 1.81 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.94 2.096 . . . . 0.0 112.15 -166.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.42 -18.58 51.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.554 2.342 . . . . 0.0 114.868 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.4 mt -57.86 -29.38 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 126.784 2.033 . . . . 0.0 111.283 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.459 ' HB2' HG11 ' A' ' 62' ' ' VAL . 16.8 t -93.76 135.68 24.74 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.008 1.723 . . . . 0.0 112.358 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -69.8 -16.05 37.2 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.371 2.047 . . . . 0.0 113.234 167.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.18 -14.21 39.18 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.316 1.046 . . . . 0.0 112.862 170.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.2 -19.43 0.35 Allowed Glycine 0 CA--C 1.546 1.972 0 O-C-N 119.923 -1.735 . . . . 0.0 114.929 -159.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -59.83 130.01 44.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.722 2.409 . . . . 0.0 111.22 169.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.74 146.37 38.93 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.977 1.311 . . . . 0.0 108.936 152.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.31 139.87 32.54 Favored 'Cis proline' 0 CA--C 1.539 0.762 0 N-CA-C 117.264 1.986 . . . . 0.0 117.264 19.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.459 HG11 ' HB2' ' A' ' 55' ' ' SER . 28.1 m -151.69 178.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 127.176 2.191 . . . . 0.0 111.447 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.16 153.88 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 121.039 -1.038 . . . . 0.0 112.454 170.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -96.96 132.03 43.15 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.334 148.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.2 mt -96.94 86.35 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.261 1.024 . . . . 0.0 108.441 168.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.3 t0 57.17 58.23 4.06 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.926 0.89 . . . . 0.0 112.924 -169.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.291 80.5 m-20 62.27 -0.75 0.46 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -174.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -88.89 108.42 19.53 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.508 -1.37 . . . . 0.0 109.496 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -66.79 153.51 43.16 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -166.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -141.23 142.87 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.988 2.115 . . . . 0.0 108.722 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.69 -163.57 0.1 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.537 1.535 . . . . 0.0 113.959 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -50.44 160.75 0.37 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.042 2.137 . . . . 0.0 116.134 -167.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.6 p -48.83 -33.33 10.31 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.978 1.311 . . . . 0.0 114.042 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.53 -1.97 58.34 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.33 -13.48 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.043 1.337 . . . . 0.0 113.773 161.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.45 -32.81 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.005 1.722 . . . . 0.0 112.416 166.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.6 -15.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.5 -58.8 0.8 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.115 0.864 . . . . 0.0 112.571 157.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.2 mt -72.67 -27.52 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 118.273 1.037 . . . . 0.0 113.78 -160.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.6 tp -77.94 -24.96 48.06 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.293 -1.505 . . . . 0.0 112.281 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -80.82 -43.14 20.49 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.892 1.277 . . . . 0.0 110.887 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 12.5 tt0 -50.13 -39.59 43.66 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.224 2.61 . . . . 0.0 113.258 170.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.45 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 98.8 mttt -105.59 4.79 30.69 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.007 1.323 . . . . 0.0 113.949 -171.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.69 140.09 54.88 Favored Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 121.499 -0.751 . . . . 0.0 111.015 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.54 -31.57 6.91 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.342 2.028 . . . . 0.0 112.328 168.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -81.38 161.25 62.81 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.75 1.22 . . . . 0.0 111.276 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.94 125.81 19.95 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.839 2.359 . . . . 0.0 115.654 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -64.94 129.5 23.39 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.602 2.868 . . . . 0.0 113.666 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 mt -103.48 10.36 37.23 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.264 1.426 . . . . 0.0 113.265 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.78 -11.2 54.17 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.2 m -58.31 117.86 23.3 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.437 -171.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.63 117.42 3.35 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.049 2.499 . . . . 0.0 110.918 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -75.57 177.82 8.18 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.717 2.278 . . . . 0.0 110.953 165.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -55.37 -33.0 63.05 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.793 -1.192 . . . . 0.0 113.166 167.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -59.5 -20.66 57.0 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.683 1.593 . . . . 0.0 114.818 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.3 -26.12 68.24 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.786 -1.196 . . . . 0.0 112.808 171.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.4 m -65.5 -17.31 64.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.793 1.637 . . . . 0.0 114.181 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.5 t -124.16 -36.82 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.273 1.429 . . . . 0.0 111.279 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.11 -31.12 77.72 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 120.483 -1.386 . . . . 0.0 114.23 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.6 p -68.65 -25.94 65.07 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.164 -1.198 . . . . 0.0 113.999 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -75.77 -41.7 52.38 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.591 1.156 . . . . 0.0 111.611 170.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.38 -35.54 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.776 1.63 . . . . 0.0 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -55.6 -49.62 91.64 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.7 -33.17 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.091 2.527 . . . . 0.0 113.137 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -71.72 -30.87 66.11 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.142 -0.974 . . . . 0.0 113.351 -170.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -75.67 -21.0 58.05 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.409 -1.432 . . . . 0.0 114.501 167.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.4 t -72.89 -34.22 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.464 -1.397 . . . . 0.0 110.941 167.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.53 -35.43 80.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.035 0.934 . . . . 0.0 112.482 168.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -63.6 -20.3 65.55 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.241 1.417 . . . . 0.0 113.457 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 mt -95.44 -2.01 49.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.649 1.58 . . . . 0.0 114.254 172.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -127.65 54.89 1.65 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.849 1.66 . . . . 0.0 110.779 164.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.8 p -62.9 29.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 131.699 4.0 . . . . 0.0 117.95 -167.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.38 -28.5 69.31 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.961 1.304 . . . . 0.0 112.471 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.3 110.5 44.97 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-O 117.074 -1.441 . . . . 0.0 107.351 159.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.71 141.65 97.92 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.495 2.13 . . . . 0.0 116.02 -152.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -64.61 -35.74 81.98 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.86 171.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.09 -18.33 63.97 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.38 -44.36 3.5 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.066 0.841 . . . . 0.0 112.954 163.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 88.1 m -61.87 -33.17 73.71 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.46 -28.15 68.1 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.912 1.285 . . . . 0.0 113.201 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -70.53 -32.84 70.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.1 0.96 . . . . 0.0 111.406 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.04 -41.2 59.64 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.317 -0.864 . . . . 0.0 112.201 168.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.29 -33.3 75.66 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 39.5 mt -65.26 -41.21 94.49 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.826 0.739 . . . . 0.0 112.616 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -74.88 -33.61 62.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.146 0.885 . . . . 0.0 112.694 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.68 -38.08 76.91 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.806 -1.183 . . . . 0.0 112.605 169.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.6 mt -63.94 -39.35 93.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.49 -1.381 . . . . 0.0 111.813 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.45 -41.02 93.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.415 1.007 . . . . 0.0 112.275 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.39 -35.78 81.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.526 0.73 . . . . 0.0 112.044 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 tp -71.2 -54.92 9.3 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.841 0.856 . . . . 0.0 111.784 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -64.74 -34.78 79.13 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.89 1.676 . . . . 0.0 113.793 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.34 -33.21 69.94 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.414 1.006 . . . . 0.0 113.772 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -101.06 -24.58 14.28 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.7 mt -66.88 -32.59 73.96 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.44 -1.412 . . . . 0.0 113.075 171.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -63.66 -18.86 64.4 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.26 -32.23 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.854 0.862 . . . . 0.0 111.71 172.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -85.11 -30.88 23.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.275 1.03 . . . . 0.0 113.464 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.31 -99.74 1.98 Allowed Glycine 0 CA--C 1.539 1.564 0 CA-C-O 117.616 -1.658 . . . . 0.0 114.288 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.71 -34.27 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.554 2.169 . . . . 0.0 116.798 -144.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -129.58 156.14 44.68 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.364 1.438 . . . . 0.0 112.439 -168.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.9 tt -78.94 -4.17 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -163.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.57 -6.14 41.02 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.68 1.592 . . . . 0.0 114.931 160.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.69 -123.82 5.49 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.309 1.433 . . . . 0.0 113.543 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -62.7 -26.53 68.71 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -155.29 164.97 38.05 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.715 2.006 . . . . 0.0 110.083 -169.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.1 mt -69.43 113.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.493 1.117 . . . . 0.0 109.876 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.1 p -136.98 -163.89 1.49 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.107 0.963 . . . . 0.0 111.01 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.97 -24.75 1.62 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -166.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.48 -42.98 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.77 1.168 . . . . 0.0 112.235 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.82 -45.53 92.07 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.077 -1.014 . . . . 0.0 111.936 166.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.81 -12.11 15.74 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 62.5 m -106.19 -39.32 5.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.461 1.504 . . . . 0.0 112.914 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.5 -32.04 9.17 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -169.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.07 84.41 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -163.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.11 -22.84 18.83 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 120.885 1.352 . . . . 0.0 113.298 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -67.05 -31.05 71.3 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 118.146 -0.931 . . . . 0.0 111.823 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.77 -42.69 73.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 118.2 -0.905 . . . . 0.0 113.252 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -65.9 -39.11 90.31 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.052 0.842 . . . . 0.0 112.447 171.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -64.15 -33.42 75.74 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.736 -1.227 . . . . 0.0 112.743 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.78 -50.89 61.24 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.598 1.09 . . . . 0.0 112.046 169.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -51.31 -39.98 58.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.941 1.297 . . . . 0.0 112.124 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.2 t -81.83 -61.85 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.253 1.021 . . . . 0.0 113.242 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.9 37.41 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.949 -1.094 . . . . 0.0 113.645 -165.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.38 -35.21 73.37 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.693 -0.629 . . . . 0.0 110.57 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.4 -27.85 42.03 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.115 1.34 . . . . 0.0 115.237 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -65.97 -20.61 66.26 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -136.74 -25.02 1.13 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -154.79 85.07 1.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.904 1.681 . . . . 0.0 109.181 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -64.79 89.05 0.07 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.259 0.624 . . . . 0.0 110.332 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -90.36 112.82 54.95 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.371 1.468 . . . . 0.0 110.632 -169.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.07 136.09 24.13 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.377 2.051 . . . . 0.0 112.226 -166.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.3 mm -80.94 109.96 15.6 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.275 1.03 . . . . 0.0 108.233 159.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -71.44 159.36 51.72 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.036 1.824 . . . . 0.0 111.342 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.67 -14.94 56.61 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -63.2 -31.12 72.19 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.207 -0.933 . . . . 0.0 113.027 166.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.53 54.62 2.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.01 1.724 . . . . 0.0 111.139 168.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -21.22 63.8 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.333 1.053 . . . . 0.0 113.628 -162.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -74.55 -54.66 7.06 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.697 1.135 . . . . 0.0 109.637 164.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.0 -40.17 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.092 0.86 . . . . 0.0 112.505 -171.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.3 tp -63.38 -30.12 71.3 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.353 1.061 . . . . 0.0 113.322 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -94.37 -24.93 17.17 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.089 -1.007 . . . . 0.0 113.172 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.29 -37.22 86.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.403 1.081 . . . . 0.0 112.485 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 71.4 mt -63.91 -35.31 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.172 -0.955 . . . . 0.0 111.917 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -66.09 -32.51 74.02 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 119.854 -1.779 . . . . 0.0 112.462 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.85 -17.21 62.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.892 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.34 -24.07 67.52 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.422 1.465 . . . . 0.0 112.982 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -83.83 12.61 5.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.927 1.291 . . . . 0.0 113.238 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.9 p -135.87 174.95 10.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.286 1.834 . . . . 0.0 112.724 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 58.59 173.52 0.06 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.612 1.965 . . . . 0.0 113.785 -172.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.422 ' OE1' ' HE3' ' A' ' 34' ' ' LYS . 18.4 mp0 -71.71 -37.91 70.58 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.205 1.002 . . . . 0.0 109.834 165.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 97.3 p -61.42 -30.56 70.64 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.377 1.871 . . . . 0.0 114.739 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -121.12 -46.69 2.3 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.114 0.87 . . . . 0.0 113.31 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.73 -33.22 71.35 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.732 -1.23 . . . . 0.0 113.351 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -70.96 -23.56 62.24 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.1 p -89.03 -3.55 58.66 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.767 0.827 . . . . 0.0 112.993 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.15 106.32 0.5 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.344 1.058 . . . . 0.0 110.574 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.54 141.48 48.47 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.396 0.678 . . . . 0.0 111.864 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.4 125.22 24.97 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.038 0.935 . . . . 0.0 111.575 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.51 -43.1 99.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -152.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.3 -35.38 75.44 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.882 0.873 . . . . 0.0 112.041 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -81.79 -10.49 59.33 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.917 1.287 . . . . 0.0 113.82 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.62 -46.85 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.595 -0.691 . . . . 0.0 109.909 164.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.51 -49.83 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.712 1.205 . . . . 0.0 111.258 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.15 66.58 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.5 -26.28 15.95 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.817 -0.991 . . . . 0.0 114.097 170.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -71.8 -35.55 70.01 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.119 1.46 . . . . 0.0 113.181 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -53.65 -51.99 71.27 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.57 -22.85 57.9 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.442 1.428 . . . . 0.0 112.832 172.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -83.9 3.99 31.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.814 1.645 . . . . 0.0 115.342 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.17 -23.82 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.198 -0.939 . . . . 0.0 110.678 152.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -102.37 -43.24 5.73 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.261 1.425 . . . . 0.0 112.802 172.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.338 0 C-N-CA 126.338 1.855 . . . . 0.0 113.864 -172.856 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtp . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.06 -170.28 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.479 1.112 . . . . 0.0 112.702 -162.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.2 mt -67.48 109.83 3.38 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.656 -1.277 . . . . 0.0 110.628 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -112.02 89.87 3.18 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.769 1.228 . . . . 0.0 109.953 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.459 HD11 HD12 ' A' ' 30' ' ' LEU . 43.9 mt -70.61 128.0 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -119.62 99.72 6.83 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.282 1.033 . . . . 0.0 109.122 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG13 HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.21 143.19 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.025 1.33 . . . . 0.0 111.061 -157.126 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 31.8 tttm -64.97 126.16 27.13 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.592 -0.692 . . . . 0.0 109.567 167.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.07 176.7 9.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.872 1.669 . . . . 0.0 111.868 169.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.4 141.9 18.63 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.409 -0.807 . . . . 0.0 112.037 163.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.8 t -55.79 122.09 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.852 -0.53 . . . . 0.0 109.94 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.91 -15.62 19.97 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.213 -1.326 . . . . 0.0 116.155 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.03 79.82 72.42 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 119.792 1.796 . . . . 0.0 112.003 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.61 -5.41 10.15 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.274 3.316 . . . . 0.0 115.735 -174.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -87.56 -6.67 58.22 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.413 1.485 . . . . 0.0 114.437 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.2 pt -142.04 163.84 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.766 1.167 . . . . 0.0 113.355 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.2 mt -82.88 -23.19 33.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -170.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 32.74 -126.63 0.3 Allowed Glycine 0 N--CA 1.477 1.392 0 C-N-CA 127.104 2.287 . . . . 0.0 117.331 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -62.75 5.84 0.11 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.306 2.642 . . . . 0.0 116.434 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -111.87 74.55 1.34 Allowed Pre-proline 0 C--O 1.253 1.276 0 O-C-N 119.836 -1.79 . . . . 0.0 110.959 -163.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.5 -28.04 45.97 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.189 2.593 . . . . 0.0 111.432 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -58.38 -42.22 86.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.098 1.759 . . . . 0.0 113.5 168.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.7 m -65.98 -41.81 90.67 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.875 -1.766 . . . . 0.0 111.008 171.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -65.86 -27.11 67.99 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.26 1.024 . . . . 0.0 112.585 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -54.06 -45.27 71.66 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.51 1.124 . . . . 0.0 112.322 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.0 t -74.87 -27.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.431 1.092 . . . . 0.0 111.824 -170.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.8 mt -71.82 -45.8 60.25 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.847 -0.533 . . . . 0.0 111.113 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.58 -47.44 76.44 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.563 1.545 . . . . 0.0 113.489 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -68.22 -24.9 64.98 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.043 1.292 . . . . 0.0 113.973 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.459 HD12 HD11 ' A' ' 5' ' ' ILE . 80.4 mt -88.75 -35.85 16.46 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.731 1.213 . . . . 0.0 112.63 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -70.98 -29.04 64.91 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.0 -42.05 90.26 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.904 -1.123 . . . . 0.0 111.885 168.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.536 ' HZ1' ' CD ' ' A' ' 81' ' ' GLU . 87.1 mttt -71.7 -11.28 60.75 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.715 1.606 . . . . 0.0 114.609 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm 64.76 3.24 1.94 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.565 1.946 . . . . 0.0 115.419 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.87 122.9 88.2 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 119.344 0.975 . . . . 0.0 111.035 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.45 151.43 53.43 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.374 2.05 . . . . 0.0 112.261 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -144.23 161.66 38.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.186 1.394 . . . . 0.0 111.04 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -99.11 126.21 44.82 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.302 1.041 . . . . 0.0 109.576 165.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 t -100.7 120.37 39.98 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.611 0.764 . . . . 0.0 111.655 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -103.37 85.98 2.57 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.158 1.783 . . . . 0.0 109.483 171.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.51 121.44 19.65 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.724 1.21 . . . . 0.0 111.653 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.4 mt -119.69 113.69 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.451 1.9 . . . . 0.0 109.838 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -81.21 98.08 7.92 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.218 -0.927 . . . . 0.0 109.865 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.6 mt 55.26 17.45 2.06 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 168.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.45 21.36 7.29 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.027 0.822 . . . . 0.0 114.901 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -65.12 12.09 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.488 1.644 . . . . 0.0 115.385 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -139.94 149.25 58.22 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.283 1.833 . . . . 0.0 110.339 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.4 174.08 5.63 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.086 2.524 . . . . 0.0 113.329 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -54.61 -21.22 9.82 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -55.17 -20.77 11.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.116 2.166 . . . . 0.0 115.798 171.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -104.73 -2.52 24.8 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.053 1.341 . . . . 0.0 113.447 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.62 -36.35 3.51 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.79 2.036 . . . . 0.0 112.252 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.47 -16.15 53.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.844 2.057 . . . . 0.0 114.921 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 31.0 mt -60.89 -32.14 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.232 1.813 . . . . 0.0 111.29 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.86 136.5 27.62 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 126.973 2.109 . . . . 0.0 110.322 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.07 -11.28 30.14 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.871 2.381 . . . . 0.0 114.797 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 12.04 6.65 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.259 2.224 . . . . 0.0 112.76 174.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.13 4.18 88.72 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 125.409 1.481 . . . . 0.0 116.39 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -88.1 91.82 8.92 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.396 1.598 . . . . 0.0 113.201 -172.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -59.93 144.1 86.74 Favored Pre-proline 0 N--CA 1.479 0.999 0 O-C-N 120.264 -1.523 . . . . 0.0 110.379 154.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 85.8 Cg_endo -75.78 139.77 62.69 Favored 'Cis proline' 0 CA--C 1.542 0.902 0 N-CA-C 116.858 1.83 . . . . 0.0 116.858 8.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -148.75 -178.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 128.282 2.633 . . . . 0.0 111.077 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.6 m -136.57 156.22 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.714 -1.241 . . . . 0.0 112.624 166.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -95.98 137.48 34.99 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.537 -0.727 . . . . 0.0 109.912 146.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.1 mt -101.0 95.73 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 163.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 55.67 52.97 10.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.822 1.249 . . . . 0.0 114.094 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 61.23 -5.06 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -169.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -80.41 113.81 18.86 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.389 1.449 . . . . 0.0 108.789 171.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -67.96 153.92 42.7 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -168.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -143.16 143.33 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 127.2 2.2 . . . . 0.0 108.503 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.6 -160.25 0.08 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.251 1.421 . . . . 0.0 113.75 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -62.22 166.99 4.37 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.995 2.118 . . . . 0.0 114.828 -163.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.8 p -55.81 -20.05 13.75 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -104.49 -19.37 14.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.298 -1.334 . . . . 0.0 113.514 -168.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.3 m -92.15 -16.52 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 155.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.09 -32.28 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.714 1.206 . . . . 0.0 112.712 175.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 p -65.6 -10.48 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.34 -58.57 0.91 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.391 0.996 . . . . 0.0 112.673 157.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.5 mt -75.83 -35.66 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.878 1.339 . . . . 0.0 113.775 -162.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 tp -75.65 -24.3 56.37 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.407 -1.433 . . . . 0.0 111.885 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.536 ' CD ' ' HZ1' ' A' ' 33' ' ' LYS . 76.6 mm-40 -76.51 -42.04 44.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.066 0.946 . . . . 0.0 111.821 174.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.417 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 15.6 tt0 -56.36 -47.96 77.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.084 2.154 . . . . 0.0 112.69 171.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.417 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 99.3 mttt -90.85 6.04 46.0 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -171.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.66 140.94 59.6 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 121.367 -0.833 . . . . 0.0 111.324 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.63 -28.38 8.22 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.317 2.011 . . . . 0.0 112.33 168.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -80.2 160.6 67.78 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.529 1.132 . . . . 0.0 111.379 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -55.92 126.49 22.57 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.53 2.153 . . . . 0.0 114.349 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -59.81 139.38 88.12 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.45 2.767 . . . . 0.0 112.837 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.64 9.23 17.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.284 1.433 . . . . 0.0 112.744 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.08 -16.7 64.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.4 m -58.38 120.79 47.29 Favored Pre-proline 0 N--CA 1.472 0.675 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.169 -170.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 74.2 Cg_endo -78.6 121.89 5.3 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.373 2.049 . . . . 0.0 111.121 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 92' ' ' PRO . 58.6 Cg_endo -72.32 177.42 7.32 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.919 2.412 . . . . 0.0 111.236 162.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.19 -27.47 65.73 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.289 -1.507 . . . . 0.0 112.954 163.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -60.94 -19.64 61.11 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.554 -1.341 . . . . 0.0 113.722 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.77 78.81 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.956 -1.09 . . . . 0.0 113.095 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.4 p -76.84 3.24 12.41 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.111 1.323 . . . . 0.0 114.349 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.4 t -120.61 -39.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.956 1.303 . . . . 0.0 110.798 170.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.89 -30.54 69.92 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.961 1.267 . . . . 0.0 114.329 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 62.6 p -68.11 -19.46 64.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.778 1.289 . . . . 0.0 114.044 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -89.97 -41.37 11.78 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.785 1.234 . . . . 0.0 111.895 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.434 HG23 ' CD1' ' A' ' 106' ' ' PHE . 96.9 mt -59.96 -38.79 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.95 1.7 . . . . 0.0 111.079 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.54 -45.37 99.86 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -85.73 -34.46 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.306 2.671 . . . . 0.0 114.696 166.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -68.0 -33.2 74.15 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 121.304 1.865 . . . . 0.0 113.051 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.434 ' CD1' HG23 ' A' ' 102' ' ' ILE . 16.3 m-85 -77.37 -27.73 52.64 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.208 -1.557 . . . . 0.0 113.098 172.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.7 t -71.95 -32.7 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 120.586 -1.321 . . . . 0.0 111.473 170.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -65.35 -38.1 89.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.413 1.085 . . . . 0.0 111.992 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -64.04 -25.01 67.92 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.955 1.302 . . . . 0.0 113.62 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.5 mt -87.94 10.54 18.47 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.558 1.543 . . . . 0.0 113.996 171.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -141.03 58.41 1.54 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.784 2.034 . . . . 0.0 109.357 165.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.6 p -58.98 27.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 1 C-N-CA 132.884 4.474 . . . . 0.0 118.461 -164.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.59 -26.2 57.66 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.16 1.784 . . . . 0.0 113.028 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -88.85 114.6 60.66 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 116.983 -1.484 . . . . 0.0 107.038 155.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -55.09 133.18 56.64 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.642 2.228 . . . . 0.0 115.011 -157.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -62.92 -34.68 77.96 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.359 -0.829 . . . . 0.0 112.437 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.17 -18.92 65.48 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.237 1.015 . . . . 0.0 113.684 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -96.13 -42.76 3.43 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.518 1.056 . . . . 0.0 112.844 165.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 86.0 m -62.8 -33.26 74.84 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.784 -0.833 . . . . 0.0 113.082 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.46 -26.37 68.48 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -70.24 -33.47 71.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.625 0.77 . . . . 0.0 110.765 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.9 -41.47 67.89 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.153 -0.967 . . . . 0.0 112.445 165.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 mt -62.2 -36.82 83.1 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.809 0.731 . . . . 0.0 112.923 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.3 mt -68.66 -38.77 80.69 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.251 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.95 -32.31 65.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.628 1.104 . . . . 0.0 112.535 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.5 -45.05 88.96 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.151 -0.968 . . . . 0.0 112.305 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -67.63 -36.11 80.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.894 -1.051 . . . . 0.0 112.952 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.05 -41.89 94.74 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.728 1.604 . . . . 0.0 112.134 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.11 -32.66 74.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.18 0.592 . . . . 0.0 112.346 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -73.07 -56.7 4.76 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.323 1.049 . . . . 0.0 111.533 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.06 -35.92 82.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.029 1.732 . . . . 0.0 114.131 -171.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.51 -32.93 74.47 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.947 0.784 . . . . 0.0 113.56 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -96.62 -28.14 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 47.1 mt -64.52 -32.47 74.12 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.114 1.324 . . . . 0.0 113.043 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -64.99 -14.69 60.97 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.55 -35.33 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.14 0.976 . . . . 0.0 111.856 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -83.58 -26.89 29.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.132 0.973 . . . . 0.0 113.458 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 107.08 -99.27 1.4 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-O 117.339 -1.812 . . . . 0.0 114.746 163.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.51 -33.4 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.004 3.136 . . . . 0.0 117.257 -151.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -129.8 158.83 38.36 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.669 1.577 . . . . 0.0 112.98 -169.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.0 tp -71.56 -8.13 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.34 -4.89 28.23 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 166.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.5 -135.05 8.2 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 120.093 1.315 . . . . 0.0 113.948 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -18.99 62.26 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.407 1.483 . . . . 0.0 113.928 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -136.39 153.94 50.96 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.723 1.609 . . . . 0.0 110.953 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.61 109.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.5 1.12 . . . . 0.0 109.508 162.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.3 p -137.65 -164.19 1.56 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.564 1.546 . . . . 0.0 110.44 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.16 -25.19 4.94 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -164.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.7 t -77.29 -40.73 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.789 1.177 . . . . 0.0 112.661 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -57.55 -48.4 79.43 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.868 -1.145 . . . . 0.0 111.685 165.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.4 mt -63.7 -9.07 12.23 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.22 1.008 . . . . 0.0 113.533 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 56.5 m -108.94 -34.18 6.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.469 1.507 . . . . 0.0 113.181 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 48.2 mt -108.91 -30.91 7.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.07 89.45 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -164.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.2 -20.09 16.81 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.333 1.355 . . . . 0.0 113.752 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -70.24 -31.86 69.44 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.998 -1.064 . . . . 0.0 112.075 172.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.99 -39.93 79.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.737 0.699 . . . . 0.0 112.303 171.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -64.82 -41.79 95.48 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.446 -0.784 . . . . 0.0 113.067 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -66.04 -32.13 73.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.869 -1.144 . . . . 0.0 112.428 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.6 tp -64.55 -50.83 65.75 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.379 0.99 . . . . 0.0 111.103 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -55.52 -54.51 43.11 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.399 1.479 . . . . 0.0 111.823 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.56 -51.1 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.8 -50.9 13.84 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.564 -0.71 . . . . 0.0 111.953 -169.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 7.0 tp -66.32 -28.42 68.67 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.888 -0.508 . . . . 0.0 111.598 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.82 -23.45 22.36 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.524 1.535 . . . . 0.0 115.677 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -67.13 -21.22 65.84 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -134.95 -28.15 1.21 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -152.21 84.78 1.26 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.227 1.811 . . . . 0.0 109.566 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -63.65 95.89 0.11 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.125 0.57 . . . . 0.0 109.985 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -91.15 109.35 34.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.874 1.27 . . . . 0.0 110.816 -167.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.62 135.8 22.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.456 2.104 . . . . 0.0 112.046 -167.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.3 mm -81.53 112.14 31.42 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.449 1.1 . . . . 0.0 108.576 162.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -69.27 157.37 61.6 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.09 1.86 . . . . 0.0 112.152 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -59.09 -23.15 61.82 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -64.95 -26.43 68.3 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 171.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.22 53.75 2.57 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.935 1.694 . . . . 0.0 111.006 167.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -21.64 63.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.147 0.979 . . . . 0.0 113.464 -160.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -76.39 -52.17 10.41 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.81 1.186 . . . . 0.0 110.355 165.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.58 -40.72 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 119.816 1.189 . . . . 0.0 112.068 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.35 -32.4 73.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.379 1.071 . . . . 0.0 113.004 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -82.17 -33.49 29.48 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.973 -1.079 . . . . 0.0 113.133 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -64.47 -36.62 84.78 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.291 1.036 . . . . 0.0 112.641 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.19 -29.13 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 120.931 -1.105 . . . . 0.0 112.29 173.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -69.05 -31.12 69.67 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 119.755 -1.841 . . . . 0.0 112.274 170.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.38 -21.59 64.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 117.914 -1.041 . . . . 0.0 113.148 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.5 -23.18 65.73 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.447 1.021 . . . . 0.0 112.797 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -91.33 17.59 8.21 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.485 1.514 . . . . 0.0 113.636 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 p -140.89 177.25 8.17 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.136 2.174 . . . . 0.0 112.779 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 57.87 177.42 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.407 1.883 . . . . 0.0 113.448 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 13.4 mp0 -75.02 -40.3 60.59 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.341 1.056 . . . . 0.0 110.084 162.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 92.2 p -57.43 -30.43 64.99 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.431 1.892 . . . . 0.0 114.531 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -122.97 -45.61 2.13 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -61.76 -32.43 72.68 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.675 -1.266 . . . . 0.0 113.356 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.12 -24.08 63.14 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.4 p -91.64 -2.36 57.1 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.367 1.067 . . . . 0.0 113.272 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -60.7 103.16 0.23 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.945 1.298 . . . . 0.0 110.268 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.72 144.23 51.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.591 0.756 . . . . 0.0 112.008 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.47 131.34 49.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.714 0.806 . . . . 0.0 111.529 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -71.78 -44.01 64.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.251 1.42 . . . . 0.0 113.469 -149.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -60.76 -32.9 72.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.628 1.171 . . . . 0.0 112.039 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -84.99 -6.85 59.33 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.3 t -75.99 -48.76 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 119.155 0.889 . . . . 0.0 109.417 159.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 70.4 mt -63.76 -52.79 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.496 1.118 . . . . 0.0 111.872 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.23 -26.4 68.1 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.17 -22.68 40.52 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.654 -1.081 . . . . 0.0 113.845 172.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -76.37 -35.66 58.57 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.058 1.429 . . . . 0.0 113.524 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -50.29 -51.9 59.16 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.29 -21.46 54.55 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.58 1.52 . . . . 0.0 113.182 174.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.541 ' HA ' ' H ' ' A' ' 212' ' ' ALA . 54.8 mttp -87.04 6.04 34.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.345 1.858 . . . . 0.0 115.461 177.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.26 -15.83 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 120.917 -1.114 . . . . 0.0 110.815 149.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -115.74 -24.56 8.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.944 1.698 . . . . 0.0 114.946 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.541 ' H ' ' HA ' ' A' ' 209' ' ' LYS . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.143 -1.884 . . . . 0.0 115.91 -170.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtp . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.87 -168.89 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.516 1.127 . . . . 0.0 112.408 -163.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.5 mt -66.9 104.28 1.33 Allowed 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.557 -1.34 . . . . 0.0 111.204 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -104.34 91.08 3.76 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.496 1.118 . . . . 0.0 109.587 168.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.418 HD11 HD12 ' A' ' 30' ' ' LEU . 47.4 mt -69.55 131.98 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -121.39 113.67 20.2 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.778 0.831 . . . . 0.0 108.785 173.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -132.6 142.26 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.033 -1.042 . . . . 0.0 110.696 -156.681 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.633 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 32.7 tttm -63.73 127.32 30.84 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.737 -0.602 . . . . 0.0 109.472 169.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.83 175.54 9.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.204 1.801 . . . . 0.0 111.882 169.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.53 140.65 33.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.617 0.767 . . . . 0.0 111.32 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.4 t -55.77 120.17 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 120.979 0.419 . . . . 0.0 110.012 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.37 -13.01 29.83 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 118.167 -1.352 . . . . 0.0 116.297 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.26 77.35 75.68 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 119.838 1.819 . . . . 0.0 112.004 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.16 -11.99 24.61 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.239 3.293 . . . . 0.0 115.859 -173.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -80.22 -8.46 59.46 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.623 1.569 . . . . 0.0 114.52 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 pt -141.92 165.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.595 1.158 . . . . 0.0 112.591 -172.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.5 mt -75.46 -44.36 44.65 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.08 -129.93 12.96 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.75 1.167 . . . . 0.0 114.882 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.12 17.29 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.928 3.291 . . . . 0.0 117.087 -173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.4 p -116.59 71.52 5.03 Favored Pre-proline 0 C--O 1.25 1.11 0 O-C-N 119.925 -1.734 . . . . 0.0 110.99 -161.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.0 -26.96 30.65 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.411 2.741 . . . . 0.0 111.931 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -60.19 -41.22 92.48 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.324 1.45 . . . . 0.0 112.797 167.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.633 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.2 m -66.11 -41.07 91.06 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.713 -1.867 . . . . 0.0 111.011 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -62.81 -29.33 70.64 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 117.489 -1.244 . . . . 0.0 112.633 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -52.43 -46.65 66.47 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.6 1.091 . . . . 0.0 112.842 172.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 t -75.43 -35.01 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.536 1.135 . . . . 0.0 111.592 -169.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.01 -44.17 80.98 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.477 0.711 . . . . 0.0 111.161 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 tp -57.14 -48.96 77.39 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.368 1.467 . . . . 0.0 112.993 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.14 -24.98 65.05 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.418 HD12 HD11 ' A' ' 5' ' ' ILE . 89.4 mt -90.7 -35.51 14.88 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.723 1.209 . . . . 0.0 112.95 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.57 -25.27 63.0 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.976 -1.077 . . . . 0.0 113.712 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -69.97 -39.78 75.76 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.696 -1.252 . . . . 0.0 112.384 167.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -69.13 -15.71 63.48 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.999 1.32 . . . . 0.0 114.229 171.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 190' ' ' GLU . 32.0 mmtm 65.0 0.91 1.32 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.572 1.949 . . . . 0.0 115.326 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.8 tt -68.03 126.67 92.93 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.026 0.93 . . . . 0.0 111.001 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.54 150.71 57.88 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.311 2.007 . . . . 0.0 112.411 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -145.27 163.94 32.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.592 1.557 . . . . 0.0 110.483 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -101.77 132.29 47.59 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.622 1.169 . . . . 0.0 109.608 163.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -106.11 115.76 30.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.751 0.82 . . . . 0.0 111.356 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -99.37 84.27 2.97 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.758 1.623 . . . . 0.0 109.757 171.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.93 130.53 43.58 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.638 0.775 . . . . 0.0 110.734 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 mt -128.97 114.84 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.642 1.977 . . . . 0.0 109.709 -170.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -83.27 96.95 8.63 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.527 -0.733 . . . . 0.0 109.53 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.0 mt 53.82 26.74 6.36 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 168.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.73 23.6 9.91 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 115.419 0.928 . . . . 0.0 115.419 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.31 12.29 0.05 Allowed 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -143.13 149.94 50.58 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.904 2.082 . . . . 0.0 110.077 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.82 168.84 8.04 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.866 2.377 . . . . 0.0 112.936 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -60.78 -14.6 22.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 116.455 -1.736 . . . . 0.0 115.319 -172.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -53.82 -20.24 5.5 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.327 2.251 . . . . 0.0 116.026 165.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -106.26 0.53 25.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.861 1.664 . . . . 0.0 113.275 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.5 mt -124.01 -40.09 2.32 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.495 2.318 . . . . 0.0 112.378 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.21 -14.27 16.74 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.333 2.253 . . . . 0.0 114.631 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.6 mt -64.31 -29.45 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 126.829 2.052 . . . . 0.0 111.434 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.8 t -91.28 139.28 25.43 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 123.661 0.784 . . . . 0.0 109.831 160.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -65.84 -14.51 44.94 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.709 2.273 . . . . 0.0 113.459 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.28 7.74 44.21 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.528 1.131 . . . . 0.0 113.212 173.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.95 11.21 73.99 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 120.704 -1.247 . . . . 0.0 114.844 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.28 162.71 23.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.625 1.57 . . . . 0.0 112.995 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.88 149.52 70.77 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 126.365 1.866 . . . . 0.0 107.653 156.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HB3' HG12 ' A' ' 7' ' ' VAL . 85.4 Cg_endo -79.13 144.32 72.75 Favored 'Cis proline' 0 CA--C 1.54 0.802 0 N-CA-C 117.202 1.962 . . . . 0.0 117.202 12.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 m -153.97 178.35 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 129.168 2.987 . . . . 0.0 110.82 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.0 m -139.34 153.02 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 120.827 -1.171 . . . . 0.0 112.739 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -96.83 130.36 44.11 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.6 -0.688 . . . . 0.0 109.246 148.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.17 85.51 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.5 t70 58.18 57.7 3.86 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.056 0.932 . . . . 0.0 113.027 -170.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.281 75.1 m-20 62.15 -4.35 0.21 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -83.5 108.83 16.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.959 1.304 . . . . 0.0 109.697 170.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -65.0 152.81 42.45 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.9 t -143.8 132.79 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.728 2.011 . . . . 0.0 108.955 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.77 -166.48 0.11 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.093 1.757 . . . . 0.0 113.774 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.31 157.48 0.97 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -158.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' A' ' 76' ' ' ILE . 93.2 p -52.22 -22.88 4.79 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.81 -10.64 44.69 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.73 -16.9 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.324 1.05 . . . . 0.0 113.205 162.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' A' ' 73' ' ' SER . 1.3 mt -55.1 -34.35 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.227 1.411 . . . . 0.0 112.828 168.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.95 -12.64 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.1 -57.9 0.71 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.829 0.728 . . . . 0.0 112.401 158.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.75 -34.83 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.235 -1.156 . . . . 0.0 113.577 -162.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.9 tp -76.86 -30.37 56.25 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.804 -1.185 . . . . 0.0 111.881 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.63 -41.71 68.51 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.689 0.796 . . . . 0.0 111.587 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -66.72 -42.78 85.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.273 1.829 . . . . 0.0 112.972 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.5 3.64 35.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.98 145.34 80.92 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 121.054 -1.029 . . . . 0.0 111.011 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.83 -26.87 12.96 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.318 2.012 . . . . 0.0 112.596 165.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -82.88 166.76 33.88 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.545 1.538 . . . . 0.0 111.864 173.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.84 132.84 52.25 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.522 2.148 . . . . 0.0 114.785 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -65.96 127.31 17.46 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.363 2.709 . . . . 0.0 112.968 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.7 mt -96.59 11.23 35.99 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.174 1.39 . . . . 0.0 112.621 174.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.16 -20.64 66.55 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.2 m -59.33 118.92 34.68 Favored Pre-proline 0 N--CA 1.474 0.774 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.377 -166.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.63 120.49 5.57 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.721 2.281 . . . . 0.0 110.827 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.81 -179.45 4.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.713 2.275 . . . . 0.0 111.056 166.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -53.74 -36.85 62.77 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.663 -1.273 . . . . 0.0 112.919 166.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.76 -18.91 57.66 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.881 1.672 . . . . 0.0 114.441 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.92 -30.4 70.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.71 1.141 . . . . 0.0 112.485 173.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -66.93 -14.31 62.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.937 1.295 . . . . 0.0 114.461 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.35 -37.95 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.013 1.325 . . . . 0.0 111.242 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.62 -31.42 74.97 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.194 1.378 . . . . 0.0 113.904 171.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.8 p -68.82 -16.94 63.92 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.944 1.372 . . . . 0.0 113.921 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -91.7 -44.89 8.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.088 1.355 . . . . 0.0 111.727 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.402 HG23 ' CD1' ' A' ' 106' ' ' PHE . 76.5 mt -60.74 -41.17 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.629 1.572 . . . . 0.0 111.035 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.96 -42.73 92.01 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -85.93 -33.76 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.069 2.513 . . . . 0.0 114.845 166.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 77.1 p -68.58 -33.86 74.81 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.172 1.805 . . . . 0.0 112.867 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.402 ' CD1' HG23 ' A' ' 102' ' ' ILE . 10.3 m-85 -75.84 -25.3 56.13 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.394 -1.441 . . . . 0.0 112.767 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.27 -34.48 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.49 -1.381 . . . . 0.0 111.312 167.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -64.9 -38.88 92.45 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.16 0.891 . . . . 0.0 111.99 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -63.73 -25.85 68.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.673 1.589 . . . . 0.0 113.749 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 mt -87.41 11.02 15.61 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.455 1.502 . . . . 0.0 113.966 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -141.9 65.81 1.36 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.728 1.611 . . . . 0.0 110.058 167.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -63.0 25.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 130.602 3.561 . . . . 0.0 118.026 -160.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -75.72 -27.36 58.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.718 1.607 . . . . 0.0 112.143 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.21 113.07 20.08 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-O 117.002 -1.475 . . . . 0.0 107.123 147.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -62.53 120.57 8.17 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 120.764 1.309 . . . . 0.0 112.674 -165.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -54.2 -35.05 61.95 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.71 -18.78 65.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.173 0.989 . . . . 0.0 113.325 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.81 -46.06 4.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.331 0.967 . . . . 0.0 112.561 163.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 m -59.64 -36.68 76.85 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.003 0.921 . . . . 0.0 112.783 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -60.99 -28.5 69.06 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.726 1.21 . . . . 0.0 113.506 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -67.31 -40.15 85.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.678 0.791 . . . . 0.0 110.354 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.12 75.09 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.319 -0.863 . . . . 0.0 112.859 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.4 mt -62.27 -37.85 87.06 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.838 0.744 . . . . 0.0 112.336 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -69.16 -36.75 77.71 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.419 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.31 -35.06 73.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.952 1.251 . . . . 0.0 112.729 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -64.25 -44.83 90.56 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.213 -0.929 . . . . 0.0 112.302 171.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.1 mt -68.37 -35.88 78.36 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.093 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -64.24 -45.1 89.64 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.822 1.646 . . . . 0.0 112.18 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.1 79.17 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.436 0.695 . . . . 0.0 112.258 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.0 tp -70.78 -58.02 4.06 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.509 1.124 . . . . 0.0 111.927 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.32 -35.06 79.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.496 1.518 . . . . 0.0 113.99 -169.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.46 87.14 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.433 -0.648 . . . . 0.0 113.509 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -91.74 -25.7 18.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.824 0.85 . . . . 0.0 113.176 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.6 mt -66.42 -33.5 75.85 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.729 -1.232 . . . . 0.0 113.281 172.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -63.88 -16.61 61.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 173.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.55 -36.38 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.122 0.969 . . . . 0.0 111.898 170.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -77.8 -25.57 49.03 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.7 -106.42 3.18 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 117.343 -1.809 . . . . 0.0 114.952 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.41 -30.58 1.11 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.437 2.758 . . . . 0.0 116.773 -144.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -133.09 160.1 38.16 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.976 1.262 . . . . 0.0 112.443 -169.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.2 tt -78.15 -5.07 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -167.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.02 -3.57 44.66 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.917 1.687 . . . . 0.0 114.776 160.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 119.34 -125.61 6.43 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.58 1.562 . . . . 0.0 113.359 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -58.6 -29.31 66.36 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -141.89 155.12 45.52 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.67 1.588 . . . . 0.0 109.825 -160.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.2 mt -70.48 105.26 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 167.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.8 p -134.87 -164.95 1.59 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.261 1.024 . . . . 0.0 110.764 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.67 -24.62 1.43 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.1 t -78.22 -42.12 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 120.012 1.278 . . . . 0.0 112.578 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.11 -47.38 83.44 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.199 1.363 . . . . 0.0 112.164 166.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.7 mt -61.21 -19.59 61.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.607 0.763 . . . . 0.0 112.773 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.9 m -93.74 -48.49 6.29 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.013 1.325 . . . . 0.0 112.47 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.4 mt -94.89 -34.56 12.38 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -162.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.3 -49.98 85.13 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -170.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.1 -21.75 17.72 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 120.649 1.268 . . . . 0.0 113.835 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -77.64 -27.75 51.14 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.002 -1.061 . . . . 0.0 112.697 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.21 -38.14 75.22 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.549 0.74 . . . . 0.0 112.243 166.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -63.29 -42.84 99.11 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.496 -0.752 . . . . 0.0 112.556 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -69.61 -28.65 66.12 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.907 -1.121 . . . . 0.0 113.352 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.2 tp -66.08 -52.56 47.62 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.105 0.962 . . . . 0.0 110.895 171.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -59.1 -51.12 71.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.571 1.548 . . . . 0.0 111.968 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.1 t -79.08 -53.79 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.55 -50.88 14.29 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.478 -0.764 . . . . 0.0 111.97 -167.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.29 -25.6 66.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 119.194 -0.431 . . . . 0.0 111.873 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.25 -23.43 25.65 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.52 1.533 . . . . 0.0 115.753 174.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -66.67 -19.6 65.8 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -135.52 -31.97 0.94 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -147.02 82.81 1.57 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.949 1.699 . . . . 0.0 109.391 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -63.87 90.9 0.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.758 0.823 . . . . 0.0 110.053 168.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -86.58 115.04 60.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.378 1.071 . . . . 0.0 111.164 -164.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.76 135.94 24.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.385 2.057 . . . . 0.0 112.128 -168.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.08 110.88 41.43 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.46 1.104 . . . . 0.0 108.413 161.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -66.19 156.64 63.88 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.888 1.725 . . . . 0.0 112.183 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.36 -22.08 52.27 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.761 1.624 . . . . 0.0 114.516 174.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -61.5 -29.46 70.0 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.038 -1.039 . . . . 0.0 112.859 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 89.8 mt -85.23 54.9 3.27 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.974 1.71 . . . . 0.0 111.286 170.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.17 -23.59 63.01 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.209 1.003 . . . . 0.0 113.532 -160.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -74.78 -53.68 8.72 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.173 0.897 . . . . 0.0 109.606 167.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.74 -39.15 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 119.777 1.171 . . . . 0.0 112.189 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.44 -35.22 79.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.8 0.84 . . . . 0.0 112.729 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.91 -28.55 35.83 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.046 -1.034 . . . . 0.0 113.179 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -68.08 -34.02 75.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.157 0.983 . . . . 0.0 112.744 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.21 -33.54 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.031 -1.043 . . . . 0.0 111.784 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -70.01 -28.94 65.9 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 119.751 -1.843 . . . . 0.0 112.498 172.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.34 -21.74 64.73 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.338 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.7 mt -60.84 -25.73 66.84 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.809 1.186 . . . . 0.0 112.855 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -89.43 13.66 13.17 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.271 1.428 . . . . 0.0 113.564 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.5 p -136.52 174.74 10.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.733 2.013 . . . . 0.0 112.638 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 57.92 175.36 0.06 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.614 1.966 . . . . 0.0 113.73 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 18.3 mp0 -72.96 -38.22 66.81 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 124.587 1.155 . . . . 0.0 109.902 164.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.7 p -60.56 -32.51 71.59 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.165 1.786 . . . . 0.0 114.486 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -121.39 -43.87 2.39 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.88 1.066 . . . . 0.0 113.88 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -60.63 -31.56 70.74 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.626 -1.296 . . . . 0.0 112.899 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -73.51 -21.59 60.36 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.1 p -93.59 -1.59 55.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.015 1.326 . . . . 0.0 113.425 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -59.33 98.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.81 1.644 . . . . 0.0 110.45 172.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.36 140.89 45.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.76 0.824 . . . . 0.0 111.711 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.26 125.04 20.96 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.805 0.842 . . . . 0.0 111.896 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -68.51 -44.9 73.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.06 1.344 . . . . 0.0 113.612 -149.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -63.43 -29.18 70.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.532 1.133 . . . . 0.0 112.331 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -82.87 -13.18 56.62 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.5 t -73.49 -45.89 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.298 0.954 . . . . 0.0 109.503 163.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.57 -53.15 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.332 1.053 . . . . 0.0 111.572 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.33 -29.98 70.29 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.91 -24.49 57.86 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.709 -1.245 . . . . 0.0 113.619 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -78.33 -32.4 49.15 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.283 1.433 . . . . 0.0 113.98 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -47.7 -53.6 29.62 Favored Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.39 -19.41 49.48 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.656 1.571 . . . . 0.0 113.54 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -85.06 5.49 29.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.348 1.859 . . . . 0.0 115.052 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.76 -20.59 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.55 -0.719 . . . . 0.0 110.997 152.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -101.95 -31.74 10.53 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.807 1.243 . . . . 0.0 114.296 168.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.167 0 C-N-CA 126.726 2.01 . . . . 0.0 113.696 -176.982 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.6 -167.08 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.154 0.981 . . . . 0.0 112.055 -162.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.6 mt -65.69 109.16 2.32 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.555 -1.34 . . . . 0.0 111.003 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -111.46 92.96 4.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.212 1.006 . . . . 0.0 109.471 167.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.427 HD11 HD12 ' A' ' 30' ' ' LEU . 53.4 mt -69.92 132.7 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.107 0.963 . . . . 0.0 108.459 174.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.5 m -120.13 114.94 22.7 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.96 141.25 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.073 -1.017 . . . . 0.0 110.863 -157.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.614 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 31.8 tttm -63.16 126.18 26.52 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 169.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.87 174.71 10.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.022 1.729 . . . . 0.0 111.733 168.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.94 140.58 30.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.681 0.792 . . . . 0.0 111.48 167.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.33 122.14 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 122.003 -0.435 . . . . 0.0 110.053 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.83 -17.82 10.47 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.389 -1.228 . . . . 0.0 115.995 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.8 79.99 67.55 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 119.587 1.694 . . . . 0.0 112.2 -172.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.87 -12.98 34.48 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.639 2.892 . . . . 0.0 116.362 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -78.25 -9.04 59.05 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.3 pt -142.89 163.68 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.927 1.291 . . . . 0.0 112.132 -167.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 mt -78.56 -41.93 30.62 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.08 -126.42 7.17 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.876 1.227 . . . . 0.0 114.494 -174.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -60.35 12.08 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 129.468 3.107 . . . . 0.0 117.455 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -113.57 71.56 1.74 Allowed Pre-proline 0 C--O 1.262 1.716 0 O-C-N 119.61 -1.931 . . . . 0.0 110.954 -161.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -69.47 -23.07 32.53 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 123.77 2.98 . . . . 0.0 112.296 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -67.34 -38.51 84.96 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.799 1.239 . . . . 0.0 112.757 169.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.2 m -64.85 -42.47 94.87 Favored 'General case' 0 C--N 1.374 1.658 0 O-C-N 119.931 -1.731 . . . . 0.0 110.99 169.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -62.16 -26.28 68.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 117.627 -1.178 . . . . 0.0 112.817 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -53.6 -47.6 70.04 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.58 1.082 . . . . 0.0 112.899 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.54 -33.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.465 1.106 . . . . 0.0 111.498 -167.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.7 mt -69.41 -40.59 77.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.739 0.815 . . . . 0.0 111.351 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.77 -48.11 82.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.321 1.449 . . . . 0.0 113.246 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 96.9 p -65.25 -38.5 90.51 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.649 1.113 . . . . 0.0 112.884 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.427 HD12 HD11 ' A' ' 5' ' ' ILE . 84.9 mt -80.18 -33.19 38.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.782 0.833 . . . . 0.0 112.769 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -73.41 -30.04 62.98 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 171.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -66.14 -41.38 90.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.837 -1.164 . . . . 0.0 111.747 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -70.85 -9.85 58.41 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm 62.33 1.8 0.77 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.186 1.794 . . . . 0.0 115.288 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.52 127.15 92.28 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.362 1.065 . . . . 0.0 110.618 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.45 147.21 64.39 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.118 1.878 . . . . 0.0 112.026 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.37 162.56 36.99 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.604 1.561 . . . . 0.0 110.322 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -101.11 137.28 39.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.609 1.564 . . . . 0.0 109.139 165.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -112.35 122.11 46.79 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.559 0.744 . . . . 0.0 111.323 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -107.77 86.26 2.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.804 1.642 . . . . 0.0 109.573 174.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.1 mt -70.4 126.69 30.35 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.381 1.073 . . . . 0.0 111.395 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.0 mt -126.75 112.2 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.444 1.898 . . . . 0.0 109.698 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -81.36 104.87 12.1 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.425 -0.797 . . . . 0.0 109.813 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.9 mt 52.29 23.67 2.51 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.79 23.78 10.52 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.224 0.85 . . . . 0.0 115.224 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -65.01 20.16 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -140.49 155.55 69.78 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 126.268 1.827 . . . . 0.0 110.679 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -60.16 167.51 7.44 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.121 1.881 . . . . 0.0 112.304 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -58.42 -15.75 12.07 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -56.37 -12.91 1.86 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.882 2.473 . . . . 0.0 116.015 171.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -117.24 -1.48 11.81 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.344 2.258 . . . . 0.0 113.416 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.0 mt -123.29 -38.68 2.54 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.557 2.343 . . . . 0.0 112.497 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.89 -13.99 7.83 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.575 2.35 . . . . 0.0 114.568 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.523 HD11 ' HE3' ' A' ' 64' ' ' LYS . 20.6 mt -64.98 -29.67 48.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.453 2.301 . . . . 0.0 111.594 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.3 t -99.27 136.32 20.5 Favored Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 123.468 0.707 . . . . 0.0 109.224 160.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.31 -14.15 42.98 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.629 2.219 . . . . 0.0 113.233 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -89.55 1.55 55.8 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.872 1.269 . . . . 0.0 113.241 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.66 11.96 82.86 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.016 1.293 . . . . 0.0 115.354 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -84.81 162.52 19.53 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.096 1.358 . . . . 0.0 112.887 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.34 148.19 66.69 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 126.484 1.914 . . . . 0.0 107.898 157.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -78.27 145.18 77.23 Favored 'Cis proline' 0 CA--C 1.539 0.768 0 N-CA-C 116.877 1.837 . . . . 0.0 116.877 12.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.3 m -154.97 176.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 128.809 2.843 . . . . 0.0 110.564 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.45 149.58 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 O-C-N 120.565 -1.334 . . . . 0.0 113.761 172.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HE3' HD11 ' A' ' 54' ' ' ILE . 93.5 mttt -95.54 126.06 40.56 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.364 1.065 . . . . 0.0 109.553 153.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.1 mt -100.17 76.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.277 1.431 . . . . 0.0 108.952 175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 58.45 60.53 2.56 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.19 0.995 . . . . 0.0 111.867 -163.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.307 61.3 m-20 64.64 -7.8 0.24 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -76.32 117.59 18.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.873 1.669 . . . . 0.0 109.884 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -69.53 143.19 53.49 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.6 t -138.3 131.34 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.832 1.653 . . . . 0.0 108.878 160.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.01 -154.83 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.222 1.809 . . . . 0.0 113.205 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.4 157.06 0.54 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -158.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.0 p -49.81 -25.55 3.19 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.879 1.671 . . . . 0.0 114.917 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -97.44 -10.15 25.96 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.8 1.24 . . . . 0.0 113.671 -171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.57 -21.82 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.159 0.984 . . . . 0.0 112.698 158.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.12 -37.98 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.965 1.706 . . . . 0.0 112.838 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.48 -16.93 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.0 -53.27 0.75 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.062 0.839 . . . . 0.0 113.268 160.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -71.33 -36.88 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.477 1.138 . . . . 0.0 113.312 -163.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.2 tp -73.89 -35.83 64.73 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.246 0.93 . . . . 0.0 111.391 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -71.68 -36.06 70.49 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.66 -32.37 73.83 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.566 1.546 . . . . 0.0 112.843 168.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -98.96 8.87 44.58 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.795 1.238 . . . . 0.0 113.085 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.43 137.03 34.64 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.92 0.888 . . . . 0.0 110.621 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.09 -29.8 17.15 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 121.669 1.58 . . . . 0.0 112.376 168.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 69.9 mm-40 -85.91 141.19 35.46 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 118.567 0.622 . . . . 0.0 111.76 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 53.1 Cg_exo -51.2 128.89 26.75 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.778 2.985 . . . . 0.0 115.792 -160.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 72.1 Cg_exo -57.81 143.45 95.55 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.206 2.604 . . . . 0.0 114.966 -174.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.4 mt -110.49 0.94 17.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.989 2.116 . . . . 0.0 112.516 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.14 -13.11 62.23 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.964 1.705 . . . . 0.0 115.33 -176.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.2 m -65.2 122.14 78.23 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-O 118.287 -0.864 . . . . 0.0 109.749 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.407 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 75.6 Cg_endo -76.89 126.39 8.72 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.932 1.755 . . . . 0.0 110.788 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 92' ' ' PRO . 68.0 Cg_endo -69.18 167.44 23.67 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.1 1.866 . . . . 0.0 110.191 155.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -26.15 61.8 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.725 -1.234 . . . . 0.0 113.665 165.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -55.44 -22.92 22.57 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.371 -1.455 . . . . 0.0 113.97 167.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.7 -24.19 67.49 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.509 -1.369 . . . . 0.0 113.903 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 p -73.56 -3.7 29.44 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.304 1.411 . . . . 0.0 113.988 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.92 -38.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.986 1.315 . . . . 0.0 111.042 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.36 75.69 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.084 -1.01 . . . . 0.0 114.497 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.8 p -68.2 -15.52 63.61 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -90.41 -42.44 10.9 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.935 1.294 . . . . 0.0 112.356 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.32 -32.43 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.134 1.374 . . . . 0.0 110.94 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.74 -55.57 44.44 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.292 -1.337 . . . . 0.0 113.929 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.2 -31.78 3.45 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.581 2.188 . . . . 0.0 113.983 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.2 p -68.13 -36.54 79.89 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.006 1.73 . . . . 0.0 112.934 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -76.33 -24.46 54.27 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.57 -1.331 . . . . 0.0 114.047 170.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.24 -34.7 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.381 -1.45 . . . . 0.0 111.305 169.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -67.01 -39.22 87.03 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.589 1.155 . . . . 0.0 112.069 171.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -61.78 -24.65 66.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.131 1.372 . . . . 0.0 114.145 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.4 mt -90.18 7.98 35.34 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.813 1.645 . . . . 0.0 114.103 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -137.83 66.66 1.44 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.351 1.46 . . . . 0.0 110.692 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -62.15 23.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 130.903 3.681 . . . . 0.0 118.324 -162.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.03 -29.57 65.53 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.379 1.472 . . . . 0.0 111.597 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -80.61 114.62 49.27 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 152.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -58.41 128.5 28.69 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.405 2.07 . . . . 0.0 114.271 -164.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -57.19 -42.45 81.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.449 1.1 . . . . 0.0 112.753 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -61.93 -24.35 66.92 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.54 -40.17 5.75 Favored Glycine 0 N--CA 1.474 1.209 0 O-C-N 121.156 -0.965 . . . . 0.0 112.494 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.2 m -61.56 -36.74 81.48 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.07 -27.26 68.23 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -68.97 -38.76 79.58 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.676 -0.64 . . . . 0.0 111.332 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.05 -37.39 78.53 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.873 -1.142 . . . . 0.0 112.659 171.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 mt -62.5 -39.64 94.15 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.508 0.595 . . . . 0.0 112.17 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.71 -44.12 87.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.44 -0.791 . . . . 0.0 112.042 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.56 -32.7 70.22 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.862 1.21 . . . . 0.0 112.842 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -64.44 -49.63 70.71 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.222 -0.924 . . . . 0.0 112.319 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.3 mt -68.25 -32.1 72.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.939 -1.029 . . . . 0.0 113.051 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -64.36 -45.55 87.27 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.627 1.558 . . . . 0.0 112.191 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.75 -31.49 72.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.113 0.565 . . . . 0.0 112.395 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 tp -75.71 -59.85 2.57 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.93 1.292 . . . . 0.0 111.822 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.25 -33.92 76.54 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.499 1.52 . . . . 0.0 114.148 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.74 -29.99 62.16 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.935 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -101.05 -26.9 13.54 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.18 -31.68 72.88 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.471 1.487 . . . . 0.0 113.328 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -64.57 -12.76 48.37 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.7 t -98.97 -35.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.911 1.284 . . . . 0.0 111.95 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -82.41 -22.05 35.5 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.04 -109.28 3.24 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-O 117.603 -1.665 . . . . 0.0 114.883 162.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.76 -30.26 3.93 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.151 3.234 . . . . 0.0 116.781 -149.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -132.45 160.23 37.04 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.201 1.364 . . . . 0.0 112.697 -169.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.8 tt -73.08 -8.21 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -171.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.92 -5.83 40.53 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 164.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 123.01 -129.97 7.64 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.966 1.257 . . . . 0.0 113.781 -175.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -71.81 -20.41 61.85 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.589 1.556 . . . . 0.0 114.005 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -139.31 153.0 47.67 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.983 1.713 . . . . 0.0 109.973 -175.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.91 105.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.771 0.828 . . . . 0.0 108.952 162.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.2 p -133.33 -164.86 1.54 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.722 1.209 . . . . 0.0 110.767 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.07 -24.26 3.75 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -165.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.27 -43.5 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.189 1.359 . . . . 0.0 112.663 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.78 -47.98 78.92 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.772 1.169 . . . . 0.0 111.834 167.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.39 -15.51 49.31 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.9 m -100.32 -36.11 9.37 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.642 1.577 . . . . 0.0 113.094 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.54 -32.85 6.55 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -165.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.26 97.81 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -167.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.69 -18.71 19.35 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.251 1.301 . . . . 0.0 114.464 175.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -70.81 -32.99 70.25 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.712 -1.242 . . . . 0.0 111.773 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.4 -34.43 72.53 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -64.93 -44.6 88.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.518 0.675 . . . . 0.0 112.362 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -69.07 -28.76 66.8 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.082 -1.011 . . . . 0.0 113.197 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.93 -56.41 19.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.686 1.194 . . . . 0.0 110.835 168.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -61.39 -46.39 90.36 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.702 1.201 . . . . 0.0 111.753 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.2 t -80.0 -53.32 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.83 -52.79 9.6 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.544 -0.723 . . . . 0.0 112.106 -167.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 9.1 tp -69.28 -21.57 63.87 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.893 -0.504 . . . . 0.0 111.942 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -51.75 -28.41 23.01 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.579 1.561 . . . . 0.0 115.388 169.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -71.73 -15.65 62.2 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -136.92 -36.65 0.68 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -150.82 77.85 1.29 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.545 1.538 . . . . 0.0 109.199 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -59.18 103.24 0.16 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.873 0.469 . . . . 0.0 110.471 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -91.87 108.37 29.49 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.194 0.997 . . . . 0.0 110.964 -168.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.34 133.77 21.55 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.256 1.97 . . . . 0.0 111.39 -171.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 42.1 mm -74.18 114.8 36.74 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 159.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -69.73 158.8 55.73 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.058 1.839 . . . . 0.0 111.435 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.36 -22.54 61.49 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -64.29 -28.63 69.85 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.97 54.3 3.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.165 1.786 . . . . 0.0 110.964 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -22.11 62.82 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.491 1.116 . . . . 0.0 113.796 -161.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -75.29 -52.8 9.97 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.663 1.119 . . . . 0.0 109.92 166.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 92.3 t -60.72 -37.85 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 119.257 0.935 . . . . 0.0 112.345 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.6 -31.9 72.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.327 1.051 . . . . 0.0 113.059 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -89.16 -26.02 21.51 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.018 -1.051 . . . . 0.0 113.258 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -67.23 -35.06 78.79 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.244 1.017 . . . . 0.0 112.759 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.7 mt -61.14 -32.93 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 120.911 -1.118 . . . . 0.0 111.998 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -69.84 -26.55 64.28 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.718 -1.863 . . . . 0.0 112.627 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.1 mt -70.02 -20.72 63.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.281 171.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.22 -24.67 67.98 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.666 1.121 . . . . 0.0 112.877 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -88.31 13.9 10.63 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.471 1.509 . . . . 0.0 113.024 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.7 p -137.56 176.71 8.46 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.116 1.766 . . . . 0.0 113.827 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 55.48 -173.1 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.211 1.804 . . . . 0.0 112.286 -169.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.471 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 13.9 mp0 -79.03 -41.18 29.49 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.161 1.384 . . . . 0.0 109.866 162.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 92.7 p -57.41 -35.9 70.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.948 2.099 . . . . 0.0 114.586 -171.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -114.11 -43.44 3.23 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.06 -30.08 70.12 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.614 -1.304 . . . . 0.0 113.812 -177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.87 -17.5 55.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 20.0 p -100.37 -6.43 25.76 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.499 1.12 . . . . 0.0 113.42 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -51.24 104.03 0.07 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.258 1.823 . . . . 0.0 110.959 163.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -81.56 145.56 30.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.24 1.016 . . . . 0.0 112.142 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.55 120.55 8.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.312 1.045 . . . . 0.0 111.884 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -65.54 -42.44 91.94 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.61 1.564 . . . . 0.0 113.873 -151.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -31.63 72.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.127 0.971 . . . . 0.0 113.014 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -81.17 -11.99 59.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.1 t -70.74 -48.99 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.834 1.197 . . . . 0.0 109.43 162.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.5 mt -64.14 -53.93 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.447 1.099 . . . . 0.0 111.81 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.84 71.74 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -77.67 -23.95 66.1 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.92 -1.113 . . . . 0.0 113.477 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -79.67 -31.11 41.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.141 1.376 . . . . 0.0 114.144 174.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -47.97 -51.11 50.17 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.58 -20.08 47.61 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 121.846 1.697 . . . . 0.0 113.937 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -88.07 4.26 45.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.185 1.794 . . . . 0.0 114.923 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.02 -25.67 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 122.6 0.36 . . . . 0.0 110.572 151.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -91.88 -38.07 12.53 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 116.804 -1.569 . . . . 0.0 114.697 168.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.797 2.039 . . . . 0.0 113.49 -179.487 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.47 -174.63 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.069 1.348 . . . . 0.0 113.618 -168.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.05 116.92 17.22 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.908 -1.12 . . . . 0.0 110.871 -170.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -127.61 122.82 34.13 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.071 0.948 . . . . 0.0 110.98 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 HG22 HG13 ' A' ' 7' ' ' VAL . 45.8 mt -102.66 132.67 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.591 1.557 . . . . 0.0 108.731 -172.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.9 m -114.26 105.15 12.82 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -120.56 143.75 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.881 1.272 . . . . 0.0 110.785 -162.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.665 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.0 tttm -63.55 127.86 33.22 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.534 169.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.94 173.91 10.2 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.85 1.66 . . . . 0.0 112.117 168.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.28 138.72 20.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.324 1.049 . . . . 0.0 111.512 163.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.8 t -56.18 123.47 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 121.056 0.455 . . . . 0.0 109.942 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.87 -11.71 26.52 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 116.446 1.338 . . . . 0.0 116.446 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.81 78.38 73.78 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.978 1.889 . . . . 0.0 112.138 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.03 -13.13 38.05 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.6 2.867 . . . . 0.0 116.693 -168.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.02 -11.19 59.89 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.2 pt -141.06 162.32 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.598 1.159 . . . . 0.0 112.346 -164.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 mt -76.56 -44.53 34.33 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.31 -128.57 13.37 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.315 0.96 . . . . 0.0 114.774 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -63.04 16.88 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.392 3.077 . . . . 0.0 116.896 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -115.56 70.45 3.25 Favored Pre-proline 0 C--O 1.256 1.396 0 O-C-N 119.717 -1.864 . . . . 0.0 110.991 -162.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -68.5 -23.83 36.89 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 123.336 2.691 . . . . 0.0 112.046 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -65.09 -41.0 95.39 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.358 1.463 . . . . 0.0 112.935 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.5 m -64.29 -41.81 96.71 Favored 'General case' 0 C--N 1.373 1.611 0 O-C-N 119.762 -1.836 . . . . 0.0 110.991 170.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -62.75 -28.32 69.89 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 117.567 -1.206 . . . . 0.0 112.641 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -53.26 -46.5 69.25 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.507 1.049 . . . . 0.0 112.88 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.13 -40.77 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.345 1.058 . . . . 0.0 111.059 -170.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.6 mt -69.2 -37.34 78.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.825 0.85 . . . . 0.0 111.789 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.3 tp -59.4 -46.01 89.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.456 1.502 . . . . 0.0 113.209 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.41 -37.87 77.67 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.702 1.137 . . . . 0.0 113.03 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -75.35 -37.28 60.76 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.86 0.864 . . . . 0.0 113.11 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -72.87 -27.29 61.82 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -68.63 -41.18 79.81 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.745 -1.222 . . . . 0.0 111.522 169.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -68.74 -11.03 59.82 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.158 1.783 . . . . 0.0 115.058 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm 62.32 3.01 0.94 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 126.394 1.878 . . . . 0.0 115.331 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.8 tt -72.06 131.13 85.67 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.805 0.842 . . . . 0.0 110.786 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.93 147.02 73.54 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.192 1.928 . . . . 0.0 112.158 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -146.19 160.94 41.28 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.095 1.758 . . . . 0.0 109.526 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -101.17 128.69 47.15 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.955 0.902 . . . . 0.0 109.551 166.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.9 t -104.7 128.19 52.7 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.207 0.603 . . . . 0.0 111.941 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -113.97 93.11 4.22 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.803 1.641 . . . . 0.0 109.925 167.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.29 136.96 50.31 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.28 1.032 . . . . 0.0 111.134 168.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.8 mt -133.58 115.04 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.808 2.043 . . . . 0.0 110.198 -167.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -82.46 111.23 18.29 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.553 -0.717 . . . . 0.0 109.736 169.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.9 mt 52.73 19.63 1.32 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 168.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.64 25.26 10.06 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.135 0.879 . . . . 0.0 115.035 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -61.89 13.41 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -138.7 152.5 70.83 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 126.187 1.795 . . . . 0.0 110.524 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -59.74 167.68 6.52 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.351 2.034 . . . . 0.0 111.868 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -61.16 -12.84 14.05 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 116.595 -1.669 . . . . 0.0 114.962 -172.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -56.95 -13.1 2.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.09 2.556 . . . . 0.0 116.433 168.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -115.96 2.12 13.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.746 2.019 . . . . 0.0 112.978 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.7 mt -127.29 -40.9 1.78 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.587 2.355 . . . . 0.0 112.266 -172.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.19 -14.92 12.18 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 127.881 2.472 . . . . 0.0 114.807 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.51 HD11 ' HE3' ' A' ' 64' ' ' LYS . 18.0 mt -63.88 -24.35 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 127.26 2.224 . . . . 0.0 111.298 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.5 t -102.82 139.23 19.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.467 1.107 . . . . 0.0 109.992 157.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -62.91 -25.37 74.23 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.433 2.089 . . . . 0.0 112.811 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -80.82 -0.88 40.79 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.312 1.445 . . . . 0.0 113.361 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.3 9.18 57.21 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 120.075 -1.641 . . . . 0.0 114.992 -170.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -69.62 158.18 35.81 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.754 1.222 . . . . 0.0 112.398 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.15 150.24 73.35 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 126.408 1.883 . . . . 0.0 107.965 154.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' A' ' 7' ' ' VAL . 58.0 Cg_endo -80.31 148.26 77.25 Favored 'Cis proline' 0 CA--C 1.541 0.859 0 N-CA-C 116.264 1.602 . . . . 0.0 116.264 8.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.0 m -155.52 170.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 127.85 2.46 . . . . 0.0 111.127 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.03 149.35 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HE3' HD11 ' A' ' 54' ' ' ILE . 89.7 mttt -96.54 123.53 40.24 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.759 2.024 . . . . 0.0 109.346 158.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.08 80.93 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.325 1.45 . . . . 0.0 108.966 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 t70 58.32 60.95 2.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.786 0.835 . . . . 0.0 111.712 -163.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 64.63 -16.76 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -75.28 123.12 24.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.059 1.344 . . . . 0.0 110.626 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -72.14 144.27 48.66 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.8 t -140.29 131.27 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 126.367 1.867 . . . . 0.0 108.723 162.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.42 -149.79 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.967 1.707 . . . . 0.0 113.342 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -37.42 154.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.643 1.977 . . . . 0.0 116.084 -165.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -50.25 -23.43 2.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.663 1.585 . . . . 0.0 114.689 163.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -98.91 -8.69 25.21 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 113.825 -171.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.5 m -104.79 -22.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.277 1.031 . . . . 0.0 112.605 158.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mt -52.02 -35.51 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.472 1.909 . . . . 0.0 113.127 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.61 -18.4 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.555 1.142 . . . . 0.0 114.018 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.62 -56.34 0.64 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.125 0.869 . . . . 0.0 112.565 158.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.48 -31.74 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.024 -1.28 . . . . 0.0 113.688 -161.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 tp -79.9 -40.78 27.51 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.315 0.962 . . . . 0.0 111.57 169.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.45 -30.64 71.39 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.29 -32.56 74.04 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.209 1.804 . . . . 0.0 114.519 168.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -115.82 -10.9 11.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.901 1.281 . . . . 0.0 113.659 -159.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -71.64 139.62 83.68 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.213 1.005 . . . . 0.0 109.701 165.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.71 -26.89 32.5 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 121.88 1.72 . . . . 0.0 113.488 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -79.74 142.64 57.19 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 118.918 0.781 . . . . 0.0 111.305 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -55.02 143.47 73.11 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.106 2.537 . . . . 0.0 116.454 -160.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.93 130.2 28.45 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.856 3.037 . . . . 0.0 113.313 -175.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.3 mt -94.55 1.65 55.67 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.867 2.067 . . . . 0.0 112.791 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.41 -25.13 68.14 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.2 m -62.8 119.14 48.66 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.114 -168.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.4 124.93 7.37 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.502 2.135 . . . . 0.0 111.349 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -75.36 177.31 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.899 2.399 . . . . 0.0 110.709 162.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -58.79 -29.08 66.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.689 -1.257 . . . . 0.0 113.535 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -57.71 -24.16 55.44 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.85 -24.53 67.78 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.805 -1.184 . . . . 0.0 113.002 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.0 p -67.12 -14.62 63.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.152 1.381 . . . . 0.0 114.096 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.59 -36.68 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.913 1.285 . . . . 0.0 111.239 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 -26.89 70.46 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 120.964 -1.085 . . . . 0.0 114.591 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 p -69.61 -15.69 63.25 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 170.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -88.51 -40.83 13.14 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.454 1.501 . . . . 0.0 111.936 169.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.84 -31.97 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.034 1.334 . . . . 0.0 111.531 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.72 -55.8 42.37 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.374 -1.298 . . . . 0.0 113.575 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.55 -32.28 3.82 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.342 2.028 . . . . 0.0 113.647 170.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 p -67.48 -32.74 73.77 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 121.17 1.805 . . . . 0.0 113.349 -170.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.15 -28.82 42.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.25 -35.76 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 120.696 -1.252 . . . . 0.0 111.262 170.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -66.43 -45.09 81.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.829 1.652 . . . . 0.0 111.7 170.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -59.33 -40.77 87.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.146 0.978 . . . . 0.0 112.721 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.2 -21.9 64.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.165 1.386 . . . . 0.0 114.501 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -98.84 71.29 1.9 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.658 1.572 . . . . 0.0 109.867 165.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.7 m -60.2 18.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.513 3.125 . . . . 0.0 118.743 -159.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -74.54 -23.09 58.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.489 1.916 . . . . 0.0 113.046 173.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -76.2 113.11 25.13 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.279 158.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.63 117.26 3.64 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.005 2.47 . . . . 0.0 112.802 -164.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -64.3 -39.61 94.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.914 -161.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.15 -25.74 68.49 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.367 -1.458 . . . . 0.0 114.165 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.58 -39.58 6.65 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.288 0.947 . . . . 0.0 113.507 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.6 m -57.16 -38.85 74.18 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.559 1.144 . . . . 0.0 111.922 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.71 -26.7 68.21 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.248 1.419 . . . . 0.0 114.0 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -71.28 -35.98 71.53 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.469 -0.77 . . . . 0.0 112.173 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.68 84.26 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.94 -1.1 . . . . 0.0 112.177 171.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.5 mt -62.55 -40.2 96.08 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.89 0.476 . . . . 0.0 111.769 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.9 -43.9 86.86 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.324 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.49 -34.43 74.32 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.052 1.296 . . . . 0.0 112.855 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -63.72 -47.63 80.3 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.233 -0.917 . . . . 0.0 112.419 170.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.52 -35.2 77.15 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.123 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -63.47 -44.3 94.82 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.352 1.433 . . . . 0.0 112.018 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.52 72.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.346 0.658 . . . . 0.0 112.689 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.82 -56.24 4.87 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.93 0.892 . . . . 0.0 111.953 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.49 -32.96 74.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.054 1.341 . . . . 0.0 114.0 -168.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.74 -34.41 60.88 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.585 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -93.38 -30.54 15.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.241 1.016 . . . . 0.0 113.202 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.74 -28.76 70.1 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.379 -1.451 . . . . 0.0 113.489 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -67.67 -11.24 57.82 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 171.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.8 t -101.29 -44.19 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.977 1.311 . . . . 0.0 111.455 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -75.48 -17.51 60.11 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.0 -110.21 3.84 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 117.772 -1.571 . . . . 0.0 115.506 159.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.83 -28.23 4.22 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.677 2.918 . . . . 0.0 116.487 -148.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -134.81 164.36 27.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.887 1.221 . . . . 0.0 112.391 -170.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.4 tt -78.55 -7.13 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.327 -0.858 . . . . 0.0 113.183 -166.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.35 -1.48 53.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.684 1.594 . . . . 0.0 114.568 161.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 111.31 -127.72 8.33 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.303 1.43 . . . . 0.0 113.334 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -64.81 -19.37 65.81 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.31 1.844 . . . . 0.0 114.238 -171.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -147.68 150.47 34.41 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.932 1.693 . . . . 0.0 109.429 -172.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.83 112.94 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.365 0.666 . . . . 0.0 109.484 164.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.3 p -140.25 -164.66 1.75 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.362 1.065 . . . . 0.0 110.9 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.63 -24.2 2.09 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -167.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.83 -43.11 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 120.234 1.379 . . . . 0.0 112.142 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.83 -44.81 96.45 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.031 -1.043 . . . . 0.0 112.187 169.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.4 -19.36 61.82 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.533 0.733 . . . . 0.0 112.841 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.9 m -95.44 -36.26 11.4 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.339 1.456 . . . . 0.0 113.115 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 48.5 mt -111.8 -36.07 5.54 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -165.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.48 -46.13 98.24 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -168.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.02 -20.38 19.41 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 120.662 1.272 . . . . 0.0 114.371 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -70.51 -32.77 70.38 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.834 -1.166 . . . . 0.0 111.77 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.91 -35.67 74.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.346 0.659 . . . . 0.0 112.597 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -65.39 -43.12 91.66 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.729 0.776 . . . . 0.0 112.378 169.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -68.0 -28.8 67.74 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.15 -0.969 . . . . 0.0 113.184 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.42 -56.3 15.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.482 1.113 . . . . 0.0 110.935 169.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -58.31 -46.18 86.62 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.511 1.124 . . . . 0.0 111.93 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.3 t -82.88 -52.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.13 -55.28 5.58 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.527 -0.733 . . . . 0.0 111.789 -167.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.36 -29.45 69.63 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.034 -0.416 . . . . 0.0 111.691 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.08 -21.31 38.19 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.04 1.305 . . . . 0.0 116.046 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -68.62 -19.34 64.43 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -131.17 -34.24 1.45 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -146.88 91.08 1.97 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.745 1.618 . . . . 0.0 109.335 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -66.58 90.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.666 0.786 . . . . 0.0 110.198 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -84.73 113.64 50.6 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.621 1.168 . . . . 0.0 111.143 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.36 136.82 22.38 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.295 1.997 . . . . 0.0 111.523 -175.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 97.0 mt -86.16 101.06 1.63 Allowed Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 161.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -70.16 160.86 48.09 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.014 1.81 . . . . 0.0 112.522 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.95 -21.54 58.55 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -172.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -61.4 -29.48 69.95 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.398 -0.814 . . . . 0.0 113.15 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.45 53.22 2.25 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.877 2.071 . . . . 0.0 111.064 171.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -21.67 63.34 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.318 1.047 . . . . 0.0 113.589 -160.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -75.05 -54.88 6.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.816 1.189 . . . . 0.0 109.823 165.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.82 -36.63 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 119.022 0.828 . . . . 0.0 112.476 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.9 tp -64.47 -32.42 74.04 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.879 -1.138 . . . . 0.0 112.957 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -81.09 -24.92 37.4 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.752 -1.218 . . . . 0.0 113.219 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -67.16 -31.62 72.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.12 0.968 . . . . 0.0 112.908 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 36.4 mm -56.28 -40.1 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 120.996 -1.065 . . . . 0.0 111.705 168.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -71.39 -22.4 61.88 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.473 -1.392 . . . . 0.0 112.288 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.76 -22.5 59.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 117.795 -1.098 . . . . 0.0 113.458 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.82 -27.03 68.48 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 120.212 1.369 . . . . 0.0 112.907 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.73 12.51 8.8 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.181 1.792 . . . . 0.0 113.463 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.9 p -137.78 178.24 7.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.832 1.653 . . . . 0.0 113.821 -167.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 56.61 -171.41 0.08 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.402 1.481 . . . . 0.0 111.351 -163.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 4.4 mp0 -78.28 -44.01 26.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.009 0.924 . . . . 0.0 109.435 156.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 59.5 p -70.01 -36.05 74.82 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 126.018 1.727 . . . . 0.0 115.456 -161.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -85.06 -50.57 7.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.278 0.945 . . . . 0.0 111.547 165.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -59.76 -34.84 73.51 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -73.09 -19.5 61.15 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.387 0.994 . . . . 0.0 113.181 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.1 p -94.7 -8.8 36.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -53.18 107.64 0.25 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.108 1.363 . . . . 0.0 110.188 167.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.62 145.4 34.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.565 0.746 . . . . 0.0 111.826 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.54 127.1 30.36 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.732 0.813 . . . . 0.0 111.158 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -69.26 -42.19 75.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.473 1.109 . . . . 0.0 113.889 -149.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -61.41 -33.67 74.08 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.693 1.197 . . . . 0.0 112.328 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -79.81 -12.78 59.75 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.21 -48.52 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 119.247 0.931 . . . . 0.0 109.591 163.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.0 mt -63.5 -55.31 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.703 1.201 . . . . 0.0 111.8 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.67 -29.14 67.53 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -78.74 -27.8 56.12 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.709 -1.244 . . . . 0.0 113.211 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -75.43 -33.41 60.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.194 1.398 . . . . 0.0 113.929 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -48.21 -52.01 45.14 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.8 -20.41 58.73 Favored 'Trans proline' 0 C--N 1.354 0.823 0 CA-C-N 121.57 1.596 . . . . 0.0 113.552 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -93.65 9.88 35.07 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.575 1.95 . . . . 0.0 114.408 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 50.0 t -68.27 -25.12 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.681 -0.637 . . . . 0.0 110.364 148.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -96.59 -50.01 4.89 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 117.833 -1.08 . . . . 0.0 113.762 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.894 0 C-N-CA 125.843 1.657 . . . . 0.0 114.539 -175.625 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.5 mtp . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 118.372 -0.823 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.94 -167.3 0.06 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.346 1.058 . . . . 0.0 112.704 -170.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.8 mt -73.16 118.31 15.95 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.945 -1.097 . . . . 0.0 111.521 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -122.3 122.21 38.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.635 1.174 . . . . 0.0 109.806 166.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mt -109.43 129.23 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.004 1.322 . . . . 0.0 108.29 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.3 m -113.27 117.52 32.09 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.79 142.76 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.222 1.009 . . . . 0.0 110.198 -161.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.699 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.8 tttm -64.32 128.78 37.25 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.451 170.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.07 174.08 9.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.996 1.719 . . . . 0.0 112.176 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.24 136.1 43.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.9 0.88 . . . . 0.0 111.107 164.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 68.1 t -57.85 122.85 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.75 -0.594 . . . . 0.0 109.763 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.04 -10.81 61.94 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 118.21 -1.328 . . . . 0.0 116.07 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.46 83.89 24.69 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 120.078 1.939 . . . . 0.0 112.293 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.83 -14.05 42.77 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.552 2.835 . . . . 0.0 116.525 -171.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -81.8 -7.03 59.56 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.2 pt -141.83 161.88 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.868 1.267 . . . . 0.0 111.957 -166.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.5 mt -77.37 -46.13 23.8 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.37 -123.89 7.39 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.829 1.204 . . . . 0.0 114.398 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -63.4 16.97 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.802 2.841 . . . . 0.0 116.894 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -116.26 71.16 4.41 Favored Pre-proline 0 C--O 1.26 1.635 0 O-C-N 119.494 -2.004 . . . . 0.0 110.945 -162.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -69.28 -21.38 35.8 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.425 2.75 . . . . 0.0 112.42 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -69.1 -42.51 76.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.441 1.496 . . . . 0.0 112.627 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.699 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -60.74 -42.48 97.46 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 119.364 -2.085 . . . . 0.0 111.014 168.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -63.1 -27.46 69.4 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 117.59 -1.195 . . . . 0.0 113.106 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -55.75 -44.96 78.12 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 120.139 1.336 . . . . 0.0 112.536 172.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -72.03 -40.09 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.904 1.281 . . . . 0.0 111.422 -171.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.43 -36.4 71.29 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.453 0.701 . . . . 0.0 111.493 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.71 -41.79 95.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.603 1.161 . . . . 0.0 113.698 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -70.42 -40.84 73.58 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.011 1.278 . . . . 0.0 112.527 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.2 -34.5 65.99 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.684 0.794 . . . . 0.0 113.036 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -78.28 -19.77 52.96 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -72.69 -40.88 65.88 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 120.709 -1.244 . . . . 0.0 112.008 162.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -74.07 -4.53 36.1 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.59 1.556 . . . . 0.0 114.775 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt 58.7 16.81 4.63 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.99 2.116 . . . . 0.0 115.197 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.5 mm -76.99 129.55 78.26 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.858 0.863 . . . . 0.0 110.317 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.95 145.76 45.88 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.462 2.108 . . . . 0.0 111.953 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -148.31 158.65 44.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.339 1.456 . . . . 0.0 110.489 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -96.8 100.93 12.44 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.387 1.075 . . . . 0.0 110.268 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -81.73 136.26 35.46 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -127.51 96.74 4.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.289 1.836 . . . . 0.0 110.165 168.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.7 mt -72.15 142.26 49.11 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.634 1.174 . . . . 0.0 111.433 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.4 mt -133.07 119.52 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.592 1.557 . . . . 0.0 110.683 -170.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -89.37 112.05 23.06 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.708 -0.62 . . . . 0.0 110.064 170.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.3 mt 51.29 22.18 1.32 Allowed 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.02 24.97 15.44 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 119.061 -0.855 . . . . 0.0 115.207 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -65.34 16.73 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -141.02 147.61 48.53 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 126.203 1.801 . . . . 0.0 110.517 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -62.99 171.66 5.84 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.475 2.116 . . . . 0.0 112.094 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -58.89 -17.67 26.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 116.919 -1.515 . . . . 0.0 115.045 -174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -57.35 -11.84 2.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.692 1.997 . . . . 0.0 116.261 169.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -116.32 3.4 13.35 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.352 1.861 . . . . 0.0 113.091 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.6 mt -131.96 -40.26 1.06 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.127 2.171 . . . . 0.0 112.594 -170.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.49 -8.78 2.02 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 128.531 2.732 . . . . 0.0 115.137 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.464 HD11 ' HE3' ' A' ' 64' ' ' LYS . 11.3 mt -68.31 -19.64 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 127.989 2.516 . . . . 0.0 111.16 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.7 p -110.56 148.07 37.71 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 124.671 1.188 . . . . 0.0 111.069 161.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.71 -20.94 59.18 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.907 2.405 . . . . 0.0 113.985 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -101.14 1.48 39.22 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.135 1.374 . . . . 0.0 114.038 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.54 11.69 80.24 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 119.219 0.918 . . . . 0.0 114.971 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -62.62 150.87 39.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.061 1.344 . . . . 0.0 110.673 171.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.42 150.33 75.3 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.224 1.41 . . . . 0.0 108.843 155.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.5 153.78 97.11 Favored 'Cis proline' 0 CA--C 1.542 0.888 0 N-CA-C 116.721 1.777 . . . . 0.0 116.721 14.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.8 m -157.13 167.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 127.964 2.506 . . . . 0.0 110.92 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.41 147.19 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.964 -1.085 . . . . 0.0 113.797 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HE3' HD11 ' A' ' 54' ' ' ILE . 87.6 mttt -100.09 115.55 30.04 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.063 1.745 . . . . 0.0 108.932 164.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.3 mt -95.05 77.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.645 1.178 . . . . 0.0 109.173 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.7 t70 58.39 60.41 2.62 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.418 -164.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.263 56.0 m-20 64.9 -10.84 0.15 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.591 2.356 . . . . 0.0 117.33 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -73.33 117.75 15.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.347 1.459 . . . . 0.0 109.928 171.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -68.75 144.49 54.35 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.0 t -141.83 131.84 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.278 1.831 . . . . 0.0 109.173 166.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.87 -149.58 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.27 1.828 . . . . 0.0 113.732 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -46.01 158.51 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.097 2.159 . . . . 0.0 116.766 -163.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.6 p -51.93 -30.52 24.83 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.624 -1.298 . . . . 0.0 113.83 168.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.65 -7.37 52.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -170.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.8 -22.13 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.282 1.033 . . . . 0.0 113.094 160.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mt -53.78 -37.79 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.694 1.598 . . . . 0.0 112.946 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.92 -11.08 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.7 -58.81 0.71 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.781 0.705 . . . . 0.0 112.341 154.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.15 -32.58 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.388 -1.066 . . . . 0.0 113.839 -161.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -77.28 -45.73 25.38 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.258 0.936 . . . . 0.0 111.752 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.31 -26.28 68.41 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.11 0.964 . . . . 0.0 113.511 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.51 -33.57 75.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.903 1.681 . . . . 0.0 114.264 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -116.28 -20.03 9.94 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.789 1.236 . . . . 0.0 113.629 -158.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -73.83 126.35 89.59 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.15 0.98 . . . . 0.0 108.701 158.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.18 -12.98 25.81 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.822 2.348 . . . . 0.0 115.333 -168.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -72.03 142.2 84.92 Favored Pre-proline 0 CA--C 1.547 0.864 0 CA-C-N 119.073 0.851 . . . . 0.0 109.637 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -57.83 134.6 63.67 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 CA-C-N 121.886 1.709 . . . . 0.0 114.939 -163.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.38 132.92 46.21 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.173 3.249 . . . . 0.0 113.578 -166.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 mt -86.45 2.61 47.15 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.171 1.388 . . . . 0.0 112.819 166.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.79 -31.85 73.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.75 1.62 . . . . 0.0 115.094 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.6 m -64.93 120.57 67.82 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.848 -164.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.34 125.98 10.06 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.192 1.928 . . . . 0.0 111.026 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -73.71 176.86 8.8 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.146 2.564 . . . . 0.0 110.765 164.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -58.56 -29.63 66.52 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.605 -1.309 . . . . 0.0 113.323 171.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -57.6 -23.96 53.78 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.022 1.329 . . . . 0.0 114.144 172.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.97 67.04 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.905 -1.122 . . . . 0.0 113.705 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.6 p -65.94 -14.23 61.18 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 171.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.61 -37.54 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.943 1.297 . . . . 0.0 111.343 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.18 -26.06 68.89 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.333 0.968 . . . . 0.0 114.897 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 p -70.15 -15.64 62.98 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -88.0 -41.07 13.37 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.281 1.432 . . . . 0.0 111.731 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.7 -31.34 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.599 1.159 . . . . 0.0 111.895 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.53 -54.65 53.85 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.612 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.66 -29.61 4.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.608 2.205 . . . . 0.0 113.874 170.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 p -70.4 -31.19 68.31 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 121.384 1.902 . . . . 0.0 113.356 -173.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.6 -34.8 74.63 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.077 -1.639 . . . . 0.0 113.517 165.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.2 t -67.02 -32.47 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.941 -1.1 . . . . 0.0 111.315 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -68.4 -44.87 74.14 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.521 1.529 . . . . 0.0 111.868 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -63.07 -37.98 89.37 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.89 1.276 . . . . 0.0 112.737 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 73.1 mt -74.82 13.67 0.61 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.815 1.646 . . . . 0.0 114.633 170.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -141.07 71.17 1.36 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.94 1.296 . . . . 0.0 111.047 160.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 m -61.15 23.26 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 130.46 3.504 . . . . 0.0 118.279 -163.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.73 -32.66 72.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.72 1.608 . . . . 0.0 111.498 167.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -79.04 113.78 38.77 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 117.821 -1.085 . . . . 0.0 108.547 160.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -58.16 128.5 28.93 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.777 1.651 . . . . 0.0 114.141 -160.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -55.24 -51.89 65.14 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.594 1.158 . . . . 0.0 113.677 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.16 -27.23 66.93 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.11 -40.18 8.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.551 1.072 . . . . 0.0 113.414 172.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.7 m -59.58 -35.11 73.64 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.988 0.915 . . . . 0.0 112.652 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.16 -29.5 70.4 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.975 1.31 . . . . 0.0 113.26 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -71.02 -38.79 72.61 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.31 -0.869 . . . . 0.0 111.705 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.84 -39.72 87.73 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.39 -0.819 . . . . 0.0 112.499 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.46 -41.13 93.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.977 0.511 . . . . 0.0 111.8 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.23 -37.09 74.92 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.885 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -65.85 -42.16 90.81 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.654 1.57 . . . . 0.0 112.525 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -62.91 -47.39 83.46 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.573 -0.704 . . . . 0.0 112.029 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.0 mt -70.68 -33.34 70.82 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.988 -1.07 . . . . 0.0 113.166 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -64.08 -43.28 95.9 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.294 1.406 . . . . 0.0 111.967 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.66 -32.58 74.31 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.75 -57.94 3.6 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.994 0.918 . . . . 0.0 112.17 174.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.88 -30.7 69.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.741 1.216 . . . . 0.0 113.946 -168.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.89 -30.93 57.84 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.081 -0.844 . . . . 0.0 113.787 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -100.0 -27.2 13.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.114 0.966 . . . . 0.0 113.526 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.43 -31.17 72.25 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.096 -1.627 . . . . 0.0 113.008 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -66.93 -9.83 42.38 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.3 t -97.31 -42.92 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.864 1.266 . . . . 0.0 111.362 171.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -80.88 -15.57 55.97 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.72 -107.21 2.86 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-O 117.398 -1.779 . . . . 0.0 115.719 157.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.41 -25.26 3.92 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.442 2.761 . . . . 0.0 116.832 -150.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -138.72 162.58 34.33 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.52 1.055 . . . . 0.0 112.225 -166.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.0 tt -77.74 -4.4 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.727 -1.233 . . . . 0.0 113.854 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.65 -4.01 38.27 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.435 1.494 . . . . 0.0 114.882 161.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.2 -127.88 7.98 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.12 1.343 . . . . 0.0 112.976 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -67.21 -21.49 65.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.187 1.795 . . . . 0.0 114.187 -170.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -144.82 150.08 36.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.236 1.815 . . . . 0.0 109.27 -173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 77.9 mt -60.33 111.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.682 0.793 . . . . 0.0 109.488 163.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 p -141.77 -159.86 1.02 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.623 1.169 . . . . 0.0 110.592 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.98 -24.89 7.21 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -166.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.04 -40.27 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 120.113 1.324 . . . . 0.0 112.409 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 -45.63 93.6 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.848 -1.157 . . . . 0.0 111.916 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.9 mt -61.41 -24.96 66.88 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.856 0.462 . . . . 0.0 112.154 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.0 m -85.63 -43.96 13.01 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.214 1.405 . . . . 0.0 113.337 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.6 mt -110.73 -33.07 6.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -161.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.51 99.67 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.22 -23.47 17.9 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 CA-C-N 120.578 1.242 . . . . 0.0 113.881 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.27 -35.29 73.66 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.032 -1.043 . . . . 0.0 111.85 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.39 -36.66 81.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.494 0.718 . . . . 0.0 112.743 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -66.84 -45.82 77.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.648 0.658 . . . . 0.0 112.427 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -62.76 -24.43 67.71 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.534 0.733 . . . . 0.0 112.633 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.8 tp -77.23 -52.51 9.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.401 1.08 . . . . 0.0 112.654 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.27 -34.3 76.28 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.319 0.648 . . . . 0.0 111.869 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.67 -61.32 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.01 -52.26 15.1 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.077 -1.014 . . . . 0.0 112.372 -164.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.9 tp -70.27 -26.91 64.03 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.888 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.83 -26.95 48.88 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.05 1.31 . . . . 0.0 115.408 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -65.23 -20.14 66.29 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -126.32 -33.95 2.55 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.226 1.01 . . . . 0.0 113.67 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -152.64 97.52 2.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.824 1.65 . . . . 0.0 109.009 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -68.44 82.17 0.26 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.42 0.688 . . . . 0.0 110.773 168.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -73.25 120.56 81.67 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.357 1.063 . . . . 0.0 111.059 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.9 128.48 12.43 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.065 1.843 . . . . 0.0 111.189 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 95.3 mt -75.94 103.21 0.96 Allowed Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 155.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -70.61 161.93 44.32 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.744 1.63 . . . . 0.0 112.521 -163.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.19 -24.78 63.4 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.901 1.68 . . . . 0.0 115.477 -170.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -62.13 -25.67 67.87 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.217 1.007 . . . . 0.0 113.367 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.8 mt -83.9 51.77 2.12 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.449 1.9 . . . . 0.0 111.06 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.48 -22.86 62.62 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.376 1.071 . . . . 0.0 113.654 -156.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -74.0 -53.49 9.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.108 1.322 . . . . 0.0 109.833 164.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.28 -37.17 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.204 0.911 . . . . 0.0 112.291 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.57 -35.2 79.65 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -74.9 -31.8 61.67 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.461 -0.774 . . . . 0.0 112.745 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -65.62 -28.74 69.34 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.616 1.167 . . . . 0.0 112.9 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.3 mm -53.86 -39.27 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.086 -1.008 . . . . 0.0 111.719 166.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -82.82 -14.56 54.14 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.658 -1.276 . . . . 0.0 112.625 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.94 -20.34 61.08 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 161.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -61.76 -23.99 66.54 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.366 1.439 . . . . 0.0 113.428 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -85.71 3.56 40.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.796 1.238 . . . . 0.0 112.501 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 p -121.9 177.14 5.41 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -162.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 56.08 -161.34 0.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.531 1.532 . . . . 0.0 110.576 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -87.08 -38.13 16.79 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 125.392 1.477 . . . . 0.0 108.902 156.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -51.62 63.29 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 129.258 3.023 . . . . 0.0 113.274 -168.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -91.31 -44.26 9.29 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -58.19 -32.6 68.41 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -77.9 -21.28 51.47 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 29.3 p -89.34 -15.59 33.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.388 1.075 . . . . 0.0 113.311 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -53.03 132.99 38.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.315 1.046 . . . . 0.0 109.414 163.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -127.56 149.65 50.05 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.53 1.132 . . . . 0.0 111.436 -171.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -54.5 124.84 17.38 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.971 0.908 . . . . 0.0 111.615 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -83.86 -34.3 24.65 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.751 -143.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -37.62 74.81 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.776 1.631 . . . . 0.0 113.022 161.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -79.55 -10.98 59.89 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.6 t -75.15 -48.2 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 120.21 1.368 . . . . 0.0 110.039 161.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.2 mt -63.03 -54.1 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.294 1.038 . . . . 0.0 111.622 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.93 -33.07 73.98 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -173.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -75.22 -23.91 72.67 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 120.843 -1.161 . . . . 0.0 113.399 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -82.61 -25.56 33.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -48.63 -51.47 52.57 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.52 -19.92 54.37 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.817 1.678 . . . . 0.0 113.594 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -87.0 -0.59 56.87 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.653 1.581 . . . . 0.0 114.746 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.14 -21.89 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.361 -0.837 . . . . 0.0 110.879 152.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -96.9 -23.46 16.33 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.863 2.065 . . . . 0.0 113.531 -173.464 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 118.288 -0.863 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.33 -166.19 0.09 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.88 0.872 . . . . 0.0 112.631 -168.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.2 mt -75.4 121.17 21.87 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.068 -1.02 . . . . 0.0 111.18 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.27 118.16 25.39 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.856 1.262 . . . . 0.0 109.64 168.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 mt -107.89 128.33 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.092 1.357 . . . . 0.0 108.626 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.4 m -113.24 116.61 30.04 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.29 142.2 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.705 1.202 . . . . 0.0 110.151 -162.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.688 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.1 tttm -63.13 127.69 32.42 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.078 169.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.71 176.16 9.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.431 1.892 . . . . 0.0 111.916 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.88 140.17 37.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.902 0.881 . . . . 0.0 111.436 164.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.97 124.61 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.07 0.462 . . . . 0.0 110.11 169.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.43 -13.4 22.1 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.03 1.3 . . . . 0.0 116.133 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.69 80.34 66.44 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 119.771 1.786 . . . . 0.0 112.203 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.22 -8.79 15.26 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.943 3.095 . . . . 0.0 116.087 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -79.48 -12.33 59.88 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.0 pt -142.03 162.17 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.675 1.19 . . . . 0.0 112.224 -167.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 mt -76.05 -43.18 45.05 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.59 -120.71 4.45 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.091 1.329 . . . . 0.0 114.211 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -66.03 12.85 0.05 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.579 2.351 . . . . 0.0 117.158 -170.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -115.68 77.07 6.03 Favored Pre-proline 0 C--O 1.27 2.179 0 O-C-N 119.634 -1.916 . . . . 0.0 110.938 -155.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.74 -24.2 25.48 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 124.483 3.455 . . . . 0.0 113.713 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -66.01 -42.62 89.47 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.433 1.093 . . . . 0.0 112.641 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.0 m -62.55 -42.92 99.84 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 119.144 -2.223 . . . . 0.0 111.022 170.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -65.06 -23.59 67.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 117.084 -1.436 . . . . 0.0 113.004 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -56.19 -47.23 78.74 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.36 1.436 . . . . 0.0 112.412 170.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.98 -41.13 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.09 1.356 . . . . 0.0 111.284 -171.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.88 -36.24 72.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.375 0.67 . . . . 0.0 111.289 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.21 -41.35 98.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.156 0.982 . . . . 0.0 113.63 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 p -69.1 -40.52 78.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.338 1.426 . . . . 0.0 112.487 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -75.84 -33.69 60.05 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -76.64 -19.77 57.43 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -76.18 -35.93 58.9 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.516 -1.365 . . . . 0.0 112.961 163.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -74.05 -2.27 23.6 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 167.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt 60.28 13.61 4.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 127.309 2.243 . . . . 0.0 115.286 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.2 mt -80.3 129.12 70.68 Favored Pre-proline 0 CA--C 1.541 0.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.963 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.0 148.71 51.62 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.555 2.17 . . . . 0.0 112.331 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -147.04 157.55 43.65 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.172 1.389 . . . . 0.0 111.428 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -90.85 97.59 11.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.424 1.09 . . . . 0.0 110.152 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.6 t -80.61 137.79 36.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -129.75 93.06 3.44 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.297 1.839 . . . . 0.0 110.563 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.1 mt -70.14 133.35 47.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.323 1.449 . . . . 0.0 111.015 170.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.39 118.74 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.884 1.673 . . . . 0.0 110.235 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -93.29 107.53 19.34 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.738 0.815 . . . . 0.0 109.92 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.6 mt 53.64 20.26 2.1 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 171.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.15 25.7 12.33 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 119.123 -0.821 . . . . 0.0 115.037 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.99 9.05 0.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.39 1.595 . . . . 0.0 115.19 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -140.19 143.6 34.32 Favored Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 126.518 1.927 . . . . 0.0 109.781 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.59 175.9 3.94 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.383 2.722 . . . . 0.0 113.129 -170.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -57.75 -20.64 36.36 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -174.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -59.19 -12.32 5.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.607 1.963 . . . . 0.0 116.099 171.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.83 -0.93 15.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.891 2.076 . . . . 0.0 113.029 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 mt -127.29 -39.27 1.9 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.241 2.217 . . . . 0.0 112.689 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -59.83 -12.0 6.54 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.328 2.651 . . . . 0.0 114.888 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.543 HD11 ' HE3' ' A' ' 64' ' ' LYS . 11.0 mt -65.51 -21.19 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 127.566 2.347 . . . . 0.0 111.43 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.1 p -106.54 147.63 35.32 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 121.626 -0.671 . . . . 0.0 110.606 157.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.78 -11.59 32.59 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.848 2.365 . . . . 0.0 113.856 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -103.42 7.17 38.02 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.014 1.326 . . . . 0.0 112.97 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.13 14.03 67.89 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.047 -1.033 . . . . 0.0 114.924 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -76.43 162.86 27.5 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.786 1.634 . . . . 0.0 112.141 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.23 151.29 73.12 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.775 2.03 . . . . 0.0 108.075 154.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.77 146.75 79.66 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 N-CA-C 116.848 1.826 . . . . 0.0 116.848 11.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -156.77 169.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 128.717 2.807 . . . . 0.0 110.735 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.5 150.39 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.635 -1.291 . . . . 0.0 114.267 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HE3' HD11 ' A' ' 54' ' ' ILE . 86.3 mttt -102.79 123.78 47.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.976 1.71 . . . . 0.0 109.085 162.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.5 mt -104.8 84.87 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.182 1.393 . . . . 0.0 108.744 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 56.04 57.89 4.76 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.743 -164.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.267 61.7 m-20 64.55 -7.03 0.26 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 117.333 2.346 . . . . 0.0 117.333 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -79.86 119.23 22.45 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.684 -1.26 . . . . 0.0 110.16 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -70.98 146.59 49.34 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.0 t -142.68 130.74 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.484 1.913 . . . . 0.0 109.531 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.57 -155.92 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.692 1.997 . . . . 0.0 114.119 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -44.16 153.12 0.15 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.908 2.083 . . . . 0.0 115.707 -161.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.1 p -50.88 -26.48 5.89 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -86.95 -12.52 47.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.06 -19.82 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.128 0.971 . . . . 0.0 113.137 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -54.34 -38.11 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.201 1.4 . . . . 0.0 112.651 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.65 -8.23 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.32 -55.24 0.64 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.914 0.769 . . . . 0.0 113.005 156.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.0 mt -74.19 -30.26 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.402 1.101 . . . . 0.0 113.631 -163.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.1 tp -73.25 -44.49 59.32 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.743 -1.223 . . . . 0.0 110.611 167.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -67.47 -26.53 66.42 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.516 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 26.1 tt0 -67.66 -46.03 73.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.819 2.048 . . . . 0.0 112.978 167.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 94.3 mttt -93.82 -13.12 27.66 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.461 1.105 . . . . 0.0 113.507 -167.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -86.72 133.11 40.43 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.789 1.636 . . . . 0.0 109.907 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.1 -15.26 25.89 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.244 1.962 . . . . 0.0 115.602 -168.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -76.27 143.9 73.87 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 119.666 1.121 . . . . 0.0 111.341 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -55.85 130.42 40.24 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.787 2.325 . . . . 0.0 114.336 -171.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -61.13 134.41 52.48 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.592 2.861 . . . . 0.0 113.574 -165.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.4 mt -81.86 -0.12 42.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.724 1.61 . . . . 0.0 112.513 165.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.48 -27.53 67.1 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.858 1.663 . . . . 0.0 114.935 -174.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.3 m -66.05 122.16 79.73 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.325 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.53 133.77 14.67 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.106 1.871 . . . . 0.0 111.451 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.93 175.14 11.22 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.924 2.416 . . . . 0.0 110.58 160.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -57.07 -31.56 65.33 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.552 -1.342 . . . . 0.0 113.344 171.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -63.18 -17.6 62.58 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.268 1.427 . . . . 0.0 113.812 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.64 -21.99 66.86 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.665 -1.272 . . . . 0.0 113.503 171.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.1 p -64.24 -12.65 43.01 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.9 t -119.27 -36.67 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.143 1.377 . . . . 0.0 111.475 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.8 -27.47 70.13 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 120.828 -1.17 . . . . 0.0 114.718 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.8 p -69.54 -18.76 63.68 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 170.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -84.22 -43.22 15.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.86 1.264 . . . . 0.0 111.501 168.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -66.9 -33.71 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.907 0.883 . . . . 0.0 111.855 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -59.46 -53.08 69.5 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.278 -1.344 . . . . 0.0 113.654 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.21 -29.86 4.69 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.8 2.333 . . . . 0.0 114.214 170.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 p -69.1 -29.93 68.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.992 1.724 . . . . 0.0 112.771 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -67.28 -38.64 85.38 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.798 -1.189 . . . . 0.0 113.739 164.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.39 -40.75 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-N 120.108 1.322 . . . . 0.0 110.806 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -65.8 -42.3 90.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.531 1.132 . . . . 0.0 112.416 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -65.94 -36.45 83.39 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.192 0.997 . . . . 0.0 113.09 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.0 mt -76.62 9.26 2.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.675 1.59 . . . . 0.0 113.7 168.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -130.5 55.74 1.8 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.402 1.881 . . . . 0.0 109.688 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 m -65.45 26.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 129.674 3.19 . . . . 0.0 117.532 -151.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.02 -22.65 39.22 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.516 1.526 . . . . 0.0 112.285 164.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.5 123.02 85.66 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 117.512 -1.232 . . . . 0.0 107.725 151.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -63.33 110.94 1.31 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 CA-C-N 121.126 1.438 . . . . 0.0 112.374 -171.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -50.08 -44.31 51.77 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -173.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -63.86 -20.62 65.96 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.42 -38.96 6.1 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.312 1.434 . . . . 0.0 113.356 167.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 m -57.44 -41.7 81.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.401 1.08 . . . . 0.0 111.956 174.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -62.37 -30.94 71.55 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.182 1.793 . . . . 0.0 113.251 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -67.5 -41.52 84.36 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.512 -0.743 . . . . 0.0 111.25 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.45 80.8 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.37 -0.832 . . . . 0.0 112.872 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.47 -36.42 83.7 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.72 -0.613 . . . . 0.0 112.468 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.3 -38.48 81.67 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.448 1.022 . . . . 0.0 112.223 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -64.97 -41.3 95.56 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.194 1.361 . . . . 0.0 112.732 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -64.47 -50.48 67.32 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.585 -0.697 . . . . 0.0 112.066 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.03 -30.91 68.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.823 -1.173 . . . . 0.0 113.236 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -63.24 -43.98 96.51 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.613 1.551 . . . . 0.0 112.053 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.85 72.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -73.84 -57.97 3.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.218 1.007 . . . . 0.0 112.05 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -66.97 -33.73 76.21 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.493 1.517 . . . . 0.0 113.856 -169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -56.26 -30.18 57.67 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.956 -0.913 . . . . 0.0 114.042 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 100.0 m-70 -104.15 -24.09 13.2 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.53 -34.04 76.9 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.264 1.393 . . . . 0.0 113.025 171.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -62.6 -13.75 34.98 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.34 -30.98 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.863 1.265 . . . . 0.0 112.057 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -97.96 -11.46 23.06 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.02 -123.59 6.03 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 117.27 -1.85 . . . . 0.0 115.473 155.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.5 -20.4 8.18 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.876 3.051 . . . . 0.0 117.282 -153.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -131.42 160.04 36.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.915 1.234 . . . . 0.0 112.465 -167.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.9 tt -76.18 -1.43 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.814 -1.179 . . . . 0.0 113.486 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -105.13 -0.65 26.39 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 162.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 117.58 -127.61 7.44 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 120.163 1.347 . . . . 0.0 113.487 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.3 -26.06 62.7 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.488 1.515 . . . . 0.0 113.84 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -131.12 151.48 51.4 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.238 1.815 . . . . 0.0 109.947 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.74 113.36 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.713 0.805 . . . . 0.0 108.948 163.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -141.57 -158.52 0.87 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.843 0.857 . . . . 0.0 110.959 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.32 -23.6 24.55 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -165.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.23 -39.0 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.595 1.089 . . . . 0.0 112.234 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.77 -45.84 92.17 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.575 1.08 . . . . 0.0 112.177 167.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.89 -26.15 67.23 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.5 m -82.21 -54.68 5.06 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.613 1.165 . . . . 0.0 112.326 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 34.0 mt -98.54 -33.09 11.13 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -160.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.08 -47.99 97.69 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.14 -26.47 14.84 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 120.908 1.36 . . . . 0.0 113.272 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -69.7 -34.95 74.64 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.289 172.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.11 -39.29 89.84 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.955 0.902 . . . . 0.0 112.418 171.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -64.95 -45.61 85.01 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.596 0.634 . . . . 0.0 112.201 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -61.61 -27.5 68.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.444 0.697 . . . . 0.0 112.346 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.8 tp -79.44 -46.71 16.98 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.28 -32.19 72.02 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.817 0.735 . . . . 0.0 111.593 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.5 t -90.07 -61.84 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.9 -50.33 20.66 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.22 -0.925 . . . . 0.0 112.809 -164.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 40.7 tp -71.93 -30.68 65.59 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 119.219 -0.42 . . . . 0.0 111.574 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.6 -26.76 60.31 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -64.13 -18.85 64.83 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.229 1.412 . . . . 0.0 114.58 171.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -124.8 -36.95 2.52 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.67 1.188 . . . . 0.0 113.42 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -151.91 94.24 1.94 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.255 1.822 . . . . 0.0 108.834 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -68.08 88.65 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.996 -0.44 . . . . 0.0 111.048 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -69.37 117.54 53.52 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.59 1.156 . . . . 0.0 111.269 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.86 111.79 3.38 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.012 1.808 . . . . 0.0 110.878 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.6 108.6 2.26 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 159.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -69.17 161.52 45.51 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.601 1.534 . . . . 0.0 112.246 -169.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.94 -26.47 64.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.549 1.539 . . . . 0.0 114.236 -176.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -65.32 -23.6 67.06 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.3 mt -85.65 50.08 1.89 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.879 1.671 . . . . 0.0 111.342 171.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -27.23 65.3 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -156.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -73.01 -50.95 20.17 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.829 1.195 . . . . 0.0 110.198 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.37 -40.22 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.883 0.765 . . . . 0.0 111.985 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.5 -41.72 96.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.475 1.11 . . . . 0.0 113.227 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -69.28 -35.14 75.73 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.373 -0.829 . . . . 0.0 112.395 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -65.47 -25.5 67.52 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.497 1.119 . . . . 0.0 112.984 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.8 mm -55.26 -37.53 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.016 -1.052 . . . . 0.0 111.785 166.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -84.52 -15.04 47.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.418 -1.426 . . . . 0.0 113.161 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 94.2 mt -73.13 -16.59 61.45 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 163.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 54.5 mt -63.47 -21.09 66.11 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.652 1.114 . . . . 0.0 113.476 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -94.95 4.97 53.2 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.424 1.49 . . . . 0.0 111.966 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -108.31 172.71 6.68 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.154 1.382 . . . . 0.0 114.627 -168.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 53.57 -157.47 0.17 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.819 1.648 . . . . 0.0 110.8 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -88.4 -38.98 14.63 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 127.573 2.349 . . . . 0.0 108.551 161.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.86 -53.63 52.82 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 129.216 3.007 . . . . 0.0 113.432 -167.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -90.27 -42.15 11.15 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -57.75 -34.86 69.98 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -76.32 -22.79 54.53 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 30.1 p -85.38 -16.35 40.14 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.287 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -49.73 137.89 15.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.318 1.047 . . . . 0.0 109.767 165.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -135.97 146.43 47.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.678 0.791 . . . . 0.0 111.701 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -49.26 114.45 1.03 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.358 1.463 . . . . 0.0 111.809 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.82 -32.58 74.14 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -153.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -59.19 -38.99 81.19 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.98 1.312 . . . . 0.0 113.053 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -81.74 -10.17 59.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.7 t -76.01 -43.85 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.07 0.85 . . . . 0.0 109.796 163.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.8 mt -66.97 -57.12 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.207 1.403 . . . . 0.0 111.819 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.27 67.98 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.47 -24.16 59.31 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.736 -1.227 . . . . 0.0 113.627 171.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -75.22 -34.73 61.5 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.096 1.448 . . . . 0.0 113.225 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -43.6 -53.04 12.78 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -174.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.34 -28.1 55.04 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 121.838 1.692 . . . . 0.0 113.811 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -82.38 0.59 41.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.476 1.91 . . . . 0.0 114.504 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.81 -25.79 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.523 0.729 . . . . 0.0 110.776 156.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -115.68 -41.27 3.25 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.165 1.386 . . . . 0.0 114.273 174.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 CA-C-O 115.924 -1.988 . . . . 0.0 114.361 -173.596 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.73 -170.07 0.05 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.083 1.353 . . . . 0.0 112.934 -169.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.8 mt -71.28 117.07 12.34 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.047 -1.033 . . . . 0.0 111.126 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -120.36 121.91 39.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.852 1.261 . . . . 0.0 109.592 167.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 37' ' ' TYR . 38.0 mt -109.52 131.98 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.921 1.288 . . . . 0.0 108.126 -174.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.6 m -112.53 128.49 56.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 166.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.55 142.14 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.509 1.123 . . . . 0.0 109.697 -164.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.758 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 32.1 tttm -63.91 128.19 34.72 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.616 170.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.66 175.85 9.82 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.904 2.082 . . . . 0.0 112.041 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.48 141.49 30.79 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.818 0.847 . . . . 0.0 111.555 164.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.39 124.5 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 120.995 0.426 . . . . 0.0 110.157 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.19 -16.68 15.57 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.984 1.278 . . . . 0.0 116.056 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.53 84.57 61.32 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.834 1.817 . . . . 0.0 112.245 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.71 -11.57 27.2 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.008 3.139 . . . . 0.0 115.755 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -79.72 -13.61 59.34 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.1 pt -141.05 160.28 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.513 1.125 . . . . 0.0 112.22 -164.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.4 mt -72.22 -47.83 47.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.2 -124.82 5.54 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.967 1.27 . . . . 0.0 114.716 -171.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.04 10.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.67 2.788 . . . . 0.0 117.964 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -112.8 76.66 2.25 Favored Pre-proline 0 C--O 1.268 2.041 0 CA-C-N 121.182 1.81 . . . . 0.0 111.02 -155.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.69 -24.91 34.55 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 124.13 3.22 . . . . 0.0 113.193 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -67.34 -40.98 85.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.262 1.025 . . . . 0.0 112.746 171.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.758 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.4 m -59.75 -43.54 94.22 Favored 'General case' 0 C--N 1.376 1.729 0 O-C-N 119.688 -1.882 . . . . 0.0 111.031 168.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -66.26 -23.5 66.41 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 117.147 -1.406 . . . . 0.0 113.009 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -56.11 -46.06 79.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 120.359 1.436 . . . . 0.0 112.288 170.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.8 t -72.99 -40.45 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.164 1.386 . . . . 0.0 111.586 -172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.9 -37.95 72.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.681 0.792 . . . . 0.0 111.314 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.1 -43.52 95.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.808 1.243 . . . . 0.0 113.175 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 p -70.44 -40.64 73.64 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.533 1.06 . . . . 0.0 112.751 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.26 -32.04 64.46 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -78.23 -25.73 47.07 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 172.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -68.47 -39.02 81.56 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.569 -1.332 . . . . 0.0 111.829 165.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -74.04 -2.12 22.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.257 1.423 . . . . 0.0 114.826 168.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm 61.57 10.42 3.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 127.447 2.299 . . . . 0.0 115.798 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.458 ' CD1' HD21 ' A' ' 84' ' ' ASN . 42.4 mt -79.61 129.85 69.94 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 121.332 -0.855 . . . . 0.0 109.943 -170.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.67 145.21 51.3 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.371 2.047 . . . . 0.0 112.04 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.402 ' CD1' HD12 ' A' ' 5' ' ' ILE . 14.5 p90 -144.93 155.61 43.52 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.808 1.243 . . . . 0.0 111.492 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.43 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 46.0 tttt -89.63 94.1 9.73 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.065 1.346 . . . . 0.0 110.242 175.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.2 t -80.99 138.47 36.06 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.43 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 75.6 m-70 -129.47 94.15 3.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.328 1.851 . . . . 0.0 110.746 172.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.0 mt -70.5 134.98 48.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.733 1.213 . . . . 0.0 111.061 170.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.1 mt -130.89 117.54 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.973 1.709 . . . . 0.0 110.467 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -88.83 101.96 14.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.542 0.737 . . . . 0.0 109.638 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.8 mt 54.54 23.48 4.63 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 166.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.51 24.37 10.19 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.291 0.876 . . . . 0.0 115.291 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.48 -0.1 1.23 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.437 1.619 . . . . 0.0 114.868 171.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -130.55 142.21 44.69 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 125.57 1.548 . . . . 0.0 110.024 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.78 176.1 3.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.358 2.705 . . . . 0.0 112.967 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -57.96 -19.83 33.42 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 116.509 -1.71 . . . . 0.0 114.917 -174.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -57.61 -16.46 10.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.117 2.167 . . . . 0.0 116.022 170.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -111.93 1.01 16.27 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.738 2.015 . . . . 0.0 112.871 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.8 mt -126.24 -39.85 2.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.2 2.2 . . . . 0.0 112.626 -171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -57.12 -15.85 6.39 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 128.57 2.748 . . . . 0.0 114.725 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.524 HD11 ' HE3' ' A' ' 64' ' ' LYS . 8.8 mt -63.01 -21.54 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 127.696 2.398 . . . . 0.0 111.233 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.5 p -106.8 145.76 31.72 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.323 0.649 . . . . 0.0 110.736 153.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.73 -15.28 44.03 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.768 2.312 . . . . 0.0 113.467 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -89.85 -6.04 56.25 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.674 1.59 . . . . 0.0 113.263 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.61 11.11 72.35 Favored Glycine 0 CA--C 1.539 1.588 0 O-C-N 120.842 -1.161 . . . . 0.0 115.021 -175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -73.96 160.39 31.41 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.862 1.665 . . . . 0.0 111.641 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.39 148.31 63.6 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 126.604 1.962 . . . . 0.0 107.899 160.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.5 152.12 93.14 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 N-CA-C 116.717 1.776 . . . . 0.0 116.717 13.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.1 m -158.63 165.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 128.444 2.698 . . . . 0.0 110.289 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.19 150.82 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 120.661 -1.274 . . . . 0.0 114.229 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HE3' HD11 ' A' ' 54' ' ' ILE . 85.4 mttt -104.55 113.78 27.58 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.118 1.767 . . . . 0.0 109.092 164.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.1 mt -88.16 80.84 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.858 1.263 . . . . 0.0 108.654 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t70 58.59 58.83 3.16 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.753 0.787 . . . . 0.0 111.584 -168.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.256 49.0 m-20 65.69 -5.72 0.47 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.874 2.175 . . . . 0.0 116.874 -175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -84.61 114.54 22.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.931 1.292 . . . . 0.0 110.047 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -71.07 150.65 45.31 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -166.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.0 t -142.02 134.03 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.916 2.086 . . . . 0.0 109.132 165.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.78 -153.23 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.143 1.777 . . . . 0.0 113.467 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -33.91 156.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.826 2.05 . . . . 0.0 116.233 -170.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 p -48.95 -26.83 2.72 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.007 1.323 . . . . 0.0 114.224 160.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -94.35 -8.55 38.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.026 1.33 . . . . 0.0 113.142 -170.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.15 -21.32 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.43 1.092 . . . . 0.0 113.013 159.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mt -54.74 -38.82 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.598 1.559 . . . . 0.0 112.315 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.33 -6.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.45 -59.81 0.52 Allowed Glycine 0 CA--C 1.534 1.227 0 CA-C-N 119.037 0.835 . . . . 0.0 112.303 155.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.91 -35.76 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.443 -1.033 . . . . 0.0 113.648 -163.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.9 tp -72.64 -46.04 55.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.979 0.809 . . . . 0.0 111.075 172.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.94 -28.47 69.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.92 -36.33 81.99 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.133 1.373 . . . . 0.0 114.245 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -111.19 -15.42 13.66 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.866 1.266 . . . . 0.0 113.168 -160.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.458 HD21 ' CD1' ' A' ' 35' ' ' ILE . 27.9 t-20 -75.19 136.99 72.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.026 1.73 . . . . 0.0 109.698 164.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.04 -20.37 21.9 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.345 2.03 . . . . 0.0 115.113 -169.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -72.34 150.02 91.66 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.11 0.868 . . . . 0.0 111.246 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -55.52 130.86 42.81 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.681 2.254 . . . . 0.0 113.478 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.99 137.97 83.59 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.742 2.961 . . . . 0.0 112.775 -167.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -86.88 -3.61 59.09 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.689 0.795 . . . . 0.0 112.731 164.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.07 81.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.041 1.336 . . . . 0.0 114.042 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.4 m -63.14 114.53 12.93 Favored Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 123.447 0.699 . . . . 0.0 110.876 -166.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.3 136.81 14.55 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.009 1.806 . . . . 0.0 111.561 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.95 174.41 12.82 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.951 2.434 . . . . 0.0 110.43 156.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -27.0 62.86 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 168.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -54.57 -24.88 22.97 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.457 -1.402 . . . . 0.0 114.03 169.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.79 68.75 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.854 -1.154 . . . . 0.0 113.664 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.2 p -72.66 -3.42 24.86 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.007 1.276 . . . . 0.0 114.025 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.1 -38.46 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.166 1.386 . . . . 0.0 110.788 170.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.64 -28.55 68.06 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.254 0.93 . . . . 0.0 114.971 173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.6 p -67.79 -17.24 64.46 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.721 1.26 . . . . 0.0 114.144 173.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -91.44 -40.65 11.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.744 1.618 . . . . 0.0 111.758 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.4 mt -65.14 -32.28 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.251 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -57.06 -55.65 41.8 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.131 -1.414 . . . . 0.0 113.845 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -77.87 -29.62 4.24 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.626 2.217 . . . . 0.0 113.989 170.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.9 p -68.94 -32.65 72.41 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.723 1.602 . . . . 0.0 112.893 -173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -66.48 -37.78 85.86 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.901 -1.125 . . . . 0.0 113.619 166.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.57 -39.03 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.583 1.083 . . . . 0.0 110.982 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -68.13 -40.86 82.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.563 1.145 . . . . 0.0 112.542 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -66.5 -36.93 83.93 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.994 0.918 . . . . 0.0 112.626 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.3 mt -75.46 21.35 0.14 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.46 1.504 . . . . 0.0 113.621 166.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.8 tttt -144.43 54.71 1.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.599 2.36 . . . . 0.0 110.159 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.8 p -62.0 26.96 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 130.396 3.478 . . . . 0.0 118.203 -160.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -75.43 -25.56 57.62 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.295 -1.503 . . . . 0.0 112.093 157.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.04 120.84 79.12 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 117.485 -1.245 . . . . 0.0 107.88 155.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -63.06 115.56 3.03 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 121.029 1.403 . . . . 0.0 112.574 -169.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -46.45 -51.38 15.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.381 1.472 . . . . 0.0 114.351 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.07 -15.06 61.95 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -93.96 -42.77 4.0 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.456 1.503 . . . . 0.0 113.403 166.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.9 m -57.6 -40.3 78.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.617 1.167 . . . . 0.0 112.025 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.21 -30.25 70.32 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.498 1.919 . . . . 0.0 113.388 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -68.59 -39.72 80.79 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.366 -0.834 . . . . 0.0 111.343 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.72 -36.31 78.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.505 -0.747 . . . . 0.0 112.781 172.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.18 -38.27 88.45 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.776 -0.577 . . . . 0.0 112.197 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.38 -35.51 79.47 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.176 0.898 . . . . 0.0 112.667 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -66.67 -43.47 84.43 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.294 1.406 . . . . 0.0 112.559 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -64.82 -45.28 86.84 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.628 -0.67 . . . . 0.0 112.43 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.0 mt -72.42 -31.71 65.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.369 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -62.54 -42.85 99.79 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 120.771 1.623 . . . . 0.0 111.875 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.34 -26.81 68.2 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 tp -81.06 -54.53 5.47 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.203 1.001 . . . . 0.0 111.763 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.37 -33.85 75.0 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.869 1.268 . . . . 0.0 114.053 -168.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.19 -28.38 66.64 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.723 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -96.89 -29.83 13.48 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.176 0.991 . . . . 0.0 113.381 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.4 mt -62.65 -33.59 75.35 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.289 -1.507 . . . . 0.0 112.841 175.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -68.57 -1.25 6.33 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.82 -44.94 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.269 1.428 . . . . 0.0 111.458 165.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -93.99 5.48 51.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -168.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.11 -165.18 26.46 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 116.191 1.236 . . . . 0.0 116.191 158.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.35 -8.73 19.9 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.768 3.645 . . . . 0.0 117.808 -136.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -118.07 165.42 13.77 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.858 -1.151 . . . . 0.0 110.746 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.253 0.9 OUTLIER -75.75 -0.18 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 120.225 -1.547 . . . . 0.0 112.898 -172.226 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.54 9.43 29.49 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 128.006 2.522 . . . . 0.0 114.567 162.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.24 -128.36 9.36 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.939 1.256 . . . . 0.0 113.589 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -62.07 -23.93 66.79 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -136.61 148.06 47.27 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.393 1.477 . . . . 0.0 109.743 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.59 118.13 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.321 1.048 . . . . 0.0 109.555 163.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.5 p -142.55 -161.79 1.31 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.157 0.983 . . . . 0.0 111.544 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.4 -23.32 3.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.126 1.77 . . . . 0.0 115.319 -172.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.78 -43.79 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.824 1.193 . . . . 0.0 111.506 174.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.18 -43.21 98.87 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.92 -1.112 . . . . 0.0 111.97 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.3 mt -61.74 -24.61 66.92 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.1 m -85.76 -39.78 16.78 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.689 1.195 . . . . 0.0 113.174 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.0 mt -114.04 -34.6 5.34 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -164.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.34 -46.77 99.76 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -168.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.03 -21.88 15.34 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 120.723 1.294 . . . . 0.0 113.752 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -68.72 -36.45 78.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.926 -1.109 . . . . 0.0 111.628 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.11 -38.85 92.55 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.648 0.658 . . . . 0.0 112.343 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -65.21 -46.57 80.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 173.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -61.55 -31.12 71.14 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.267 0.627 . . . . 0.0 112.173 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.1 tp -76.66 -45.55 29.37 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.316 1.046 . . . . 0.0 113.418 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.62 -35.11 75.34 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.238 0.615 . . . . 0.0 111.635 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.4 t -89.08 -59.86 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.44 -48.55 22.26 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.294 -0.879 . . . . 0.0 113.11 -166.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.6 tp -73.74 -33.73 64.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.428 172.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.98 -26.05 60.34 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.888 -0.951 . . . . 0.0 115.345 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -62.92 -20.75 65.48 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.375 1.47 . . . . 0.0 114.599 170.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -123.87 -35.77 2.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.614 1.166 . . . . 0.0 113.432 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -150.79 98.91 2.67 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.444 1.898 . . . . 0.0 108.714 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -68.81 88.16 0.37 Allowed 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.972 -0.455 . . . . 0.0 110.504 168.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -70.04 116.64 46.22 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.194 0.997 . . . . 0.0 110.747 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.93 120.58 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.008 1.805 . . . . 0.0 111.035 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.25 109.21 4.46 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 155.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -69.24 166.01 28.42 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.676 1.584 . . . . 0.0 112.444 -170.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -26.89 63.75 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.736 1.615 . . . . 0.0 113.676 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -64.79 -26.46 68.36 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.615 1.166 . . . . 0.0 113.779 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.9 mt -89.86 50.24 1.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.293 1.837 . . . . 0.0 111.169 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -30.22 70.73 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.533 1.133 . . . . 0.0 113.504 -157.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -76.82 -45.39 28.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.535 1.061 . . . . 0.0 111.525 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 62.4 t -60.61 -38.76 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 118.851 0.75 . . . . 0.0 111.588 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.3 tp -64.65 -43.44 93.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.756 1.222 . . . . 0.0 113.187 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -68.48 -34.47 75.99 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.392 -0.817 . . . . 0.0 112.703 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.2 -28.4 70.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.174 0.99 . . . . 0.0 112.949 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 43.5 mm -54.21 -37.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.123 -0.985 . . . . 0.0 111.905 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -86.07 -11.79 51.86 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.565 -1.334 . . . . 0.0 113.831 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.5 mt -72.27 -21.6 61.34 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 117.89 -1.053 . . . . 0.0 113.35 162.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 58.4 mt -62.19 -23.16 66.46 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.566 1.076 . . . . 0.0 113.232 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -90.61 13.24 16.49 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.581 1.552 . . . . 0.0 112.83 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.1 p -132.64 176.59 8.32 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.228 1.411 . . . . 0.0 114.511 -167.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 53.62 -167.87 0.06 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.919 1.688 . . . . 0.0 110.846 -166.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -76.03 -42.83 46.63 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.085 1.354 . . . . 0.0 109.622 153.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -52.08 46.62 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 128.308 2.643 . . . . 0.0 113.081 -165.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -91.9 -44.84 8.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.746 0.419 . . . . 0.0 112.015 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -61.94 -28.12 69.31 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -172.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.86 -22.35 50.01 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.645 1.111 . . . . 0.0 113.619 171.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 26.8 p -89.32 -14.48 35.61 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.601 1.16 . . . . 0.0 113.595 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -51.86 130.92 30.3 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.573 1.149 . . . . 0.0 109.315 163.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -126.08 142.51 51.49 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.095 0.958 . . . . 0.0 111.418 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -52.43 120.27 5.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.537 1.135 . . . . 0.0 111.994 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.7 mp0 -67.91 -34.89 77.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.647 1.179 . . . . 0.0 113.883 -148.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -60.34 -37.18 79.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.832 1.253 . . . . 0.0 112.853 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -79.41 -9.82 59.68 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.604 -1.31 . . . . 0.0 114.03 174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.8 t -79.94 -44.0 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 118.912 0.778 . . . . 0.0 110.068 164.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.3 mt -65.93 -57.7 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.332 1.453 . . . . 0.0 111.633 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.72 69.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.715 0.806 . . . . 0.0 112.994 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.53 -22.67 59.8 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 120.781 -1.199 . . . . 0.0 113.96 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -72.86 -35.95 67.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.654 1.727 . . . . 0.0 112.619 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -44.34 -53.12 14.95 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -171.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.77 -27.55 59.79 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 122.085 1.78 . . . . 0.0 113.691 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -85.16 1.12 49.39 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.247 1.819 . . . . 0.0 114.416 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.3 -24.44 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.428 0.691 . . . . 0.0 110.31 156.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -120.7 -37.15 3.04 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.928 1.291 . . . . 0.0 113.861 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 115.135 -2.364 . . . . 0.0 114.5 -179.716 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.45 -169.49 0.06 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.991 1.316 . . . . 0.0 112.815 -167.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.42 116.04 10.3 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.938 -1.101 . . . . 0.0 110.956 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -120.19 115.37 23.51 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.849 1.26 . . . . 0.0 109.756 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 mt -103.35 136.75 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.094 1.358 . . . . 0.0 108.378 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.8 m -117.15 126.31 52.61 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 166.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.12 140.06 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.483 1.113 . . . . 0.0 109.98 -164.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.675 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.5 tttm -64.69 127.49 31.75 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.684 -0.635 . . . . 0.0 109.465 171.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.49 176.78 8.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.641 1.977 . . . . 0.0 112.223 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.72 140.49 29.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.924 0.89 . . . . 0.0 111.737 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.24 121.76 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.018 0.437 . . . . 0.0 109.952 167.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.54 -9.41 50.23 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.005 1.288 . . . . 0.0 116.307 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.31 84.36 24.15 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 119.999 1.899 . . . . 0.0 112.392 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.69 -10.68 27.47 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.237 2.625 . . . . 0.0 116.437 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -77.38 -11.51 59.85 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.2 pt -143.2 161.21 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.867 1.267 . . . . 0.0 112.197 -165.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.4 mt -76.19 -43.94 40.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.3 -126.18 8.93 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.761 1.172 . . . . 0.0 114.764 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.25 13.38 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.747 2.819 . . . . 0.0 117.461 -172.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -116.9 71.42 5.43 Favored Pre-proline 0 C--O 1.266 1.937 0 O-C-N 119.808 -1.808 . . . . 0.0 110.998 -156.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.0 -22.03 31.57 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.843 3.029 . . . . 0.0 113.365 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -67.64 -39.66 84.61 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.361 -0.837 . . . . 0.0 112.63 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.9 m -60.3 -42.72 96.1 Favored 'General case' 0 C--N 1.379 1.869 0 O-C-N 119.8 -1.812 . . . . 0.0 110.98 168.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -64.63 -25.7 68.08 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.182 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -55.3 -45.03 76.25 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 120.212 1.369 . . . . 0.0 112.545 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.5 t -73.22 -38.69 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.344 1.458 . . . . 0.0 111.727 -172.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.19 -38.46 69.07 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.663 0.785 . . . . 0.0 111.307 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.77 -43.32 98.19 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.146 1.379 . . . . 0.0 113.18 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 p -70.31 -40.58 74.12 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.627 1.103 . . . . 0.0 112.727 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.49 -32.64 68.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -78.74 -23.94 45.14 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -69.84 -37.77 76.27 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.404 -1.435 . . . . 0.0 112.184 164.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' A' ' 86' ' ' GLU . 76.7 mttt -74.58 -4.34 36.47 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.79 1.636 . . . . 0.0 114.46 168.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm 60.23 15.97 5.73 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 127.063 2.145 . . . . 0.0 115.356 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -81.56 132.08 56.24 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.142 -0.973 . . . . 0.0 110.31 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.58 142.22 43.8 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.513 2.142 . . . . 0.0 112.138 171.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -143.72 156.28 44.47 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.041 1.336 . . . . 0.0 111.559 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 43.6 tttt -90.76 99.72 12.7 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.807 1.243 . . . . 0.0 110.004 173.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -83.57 129.29 34.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.401 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 86.8 m-70 -111.87 98.86 7.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.945 1.698 . . . . 0.0 110.353 164.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.1 mt -74.02 132.54 42.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.099 0.96 . . . . 0.0 111.533 166.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 93.6 mt -129.45 115.87 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.117 1.767 . . . . 0.0 109.866 -170.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -82.4 109.0 16.25 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.428 -0.795 . . . . 0.0 109.765 169.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.7 mt 51.4 26.1 2.95 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 168.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.76 22.51 15.8 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.232 0.853 . . . . 0.0 115.232 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -66.44 18.78 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -138.8 148.82 59.72 Favored Pre-proline 0 N--CA 1.474 0.758 0 C-N-CA 126.005 1.722 . . . . 0.0 110.32 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.18 173.48 5.05 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.785 2.323 . . . . 0.0 112.472 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -57.1 -18.95 16.84 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -55.59 -15.49 2.97 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.241 2.217 . . . . 0.0 116.248 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -116.46 3.51 13.24 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.737 2.015 . . . . 0.0 113.375 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.1 mt -128.83 -39.26 1.61 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.558 2.343 . . . . 0.0 112.423 -171.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.76 -14.55 5.98 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 128.89 2.876 . . . . 0.0 114.769 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.552 HD11 ' HE3' ' A' ' 64' ' ' LYS . 12.5 mt -61.78 -21.7 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 128.016 2.526 . . . . 0.0 111.229 172.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.3 p -109.84 149.52 40.08 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 111.011 157.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.94 -9.85 26.98 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.264 2.643 . . . . 0.0 114.177 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 39.3 mt-10 -107.69 -1.33 21.16 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.84 1.656 . . . . 0.0 112.881 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.66 13.93 75.0 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 120.983 -1.073 . . . . 0.0 114.922 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HE2' ' HB2' ' A' ' 57' ' ' GLU . 52.4 mtmt -69.45 160.76 30.78 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.932 1.293 . . . . 0.0 111.941 173.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 m -136.96 149.33 66.23 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 126.491 1.916 . . . . 0.0 107.949 155.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.58 150.83 91.27 Favored 'Cis proline' 0 CA--C 1.538 0.722 0 N-CA-C 116.559 1.715 . . . . 0.0 116.559 13.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 m -158.05 167.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 128.231 2.613 . . . . 0.0 110.499 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.35 152.93 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.654 -1.279 . . . . 0.0 114.101 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.552 ' HE3' HD11 ' A' ' 54' ' ' ILE . 79.2 mttt -108.1 120.71 43.1 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.703 1.601 . . . . 0.0 109.377 162.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 54.8 mt -93.96 82.25 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.542 1.537 . . . . 0.0 108.6 175.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.3 t70 58.01 57.18 4.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.595 0.758 . . . . 0.0 111.941 -167.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.254 48.4 m-20 65.42 0.41 1.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -94.01 111.83 23.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.119 1.368 . . . . 0.0 110.21 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -73.76 152.22 40.41 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -161.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -140.67 134.09 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 127.038 2.135 . . . . 0.0 108.782 164.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.21 -149.57 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.29 1.836 . . . . 0.0 113.166 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -41.31 157.09 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.516 1.926 . . . . 0.0 115.232 -166.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.3 p -48.38 -29.75 4.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.421 1.488 . . . . 0.0 114.426 166.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.37 -7.41 50.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.336 1.054 . . . . 0.0 113.566 -170.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.08 -20.92 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.477 1.111 . . . . 0.0 112.974 159.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.6 mt -54.99 -39.87 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.849 1.26 . . . . 0.0 112.202 171.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 m -63.04 -3.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -117.36 -53.15 0.32 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.215 0.912 . . . . 0.0 113.111 156.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.4 mt -71.16 -30.81 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 121.238 -1.154 . . . . 0.0 113.263 -166.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 tp -74.42 -45.92 43.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.657 1.117 . . . . 0.0 110.646 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -61.23 -35.26 76.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.274 1.03 . . . . 0.0 113.679 -171.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -73.1 -31.11 64.14 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.257 1.423 . . . . 0.0 114.3 172.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -94.64 -11.96 28.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.803 1.241 . . . . 0.0 112.988 -171.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.24 144.08 53.43 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.12 1.768 . . . . 0.0 110.382 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.58 -19.23 19.17 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.281 1.987 . . . . 0.0 115.043 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB3' ' HE2' ' A' ' 33' ' ' LYS . 3.2 mm-40 -75.66 147.78 81.88 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.569 1.077 . . . . 0.0 109.942 165.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.21 145.84 63.5 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.519 2.813 . . . . 0.0 114.146 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -64.05 125.7 15.78 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.922 2.415 . . . . 0.0 112.212 -172.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.433 ' HG ' ' HE3' ' A' ' 33' ' ' LYS . 21.1 mt -73.31 -1.02 16.28 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.861 -1.15 . . . . 0.0 112.918 164.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.15 73.62 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.621 1.568 . . . . 0.0 113.654 174.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.5 m -61.54 113.12 7.3 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.434 0.693 . . . . 0.0 110.864 -169.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.11 135.62 11.1 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.97 1.78 . . . . 0.0 111.825 -166.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -75.06 172.43 16.38 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.809 2.339 . . . . 0.0 110.728 160.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -60.03 -26.51 66.16 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.647 -1.283 . . . . 0.0 113.399 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -58.05 -22.91 52.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.958 1.303 . . . . 0.0 114.021 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.59 -23.32 67.23 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.942 -1.099 . . . . 0.0 113.694 173.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.4 p -65.87 -14.5 61.58 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.4 t -116.33 -38.87 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.004 1.322 . . . . 0.0 111.663 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.47 -27.14 69.04 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.513 1.054 . . . . 0.0 114.892 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.1 p -67.97 -20.43 65.04 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 171.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -86.63 -39.88 15.68 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.307 1.443 . . . . 0.0 111.793 171.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.2 mt -66.88 -32.81 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.614 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.87 -51.67 80.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-O 117.438 -1.267 . . . . 0.0 113.987 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.81 -28.29 3.42 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.117 2.545 . . . . 0.0 114.333 169.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.6 p -69.24 -29.89 67.91 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.305 1.866 . . . . 0.0 112.841 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -65.39 -39.88 92.77 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.7 -1.25 . . . . 0.0 113.401 164.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.21 -38.76 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 119.974 1.261 . . . . 0.0 111.035 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -66.7 -42.67 86.03 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.418 1.087 . . . . 0.0 112.454 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -64.57 -39.95 94.66 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.839 0.856 . . . . 0.0 112.879 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.5 mt -70.99 5.95 1.79 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.475 1.51 . . . . 0.0 114.195 168.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -128.93 55.81 1.71 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.036 2.134 . . . . 0.0 109.577 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -61.77 20.94 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 129.733 3.213 . . . . 0.0 117.474 -159.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -73.07 -22.02 60.67 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.745 -1.222 . . . . 0.0 111.966 158.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -72.18 122.81 88.39 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.687 -1.149 . . . . 0.0 108.166 152.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -64.31 115.27 3.07 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.547 1.498 . . . . 0.0 112.656 -170.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -50.08 -44.62 51.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.48 -16.02 63.23 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -98.03 -38.23 4.15 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.259 1.409 . . . . 0.0 113.098 167.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.0 m -59.31 -39.48 83.21 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.34 1.07 . . . . 0.0 112.252 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -63.07 -26.35 68.79 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.009 1.724 . . . . 0.0 113.21 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -69.83 -41.04 75.48 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.316 -0.865 . . . . 0.0 111.269 173.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.4 87.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.336 -0.852 . . . . 0.0 112.503 171.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.65 -40.37 96.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.273 0.488 . . . . 0.0 112.286 172.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.87 -42.3 94.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.221 0.919 . . . . 0.0 112.118 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -69.39 -36.19 76.54 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.892 1.224 . . . . 0.0 112.839 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -66.16 -46.25 78.11 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.298 -0.877 . . . . 0.0 112.326 171.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.69 -31.45 69.5 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.692 -1.147 . . . . 0.0 113.29 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -62.27 -45.99 90.82 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.591 1.541 . . . . 0.0 111.72 172.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.85 -29.62 70.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.501 0.72 . . . . 0.0 112.667 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -77.24 -57.66 3.71 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.117 0.967 . . . . 0.0 112.048 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.81 -33.0 74.64 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.425 1.49 . . . . 0.0 113.796 -170.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.03 -27.7 57.46 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.123 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -105.94 -20.15 13.52 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.34 -35.04 79.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.386 1.448 . . . . 0.0 112.376 171.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -65.21 -7.26 12.08 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.27 -38.53 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.796 1.238 . . . . 0.0 111.78 170.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -102.02 7.14 41.36 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.51 -141.27 15.51 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-O 117.41 -1.772 . . . . 0.0 115.891 157.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.84 -7.74 9.36 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.368 2.712 . . . . 0.0 118.072 -143.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -130.37 162.12 29.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.539 1.518 . . . . 0.0 111.633 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 tt -75.45 -4.42 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.428 -1.42 . . . . 0.0 113.541 -171.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.39 2.06 47.52 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 126.458 1.903 . . . . 0.0 115.206 161.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.47 -127.53 9.12 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.647 1.594 . . . . 0.0 113.133 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -62.2 -27.48 69.0 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -138.42 149.07 45.14 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.997 1.719 . . . . 0.0 109.598 -173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.9 mt -60.39 114.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.55 1.14 . . . . 0.0 109.936 164.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.9 p -143.38 -157.91 0.82 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.366 1.066 . . . . 0.0 111.044 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.71 -25.6 4.52 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -169.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.4 t -75.16 -40.83 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.863 1.21 . . . . 0.0 111.954 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.8 -44.54 96.65 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.047 -1.033 . . . . 0.0 112.179 167.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.35 -27.14 67.13 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.701 0.4 . . . . 0.0 112.068 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.4 m -83.67 -49.64 8.95 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.765 1.226 . . . . 0.0 112.638 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.5 mt -103.08 -33.85 9.1 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -162.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.4 99.02 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -171.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.24 -26.74 12.23 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 CA-C-N 120.758 1.306 . . . . 0.0 113.228 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -68.52 -34.82 76.55 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.14 -0.975 . . . . 0.0 112.235 172.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.51 -41.33 96.49 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.857 0.863 . . . . 0.0 112.571 172.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -65.26 -43.78 90.22 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.822 0.737 . . . . 0.0 112.508 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -63.2 -31.22 72.31 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.551 -0.718 . . . . 0.0 112.631 176.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.54 -49.5 26.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.482 1.513 . . . . 0.0 112.53 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -57.97 -35.81 71.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.338 1.055 . . . . 0.0 111.974 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.0 t -90.46 -63.33 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.625 0.77 . . . . 0.0 113.001 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.16 -47.74 23.1 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.055 -1.028 . . . . 0.0 113.558 -164.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.9 tt -76.35 -33.8 58.94 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.82 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.74 -27.31 66.29 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 118.681 -1.066 . . . . 0.0 115.702 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.03 -23.89 65.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.818 1.247 . . . . 0.0 114.218 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -116.73 -30.19 5.85 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.322 1.049 . . . . 0.0 113.34 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -150.7 96.38 2.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.755 1.622 . . . . 0.0 109.449 168.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.38 99.02 0.52 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.812 -0.555 . . . . 0.0 110.414 169.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.3 t90 -77.42 113.13 28.8 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.616 1.166 . . . . 0.0 110.991 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.9 112.56 3.59 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.107 1.871 . . . . 0.0 110.905 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 85.3 mt -65.49 114.06 14.18 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 164.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -67.43 159.04 54.24 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.801 1.667 . . . . 0.0 112.714 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.66 -27.48 64.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.016 1.727 . . . . 0.0 113.679 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -63.76 -24.89 67.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.677 1.191 . . . . 0.0 113.82 173.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.49 51.28 2.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.75 1.62 . . . . 0.0 111.183 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.41 -27.69 67.28 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.454 1.101 . . . . 0.0 113.781 -156.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -74.63 -51.68 13.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.883 1.22 . . . . 0.0 110.428 168.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.5 t -59.21 -37.79 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 118.959 0.8 . . . . 0.0 112.087 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.0 tp -62.34 -44.23 96.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.906 1.283 . . . . 0.0 113.136 174.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -71.44 -32.45 68.36 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.572 -0.705 . . . . 0.0 112.842 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.07 -29.63 70.75 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.445 1.098 . . . . 0.0 112.99 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.3 mm -54.18 -39.43 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.323 -0.861 . . . . 0.0 111.429 168.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -85.47 -5.35 59.3 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.472 -1.392 . . . . 0.0 114.238 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.3 mt -76.56 -18.51 58.63 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.609 159.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.68 -21.45 66.4 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.116 1.325 . . . . 0.0 113.318 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -89.34 8.59 29.84 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.631 1.572 . . . . 0.0 113.102 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.2 p -128.94 175.27 8.79 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -165.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 53.88 -164.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.265 1.826 . . . . 0.0 110.795 -166.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -80.62 -39.0 28.21 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.34 1.456 . . . . 0.0 109.426 158.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -49.67 75.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.151 2.58 . . . . 0.0 112.948 -165.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -96.0 -42.54 8.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 193' ' ' LYS . 33.7 ttpt -59.5 -33.82 71.82 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.03 -25.38 55.61 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.4 p -89.43 -10.57 45.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -55.32 122.83 12.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.407 1.083 . . . . 0.0 110.221 167.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -93.46 153.99 18.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.046 0.938 . . . . 0.0 112.56 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.8 128.95 38.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.893 0.877 . . . . 0.0 111.051 166.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -79.39 -35.18 41.1 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.455 1.502 . . . . 0.0 113.47 -147.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -39.09 80.86 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.608 1.563 . . . . 0.0 112.982 168.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -81.45 -8.16 59.69 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.12 -46.77 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 120.078 1.308 . . . . 0.0 110.205 160.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.6 mt -63.14 -56.34 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.776 1.23 . . . . 0.0 111.4 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.84 68.88 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -84.48 -19.84 59.55 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 120.95 -1.094 . . . . 0.0 114.017 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -75.82 -31.98 59.62 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.554 1.677 . . . . 0.0 113.199 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -43.27 -56.15 7.06 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.59 -29.51 52.3 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 121.968 1.739 . . . . 0.0 113.421 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -82.12 -3.24 54.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.941 1.696 . . . . 0.0 114.482 -175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.2 p -69.95 -13.93 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 118.707 0.685 . . . . 0.0 112.299 162.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -122.2 -40.63 2.48 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.451 1.5 . . . . 0.0 114.093 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.141 0 CA-C-O 116.215 -1.85 . . . . 0.0 114.362 -175.698 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.29 -164.05 0.07 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.973 0.909 . . . . 0.0 111.845 -163.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.96 105.04 5.03 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.074 -1.016 . . . . 0.0 111.231 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -112.91 118.75 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.056 0.942 . . . . 0.0 109.832 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.4 mt -102.67 142.35 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.322 1.449 . . . . 0.0 108.333 -176.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.9 m -121.93 135.16 54.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.841 0.746 . . . . 0.0 109.72 162.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.92 142.6 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.28 1.032 . . . . 0.0 110.06 -163.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.715 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 31.1 tttm -64.25 127.51 31.77 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.71 176.24 9.11 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.394 1.878 . . . . 0.0 111.916 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.82 140.32 30.52 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.542 -0.724 . . . . 0.0 111.934 167.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.5 t -54.12 121.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 121.061 0.457 . . . . 0.0 109.966 168.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.56 -9.12 51.96 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 118.26 -1.3 . . . . 0.0 116.265 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.3 84.27 24.43 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 120.106 1.953 . . . . 0.0 112.459 -172.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.59 -12.79 35.32 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.206 2.604 . . . . 0.0 116.476 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -74.51 -11.23 60.16 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 pt -145.74 163.37 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.117 1.367 . . . . 0.0 112.243 -164.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.8 mt -75.83 -43.64 44.9 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.84 -127.12 8.78 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.702 1.144 . . . . 0.0 115.001 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.416 ' OD2' ' HE3' ' A' ' 209' ' ' LYS . 7.9 p-10 -65.23 16.42 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.525 2.73 . . . . 0.0 117.026 -170.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.4 p -115.2 73.49 3.56 Favored Pre-proline 0 C--O 1.262 1.733 0 O-C-N 119.755 -1.841 . . . . 0.0 110.967 -158.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.81 -26.88 31.88 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.593 2.862 . . . . 0.0 112.76 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -63.03 -42.02 99.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.649 1.18 . . . . 0.0 112.661 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.715 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.4 m -61.34 -42.61 98.97 Favored 'General case' 0 C--N 1.376 1.746 0 O-C-N 119.543 -1.973 . . . . 0.0 111.02 170.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -65.5 -26.9 68.12 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 117.284 -1.341 . . . . 0.0 112.797 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -54.45 -44.12 72.23 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.772 1.169 . . . . 0.0 112.776 171.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.4 t -73.38 -38.39 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.261 1.424 . . . . 0.0 112.043 -172.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -74.85 -36.73 62.34 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.691 0.796 . . . . 0.0 111.432 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -59.25 -44.29 92.4 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.501 1.52 . . . . 0.0 113.271 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 p -70.06 -39.5 75.64 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.609 1.095 . . . . 0.0 112.998 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.78 -33.44 66.3 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -77.85 -25.37 48.69 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 173.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -67.04 -39.92 87.06 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.776 -1.202 . . . . 0.0 111.948 163.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -75.02 -1.79 24.33 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 169.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm 62.68 10.17 4.0 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.943 2.097 . . . . 0.0 115.6 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.403 ' CD1' HD21 ' A' ' 84' ' ' ASN . 59.8 mt -80.47 130.54 64.64 Favored Pre-proline 0 N--CA 1.472 0.648 0 O-C-N 121.159 -0.963 . . . . 0.0 110.374 -168.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.63 145.85 53.24 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.577 2.185 . . . . 0.0 112.195 171.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -146.64 161.17 41.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.956 1.702 . . . . 0.0 109.957 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -99.75 103.17 14.8 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.393 -0.817 . . . . 0.0 110.133 170.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.4 t -82.99 136.08 34.64 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.612 0.765 . . . . 0.0 112.364 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -119.63 95.12 4.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.557 1.543 . . . . 0.0 109.525 172.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.2 mt -70.94 136.46 48.53 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.56 0.744 . . . . 0.0 110.919 172.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.414 HD12 HG11 ' A' ' 60' ' ' VAL . 4.1 mt -132.12 117.43 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.471 1.508 . . . . 0.0 110.23 -174.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -83.05 107.56 15.72 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.452 -0.78 . . . . 0.0 109.546 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.0 mt 52.13 23.59 2.36 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 169.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.4 21.08 11.94 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -66.41 23.17 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -140.93 150.84 60.79 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 125.729 1.612 . . . . 0.0 111.276 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -60.53 162.41 17.97 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.445 2.096 . . . . 0.0 111.674 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.67 -10.62 20.04 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -167.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -55.84 -24.25 35.39 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.106 2.162 . . . . 0.0 114.882 170.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -102.96 3.47 36.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.654 1.582 . . . . 0.0 113.454 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.6 mt -128.77 -39.55 1.61 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.204 2.202 . . . . 0.0 112.539 -169.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.22 -11.98 4.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 128.509 2.723 . . . . 0.0 114.669 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.7 mt -63.04 -21.0 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 127.039 2.136 . . . . 0.0 111.162 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -109.93 148.43 38.24 Favored Pre-proline 0 N--CA 1.472 0.647 0 C-N-CA 124.123 0.969 . . . . 0.0 111.104 157.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.61 -15.96 45.85 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.843 2.362 . . . . 0.0 113.426 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.71 -0.28 54.43 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.422 1.489 . . . . 0.0 113.01 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 12.57 63.86 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 120.907 -1.121 . . . . 0.0 114.847 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -76.62 164.29 26.05 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.931 1.692 . . . . 0.0 112.089 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.414 HG11 HD12 ' A' ' 42' ' ' ILE . 35.4 m -133.17 150.24 74.85 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.439 1.895 . . . . 0.0 108.129 154.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.94 151.89 94.54 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 N-CA-C 116.723 1.778 . . . . 0.0 116.723 13.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.4 m -158.09 165.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 128.528 2.731 . . . . 0.0 110.603 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.36 145.35 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 120.92 -1.113 . . . . 0.0 113.938 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -97.95 111.04 23.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.885 1.674 . . . . 0.0 109.067 161.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.34 83.99 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.619 1.168 . . . . 0.0 108.384 174.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 55.94 51.38 12.21 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.276 1.03 . . . . 0.0 113.244 -166.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.68 25.2 14.12 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -175.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -113.93 111.74 22.19 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.034 1.333 . . . . 0.0 108.517 169.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -84.73 149.96 25.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.254 -151.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.05 132.36 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.761 1.624 . . . . 0.0 109.357 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.44 -149.45 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.054 1.742 . . . . 0.0 113.149 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -35.08 155.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.805 2.042 . . . . 0.0 116.411 -171.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 p -47.51 -30.47 3.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.181 1.392 . . . . 0.0 113.934 160.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -90.6 -8.44 50.15 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.623 1.169 . . . . 0.0 113.303 -171.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.75 -23.33 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.085 0.954 . . . . 0.0 113.01 158.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.4 mt -56.48 -40.06 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.023 1.329 . . . . 0.0 112.184 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -61.43 -9.39 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.82 -58.52 0.57 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.482 1.039 . . . . 0.0 112.935 158.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.0 -35.59 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.229 -1.16 . . . . 0.0 113.366 -164.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.63 -43.21 63.55 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.346 0.976 . . . . 0.0 110.922 171.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -64.9 -28.24 69.4 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -68.5 -37.19 79.85 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.249 1.419 . . . . 0.0 114.57 167.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -108.28 -12.35 15.08 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.959 1.303 . . . . 0.0 113.259 -161.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.403 HD21 ' CD1' ' A' ' 35' ' ' ILE . 25.6 t-20 -73.21 142.55 82.25 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.122 1.769 . . . . 0.0 109.99 163.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.05 -21.94 20.05 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.149 1.9 . . . . 0.0 114.656 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -74.58 146.67 83.84 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 119.154 0.888 . . . . 0.0 110.476 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -55.24 144.81 69.3 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.845 2.363 . . . . 0.0 114.08 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.83 133.6 51.91 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.315 2.676 . . . . 0.0 112.765 -171.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.4 mt -80.37 -0.92 39.0 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.533 -0.729 . . . . 0.0 112.915 160.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.06 -32.09 73.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.316 1.447 . . . . 0.0 114.057 175.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.0 m -62.71 115.38 16.55 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 123.577 0.751 . . . . 0.0 110.777 -168.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -80.17 134.72 10.52 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 121.889 1.726 . . . . 0.0 112.099 -168.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -75.63 175.13 11.69 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.971 2.447 . . . . 0.0 110.61 156.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -58.19 -29.18 65.45 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.578 -1.326 . . . . 0.0 113.458 173.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -57.69 -25.25 60.03 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.316 1.446 . . . . 0.0 114.4 173.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.38 -28.25 69.86 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.91 0.777 . . . . 0.0 113.05 175.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.3 p -61.91 -42.54 99.21 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.296 0.638 . . . . 0.0 112.226 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.57 -38.33 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.946 0.898 . . . . 0.0 112.11 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.11 -23.77 64.35 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.957 1.265 . . . . 0.0 114.368 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 p -62.66 -25.25 68.04 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 172.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -84.17 -41.57 16.88 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.853 1.261 . . . . 0.0 112.368 173.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.3 mt -68.34 -34.9 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.098 0.959 . . . . 0.0 111.316 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.32 -48.56 93.66 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 120.519 -1.363 . . . . 0.0 114.301 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.99 -31.5 2.27 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.289 2.659 . . . . 0.0 114.129 170.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.2 p -69.25 -26.41 64.77 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 121.207 1.821 . . . . 0.0 112.987 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -62.38 -42.03 99.1 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.358 -1.464 . . . . 0.0 113.531 161.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.48 -36.73 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 119.856 1.207 . . . . 0.0 110.821 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -66.65 -44.23 82.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.415 1.486 . . . . 0.0 112.306 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -66.78 -37.29 84.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.046 1.338 . . . . 0.0 113.295 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.6 mt -75.95 13.9 0.78 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.862 1.265 . . . . 0.0 113.627 168.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -140.02 60.25 1.56 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.02 2.128 . . . . 0.0 110.12 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -57.0 17.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 130.799 3.64 . . . . 0.0 119.237 -160.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.59 -30.42 64.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.294 1.838 . . . . 0.0 111.835 169.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -81.13 121.78 80.9 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 117.726 -1.13 . . . . 0.0 108.324 159.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -56.72 124.75 16.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.3 2.0 . . . . 0.0 114.056 -167.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -60.35 -43.69 96.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 117.791 -1.099 . . . . 0.0 113.538 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.86 -20.78 66.08 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.49 -39.76 6.63 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.025 -1.047 . . . . 0.0 113.227 170.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.5 m -67.89 -26.8 66.18 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.445 -1.032 . . . . 0.0 113.524 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -65.19 -36.9 85.64 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.93 1.292 . . . . 0.0 112.219 170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -68.11 -39.43 82.79 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.225 -0.922 . . . . 0.0 111.73 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.41 -42.95 92.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.075 0.55 . . . . 0.0 112.472 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -62.49 -39.3 93.04 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.014 0.926 . . . . 0.0 112.475 174.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.76 -37.23 86.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.756 1.162 . . . . 0.0 112.2 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.485 ' HA ' ' HE3' ' A' ' 128' ' ' LYS . 10.5 tp10 -69.9 -33.83 72.72 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.723 1.147 . . . . 0.0 113.11 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -70.88 -44.94 65.28 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.837 -1.165 . . . . 0.0 112.692 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.5 mt -73.52 -31.34 63.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.666 -1.159 . . . . 0.0 113.389 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 125' ' ' GLU . 39.5 mtmt -59.03 -43.06 91.57 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.381 1.446 . . . . 0.0 112.214 173.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.07 72.81 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.07 -54.23 8.28 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.66 0.784 . . . . 0.0 111.454 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.03 -35.79 81.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.688 1.595 . . . . 0.0 113.661 -172.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.14 -34.5 73.49 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.708 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -93.15 -27.55 16.84 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.7 mt -64.54 -36.89 85.67 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.306 1.412 . . . . 0.0 112.3 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -64.06 -9.21 14.91 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 172.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.5 t -98.48 -33.48 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.871 1.268 . . . . 0.0 112.334 171.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -95.42 -25.08 16.4 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.99 -167.83 16.43 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-O 118.478 -1.179 . . . . 0.0 114.751 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -81.77 -5.75 12.37 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.607 2.871 . . . . 0.0 117.107 -122.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -107.47 160.17 15.85 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.77 -1.206 . . . . 0.0 110.685 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.261 8.7 tt -76.71 -3.72 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 119.915 -1.741 . . . . 0.0 112.907 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.5 -1.29 44.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.158 1.783 . . . . 0.0 115.377 159.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.64 -125.87 7.79 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 120.411 1.46 . . . . 0.0 113.917 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -69.44 -20.7 63.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.687 1.195 . . . . 0.0 113.972 -171.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -138.87 150.68 46.26 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.312 1.845 . . . . 0.0 109.825 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.8 mt -66.67 111.71 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.613 0.765 . . . . 0.0 109.264 165.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.9 p -140.57 -162.64 1.39 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.476 1.11 . . . . 0.0 110.845 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.02 -25.52 3.46 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.37 -40.63 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 119.812 1.187 . . . . 0.0 112.101 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.67 -45.02 95.78 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.768 -1.207 . . . . 0.0 112.475 166.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.97 -24.99 64.86 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.9 m -86.61 -55.44 3.87 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.789 1.235 . . . . 0.0 112.35 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.15 -31.5 14.76 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -161.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.94 -50.74 84.99 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -169.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.86 -23.83 18.48 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 120.842 1.337 . . . . 0.0 112.799 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -72.82 -35.69 67.36 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.414 172.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 41.4 mt -63.7 -37.85 88.92 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.249 0.931 . . . . 0.0 112.726 169.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -64.34 -42.89 96.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.412 0.551 . . . . 0.0 112.27 172.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -68.19 -27.07 66.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.815 0.846 . . . . 0.0 113.117 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.03 -55.91 12.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.549 1.14 . . . . 0.0 111.466 166.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -60.0 -36.62 77.59 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.723 0.692 . . . . 0.0 112.042 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 78.2 t -86.78 -66.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.06 -50.32 15.05 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.125 -0.984 . . . . 0.0 113.251 -161.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 52.6 tp -79.65 -32.74 41.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.846 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.11 -25.88 65.05 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.554 1.073 . . . . 0.0 114.999 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -63.14 -24.17 67.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -115.46 -28.36 6.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.143 0.977 . . . . 0.0 113.553 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -148.76 101.87 3.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.211 1.404 . . . . 0.0 109.109 164.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -71.63 85.5 0.89 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.505 0.722 . . . . 0.0 110.092 170.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -68.55 113.86 18.39 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.802 1.241 . . . . 0.0 110.302 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.97 120.62 6.45 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.974 1.783 . . . . 0.0 110.907 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 52.9 mt -68.36 117.26 48.07 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 163.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -64.39 157.72 53.05 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.208 1.938 . . . . 0.0 112.826 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -27.94 66.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.599 1.56 . . . . 0.0 113.196 174.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -65.82 -27.01 67.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.473 1.109 . . . . 0.0 113.659 173.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.3 mt -85.79 52.32 2.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.073 1.349 . . . . 0.0 110.793 168.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.15 -29.71 71.01 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.46 1.104 . . . . 0.0 112.63 -161.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -76.66 -47.23 22.8 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.597 0.635 . . . . 0.0 111.604 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.03 -40.51 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.231 0.612 . . . . 0.0 111.16 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.67 -45.17 91.33 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.768 1.227 . . . . 0.0 113.245 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -67.1 -36.65 82.39 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.49 -0.756 . . . . 0.0 112.517 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -63.84 -27.46 69.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.943 0.897 . . . . 0.0 113.365 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 44.0 mm -54.14 -36.17 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 120.997 -1.064 . . . . 0.0 111.962 168.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -89.03 -8.69 53.52 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.537 -1.352 . . . . 0.0 114.054 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 78.3 mt -74.08 -19.08 60.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 116.645 -1.645 . . . . 0.0 113.611 158.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 56.2 mt -62.96 -22.41 66.79 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.369 1.44 . . . . 0.0 113.055 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -93.56 9.04 38.41 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.364 1.466 . . . . 0.0 112.982 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.3 p -123.44 176.46 6.15 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.008 1.723 . . . . 0.0 114.424 -166.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 52.7 -163.87 0.08 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.81 1.644 . . . . 0.0 110.763 -170.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 11.1 mp0 -78.68 -43.58 25.67 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 125.947 1.699 . . . . 0.0 110.275 154.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.02 -49.58 71.19 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 128.013 2.525 . . . . 0.0 112.916 -164.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -91.13 -44.92 8.97 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.79 -34.03 71.01 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -75.03 -24.53 58.32 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.419 1.009 . . . . 0.0 113.424 174.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 35.9 p -88.48 -12.29 43.44 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -53.56 110.55 0.58 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.14 1.376 . . . . 0.0 110.041 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.44 141.52 28.65 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.684 0.793 . . . . 0.0 112.005 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.61 119.47 5.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.703 1.201 . . . . 0.0 111.837 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -67.81 -38.01 82.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -149.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -59.15 -36.57 75.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.131 1.372 . . . . 0.0 112.502 174.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -82.35 -11.17 58.75 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.88 -43.97 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.921 0.782 . . . . 0.0 109.912 164.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.8 mt -62.28 -57.0 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.281 1.432 . . . . 0.0 111.364 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.53 70.38 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.37 -19.9 65.57 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.947 -1.096 . . . . 0.0 114.11 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -80.13 -27.57 39.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.586 1.193 . . . . 0.0 113.578 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -50.65 -49.94 75.8 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.47 -25.18 30.18 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 CA-C-N 121.881 1.707 . . . . 0.0 113.293 173.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.416 ' HE3' ' OD2' ' A' ' 19' ' ' ASP . 57.1 mttm -84.58 -12.92 53.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.989 1.716 . . . . 0.0 114.984 -175.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -22.29 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 118.634 0.652 . . . . 0.0 111.372 161.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -97.76 -53.18 3.5 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 117.414 -1.279 . . . . 0.0 114.01 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 C-N-CA 126.712 2.005 . . . . 0.0 114.026 -168.964 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.0 mtp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 119.113 -0.47 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.31 -164.73 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.51 1.124 . . . . 0.0 112.004 -169.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.4 mt -71.1 103.7 2.82 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.92 -1.112 . . . . 0.0 110.847 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -109.59 118.76 37.42 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.793 0.837 . . . . 0.0 109.654 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.1 mt -100.1 142.66 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.399 1.08 . . . . 0.0 108.17 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.1 m -123.6 132.32 53.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.634 0.652 . . . . 0.0 109.406 163.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.1 142.06 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.701 1.201 . . . . 0.0 109.775 -162.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.67 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 32.0 tttm -65.58 127.48 32.04 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.352 -0.843 . . . . 0.0 109.377 171.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.53 176.36 9.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.7 2.0 . . . . 0.0 111.767 170.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.25 141.79 34.08 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.434 -0.791 . . . . 0.0 111.621 166.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 81.5 t -54.46 121.36 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.941 -0.474 . . . . 0.0 109.88 168.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.31 -15.39 34.63 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.073 1.321 . . . . 0.0 116.085 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -132.53 90.35 33.59 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 119.768 1.784 . . . . 0.0 112.211 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.36 -13.44 39.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.396 2.731 . . . . 0.0 115.249 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -76.14 -12.38 60.1 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.6 pt -142.93 162.64 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.796 1.238 . . . . 0.0 112.113 -165.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.1 mt -74.4 -43.05 58.06 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.23 -125.94 7.17 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.907 1.241 . . . . 0.0 114.622 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.96 18.51 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 128.774 2.83 . . . . 0.0 117.178 -172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -119.23 68.78 9.99 Favored Pre-proline 0 C--O 1.262 1.749 0 O-C-N 120.558 -1.339 . . . . 0.0 110.965 -160.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.37 -22.11 39.97 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.975 3.117 . . . . 0.0 113.12 174.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -62.93 -42.22 99.73 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.405 -0.809 . . . . 0.0 112.786 167.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.2 m -61.57 -41.82 97.95 Favored 'General case' 0 C--N 1.369 1.447 0 O-C-N 120.015 -1.678 . . . . 0.0 111.006 170.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.04 -29.46 70.83 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 117.192 -1.385 . . . . 0.0 113.014 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -54.1 -43.19 70.2 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.141 1.337 . . . . 0.0 112.718 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.78 -36.72 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.369 1.468 . . . . 0.0 111.941 -173.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.31 -39.7 65.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.756 0.822 . . . . 0.0 111.279 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 191' ' ' SER . 16.7 tp -57.58 -44.79 85.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.975 1.71 . . . . 0.0 112.977 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -68.91 -43.13 75.82 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.48 1.037 . . . . 0.0 112.799 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.04 -32.44 69.17 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -77.73 -25.52 49.33 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 173.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -70.68 -36.04 73.11 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.441 -1.412 . . . . 0.0 112.106 164.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE3' ' HG ' ' A' ' 89' ' ' LEU . 65.2 mttt -73.21 -3.49 27.02 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 167.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm 60.93 12.55 3.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.241 2.217 . . . . 0.0 115.024 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.8 mt -80.14 131.01 63.99 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 124.223 1.009 . . . . 0.0 110.307 -172.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.75 147.06 44.12 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.791 2.328 . . . . 0.0 112.483 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -147.33 159.28 43.86 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.489 1.516 . . . . 0.0 110.972 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -96.89 95.08 7.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.368 1.067 . . . . 0.0 110.289 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.7 t -82.06 136.54 35.2 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -118.7 100.6 7.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.758 1.623 . . . . 0.0 109.5 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.0 mt -73.14 135.9 44.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.375 0.67 . . . . 0.0 110.717 170.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mt -129.5 117.35 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.41 1.484 . . . . 0.0 110.532 -172.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -86.77 101.16 13.06 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.697 -0.627 . . . . 0.0 109.964 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.2 mt 53.67 21.52 2.66 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 170.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.06 23.54 9.1 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-O 118.884 -0.954 . . . . 0.0 115.246 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -64.15 10.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -140.15 145.34 41.42 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 126.0 1.72 . . . . 0.0 110.305 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -63.5 167.67 12.78 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.084 2.523 . . . . 0.0 112.238 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.53 -13.95 36.5 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 116.268 -1.825 . . . . 0.0 115.627 -168.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -56.64 -17.68 9.56 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 167.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -108.58 6.43 25.95 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.82 1.648 . . . . 0.0 113.517 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.1 mt -130.8 -41.07 1.17 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.461 2.304 . . . . 0.0 112.702 -170.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.93 -6.58 3.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.286 2.635 . . . . 0.0 114.961 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.1 mt -63.39 -17.87 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 126.961 2.104 . . . . 0.0 111.123 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 p -115.43 149.95 43.74 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.426 1.09 . . . . 0.0 111.446 156.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.25 -27.0 56.27 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.801 2.334 . . . . 0.0 113.043 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -75.27 -10.36 59.39 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.504 1.522 . . . . 0.0 113.626 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.62 12.5 59.24 Favored Glycine 0 CA--C 1.54 1.608 0 O-C-N 120.431 -1.418 . . . . 0.0 114.39 -166.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -70.57 160.1 33.12 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.148 1.379 . . . . 0.0 111.295 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG12 HG22 ' A' ' 62' ' ' VAL . 35.4 m -135.09 149.39 70.09 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 125.965 1.706 . . . . 0.0 108.465 155.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -75.91 151.7 95.88 Favored 'Cis proline' 0 CA--C 1.541 0.855 0 N-CA-C 117.192 1.959 . . . . 0.0 117.192 15.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 60' ' ' VAL . 23.8 m -157.44 166.77 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 128.399 2.68 . . . . 0.0 111.023 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.78 144.83 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 171.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -96.14 111.0 23.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.703 2.001 . . . . 0.0 109.063 162.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.3 mt -89.55 79.75 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.052 0.941 . . . . 0.0 108.935 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.87 52.35 10.84 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.039 0.936 . . . . 0.0 112.207 -163.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.77 18.8 7.62 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -174.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -102.71 105.89 16.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.035 -1.041 . . . . 0.0 108.452 167.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -75.94 150.56 37.47 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -157.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.0 t -141.88 133.19 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.483 1.913 . . . . 0.0 108.829 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.63 -145.24 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.214 1.806 . . . . 0.0 113.341 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -38.3 154.19 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.395 1.878 . . . . 0.0 116.026 -170.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.0 p -48.9 -30.29 5.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.099 1.36 . . . . 0.0 113.831 164.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -92.13 -6.23 51.2 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.221 1.008 . . . . 0.0 113.341 -171.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.8 m -106.04 -22.07 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.195 0.998 . . . . 0.0 113.082 158.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.4 mt -56.24 -40.15 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.043 1.337 . . . . 0.0 112.136 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 m -62.12 -9.89 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 114.509 1.299 . . . . 0.0 114.509 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.05 -57.76 0.68 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.275 0.94 . . . . 0.0 113.038 159.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.2 mt -75.0 -30.3 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -163.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 tp -72.83 -43.31 62.82 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.671 -1.268 . . . . 0.0 110.612 167.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -65.96 -30.37 70.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.507 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 21.9 tt0 -65.09 -45.89 83.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.449 1.9 . . . . 0.0 113.013 168.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 94.8 mttt -92.73 -9.44 40.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.58 1.152 . . . . 0.0 113.728 -168.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.16 142.73 55.56 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.568 1.547 . . . . 0.0 110.494 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.12 -16.49 28.58 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.254 1.969 . . . . 0.0 115.263 -173.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -81.97 149.03 62.21 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 119.812 1.187 . . . . 0.0 110.957 165.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -53.03 146.16 38.76 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.262 2.641 . . . . 0.0 115.042 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.03 124.33 12.09 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.533 2.822 . . . . 0.0 113.57 -167.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HG ' ' HE3' ' A' ' 33' ' ' LYS . 19.4 mt -70.81 -5.72 32.36 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.328 -0.857 . . . . 0.0 113.186 163.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.26 -28.44 64.92 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.134 1.374 . . . . 0.0 113.513 170.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.3 m -61.88 113.59 8.87 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.134 0.973 . . . . 0.0 110.893 -166.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -80.21 125.08 5.66 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.156 1.904 . . . . 0.0 111.88 -171.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.49 170.97 18.69 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.378 2.052 . . . . 0.0 110.071 154.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.37 -23.98 64.72 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.847 -1.158 . . . . 0.0 113.79 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -54.9 -27.43 42.89 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.423 1.489 . . . . 0.0 114.247 170.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.04 -27.53 69.17 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.4 p -64.08 -42.38 96.98 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.861 0.755 . . . . 0.0 112.1 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 t -79.63 -38.82 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.52 1.128 . . . . 0.0 111.681 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.11 -23.28 61.63 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.038 1.304 . . . . 0.0 114.483 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.5 p -63.63 -24.85 67.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.868 1.267 . . . . 0.0 113.75 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -84.01 -45.32 13.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.688 1.195 . . . . 0.0 111.873 170.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.6 mt -68.23 -36.66 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.723 0.809 . . . . 0.0 111.466 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -61.17 -47.65 94.11 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 120.43 -1.419 . . . . 0.0 113.984 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.52 -31.78 2.49 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.087 2.525 . . . . 0.0 114.28 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.7 p -70.08 -24.0 63.15 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.147 1.794 . . . . 0.0 113.292 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -62.84 -40.2 96.71 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.057 -1.652 . . . . 0.0 113.575 161.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.8 t -66.12 -37.6 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.875 -1.141 . . . . 0.0 110.649 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -63.76 -45.56 89.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.317 1.447 . . . . 0.0 111.934 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -63.42 -41.37 98.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.178 1.391 . . . . 0.0 112.839 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.1 mt -69.89 -20.5 63.37 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 173.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -104.04 68.93 0.92 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.357 1.463 . . . . 0.0 110.436 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 m -64.91 27.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.61 2.764 . . . . 0.0 117.793 -162.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.628 ' HE3' ' HA ' ' A' ' 211' ' ' ASN . 93.3 mttt -70.63 -35.24 72.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.908 1.283 . . . . 0.0 112.447 163.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -78.08 116.71 60.94 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 117.494 -1.241 . . . . 0.0 107.793 164.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -53.43 125.27 17.94 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.674 2.25 . . . . 0.0 113.602 -164.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -55.92 -46.57 78.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.137 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.99 -27.68 68.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.54 -34.05 12.49 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.095 -1.003 . . . . 0.0 113.584 173.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.9 m -71.34 -26.72 62.95 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.451 -1.029 . . . . 0.0 113.103 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -64.01 -45.48 88.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.585 1.554 . . . . 0.0 111.57 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -63.72 -40.35 96.55 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.773 -0.58 . . . . 0.0 112.092 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.25 96.2 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.379 -0.826 . . . . 0.0 112.851 172.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.23 -32.05 73.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 117.891 -1.052 . . . . 0.0 112.873 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.25 -40.58 96.67 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.476 1.489 . . . . 0.0 111.718 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.78 -31.19 64.7 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.79 -47.59 62.3 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.205 -0.934 . . . . 0.0 112.28 169.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.8 mt -70.45 -31.11 68.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 117.957 -1.021 . . . . 0.0 113.122 -176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -56.72 -45.31 81.97 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.945 1.248 . . . . 0.0 112.264 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.7 -28.03 66.47 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.98 0.734 . . . . 0.0 112.98 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -78.01 -56.97 4.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.148 0.979 . . . . 0.0 111.222 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.85 -35.05 79.87 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.145 1.778 . . . . 0.0 113.794 -172.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.6 -33.34 66.78 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.895 -0.947 . . . . 0.0 113.903 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -97.08 -26.52 14.96 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.2 mt -61.46 -37.62 84.25 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.467 1.485 . . . . 0.0 112.217 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.93 -12.78 40.36 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.61 -33.66 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.039 1.335 . . . . 0.0 111.679 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -89.03 -50.21 6.3 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.95 -172.81 45.43 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 -167.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -96.34 -8.09 1.13 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.311 3.341 . . . . 0.0 114.487 -171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -100.6 156.71 17.15 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.07 0.948 . . . . 0.0 110.404 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.273 9.8 tt -77.49 0.73 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 120.517 -1.365 . . . . 0.0 113.407 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.26 5.68 37.66 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.626 1.97 . . . . 0.0 114.957 159.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.88 -122.0 7.44 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.56 1.552 . . . . 0.0 113.562 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -66.66 -25.15 66.43 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.751 2.02 . . . . 0.0 114.055 -170.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -143.53 151.54 40.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.021 1.728 . . . . 0.0 109.077 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.6 mt -57.84 112.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.248 1.019 . . . . 0.0 109.802 160.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.7 p -140.23 -162.88 1.41 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.924 1.69 . . . . 0.0 110.773 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.26 -25.42 2.32 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.39 -37.78 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 117.543 -1.217 . . . . 0.0 112.514 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.86 -44.34 96.38 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.753 -1.217 . . . . 0.0 112.296 163.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.0 mt -58.54 -27.61 64.71 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 175.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.5 m -83.97 -60.99 1.93 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.939 1.296 . . . . 0.0 112.55 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.96 -33.2 17.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -160.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.01 90.4 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -171.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -71.97 -27.6 17.25 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 CA-C-N 120.887 1.352 . . . . 0.0 112.676 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -72.6 -33.09 66.46 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 117.629 -1.177 . . . . 0.0 112.641 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.6 mt -64.6 -40.11 94.93 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.075 0.852 . . . . 0.0 112.604 168.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -63.33 -45.07 92.99 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.805 0.729 . . . . 0.0 112.245 173.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -65.24 -27.7 68.84 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.486 -0.758 . . . . 0.0 112.939 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.41 -50.06 20.01 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.772 1.229 . . . . 0.0 113.173 171.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -58.5 -36.76 74.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.231 0.923 . . . . 0.0 111.437 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -81.78 -70.05 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.512 0.725 . . . . 0.0 112.73 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.44 -43.79 31.27 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.957 -1.09 . . . . 0.0 113.623 -163.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.6 tp -79.48 -36.04 39.3 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.983 0.356 . . . . 0.0 111.387 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.56 -29.77 70.38 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.758 1.17 . . . . 0.0 114.638 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -60.81 -33.95 73.79 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 172.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -103.56 -26.31 12.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -152.69 103.69 2.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.048 1.339 . . . . 0.0 109.486 165.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -72.79 76.65 1.13 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.038 0.935 . . . . 0.0 111.754 173.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 41.0 t90 -64.4 111.49 5.69 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.245 1.418 . . . . 0.0 110.631 174.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.7 126.72 9.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.764 1.643 . . . . 0.0 110.21 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.92 117.44 45.51 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 166.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -64.64 159.35 45.4 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.074 1.85 . . . . 0.0 112.868 -174.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -27.31 65.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.68 1.592 . . . . 0.0 113.505 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -68.43 -24.55 64.75 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 73.2 mt -88.53 51.82 2.28 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.417 1.487 . . . . 0.0 110.922 168.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.65 -29.23 69.2 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.805 1.242 . . . . 0.0 113.235 -159.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -72.94 -53.02 12.35 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 119.384 0.993 . . . . 0.0 110.295 171.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.22 -35.15 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 118.909 0.777 . . . . 0.0 111.884 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.4 tp -61.68 -46.09 91.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.704 1.202 . . . . 0.0 113.269 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -69.11 -37.33 78.33 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.537 -0.727 . . . . 0.0 112.601 174.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -62.05 -27.48 68.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.194 1.398 . . . . 0.0 113.479 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 43.8 mm -50.99 -36.35 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.801 0.84 . . . . 0.0 112.163 168.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -85.08 -6.38 59.31 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.322 -1.487 . . . . 0.0 113.859 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 26.2 mt -75.5 -21.8 57.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 117.646 -1.169 . . . . 0.0 113.758 159.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 61.1 mt -62.65 -21.14 65.47 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.947 1.248 . . . . 0.0 113.331 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -95.0 11.28 32.52 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.457 1.503 . . . . 0.0 112.979 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.1 p -130.58 178.57 6.52 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -164.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 54.03 -161.68 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.925 1.69 . . . . 0.0 110.823 -170.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 9.1 mp0 -82.28 -45.01 15.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 125.675 1.59 . . . . 0.0 109.312 157.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.4 ' HB2' HD12 ' A' ' 28' ' ' LEU . 54.4 p -55.34 -33.33 63.28 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.669 2.388 . . . . 0.0 115.78 -168.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -110.83 -40.24 4.6 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.299 0.954 . . . . 0.0 112.865 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -62.22 -29.36 70.33 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.447 -1.408 . . . . 0.0 113.817 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.75 -26.46 44.61 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 171.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 35.3 p -89.58 -9.04 51.25 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -50.65 114.99 1.29 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.781 1.633 . . . . 0.0 110.099 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -96.36 139.93 31.76 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.677 0.791 . . . . 0.0 111.934 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.35 117.29 3.41 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.785 1.234 . . . . 0.0 111.924 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -67.42 -36.92 82.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.98 1.312 . . . . 0.0 114.052 -149.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -62.06 -36.28 81.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.008 1.323 . . . . 0.0 112.454 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -83.15 -7.56 59.61 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.3 t -78.03 -43.31 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 119.352 0.978 . . . . 0.0 110.033 161.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.0 mt -63.49 -57.67 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.27 1.428 . . . . 0.0 111.394 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.14 69.31 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.27 -14.51 62.02 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 120.934 -1.104 . . . . 0.0 114.324 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -76.67 -37.72 55.72 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.15 1.475 . . . . 0.0 111.838 166.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -46.71 -56.43 11.53 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -168.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.44 -24.91 63.63 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 CA-C-N 122.116 1.791 . . . . 0.0 113.359 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -82.07 -3.66 55.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.225 1.41 . . . . 0.0 114.324 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.0 -20.03 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.248 0.931 . . . . 0.0 110.973 159.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.628 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 23.8 m-80 -105.91 -12.25 15.9 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 175.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.442 0 CA-C-O 115.505 -2.188 . . . . 0.0 115.264 -162.12 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.43 -166.36 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.841 0.856 . . . . 0.0 111.89 -166.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 mt -68.53 112.81 5.56 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.788 -1.195 . . . . 0.0 110.771 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -117.41 101.89 8.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.566 1.146 . . . . 0.0 109.049 167.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.9 mt -81.31 137.52 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.647 1.179 . . . . 0.0 108.656 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.6 m -121.29 132.55 54.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.315 0.507 . . . . 0.0 109.634 166.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.55 142.87 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.097 -1.002 . . . . 0.0 111.079 -158.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.704 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.8 tttm -66.28 128.49 36.33 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.623 -0.673 . . . . 0.0 109.331 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.25 176.13 8.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.017 1.727 . . . . 0.0 112.08 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.08 142.59 19.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.751 0.82 . . . . 0.0 111.951 167.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.4 t -54.45 121.59 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 120.965 0.412 . . . . 0.0 110.15 167.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.8 -8.6 42.22 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.042 1.306 . . . . 0.0 116.357 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.54 83.84 29.72 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 119.929 1.864 . . . . 0.0 112.278 -170.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.8 -13.7 40.8 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.582 2.855 . . . . 0.0 116.613 -172.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -81.84 -6.24 58.91 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.2 pt -142.97 160.01 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.179 1.392 . . . . 0.0 111.762 -167.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.5 mt -73.84 -43.28 59.18 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.83 -128.22 9.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.548 1.071 . . . . 0.0 114.593 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.04 15.56 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.426 2.69 . . . . 0.0 117.266 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -116.31 73.12 5.23 Favored Pre-proline 0 C--O 1.26 1.622 0 O-C-N 119.928 -1.732 . . . . 0.0 110.948 -158.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.23 -25.01 37.24 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 123.966 3.111 . . . . 0.0 113.098 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -66.97 -33.46 75.62 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.93 -1.106 . . . . 0.0 112.712 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.704 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.4 m -68.02 -43.47 78.7 Favored 'General case' 0 C--N 1.374 1.671 0 O-C-N 119.342 -2.099 . . . . 0.0 110.957 169.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.98 -36.12 76.47 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.799 0.84 . . . . 0.0 112.28 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -54.43 -39.8 67.7 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.582 1.553 . . . . 0.0 113.743 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.78 -36.93 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.843 0.857 . . . . 0.0 112.571 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.25 -39.11 82.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.157 0.583 . . . . 0.0 111.524 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.87 -41.41 95.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.358 1.463 . . . . 0.0 113.78 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 p -72.54 -38.8 67.89 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 119.822 1.192 . . . . 0.0 112.835 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -71.77 -36.8 70.47 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.94 0.896 . . . . 0.0 112.738 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -73.52 -28.81 62.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -69.58 -40.64 76.62 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.711 -1.243 . . . . 0.0 112.215 168.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -71.26 -4.2 24.5 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.23 1.412 . . . . 0.0 114.372 169.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' HE3' ' OE1' ' A' ' 190' ' ' GLU . 30.6 mmtm 60.58 14.91 5.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.891 2.076 . . . . 0.0 114.876 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.57 128.65 74.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.169 0.988 . . . . 0.0 109.964 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.7 149.4 54.64 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.709 2.273 . . . . 0.0 112.203 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -147.91 158.5 44.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.405 1.482 . . . . 0.0 110.246 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -85.29 146.72 26.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.076 0.951 . . . . 0.0 108.957 160.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 t -132.47 137.98 47.43 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.412 0.685 . . . . 0.0 112.008 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -126.08 88.18 2.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.531 1.932 . . . . 0.0 109.449 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.18 135.39 49.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.719 0.807 . . . . 0.0 110.889 171.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.8 mt -131.73 121.27 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.456 1.502 . . . . 0.0 110.048 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -87.85 111.78 21.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 168.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.7 mt 51.7 27.45 4.08 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 167.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.28 17.54 39.49 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -67.23 12.3 0.09 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -138.69 138.52 21.99 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 126.114 1.766 . . . . 0.0 108.503 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.75 170.11 7.65 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.817 2.345 . . . . 0.0 112.793 -165.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -57.87 -17.24 15.2 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -173.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -58.71 -16.19 15.38 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.295 -2.128 . . . . 0.0 116.235 166.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -107.97 7.01 27.7 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.597 1.559 . . . . 0.0 113.1 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.4 mt -132.36 -38.59 1.05 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.441 2.297 . . . . 0.0 112.941 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -57.58 -16.17 9.49 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 128.389 2.676 . . . . 0.0 113.932 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.6 mt -59.9 -19.7 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 126.804 2.042 . . . . 0.0 110.942 172.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -109.05 147.94 36.93 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.369 1.068 . . . . 0.0 110.723 153.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -66.57 -14.03 42.34 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.55 2.167 . . . . 0.0 112.939 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.05 -12.68 54.76 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.544 1.938 . . . . 0.0 112.717 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.5 15.06 65.58 Favored Glycine 0 CA--C 1.538 1.518 0 O-C-N 121.014 -1.054 . . . . 0.0 114.447 -168.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -82.63 167.47 18.24 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.407 1.483 . . . . 0.0 111.896 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.474 HG12 HG22 ' A' ' 62' ' ' VAL . 15.9 m -134.13 149.46 71.52 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 126.197 1.799 . . . . 0.0 108.504 152.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.16 151.29 95.02 Favored 'Cis proline' 0 CA--C 1.539 0.734 0 N-CA-C 116.765 1.794 . . . . 0.0 116.765 14.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 60' ' ' VAL . 30.3 m -157.45 168.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 128.16 2.584 . . . . 0.0 110.622 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.0 m -137.22 143.9 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 120.907 -1.121 . . . . 0.0 113.995 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -91.31 117.24 29.49 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.416 156.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.0 mt -92.33 76.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.25 1.02 . . . . 0.0 109.185 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 56.88 55.77 5.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.905 0.882 . . . . 0.0 112.089 -163.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.15 16.56 4.93 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -175.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -98.6 103.58 15.55 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.519 -1.363 . . . . 0.0 108.77 167.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -74.57 148.03 41.19 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -159.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.68 133.2 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.511 1.924 . . . . 0.0 109.074 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.99 -147.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.296 1.839 . . . . 0.0 113.202 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -38.85 153.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.891 2.077 . . . . 0.0 116.291 -168.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.3 p -49.73 -27.69 5.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.761 1.624 . . . . 0.0 114.22 168.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -95.11 -8.42 36.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.591 1.156 . . . . 0.0 113.422 -170.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -105.0 -20.5 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.235 1.014 . . . . 0.0 112.748 159.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.0 mt -55.46 -39.55 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.334 1.454 . . . . 0.0 112.286 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.83 -6.53 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.03 -55.62 0.56 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-N 119.034 0.834 . . . . 0.0 112.803 158.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.0 mt -74.38 -32.36 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 121.657 -0.908 . . . . 0.0 113.155 -164.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.5 tp -73.79 -43.62 58.36 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.54 167.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -64.31 -29.17 70.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 30.0 tt0 -69.38 -44.8 70.76 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.054 1.742 . . . . 0.0 113.425 168.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.502 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 92.0 mttt -96.76 -8.67 30.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.435 1.094 . . . . 0.0 113.545 -165.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -80.7 141.02 51.39 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 126.35 1.86 . . . . 0.0 109.862 170.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.26 -19.35 25.84 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.153 1.902 . . . . 0.0 115.03 -171.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -79.95 145.34 61.25 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.169 0.895 . . . . 0.0 110.804 171.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -54.86 145.61 60.85 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.939 2.426 . . . . 0.0 115.114 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.6 123.73 11.82 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.779 2.986 . . . . 0.0 113.28 -167.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.56 -5.67 30.82 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.359 -0.838 . . . . 0.0 113.246 164.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.23 -26.49 64.92 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.557 1.543 . . . . 0.0 113.742 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -63.04 114.25 11.89 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.044 0.938 . . . . 0.0 110.923 -169.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.5 127.35 6.47 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.084 1.856 . . . . 0.0 112.115 -169.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -73.58 171.94 16.75 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.945 1.763 . . . . 0.0 110.146 152.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -57.7 -28.29 63.7 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.931 -1.106 . . . . 0.0 113.627 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -55.74 -26.38 45.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.651 1.58 . . . . 0.0 114.511 173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.96 72.01 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.479 1.036 . . . . 0.0 112.671 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.6 p -64.9 -34.93 79.56 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.45 0.7 . . . . 0.0 112.453 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 31.4 t -86.76 -39.63 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.158 0.983 . . . . 0.0 112.055 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.79 60.45 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.142 1.353 . . . . 0.0 114.017 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.3 p -63.96 -24.44 67.72 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 171.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -82.44 -45.55 14.63 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.775 1.23 . . . . 0.0 111.873 170.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.9 mt -68.34 -35.16 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.123 0.969 . . . . 0.0 111.401 -172.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.6 -46.71 93.82 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.394 -1.441 . . . . 0.0 114.407 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.14 -31.24 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.193 2.595 . . . . 0.0 114.218 168.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.4 p -70.61 -23.54 62.58 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.279 1.854 . . . . 0.0 113.315 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -64.5 -39.09 93.14 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 119.97 -1.706 . . . . 0.0 113.544 161.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.81 -34.85 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 120.878 -1.139 . . . . 0.0 111.253 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -59.63 -52.2 66.54 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.024 1.33 . . . . 0.0 111.262 167.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -60.47 -38.29 83.73 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.703 1.201 . . . . 0.0 112.99 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.27 -24.23 57.53 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -94.48 61.11 2.7 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.325 1.45 . . . . 0.0 110.098 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.8 m -65.1 30.07 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.92 2.488 . . . . 0.0 117.517 -158.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -67.0 -38.28 85.72 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.147 1.379 . . . . 0.0 111.538 159.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -83.09 117.78 69.65 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.563 175.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -54.09 123.29 13.15 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.362 2.041 . . . . 0.0 114.419 -159.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -58.2 -46.62 85.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.276 1.03 . . . . 0.0 112.874 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.6 -23.79 67.53 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.43 -31.41 13.67 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 121.054 -1.029 . . . . 0.0 113.51 170.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 74.1 m -72.06 -28.89 63.63 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.45 1.1 . . . . 0.0 113.09 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 168' ' ' LYS . 79.0 mt-10 -61.65 -43.78 98.22 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.301 1.441 . . . . 0.0 111.817 168.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -66.3 -38.77 88.51 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.581 -0.699 . . . . 0.0 112.171 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.24 -41.84 93.94 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.44 -0.787 . . . . 0.0 112.684 171.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -66.49 -29.9 70.11 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 117.813 -1.089 . . . . 0.0 113.159 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.69 -43.53 97.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.562 1.528 . . . . 0.0 111.623 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -74.07 -31.78 62.99 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -67.97 -46.36 71.58 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.119 -0.988 . . . . 0.0 112.585 170.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.66 -29.73 62.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.845 -1.074 . . . . 0.0 113.026 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -57.21 -46.1 83.22 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.243 1.383 . . . . 0.0 112.195 171.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.1 70.65 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.375 0.67 . . . . 0.0 112.551 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.4 tp -75.73 -54.85 6.3 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.102 0.961 . . . . 0.0 111.278 173.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.63 -37.66 85.3 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.604 1.561 . . . . 0.0 113.94 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.38 -35.5 88.72 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.533 -0.593 . . . . 0.0 113.406 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -89.44 -29.42 19.03 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 173.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 21.5 mt -61.63 -38.67 88.51 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.409 1.459 . . . . 0.0 112.475 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -65.48 -5.65 8.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.26 -23.17 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.403 1.481 . . . . 0.0 112.292 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -108.45 -22.4 12.32 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -167.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.75 -163.63 34.78 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 121.023 1.738 . . . . 0.0 116.062 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -102.19 -11.0 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.493 3.462 . . . . 0.0 114.518 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -101.76 158.23 16.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.353 1.061 . . . . 0.0 110.833 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.272 6.1 tt -78.27 5.54 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.418 -1.426 . . . . 0.0 113.294 -171.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -106.95 3.46 26.15 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.01 2.124 . . . . 0.0 115.038 159.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.05 -129.77 9.98 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.683 1.611 . . . . 0.0 113.289 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.01 -34.98 72.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.542 1.537 . . . . 0.0 113.712 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -129.55 151.48 50.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.255 1.822 . . . . 0.0 109.603 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.46 118.7 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.697 0.799 . . . . 0.0 109.848 162.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.3 p -140.89 -164.44 1.74 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.134 0.974 . . . . 0.0 111.42 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.34 -22.25 1.75 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.77 -36.49 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 120.125 1.329 . . . . 0.0 112.594 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.65 -43.22 97.42 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.383 -1.448 . . . . 0.0 112.468 164.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.2 mt -59.82 -31.74 70.0 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.22 -0.3 . . . . 0.0 111.334 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.1 m -74.57 -57.57 3.84 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.786 0.834 . . . . 0.0 111.979 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.0 mt -96.37 -33.6 11.86 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -159.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.89 -49.93 89.03 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.78 -26.87 18.69 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 120.944 1.373 . . . . 0.0 112.492 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.66 -33.9 64.68 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.772 173.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.52 -40.5 95.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.034 0.933 . . . . 0.0 112.388 169.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -63.98 -44.58 92.28 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.438 0.563 . . . . 0.0 112.183 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -63.5 -28.36 69.9 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.486 -0.759 . . . . 0.0 112.804 174.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.5 mt -75.61 -48.76 20.86 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.794 1.238 . . . . 0.0 113.631 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -58.86 -34.5 71.68 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.744 1.156 . . . . 0.0 111.232 177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -86.27 -68.59 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.148 0.979 . . . . 0.0 113.112 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.75 -45.59 35.6 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.056 -1.027 . . . . 0.0 113.229 -166.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 10.8 tp -79.82 -35.36 38.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.167 0.44 . . . . 0.0 111.587 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.19 -25.96 65.31 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.856 1.217 . . . . 0.0 114.992 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -63.0 -34.94 78.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.385 1.074 . . . . 0.0 113.697 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -100.52 -28.88 12.67 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.495 ' HZ3' ' CD ' ' A' ' 120' ' ' GLU . 79.6 tttt -152.77 102.87 2.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.183 1.393 . . . . 0.0 109.641 168.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -72.19 85.56 1.05 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.584 0.754 . . . . 0.0 110.579 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.2 t90 -76.12 110.8 12.13 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.637 1.175 . . . . 0.0 110.477 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.45 130.35 14.88 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.008 1.805 . . . . 0.0 110.795 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.9 mt -68.87 119.03 66.74 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.93 157.68 55.53 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.129 1.886 . . . . 0.0 112.843 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.78 -25.59 65.03 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -65.85 -27.71 68.44 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.173 -0.955 . . . . 0.0 113.484 172.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.27 51.29 2.0 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.028 1.731 . . . . 0.0 110.932 170.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -31.93 73.4 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.148 1.379 . . . . 0.0 113.359 -160.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -74.98 -45.13 44.18 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.325 -0.86 . . . . 0.0 110.749 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.74 -39.43 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.358 0.981 . . . . 0.0 111.116 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.08 -49.4 74.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.294 1.437 . . . . 0.0 112.99 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -65.92 -37.09 85.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.513 -0.742 . . . . 0.0 112.826 177.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -63.06 -26.96 69.08 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.385 1.074 . . . . 0.0 113.294 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 42.8 mm -52.41 -37.86 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.794 0.838 . . . . 0.0 112.105 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -82.87 -6.04 59.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.361 -1.462 . . . . 0.0 113.497 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.47 -22.05 51.95 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 161.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.5 mt -62.73 -20.2 64.68 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.054 1.297 . . . . 0.0 113.466 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -91.52 7.25 42.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.05 1.34 . . . . 0.0 112.993 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.3 p -130.42 179.15 6.09 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -159.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 54.5 -160.25 0.16 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.152 1.781 . . . . 0.0 110.622 -167.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.442 ' OE1' ' HE3' ' A' ' 34' ' ' LYS . 16.1 mp0 -81.28 -40.19 24.08 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 125.92 1.688 . . . . 0.0 108.733 156.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -45.04 78.38 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 129.5 3.12 . . . . 0.0 113.908 -164.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -102.97 -38.45 7.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.475 0.71 . . . . 0.0 112.809 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -60.8 -31.33 70.72 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.472 -1.393 . . . . 0.0 113.389 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -78.22 -25.65 47.06 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 44.7 p -89.49 -8.37 53.01 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -52.71 115.65 1.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.252 1.421 . . . . 0.0 110.189 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -99.88 131.94 45.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.083 0.953 . . . . 0.0 111.421 -175.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -49.37 114.29 1.0 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.344 1.058 . . . . 0.0 112.354 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -62.46 -36.35 82.16 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -151.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -61.75 -36.2 80.3 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.073 1.349 . . . . 0.0 112.616 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -80.15 -11.65 59.73 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.42 -44.19 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.173 0.897 . . . . 0.0 109.812 165.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.3 mt -63.92 -57.16 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.146 1.379 . . . . 0.0 111.457 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.31 -28.14 67.74 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.32 -25.33 48.19 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 120.854 -1.154 . . . . 0.0 113.786 174.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -68.01 -37.96 82.05 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.13 1.465 . . . . 0.0 112.395 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -47.61 -55.07 18.26 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -166.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.34 -21.97 66.49 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 CA-C-N 122.352 1.876 . . . . 0.0 113.652 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -88.59 5.34 43.32 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.219 1.808 . . . . 0.0 114.383 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.11 -27.36 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.85 -0.531 . . . . 0.0 110.711 151.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -104.31 -40.4 6.12 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.622 -1.656 . . . . 0.0 113.926 -177.94 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 118.833 -0.603 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.25 -167.19 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.465 1.106 . . . . 0.0 112.036 -165.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.19 119.59 13.71 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.022 -1.049 . . . . 0.0 111.164 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.08 97.29 3.96 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.147 0.979 . . . . 0.0 109.328 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 mt -76.63 140.18 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.959 1.304 . . . . 0.0 108.715 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.6 m -118.01 137.39 52.91 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 159.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.81 142.38 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.36 1.064 . . . . 0.0 110.577 -161.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.694 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.9 tttm -66.54 129.14 38.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.62 -0.675 . . . . 0.0 109.271 169.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.63 173.62 8.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.54 1.936 . . . . 0.0 112.058 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.09 142.2 31.59 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.075 0.95 . . . . 0.0 111.847 169.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.36 120.98 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 121.007 0.432 . . . . 0.0 110.355 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.14 -10.08 22.59 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.945 1.26 . . . . 0.0 116.229 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.45 79.64 71.93 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 119.694 1.747 . . . . 0.0 111.66 -172.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.39 -11.65 29.31 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.849 3.033 . . . . 0.0 116.531 -170.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -84.69 -4.15 58.89 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.6 pt -143.08 161.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.325 1.45 . . . . 0.0 111.793 -169.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.4 -44.61 51.24 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.09 -123.67 5.84 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.849 1.214 . . . . 0.0 114.577 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.97 13.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.701 2.4 . . . . 0.0 117.192 -173.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.407 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.8 p -114.68 72.75 2.76 Favored Pre-proline 0 C--O 1.261 1.706 0 O-C-N 120.108 -1.62 . . . . 0.0 110.983 -159.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.18 -27.81 41.14 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.824 3.016 . . . . 0.0 112.303 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -63.64 -37.06 85.9 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.791 -1.193 . . . . 0.0 113.114 172.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.694 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -62.97 -41.78 99.64 Favored 'General case' 0 C--N 1.37 1.497 0 O-C-N 120.576 -1.327 . . . . 0.0 110.991 173.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -63.12 -27.99 69.76 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.453 1.101 . . . . 0.0 113.011 -176.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.522 HH12 ' CG ' ' A' ' 74' ' ' ASP . 75.4 mtp180 -58.13 -42.95 86.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.48 1.112 . . . . 0.0 113.145 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.1 t -74.04 -37.09 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.289 1.036 . . . . 0.0 111.441 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.09 -40.01 86.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.756 0.822 . . . . 0.0 111.141 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.23 -42.58 99.44 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -69.98 -41.81 73.94 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.312 1.415 . . . . 0.0 112.476 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.96 -36.19 69.78 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -76.13 -26.55 56.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -68.92 -41.95 77.48 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.585 -1.322 . . . . 0.0 111.87 167.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -70.73 -7.77 47.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.87 1.668 . . . . 0.0 114.243 170.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm 58.88 18.02 5.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.964 2.106 . . . . 0.0 114.707 -177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.7 mt -77.64 133.66 66.52 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.249 1.02 . . . . 0.0 110.13 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.31 146.15 44.81 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.801 2.334 . . . . 0.0 112.666 173.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -148.65 160.24 43.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.931 1.693 . . . . 0.0 110.335 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -85.24 151.6 23.95 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.24 -0.913 . . . . 0.0 109.576 158.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.2 t -134.15 130.53 37.45 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.76 0.824 . . . . 0.0 110.902 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -121.9 87.39 2.74 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.488 1.515 . . . . 0.0 109.508 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.48 135.0 50.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.939 0.895 . . . . 0.0 111.072 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 60' ' ' VAL . 30.8 mt -131.62 121.83 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.355 1.462 . . . . 0.0 110.262 -174.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -88.1 111.12 21.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 168.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.2 mt 52.21 24.1 2.65 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 168.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.28 19.3 28.49 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.743 -1.032 . . . . 0.0 115.586 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -64.75 11.39 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -140.21 143.56 34.13 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 126.171 1.788 . . . . 0.0 110.504 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.04 161.48 22.33 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.081 2.521 . . . . 0.0 113.135 -167.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.14 -12.51 28.01 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -166.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -50.11 -31.42 13.29 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.107 1.763 . . . . 0.0 115.527 161.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -94.26 3.13 55.65 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.919 1.288 . . . . 0.0 113.901 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.4 mt -128.62 -40.2 1.59 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.121 2.168 . . . . 0.0 113.168 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.72 -16.66 11.69 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 127.961 2.504 . . . . 0.0 113.623 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.9 mt -58.92 -20.78 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 126.974 2.109 . . . . 0.0 111.063 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.5 p -109.56 147.8 36.82 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.921 1.288 . . . . 0.0 110.894 155.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -67.38 -17.62 49.39 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.592 2.195 . . . . 0.0 112.948 171.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.8 -8.91 59.12 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.527 1.531 . . . . 0.0 113.312 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.29 70.35 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 120.73 -1.231 . . . . 0.0 114.73 -172.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -83.46 174.52 10.56 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.405 1.882 . . . . 0.0 112.522 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 62' ' ' VAL . 12.3 m -138.09 152.51 72.01 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 126.565 1.946 . . . . 0.0 109.098 154.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.85 153.27 99.08 Favored 'Cis proline' 0 C--N 1.35 0.624 0 N-CA-C 116.535 1.706 . . . . 0.0 116.535 9.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 60' ' ' VAL . 26.9 m -156.5 167.67 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 128.783 2.833 . . . . 0.0 109.811 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -137.01 140.65 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 O-C-N 120.667 -1.271 . . . . 0.0 114.051 170.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -86.33 108.26 18.35 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.101 1.36 . . . . 0.0 108.739 156.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.9 mt -86.75 76.69 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.304 1.042 . . . . 0.0 109.151 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.6 t70 55.32 53.48 9.89 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.053 0.93 . . . . 0.0 111.819 -162.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.25 15.12 5.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -95.72 107.03 19.21 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.674 -1.266 . . . . 0.0 108.785 167.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -75.5 147.25 39.94 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -159.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -141.14 132.25 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.938 1.695 . . . . 0.0 109.816 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.2 -150.52 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.066 2.146 . . . . 0.0 114.295 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.12 154.1 0.61 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.757 2.023 . . . . 0.0 114.362 -171.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.6 p -54.72 -27.19 38.93 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 25' ' ' ARG . 39.5 m-20 -70.27 -20.19 63.06 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -97.58 -20.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.266 0.939 . . . . 0.0 112.973 167.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.22 -42.9 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 O-C-N 121.121 -0.987 . . . . 0.0 111.652 170.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -63.48 -6.91 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.53 -58.43 0.55 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.515 1.055 . . . . 0.0 113.382 160.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.32 -31.61 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.404 1.082 . . . . 0.0 113.2 -165.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.05 -43.66 61.67 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.037 -1.039 . . . . 0.0 110.5 167.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -66.09 -27.83 68.36 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 25.0 tt0 -69.7 -45.83 67.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.84 1.656 . . . . 0.0 112.976 167.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.513 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.9 mttt -94.21 -8.36 39.51 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.354 1.062 . . . . 0.0 113.605 -166.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -80.45 141.25 52.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.071 1.748 . . . . 0.0 109.7 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.69 -15.45 27.05 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.018 1.812 . . . . 0.0 114.849 -172.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -84.06 141.15 40.2 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.901 171.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -49.98 142.27 27.31 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.921 3.081 . . . . 0.0 115.208 -173.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.89 118.09 5.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.29 2.66 . . . . 0.0 112.351 -169.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.56 -11.99 48.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.062 0.945 . . . . 0.0 112.774 165.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.01 -24.66 40.43 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.678 1.591 . . . . 0.0 113.645 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.2 m -65.29 116.13 27.91 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.821 0.848 . . . . 0.0 110.532 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.48 125.23 6.81 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.124 1.883 . . . . 0.0 112.513 -170.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.58 174.27 12.91 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.568 2.179 . . . . 0.0 110.288 154.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.23 -34.51 60.85 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.784 -1.198 . . . . 0.0 113.315 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -59.34 -22.88 61.96 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.894 1.678 . . . . 0.0 114.862 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.58 70.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.151 0.887 . . . . 0.0 112.899 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 85.4 p -64.57 -43.77 92.84 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.622 -0.673 . . . . 0.0 112.048 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.44 -39.8 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.265 1.026 . . . . 0.0 111.44 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.44 -24.51 67.7 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.52 1.533 . . . . 0.0 114.332 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.3 p -61.46 -26.02 67.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.451 1.125 . . . . 0.0 113.558 172.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -89.95 -39.98 12.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.638 1.175 . . . . 0.0 113.021 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.29 -32.74 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.587 0.755 . . . . 0.0 111.165 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.53 -49.26 93.09 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 120.551 -1.343 . . . . 0.0 114.015 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.31 -32.37 3.07 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.865 2.377 . . . . 0.0 113.699 168.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.8 p -71.96 -23.84 61.5 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 121.502 1.955 . . . . 0.0 114.043 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -64.94 -41.71 95.27 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 119.75 -1.844 . . . . 0.0 113.272 161.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.45 -33.88 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 121.063 -1.023 . . . . 0.0 111.126 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -61.37 -49.17 78.0 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.555 1.142 . . . . 0.0 111.634 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.13 -38.92 88.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.203 1.001 . . . . 0.0 112.156 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.2 mt -73.03 -7.61 52.03 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -116.91 58.73 0.77 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.797 2.039 . . . . 0.0 110.362 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.3 m -65.72 29.14 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.086 2.954 . . . . 0.0 117.572 -158.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 211' ' ' ASN . 93.0 mttt -64.98 -38.04 89.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.39 1.076 . . . . 0.0 111.959 161.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -90.4 131.27 38.85 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.772 -1.108 . . . . 0.0 108.324 170.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -58.13 135.52 68.94 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.263 1.975 . . . . 0.0 114.668 -161.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -61.72 -51.31 68.9 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.475 1.11 . . . . 0.0 112.591 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -23.24 64.71 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.97 -35.55 8.96 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 121.41 -0.806 . . . . 0.0 113.589 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.1 m -74.1 -26.22 60.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.404 -1.056 . . . . 0.0 112.847 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -62.19 -44.89 95.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.634 1.574 . . . . 0.0 111.545 164.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.41 -33.05 73.54 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.522 -0.737 . . . . 0.0 112.821 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.71 85.88 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.559 -0.713 . . . . 0.0 112.308 168.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.2 mt -64.64 -30.39 71.41 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.022 -0.989 . . . . 0.0 112.886 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.23 -35.19 76.55 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.336 1.425 . . . . 0.0 112.411 170.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -77.88 -38.87 44.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.484 1.038 . . . . 0.0 112.388 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -70.67 -41.44 72.07 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.602 -1.311 . . . . 0.0 113.167 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.5 mt -74.26 -25.94 59.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 117.416 -1.278 . . . . 0.0 112.532 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -58.84 -47.08 86.13 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 120.875 1.671 . . . . 0.0 112.262 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.92 66.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.838 0.855 . . . . 0.0 113.056 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 tp -83.8 -56.12 3.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.693 1.197 . . . . 0.0 111.445 174.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.07 -36.03 81.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.875 1.67 . . . . 0.0 113.992 -165.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.91 -34.64 89.49 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.681 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -90.36 -26.66 19.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.839 0.856 . . . . 0.0 113.15 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.2 mt -62.5 -38.86 91.56 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.245 0.93 . . . . 0.0 111.926 174.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -65.75 -2.05 3.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.13 -28.41 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.105 1.362 . . . . 0.0 112.491 171.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -86.6 -54.83 4.17 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 164.3 175.37 35.07 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.238 -0.914 . . . . 0.0 115.274 -169.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.89 -7.84 14.41 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.581 3.521 . . . . 0.0 115.783 -160.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -98.98 164.52 12.15 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.891 -1.131 . . . . 0.0 111.306 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.252 9.2 tt -78.78 -0.95 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 120.292 -1.505 . . . . 0.0 113.081 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -99.67 -4.92 29.81 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.49 1.916 . . . . 0.0 115.078 160.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.98 -129.76 9.55 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 120.287 1.403 . . . . 0.0 113.785 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.06 -24.23 65.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.65 1.58 . . . . 0.0 114.58 -172.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -130.73 151.77 50.81 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 126.588 1.955 . . . . 0.0 109.554 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 76.5 mt -67.38 119.66 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.997 0.919 . . . . 0.0 109.541 162.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.1 p -137.45 -166.66 1.98 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.168 1.387 . . . . 0.0 112.667 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.75 -20.34 3.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.834 1.654 . . . . 0.0 114.65 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.56 -38.1 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.062 1.301 . . . . 0.0 111.898 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.0 -42.58 94.36 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.332 -1.48 . . . . 0.0 112.045 165.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.9 mt -64.18 -15.81 60.64 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.0 m -95.53 -50.38 5.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.503 1.521 . . . . 0.0 112.491 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.5 mt -100.26 -34.15 10.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.299 1.44 . . . . 0.0 114.159 -164.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.63 90.08 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -170.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.93 -24.32 17.71 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 CA-C-N 120.714 1.291 . . . . 0.0 112.942 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.77 -33.46 66.32 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 117.775 -1.107 . . . . 0.0 112.334 173.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.78 -41.9 95.49 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.517 0.727 . . . . 0.0 112.637 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.66 -46.7 87.0 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.766 0.794 . . . . 0.0 111.929 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -64.81 -27.74 69.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.787 0.835 . . . . 0.0 112.889 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.31 -49.97 24.65 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.311 1.044 . . . . 0.0 113.33 170.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.96 -34.28 71.61 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.949 0.795 . . . . 0.0 111.694 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.32 -68.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.69 0.796 . . . . 0.0 112.86 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.73 -46.49 37.06 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.106 -0.996 . . . . 0.0 113.195 -161.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 19.5 tp -79.84 -32.34 40.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 119.247 -0.406 . . . . 0.0 111.649 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.89 -28.29 65.74 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.641 1.115 . . . . 0.0 114.946 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -61.11 -32.11 71.79 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.88 -28.91 11.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.975 0.91 . . . . 0.0 113.087 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -153.23 98.51 2.28 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.667 1.587 . . . . 0.0 109.612 169.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.41 84.14 0.8 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.548 0.739 . . . . 0.0 110.706 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 44.1 t90 -77.2 106.73 3.9 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.972 1.309 . . . . 0.0 110.169 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.23 134.6 25.25 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.649 1.566 . . . . 0.0 109.959 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.8 mm -65.49 117.2 38.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.078 -0.963 . . . . 0.0 108.652 166.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.69 159.35 45.64 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.068 1.846 . . . . 0.0 112.782 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -23.96 65.8 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.361 1.465 . . . . 0.0 114.439 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -66.12 -33.58 76.1 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.012 -1.055 . . . . 0.0 113.019 171.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.8 mt -86.85 48.42 1.64 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.595 1.958 . . . . 0.0 111.025 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -31.5 70.04 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.238 1.415 . . . . 0.0 112.613 -167.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -77.93 -42.04 34.4 Favored 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.643 -0.661 . . . . 0.0 112.366 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.1 -38.89 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.615 0.766 . . . . 0.0 110.734 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.7 tp -61.19 -47.96 83.75 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.771 1.228 . . . . 0.0 113.182 172.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -68.86 -40.31 79.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.571 -0.706 . . . . 0.0 112.794 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -64.0 -31.21 72.32 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.589 1.156 . . . . 0.0 112.892 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.6 mt -55.47 -32.03 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 O-C-N 121.515 -0.74 . . . . 0.0 112.014 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -83.4 -10.61 58.32 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.089 -1.632 . . . . 0.0 114.243 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.79 -20.07 60.58 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.058 -1.026 . . . . 0.0 113.596 161.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.46 -16.41 62.38 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.623 1.102 . . . . 0.0 113.836 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -92.94 6.54 47.45 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.634 1.574 . . . . 0.0 112.577 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 p -131.7 -179.04 5.14 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -159.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 55.61 -162.01 0.16 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.066 1.746 . . . . 0.0 109.889 -166.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -80.48 -36.52 33.31 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.386 153.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -42.36 83.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 128.633 2.773 . . . . 0.0 114.327 -164.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -105.05 -34.97 7.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -55.51 -34.75 64.91 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.128 1.371 . . . . 0.0 113.359 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -79.75 -21.22 44.74 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 60.0 p -93.42 -12.67 29.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -51.05 117.67 2.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.883 1.273 . . . . 0.0 109.926 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -99.41 140.83 33.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.046 0.938 . . . . 0.0 111.59 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.4 119.92 6.34 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.978 1.311 . . . . 0.0 111.792 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -68.1 -41.57 81.61 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.265 1.426 . . . . 0.0 114.082 -149.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.1 -36.62 80.17 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.837 1.255 . . . . 0.0 112.926 171.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -78.2 -10.48 59.66 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.3 -47.28 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.9 1.227 . . . . 0.0 110.452 160.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.63 -57.15 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.017 1.327 . . . . 0.0 111.737 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.72 -25.7 64.89 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.75 -27.72 37.5 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.006 -1.059 . . . . 0.0 113.477 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 40.6 t90 -68.91 -39.8 79.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.901 1.351 . . . . 0.0 112.371 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -44.11 -56.32 7.97 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -166.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.35 -21.72 60.84 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 CA-C-N 122.206 1.823 . . . . 0.0 113.781 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -84.18 3.33 35.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.693 1.597 . . . . 0.0 114.187 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 2.2 p -60.22 -25.44 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.4 0.546 . . . . 0.0 111.226 154.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.509 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 17.5 m-80 -104.01 -37.0 7.54 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.359 -1.782 . . . . 0.0 115.277 -159.382 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.08 -160.61 0.1 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.564 0.745 . . . . 0.0 111.718 -168.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.1 123.56 22.4 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.327 -0.858 . . . . 0.0 110.629 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -130.78 103.2 6.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.375 1.07 . . . . 0.0 108.369 168.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.4 mt -75.03 139.83 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 m -118.37 137.33 53.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 158.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.25 142.39 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.911 -1.118 . . . . 0.0 110.542 -159.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.682 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 35.0 tttm -67.83 126.61 29.96 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.357 170.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.02 175.61 8.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.003 1.721 . . . . 0.0 111.845 170.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.39 141.96 28.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.852 0.861 . . . . 0.0 111.673 167.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.9 t -54.35 119.8 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.073 0.463 . . . . 0.0 110.15 168.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.65 -13.06 31.27 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.35 83.15 63.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.902 1.851 . . . . 0.0 112.011 -172.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.21 -10.65 26.65 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.713 2.942 . . . . 0.0 116.266 -171.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -83.1 -6.9 59.66 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 pt -142.92 161.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.186 1.394 . . . . 0.0 111.578 -167.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.42 -41.0 61.63 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.01 -125.51 6.63 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.729 1.157 . . . . 0.0 114.622 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.43 14.29 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.118 2.567 . . . . 0.0 116.92 -171.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.459 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 68.7 m -115.02 76.39 4.44 Favored Pre-proline 0 C--O 1.257 1.476 0 O-C-N 120.052 -1.655 . . . . 0.0 110.974 -158.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.23 -28.15 40.5 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.535 2.824 . . . . 0.0 112.113 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -64.83 -37.36 87.34 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.231 -0.918 . . . . 0.0 113.159 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -62.45 -40.03 95.3 Favored 'General case' 0 C--N 1.364 1.205 0 O-C-N 119.659 -1.901 . . . . 0.0 110.986 172.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -66.01 -27.7 68.32 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.199 1.0 . . . . 0.0 112.753 -176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -58.01 -43.51 86.73 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.509 1.123 . . . . 0.0 112.761 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 t -73.92 -38.5 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.808 1.243 . . . . 0.0 111.826 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.0 mt -66.91 -39.59 87.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.57 0.748 . . . . 0.0 111.405 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.85 -41.45 99.37 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.052 0.941 . . . . 0.0 113.268 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 p -70.26 -43.66 70.04 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.772 1.169 . . . . 0.0 112.397 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.69 -35.01 72.57 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -77.59 -23.25 49.96 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 172.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -71.2 -43.04 68.19 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.472 -1.393 . . . . 0.0 112.005 166.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -70.69 -8.15 49.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.702 1.601 . . . . 0.0 114.291 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 59.09 16.14 4.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 127.065 2.146 . . . . 0.0 114.64 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.58 128.81 73.65 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.397 1.079 . . . . 0.0 109.799 -176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.58 155.74 44.97 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.981 2.454 . . . . 0.0 113.258 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -152.32 159.16 43.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.128 1.771 . . . . 0.0 110.165 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -77.41 151.06 34.95 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.991 -1.068 . . . . 0.0 109.482 152.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 t -127.81 126.61 42.03 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.772 0.829 . . . . 0.0 110.713 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -117.91 83.38 1.99 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.521 1.529 . . . . 0.0 109.161 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.7 mt -65.6 135.51 55.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.506 0.723 . . . . 0.0 110.804 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.459 HG22 ' H ' ' A' ' 45' ' ' GLY . 10.8 mt -130.12 120.13 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.533 1.533 . . . . 0.0 110.004 -174.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -84.47 103.58 13.74 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.606 -0.684 . . . . 0.0 109.394 167.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt 54.89 15.18 1.06 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 168.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.459 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 111.67 17.23 8.72 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.779 1.18 . . . . 0.0 115.343 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -65.4 12.19 0.05 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 120.036 1.918 . . . . 0.0 116.167 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.93 143.95 36.45 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 126.084 1.753 . . . . 0.0 109.909 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.88 163.29 19.49 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.889 2.393 . . . . 0.0 112.516 -167.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -64.43 -11.84 37.32 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 116.798 -1.572 . . . . 0.0 115.077 -167.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -55.53 -22.35 21.06 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 163.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -101.93 2.63 38.2 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.443 1.497 . . . . 0.0 113.302 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.8 mt -126.81 -38.08 2.08 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.112 2.165 . . . . 0.0 112.843 -171.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.25 -17.57 20.29 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.865 2.466 . . . . 0.0 113.324 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.78 -20.5 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 127.156 2.182 . . . . 0.0 111.322 171.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 93.9 p -116.14 137.41 23.42 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.142 1.377 . . . . 0.0 111.499 158.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.99 -25.22 38.49 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.582 2.188 . . . . 0.0 113.039 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.7 pm0 -71.99 -8.27 53.54 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.295 1.038 . . . . 0.0 113.7 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.64 51.29 48.65 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.832 1.196 . . . . 0.0 112.973 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -131.64 174.22 10.34 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.251 2.22 . . . . 0.0 110.877 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG12 HG22 ' A' ' 62' ' ' VAL . 23.5 m -140.57 152.6 66.68 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.752 1.621 . . . . 0.0 108.284 163.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -66.09 156.21 80.38 Favored 'Cis proline' 0 C--N 1.348 0.511 0 N-CA-C 116.845 1.825 . . . . 0.0 116.845 11.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG22 HG12 ' A' ' 60' ' ' VAL . 31.2 m -158.08 167.49 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 128.577 2.751 . . . . 0.0 109.027 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.05 148.67 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 120.92 -1.113 . . . . 0.0 113.293 166.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -90.54 140.86 29.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.476 153.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.9 mt -116.93 72.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 126.734 2.014 . . . . 0.0 108.039 170.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.2 t70 57.31 61.12 2.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.112 1.365 . . . . 0.0 112.19 -165.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.307 5.2 m-20 57.96 9.82 1.01 Allowed 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 -175.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -88.85 120.86 30.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.578 1.151 . . . . 0.0 108.316 163.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -87.99 152.18 22.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -164.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -143.34 133.84 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.888 2.075 . . . . 0.0 109.206 171.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.07 -147.9 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.857 2.063 . . . . 0.0 113.641 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -50.29 159.37 0.47 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -170.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 p -39.42 -40.71 0.86 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.849 2.06 . . . . 0.0 115.341 166.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -15.14 60.75 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.1 m -103.33 -22.52 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.75 0.704 . . . . 0.0 112.86 165.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.7 mt -59.55 -42.38 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.483 1.113 . . . . 0.0 111.872 170.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.2 m -62.68 -8.16 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.04 -58.38 0.56 Allowed Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.4 1.0 . . . . 0.0 113.297 159.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.55 -32.25 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.777 1.231 . . . . 0.0 113.313 -164.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.39 -45.36 55.24 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.998 -1.064 . . . . 0.0 110.315 167.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.92 -30.33 71.43 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 18.8 tt0 -66.11 -46.2 78.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.128 1.771 . . . . 0.0 112.943 168.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.8 mttt -90.73 -9.35 47.02 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.716 1.206 . . . . 0.0 113.336 -169.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -76.06 140.59 70.14 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.011 1.724 . . . . 0.0 110.106 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.68 -11.99 22.17 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.946 1.764 . . . . 0.0 115.057 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -87.6 151.18 50.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.825 1.193 . . . . 0.0 111.056 164.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.48 144.42 18.67 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.652 2.902 . . . . 0.0 114.904 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.44 126.35 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.054 2.503 . . . . 0.0 112.285 -172.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.1 mt -67.02 -10.43 49.69 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 163.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.14 -21.57 47.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.697 1.599 . . . . 0.0 114.092 169.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.9 m -63.75 114.56 13.83 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 123.846 0.858 . . . . 0.0 110.245 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.17 127.44 7.58 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.014 1.809 . . . . 0.0 112.226 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.2 175.16 11.62 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.43 2.087 . . . . 0.0 110.143 154.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -56.12 -31.91 63.73 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.568 -1.333 . . . . 0.0 113.507 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -59.31 -21.09 59.21 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.445 1.498 . . . . 0.0 114.648 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.99 73.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.843 1.201 . . . . 0.0 112.593 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 79.9 p -64.48 -41.33 96.53 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.607 -0.683 . . . . 0.0 112.098 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.96 -42.0 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.812 1.245 . . . . 0.0 111.557 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.04 -23.29 65.78 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.725 1.631 . . . . 0.0 114.522 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -61.99 -24.55 67.1 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -85.8 -44.28 12.61 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.571 1.148 . . . . 0.0 112.427 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.1 mt -67.12 -37.75 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 111.262 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -58.94 -46.64 99.52 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.533 -1.223 . . . . 0.0 114.023 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.94 -29.96 1.9 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.8 2.333 . . . . 0.0 114.172 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.2 p -70.86 -28.65 64.73 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 121.673 2.033 . . . . 0.0 113.542 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -58.6 -39.64 80.97 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.58 -1.325 . . . . 0.0 112.847 162.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.3 -29.81 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.188 -0.945 . . . . 0.0 111.627 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -68.04 -43.8 77.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.768 0.827 . . . . 0.0 111.84 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -65.34 -31.44 72.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.286 1.034 . . . . 0.0 112.843 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.9 mt -82.21 6.79 15.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.44 1.896 . . . . 0.0 114.113 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -132.8 54.81 1.93 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.6 1.96 . . . . 0.0 110.422 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -61.65 16.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 129.768 3.227 . . . . 0.0 118.405 -155.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -62.32 -42.69 99.59 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.765 -1.209 . . . . 0.0 110.911 166.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 54.6 m-20 -84.6 128.7 60.19 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.93 -1.033 . . . . 0.0 108.469 174.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 89.4 Cg_exo -60.92 129.99 31.08 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 120.911 1.361 . . . . 0.0 115.511 -153.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -68.91 -39.7 79.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 117.542 -1.218 . . . . 0.0 113.785 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -59.72 -30.45 68.83 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.66 -34.22 11.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.145 0.879 . . . . 0.0 113.666 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 51.0 m -68.65 -27.58 66.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.216 1.006 . . . . 0.0 112.139 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -62.49 -41.17 98.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.136 1.374 . . . . 0.0 112.29 167.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -69.8 -36.09 75.39 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.268 -0.895 . . . . 0.0 112.261 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.2 97.71 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.244 -0.91 . . . . 0.0 112.149 171.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.0 mt -67.71 -31.88 72.13 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.728 -1.129 . . . . 0.0 113.001 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.27 -45.26 95.23 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.664 1.574 . . . . 0.0 111.553 172.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -72.12 -34.71 68.8 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.766 1.166 . . . . 0.0 113.086 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -68.71 -40.41 79.99 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.264 -0.898 . . . . 0.0 112.655 173.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.9 -27.6 39.96 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.061 -1.024 . . . . 0.0 113.47 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -59.29 -41.88 89.98 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.373 1.442 . . . . 0.0 111.935 171.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.78 -24.79 67.01 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -82.35 -54.54 5.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.032 1.333 . . . . 0.0 111.587 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.44 -36.42 76.62 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -158.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.28 -35.65 92.23 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.017 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -83.6 -27.44 29.19 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.816 0.846 . . . . 0.0 112.959 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.04 -40.55 98.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.007 0.822 . . . . 0.0 111.767 172.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -62.97 -9.53 10.27 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.62 -35.33 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.347 1.059 . . . . 0.0 112.328 171.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -86.54 -55.26 3.96 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.76 177.56 34.93 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 -171.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.69 -7.72 17.75 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.919 3.746 . . . . 0.0 116.172 -158.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.47 167.46 11.14 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.637 1.108 . . . . 0.0 111.506 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.25 9.6 tt -78.22 4.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.359 -1.463 . . . . 0.0 112.792 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -108.83 -0.1 20.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.316 2.246 . . . . 0.0 114.721 163.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.15 -130.94 10.39 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.915 1.234 . . . . 0.0 113.751 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -26.61 67.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.67 1.588 . . . . 0.0 114.395 -170.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -127.41 151.83 48.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.178 1.791 . . . . 0.0 110.142 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.75 129.39 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.676 -0.64 . . . . 0.0 109.908 161.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.6 p -137.8 -170.76 2.84 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.821 1.248 . . . . 0.0 112.005 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.13 -16.95 3.47 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 173.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.1 t -72.78 -41.01 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.598 1.09 . . . . 0.0 111.819 171.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.59 -42.51 95.53 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.589 -1.319 . . . . 0.0 112.392 166.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.0 mt -61.26 -18.0 56.25 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 175.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.2 m -99.44 -46.32 5.53 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.445 1.098 . . . . 0.0 112.371 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.3 mt -96.55 -36.01 10.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.17 -47.64 94.15 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -171.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.21 -24.75 16.53 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 121.024 1.401 . . . . 0.0 112.954 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -72.14 -33.85 68.08 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 117.905 -1.045 . . . . 0.0 112.308 172.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.7 mt -65.65 -41.27 92.75 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.803 0.841 . . . . 0.0 112.912 168.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -62.19 -47.02 86.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.867 0.758 . . . . 0.0 112.101 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -64.61 -27.58 69.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.86 0.864 . . . . 0.0 112.817 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.45 -51.02 22.06 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.535 1.134 . . . . 0.0 113.479 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.3 -32.16 70.96 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.269 0.94 . . . . 0.0 111.744 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.5 -68.76 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.633 0.773 . . . . 0.0 112.913 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.19 -47.05 38.17 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.098 -1.001 . . . . 0.0 113.435 -161.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 52.4 tp -81.82 -33.31 30.8 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.721 175.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.38 -26.81 64.67 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.41 1.005 . . . . 0.0 114.555 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -59.86 -33.73 72.19 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 169.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -102.93 -29.42 11.43 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.029 0.932 . . . . 0.0 113.394 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -152.03 98.77 2.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.286 1.434 . . . . 0.0 109.266 168.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -72.81 78.55 1.13 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.646 0.778 . . . . 0.0 110.78 171.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -70.4 115.55 36.02 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.012 0.925 . . . . 0.0 110.109 175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.53 124.6 10.45 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.639 1.559 . . . . 0.0 110.048 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.1 mt -62.27 115.15 14.38 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 163.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.28 157.23 55.23 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.547 1.498 . . . . 0.0 112.676 -170.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -25.1 62.22 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.714 1.606 . . . . 0.0 113.707 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -67.29 -36.38 81.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.19 1.396 . . . . 0.0 113.101 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.71 49.56 1.21 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.135 1.774 . . . . 0.0 110.824 164.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -37.12 70.53 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.032 1.733 . . . . 0.0 112.339 -166.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -80.73 -41.01 24.28 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.803 0.841 . . . . 0.0 111.961 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.67 -40.62 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.595 0.758 . . . . 0.0 110.753 171.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.85 -49.13 76.08 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.872 1.269 . . . . 0.0 112.997 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -65.92 -37.12 85.23 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.545 -0.722 . . . . 0.0 112.715 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -62.17 -27.59 69.07 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.122 0.969 . . . . 0.0 113.266 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 42.0 mm -53.15 -37.61 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.319 -0.863 . . . . 0.0 111.994 170.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -83.24 -7.13 59.65 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.701 -1.249 . . . . 0.0 113.48 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 47.7 mt -75.67 -22.46 56.7 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 117.874 -1.06 . . . . 0.0 113.454 160.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.89 -19.76 66.08 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.956 1.253 . . . . 0.0 113.654 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -88.25 4.94 43.99 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.807 -1.183 . . . . 0.0 113.906 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -134.33 -176.63 4.27 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -158.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.4 mtp85 54.78 -161.64 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.637 1.575 . . . . 0.0 109.914 -162.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.42 -38.42 24.08 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.783 1.233 . . . . 0.0 108.468 156.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.89 -52.93 58.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 129.542 3.137 . . . . 0.0 113.531 -167.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -97.48 -35.03 10.78 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -57.63 -32.43 67.24 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.69 -1.256 . . . . 0.0 113.105 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -80.81 -21.68 40.67 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.1 p -89.08 -13.23 39.09 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -52.64 110.11 0.48 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.923 1.289 . . . . 0.0 110.523 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -92.45 136.41 33.23 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.866 0.866 . . . . 0.0 111.763 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.5 121.28 8.67 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.712 1.205 . . . . 0.0 112.36 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.5 mp0 -70.21 -39.95 74.84 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -144.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -60.91 -35.31 76.35 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.625 1.17 . . . . 0.0 112.355 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -79.58 -12.65 59.84 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.19 -44.09 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.897 166.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.1 mt -63.63 -57.68 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.955 1.302 . . . . 0.0 111.182 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.05 -24.85 66.03 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -86.34 -27.78 29.46 Favored Glycine 0 CA--C 1.536 1.356 0 O-C-N 120.938 -1.101 . . . . 0.0 113.562 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 50.5 t90 -69.97 -41.4 74.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.242 1.521 . . . . 0.0 112.471 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -43.05 -56.86 5.78 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -167.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.75 -23.07 56.25 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 CA-C-N 122.21 1.825 . . . . 0.0 113.92 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -81.87 4.47 22.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.344 1.458 . . . . 0.0 113.895 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.9 p -63.08 -19.5 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.253 0.478 . . . . 0.0 111.905 159.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -125.63 -31.06 3.0 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.083 1.353 . . . . 0.0 113.878 170.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 CA-C-O 115.75 -2.071 . . . . 0.0 114.321 176.158 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.72 -164.06 0.08 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.025 0.93 . . . . 0.0 111.872 -169.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 78.5 mt -69.67 119.27 13.66 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.723 -1.236 . . . . 0.0 111.132 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -128.5 91.58 3.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.539 1.161 . . . . 0.0 109.159 173.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 30' ' ' LEU . 54.9 mt -68.38 138.37 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 124.945 1.298 . . . . 0.0 108.312 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.0 m -123.98 133.47 53.68 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 165.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.53 141.93 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 121.011 -1.056 . . . . 0.0 110.977 -158.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.693 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.4 tttm -65.55 126.36 28.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 170.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.03 173.77 10.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.851 1.661 . . . . 0.0 111.663 169.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.07 142.48 19.95 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.616 0.766 . . . . 0.0 111.604 168.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.07 120.88 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 166.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.89 -16.62 31.2 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.069 1.319 . . . . 0.0 116.144 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.22 87.51 50.78 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 119.757 1.779 . . . . 0.0 112.095 -171.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.03 -4.78 10.84 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.022 3.148 . . . . 0.0 115.715 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -92.23 -6.84 49.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.929 1.291 . . . . 0.0 114.286 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.44 163.84 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.111 1.365 . . . . 0.0 111.701 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.11 -40.44 31.07 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -175.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.88 -124.59 6.07 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.912 1.244 . . . . 0.0 114.725 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -65.56 15.43 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.115 2.566 . . . . 0.0 116.67 -173.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.428 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 68.7 m -116.36 72.76 5.16 Favored Pre-proline 0 C--O 1.259 1.562 0 O-C-N 120.207 -1.558 . . . . 0.0 110.972 -160.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -66.08 -30.66 47.01 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.474 2.783 . . . . 0.0 111.935 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -61.81 -35.96 79.74 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.233 -0.917 . . . . 0.0 113.27 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.693 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.6 m -65.24 -41.9 93.86 Favored 'General case' 0 C--N 1.37 1.47 0 O-C-N 120.101 -1.624 . . . . 0.0 111.003 172.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -63.91 -27.88 69.45 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.274 1.03 . . . . 0.0 112.687 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.569 HH12 ' CG ' ' A' ' 74' ' ' ASP . 72.4 mtp180 -56.52 -43.2 79.59 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.717 1.207 . . . . 0.0 112.779 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 t -74.99 -35.78 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.889 1.276 . . . . 0.0 112.005 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.81 -40.35 83.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.306 0.642 . . . . 0.0 111.236 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.09 -44.56 96.4 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.5 p -71.66 -37.84 70.74 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.284 1.402 . . . . 0.0 112.877 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.401 HD12 HD11 ' A' ' 5' ' ' ILE . 91.5 mt -71.8 -32.16 67.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.629 0.772 . . . . 0.0 112.853 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -76.6 -29.8 56.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -42.79 77.64 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.285 -1.51 . . . . 0.0 111.652 167.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -69.68 -9.2 53.38 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.925 -1.109 . . . . 0.0 113.408 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 mttp 58.14 26.36 13.62 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.286 2.234 . . . . 0.0 113.107 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -85.51 133.96 41.09 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.823 1.649 . . . . 0.0 110.159 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.15 148.25 49.83 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.943 2.428 . . . . 0.0 113.161 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -148.59 162.78 38.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.371 1.468 . . . . 0.0 111.724 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -86.0 150.87 24.17 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.906 -1.121 . . . . 0.0 109.639 152.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.1 t -135.39 111.27 9.42 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.862 0.865 . . . . 0.0 110.558 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -100.69 86.72 3.17 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.033 1.733 . . . . 0.0 109.111 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.97 132.8 49.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.339 0.656 . . . . 0.0 110.664 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 45' ' ' GLY . 7.1 mt -128.0 117.49 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.588 1.555 . . . . 0.0 110.119 -174.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -81.97 99.85 9.35 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.493 -0.754 . . . . 0.0 109.217 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.9 mt 53.85 25.8 5.58 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 168.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 105.09 15.01 21.2 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-O 118.614 -1.103 . . . . 0.0 115.744 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.32 12.18 0.05 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -140.17 146.08 44.55 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 125.842 1.657 . . . . 0.0 110.609 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -60.78 157.58 37.18 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.975 2.45 . . . . 0.0 112.799 -168.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -64.12 -12.85 43.44 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -168.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -51.6 -26.77 9.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.61 1.964 . . . . 0.0 115.863 161.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -100.24 3.53 43.64 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.694 1.598 . . . . 0.0 113.874 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.5 mt -124.81 -41.07 2.14 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.304 2.242 . . . . 0.0 112.887 -171.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -58.76 -16.33 16.3 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.526 2.33 . . . . 0.0 113.608 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.8 mt -58.05 -21.65 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 127.044 2.137 . . . . 0.0 111.173 171.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.1 p -111.52 147.41 36.66 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.037 0.935 . . . . 0.0 111.338 155.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.26 -12.68 35.71 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.887 2.391 . . . . 0.0 113.065 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.4 -13.97 59.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.412 1.485 . . . . 0.0 113.339 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.38 13.86 61.14 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.002 -1.062 . . . . 0.0 114.195 -166.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -88.4 167.43 13.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.506 1.522 . . . . 0.0 111.402 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.547 HG12 HG22 ' A' ' 62' ' ' VAL . 25.0 m -133.49 152.33 78.97 Favored Pre-proline 0 N--CA 1.469 0.498 0 C-N-CA 125.915 1.686 . . . . 0.0 109.207 157.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.32 151.83 63.99 Favored 'Cis proline' 0 C--N 1.35 0.632 0 N-CA-C 117.378 2.03 . . . . 0.0 117.378 10.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.547 HG22 HG12 ' A' ' 60' ' ' VAL . 29.1 m -158.87 171.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 129.264 3.026 . . . . 0.0 110.196 174.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.61 141.64 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 120.791 -1.193 . . . . 0.0 113.514 165.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -84.58 121.38 27.53 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.903 0.881 . . . . 0.0 108.74 153.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.2 mt -98.82 79.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.737 1.215 . . . . 0.0 108.652 170.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 55.55 53.41 9.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.279 1.032 . . . . 0.0 112.152 -165.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.81 14.09 3.06 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -174.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -94.99 109.93 21.89 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.428 -1.42 . . . . 0.0 108.56 166.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -77.8 147.31 35.32 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -160.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.35 132.28 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.902 1.681 . . . . 0.0 108.846 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.57 -142.15 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.972 1.709 . . . . 0.0 113.029 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.43 169.05 2.43 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -164.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.0 p -50.45 -39.73 48.53 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.569 ' CG ' HH12 ' A' ' 25' ' ' ARG . 7.4 m-20 -72.87 -22.38 60.78 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.51 1.505 . . . . 0.0 113.156 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -92.49 -24.03 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.962 -1.086 . . . . 0.0 113.818 165.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.1 mt -61.8 -42.87 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.123 1.329 . . . . 0.0 111.487 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.93 -7.08 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.66 -59.56 0.63 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.637 1.113 . . . . 0.0 113.36 159.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.0 mt -75.18 -33.34 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.677 1.191 . . . . 0.0 113.476 -164.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.08 -42.58 66.01 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.827 -1.171 . . . . 0.0 110.207 168.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -65.28 -28.88 69.64 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 22.4 tt0 -69.41 -43.86 72.57 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.995 2.118 . . . . 0.0 113.088 168.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 95.5 mttt -94.03 -7.15 43.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.481 1.112 . . . . 0.0 113.695 -168.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -77.22 141.38 66.63 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.978 1.311 . . . . 0.0 110.082 171.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -68.21 -26.34 36.09 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 121.918 1.746 . . . . 0.0 113.815 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -82.24 142.64 47.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.941 0.791 . . . . 0.0 110.79 172.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -53.74 150.84 27.59 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.561 2.841 . . . . 0.0 116.325 -166.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.08 118.95 5.89 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.087 2.524 . . . . 0.0 112.523 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.1 mt -67.61 -10.91 56.34 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.85 1.26 . . . . 0.0 112.504 162.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.99 -21.87 33.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.75 1.62 . . . . 0.0 113.922 165.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -61.17 114.47 10.75 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 124.01 0.924 . . . . 0.0 110.226 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.05 125.58 7.33 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.159 1.906 . . . . 0.0 112.304 -168.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -76.34 174.64 12.49 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.505 2.137 . . . . 0.0 110.216 156.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -54.52 -34.93 62.59 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.862 -1.149 . . . . 0.0 113.235 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -58.26 -21.06 46.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.099 1.759 . . . . 0.0 114.844 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.82 -30.37 71.43 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 120.263 1.392 . . . . 0.0 112.87 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.9 p -67.5 -15.65 63.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.622 1.169 . . . . 0.0 114.061 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.0 t -111.91 -39.84 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.222 1.409 . . . . 0.0 111.679 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.82 -24.01 67.88 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.198 1.38 . . . . 0.0 114.434 175.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.5 p -66.11 -19.6 65.89 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -85.99 -43.03 13.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.478 1.111 . . . . 0.0 112.329 166.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.2 mt -68.55 -34.68 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.375 0.67 . . . . 0.0 111.544 -174.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.41 -45.77 97.46 Favored Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 120.319 -1.488 . . . . 0.0 114.068 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.59 -22.23 4.68 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.161 2.574 . . . . 0.0 114.712 168.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.1 p -75.6 -26.53 57.93 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.856 2.116 . . . . 0.0 114.289 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -60.65 -39.33 87.92 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.136 -0.978 . . . . 0.0 112.582 159.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.37 -38.86 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 119.516 1.053 . . . . 0.0 111.752 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -62.85 -45.77 91.01 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.159 0.891 . . . . 0.0 112.042 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -68.66 -30.12 68.74 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.251 1.02 . . . . 0.0 113.307 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.7 mt -82.82 -2.34 54.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.381 1.873 . . . . 0.0 114.082 168.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -122.32 56.95 1.09 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.937 1.695 . . . . 0.0 109.687 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 m -66.43 24.49 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.042 2.937 . . . . 0.0 116.301 -161.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -68.09 -29.78 68.8 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.282 1.033 . . . . 0.0 111.377 152.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.36 141.16 93.26 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.785 160.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -68.11 98.22 0.52 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.015 1.81 . . . . 0.0 112.687 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -51.85 -42.34 62.53 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -171.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -22.36 66.74 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.978 1.263 . . . . 0.0 114.189 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.01 -32.6 9.69 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.52 1.057 . . . . 0.0 113.599 168.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.8 m -62.25 -31.63 72.22 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.097 0.959 . . . . 0.0 112.182 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.451 ' CD ' ' HZ3' ' A' ' 168' ' ' LYS . 57.0 mt-10 -62.7 -44.29 96.61 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.117 1.767 . . . . 0.0 112.128 172.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -66.41 -36.81 83.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.509 -0.745 . . . . 0.0 112.157 175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.8 94.98 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.283 -0.885 . . . . 0.0 112.393 172.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.72 -33.07 75.04 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.065 -0.969 . . . . 0.0 112.874 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.7 mt -61.65 -43.37 98.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.458 1.481 . . . . 0.0 111.911 174.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -73.01 -31.87 64.75 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.516 1.053 . . . . 0.0 113.186 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -66.86 -43.78 82.72 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.264 -0.897 . . . . 0.0 112.279 170.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.44 -28.77 52.6 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.255 1.022 . . . . 0.0 113.525 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -59.85 -39.59 85.7 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 120.081 1.31 . . . . 0.0 112.51 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.99 -24.1 66.71 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 tp -85.15 -54.89 4.33 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.39 1.476 . . . . 0.0 111.635 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.27 -37.88 81.16 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -158.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.52 -34.32 88.79 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.217 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -84.5 -27.24 27.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.82 0.848 . . . . 0.0 112.883 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.48 -39.54 94.74 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.451 -0.781 . . . . 0.0 112.05 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -64.08 -6.07 5.8 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.41 -35.36 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.54 1.136 . . . . 0.0 112.368 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -82.64 -53.81 5.65 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 159.16 178.68 33.39 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 -170.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.63 -13.24 18.19 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.781 3.654 . . . . 0.0 115.986 -159.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -86.27 169.16 13.26 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.668 1.122 . . . . 0.0 111.559 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.255 9.9 tt -77.95 9.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.307 -1.496 . . . . 0.0 112.572 176.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.29 2.27 10.29 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.818 2.447 . . . . 0.0 114.173 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.15 -128.99 9.75 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 119.399 1.0 . . . . 0.0 113.86 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -67.12 -24.4 65.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.222 1.409 . . . . 0.0 114.119 -168.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -136.32 157.13 47.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.004 1.722 . . . . 0.0 110.274 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 81.1 mt -65.37 136.24 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.751 0.821 . . . . 0.0 109.597 164.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.4 p -138.9 -174.16 3.77 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.496 1.119 . . . . 0.0 111.77 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.71 -16.02 5.63 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 170.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.3 t -71.25 -43.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.499 1.045 . . . . 0.0 111.616 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.4 -42.44 96.1 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.227 -1.546 . . . . 0.0 112.643 166.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 37.4 mt -62.41 -16.6 55.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.6 m -98.27 -48.57 5.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.939 1.296 . . . . 0.0 112.331 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 28.3 mt -92.68 -37.35 12.45 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.77 1.228 . . . . 0.0 114.083 -168.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.73 -48.53 89.41 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -169.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.62 -27.11 15.69 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 120.859 1.342 . . . . 0.0 112.83 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.1 -33.98 74.35 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 117.3 -1.333 . . . . 0.0 112.39 171.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.06 -42.21 94.43 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.379 0.991 . . . . 0.0 112.641 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -64.83 -44.69 88.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.311 0.959 . . . . 0.0 112.174 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -62.3 -32.19 72.89 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.665 -0.647 . . . . 0.0 112.496 175.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.3 tp -74.01 -45.31 50.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.421 1.488 . . . . 0.0 113.427 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.6 -37.7 73.68 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.937 1.295 . . . . 0.0 111.44 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.65 -59.4 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.8 -51.03 17.72 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.169 -0.957 . . . . 0.0 113.507 -166.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.0 tp -75.9 -36.3 59.5 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.202 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.17 -26.53 63.79 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.972 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -60.11 -32.69 71.23 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 170.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.21 -30.22 9.34 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.141 0.977 . . . . 0.0 113.626 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.451 ' HZ3' ' CD ' ' A' ' 120' ' ' GLU . 80.8 tttt -150.58 96.72 2.41 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.534 1.534 . . . . 0.0 109.548 168.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.9 75.13 0.89 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.862 0.865 . . . . 0.0 111.008 168.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -67.55 117.46 47.59 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 123.926 0.89 . . . . 0.0 110.339 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.83 121.8 8.24 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.744 1.629 . . . . 0.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 37.6 mt -61.3 112.76 6.42 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 161.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.8 156.28 62.67 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.567 1.512 . . . . 0.0 112.528 -169.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -21.77 63.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.125 1.37 . . . . 0.0 114.258 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -64.89 -37.47 87.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.182 0.993 . . . . 0.0 112.847 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.7 mt -81.23 49.09 1.21 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.288 1.835 . . . . 0.0 111.253 166.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -32.84 70.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.313 1.445 . . . . 0.0 112.306 -166.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -81.41 -39.54 24.8 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.499 0.72 . . . . 0.0 112.18 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.93 -40.86 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.427 0.691 . . . . 0.0 110.647 170.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 67.7 tp -64.59 -43.69 93.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.678 1.191 . . . . 0.0 113.333 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -69.33 -36.49 77.0 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.457 -0.777 . . . . 0.0 112.943 175.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -62.4 -26.68 68.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.964 0.906 . . . . 0.0 113.21 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 43.0 mm -51.36 -37.6 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.147 0.979 . . . . 0.0 112.16 168.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -78.8 -13.25 59.91 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.411 -1.431 . . . . 0.0 113.279 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 33.9 mt -74.81 -24.7 58.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.984 -1.007 . . . . 0.0 113.172 165.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.49 -23.78 67.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.361 0.982 . . . . 0.0 112.797 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -88.47 3.55 49.73 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.996 -1.065 . . . . 0.0 113.829 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.5 p -130.27 178.03 6.88 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -157.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 56.71 -170.36 0.09 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.154 1.781 . . . . 0.0 110.993 -173.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -72.8 -37.88 67.39 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.829 -1.17 . . . . 0.0 111.645 156.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -48.83 74.57 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.535 1.134 . . . . 0.0 113.679 -162.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -95.83 -35.03 11.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.01 -30.06 70.08 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.692 -1.255 . . . . 0.0 113.205 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.13 -24.87 51.64 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 63.3 p -90.25 -11.22 41.56 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -56.25 105.43 0.2 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.083 1.353 . . . . 0.0 110.512 171.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -76.12 151.63 36.95 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.998 0.919 . . . . 0.0 112.37 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.62 130.31 45.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.18 0.992 . . . . 0.0 111.303 166.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.56 -37.47 21.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.326 1.45 . . . . 0.0 112.902 -144.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -39.95 82.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.826 1.65 . . . . 0.0 113.037 167.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -79.99 -8.89 59.59 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.78 -47.77 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 120.103 1.319 . . . . 0.0 109.939 160.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.1 mt -65.14 -56.65 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.5 1.12 . . . . 0.0 111.204 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.45 -24.61 65.64 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.092 0.957 . . . . 0.0 113.45 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -85.13 -30.4 25.63 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.08 -1.012 . . . . 0.0 113.424 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -70.69 -36.56 73.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.127 1.464 . . . . 0.0 113.01 174.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -42.37 -56.51 5.5 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -164.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.64 -23.57 42.53 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 CA-C-N 122.359 1.878 . . . . 0.0 114.12 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -77.17 2.68 14.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.226 1.81 . . . . 0.0 113.904 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.38 -19.77 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.856 0.862 . . . . 0.0 112.377 156.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.44 -30.68 2.1 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 174.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 116.073 -1.918 . . . . 0.0 113.799 -179.616 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.02 -157.53 0.11 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.717 0.807 . . . . 0.0 112.002 -173.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.4 mt -73.07 119.51 17.42 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.358 -0.839 . . . . 0.0 111.182 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -123.94 98.51 5.83 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.833 1.253 . . . . 0.0 108.127 166.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.442 HD11 HD12 ' A' ' 30' ' ' LEU . 45.9 mt -74.22 135.02 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.2 m -120.53 129.89 54.0 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.1 140.2 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.99 -1.069 . . . . 0.0 110.737 -156.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.644 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.8 tttm -65.74 125.53 25.58 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 170.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.76 174.65 10.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.914 1.686 . . . . 0.0 111.76 169.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.55 140.85 21.8 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.884 0.874 . . . . 0.0 111.691 166.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.5 t -53.76 121.07 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.943 0.401 . . . . 0.0 110.091 167.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.3 -11.95 34.88 Favored Glycine 0 CA--C 1.536 1.403 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.91 83.93 55.37 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.979 1.89 . . . . 0.0 111.93 -172.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.24 -8.75 19.55 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.765 2.976 . . . . 0.0 116.742 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -91.63 -1.91 57.28 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.4 pt -142.56 163.09 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.253 1.421 . . . . 0.0 111.566 -170.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 mt -77.39 -41.75 38.95 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.28 -125.06 6.79 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.74 1.162 . . . . 0.0 114.961 -176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -65.1 13.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.318 2.647 . . . . 0.0 116.605 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.464 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 69.2 m -115.4 73.91 4.05 Favored Pre-proline 0 C--O 1.256 1.417 0 O-C-N 120.559 -1.338 . . . . 0.0 110.942 -160.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.77 -29.49 42.41 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 123.549 2.833 . . . . 0.0 111.804 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -61.19 -39.44 90.19 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.217 -0.927 . . . . 0.0 112.789 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.8 m -63.34 -42.43 98.94 Favored 'General case' 0 C--N 1.373 1.612 0 O-C-N 120.343 -1.473 . . . . 0.0 110.987 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -60.86 -32.92 72.32 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.878 0.871 . . . . 0.0 112.776 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.49 HH12 ' CG ' ' A' ' 74' ' ' ASP . 73.0 mtp180 -52.5 -43.55 65.12 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.783 1.233 . . . . 0.0 113.027 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -77.61 -32.2 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.058 1.343 . . . . 0.0 112.364 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.83 -37.47 76.21 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.074 -0.391 . . . . 0.0 111.27 168.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.59 -42.18 98.29 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.574 0.954 . . . . 0.0 113.574 -163.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.9 p -74.92 -38.57 61.77 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.953 0.797 . . . . 0.0 112.937 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.442 HD12 HD11 ' A' ' 5' ' ' ILE . 88.1 mt -67.89 -34.8 77.36 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.235 0.614 . . . . 0.0 112.609 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -77.66 -24.5 49.4 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -73.86 -42.65 60.48 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.691 -1.256 . . . . 0.0 112.283 169.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -66.52 -13.3 60.75 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.66 1.984 . . . . 0.0 112.846 167.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.8 mttm 61.86 21.47 12.28 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 127.827 2.451 . . . . 0.0 113.905 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.51 127.04 72.19 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.152 1.381 . . . . 0.0 109.66 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.3 152.46 49.93 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.93 2.42 . . . . 0.0 113.033 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -146.93 166.42 26.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.866 1.666 . . . . 0.0 111.13 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -89.8 148.87 22.96 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.04 -1.037 . . . . 0.0 109.813 156.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.1 t -131.98 108.73 9.55 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.868 0.867 . . . . 0.0 110.493 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -100.11 83.34 2.67 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.855 1.662 . . . . 0.0 108.494 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -69.23 130.5 42.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.418 0.687 . . . . 0.0 110.449 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 45' ' ' GLY . 9.3 mt -127.75 119.13 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.603 1.561 . . . . 0.0 110.266 -172.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -82.63 98.14 8.86 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 168.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt 53.72 30.11 10.58 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 167.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 99.55 16.19 29.91 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.79 8.53 0.18 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.089 1.945 . . . . 0.0 115.812 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -140.88 145.44 39.59 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 126.522 1.929 . . . . 0.0 110.02 -177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -62.46 161.26 28.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.153 2.569 . . . . 0.0 113.497 -164.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.95 -10.66 41.17 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -170.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -52.13 -21.71 3.54 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.284 1.834 . . . . 0.0 115.745 158.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -108.56 5.22 24.88 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.365 1.466 . . . . 0.0 113.516 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.7 mt -125.59 -40.76 2.05 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.969 2.108 . . . . 0.0 113.034 -171.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -61.09 -13.81 19.71 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 126.811 2.044 . . . . 0.0 113.641 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.5 mt -58.62 -21.39 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 126.816 2.046 . . . . 0.0 111.167 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 84.1 p -110.84 147.16 35.91 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.616 1.166 . . . . 0.0 111.203 155.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.05 -17.13 40.91 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.542 2.161 . . . . 0.0 113.025 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.12 -10.35 59.58 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.688 1.595 . . . . 0.0 112.997 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.91 13.69 62.03 Favored Glycine 0 CA--C 1.537 1.469 0 O-C-N 120.658 -1.276 . . . . 0.0 114.358 -169.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -81.35 168.72 18.09 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.465 1.906 . . . . 0.0 112.109 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 62' ' ' VAL . 15.3 m -136.71 151.05 71.87 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 113.211 -1.813 . . . . 0.0 108.769 153.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.9 151.07 91.46 Favored 'Cis proline' 0 C--N 1.349 0.562 0 N-CA-C 117.245 1.979 . . . . 0.0 117.245 11.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.523 HG22 HG12 ' A' ' 60' ' ' VAL . 35.8 m -154.58 170.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 128.779 2.832 . . . . 0.0 109.468 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.35 145.42 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 120.777 -1.202 . . . . 0.0 113.085 165.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -86.94 139.78 30.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.882 151.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.4 mt -118.52 81.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.249 1.42 . . . . 0.0 108.222 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.3 t70 55.53 55.38 7.35 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.171 1.388 . . . . 0.0 112.807 -164.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.72 20.29 3.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.746 2.018 . . . . 0.0 116.098 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -100.77 112.42 24.83 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.987 -1.071 . . . . 0.0 108.649 165.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -80.24 150.59 29.99 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -160.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.67 127.9 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.556 1.943 . . . . 0.0 109.029 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.93 -150.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.58 1.952 . . . . 0.0 113.825 -174.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.16 157.55 0.44 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -169.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.4 p -54.97 -28.26 50.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -173.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.49 ' CG ' HH12 ' A' ' 25' ' ' ARG . 3.3 m-20 -72.56 -21.41 61.16 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.076 1.351 . . . . 0.0 114.076 177.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 m -93.94 -23.59 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.729 1.149 . . . . 0.0 112.925 165.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.3 -42.34 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.276 0.944 . . . . 0.0 112.077 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -63.9 -6.17 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.43 -58.21 0.62 Allowed Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.602 1.096 . . . . 0.0 113.311 158.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -76.46 -31.08 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.602 1.161 . . . . 0.0 113.584 -163.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.6 tp -73.66 -40.28 63.83 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.526 -1.359 . . . . 0.0 110.746 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -65.14 -30.68 71.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.797 0.839 . . . . 0.0 113.11 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 25.3 tt0 -67.43 -42.26 83.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.384 1.874 . . . . 0.0 113.071 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.528 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.0 mttt -97.4 -7.33 32.01 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.537 1.135 . . . . 0.0 113.879 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.03 141.68 58.86 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.782 1.233 . . . . 0.0 110.015 169.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.23 -23.84 32.76 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.922 1.748 . . . . 0.0 114.252 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.33 139.57 60.09 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 117.734 -1.127 . . . . 0.0 110.343 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.53 146.73 18.87 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.869 3.046 . . . . 0.0 115.812 -171.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.47 120.24 7.4 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.875 2.383 . . . . 0.0 112.246 -173.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.4 mt -68.68 -8.6 43.97 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.042 0.937 . . . . 0.0 112.786 165.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.52 53.08 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.697 1.599 . . . . 0.0 113.717 164.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -61.58 112.11 5.49 Favored Pre-proline 0 N--CA 1.472 0.637 0 C-N-CA 124.072 0.949 . . . . 0.0 110.182 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.01 129.23 12.13 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.977 1.785 . . . . 0.0 112.246 -165.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -76.97 175.67 11.1 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.675 2.25 . . . . 0.0 110.401 157.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -53.56 -36.86 62.31 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.904 -1.123 . . . . 0.0 112.88 171.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -60.95 -15.93 36.9 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.063 1.745 . . . . 0.0 114.815 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.92 -30.29 70.11 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 120.321 1.419 . . . . 0.0 112.73 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.1 p -71.35 -8.62 54.96 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.179 1.392 . . . . 0.0 114.561 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.59 -41.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.735 1.214 . . . . 0.0 111.651 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.57 -22.92 68.31 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.106 1.336 . . . . 0.0 114.308 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.1 p -67.39 -18.16 65.02 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 168.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -87.91 -43.03 12.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.658 1.183 . . . . 0.0 112.15 165.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.57 -33.83 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.261 0.625 . . . . 0.0 111.721 -173.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.41 -48.78 92.86 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 120.387 -1.445 . . . . 0.0 113.743 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -79.89 -22.09 7.77 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.937 2.425 . . . . 0.0 114.998 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.0 p -73.85 -29.97 62.41 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 121.882 2.128 . . . . 0.0 113.363 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -62.85 -34.23 76.91 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.903 -1.123 . . . . 0.0 113.168 161.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.35 -41.93 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.056 1.298 . . . . 0.0 111.484 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -64.32 -43.66 93.99 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.337 0.971 . . . . 0.0 112.313 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.5 -30.19 70.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.053 0.941 . . . . 0.0 112.345 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.5 mt -91.97 20.94 5.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.79 1.636 . . . . 0.0 113.583 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -138.03 62.85 1.56 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.013 1.725 . . . . 0.0 110.33 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -60.46 13.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 129.158 2.983 . . . . 0.0 117.636 -164.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -68.3 -35.93 78.58 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.007 -1.058 . . . . 0.0 111.364 160.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -76.63 148.96 80.48 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.68 0.392 . . . . 0.0 110.128 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.23 106.48 1.57 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.083 1.856 . . . . 0.0 110.77 -175.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -62.04 -38.11 87.49 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.537 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.96 -27.65 68.99 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.383 -1.448 . . . . 0.0 114.455 173.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.27 -31.16 20.39 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.023 -1.048 . . . . 0.0 113.521 171.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.2 m -69.31 -29.91 67.86 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.626 1.171 . . . . 0.0 112.091 173.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.53 -44.21 96.92 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.177 1.791 . . . . 0.0 111.802 169.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -66.69 -37.14 84.14 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.3 -0.875 . . . . 0.0 112.534 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.38 93.73 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.381 -0.824 . . . . 0.0 112.461 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.5 tp -64.88 -36.49 84.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.916 1.286 . . . . 0.0 112.382 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -60.3 -40.2 89.65 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.521 1.055 . . . . 0.0 112.473 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -74.06 -27.7 61.04 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.953 0.797 . . . . 0.0 112.899 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -69.65 -44.66 70.12 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.186 -0.947 . . . . 0.0 112.097 168.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -72.18 -28.65 63.35 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -60.9 -38.09 84.51 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.911 1.232 . . . . 0.0 112.937 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.25 64.96 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 174.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 tp -87.53 -57.76 2.83 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.477 1.511 . . . . 0.0 112.011 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.36 -37.55 85.55 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -159.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.74 -34.05 88.9 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.708 -0.62 . . . . 0.0 113.657 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -89.78 -24.29 21.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.845 0.858 . . . . 0.0 112.997 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.6 -39.76 95.2 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.23 -0.919 . . . . 0.0 111.924 166.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -64.81 -5.54 6.16 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 172.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.2 t -101.15 -37.13 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.841 1.256 . . . . 0.0 112.31 168.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -82.13 -49.24 10.39 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 155.26 177.22 28.31 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 121.05 -1.031 . . . . 0.0 115.642 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.29 -13.65 20.76 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.933 3.755 . . . . 0.0 116.132 -161.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -82.93 170.02 15.39 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.515 1.052 . . . . 0.0 111.7 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.6 tt -78.74 10.85 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.503 -1.373 . . . . 0.0 112.532 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.65 5.32 6.14 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.798 2.439 . . . . 0.0 114.08 169.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.46 -120.87 6.97 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 119.08 0.855 . . . . 0.0 113.892 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -70.1 -22.31 63.04 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.229 1.012 . . . . 0.0 113.631 -164.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.0 pttt -144.2 168.54 19.79 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.542 1.937 . . . . 0.0 111.858 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.5 mt -67.77 131.72 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 161.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.2 p -130.3 -176.97 4.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.984 1.313 . . . . 0.0 111.219 173.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.19 -16.93 6.03 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 170.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.51 -46.58 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.714 0.806 . . . . 0.0 111.442 168.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.97 -41.25 99.49 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.442 -1.411 . . . . 0.0 112.936 168.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.8 mt -64.78 0.33 1.2 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.3 m -121.8 -43.0 2.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.625 1.17 . . . . 0.0 112.012 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.37 -40.09 13.82 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.778 1.231 . . . . 0.0 113.977 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.58 97.65 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -170.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.67 -25.43 12.6 Favored 'Trans proline' 0 C--N 1.35 0.632 0 CA-C-N 120.752 1.304 . . . . 0.0 112.8 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -68.88 -35.33 76.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 117.526 -1.226 . . . . 0.0 112.172 170.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.4 mt -64.84 -41.4 95.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 118.358 -0.829 . . . . 0.0 112.821 170.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -65.38 -42.08 93.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.321 0.964 . . . . 0.0 112.509 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -64.64 -30.07 71.09 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.304 -0.873 . . . . 0.0 112.435 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.2 tp -75.29 -44.48 45.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.001 1.321 . . . . 0.0 113.292 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -58.87 -36.41 74.57 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.696 1.198 . . . . 0.0 111.52 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.69 -57.07 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.69 -51.64 15.96 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.197 -0.939 . . . . 0.0 113.235 -166.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 60.6 tp -75.79 -33.4 60.16 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.564 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.22 -27.84 60.79 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.964 -0.909 . . . . 0.0 114.967 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -60.87 -27.27 68.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.182 1.393 . . . . 0.0 114.539 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -114.35 -33.07 5.74 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.604 1.162 . . . . 0.0 113.236 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -149.77 94.95 2.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.014 1.726 . . . . 0.0 109.091 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -71.17 76.53 0.7 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.65 0.78 . . . . 0.0 111.096 168.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -68.44 118.75 62.86 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 123.729 0.812 . . . . 0.0 110.234 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.96 128.63 14.27 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.644 1.563 . . . . 0.0 110.226 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.52 114.77 14.25 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 158.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -64.1 154.34 71.1 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.424 1.416 . . . . 0.0 113.29 -169.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -26.27 61.82 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.65 1.98 . . . . 0.0 113.489 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -62.95 -36.95 85.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.962 1.305 . . . . 0.0 112.607 172.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 87.2 mt -88.48 49.66 1.83 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.106 1.762 . . . . 0.0 111.239 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -28.96 69.62 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.283 1.433 . . . . 0.0 112.225 -166.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -80.15 -38.21 31.88 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.43 -0.794 . . . . 0.0 112.492 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.8 t -65.44 -39.17 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.773 0.829 . . . . 0.0 110.828 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 68.4 tp -65.02 -44.54 88.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.094 0.957 . . . . 0.0 113.117 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -67.3 -34.44 77.38 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.289 -0.882 . . . . 0.0 112.999 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -62.68 -26.94 68.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.838 0.855 . . . . 0.0 113.246 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.3 mm -53.7 -36.53 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 121.331 -0.856 . . . . 0.0 111.789 168.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -82.76 -7.43 59.65 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.418 -1.426 . . . . 0.0 113.713 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.27 -18.51 52.59 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 117.658 -1.163 . . . . 0.0 113.787 160.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.77 -17.49 63.11 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.117 1.326 . . . . 0.0 113.602 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -93.11 3.79 55.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.707 1.603 . . . . 0.0 113.749 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.6 p -123.17 178.77 4.95 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -159.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.7 mtp85 57.54 -165.57 0.16 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.335 1.854 . . . . 0.0 112.022 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -80.6 -38.31 29.62 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.62 1.168 . . . . 0.0 110.146 165.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.5 p -62.97 -81.13 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.484 2.314 . . . . 0.0 113.673 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -61.11 -39.82 91.44 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.172 -0.955 . . . . 0.0 113.507 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.35 -31.1 68.88 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.184 1.394 . . . . 0.0 113.736 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.31 -29.39 31.13 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.101 0.864 . . . . 0.0 113.22 172.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 81.5 p -75.8 -16.91 60.03 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 174.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -60.46 99.36 0.08 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.3 1.44 . . . . 0.0 112.125 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.61 150.42 41.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.37 123.16 18.02 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.008 1.323 . . . . 0.0 111.849 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -64.11 -47.04 81.57 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.956 1.702 . . . . 0.0 115.326 -153.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -61.71 -35.01 76.79 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.851 0.86 . . . . 0.0 112.258 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -77.97 -12.33 59.98 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.59 -45.54 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.406 1.003 . . . . 0.0 109.946 165.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.7 mt -67.16 -58.0 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.985 1.314 . . . . 0.0 111.585 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.06 -27.94 67.79 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.72 -21.01 62.47 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 120.848 -1.157 . . . . 0.0 113.782 171.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -80.2 -25.45 39.66 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.409 1.605 . . . . 0.0 113.841 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -47.27 -53.99 24.62 Favored Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -173.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.64 -18.5 37.53 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 122.295 1.855 . . . . 0.0 114.024 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -81.73 4.96 20.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.006 1.723 . . . . 0.0 114.11 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.32 -18.61 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 120.972 -1.08 . . . . 0.0 112.012 154.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -124.08 -35.64 2.8 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.12 1.368 . . . . 0.0 113.695 174.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 115.713 -2.089 . . . . 0.0 113.904 177.736 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.8 ttm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.63 -159.77 0.1 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.94 0.896 . . . . 0.0 111.514 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.0 mt -69.92 119.9 14.83 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.302 -0.873 . . . . 0.0 110.94 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -130.4 93.09 3.38 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 30' ' ' LEU . 55.6 mt -74.05 139.14 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.599 1.159 . . . . 0.0 108.642 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.8 m -119.98 135.86 54.75 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 167.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.32 141.72 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.936 -1.103 . . . . 0.0 110.292 -162.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.708 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.2 tttm -66.4 127.66 33.16 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 170.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.24 172.92 12.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.488 1.515 . . . . 0.0 111.732 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.54 139.82 36.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.186 0.994 . . . . 0.0 111.438 168.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 120.44 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.191 0.52 . . . . 0.0 110.05 169.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.66 -12.1 42.77 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 118.274 -1.292 . . . . 0.0 116.254 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.85 85.16 58.74 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 120.011 1.906 . . . . 0.0 111.891 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.82 -6.37 13.97 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.429 3.419 . . . . 0.0 117.179 -168.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -101.78 0.75 36.33 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.9 pt -141.81 162.59 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.61 1.564 . . . . 0.0 111.118 -172.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.07 -48.28 30.85 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.71 -126.71 13.42 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.338 0.97 . . . . 0.0 114.398 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.95 23.25 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 128.189 2.596 . . . . 0.0 117.009 -172.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.495 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.8 p -121.63 71.09 27.11 Favored Pre-proline 0 C--O 1.257 1.459 0 O-C-N 120.191 -1.568 . . . . 0.0 110.962 -159.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.75 -29.4 42.68 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.754 2.969 . . . . 0.0 112.424 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -61.96 -39.13 91.07 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.6 m -63.09 -45.81 90.37 Favored 'General case' 0 C--N 1.376 1.739 0 CA-C-N 120.2 1.364 . . . . 0.0 111.018 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -57.56 -33.09 67.77 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.712 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' A' ' 74' ' ' ASP . 74.7 mtp180 -53.72 -43.82 69.35 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.756 1.223 . . . . 0.0 112.883 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -76.74 -27.25 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.394 1.477 . . . . 0.0 112.098 -170.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.59 -42.36 52.18 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.704 0.802 . . . . 0.0 111.076 169.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.64 -39.07 83.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -161.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 p -72.8 -43.45 62.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.121 0.873 . . . . 0.0 112.661 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.485 HD12 HD11 ' A' ' 5' ' ' ILE . 99.4 mt -66.32 -32.39 73.77 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.058 0.943 . . . . 0.0 112.08 177.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -79.55 -26.98 41.27 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -75.29 -39.05 60.04 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.064 0.847 . . . . 0.0 112.33 168.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -68.99 -9.62 53.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.931 1.693 . . . . 0.0 113.063 167.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 83.4 mttt 58.62 21.52 8.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.812 2.445 . . . . 0.0 114.746 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.98 123.53 83.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.497 1.119 . . . . 0.0 109.31 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.54 152.64 54.38 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.77 2.313 . . . . 0.0 112.519 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.434 ' CD1' HD12 ' A' ' 5' ' ' ILE . 35.4 p90 -150.78 160.32 43.95 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.462 1.505 . . . . 0.0 110.94 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -81.74 146.78 29.79 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.136 -0.978 . . . . 0.0 109.636 159.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -123.2 126.84 47.71 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.715 0.806 . . . . 0.0 111.319 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -115.09 80.72 1.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.748 1.619 . . . . 0.0 108.972 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.04 130.66 43.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.136 0.974 . . . . 0.0 110.368 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -129.74 120.34 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.772 1.229 . . . . 0.0 110.587 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -86.86 101.09 13.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.46 0.704 . . . . 0.0 109.246 168.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.5 mt 53.21 28.17 6.81 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 167.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.41 16.64 24.26 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -65.97 3.49 0.82 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 120.227 2.014 . . . . 0.0 115.698 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -140.15 146.92 48.25 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 126.541 1.936 . . . . 0.0 110.029 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.25 160.23 31.75 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.013 2.475 . . . . 0.0 113.772 -163.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.29 -10.38 23.57 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -55.35 -20.08 10.69 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.41 1.884 . . . . 0.0 114.902 164.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -108.39 9.84 27.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.37 1.868 . . . . 0.0 113.173 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.3 mt -132.68 -41.57 0.94 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.406 2.282 . . . . 0.0 112.637 -171.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.41 -13.53 20.88 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.905 2.482 . . . . 0.0 113.578 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mt -59.81 -21.93 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 127.162 2.185 . . . . 0.0 111.045 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.6 p -106.85 149.67 38.79 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.403 1.481 . . . . 0.0 110.998 156.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -68.52 -17.4 43.5 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.519 2.146 . . . . 0.0 112.975 170.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -82.09 -9.78 59.42 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.515 1.526 . . . . 0.0 113.443 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.5 23.09 73.56 Favored Glycine 0 CA--C 1.539 1.565 0 O-C-N 121.041 -1.037 . . . . 0.0 114.118 -171.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -89.63 172.69 8.77 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.497 1.919 . . . . 0.0 113.598 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.08 153.53 81.78 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 112.945 -1.934 . . . . 0.0 108.619 152.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.15 152.14 80.06 Favored 'Cis proline' 0 CA--C 1.536 0.587 0 N-CA-C 115.108 1.157 . . . . 0.0 115.108 5.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.1 m -155.19 164.65 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 128.141 2.577 . . . . 0.0 109.06 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.59 144.42 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 120.157 -1.589 . . . . 0.0 114.028 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -88.88 132.14 34.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.899 155.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.7 mt -109.27 79.64 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.829 1.252 . . . . 0.0 108.326 168.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 55.76 57.09 5.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.718 1.207 . . . . 0.0 112.865 -165.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.8 14.19 3.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -98.37 107.23 19.64 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.409 -1.432 . . . . 0.0 108.36 168.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -76.73 148.81 36.5 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.532 1.133 . . . . 0.0 113.712 -160.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -141.8 127.94 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.415 1.886 . . . . 0.0 109.34 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.53 -152.46 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.393 1.877 . . . . 0.0 113.828 -174.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.92 159.25 0.59 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.398 1.879 . . . . 0.0 115.211 -167.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.0 p -54.48 -29.06 48.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 25' ' ' ARG . 41.6 m-20 -73.41 -15.53 61.35 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 m -100.2 -22.23 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.296 0.953 . . . . 0.0 113.007 163.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.1 mt -61.01 -40.82 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.449 1.022 . . . . 0.0 111.928 173.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.1 m -62.01 -7.39 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.17 -56.73 0.52 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.679 1.133 . . . . 0.0 113.346 161.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.1 mt -75.77 -31.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.648 1.179 . . . . 0.0 113.327 -164.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.5 tp -71.7 -42.7 67.07 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.83 -1.169 . . . . 0.0 110.51 168.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -65.26 -30.69 71.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 33.2 tt0 -66.25 -42.61 88.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.245 1.818 . . . . 0.0 112.996 169.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.532 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 94.5 mttt -99.78 -4.8 29.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.675 1.19 . . . . 0.0 113.621 -167.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -79.2 142.34 59.0 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.49 1.516 . . . . 0.0 110.188 170.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.7 -22.26 20.83 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.875 1.717 . . . . 0.0 114.004 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -80.08 145.43 60.88 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.043 169.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.52 149.09 24.89 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.632 2.888 . . . . 0.0 115.684 -172.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.13 120.47 7.62 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.939 2.426 . . . . 0.0 112.334 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.5 -10.13 53.55 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.436 -0.79 . . . . 0.0 112.593 164.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.58 -19.48 49.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.957 1.703 . . . . 0.0 114.211 166.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.5 m -59.91 112.88 6.02 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 123.712 0.805 . . . . 0.0 109.909 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.63 126.34 10.76 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.718 1.612 . . . . 0.0 111.852 -165.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.74 164.5 33.06 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.457 2.105 . . . . 0.0 110.788 159.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -51.97 -33.84 39.67 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.289 1.436 . . . . 0.0 112.961 160.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -60.63 -18.6 54.37 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 172.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.45 -29.9 70.85 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.505 -1.372 . . . . 0.0 113.182 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 94.3 p -67.61 -15.16 63.51 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.73 -38.79 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.419 1.488 . . . . 0.0 111.271 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.18 -27.8 71.16 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.31 0.957 . . . . 0.0 114.151 173.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.6 p -66.87 -19.49 65.74 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 171.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -87.91 -43.93 11.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.301 1.04 . . . . 0.0 112.837 167.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.8 mt -65.28 -32.79 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 122.605 0.362 . . . . 0.0 110.827 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.17 -49.57 90.16 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.238 -1.363 . . . . 0.0 114.449 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.32 -23.19 10.37 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.56 2.84 . . . . 0.0 114.128 167.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.493 ' HA ' ' CE ' ' A' ' 108' ' ' LYS . 17.2 m -66.88 -31.78 72.61 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.955 1.707 . . . . 0.0 114.147 171.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -67.73 -27.78 67.09 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 164.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.29 -42.27 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.313 1.415 . . . . 0.0 111.331 173.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.493 ' CE ' ' HA ' ' A' ' 105' ' ' SER . 53.3 mtmt -59.94 -47.87 84.03 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.035 0.834 . . . . 0.0 111.473 171.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -32.5 73.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.48 0.712 . . . . 0.0 112.333 -173.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.6 mt -88.01 17.03 5.26 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.537 1.535 . . . . 0.0 113.423 170.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -134.68 64.04 1.61 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.948 1.699 . . . . 0.0 110.335 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -60.39 10.22 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.351 2.66 . . . . 0.0 117.262 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -63.72 -33.33 75.42 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.012 -1.055 . . . . 0.0 111.605 156.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -82.23 149.1 61.38 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.044 0.938 . . . . 0.0 110.637 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.24 98.37 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.622 2.214 . . . . 0.0 110.913 -174.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -61.79 -31.81 72.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 116.925 -1.512 . . . . 0.0 114.394 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.34 -29.03 70.17 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.666 -1.272 . . . . 0.0 113.695 172.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.54 -27.63 32.07 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 120.891 -1.131 . . . . 0.0 113.656 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.1 m -70.93 -31.39 67.97 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.548 -0.972 . . . . 0.0 112.336 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.28 -44.09 96.08 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.879 1.672 . . . . 0.0 111.486 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -64.23 -41.46 97.0 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.466 -0.771 . . . . 0.0 112.788 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.4 95.02 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.382 -0.824 . . . . 0.0 112.66 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.9 tp -66.84 -36.58 82.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.738 1.215 . . . . 0.0 112.068 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.59 -38.1 83.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.809 1.186 . . . . 0.0 112.743 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.91 -29.22 62.97 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.063 0.847 . . . . 0.0 112.681 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -74.85 -37.6 62.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.201 1.0 . . . . 0.0 112.311 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.4 mt -71.9 -32.89 67.86 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.794 -1.191 . . . . 0.0 113.104 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -61.51 -39.45 91.03 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 120.014 1.279 . . . . 0.0 112.54 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.8 -25.46 67.25 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 174.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -86.29 -57.7 2.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.207 1.403 . . . . 0.0 112.46 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.71 -44.54 89.93 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -157.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.49 -24.79 69.64 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.637 -0.535 . . . . 0.0 113.312 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -89.23 -29.78 19.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.06 -0.972 . . . . 0.0 112.91 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.13 -39.4 86.14 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.32 1.418 . . . . 0.0 111.826 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 178' ' ' HIS . 86.0 mttt -60.77 -12.42 10.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.692 1.597 . . . . 0.0 114.778 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 99.4 t -96.58 -31.02 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.087 1.355 . . . . 0.0 112.663 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -103.93 -27.72 12.0 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -167.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.22 177.43 19.09 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 120.095 1.316 . . . . 0.0 115.459 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.11 -11.39 23.23 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.761 3.64 . . . . 0.0 116.131 -163.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -84.6 173.29 10.9 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.522 1.055 . . . . 0.0 112.222 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.2 tt -79.65 13.15 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 120.874 -1.141 . . . . 0.0 112.411 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.72 24.87 2.4 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.161 2.584 . . . . 0.0 112.783 169.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.94 -117.55 4.44 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.733 -1.229 . . . . 0.0 113.408 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -64.56 -23.92 67.43 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -165.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -152.84 166.4 32.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.929 1.291 . . . . 0.0 112.617 -168.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.1 mt -66.16 128.95 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.5 0.72 . . . . 0.0 109.193 161.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.9 p -127.74 -178.69 4.59 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.069 1.748 . . . . 0.0 110.55 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.14 -15.31 13.76 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.374 -1.454 . . . . 0.0 114.823 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.37 -45.94 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.971 0.805 . . . . 0.0 111.178 167.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.98 -41.85 98.48 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.745 -1.222 . . . . 0.0 112.678 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.9 -0.88 1.69 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 172.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.1 m -121.53 -37.79 2.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.652 1.181 . . . . 0.0 112.061 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.8 mt -94.16 -38.22 11.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.854 1.262 . . . . 0.0 114.042 -176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.56 -47.7 92.25 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -169.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -74.27 -23.82 15.09 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.967 1.381 . . . . 0.0 113.046 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -70.3 -35.19 73.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.469 -1.253 . . . . 0.0 112.28 170.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 24.3 mt -64.7 -40.97 96.29 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.347 0.976 . . . . 0.0 112.585 168.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -62.21 -48.54 79.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.723 0.773 . . . . 0.0 112.188 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -64.6 -25.16 67.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.867 0.867 . . . . 0.0 112.573 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 32.1 tp -79.41 -43.28 23.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.802 1.241 . . . . 0.0 113.793 175.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -60.72 -32.86 72.1 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.739 0.815 . . . . 0.0 111.544 174.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 80.5 t -92.93 -62.44 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.029 0.931 . . . . 0.0 113.243 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.29 -51.89 27.03 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.323 0.965 . . . . 0.0 113.19 -166.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 53.8 tp -76.3 -35.69 58.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.542 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.87 -26.54 60.7 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.024 -0.876 . . . . 0.0 114.897 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -60.11 -32.07 70.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.962 1.305 . . . . 0.0 114.332 169.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -107.38 -32.0 7.93 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.439 1.095 . . . . 0.0 113.311 -178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -149.58 96.34 2.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.79 1.636 . . . . 0.0 108.963 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -71.81 77.33 0.87 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.858 0.863 . . . . 0.0 110.712 169.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 87.0 t90 -75.83 114.85 40.78 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.91 0.884 . . . . 0.0 109.947 172.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -72.74 138.92 29.87 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.731 1.62 . . . . 0.0 110.4 177.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.6 mt -65.48 120.1 65.27 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 155.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -60.88 154.86 53.1 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.235 1.956 . . . . 0.0 113.154 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -22.35 64.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.446 1.499 . . . . 0.0 114.188 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -59.91 -42.74 94.53 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 112.157 168.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 78.4 mt -87.91 45.78 1.31 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.382 2.273 . . . . 0.0 111.326 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -29.26 67.72 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.658 1.583 . . . . 0.0 113.331 -168.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 135' ' ' LYS . 43.7 t-80 -79.69 -38.42 33.54 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.417 -0.802 . . . . 0.0 112.138 -175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.7 t -69.87 -36.08 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.888 -0.508 . . . . 0.0 111.077 170.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.6 tp -61.55 -42.93 99.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.116 0.966 . . . . 0.0 112.926 170.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -70.82 -32.2 69.18 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.284 -0.885 . . . . 0.0 113.264 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -63.02 -29.9 71.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.017 0.826 . . . . 0.0 112.932 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.47 -36.25 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.553 0.741 . . . . 0.0 111.503 169.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -81.78 -5.41 58.15 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.302 -1.499 . . . . 0.0 114.179 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.47 -22.74 54.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 117.989 -1.005 . . . . 0.0 113.357 159.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.34 -16.35 63.51 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.893 1.224 . . . . 0.0 114.17 -170.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -93.11 4.97 53.1 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.844 -1.16 . . . . 0.0 114.125 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.4 p -131.82 -174.68 3.49 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -158.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 59.31 -172.92 0.11 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.343 1.857 . . . . 0.0 111.809 -170.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -71.55 -34.87 70.38 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.918 163.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.4 p -76.7 -80.85 0.09 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.723 2.009 . . . . 0.0 112.558 -172.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -55.64 -40.49 72.26 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.206 -0.934 . . . . 0.0 113.258 -168.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.99 -38.52 67.95 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.105 1.762 . . . . 0.0 114.57 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -79.96 -33.36 39.58 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.178 0.899 . . . . 0.0 112.295 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 12.2 p -72.2 -7.44 49.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 171.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 199' ' ' GLU . 33.5 ttt180 -60.4 109.84 1.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.072 1.305 . . . . 0.0 110.162 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -84.77 142.1 30.05 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.616 0.766 . . . . 0.0 111.833 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.11 125.95 25.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.722 1.209 . . . . 0.0 111.995 177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 196' ' ' ARG . 1.0 OUTLIER -75.79 -34.96 60.22 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -151.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -39.02 92.8 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.85 -1.156 . . . . 0.0 112.757 169.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -76.86 -19.52 57.38 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.943 -1.098 . . . . 0.0 113.92 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 45.8 t -69.15 -46.11 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.082 0.855 . . . . 0.0 110.657 166.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mt -67.49 -55.63 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.028 0.931 . . . . 0.0 111.275 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.92 76.71 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -78.68 -18.18 75.98 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.846 -1.158 . . . . 0.0 113.721 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 58.2 t90 -82.43 -21.24 35.78 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.681 1.74 . . . . 0.0 114.069 173.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -45.83 -51.29 30.98 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.96 -18.39 24.32 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.179 1.919 . . . . 0.0 114.467 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -77.87 0.24 24.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.452 1.501 . . . . 0.0 114.345 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.3 m -60.48 -20.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.244 -0.91 . . . . 0.0 112.426 155.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -122.54 -33.48 3.42 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.592 1.557 . . . . 0.0 113.18 173.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -178.663 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.15 -161.14 0.08 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.178 0.991 . . . . 0.0 111.826 -169.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.5 mt -72.5 124.93 26.21 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.938 -1.102 . . . . 0.0 111.45 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -137.41 101.03 4.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.136 0.975 . . . . 0.0 108.777 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.652 HD11 HD12 ' A' ' 30' ' ' LEU . 64.3 mt -87.04 130.6 36.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 125.125 1.37 . . . . 0.0 108.605 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m -110.59 134.44 52.41 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.658 0.783 . . . . 0.0 109.418 169.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.04 140.66 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 121.114 -0.991 . . . . 0.0 110.8 -164.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.735 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.6 tttm -66.53 126.84 30.14 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 170.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.21 173.15 11.26 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.776 1.63 . . . . 0.0 111.657 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.07 139.56 34.52 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.245 1.018 . . . . 0.0 111.372 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.4 t -54.67 118.3 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.006 0.431 . . . . 0.0 109.976 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.55 -10.22 65.25 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.471 1.349 . . . . 0.0 116.471 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.7 84.93 43.39 Favored Pre-proline 0 CA--C 1.552 1.019 0 CA-C-N 120.325 2.063 . . . . 0.0 112.397 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.5 5.24 1.01 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 125.281 3.987 . . . . 0.0 117.82 -168.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.74 6.11 10.98 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.704 1.201 . . . . 0.0 113.551 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.1 pt -140.36 160.84 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.906 1.682 . . . . 0.0 110.563 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 mt -74.64 -48.68 24.9 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.29 -125.44 10.21 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.318 0.961 . . . . 0.0 114.539 -174.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.2 21.16 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.084 2.554 . . . . 0.0 116.886 -171.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.463 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.4 p -121.13 70.18 20.3 Favored Pre-proline 0 C--O 1.255 1.36 0 O-C-N 120.241 -1.537 . . . . 0.0 111.006 -158.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -68.42 -29.24 31.61 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.431 2.754 . . . . 0.0 112.067 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -59.85 -38.65 82.71 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.704 0.802 . . . . 0.0 113.109 168.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.735 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.6 m -64.87 -45.96 83.82 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 119.995 1.271 . . . . 0.0 111.0 173.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -55.85 -36.09 67.17 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.089 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.528 HH12 ' CG ' ' A' ' 74' ' ' ASP . 76.1 mtp180 -52.02 -45.94 64.79 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.689 1.196 . . . . 0.0 113.305 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.77 -32.57 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.337 1.455 . . . . 0.0 111.792 -169.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.14 -42.15 72.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.731 0.813 . . . . 0.0 111.027 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.0 tp -60.16 -39.26 85.78 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 p -71.63 -44.47 64.32 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.187 0.903 . . . . 0.0 112.753 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.652 HD12 HD11 ' A' ' 5' ' ' ILE . 96.9 mt -72.76 -31.46 64.94 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.917 0.887 . . . . 0.0 112.251 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -79.08 -23.51 44.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -74.85 -41.23 60.25 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.218 0.917 . . . . 0.0 112.066 167.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -69.22 -8.58 47.16 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.135 1.374 . . . . 0.0 113.372 167.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HE2' ' HG3' ' A' ' 190' ' ' GLU . 66.9 mttt 58.88 18.37 6.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.783 2.433 . . . . 0.0 115.22 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.8 mt -76.04 125.74 87.66 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.062 0.945 . . . . 0.0 109.462 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.7 150.01 68.02 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.617 2.211 . . . . 0.0 112.463 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.497 ' CD1' HD12 ' A' ' 5' ' ' ILE . 45.8 p90 -150.5 160.13 43.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.585 1.554 . . . . 0.0 110.718 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -84.95 131.46 34.48 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.957 -1.089 . . . . 0.0 110.085 163.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.2 t -93.25 131.65 38.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.29 0.636 . . . . 0.0 112.136 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -125.77 74.33 1.41 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.853 1.661 . . . . 0.0 109.665 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.8 mt -65.94 134.36 52.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.912 0.885 . . . . 0.0 110.561 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 mt -135.27 125.89 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.001 1.32 . . . . 0.0 110.667 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -88.26 100.27 12.86 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.328 -0.857 . . . . 0.0 109.684 166.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.3 mt 54.88 24.52 5.86 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 165.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.71 17.43 21.33 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.731 1.052 . . . . 0.0 115.731 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' OD2' ' HE3' ' A' ' 47' ' ' LYS . 4.1 p-10 -65.4 -7.31 13.25 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.852 1.826 . . . . 0.0 114.661 174.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HE3' ' OD2' ' A' ' 46' ' ' ASP . 71.9 mttt -133.9 143.04 45.78 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.944 2.098 . . . . 0.0 108.565 -178.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.69 165.05 21.89 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.359 2.706 . . . . 0.0 114.657 -155.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -59.14 -15.09 12.56 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -56.29 -18.01 9.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.322 1.849 . . . . 0.0 115.199 168.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -112.66 11.54 19.57 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.103 2.161 . . . . 0.0 113.026 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.9 mt -137.86 -38.62 0.57 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.274 2.23 . . . . 0.0 112.507 -169.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.32 -14.71 19.87 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 128.165 2.586 . . . . 0.0 113.61 171.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.83 -21.15 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 127.022 2.129 . . . . 0.0 111.074 168.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.2 p -105.83 149.25 37.77 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.167 1.387 . . . . 0.0 110.9 153.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.92 -12.46 35.38 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.569 2.179 . . . . 0.0 113.213 169.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 2.0 mm-40 -87.02 -10.88 52.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.204 1.802 . . . . 0.0 113.369 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.03 27.88 72.44 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-N 119.061 0.846 . . . . 0.0 114.335 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' A' ' 57' ' ' GLU . 36.1 mtmt -102.08 169.98 8.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.827 1.651 . . . . 0.0 113.297 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.49 155.61 68.74 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 126.535 1.934 . . . . 0.0 108.719 154.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -82.2 148.87 69.77 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 119.995 1.034 . . . . 0.0 114.754 2.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.6 m -156.13 159.79 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 128.081 2.552 . . . . 0.0 109.391 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.34 147.05 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.172 -1.58 . . . . 0.0 114.691 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -95.41 124.03 39.23 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.344 1.458 . . . . 0.0 109.771 162.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.1 mt -100.31 79.02 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.989 1.315 . . . . 0.0 108.353 168.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.97 54.67 6.79 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.475 1.11 . . . . 0.0 112.755 -165.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.264 0.5 OUTLIER 58.67 17.56 5.18 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.171 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -100.37 114.51 28.09 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.061 1.344 . . . . 0.0 108.178 167.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -83.36 148.28 27.41 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -157.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -140.12 129.16 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.402 1.881 . . . . 0.0 109.392 172.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.45 -148.06 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.4 1.88 . . . . 0.0 113.533 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -44.09 159.29 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 -168.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.4 p -54.34 -32.22 56.23 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.528 ' CG ' HH12 ' A' ' 25' ' ' ARG . 41.1 m-20 -74.51 -17.81 60.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 176.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 m -96.27 -25.02 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.46 1.027 . . . . 0.0 112.687 164.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.5 mt -60.62 -41.96 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.973 0.909 . . . . 0.0 112.076 173.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -62.28 -8.76 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.92 -62.03 0.58 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.392 0.996 . . . . 0.0 112.888 159.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.96 -32.94 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.035 1.334 . . . . 0.0 113.613 -163.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.8 tp -70.61 -46.18 63.87 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.955 -1.09 . . . . 0.0 110.55 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -65.31 -34.79 79.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.504 1.121 . . . . 0.0 113.086 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 5.4 tt0 -58.88 -41.38 86.97 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.033 2.133 . . . . 0.0 112.785 169.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.7 mttt -101.93 6.24 41.23 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.925 1.29 . . . . 0.0 113.358 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -89.77 144.34 31.56 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.19 1.396 . . . . 0.0 111.014 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.88 -22.34 23.51 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.027 1.818 . . . . 0.0 114.385 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -82.66 144.08 48.23 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 119.223 0.92 . . . . 0.0 109.806 164.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -54.36 149.47 37.59 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.221 2.614 . . . . 0.0 115.18 -175.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.13 124.22 13.12 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.43 2.753 . . . . 0.0 112.849 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.2 mt -68.63 -11.48 60.13 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.309 -0.87 . . . . 0.0 112.293 161.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.24 -13.19 35.17 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.784 1.634 . . . . 0.0 114.73 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 m -60.49 116.63 18.88 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.859 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.17 123.86 7.5 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 121.927 1.751 . . . . 0.0 112.132 -166.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.04 172.06 17.11 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.757 2.305 . . . . 0.0 110.499 161.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.58 -33.4 68.14 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.458 -1.401 . . . . 0.0 112.682 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -60.99 -13.82 18.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.042 1.737 . . . . 0.0 114.983 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.67 69.99 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.111 1.323 . . . . 0.0 112.547 172.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.5 p -70.88 -13.18 61.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.15 -42.63 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.807 1.243 . . . . 0.0 111.267 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.34 -26.53 72.66 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 121.014 -1.054 . . . . 0.0 114.292 174.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.7 p -68.84 -17.38 63.99 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.59 -47.03 10.96 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.541 1.064 . . . . 0.0 112.646 163.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 75.9 mt -65.78 -30.16 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.689 0.396 . . . . 0.0 111.12 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.09 -50.64 85.29 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 117.117 -1.42 . . . . 0.0 114.139 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.76 -27.38 8.87 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.301 2.667 . . . . 0.0 114.559 168.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.6 m -63.95 -35.09 79.54 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.035 1.743 . . . . 0.0 112.825 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -65.57 -29.03 69.58 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.723 -1.235 . . . . 0.0 113.912 166.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.9 t -66.68 -42.43 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.324 1.42 . . . . 0.0 110.539 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.73 -44.95 92.04 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.397 0.679 . . . . 0.0 112.78 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.81 -21.8 63.36 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.2 0.524 . . . . 0.0 112.104 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.7 mt -96.22 20.46 10.3 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.257 1.823 . . . . 0.0 113.402 167.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -140.23 69.21 1.35 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.512 1.525 . . . . 0.0 109.608 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.26 8.6 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.976 2.51 . . . . 0.0 116.608 -169.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -70.11 -33.6 72.05 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.82 1.248 . . . . 0.0 112.494 158.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -69.52 149.71 97.01 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.217 0.607 . . . . 0.0 109.971 159.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.17 101.43 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.339 2.026 . . . . 0.0 110.3 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.18 -39.65 79.47 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.64 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.49 -18.11 63.66 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.7 -28.99 14.38 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 121.196 -0.94 . . . . 0.0 113.355 168.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 60.8 m -69.53 -32.55 71.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.494 1.118 . . . . 0.0 111.907 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -58.23 -45.23 88.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.016 2.126 . . . . 0.0 111.887 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.19 -41.47 97.08 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.497 -0.752 . . . . 0.0 112.513 175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.87 -42.71 94.61 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.706 -0.621 . . . . 0.0 112.646 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.18 -37.4 87.23 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.548 1.139 . . . . 0.0 112.582 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.6 mt -60.88 -37.41 82.08 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.96 0.8 . . . . 0.0 112.658 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -71.22 -33.44 69.89 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.295 0.952 . . . . 0.0 112.605 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -71.19 -35.3 71.52 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.262 -0.899 . . . . 0.0 112.389 174.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -71.73 -31.64 66.91 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.855 0.862 . . . . 0.0 113.315 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -63.69 -36.3 83.38 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.029 1.286 . . . . 0.0 112.697 173.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.6 -28.69 68.7 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.02 -58.12 3.0 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.257 1.423 . . . . 0.0 112.911 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.16 -40.88 90.86 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -155.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.58 -26.68 72.03 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.679 -0.512 . . . . 0.0 113.729 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -89.98 -25.91 20.63 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.005 0.922 . . . . 0.0 113.06 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.67 -40.53 97.35 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.123 -0.986 . . . . 0.0 112.099 165.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -61.12 -14.19 22.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.018 1.327 . . . . 0.0 114.455 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.4 -34.48 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.733 1.213 . . . . 0.0 112.461 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -88.49 -53.49 4.63 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -174.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.54 177.41 34.6 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.646 1.019 . . . . 0.0 115.646 -169.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.07 -8.94 19.15 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.902 3.735 . . . . 0.0 116.503 -160.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -92.01 173.47 7.82 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.846 1.203 . . . . 0.0 112.199 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.258 8.5 tt -80.04 12.59 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.525 -1.36 . . . . 0.0 112.677 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.22 11.12 3.86 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.312 2.245 . . . . 0.0 113.543 168.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.99 -128.95 9.73 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 119.14 0.882 . . . . 0.0 113.748 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.92 -22.71 65.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.365 1.466 . . . . 0.0 114.541 -168.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -136.11 157.08 47.68 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.217 1.407 . . . . 0.0 112.04 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.35 131.64 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.875 1.27 . . . . 0.0 109.893 159.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.1 p -130.75 -176.08 3.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.304 1.842 . . . . 0.0 111.335 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.92 -14.52 22.97 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.125 -1.609 . . . . 0.0 114.787 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.66 -46.53 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.953 0.797 . . . . 0.0 110.874 167.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.7 -42.22 98.64 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.71 -1.244 . . . . 0.0 112.931 169.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.0 mt -64.48 -3.54 3.13 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.8 m -117.85 -39.46 3.11 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 120.892 -1.13 . . . . 0.0 112.055 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 21.8 mt -91.26 -38.97 12.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.593 1.157 . . . . 0.0 114.044 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.2 98.4 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.8 -22.66 13.25 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 121.07 1.418 . . . . 0.0 113.269 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -72.27 -33.92 67.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 117.544 -1.217 . . . . 0.0 112.319 170.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 30.2 mt -63.85 -41.27 97.85 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.036 0.835 . . . . 0.0 112.524 167.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -62.36 -45.31 93.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.575 0.625 . . . . 0.0 112.369 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -66.23 -25.91 67.12 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.536 0.734 . . . . 0.0 112.604 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.5 tp -77.37 -44.99 27.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.661 1.184 . . . . 0.0 113.137 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -61.39 -36.28 79.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.912 0.885 . . . . 0.0 111.498 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.71 -60.89 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.09 -47.98 15.16 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.148 -0.97 . . . . 0.0 113.332 -165.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.51 -37.13 79.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.382 0.537 . . . . 0.0 111.029 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.13 -27.86 60.56 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 115.636 1.014 . . . . 0.0 115.636 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -62.52 -30.25 71.15 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 171.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.41 -30.55 7.62 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.364 1.066 . . . . 0.0 113.149 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -149.43 101.07 3.07 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.243 1.817 . . . . 0.0 108.806 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -69.04 88.94 0.41 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.143 0.577 . . . . 0.0 110.495 168.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -82.78 111.33 28.69 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.605 1.162 . . . . 0.0 110.395 172.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.99 136.82 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.72 1.613 . . . . 0.0 109.812 170.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.1 mt -65.39 119.42 59.42 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 161.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -59.5 152.69 59.86 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.305 2.003 . . . . 0.0 113.339 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -23.1 64.79 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -63.72 -40.6 97.15 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.924 -1.11 . . . . 0.0 112.358 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.08 44.82 1.11 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.698 2.399 . . . . 0.0 111.187 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -28.39 69.23 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.356 1.462 . . . . 0.0 113.063 -167.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -77.28 -41.61 40.22 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.348 -0.845 . . . . 0.0 112.103 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 20.2 t -71.0 -32.9 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 118.908 -0.567 . . . . 0.0 111.368 171.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.39 -43.83 98.2 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.882 0.873 . . . . 0.0 112.826 168.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -69.1 -32.78 72.43 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.284 -0.885 . . . . 0.0 112.85 173.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -63.87 -27.5 69.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.721 0.809 . . . . 0.0 113.066 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.3 mt -53.16 -39.77 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.269 -0.895 . . . . 0.0 111.243 167.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -79.37 -10.27 59.77 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.262 -1.524 . . . . 0.0 113.488 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.22 -21.75 53.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 117.602 -1.19 . . . . 0.0 113.594 162.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.57 -21.77 65.85 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.115 1.325 . . . . 0.0 113.687 -177.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -89.3 5.13 46.37 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.803 -1.186 . . . . 0.0 114.071 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.2 p -129.68 -175.22 3.53 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -159.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 59.52 -169.8 0.14 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.339 1.856 . . . . 0.0 112.164 -172.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.402 ' HG3' ' HE2' ' A' ' 34' ' ' LYS . 70.3 mm-40 -70.28 -49.79 46.1 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.086 160.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -61.5 -78.19 0.04 OUTLIER 'General case' 0 C--O 1.231 0.113 0 C-N-CA 127.572 2.349 . . . . 0.0 113.267 -169.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -57.41 -40.39 78.19 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.737 0.699 . . . . 0.0 112.362 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.56 -40.38 91.4 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.14 1.376 . . . . 0.0 114.458 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.25 -35.95 74.15 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 120.114 1.324 . . . . 0.0 111.868 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.1 p -76.16 -1.61 27.08 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -64.71 99.14 0.3 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.273 1.397 . . . . 0.0 110.772 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.72 134.56 45.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.363 0.665 . . . . 0.0 111.736 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.65 122.78 13.6 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.026 0.93 . . . . 0.0 111.931 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.0 mp0 -68.51 -40.68 80.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.013 1.325 . . . . 0.0 113.962 -148.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -61.7 -33.98 74.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.339 1.056 . . . . 0.0 112.442 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -79.01 -15.05 58.78 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.973 -1.079 . . . . 0.0 113.778 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.44 -46.11 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 119.038 0.836 . . . . 0.0 109.829 166.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -63.83 -54.5 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.81 1.244 . . . . 0.0 111.272 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.52 -34.33 77.99 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.58 -15.74 72.72 Favored Glycine 0 CA--C 1.537 1.406 0 O-C-N 120.975 -1.078 . . . . 0.0 114.116 173.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -82.22 -21.96 36.13 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.804 1.802 . . . . 0.0 113.891 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -48.68 -47.36 71.58 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.98 -23.77 15.82 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 CA-C-N 122.16 1.807 . . . . 0.0 114.168 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.0 -1.82 30.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.862 1.665 . . . . 0.0 114.557 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 m -61.2 -20.47 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.48 -0.763 . . . . 0.0 112.239 158.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -118.86 -32.33 4.53 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.057 1.343 . . . . 0.0 114.461 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.25 0 CA-C-O 116.447 -1.74 . . . . 0.0 114.689 -174.855 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtp . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 119.67 -0.205 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.29 178.49 0.06 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.147 1.779 . . . . 0.0 113.285 -161.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.4 mt -64.7 99.82 0.35 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.171 -0.955 . . . . 0.0 110.57 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -99.27 92.96 5.68 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.125 0.97 . . . . 0.0 109.717 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.442 HD11 HD12 ' A' ' 30' ' ' LEU . 90.0 mt -78.94 119.37 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -114.91 109.06 17.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.104 0.865 . . . . 0.0 109.929 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.55 141.01 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.512 -0.742 . . . . 0.0 111.534 -153.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 19' ' ' ASP . 10.9 ttpp -66.43 124.73 23.56 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.957 167.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.6 -174.81 3.1 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.583 1.953 . . . . 0.0 111.357 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 149.04 12.23 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.376 0.671 . . . . 0.0 112.058 158.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.7 t -57.09 130.96 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.145 0.498 . . . . 0.0 110.266 162.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.97 -19.75 5.06 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.044 1.306 . . . . 0.0 115.921 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.65 89.41 43.68 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 119.624 1.712 . . . . 0.0 112.507 -170.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.71 32.1 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.149 1 C-N-CA 125.42 4.08 . . . . 0.0 115.105 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -136.71 0.38 2.45 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.77 1.628 . . . . 0.0 113.366 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.3 pt -142.51 157.67 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.992 1.317 . . . . 0.0 111.565 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.9 mt -85.35 -20.25 30.22 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -158.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 39.28 -135.98 1.4 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 127.381 2.419 . . . . 0.0 118.294 167.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 8' ' ' LYS . 7.7 p-10 -71.95 7.46 1.59 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.679 1.992 . . . . 0.0 115.233 -167.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.424 ' OG ' ' HE3' ' A' ' 8' ' ' LYS . 69.1 m -117.86 91.01 38.13 Favored Pre-proline 0 CA--C 1.51 -0.563 0 O-C-N 120.429 -1.419 . . . . 0.0 110.956 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.422 ' HD3' ' CD2' ' A' ' 159' ' ' HIS . 78.5 Cg_endo -63.98 -24.21 67.35 Favored 'Trans proline' 0 C--N 1.391 2.801 0 O-C-N 116.555 -2.392 . . . . 0.0 111.268 166.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -54.31 -42.31 69.97 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.902 2.481 . . . . 0.0 114.564 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.8 p -79.9 -32.02 40.24 Favored 'General case' 0 C--N 1.372 1.578 0 CA-C-N 120.768 1.622 . . . . 0.0 111.014 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.71 -27.35 68.85 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.15 1.38 . . . . 0.0 112.984 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.532 HH12 ' CG ' ' A' ' 74' ' ' ASP . 86.8 mtt180 -56.18 -42.8 77.67 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.476 1.111 . . . . 0.0 113.917 169.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.19 -34.59 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.792 0.837 . . . . 0.0 110.454 -170.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.5 mt -66.98 -44.86 79.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.272 1.029 . . . . 0.0 110.828 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 tp -56.48 -51.58 67.92 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.216 1.406 . . . . 0.0 113.196 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.08 -19.64 63.25 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.868 1.213 . . . . 0.0 113.981 -176.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.442 HD12 HD11 ' A' ' 5' ' ' ILE . 89.1 mt -93.01 -37.2 12.32 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.201 1.0 . . . . 0.0 112.716 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -68.93 -27.76 66.04 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.088 -1.008 . . . . 0.0 113.51 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -66.87 -41.83 86.62 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.953 -1.092 . . . . 0.0 111.78 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 81' ' ' GLU . 37.9 mttp -71.21 -11.61 61.02 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.283 1.433 . . . . 0.0 114.853 169.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm 63.67 7.43 3.13 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.253 1.821 . . . . 0.0 115.22 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.8 tt -74.54 130.7 81.32 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.086 0.954 . . . . 0.0 111.483 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.49 152.64 38.74 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.909 2.406 . . . . 0.0 113.698 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -152.39 176.02 12.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.929 1.692 . . . . 0.0 111.175 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -127.73 141.88 51.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.794 1.238 . . . . 0.0 110.864 164.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t -108.75 99.1 8.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.459 1.104 . . . . 0.0 111.499 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -78.0 86.62 4.18 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.154 1.381 . . . . 0.0 110.01 172.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.55 126.91 31.62 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.424 1.089 . . . . 0.0 112.439 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.458 HD12 HG11 ' A' ' 60' ' ' VAL . 5.2 mt -114.26 121.76 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.091 1.756 . . . . 0.0 110.235 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -82.88 95.89 8.09 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.229 -0.919 . . . . 0.0 109.306 162.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 mt 60.56 -12.79 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.986 2.587 . . . . 0.0 117.986 168.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.43 5.71 0.19 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.842 1.687 . . . . 0.0 114.149 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.01 -5.23 20.45 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.528 1.664 . . . . 0.0 115.052 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -109.3 137.23 20.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 124.411 1.084 . . . . 0.0 109.269 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.26 175.93 6.17 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.453 2.768 . . . . 0.0 113.643 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -47.41 -31.74 4.37 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -57.84 -23.36 52.4 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -93.29 -6.9 46.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.558 1.543 . . . . 0.0 114.079 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.7 mt -114.47 -36.46 4.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.786 2.034 . . . . 0.0 112.383 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -64.59 -5.38 5.44 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.954 2.901 . . . . 0.0 114.614 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.15 -22.19 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 126.492 1.917 . . . . 0.0 110.97 168.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -92.34 139.71 24.09 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.297 1.439 . . . . 0.0 111.615 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -68.96 -19.04 40.49 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.646 2.23 . . . . 0.0 112.883 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.11 -6.74 41.26 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.898 1.679 . . . . 0.0 112.884 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.39 2.3 26.22 Favored Glycine 0 CA--C 1.54 1.647 0 O-C-N 120.844 -1.16 . . . . 0.0 114.736 -163.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -89.46 129.12 36.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.712 1.605 . . . . 0.0 110.56 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.458 HG11 HD12 ' A' ' 42' ' ' ILE . 15.3 m -82.98 148.74 57.64 Favored Pre-proline 0 N--CA 1.474 0.741 0 O-C-N 121.316 -0.865 . . . . 0.0 109.496 154.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.29 134.14 20.67 Favored 'Cis proline' 0 CA--C 1.543 0.97 0 N-CA-C 116.511 1.697 . . . . 0.0 116.511 9.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 m -147.56 175.09 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 127.506 2.322 . . . . 0.0 111.615 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.4 m -138.17 148.65 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 120.767 -1.208 . . . . 0.0 113.664 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -93.33 132.05 37.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.209 1.003 . . . . 0.0 109.787 153.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.4 79.69 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.863 1.265 . . . . 0.0 108.452 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.6 t70 60.38 61.57 1.75 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.0 0.92 . . . . 0.0 112.385 -170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 61.93 -10.94 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -170.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -79.36 105.2 10.51 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.626 -1.296 . . . . 0.0 109.718 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -70.6 156.09 39.89 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -166.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.0 t -147.58 136.2 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.633 2.373 . . . . 0.0 109.359 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.93 -171.33 0.53 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.403 1.881 . . . . 0.0 114.337 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.96 166.56 9.06 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -154.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.3 p -50.82 -16.2 0.38 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.532 ' CG ' HH12 ' A' ' 25' ' ' ARG . 7.9 m-20 -103.42 -15.44 15.9 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.105 1.762 . . . . 0.0 111.636 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -108.58 -14.1 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.307 1.443 . . . . 0.0 113.437 165.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.72 -33.45 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.434 1.493 . . . . 0.0 112.564 164.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.6 -15.5 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.761 1.224 . . . . 0.0 113.185 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.85 -56.54 0.8 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.314 0.959 . . . . 0.0 113.224 158.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 mt -73.12 -29.67 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.64 1.22 . . . . 0.0 113.45 -161.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.0 tp -77.48 -14.37 59.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.622 -1.299 . . . . 0.0 112.694 173.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 33' ' ' LYS . 47.7 mm-40 -91.99 -42.71 9.84 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.705 1.602 . . . . 0.0 110.773 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 11.7 tt0 -50.89 -45.37 60.1 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.065 2.546 . . . . 0.0 112.977 170.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.442 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 98.5 mttt -98.91 9.99 42.33 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.728 1.211 . . . . 0.0 113.496 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.22 139.53 34.32 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.876 0.87 . . . . 0.0 111.511 -175.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -75.63 -27.58 8.9 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.097 1.864 . . . . 0.0 112.998 166.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -88.18 158.96 48.85 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.129 0.972 . . . . 0.0 111.453 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -50.85 125.36 15.73 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.538 2.825 . . . . 0.0 115.849 -168.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -59.95 142.13 97.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.57 2.847 . . . . 0.0 113.764 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.0 mt -114.89 8.18 15.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.696 1.599 . . . . 0.0 112.948 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.46 -12.15 59.59 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.7 m -57.85 117.3 18.31 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 123.971 0.908 . . . . 0.0 111.999 -169.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -86.03 115.0 1.4 Allowed 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.415 2.743 . . . . 0.0 111.248 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -78.18 -177.41 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.328 2.685 . . . . 0.0 111.151 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -55.48 -34.75 64.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.182 1.793 . . . . 0.0 112.372 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -60.97 -19.56 61.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.259 1.424 . . . . 0.0 114.284 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.29 68.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.168 0.894 . . . . 0.0 112.766 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.4 p -63.41 -59.2 5.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.969 0.804 . . . . 0.0 111.838 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.1 -37.07 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.542 1.137 . . . . 0.0 111.595 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.48 -31.27 79.03 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.069 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.2 p -71.15 -19.03 62.47 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.597 1.198 . . . . 0.0 114.193 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -86.27 -39.51 16.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.792 1.237 . . . . 0.0 112.471 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.5 -39.38 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.447 1.499 . . . . 0.0 111.45 173.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.3 -55.42 31.73 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.659 1.584 . . . . 0.0 114.202 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.99 -33.33 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.276 2.651 . . . . 0.0 113.117 172.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.5 p -65.99 -30.81 71.43 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.365 1.438 . . . . 0.0 112.352 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -79.91 -19.6 47.75 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.116 -1.615 . . . . 0.0 113.794 172.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.4 t -72.63 -42.26 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.448 -1.408 . . . . 0.0 110.23 163.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -68.42 -27.47 66.23 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.61 -40.72 84.07 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.279 1.432 . . . . 0.0 111.873 170.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.15 8.64 10.39 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.057 1.743 . . . . 0.0 114.688 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -142.21 35.62 1.52 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.494 2.718 . . . . 0.0 110.911 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 p -81.24 58.92 3.73 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.651 1.98 . . . . 0.0 113.487 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.32 -45.23 94.17 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.3 1.04 . . . . 0.0 110.061 161.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.91 119.88 67.3 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 128.349 2.66 . . . . 0.0 107.694 155.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.7 133.65 59.37 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.41 2.073 . . . . 0.0 115.833 -160.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -68.06 -31.61 71.37 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.018 -0.991 . . . . 0.0 112.103 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.78 -31.92 68.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.388 1.475 . . . . 0.0 113.993 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.66 -34.66 9.02 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 123.981 0.801 . . . . 0.0 113.279 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.9 m -64.1 -42.59 96.84 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.155 1.382 . . . . 0.0 112.078 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -58.97 -27.86 65.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.84 2.056 . . . . 0.0 113.128 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -68.36 -19.9 64.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.032 0.933 . . . . 0.0 112.804 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.24 -35.96 14.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.76 0.824 . . . . 0.0 112.427 166.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.9 mt -65.66 -34.49 78.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -62.64 -37.22 85.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.747 0.703 . . . . 0.0 112.072 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.98 -30.74 34.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.132 0.573 . . . . 0.0 112.527 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.08 -46.08 90.69 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.966 0.906 . . . . 0.0 111.944 166.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.95 -40.46 95.05 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.023 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -63.2 -42.05 99.25 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 120.343 1.429 . . . . 0.0 112.585 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.78 -35.07 79.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.274 0.63 . . . . 0.0 112.243 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.62 -54.86 7.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.772 0.829 . . . . 0.0 111.49 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.25 -35.69 81.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.692 1.997 . . . . 0.0 114.055 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.54 -33.44 81.72 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.913 0.768 . . . . 0.0 113.706 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -95.14 -29.08 14.74 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.9 mt -65.47 -32.8 74.61 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.543 -1.348 . . . . 0.0 113.259 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -66.06 -11.23 47.0 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 t -85.29 -28.69 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.948 0.899 . . . . 0.0 111.953 169.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -94.31 -37.35 11.55 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.756 1.222 . . . . 0.0 113.313 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.17 -72.34 0.22 Allowed Glycine 0 CA--C 1.541 1.712 0 CA-C-O 116.537 -2.257 . . . . 0.0 116.464 167.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -100.44 -35.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.969 0 N-CA-C 117.633 2.128 . . . . 0.0 117.633 -155.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -134.06 157.66 45.55 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.259 1.39 . . . . 0.0 112.856 -167.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.8 mt -71.09 -13.29 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.09 2.78 53.5 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 165.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 112.92 -134.28 11.85 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.062 1.315 . . . . 0.0 113.258 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -65.29 -25.45 67.64 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -139.67 163.89 31.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.77 1.228 . . . . 0.0 110.729 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.34 120.49 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.622 0.769 . . . . 0.0 110.637 170.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.7 p -144.39 -164.69 1.96 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.211 2.205 . . . . 0.0 109.321 163.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.57 -30.62 3.72 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 -160.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.96 -38.35 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 120.657 1.571 . . . . 0.0 112.771 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -62.76 -40.37 97.04 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.454 -0.779 . . . . 0.0 111.339 166.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.1 mt -64.94 -33.17 75.4 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.736 -0.602 . . . . 0.0 111.945 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.8 m -69.89 -38.37 76.31 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 120.179 -1.575 . . . . 0.0 113.237 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.5 mt -118.49 -32.18 4.69 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -159.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.3 -53.95 56.21 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 120.595 1.543 . . . . 0.0 115.084 -162.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.02 -19.8 29.69 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.577 1.518 . . . . 0.0 113.359 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -72.07 -30.97 65.66 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.593 -1.317 . . . . 0.0 111.849 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.81 -42.69 76.93 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.684 0.794 . . . . 0.0 111.895 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -64.88 -39.32 93.35 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 171.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.422 ' CD2' ' HD3' ' A' ' 21' ' ' PRO . 17.4 t-80 -65.04 -32.72 74.59 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 119.857 -1.777 . . . . 0.0 112.154 172.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.0 tp -68.4 -48.44 64.67 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.925 1.239 . . . . 0.0 111.072 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -51.61 -46.73 63.69 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.766 1.626 . . . . 0.0 112.195 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 82.9 t -74.13 -57.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.807 0.843 . . . . 0.0 113.261 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.93 -35.6 28.93 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.963 -1.086 . . . . 0.0 113.507 -167.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 tp -72.36 -32.33 66.37 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.681 -0.637 . . . . 0.0 111.205 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.75 -27.65 36.39 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.91 1.243 . . . . 0.0 114.855 171.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -68.04 -18.69 64.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -141.59 -27.3 0.67 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -149.69 81.61 1.4 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.512 1.525 . . . . 0.0 109.317 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.88 74.66 0.11 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.287 1.435 . . . . 0.0 112.282 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -70.58 112.93 14.69 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.334 1.854 . . . . 0.0 112.173 -169.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.11 142.02 27.01 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.546 2.164 . . . . 0.0 111.749 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.6 mm -92.25 112.82 57.01 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.371 1.068 . . . . 0.0 108.897 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -67.55 155.09 71.62 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.474 2.116 . . . . 0.0 112.116 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.78 -14.49 53.18 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -61.76 -31.37 71.56 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.216 -0.928 . . . . 0.0 112.724 167.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.92 56.68 3.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.477 1.911 . . . . 0.0 110.814 168.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -24.06 64.96 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.336 1.055 . . . . 0.0 113.277 -160.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -74.64 -51.74 13.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.413 1.006 . . . . 0.0 110.305 165.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 24.5 t -57.37 -46.91 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.288 0.949 . . . . 0.0 112.675 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 58.6 tp -64.3 -29.24 70.33 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -91.42 -30.6 16.41 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.149 -0.969 . . . . 0.0 113.328 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -63.65 -36.59 84.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.23 1.412 . . . . 0.0 112.933 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.84 -37.19 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.376 -0.827 . . . . 0.0 111.582 172.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -66.62 -30.16 70.37 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.044 -1.66 . . . . 0.0 112.654 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.3 mt -70.84 -20.18 62.57 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.412 -1.28 . . . . 0.0 113.219 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.1 mt -65.85 -22.62 66.55 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.117 1.326 . . . . 0.0 112.715 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -83.7 17.36 2.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.541 1.536 . . . . 0.0 113.486 171.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 p -142.33 178.57 7.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.126 2.17 . . . . 0.0 113.045 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 58.82 174.42 0.07 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.064 1.746 . . . . 0.0 113.609 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 190' ' ' GLU . 5.1 mp0 -74.56 -44.51 50.68 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.791 1.236 . . . . 0.0 109.563 166.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -20.68 66.33 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.578 1.951 . . . . 0.0 116.042 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -116.24 -48.08 2.73 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.132 1.333 . . . . 0.0 113.59 171.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -63.13 -30.08 71.31 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.37 -1.456 . . . . 0.0 114.529 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -74.2 -18.74 60.72 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.5 p -97.82 -1.49 43.05 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.698 1.199 . . . . 0.0 112.757 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -59.43 123.51 17.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.543 1.537 . . . . 0.0 111.429 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.63 165.45 24.25 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.572 1.149 . . . . 0.0 113.162 170.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.8 125.56 29.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.028 0.531 . . . . 0.0 110.14 161.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.03 -34.07 57.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -150.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -36.94 79.05 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.168 1.387 . . . . 0.0 110.853 169.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -84.74 -7.47 59.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.978 1.711 . . . . 0.0 113.07 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 31.3 t -77.06 -51.04 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.472 -0.768 . . . . 0.0 109.413 158.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.05 -50.5 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.721 1.208 . . . . 0.0 111.669 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.14 -15.28 63.38 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.74 -25.26 18.35 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.471 -0.768 . . . . 0.0 113.862 168.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -78.24 -31.44 49.25 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.033 1.333 . . . . 0.0 113.732 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -48.02 -56.63 12.93 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -69.65 -20.72 34.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 120.652 1.269 . . . . 0.0 112.022 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -84.86 3.84 36.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.242 1.817 . . . . 0.0 114.005 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 65.5 t -68.62 -28.79 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.127 0.876 . . . . 0.0 110.312 153.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -96.96 -51.99 4.04 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.34 -1.314 . . . . 0.0 113.832 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 C-N-CA 126.954 2.102 . . . . 0.0 113.234 -177.138 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 ttm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 118.373 -0.823 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.47 -169.37 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.21 1.004 . . . . 0.0 112.233 -168.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.2 mt -71.78 116.09 11.75 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.916 -1.115 . . . . 0.0 110.597 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -125.71 111.29 14.75 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.503 HD11 HD12 ' A' ' 30' ' ' LEU . 52.9 mt -92.15 135.29 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 m -112.0 137.75 49.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.227 0.611 . . . . 0.0 109.621 163.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.69 140.95 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.03 -1.044 . . . . 0.0 110.153 -162.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 31.7 tttm -66.45 124.68 23.43 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 170.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.87 172.73 12.97 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.256 1.423 . . . . 0.0 111.524 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.39 140.84 32.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.055 0.942 . . . . 0.0 111.624 169.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.4 t -54.57 119.42 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.19 0.519 . . . . 0.0 109.949 171.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.04 -13.86 41.86 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 116.425 1.33 . . . . 0.0 116.425 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.04 84.39 63.42 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 120.128 1.964 . . . . 0.0 112.044 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.23 7.56 0.63 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 125.149 3.899 . . . . 0.0 117.658 -167.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -120.74 6.27 10.48 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.876 1.271 . . . . 0.0 113.509 -172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.5 pt -142.09 160.28 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.176 1.79 . . . . 0.0 110.44 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.35 -48.73 31.82 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.75 -125.83 12.16 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.657 1.122 . . . . 0.0 114.601 -174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.79 18.04 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.348 2.659 . . . . 0.0 117.154 -171.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.467 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.9 p -118.45 75.39 12.17 Favored Pre-proline 0 C--O 1.25 1.12 0 O-C-N 120.344 -1.472 . . . . 0.0 110.955 -159.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.65 -31.91 39.5 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.936 2.424 . . . . 0.0 111.865 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -62.45 -37.16 84.81 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.962 0.905 . . . . 0.0 113.061 171.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -63.99 -46.27 85.28 Favored 'General case' 0 C--N 1.379 1.863 0 O-C-N 119.924 -1.735 . . . . 0.0 110.994 171.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -56.92 -37.16 71.07 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.198 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.5 HH12 ' CG ' ' A' ' 74' ' ' ASP . 69.9 mtp180 -52.59 -44.05 65.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.187 0.995 . . . . 0.0 112.714 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -78.63 -28.85 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.019 1.328 . . . . 0.0 112.441 -168.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.9 mt -71.79 -41.11 68.7 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.245 -0.285 . . . . 0.0 111.278 166.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -60.47 -35.72 76.57 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -162.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.7 p -69.59 -48.28 60.7 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.325 0.966 . . . . 0.0 112.569 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.503 HD12 HD11 ' A' ' 5' ' ' ILE . 96.3 mt -71.52 -31.77 67.43 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.703 0.801 . . . . 0.0 112.167 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -77.69 -23.49 49.51 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -77.42 -40.38 43.66 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.146 0.885 . . . . 0.0 112.507 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -67.91 -9.58 46.21 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.859 1.264 . . . . 0.0 112.92 165.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 mttt 58.29 17.72 4.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.034 2.534 . . . . 0.0 114.676 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.84 124.93 91.61 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.035 0.934 . . . . 0.0 108.806 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.29 140.25 57.9 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.804 1.669 . . . . 0.0 111.001 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CD1' HD12 ' A' ' 5' ' ' ILE . 45.3 p90 -138.4 160.72 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.468 1.507 . . . . 0.0 109.709 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -93.41 122.77 36.18 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.385 1.074 . . . . 0.0 110.05 172.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.7 t -87.93 134.13 33.78 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -127.5 76.61 1.68 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.279 1.832 . . . . 0.0 109.912 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.0 mt -68.49 133.2 48.24 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.923 0.889 . . . . 0.0 111.253 170.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 mt -134.98 122.72 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.66 1.584 . . . . 0.0 110.512 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -83.34 98.85 9.67 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.278 -0.889 . . . . 0.0 109.602 169.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.6 mt 60.03 -6.87 0.07 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.6 11.84 0.83 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.751 1.644 . . . . 0.0 115.074 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.81 -5.5 12.47 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.045 1.923 . . . . 0.0 115.169 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -134.44 145.14 53.95 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 126.442 1.897 . . . . 0.0 109.164 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.12 158.85 41.73 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.794 2.329 . . . . 0.0 114.184 -153.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -63.64 -10.73 20.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -56.5 -19.18 14.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.117 1.767 . . . . 0.0 114.641 165.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.32 9.0 21.6 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.082 2.153 . . . . 0.0 113.098 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.2 mt -126.67 -41.28 1.86 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.525 2.33 . . . . 0.0 111.833 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -65.73 -7.15 14.12 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 128.207 2.603 . . . . 0.0 114.042 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.0 mt -60.57 -19.44 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 126.598 1.959 . . . . 0.0 110.95 163.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.2 p -113.96 143.13 29.03 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 126.87 2.068 . . . . 0.0 111.477 160.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.4 -24.86 36.38 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.477 2.118 . . . . 0.0 113.195 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -77.51 3.94 12.33 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.217 1.407 . . . . 0.0 114.724 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.61 47.23 91.26 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.217 0.913 . . . . 0.0 112.642 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -125.75 176.67 6.75 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.31 1.444 . . . . 0.0 112.48 -167.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.82 148.03 40.97 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 126.875 2.07 . . . . 0.0 107.155 168.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.5 158.23 98.97 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 N-CA-C 115.293 1.228 . . . . 0.0 115.293 5.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -156.97 161.53 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.044 2.538 . . . . 0.0 108.659 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.14 148.01 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 120.486 -1.384 . . . . 0.0 114.617 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -98.55 126.79 44.24 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.711 1.604 . . . . 0.0 109.855 162.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.2 mt -103.14 69.76 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.348 1.459 . . . . 0.0 108.701 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.257 23.3 t70 58.87 58.92 3.02 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.477 1.132 . . . . 0.0 112.102 -162.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.57 13.64 2.66 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -175.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -90.92 112.17 23.92 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.889 -1.132 . . . . 0.0 108.77 164.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -83.06 149.77 26.72 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -162.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.7 t -144.61 135.42 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.766 2.026 . . . . 0.0 109.956 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.93 -149.49 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.006 2.122 . . . . 0.0 113.95 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -51.84 161.0 0.61 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.3 p -38.71 -43.05 0.86 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.901 2.481 . . . . 0.0 116.088 166.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.5 ' CG ' HH12 ' A' ' 25' ' ' ARG . 3.2 m-20 -73.75 -13.84 61.03 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.362 1.437 . . . . 0.0 114.778 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.78 -24.49 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.555 1.071 . . . . 0.0 113.157 162.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.31 -40.72 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 119.527 1.058 . . . . 0.0 111.994 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -63.59 -5.28 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.44 -61.47 0.5 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.276 0.941 . . . . 0.0 112.923 158.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.0 mt -70.79 -28.32 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.048 1.339 . . . . 0.0 113.672 -163.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.28 -46.6 55.14 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.768 -1.207 . . . . 0.0 110.929 170.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -69.25 -27.36 65.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.576 1.15 . . . . 0.0 113.34 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.55 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 38.2 tt0 -63.61 -32.66 74.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.893 2.077 . . . . 0.0 113.203 167.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 91.1 mttt -114.07 3.13 15.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.249 1.42 . . . . 0.0 113.131 -168.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -86.61 142.63 35.02 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.671 1.588 . . . . 0.0 110.157 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.59 -24.74 18.37 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.947 1.765 . . . . 0.0 113.898 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -80.89 146.53 59.78 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 118.779 0.718 . . . . 0.0 109.921 169.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -54.66 149.8 38.57 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.137 2.558 . . . . 0.0 115.585 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.21 121.97 8.99 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.712 2.274 . . . . 0.0 112.591 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 mt -63.07 -17.7 62.56 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.187 1.395 . . . . 0.0 111.577 157.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.78 -8.38 14.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.136 1.774 . . . . 0.0 114.959 169.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.8 m -59.69 114.74 10.31 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 119.195 0.907 . . . . 0.0 109.532 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.92 125.18 10.21 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 121.854 1.703 . . . . 0.0 111.937 -165.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.53 159.24 53.49 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.681 2.254 . . . . 0.0 110.79 163.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.52 -34.07 23.92 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.561 1.544 . . . . 0.0 113.102 159.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -63.01 -13.97 42.03 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.03 71.5 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.372 -1.455 . . . . 0.0 113.14 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.7 p -71.15 -7.25 45.41 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.44 -40.88 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.422 1.489 . . . . 0.0 111.387 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.99 -31.89 80.22 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.268 0.937 . . . . 0.0 114.429 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.1 p -66.91 -13.08 61.35 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 172.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -90.67 -43.75 9.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.915 1.286 . . . . 0.0 112.073 169.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.37 -34.2 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.31 1.044 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 152' ' ' SER . 88.4 t80 -59.65 -49.29 92.66 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -77.91 -21.04 11.28 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.339 2.693 . . . . 0.0 113.975 167.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.512 ' HA ' ' CE ' ' A' ' 108' ' ' LYS . 58.3 m -69.52 -31.28 69.41 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.703 1.592 . . . . 0.0 114.802 173.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -67.17 -28.46 68.13 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.042 -1.036 . . . . 0.0 113.734 162.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.18 -47.72 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 120.57 1.532 . . . . 0.0 110.926 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.512 ' CE ' ' HA ' ' A' ' 105' ' ' SER . 51.0 mtmt -59.81 -45.4 92.47 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.087 0.955 . . . . 0.0 111.683 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.77 -20.56 61.16 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.569 0.747 . . . . 0.0 112.98 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.59 20.19 9.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.722 1.609 . . . . 0.0 113.207 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -132.07 62.08 1.65 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.133 1.373 . . . . 0.0 110.52 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -59.81 5.26 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -165.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -64.23 -34.11 77.34 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.822 -1.174 . . . . 0.0 111.561 155.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.28 149.46 94.12 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.802 1.241 . . . . 0.0 110.98 166.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.0 88.99 0.9 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.582 2.188 . . . . 0.0 110.484 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -51.57 -40.43 59.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.84 -10.94 60.58 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -96.93 -33.88 5.9 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.868 1.223 . . . . 0.0 113.63 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.4 m -61.79 -33.37 73.99 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.482 -1.011 . . . . 0.0 112.227 168.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -54.4 -44.41 72.32 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 128.284 2.633 . . . . 0.0 111.707 170.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -71.18 -38.76 72.1 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.228 -0.92 . . . . 0.0 112.451 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.67 -41.4 92.54 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.327 -0.858 . . . . 0.0 112.461 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.9 tp -64.68 -37.31 87.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.42 1.088 . . . . 0.0 112.347 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.88 -39.59 94.92 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.082 0.856 . . . . 0.0 112.629 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -69.38 -34.88 75.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.655 1.116 . . . . 0.0 112.743 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -67.45 -37.72 83.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.351 -0.843 . . . . 0.0 112.631 172.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.51 -33.15 62.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 113.49 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -60.19 -36.87 78.59 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.68 1.127 . . . . 0.0 112.553 173.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.81 -19.2 65.8 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.5 tp -96.86 -54.42 3.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.242 1.417 . . . . 0.0 112.618 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.8 -43.06 99.81 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -154.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.49 -25.75 73.75 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 121.632 -0.668 . . . . 0.0 113.806 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -89.15 -28.49 20.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.58 1.152 . . . . 0.0 112.995 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.82 -41.62 82.63 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.456 0.702 . . . . 0.0 112.2 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -59.46 -20.3 54.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.231 1.812 . . . . 0.0 114.362 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.4 t -84.82 -26.1 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.584 1.153 . . . . 0.0 112.244 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -105.13 -36.44 7.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.941 1.296 . . . . 0.0 113.535 -171.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.04 -176.23 35.11 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.287 -0.883 . . . . 0.0 114.197 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.03 -2.24 10.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.424 3.416 . . . . 0.0 115.498 -166.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -94.95 168.47 10.77 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.576 -1.328 . . . . 0.0 112.619 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.27 7.4 tt -77.41 9.66 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 120.678 -1.264 . . . . 0.0 112.93 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.84 31.69 3.3 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.001 2.12 . . . . 0.0 113.319 159.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.61 -115.59 4.05 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.202 -1.561 . . . . 0.0 113.613 172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -62.12 -25.77 67.92 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -166.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -152.65 170.62 19.78 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.649 1.179 . . . . 0.0 112.153 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.09 138.86 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.536 1.134 . . . . 0.0 109.708 164.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.5 p -139.91 -179.55 6.02 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.308 1.843 . . . . 0.0 110.743 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.77 -16.02 46.14 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.285 -1.509 . . . . 0.0 114.708 167.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.15 -42.98 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 119.634 1.106 . . . . 0.0 110.905 167.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.03 -40.94 99.23 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.88 -1.138 . . . . 0.0 112.798 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.0 mt -67.61 6.94 0.55 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.683 1.193 . . . . 0.0 113.93 170.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.409 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 13.2 p -124.62 -40.93 2.17 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.618 -1.301 . . . . 0.0 111.682 174.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 22.8 mt -93.06 -39.7 10.93 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.73 1.212 . . . . 0.0 113.977 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.72 99.33 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.79 -26.27 13.67 Favored 'Trans proline' 0 C--N 1.35 0.637 0 CA-C-N 121.027 1.402 . . . . 0.0 113.266 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -71.83 -32.22 67.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 117.551 -1.214 . . . . 0.0 112.581 172.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.01 -40.95 91.56 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.124 0.875 . . . . 0.0 112.694 167.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -62.5 -45.48 92.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.85 0.75 . . . . 0.0 112.112 175.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -64.95 -27.75 69.05 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.314 0.646 . . . . 0.0 112.443 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 tp -75.85 -45.68 34.4 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.298 1.039 . . . . 0.0 113.576 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -60.54 -37.88 82.65 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.018 0.826 . . . . 0.0 111.238 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.76 -57.97 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.32 -49.56 12.23 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.118 -0.989 . . . . 0.0 113.57 -165.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 54.5 tp -68.49 -37.67 80.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.266 0.485 . . . . 0.0 110.908 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.96 -26.99 61.56 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.271 0.938 . . . . 0.0 115.375 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -63.79 -32.59 74.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.562 1.145 . . . . 0.0 113.98 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -107.89 -31.93 7.8 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.108 0.963 . . . . 0.0 113.416 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -145.87 102.76 3.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.037 1.735 . . . . 0.0 107.936 167.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -68.62 85.71 0.3 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.622 0.769 . . . . 0.0 110.455 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -85.72 110.35 29.33 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.005 1.322 . . . . 0.0 110.133 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.09 139.22 32.29 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.698 1.599 . . . . 0.0 109.852 171.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.5 mt -65.09 121.47 74.4 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 159.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -60.46 158.47 31.56 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.335 2.023 . . . . 0.0 113.563 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.21 -28.57 69.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.469 1.108 . . . . 0.0 113.642 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -61.5 -23.59 66.01 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.347 -1.47 . . . . 0.0 113.287 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 79.8 mt -104.24 43.25 1.11 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.956 2.503 . . . . 0.0 111.527 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -46.24 -39.55 10.07 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.075 2.15 . . . . 0.0 113.909 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -73.45 -44.66 57.66 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.855 -1.153 . . . . 0.0 111.698 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 23.8 t -69.89 -33.52 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.634 -0.666 . . . . 0.0 110.963 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.48 -43.92 98.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.417 1.087 . . . . 0.0 112.939 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -70.66 -31.75 68.78 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.145 -0.972 . . . . 0.0 113.331 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -63.9 -25.99 68.4 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.875 0.762 . . . . 0.0 112.9 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.3 mt -52.74 -38.58 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.269 -0.894 . . . . 0.0 111.461 166.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -79.95 -9.57 59.69 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.204 -1.56 . . . . 0.0 114.07 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.81 -19.05 55.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 116.791 -1.576 . . . . 0.0 113.402 162.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.0 mt -64.64 -20.35 66.23 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.441 1.473 . . . . 0.0 113.231 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -92.23 4.2 53.77 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.9 p -123.78 -177.88 3.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.257 1.823 . . . . 0.0 114.475 -159.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 56.8 -168.45 0.11 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.232 1.813 . . . . 0.0 111.37 -173.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -73.97 -43.36 58.43 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.73 162.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.4 p -63.68 -78.6 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.397 2.279 . . . . 0.0 113.713 -172.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -57.93 -38.76 76.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.531 -0.731 . . . . 0.0 112.366 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -60.81 -34.98 75.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -75.16 -36.71 61.51 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.164 1.347 . . . . 0.0 112.317 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 23.7 p -69.54 -15.4 63.23 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -54.12 101.65 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.345 1.458 . . . . 0.0 111.43 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.92 135.6 37.02 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.353 0.661 . . . . 0.0 111.352 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.9 121.47 9.34 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.214 1.006 . . . . 0.0 111.792 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 -69.46 -40.65 77.02 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.574 1.149 . . . . 0.0 113.811 -148.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -61.35 -33.44 73.64 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.377 1.071 . . . . 0.0 112.563 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -81.66 -10.32 59.43 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.75 -46.91 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.092 0.86 . . . . 0.0 109.713 162.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 mt -64.36 -53.48 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.869 1.268 . . . . 0.0 111.606 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.75 -27.38 68.26 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.93 -14.46 60.8 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.478 -1.179 . . . . 0.0 113.985 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -82.89 -22.9 33.82 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.789 1.794 . . . . 0.0 113.826 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -48.85 -47.88 72.23 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.57 -19.51 18.9 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 122.009 1.806 . . . . 0.0 114.426 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -79.7 -2.43 42.86 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.537 1.535 . . . . 0.0 115.0 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.1 m -58.4 -20.51 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.396 -0.815 . . . . 0.0 112.428 157.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -118.23 -31.17 5.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.645 1.578 . . . . 0.0 114.75 168.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.754 1.222 . . . . 0.0 114.123 -179.533 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtp . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.8 -175.17 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.821 1.248 . . . . 0.0 112.604 -158.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.45 105.62 0.79 Allowed 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.637 -1.289 . . . . 0.0 110.576 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -106.91 90.04 3.19 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.601 1.16 . . . . 0.0 109.432 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.424 HG22 HG13 ' A' ' 7' ' ' VAL . 39.8 mt -70.32 129.01 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.125 0.97 . . . . 0.0 108.481 174.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.9 m -120.02 111.44 17.89 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.084 0.954 . . . . 0.0 109.361 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.424 HG13 HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -137.1 139.32 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.622 0.769 . . . . 0.0 111.657 -154.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -64.5 126.77 28.89 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.25 0.548 . . . . 0.0 110.131 168.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.64 -171.44 2.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.156 2.183 . . . . 0.0 111.834 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.33 147.21 13.92 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.33 -0.857 . . . . 0.0 111.486 154.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.01 128.88 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.279 0.562 . . . . 0.0 109.792 159.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.95 -23.64 5.78 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.105 1.336 . . . . 0.0 116.214 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.64 87.64 54.35 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 119.868 1.834 . . . . 0.0 112.818 -168.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.24 17.8 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 125.254 3.969 . . . . 0.0 115.444 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -114.9 -5.2 12.56 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.345 1.858 . . . . 0.0 113.476 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.3 pt -143.29 160.3 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.213 1.405 . . . . 0.0 111.722 -173.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.1 mt -79.65 -32.1 41.56 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -168.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.72 -129.59 7.62 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.645 1.593 . . . . 0.0 115.874 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -64.55 2.38 0.65 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.705 2.002 . . . . 0.0 115.474 -172.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.589 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 68.7 m -108.54 80.68 1.23 Allowed Pre-proline 0 C--O 1.255 1.347 0 C-N-CA 125.021 1.328 . . . . 0.0 111.015 -164.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.72 -24.51 68.94 Favored 'Trans proline' 0 C--N 1.373 1.817 0 O-C-N 116.433 -2.456 . . . . 0.0 111.284 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.08 -38.05 87.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.923 1.689 . . . . 0.0 114.313 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 20' ' ' SER . 30.9 p -78.62 -30.93 46.75 Favored 'General case' 0 C--N 1.376 1.735 0 O-C-N 119.906 -1.746 . . . . 0.0 110.964 171.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -64.19 -27.36 69.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.52 1.128 . . . . 0.0 113.198 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -53.8 -44.19 69.95 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.423 1.089 . . . . 0.0 112.164 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 t -76.72 -32.02 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.598 1.159 . . . . 0.0 111.542 -171.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.1 mt -65.08 -47.48 77.12 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 122.1 -0.375 . . . . 0.0 111.154 167.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.02 -47.76 80.11 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.999 1.32 . . . . 0.0 113.233 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -23.13 64.14 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.2 mt -90.62 -39.42 12.51 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.285 1.034 . . . . 0.0 112.339 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -69.04 -24.06 64.14 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.37 -37.98 63.3 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.598 -1.313 . . . . 0.0 113.123 167.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -70.45 -12.06 61.33 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 168.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 190' ' ' GLU . 33.0 mmtm 62.51 8.55 2.93 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.681 1.992 . . . . 0.0 114.481 -173.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 tt -71.33 130.43 87.73 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.887 1.275 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.67 151.13 51.76 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.627 2.218 . . . . 0.0 112.795 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -148.93 165.61 31.06 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.136 1.374 . . . . 0.0 111.339 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -110.3 131.85 54.69 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.23 1.812 . . . . 0.0 109.247 168.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.5 t -107.79 123.78 49.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.508 0.723 . . . . 0.0 111.756 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.62 86.22 2.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.863 1.665 . . . . 0.0 109.597 174.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.6 mt -73.02 124.11 24.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.849 1.26 . . . . 0.0 111.444 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mt -123.19 117.53 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 126.313 1.845 . . . . 0.0 109.483 -167.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -83.45 94.04 7.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.777 0.831 . . . . 0.0 109.392 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.2 mt 57.67 11.51 1.32 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 166.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.06 22.8 5.49 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 119.084 0.856 . . . . 0.0 114.9 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -62.47 -7.14 4.05 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.169 1.485 . . . . 0.0 114.017 168.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -122.15 145.44 44.05 Favored Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 125.319 1.448 . . . . 0.0 111.122 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.59 176.38 5.08 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.413 2.742 . . . . 0.0 113.359 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -51.37 -26.69 8.2 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.617 1.967 . . . . 0.0 115.728 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -57.13 -20.79 28.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.153 1.781 . . . . 0.0 115.778 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -100.64 -0.82 36.78 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.265 1.426 . . . . 0.0 113.725 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.4 mt -128.28 -37.96 1.81 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.94 2.096 . . . . 0.0 112.15 -166.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.42 -18.58 51.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.554 2.342 . . . . 0.0 114.868 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.4 mt -57.86 -29.38 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 126.784 2.033 . . . . 0.0 111.283 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.459 ' HB2' HG11 ' A' ' 62' ' ' VAL . 16.8 t -93.76 135.68 24.74 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.008 1.723 . . . . 0.0 112.358 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -69.8 -16.05 37.2 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.371 2.047 . . . . 0.0 113.234 167.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.18 -14.21 39.18 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.316 1.046 . . . . 0.0 112.862 170.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.2 -19.43 0.35 Allowed Glycine 0 CA--C 1.546 1.972 0 O-C-N 119.923 -1.735 . . . . 0.0 114.929 -159.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -59.83 130.01 44.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.722 2.409 . . . . 0.0 111.22 169.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.74 146.37 38.93 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.977 1.311 . . . . 0.0 108.936 152.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.31 139.87 32.54 Favored 'Cis proline' 0 CA--C 1.539 0.762 0 N-CA-C 117.264 1.986 . . . . 0.0 117.264 19.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.459 HG11 ' HB2' ' A' ' 55' ' ' SER . 28.1 m -151.69 178.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 127.176 2.191 . . . . 0.0 111.447 175.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.16 153.88 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 121.039 -1.038 . . . . 0.0 112.454 170.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -96.96 132.03 43.15 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.334 148.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.2 mt -96.94 86.35 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.261 1.024 . . . . 0.0 108.441 168.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.3 t0 57.17 58.23 4.06 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.926 0.89 . . . . 0.0 112.924 -169.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.291 80.5 m-20 62.27 -0.75 0.46 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -174.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -88.89 108.42 19.53 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.508 -1.37 . . . . 0.0 109.496 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -66.79 153.51 43.16 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -166.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -141.23 142.87 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.988 2.115 . . . . 0.0 108.722 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.69 -163.57 0.1 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.537 1.535 . . . . 0.0 113.959 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -50.44 160.75 0.37 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.042 2.137 . . . . 0.0 116.134 -167.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.6 p -48.83 -33.33 10.31 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.978 1.311 . . . . 0.0 114.042 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.53 -1.97 58.34 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.33 -13.48 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.043 1.337 . . . . 0.0 113.773 161.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.45 -32.81 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.005 1.722 . . . . 0.0 112.416 166.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.6 -15.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.5 -58.8 0.8 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.115 0.864 . . . . 0.0 112.571 157.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.2 mt -72.67 -27.52 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 118.273 1.037 . . . . 0.0 113.78 -160.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.6 tp -77.94 -24.96 48.06 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.293 -1.505 . . . . 0.0 112.281 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -80.82 -43.14 20.49 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.892 1.277 . . . . 0.0 110.887 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 12.5 tt0 -50.13 -39.59 43.66 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.224 2.61 . . . . 0.0 113.258 170.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.45 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 98.8 mttt -105.59 4.79 30.69 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.007 1.323 . . . . 0.0 113.949 -171.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.69 140.09 54.88 Favored Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 121.499 -0.751 . . . . 0.0 111.015 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.54 -31.57 6.91 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.342 2.028 . . . . 0.0 112.328 168.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -81.38 161.25 62.81 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.75 1.22 . . . . 0.0 111.276 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.94 125.81 19.95 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.839 2.359 . . . . 0.0 115.654 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -64.94 129.5 23.39 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.602 2.868 . . . . 0.0 113.666 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 mt -103.48 10.36 37.23 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.264 1.426 . . . . 0.0 113.265 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.78 -11.2 54.17 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.2 m -58.31 117.86 23.3 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.437 -171.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.63 117.42 3.35 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.049 2.499 . . . . 0.0 110.918 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -75.57 177.82 8.18 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.717 2.278 . . . . 0.0 110.953 165.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -55.37 -33.0 63.05 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.793 -1.192 . . . . 0.0 113.166 167.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -59.5 -20.66 57.0 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.683 1.593 . . . . 0.0 114.818 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.3 -26.12 68.24 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.786 -1.196 . . . . 0.0 112.808 171.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.4 m -65.5 -17.31 64.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.793 1.637 . . . . 0.0 114.181 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.5 t -124.16 -36.82 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.273 1.429 . . . . 0.0 111.279 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.11 -31.12 77.72 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 120.483 -1.386 . . . . 0.0 114.23 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.6 p -68.65 -25.94 65.07 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.164 -1.198 . . . . 0.0 113.999 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -75.77 -41.7 52.38 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.591 1.156 . . . . 0.0 111.611 170.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.38 -35.54 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.776 1.63 . . . . 0.0 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -55.6 -49.62 91.64 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.7 -33.17 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.091 2.527 . . . . 0.0 113.137 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -71.72 -30.87 66.11 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.142 -0.974 . . . . 0.0 113.351 -170.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -75.67 -21.0 58.05 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.409 -1.432 . . . . 0.0 114.501 167.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.4 t -72.89 -34.22 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.464 -1.397 . . . . 0.0 110.941 167.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.53 -35.43 80.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.035 0.934 . . . . 0.0 112.482 168.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -63.6 -20.3 65.55 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.241 1.417 . . . . 0.0 113.457 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.3 mt -95.44 -2.01 49.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.649 1.58 . . . . 0.0 114.254 172.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -127.65 54.89 1.65 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.849 1.66 . . . . 0.0 110.779 164.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.8 p -62.9 29.49 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 131.699 4.0 . . . . 0.0 117.95 -167.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.38 -28.5 69.31 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.961 1.304 . . . . 0.0 112.471 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.3 110.5 44.97 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-O 117.074 -1.441 . . . . 0.0 107.351 159.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.71 141.65 97.92 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.495 2.13 . . . . 0.0 116.02 -152.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -64.61 -35.74 81.98 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.86 171.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.09 -18.33 63.97 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.38 -44.36 3.5 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.066 0.841 . . . . 0.0 112.954 163.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 88.1 m -61.87 -33.17 73.71 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.46 -28.15 68.1 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.912 1.285 . . . . 0.0 113.201 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -70.53 -32.84 70.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.1 0.96 . . . . 0.0 111.406 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.04 -41.2 59.64 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.317 -0.864 . . . . 0.0 112.201 168.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.29 -33.3 75.66 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 39.5 mt -65.26 -41.21 94.49 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.826 0.739 . . . . 0.0 112.616 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -74.88 -33.61 62.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.146 0.885 . . . . 0.0 112.694 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.68 -38.08 76.91 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.806 -1.183 . . . . 0.0 112.605 169.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.6 mt -63.94 -39.35 93.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.49 -1.381 . . . . 0.0 111.813 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.45 -41.02 93.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.415 1.007 . . . . 0.0 112.275 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.39 -35.78 81.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.526 0.73 . . . . 0.0 112.044 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 tp -71.2 -54.92 9.3 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.841 0.856 . . . . 0.0 111.784 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -64.74 -34.78 79.13 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.89 1.676 . . . . 0.0 113.793 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.34 -33.21 69.94 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.414 1.006 . . . . 0.0 113.772 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -101.06 -24.58 14.28 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.7 mt -66.88 -32.59 73.96 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.44 -1.412 . . . . 0.0 113.075 171.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -63.66 -18.86 64.4 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.26 -32.23 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.854 0.862 . . . . 0.0 111.71 172.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -85.11 -30.88 23.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.275 1.03 . . . . 0.0 113.464 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.31 -99.74 1.98 Allowed Glycine 0 CA--C 1.539 1.564 0 CA-C-O 117.616 -1.658 . . . . 0.0 114.288 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.71 -34.27 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.554 2.169 . . . . 0.0 116.798 -144.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -129.58 156.14 44.68 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.364 1.438 . . . . 0.0 112.439 -168.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.9 tt -78.94 -4.17 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -163.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.57 -6.14 41.02 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.68 1.592 . . . . 0.0 114.931 160.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.69 -123.82 5.49 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.309 1.433 . . . . 0.0 113.543 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -62.7 -26.53 68.71 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -155.29 164.97 38.05 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.715 2.006 . . . . 0.0 110.083 -169.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.1 mt -69.43 113.45 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.493 1.117 . . . . 0.0 109.876 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.1 p -136.98 -163.89 1.49 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.107 0.963 . . . . 0.0 111.01 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.97 -24.75 1.62 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -166.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.48 -42.98 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.77 1.168 . . . . 0.0 112.235 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.82 -45.53 92.07 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.077 -1.014 . . . . 0.0 111.936 166.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.81 -12.11 15.74 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 62.5 m -106.19 -39.32 5.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.461 1.504 . . . . 0.0 112.914 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.5 -32.04 9.17 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -169.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.07 84.41 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -163.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.11 -22.84 18.83 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 120.885 1.352 . . . . 0.0 113.298 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -67.05 -31.05 71.3 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 118.146 -0.931 . . . . 0.0 111.823 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.77 -42.69 73.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 118.2 -0.905 . . . . 0.0 113.252 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -65.9 -39.11 90.31 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.052 0.842 . . . . 0.0 112.447 171.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -64.15 -33.42 75.74 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.736 -1.227 . . . . 0.0 112.743 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.78 -50.89 61.24 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.598 1.09 . . . . 0.0 112.046 169.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -51.31 -39.98 58.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.941 1.297 . . . . 0.0 112.124 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.2 t -81.83 -61.85 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.253 1.021 . . . . 0.0 113.242 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.9 37.41 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.949 -1.094 . . . . 0.0 113.645 -165.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.38 -35.21 73.37 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.693 -0.629 . . . . 0.0 110.57 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.4 -27.85 42.03 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.115 1.34 . . . . 0.0 115.237 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -65.97 -20.61 66.26 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -136.74 -25.02 1.13 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -154.79 85.07 1.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.904 1.681 . . . . 0.0 109.181 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -64.79 89.05 0.07 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.259 0.624 . . . . 0.0 110.332 169.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -90.36 112.82 54.95 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.371 1.468 . . . . 0.0 110.632 -169.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.07 136.09 24.13 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.377 2.051 . . . . 0.0 112.226 -166.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.3 mm -80.94 109.96 15.6 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.275 1.03 . . . . 0.0 108.233 159.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -71.44 159.36 51.72 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.036 1.824 . . . . 0.0 111.342 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.67 -14.94 56.61 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -63.2 -31.12 72.19 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.207 -0.933 . . . . 0.0 113.027 166.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.53 54.62 2.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.01 1.724 . . . . 0.0 111.139 168.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -21.22 63.8 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.333 1.053 . . . . 0.0 113.628 -162.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -74.55 -54.66 7.06 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.697 1.135 . . . . 0.0 109.637 164.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.0 -40.17 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.092 0.86 . . . . 0.0 112.505 -171.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.3 tp -63.38 -30.12 71.3 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.353 1.061 . . . . 0.0 113.322 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -94.37 -24.93 17.17 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.089 -1.007 . . . . 0.0 113.172 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.29 -37.22 86.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.403 1.081 . . . . 0.0 112.485 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 71.4 mt -63.91 -35.31 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.172 -0.955 . . . . 0.0 111.917 172.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -66.09 -32.51 74.02 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 119.854 -1.779 . . . . 0.0 112.462 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.85 -17.21 62.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.892 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.34 -24.07 67.52 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.422 1.465 . . . . 0.0 112.982 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -83.83 12.61 5.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.927 1.291 . . . . 0.0 113.238 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.9 p -135.87 174.95 10.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.286 1.834 . . . . 0.0 112.724 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 58.59 173.52 0.06 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.612 1.965 . . . . 0.0 113.785 -172.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.422 ' OE1' ' HE3' ' A' ' 34' ' ' LYS . 18.4 mp0 -71.71 -37.91 70.58 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.205 1.002 . . . . 0.0 109.834 165.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 97.3 p -61.42 -30.56 70.64 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.377 1.871 . . . . 0.0 114.739 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -121.12 -46.69 2.3 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.114 0.87 . . . . 0.0 113.31 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.73 -33.22 71.35 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.732 -1.23 . . . . 0.0 113.351 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -70.96 -23.56 62.24 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.1 p -89.03 -3.55 58.66 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.767 0.827 . . . . 0.0 112.993 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.15 106.32 0.5 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.344 1.058 . . . . 0.0 110.574 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.54 141.48 48.47 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.396 0.678 . . . . 0.0 111.864 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.4 125.22 24.97 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.038 0.935 . . . . 0.0 111.575 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -62.51 -43.1 99.64 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -152.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.3 -35.38 75.44 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.882 0.873 . . . . 0.0 112.041 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -81.79 -10.49 59.33 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.917 1.287 . . . . 0.0 113.82 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.62 -46.85 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.595 -0.691 . . . . 0.0 109.909 164.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.51 -49.83 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.712 1.205 . . . . 0.0 111.258 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.15 66.58 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.5 -26.28 15.95 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.817 -0.991 . . . . 0.0 114.097 170.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -71.8 -35.55 70.01 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.119 1.46 . . . . 0.0 113.181 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -53.65 -51.99 71.27 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.57 -22.85 57.9 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.442 1.428 . . . . 0.0 112.832 172.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -83.9 3.99 31.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.814 1.645 . . . . 0.0 115.342 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.17 -23.82 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.198 -0.939 . . . . 0.0 110.678 152.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -102.37 -43.24 5.73 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.261 1.425 . . . . 0.0 112.802 172.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.338 0 C-N-CA 126.338 1.855 . . . . 0.0 113.864 -172.856 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtp . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.06 -170.28 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.479 1.112 . . . . 0.0 112.702 -162.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.2 mt -67.48 109.83 3.38 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.656 -1.277 . . . . 0.0 110.628 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -112.02 89.87 3.18 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.769 1.228 . . . . 0.0 109.953 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.459 HD11 HD12 ' A' ' 30' ' ' LEU . 43.9 mt -70.61 128.0 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -119.62 99.72 6.83 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.282 1.033 . . . . 0.0 109.122 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG13 HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.21 143.19 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.025 1.33 . . . . 0.0 111.061 -157.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 31.8 tttm -64.97 126.16 27.13 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.592 -0.692 . . . . 0.0 109.567 167.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.07 176.7 9.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.872 1.669 . . . . 0.0 111.868 169.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.4 141.9 18.63 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.409 -0.807 . . . . 0.0 112.037 163.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.8 t -55.79 122.09 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.852 -0.53 . . . . 0.0 109.94 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.91 -15.62 19.97 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.213 -1.326 . . . . 0.0 116.155 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.03 79.82 72.42 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 119.792 1.796 . . . . 0.0 112.003 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.61 -5.41 10.15 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.274 3.316 . . . . 0.0 115.735 -174.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -87.56 -6.67 58.22 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.413 1.485 . . . . 0.0 114.437 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.2 pt -142.04 163.84 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.766 1.167 . . . . 0.0 113.355 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.2 mt -82.88 -23.19 33.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -170.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 32.74 -126.63 0.3 Allowed Glycine 0 N--CA 1.477 1.392 0 C-N-CA 127.104 2.287 . . . . 0.0 117.331 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -62.75 5.84 0.11 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.306 2.642 . . . . 0.0 116.434 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -111.87 74.55 1.34 Allowed Pre-proline 0 C--O 1.253 1.276 0 O-C-N 119.836 -1.79 . . . . 0.0 110.959 -163.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.5 -28.04 45.97 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.189 2.593 . . . . 0.0 111.432 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -58.38 -42.22 86.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.098 1.759 . . . . 0.0 113.5 168.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.7 m -65.98 -41.81 90.67 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.875 -1.766 . . . . 0.0 111.008 171.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -65.86 -27.11 67.99 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.26 1.024 . . . . 0.0 112.585 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -54.06 -45.27 71.66 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.51 1.124 . . . . 0.0 112.322 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.0 t -74.87 -27.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.431 1.092 . . . . 0.0 111.824 -170.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.8 mt -71.82 -45.8 60.25 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.847 -0.533 . . . . 0.0 111.113 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.58 -47.44 76.44 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.563 1.545 . . . . 0.0 113.489 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -68.22 -24.9 64.98 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.043 1.292 . . . . 0.0 113.973 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.459 HD12 HD11 ' A' ' 5' ' ' ILE . 80.4 mt -88.75 -35.85 16.46 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.731 1.213 . . . . 0.0 112.63 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -70.98 -29.04 64.91 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.0 -42.05 90.26 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.904 -1.123 . . . . 0.0 111.885 168.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.536 ' HZ1' ' CD ' ' A' ' 81' ' ' GLU . 87.1 mttt -71.7 -11.28 60.75 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.715 1.606 . . . . 0.0 114.609 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm 64.76 3.24 1.94 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.565 1.946 . . . . 0.0 115.419 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.87 122.9 88.2 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 119.344 0.975 . . . . 0.0 111.035 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.45 151.43 53.43 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.374 2.05 . . . . 0.0 112.261 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -144.23 161.66 38.33 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.186 1.394 . . . . 0.0 111.04 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -99.11 126.21 44.82 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.302 1.041 . . . . 0.0 109.576 165.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 t -100.7 120.37 39.98 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.611 0.764 . . . . 0.0 111.655 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -103.37 85.98 2.57 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.158 1.783 . . . . 0.0 109.483 171.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.6 mt -72.51 121.44 19.65 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.724 1.21 . . . . 0.0 111.653 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.4 mt -119.69 113.69 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.451 1.9 . . . . 0.0 109.838 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -81.21 98.08 7.92 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.218 -0.927 . . . . 0.0 109.865 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.6 mt 55.26 17.45 2.06 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 168.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.45 21.36 7.29 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.027 0.822 . . . . 0.0 114.901 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -65.12 12.09 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.488 1.644 . . . . 0.0 115.385 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -139.94 149.25 58.22 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.283 1.833 . . . . 0.0 110.339 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -65.4 174.08 5.63 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.086 2.524 . . . . 0.0 113.329 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -54.61 -21.22 9.82 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -55.17 -20.77 11.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.116 2.166 . . . . 0.0 115.798 171.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -104.73 -2.52 24.8 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.053 1.341 . . . . 0.0 113.447 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.62 -36.35 3.51 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.79 2.036 . . . . 0.0 112.252 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.47 -16.15 53.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.844 2.057 . . . . 0.0 114.921 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 31.0 mt -60.89 -32.14 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.232 1.813 . . . . 0.0 111.29 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.86 136.5 27.62 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 126.973 2.109 . . . . 0.0 110.322 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.07 -11.28 30.14 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.871 2.381 . . . . 0.0 114.797 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 12.04 6.65 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.259 2.224 . . . . 0.0 112.76 174.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.13 4.18 88.72 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 125.409 1.481 . . . . 0.0 116.39 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -88.1 91.82 8.92 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.396 1.598 . . . . 0.0 113.201 -172.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -59.93 144.1 86.74 Favored Pre-proline 0 N--CA 1.479 0.999 0 O-C-N 120.264 -1.523 . . . . 0.0 110.379 154.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 85.8 Cg_endo -75.78 139.77 62.69 Favored 'Cis proline' 0 CA--C 1.542 0.902 0 N-CA-C 116.858 1.83 . . . . 0.0 116.858 8.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -148.75 -178.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 128.282 2.633 . . . . 0.0 111.077 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.6 m -136.57 156.22 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.714 -1.241 . . . . 0.0 112.624 166.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -95.98 137.48 34.99 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.537 -0.727 . . . . 0.0 109.912 146.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.1 mt -101.0 95.73 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 163.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 55.67 52.97 10.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.822 1.249 . . . . 0.0 114.094 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 61.23 -5.06 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -169.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -80.41 113.81 18.86 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.389 1.449 . . . . 0.0 108.789 171.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -67.96 153.92 42.7 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -168.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -143.16 143.33 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 127.2 2.2 . . . . 0.0 108.503 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.6 -160.25 0.08 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.251 1.421 . . . . 0.0 113.75 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -62.22 166.99 4.37 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.995 2.118 . . . . 0.0 114.828 -163.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.8 p -55.81 -20.05 13.75 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -104.49 -19.37 14.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.298 -1.334 . . . . 0.0 113.514 -168.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.3 m -92.15 -16.52 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 155.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.09 -32.28 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.714 1.206 . . . . 0.0 112.712 175.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 p -65.6 -10.48 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.34 -58.57 0.91 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.391 0.996 . . . . 0.0 112.673 157.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.5 mt -75.83 -35.66 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.878 1.339 . . . . 0.0 113.775 -162.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 tp -75.65 -24.3 56.37 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.407 -1.433 . . . . 0.0 111.885 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.536 ' CD ' ' HZ1' ' A' ' 33' ' ' LYS . 76.6 mm-40 -76.51 -42.04 44.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.066 0.946 . . . . 0.0 111.821 174.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.417 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 15.6 tt0 -56.36 -47.96 77.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.084 2.154 . . . . 0.0 112.69 171.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.417 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 99.3 mttt -90.85 6.04 46.0 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -171.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.66 140.94 59.6 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 121.367 -0.833 . . . . 0.0 111.324 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.63 -28.38 8.22 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.317 2.011 . . . . 0.0 112.33 168.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -80.2 160.6 67.78 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.529 1.132 . . . . 0.0 111.379 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -55.92 126.49 22.57 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.53 2.153 . . . . 0.0 114.349 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -59.81 139.38 88.12 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.45 2.767 . . . . 0.0 112.837 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.8 mt -113.64 9.23 17.82 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.284 1.433 . . . . 0.0 112.744 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.08 -16.7 64.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.4 m -58.38 120.79 47.29 Favored Pre-proline 0 N--CA 1.472 0.675 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.169 -170.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 74.2 Cg_endo -78.6 121.89 5.3 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.373 2.049 . . . . 0.0 111.121 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 92' ' ' PRO . 58.6 Cg_endo -72.32 177.42 7.32 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.919 2.412 . . . . 0.0 111.236 162.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.19 -27.47 65.73 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.289 -1.507 . . . . 0.0 112.954 163.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -60.94 -19.64 61.11 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.554 -1.341 . . . . 0.0 113.722 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.77 78.81 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.956 -1.09 . . . . 0.0 113.095 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.4 p -76.84 3.24 12.41 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.111 1.323 . . . . 0.0 114.349 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.4 t -120.61 -39.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.956 1.303 . . . . 0.0 110.798 170.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.89 -30.54 69.92 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.961 1.267 . . . . 0.0 114.329 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 62.6 p -68.11 -19.46 64.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.778 1.289 . . . . 0.0 114.044 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -89.97 -41.37 11.78 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.785 1.234 . . . . 0.0 111.895 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.434 HG23 ' CD1' ' A' ' 106' ' ' PHE . 96.9 mt -59.96 -38.79 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.95 1.7 . . . . 0.0 111.079 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.54 -45.37 99.86 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -85.73 -34.46 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.306 2.671 . . . . 0.0 114.696 166.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -68.0 -33.2 74.15 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 121.304 1.865 . . . . 0.0 113.051 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.434 ' CD1' HG23 ' A' ' 102' ' ' ILE . 16.3 m-85 -77.37 -27.73 52.64 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.208 -1.557 . . . . 0.0 113.098 172.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.7 t -71.95 -32.7 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 120.586 -1.321 . . . . 0.0 111.473 170.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -65.35 -38.1 89.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.413 1.085 . . . . 0.0 111.992 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -64.04 -25.01 67.92 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.955 1.302 . . . . 0.0 113.62 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.5 mt -87.94 10.54 18.47 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.558 1.543 . . . . 0.0 113.996 171.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -141.03 58.41 1.54 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.784 2.034 . . . . 0.0 109.357 165.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.6 p -58.98 27.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.914 1 C-N-CA 132.884 4.474 . . . . 0.0 118.461 -164.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.59 -26.2 57.66 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.16 1.784 . . . . 0.0 113.028 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -88.85 114.6 60.66 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 116.983 -1.484 . . . . 0.0 107.038 155.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -55.09 133.18 56.64 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.642 2.228 . . . . 0.0 115.011 -157.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -62.92 -34.68 77.96 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.359 -0.829 . . . . 0.0 112.437 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.17 -18.92 65.48 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.237 1.015 . . . . 0.0 113.684 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -96.13 -42.76 3.43 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.518 1.056 . . . . 0.0 112.844 165.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 86.0 m -62.8 -33.26 74.84 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.784 -0.833 . . . . 0.0 113.082 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.46 -26.37 68.48 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -70.24 -33.47 71.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.625 0.77 . . . . 0.0 110.765 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.9 -41.47 67.89 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.153 -0.967 . . . . 0.0 112.445 165.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 mt -62.2 -36.82 83.1 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.809 0.731 . . . . 0.0 112.923 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.3 mt -68.66 -38.77 80.69 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.251 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.95 -32.31 65.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 119.628 1.104 . . . . 0.0 112.535 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.5 -45.05 88.96 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.151 -0.968 . . . . 0.0 112.305 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -67.63 -36.11 80.17 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.894 -1.051 . . . . 0.0 112.952 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.05 -41.89 94.74 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.728 1.604 . . . . 0.0 112.134 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.11 -32.66 74.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.18 0.592 . . . . 0.0 112.346 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -73.07 -56.7 4.76 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.323 1.049 . . . . 0.0 111.533 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.06 -35.92 82.69 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.029 1.732 . . . . 0.0 114.131 -171.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.51 -32.93 74.47 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.947 0.784 . . . . 0.0 113.56 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -96.62 -28.14 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 47.1 mt -64.52 -32.47 74.12 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.114 1.324 . . . . 0.0 113.043 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -64.99 -14.69 60.97 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.55 -35.33 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.14 0.976 . . . . 0.0 111.856 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -83.58 -26.89 29.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.132 0.973 . . . . 0.0 113.458 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 107.08 -99.27 1.4 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-O 117.339 -1.812 . . . . 0.0 114.746 163.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.51 -33.4 0.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.004 3.136 . . . . 0.0 117.257 -151.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -129.8 158.83 38.36 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.669 1.577 . . . . 0.0 112.98 -169.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.0 tp -71.56 -8.13 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.34 -4.89 28.23 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 166.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.5 -135.05 8.2 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 120.093 1.315 . . . . 0.0 113.948 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -18.99 62.26 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.407 1.483 . . . . 0.0 113.928 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -136.39 153.94 50.96 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.723 1.609 . . . . 0.0 110.953 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.61 109.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.5 1.12 . . . . 0.0 109.508 162.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.3 p -137.65 -164.19 1.56 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.564 1.546 . . . . 0.0 110.44 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.16 -25.19 4.94 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -164.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.7 t -77.29 -40.73 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.789 1.177 . . . . 0.0 112.661 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -57.55 -48.4 79.43 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.868 -1.145 . . . . 0.0 111.685 165.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.4 mt -63.7 -9.07 12.23 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.22 1.008 . . . . 0.0 113.533 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 56.5 m -108.94 -34.18 6.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.469 1.507 . . . . 0.0 113.181 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 48.2 mt -108.91 -30.91 7.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.07 89.45 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -164.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.2 -20.09 16.81 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.333 1.355 . . . . 0.0 113.752 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -70.24 -31.86 69.44 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.998 -1.064 . . . . 0.0 112.075 172.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.99 -39.93 79.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.737 0.699 . . . . 0.0 112.303 171.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -64.82 -41.79 95.48 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.446 -0.784 . . . . 0.0 113.067 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -66.04 -32.13 73.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.869 -1.144 . . . . 0.0 112.428 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.6 tp -64.55 -50.83 65.75 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.379 0.99 . . . . 0.0 111.103 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -55.52 -54.51 43.11 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.399 1.479 . . . . 0.0 111.823 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.56 -51.1 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.8 -50.9 13.84 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.564 -0.71 . . . . 0.0 111.953 -169.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 7.0 tp -66.32 -28.42 68.67 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.888 -0.508 . . . . 0.0 111.598 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.82 -23.45 22.36 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.524 1.535 . . . . 0.0 115.677 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -67.13 -21.22 65.84 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -134.95 -28.15 1.21 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -152.21 84.78 1.26 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.227 1.811 . . . . 0.0 109.566 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -63.65 95.89 0.11 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.125 0.57 . . . . 0.0 109.985 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -91.15 109.35 34.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.874 1.27 . . . . 0.0 110.816 -167.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.62 135.8 22.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.456 2.104 . . . . 0.0 112.046 -167.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.3 mm -81.53 112.14 31.42 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.449 1.1 . . . . 0.0 108.576 162.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -69.27 157.37 61.6 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.09 1.86 . . . . 0.0 112.152 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -59.09 -23.15 61.82 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -64.95 -26.43 68.3 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 171.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.22 53.75 2.57 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.935 1.694 . . . . 0.0 111.006 167.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -21.64 63.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.147 0.979 . . . . 0.0 113.464 -160.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -76.39 -52.17 10.41 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.81 1.186 . . . . 0.0 110.355 165.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.58 -40.72 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 119.816 1.189 . . . . 0.0 112.068 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.35 -32.4 73.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.379 1.071 . . . . 0.0 113.004 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -82.17 -33.49 29.48 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.973 -1.079 . . . . 0.0 113.133 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -64.47 -36.62 84.78 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.291 1.036 . . . . 0.0 112.641 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.19 -29.13 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 120.931 -1.105 . . . . 0.0 112.29 173.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -69.05 -31.12 69.67 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 119.755 -1.841 . . . . 0.0 112.274 170.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.0 mt -68.38 -21.59 64.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 117.914 -1.041 . . . . 0.0 113.148 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.5 -23.18 65.73 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.447 1.021 . . . . 0.0 112.797 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -91.33 17.59 8.21 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.485 1.514 . . . . 0.0 113.636 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 p -140.89 177.25 8.17 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.136 2.174 . . . . 0.0 112.779 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 57.87 177.42 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.407 1.883 . . . . 0.0 113.448 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 190' ' ' GLU . 13.4 mp0 -75.02 -40.3 60.59 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.341 1.056 . . . . 0.0 110.084 162.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 92.2 p -57.43 -30.43 64.99 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.431 1.892 . . . . 0.0 114.531 -172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -122.97 -45.61 2.13 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -61.76 -32.43 72.68 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.675 -1.266 . . . . 0.0 113.356 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.12 -24.08 63.14 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.4 p -91.64 -2.36 57.1 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.367 1.067 . . . . 0.0 113.272 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -60.7 103.16 0.23 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.945 1.298 . . . . 0.0 110.268 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.72 144.23 51.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.591 0.756 . . . . 0.0 112.008 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.47 131.34 49.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.714 0.806 . . . . 0.0 111.529 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -71.78 -44.01 64.72 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.251 1.42 . . . . 0.0 113.469 -149.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -60.76 -32.9 72.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.628 1.171 . . . . 0.0 112.039 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -84.99 -6.85 59.33 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.3 t -75.99 -48.76 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 119.155 0.889 . . . . 0.0 109.417 159.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 70.4 mt -63.76 -52.79 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.496 1.118 . . . . 0.0 111.872 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.23 -26.4 68.1 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.17 -22.68 40.52 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.654 -1.081 . . . . 0.0 113.845 172.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -76.37 -35.66 58.57 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.058 1.429 . . . . 0.0 113.524 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -50.29 -51.9 59.16 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.29 -21.46 54.55 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.58 1.52 . . . . 0.0 113.182 174.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.541 ' HA ' ' H ' ' A' ' 212' ' ' ALA . 54.8 mttp -87.04 6.04 34.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.345 1.858 . . . . 0.0 115.461 177.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.26 -15.83 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 120.917 -1.114 . . . . 0.0 110.815 149.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -115.74 -24.56 8.17 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.944 1.698 . . . . 0.0 114.946 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.541 ' H ' ' HA ' ' A' ' 209' ' ' LYS . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.143 -1.884 . . . . 0.0 115.91 -170.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtp . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.87 -168.89 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.516 1.127 . . . . 0.0 112.408 -163.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.5 mt -66.9 104.28 1.33 Allowed 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.557 -1.34 . . . . 0.0 111.204 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -104.34 91.08 3.76 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.496 1.118 . . . . 0.0 109.587 168.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.418 HD11 HD12 ' A' ' 30' ' ' LEU . 47.4 mt -69.55 131.98 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -121.39 113.67 20.2 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.778 0.831 . . . . 0.0 108.785 173.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -132.6 142.26 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.033 -1.042 . . . . 0.0 110.696 -156.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.633 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 32.7 tttm -63.73 127.32 30.84 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.737 -0.602 . . . . 0.0 109.472 169.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.83 175.54 9.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.204 1.801 . . . . 0.0 111.882 169.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.53 140.65 33.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.617 0.767 . . . . 0.0 111.32 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.4 t -55.77 120.17 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 120.979 0.419 . . . . 0.0 110.012 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.37 -13.01 29.83 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 118.167 -1.352 . . . . 0.0 116.297 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.26 77.35 75.68 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 119.838 1.819 . . . . 0.0 112.004 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.16 -11.99 24.61 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.239 3.293 . . . . 0.0 115.859 -173.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -80.22 -8.46 59.46 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.623 1.569 . . . . 0.0 114.52 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 pt -141.92 165.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.595 1.158 . . . . 0.0 112.591 -172.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.5 mt -75.46 -44.36 44.65 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.08 -129.93 12.96 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.75 1.167 . . . . 0.0 114.882 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.12 17.29 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.928 3.291 . . . . 0.0 117.087 -173.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.4 p -116.59 71.52 5.03 Favored Pre-proline 0 C--O 1.25 1.11 0 O-C-N 119.925 -1.734 . . . . 0.0 110.99 -161.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.0 -26.96 30.65 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.411 2.741 . . . . 0.0 111.931 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -60.19 -41.22 92.48 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.324 1.45 . . . . 0.0 112.797 167.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.633 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.2 m -66.11 -41.07 91.06 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.713 -1.867 . . . . 0.0 111.011 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -62.81 -29.33 70.64 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 117.489 -1.244 . . . . 0.0 112.633 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -52.43 -46.65 66.47 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.6 1.091 . . . . 0.0 112.842 172.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 t -75.43 -35.01 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.536 1.135 . . . . 0.0 111.592 -169.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.01 -44.17 80.98 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.477 0.711 . . . . 0.0 111.161 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 tp -57.14 -48.96 77.39 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.368 1.467 . . . . 0.0 112.993 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.14 -24.98 65.05 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.418 HD12 HD11 ' A' ' 5' ' ' ILE . 89.4 mt -90.7 -35.51 14.88 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.723 1.209 . . . . 0.0 112.95 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.57 -25.27 63.0 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.976 -1.077 . . . . 0.0 113.712 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -69.97 -39.78 75.76 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.696 -1.252 . . . . 0.0 112.384 167.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -69.13 -15.71 63.48 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.999 1.32 . . . . 0.0 114.229 171.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 190' ' ' GLU . 32.0 mmtm 65.0 0.91 1.32 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.572 1.949 . . . . 0.0 115.326 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.8 tt -68.03 126.67 92.93 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.026 0.93 . . . . 0.0 111.001 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.54 150.71 57.88 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.311 2.007 . . . . 0.0 112.411 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -145.27 163.94 32.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.592 1.557 . . . . 0.0 110.483 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -101.77 132.29 47.59 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.622 1.169 . . . . 0.0 109.608 163.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -106.11 115.76 30.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.751 0.82 . . . . 0.0 111.356 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -99.37 84.27 2.97 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.758 1.623 . . . . 0.0 109.757 171.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.93 130.53 43.58 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.638 0.775 . . . . 0.0 110.734 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 mt -128.97 114.84 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.642 1.977 . . . . 0.0 109.709 -170.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -83.27 96.95 8.63 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.527 -0.733 . . . . 0.0 109.53 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.0 mt 53.82 26.74 6.36 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 168.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.73 23.6 9.91 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 115.419 0.928 . . . . 0.0 115.419 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.31 12.29 0.05 Allowed 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -143.13 149.94 50.58 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.904 2.082 . . . . 0.0 110.077 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.82 168.84 8.04 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.866 2.377 . . . . 0.0 112.936 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -60.78 -14.6 22.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 116.455 -1.736 . . . . 0.0 115.319 -172.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -53.82 -20.24 5.5 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.327 2.251 . . . . 0.0 116.026 165.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -106.26 0.53 25.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.861 1.664 . . . . 0.0 113.275 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.5 mt -124.01 -40.09 2.32 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.495 2.318 . . . . 0.0 112.378 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.21 -14.27 16.74 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.333 2.253 . . . . 0.0 114.631 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.6 mt -64.31 -29.45 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 126.829 2.052 . . . . 0.0 111.434 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.8 t -91.28 139.28 25.43 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 123.661 0.784 . . . . 0.0 109.831 160.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -65.84 -14.51 44.94 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.709 2.273 . . . . 0.0 113.459 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.28 7.74 44.21 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.528 1.131 . . . . 0.0 113.212 173.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.95 11.21 73.99 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 120.704 -1.247 . . . . 0.0 114.844 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.28 162.71 23.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.625 1.57 . . . . 0.0 112.995 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.88 149.52 70.77 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 126.365 1.866 . . . . 0.0 107.653 156.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HB3' HG12 ' A' ' 7' ' ' VAL . 85.4 Cg_endo -79.13 144.32 72.75 Favored 'Cis proline' 0 CA--C 1.54 0.802 0 N-CA-C 117.202 1.962 . . . . 0.0 117.202 12.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 m -153.97 178.35 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 129.168 2.987 . . . . 0.0 110.82 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.0 m -139.34 153.02 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 120.827 -1.171 . . . . 0.0 112.739 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -96.83 130.36 44.11 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.6 -0.688 . . . . 0.0 109.246 148.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.17 85.51 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.5 t70 58.18 57.7 3.86 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.056 0.932 . . . . 0.0 113.027 -170.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.281 75.1 m-20 62.15 -4.35 0.21 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -83.5 108.83 16.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.959 1.304 . . . . 0.0 109.697 170.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -65.0 152.81 42.45 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.9 t -143.8 132.79 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.728 2.011 . . . . 0.0 108.955 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.77 -166.48 0.11 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.093 1.757 . . . . 0.0 113.774 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.31 157.48 0.97 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -158.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' A' ' 76' ' ' ILE . 93.2 p -52.22 -22.88 4.79 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -89.81 -10.64 44.69 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.73 -16.9 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.324 1.05 . . . . 0.0 113.205 162.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' A' ' 73' ' ' SER . 1.3 mt -55.1 -34.35 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.227 1.411 . . . . 0.0 112.828 168.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.95 -12.64 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.1 -57.9 0.71 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.829 0.728 . . . . 0.0 112.401 158.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.75 -34.83 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.235 -1.156 . . . . 0.0 113.577 -162.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.9 tp -76.86 -30.37 56.25 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.804 -1.185 . . . . 0.0 111.881 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.63 -41.71 68.51 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.689 0.796 . . . . 0.0 111.587 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -66.72 -42.78 85.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.273 1.829 . . . . 0.0 112.972 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -84.5 3.64 35.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.98 145.34 80.92 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 121.054 -1.029 . . . . 0.0 111.011 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.83 -26.87 12.96 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.318 2.012 . . . . 0.0 112.596 165.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -82.88 166.76 33.88 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.545 1.538 . . . . 0.0 111.864 173.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.84 132.84 52.25 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.522 2.148 . . . . 0.0 114.785 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -65.96 127.31 17.46 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.363 2.709 . . . . 0.0 112.968 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.7 mt -96.59 11.23 35.99 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.174 1.39 . . . . 0.0 112.621 174.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.16 -20.64 66.55 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.2 m -59.33 118.92 34.68 Favored Pre-proline 0 N--CA 1.474 0.774 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.377 -166.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.63 120.49 5.57 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.721 2.281 . . . . 0.0 110.827 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.81 -179.45 4.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.713 2.275 . . . . 0.0 111.056 166.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -53.74 -36.85 62.77 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.663 -1.273 . . . . 0.0 112.919 166.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.76 -18.91 57.66 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.881 1.672 . . . . 0.0 114.441 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.92 -30.4 70.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.71 1.141 . . . . 0.0 112.485 173.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -66.93 -14.31 62.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.937 1.295 . . . . 0.0 114.461 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.35 -37.95 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.013 1.325 . . . . 0.0 111.242 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.62 -31.42 74.97 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.194 1.378 . . . . 0.0 113.904 171.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.8 p -68.82 -16.94 63.92 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.944 1.372 . . . . 0.0 113.921 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -91.7 -44.89 8.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.088 1.355 . . . . 0.0 111.727 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.402 HG23 ' CD1' ' A' ' 106' ' ' PHE . 76.5 mt -60.74 -41.17 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.629 1.572 . . . . 0.0 111.035 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.96 -42.73 92.01 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -85.93 -33.76 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.069 2.513 . . . . 0.0 114.845 166.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 77.1 p -68.58 -33.86 74.81 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.172 1.805 . . . . 0.0 112.867 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.402 ' CD1' HG23 ' A' ' 102' ' ' ILE . 10.3 m-85 -75.84 -25.3 56.13 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.394 -1.441 . . . . 0.0 112.767 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.27 -34.48 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.49 -1.381 . . . . 0.0 111.312 167.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -64.9 -38.88 92.45 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.16 0.891 . . . . 0.0 111.99 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -63.73 -25.85 68.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.673 1.589 . . . . 0.0 113.749 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 mt -87.41 11.02 15.61 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.455 1.502 . . . . 0.0 113.966 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -141.9 65.81 1.36 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.728 1.611 . . . . 0.0 110.058 167.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -63.0 25.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 130.602 3.561 . . . . 0.0 118.026 -160.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -75.72 -27.36 58.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.718 1.607 . . . . 0.0 112.143 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.21 113.07 20.08 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-O 117.002 -1.475 . . . . 0.0 107.123 147.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -62.53 120.57 8.17 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 120.764 1.309 . . . . 0.0 112.674 -165.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -54.2 -35.05 61.95 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.71 -18.78 65.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.173 0.989 . . . . 0.0 113.325 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.81 -46.06 4.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.331 0.967 . . . . 0.0 112.561 163.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 m -59.64 -36.68 76.85 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.003 0.921 . . . . 0.0 112.783 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -60.99 -28.5 69.06 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.726 1.21 . . . . 0.0 113.506 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -67.31 -40.15 85.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.678 0.791 . . . . 0.0 110.354 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.12 75.09 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.319 -0.863 . . . . 0.0 112.859 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.4 mt -62.27 -37.85 87.06 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.838 0.744 . . . . 0.0 112.336 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -69.16 -36.75 77.71 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.175 -0.917 . . . . 0.0 112.419 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.31 -35.06 73.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.952 1.251 . . . . 0.0 112.729 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -64.25 -44.83 90.56 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.213 -0.929 . . . . 0.0 112.302 171.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.1 mt -68.37 -35.88 78.36 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.093 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -64.24 -45.1 89.64 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.822 1.646 . . . . 0.0 112.18 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.1 79.17 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.436 0.695 . . . . 0.0 112.258 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.0 tp -70.78 -58.02 4.06 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.509 1.124 . . . . 0.0 111.927 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.32 -35.06 79.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.496 1.518 . . . . 0.0 113.99 -169.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.46 87.14 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.433 -0.648 . . . . 0.0 113.509 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -91.74 -25.7 18.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.824 0.85 . . . . 0.0 113.176 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.6 mt -66.42 -33.5 75.85 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.729 -1.232 . . . . 0.0 113.281 172.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -63.88 -16.61 61.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 173.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.55 -36.38 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.122 0.969 . . . . 0.0 111.898 170.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -77.8 -25.57 49.03 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.7 -106.42 3.18 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 117.343 -1.809 . . . . 0.0 114.952 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.41 -30.58 1.11 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.437 2.758 . . . . 0.0 116.773 -144.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -133.09 160.1 38.16 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.976 1.262 . . . . 0.0 112.443 -169.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.2 tt -78.15 -5.07 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -167.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.02 -3.57 44.66 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.917 1.687 . . . . 0.0 114.776 160.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 119.34 -125.61 6.43 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.58 1.562 . . . . 0.0 113.359 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -58.6 -29.31 66.36 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -141.89 155.12 45.52 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.67 1.588 . . . . 0.0 109.825 -160.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.2 mt -70.48 105.26 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 167.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.8 p -134.87 -164.95 1.59 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.261 1.024 . . . . 0.0 110.764 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.67 -24.62 1.43 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.1 t -78.22 -42.12 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 120.012 1.278 . . . . 0.0 112.578 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.11 -47.38 83.44 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.199 1.363 . . . . 0.0 112.164 166.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.7 mt -61.21 -19.59 61.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.607 0.763 . . . . 0.0 112.773 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.9 m -93.74 -48.49 6.29 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.013 1.325 . . . . 0.0 112.47 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.4 mt -94.89 -34.56 12.38 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -162.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.3 -49.98 85.13 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -170.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.1 -21.75 17.72 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 120.649 1.268 . . . . 0.0 113.835 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -77.64 -27.75 51.14 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.002 -1.061 . . . . 0.0 112.697 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.21 -38.14 75.22 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.549 0.74 . . . . 0.0 112.243 166.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -63.29 -42.84 99.11 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.496 -0.752 . . . . 0.0 112.556 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -69.61 -28.65 66.12 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.907 -1.121 . . . . 0.0 113.352 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.2 tp -66.08 -52.56 47.62 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.105 0.962 . . . . 0.0 110.895 171.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -59.1 -51.12 71.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.571 1.548 . . . . 0.0 111.968 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.1 t -79.08 -53.79 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.55 -50.88 14.29 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.478 -0.764 . . . . 0.0 111.97 -167.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.29 -25.6 66.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 119.194 -0.431 . . . . 0.0 111.873 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.25 -23.43 25.65 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.52 1.533 . . . . 0.0 115.753 174.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -66.67 -19.6 65.8 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -135.52 -31.97 0.94 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -147.02 82.81 1.57 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.949 1.699 . . . . 0.0 109.391 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -63.87 90.9 0.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.758 0.823 . . . . 0.0 110.053 168.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 46.9 t90 -86.58 115.04 60.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.378 1.071 . . . . 0.0 111.164 -164.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.76 135.94 24.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.385 2.057 . . . . 0.0 112.128 -168.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.08 110.88 41.43 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.46 1.104 . . . . 0.0 108.413 161.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -66.19 156.64 63.88 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.888 1.725 . . . . 0.0 112.183 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.36 -22.08 52.27 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.761 1.624 . . . . 0.0 114.516 174.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -61.5 -29.46 70.0 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.038 -1.039 . . . . 0.0 112.859 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 89.8 mt -85.23 54.9 3.27 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.974 1.71 . . . . 0.0 111.286 170.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.17 -23.59 63.01 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.209 1.003 . . . . 0.0 113.532 -160.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -74.78 -53.68 8.72 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.173 0.897 . . . . 0.0 109.606 167.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.74 -39.15 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 119.777 1.171 . . . . 0.0 112.189 -173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.44 -35.22 79.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.8 0.84 . . . . 0.0 112.729 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.91 -28.55 35.83 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.046 -1.034 . . . . 0.0 113.179 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -68.08 -34.02 75.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.157 0.983 . . . . 0.0 112.744 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.21 -33.54 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.031 -1.043 . . . . 0.0 111.784 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -70.01 -28.94 65.9 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 119.751 -1.843 . . . . 0.0 112.498 172.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 90.5 mt -68.34 -21.74 64.73 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.338 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.7 mt -60.84 -25.73 66.84 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.809 1.186 . . . . 0.0 112.855 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -89.43 13.66 13.17 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.271 1.428 . . . . 0.0 113.564 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.5 p -136.52 174.74 10.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.733 2.013 . . . . 0.0 112.638 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 57.92 175.36 0.06 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.614 1.966 . . . . 0.0 113.73 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 190' ' ' GLU . 18.3 mp0 -72.96 -38.22 66.81 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 124.587 1.155 . . . . 0.0 109.902 164.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 99.7 p -60.56 -32.51 71.59 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.165 1.786 . . . . 0.0 114.486 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -121.39 -43.87 2.39 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.88 1.066 . . . . 0.0 113.88 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -60.63 -31.56 70.74 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.626 -1.296 . . . . 0.0 112.899 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -73.51 -21.59 60.36 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.1 p -93.59 -1.59 55.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.015 1.326 . . . . 0.0 113.425 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -59.33 98.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.81 1.644 . . . . 0.0 110.45 172.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.36 140.89 45.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.76 0.824 . . . . 0.0 111.711 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.26 125.04 20.96 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.805 0.842 . . . . 0.0 111.896 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -68.51 -44.9 73.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.06 1.344 . . . . 0.0 113.612 -149.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -63.43 -29.18 70.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.532 1.133 . . . . 0.0 112.331 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -82.87 -13.18 56.62 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.5 t -73.49 -45.89 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.298 0.954 . . . . 0.0 109.503 163.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.57 -53.15 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.332 1.053 . . . . 0.0 111.572 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.33 -29.98 70.29 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.91 -24.49 57.86 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.709 -1.245 . . . . 0.0 113.619 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -78.33 -32.4 49.15 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.283 1.433 . . . . 0.0 113.98 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -47.7 -53.6 29.62 Favored Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.39 -19.41 49.48 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.656 1.571 . . . . 0.0 113.54 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -85.06 5.49 29.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.348 1.859 . . . . 0.0 115.052 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.76 -20.59 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.55 -0.719 . . . . 0.0 110.997 152.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -101.95 -31.74 10.53 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.807 1.243 . . . . 0.0 114.296 168.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.167 0 C-N-CA 126.726 2.01 . . . . 0.0 113.696 -176.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.6 -167.08 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.154 0.981 . . . . 0.0 112.055 -162.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.6 mt -65.69 109.16 2.32 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.555 -1.34 . . . . 0.0 111.003 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -111.46 92.96 4.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.212 1.006 . . . . 0.0 109.471 167.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.427 HD11 HD12 ' A' ' 30' ' ' LEU . 53.4 mt -69.92 132.7 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.107 0.963 . . . . 0.0 108.459 174.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.5 m -120.13 114.94 22.7 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.96 141.25 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.073 -1.017 . . . . 0.0 110.863 -157.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.614 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 31.8 tttm -63.16 126.18 26.52 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 169.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.87 174.71 10.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.022 1.729 . . . . 0.0 111.733 168.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.94 140.58 30.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.681 0.792 . . . . 0.0 111.48 167.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.7 t -55.33 122.14 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 122.003 -0.435 . . . . 0.0 110.053 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.83 -17.82 10.47 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.389 -1.228 . . . . 0.0 115.995 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.8 79.99 67.55 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 119.587 1.694 . . . . 0.0 112.2 -172.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.87 -12.98 34.48 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.639 2.892 . . . . 0.0 116.362 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -78.25 -9.04 59.05 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.3 pt -142.89 163.68 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.927 1.291 . . . . 0.0 112.132 -167.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 mt -78.56 -41.93 30.62 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.08 -126.42 7.17 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.876 1.227 . . . . 0.0 114.494 -174.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -60.35 12.08 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 129.468 3.107 . . . . 0.0 117.455 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.0 m -113.57 71.56 1.74 Allowed Pre-proline 0 C--O 1.262 1.716 0 O-C-N 119.61 -1.931 . . . . 0.0 110.954 -161.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -69.47 -23.07 32.53 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 123.77 2.98 . . . . 0.0 112.296 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -67.34 -38.51 84.96 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.799 1.239 . . . . 0.0 112.757 169.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.2 m -64.85 -42.47 94.87 Favored 'General case' 0 C--N 1.374 1.658 0 O-C-N 119.931 -1.731 . . . . 0.0 110.99 169.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -62.16 -26.28 68.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 117.627 -1.178 . . . . 0.0 112.817 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -53.6 -47.6 70.04 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.58 1.082 . . . . 0.0 112.899 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.54 -33.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.465 1.106 . . . . 0.0 111.498 -167.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.7 mt -69.41 -40.59 77.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.739 0.815 . . . . 0.0 111.351 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.77 -48.11 82.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.321 1.449 . . . . 0.0 113.246 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 96.9 p -65.25 -38.5 90.51 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.649 1.113 . . . . 0.0 112.884 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.427 HD12 HD11 ' A' ' 5' ' ' ILE . 84.9 mt -80.18 -33.19 38.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.782 0.833 . . . . 0.0 112.769 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -73.41 -30.04 62.98 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 171.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -66.14 -41.38 90.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.837 -1.164 . . . . 0.0 111.747 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -70.85 -9.85 58.41 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm 62.33 1.8 0.77 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.186 1.794 . . . . 0.0 115.288 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.52 127.15 92.28 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.362 1.065 . . . . 0.0 110.618 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.45 147.21 64.39 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.118 1.878 . . . . 0.0 112.026 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.37 162.56 36.99 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.604 1.561 . . . . 0.0 110.322 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -101.11 137.28 39.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.609 1.564 . . . . 0.0 109.139 165.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -112.35 122.11 46.79 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.559 0.744 . . . . 0.0 111.323 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -107.77 86.26 2.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.804 1.642 . . . . 0.0 109.573 174.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.1 mt -70.4 126.69 30.35 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.381 1.073 . . . . 0.0 111.395 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.0 mt -126.75 112.2 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.444 1.898 . . . . 0.0 109.698 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -81.36 104.87 12.1 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.425 -0.797 . . . . 0.0 109.813 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.9 mt 52.29 23.67 2.51 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.79 23.78 10.52 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.224 0.85 . . . . 0.0 115.224 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -65.01 20.16 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -140.49 155.55 69.78 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 126.268 1.827 . . . . 0.0 110.679 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -60.16 167.51 7.44 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.121 1.881 . . . . 0.0 112.304 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -58.42 -15.75 12.07 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -56.37 -12.91 1.86 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.882 2.473 . . . . 0.0 116.015 171.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -117.24 -1.48 11.81 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.344 2.258 . . . . 0.0 113.416 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.0 mt -123.29 -38.68 2.54 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.557 2.343 . . . . 0.0 112.497 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.89 -13.99 7.83 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.575 2.35 . . . . 0.0 114.568 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.523 HD11 ' HE3' ' A' ' 64' ' ' LYS . 20.6 mt -64.98 -29.67 48.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.453 2.301 . . . . 0.0 111.594 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.3 t -99.27 136.32 20.5 Favored Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 123.468 0.707 . . . . 0.0 109.224 160.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.31 -14.15 42.98 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.629 2.219 . . . . 0.0 113.233 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -89.55 1.55 55.8 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.872 1.269 . . . . 0.0 113.241 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.66 11.96 82.86 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.016 1.293 . . . . 0.0 115.354 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -84.81 162.52 19.53 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.096 1.358 . . . . 0.0 112.887 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.34 148.19 66.69 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 126.484 1.914 . . . . 0.0 107.898 157.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -78.27 145.18 77.23 Favored 'Cis proline' 0 CA--C 1.539 0.768 0 N-CA-C 116.877 1.837 . . . . 0.0 116.877 12.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.3 m -154.97 176.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 128.809 2.843 . . . . 0.0 110.564 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.45 149.58 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 O-C-N 120.565 -1.334 . . . . 0.0 113.761 172.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HE3' HD11 ' A' ' 54' ' ' ILE . 93.5 mttt -95.54 126.06 40.56 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.364 1.065 . . . . 0.0 109.553 153.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.1 mt -100.17 76.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.277 1.431 . . . . 0.0 108.952 175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 58.45 60.53 2.56 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.19 0.995 . . . . 0.0 111.867 -163.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.307 61.3 m-20 64.64 -7.8 0.24 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -76.32 117.59 18.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.873 1.669 . . . . 0.0 109.884 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -69.53 143.19 53.49 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.6 t -138.3 131.34 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.832 1.653 . . . . 0.0 108.878 160.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.01 -154.83 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.222 1.809 . . . . 0.0 113.205 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.4 157.06 0.54 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -158.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.0 p -49.81 -25.55 3.19 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.879 1.671 . . . . 0.0 114.917 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -97.44 -10.15 25.96 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.8 1.24 . . . . 0.0 113.671 -171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.57 -21.82 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.159 0.984 . . . . 0.0 112.698 158.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.12 -37.98 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.965 1.706 . . . . 0.0 112.838 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.48 -16.93 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.0 -53.27 0.75 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.062 0.839 . . . . 0.0 113.268 160.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -71.33 -36.88 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.477 1.138 . . . . 0.0 113.312 -163.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.2 tp -73.89 -35.83 64.73 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.246 0.93 . . . . 0.0 111.391 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -71.68 -36.06 70.49 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.66 -32.37 73.83 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.566 1.546 . . . . 0.0 112.843 168.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -98.96 8.87 44.58 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.795 1.238 . . . . 0.0 113.085 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.43 137.03 34.64 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.92 0.888 . . . . 0.0 110.621 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.09 -29.8 17.15 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 121.669 1.58 . . . . 0.0 112.376 168.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 69.9 mm-40 -85.91 141.19 35.46 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 118.567 0.622 . . . . 0.0 111.76 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 53.1 Cg_exo -51.2 128.89 26.75 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.778 2.985 . . . . 0.0 115.792 -160.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 72.1 Cg_exo -57.81 143.45 95.55 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.206 2.604 . . . . 0.0 114.966 -174.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.4 mt -110.49 0.94 17.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.989 2.116 . . . . 0.0 112.516 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.14 -13.11 62.23 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.964 1.705 . . . . 0.0 115.33 -176.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.2 m -65.2 122.14 78.23 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-O 118.287 -0.864 . . . . 0.0 109.749 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.407 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 75.6 Cg_endo -76.89 126.39 8.72 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 121.932 1.755 . . . . 0.0 110.788 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 92' ' ' PRO . 68.0 Cg_endo -69.18 167.44 23.67 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.1 1.866 . . . . 0.0 110.191 155.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -26.15 61.8 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.725 -1.234 . . . . 0.0 113.665 165.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -55.44 -22.92 22.57 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.371 -1.455 . . . . 0.0 113.97 167.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.7 -24.19 67.49 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.509 -1.369 . . . . 0.0 113.903 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 p -73.56 -3.7 29.44 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.304 1.411 . . . . 0.0 113.988 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.92 -38.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.986 1.315 . . . . 0.0 111.042 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.36 75.69 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.084 -1.01 . . . . 0.0 114.497 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.8 p -68.2 -15.52 63.61 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -90.41 -42.44 10.9 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.935 1.294 . . . . 0.0 112.356 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.32 -32.43 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.134 1.374 . . . . 0.0 110.94 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -59.74 -55.57 44.44 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.292 -1.337 . . . . 0.0 113.929 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.2 -31.78 3.45 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.581 2.188 . . . . 0.0 113.983 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.2 p -68.13 -36.54 79.89 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.006 1.73 . . . . 0.0 112.934 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -76.33 -24.46 54.27 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.57 -1.331 . . . . 0.0 114.047 170.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.24 -34.7 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.381 -1.45 . . . . 0.0 111.305 169.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -67.01 -39.22 87.03 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.589 1.155 . . . . 0.0 112.069 171.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -61.78 -24.65 66.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.131 1.372 . . . . 0.0 114.145 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.4 mt -90.18 7.98 35.34 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.813 1.645 . . . . 0.0 114.103 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -137.83 66.66 1.44 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.351 1.46 . . . . 0.0 110.692 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -62.15 23.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 130.903 3.681 . . . . 0.0 118.324 -162.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.03 -29.57 65.53 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.379 1.472 . . . . 0.0 111.597 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -80.61 114.62 49.27 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 152.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -58.41 128.5 28.69 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.405 2.07 . . . . 0.0 114.271 -164.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -57.19 -42.45 81.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.449 1.1 . . . . 0.0 112.753 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -61.93 -24.35 66.92 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.54 -40.17 5.75 Favored Glycine 0 N--CA 1.474 1.209 0 O-C-N 121.156 -0.965 . . . . 0.0 112.494 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.2 m -61.56 -36.74 81.48 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.07 -27.26 68.23 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -68.97 -38.76 79.58 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.676 -0.64 . . . . 0.0 111.332 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.05 -37.39 78.53 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.873 -1.142 . . . . 0.0 112.659 171.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 mt -62.5 -39.64 94.15 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.508 0.595 . . . . 0.0 112.17 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.71 -44.12 87.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.44 -0.791 . . . . 0.0 112.042 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.56 -32.7 70.22 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.862 1.21 . . . . 0.0 112.842 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -64.44 -49.63 70.71 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.222 -0.924 . . . . 0.0 112.319 169.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.3 mt -68.25 -32.1 72.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.939 -1.029 . . . . 0.0 113.051 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -64.36 -45.55 87.27 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.627 1.558 . . . . 0.0 112.191 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.75 -31.49 72.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.113 0.565 . . . . 0.0 112.395 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 tp -75.71 -59.85 2.57 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.93 1.292 . . . . 0.0 111.822 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.25 -33.92 76.54 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.499 1.52 . . . . 0.0 114.148 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.74 -29.99 62.16 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.935 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -101.05 -26.9 13.54 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.18 -31.68 72.88 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.471 1.487 . . . . 0.0 113.328 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -64.57 -12.76 48.37 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.7 t -98.97 -35.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.911 1.284 . . . . 0.0 111.95 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -82.41 -22.05 35.5 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.04 -109.28 3.24 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-O 117.603 -1.665 . . . . 0.0 114.883 162.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.76 -30.26 3.93 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.151 3.234 . . . . 0.0 116.781 -149.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -132.45 160.23 37.04 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.201 1.364 . . . . 0.0 112.697 -169.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.8 tt -73.08 -8.21 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -171.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.92 -5.83 40.53 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 164.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 123.01 -129.97 7.64 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.966 1.257 . . . . 0.0 113.781 -175.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -71.81 -20.41 61.85 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.589 1.556 . . . . 0.0 114.005 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -139.31 153.0 47.67 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.983 1.713 . . . . 0.0 109.973 -175.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.91 105.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.771 0.828 . . . . 0.0 108.952 162.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.2 p -133.33 -164.86 1.54 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.722 1.209 . . . . 0.0 110.767 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.07 -24.26 3.75 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -165.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.27 -43.5 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.189 1.359 . . . . 0.0 112.663 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.78 -47.98 78.92 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.772 1.169 . . . . 0.0 111.834 167.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.39 -15.51 49.31 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.9 m -100.32 -36.11 9.37 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.642 1.577 . . . . 0.0 113.094 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.1 mt -111.54 -32.85 6.55 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -165.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.26 97.81 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -167.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.69 -18.71 19.35 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.251 1.301 . . . . 0.0 114.464 175.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -70.81 -32.99 70.25 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.712 -1.242 . . . . 0.0 111.773 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.4 -34.43 72.53 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -64.93 -44.6 88.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.518 0.675 . . . . 0.0 112.362 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -69.07 -28.76 66.8 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.082 -1.011 . . . . 0.0 113.197 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.93 -56.41 19.53 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.686 1.194 . . . . 0.0 110.835 168.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -61.39 -46.39 90.36 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.702 1.201 . . . . 0.0 111.753 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.2 t -80.0 -53.32 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.83 -52.79 9.6 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.544 -0.723 . . . . 0.0 112.106 -167.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 9.1 tp -69.28 -21.57 63.87 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.893 -0.504 . . . . 0.0 111.942 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -51.75 -28.41 23.01 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.579 1.561 . . . . 0.0 115.388 169.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -71.73 -15.65 62.2 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -136.92 -36.65 0.68 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -150.82 77.85 1.29 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.545 1.538 . . . . 0.0 109.199 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -59.18 103.24 0.16 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.873 0.469 . . . . 0.0 110.471 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -91.87 108.37 29.49 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.194 0.997 . . . . 0.0 110.964 -168.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.34 133.77 21.55 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.256 1.97 . . . . 0.0 111.39 -171.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 42.1 mm -74.18 114.8 36.74 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 159.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -69.73 158.8 55.73 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.058 1.839 . . . . 0.0 111.435 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.36 -22.54 61.49 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -64.29 -28.63 69.85 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.97 54.3 3.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.165 1.786 . . . . 0.0 110.964 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -22.11 62.82 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.491 1.116 . . . . 0.0 113.796 -161.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -75.29 -52.8 9.97 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.663 1.119 . . . . 0.0 109.92 166.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 92.3 t -60.72 -37.85 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 119.257 0.935 . . . . 0.0 112.345 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.6 -31.9 72.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.327 1.051 . . . . 0.0 113.059 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -89.16 -26.02 21.51 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.018 -1.051 . . . . 0.0 113.258 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -67.23 -35.06 78.79 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.244 1.017 . . . . 0.0 112.759 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.7 mt -61.14 -32.93 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 120.911 -1.118 . . . . 0.0 111.998 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -69.84 -26.55 64.28 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 119.718 -1.863 . . . . 0.0 112.627 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.1 mt -70.02 -20.72 63.25 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.281 171.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.22 -24.67 67.98 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.666 1.121 . . . . 0.0 112.877 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -88.31 13.9 10.63 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.471 1.509 . . . . 0.0 113.024 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.7 p -137.56 176.71 8.46 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.116 1.766 . . . . 0.0 113.827 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 55.48 -173.1 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.211 1.804 . . . . 0.0 112.286 -169.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 190' ' ' GLU . 13.9 mp0 -79.03 -41.18 29.49 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.161 1.384 . . . . 0.0 109.866 162.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 92.7 p -57.41 -35.9 70.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.948 2.099 . . . . 0.0 114.586 -171.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -114.11 -43.44 3.23 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.06 -30.08 70.12 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.614 -1.304 . . . . 0.0 113.812 -177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.87 -17.5 55.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 20.0 p -100.37 -6.43 25.76 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.499 1.12 . . . . 0.0 113.42 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -51.24 104.03 0.07 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.258 1.823 . . . . 0.0 110.959 163.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -81.56 145.56 30.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.24 1.016 . . . . 0.0 112.142 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.55 120.55 8.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.312 1.045 . . . . 0.0 111.884 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -65.54 -42.44 91.94 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.61 1.564 . . . . 0.0 113.873 -151.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -31.63 72.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.127 0.971 . . . . 0.0 113.014 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -81.17 -11.99 59.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.1 t -70.74 -48.99 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.834 1.197 . . . . 0.0 109.43 162.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.5 mt -64.14 -53.93 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.447 1.099 . . . . 0.0 111.81 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.84 71.74 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -77.67 -23.95 66.1 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.92 -1.113 . . . . 0.0 113.477 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -79.67 -31.11 41.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.141 1.376 . . . . 0.0 114.144 174.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -47.97 -51.11 50.17 Favored Pre-proline 0 CA--C 1.554 1.122 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.58 -20.08 47.61 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 121.846 1.697 . . . . 0.0 113.937 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -88.07 4.26 45.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.185 1.794 . . . . 0.0 114.923 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.02 -25.67 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 122.6 0.36 . . . . 0.0 110.572 151.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -91.88 -38.07 12.53 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 116.804 -1.569 . . . . 0.0 114.697 168.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.797 2.039 . . . . 0.0 113.49 -179.487 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.47 -174.63 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.069 1.348 . . . . 0.0 113.618 -168.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.05 116.92 17.22 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.908 -1.12 . . . . 0.0 110.871 -170.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -127.61 122.82 34.13 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.071 0.948 . . . . 0.0 110.98 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 HG22 HG13 ' A' ' 7' ' ' VAL . 45.8 mt -102.66 132.67 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.591 1.557 . . . . 0.0 108.731 -172.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.9 m -114.26 105.15 12.82 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -120.56 143.75 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.881 1.272 . . . . 0.0 110.785 -162.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.665 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.0 tttm -63.55 127.86 33.22 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.534 169.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.94 173.91 10.2 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.85 1.66 . . . . 0.0 112.117 168.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.28 138.72 20.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.324 1.049 . . . . 0.0 111.512 163.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.8 t -56.18 123.47 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 121.056 0.455 . . . . 0.0 109.942 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.87 -11.71 26.52 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 116.446 1.338 . . . . 0.0 116.446 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.81 78.38 73.78 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.978 1.889 . . . . 0.0 112.138 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.03 -13.13 38.05 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.6 2.867 . . . . 0.0 116.693 -168.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.02 -11.19 59.89 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.2 pt -141.06 162.32 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.598 1.159 . . . . 0.0 112.346 -164.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 mt -76.56 -44.53 34.33 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.31 -128.57 13.37 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.315 0.96 . . . . 0.0 114.774 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -63.04 16.88 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.392 3.077 . . . . 0.0 116.896 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -115.56 70.45 3.25 Favored Pre-proline 0 C--O 1.256 1.396 0 O-C-N 119.717 -1.864 . . . . 0.0 110.991 -162.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -68.5 -23.83 36.89 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 123.336 2.691 . . . . 0.0 112.046 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -65.09 -41.0 95.39 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.358 1.463 . . . . 0.0 112.935 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.5 m -64.29 -41.81 96.71 Favored 'General case' 0 C--N 1.373 1.611 0 O-C-N 119.762 -1.836 . . . . 0.0 110.991 170.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -62.75 -28.32 69.89 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 117.567 -1.206 . . . . 0.0 112.641 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -53.26 -46.5 69.25 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.507 1.049 . . . . 0.0 112.88 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.13 -40.77 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.345 1.058 . . . . 0.0 111.059 -170.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.6 mt -69.2 -37.34 78.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.825 0.85 . . . . 0.0 111.789 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.3 tp -59.4 -46.01 89.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.456 1.502 . . . . 0.0 113.209 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.41 -37.87 77.67 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.702 1.137 . . . . 0.0 113.03 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -75.35 -37.28 60.76 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.86 0.864 . . . . 0.0 113.11 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -72.87 -27.29 61.82 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -68.63 -41.18 79.81 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.745 -1.222 . . . . 0.0 111.522 169.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -68.74 -11.03 59.82 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.158 1.783 . . . . 0.0 115.058 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm 62.32 3.01 0.94 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 126.394 1.878 . . . . 0.0 115.331 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.8 tt -72.06 131.13 85.67 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.805 0.842 . . . . 0.0 110.786 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.93 147.02 73.54 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.192 1.928 . . . . 0.0 112.158 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -146.19 160.94 41.28 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 126.095 1.758 . . . . 0.0 109.526 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -101.17 128.69 47.15 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.955 0.902 . . . . 0.0 109.551 166.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.9 t -104.7 128.19 52.7 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.207 0.603 . . . . 0.0 111.941 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -113.97 93.11 4.22 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.803 1.641 . . . . 0.0 109.925 167.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.29 136.96 50.31 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.28 1.032 . . . . 0.0 111.134 168.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.8 mt -133.58 115.04 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.808 2.043 . . . . 0.0 110.198 -167.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -82.46 111.23 18.29 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.553 -0.717 . . . . 0.0 109.736 169.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.9 mt 52.73 19.63 1.32 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 168.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.64 25.26 10.06 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.135 0.879 . . . . 0.0 115.035 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -61.89 13.41 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -138.7 152.5 70.83 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 126.187 1.795 . . . . 0.0 110.524 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -59.74 167.68 6.52 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.351 2.034 . . . . 0.0 111.868 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -61.16 -12.84 14.05 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 116.595 -1.669 . . . . 0.0 114.962 -172.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -56.95 -13.1 2.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.09 2.556 . . . . 0.0 116.433 168.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -115.96 2.12 13.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.746 2.019 . . . . 0.0 112.978 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.7 mt -127.29 -40.9 1.78 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.587 2.355 . . . . 0.0 112.266 -172.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.19 -14.92 12.18 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 127.881 2.472 . . . . 0.0 114.807 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.51 HD11 ' HE3' ' A' ' 64' ' ' LYS . 18.0 mt -63.88 -24.35 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 127.26 2.224 . . . . 0.0 111.298 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.5 t -102.82 139.23 19.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.467 1.107 . . . . 0.0 109.992 157.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -62.91 -25.37 74.23 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.433 2.089 . . . . 0.0 112.811 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -80.82 -0.88 40.79 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.312 1.445 . . . . 0.0 113.361 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.3 9.18 57.21 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 120.075 -1.641 . . . . 0.0 114.992 -170.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -69.62 158.18 35.81 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.754 1.222 . . . . 0.0 112.398 -175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.15 150.24 73.35 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 126.408 1.883 . . . . 0.0 107.965 154.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' A' ' 7' ' ' VAL . 58.0 Cg_endo -80.31 148.26 77.25 Favored 'Cis proline' 0 CA--C 1.541 0.859 0 N-CA-C 116.264 1.602 . . . . 0.0 116.264 8.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.0 m -155.52 170.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 127.85 2.46 . . . . 0.0 111.127 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.03 149.35 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HE3' HD11 ' A' ' 54' ' ' ILE . 89.7 mttt -96.54 123.53 40.24 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.759 2.024 . . . . 0.0 109.346 158.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.7 mt -103.08 80.93 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.325 1.45 . . . . 0.0 108.966 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 t70 58.32 60.95 2.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.786 0.835 . . . . 0.0 111.712 -163.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 64.63 -16.76 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -75.28 123.12 24.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.059 1.344 . . . . 0.0 110.626 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -72.14 144.27 48.66 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.8 t -140.29 131.27 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 126.367 1.867 . . . . 0.0 108.723 162.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.42 -149.79 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.967 1.707 . . . . 0.0 113.342 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -37.42 154.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.643 1.977 . . . . 0.0 116.084 -165.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -50.25 -23.43 2.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.663 1.585 . . . . 0.0 114.689 163.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -98.91 -8.69 25.21 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 113.825 -171.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.5 m -104.79 -22.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.277 1.031 . . . . 0.0 112.605 158.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mt -52.02 -35.51 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.472 1.909 . . . . 0.0 113.127 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.61 -18.4 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.555 1.142 . . . . 0.0 114.018 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.62 -56.34 0.64 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.125 0.869 . . . . 0.0 112.565 158.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.48 -31.74 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.024 -1.28 . . . . 0.0 113.688 -161.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 tp -79.9 -40.78 27.51 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.315 0.962 . . . . 0.0 111.57 169.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.45 -30.64 71.39 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.29 -32.56 74.04 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.209 1.804 . . . . 0.0 114.519 168.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -115.82 -10.9 11.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.901 1.281 . . . . 0.0 113.659 -159.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -71.64 139.62 83.68 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.213 1.005 . . . . 0.0 109.701 165.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.71 -26.89 32.5 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 121.88 1.72 . . . . 0.0 113.488 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -79.74 142.64 57.19 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 118.918 0.781 . . . . 0.0 111.305 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -55.02 143.47 73.11 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.106 2.537 . . . . 0.0 116.454 -160.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.93 130.2 28.45 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.856 3.037 . . . . 0.0 113.313 -175.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.3 mt -94.55 1.65 55.67 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.867 2.067 . . . . 0.0 112.791 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.41 -25.13 68.14 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.2 m -62.8 119.14 48.66 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-O 118.545 -0.741 . . . . 0.0 111.114 -168.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.4 124.93 7.37 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.502 2.135 . . . . 0.0 111.349 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -75.36 177.31 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.899 2.399 . . . . 0.0 110.709 162.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -58.79 -29.08 66.55 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.689 -1.257 . . . . 0.0 113.535 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -57.71 -24.16 55.44 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.85 -24.53 67.78 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.805 -1.184 . . . . 0.0 113.002 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.0 p -67.12 -14.62 63.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.152 1.381 . . . . 0.0 114.096 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.59 -36.68 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.913 1.285 . . . . 0.0 111.239 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 -26.89 70.46 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 120.964 -1.085 . . . . 0.0 114.591 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 p -69.61 -15.69 63.25 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 170.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -88.51 -40.83 13.14 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.454 1.501 . . . . 0.0 111.936 169.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.84 -31.97 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.034 1.334 . . . . 0.0 111.531 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -58.72 -55.8 42.37 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.374 -1.298 . . . . 0.0 113.575 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.55 -32.28 3.82 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.342 2.028 . . . . 0.0 113.647 170.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 p -67.48 -32.74 73.77 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 121.17 1.805 . . . . 0.0 113.349 -170.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.15 -28.82 42.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.25 -35.76 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 120.696 -1.252 . . . . 0.0 111.262 170.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -66.43 -45.09 81.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.829 1.652 . . . . 0.0 111.7 170.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -59.33 -40.77 87.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.146 0.978 . . . . 0.0 112.721 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.2 -21.9 64.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.165 1.386 . . . . 0.0 114.501 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -98.84 71.29 1.9 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.658 1.572 . . . . 0.0 109.867 165.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.7 m -60.2 18.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.513 3.125 . . . . 0.0 118.743 -159.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -74.54 -23.09 58.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.489 1.916 . . . . 0.0 113.046 173.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -76.2 113.11 25.13 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.279 158.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.63 117.26 3.64 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.005 2.47 . . . . 0.0 112.802 -164.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.3 -39.61 94.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.914 -161.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.15 -25.74 68.49 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.367 -1.458 . . . . 0.0 114.165 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.58 -39.58 6.65 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.288 0.947 . . . . 0.0 113.507 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.6 m -57.16 -38.85 74.18 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.559 1.144 . . . . 0.0 111.922 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.71 -26.7 68.21 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.248 1.419 . . . . 0.0 114.0 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -71.28 -35.98 71.53 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.469 -0.77 . . . . 0.0 112.173 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.68 84.26 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.94 -1.1 . . . . 0.0 112.177 171.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.5 mt -62.55 -40.2 96.08 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.89 0.476 . . . . 0.0 111.769 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.8 mt -65.9 -43.9 86.86 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.324 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.49 -34.43 74.32 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.052 1.296 . . . . 0.0 112.855 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -63.72 -47.63 80.3 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.233 -0.917 . . . . 0.0 112.419 170.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.52 -35.2 77.15 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.123 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -63.47 -44.3 94.82 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.352 1.433 . . . . 0.0 112.018 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.52 72.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.346 0.658 . . . . 0.0 112.689 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.82 -56.24 4.87 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.93 0.892 . . . . 0.0 111.953 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.49 -32.96 74.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.054 1.341 . . . . 0.0 114.0 -168.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.74 -34.41 60.88 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.585 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -93.38 -30.54 15.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.241 1.016 . . . . 0.0 113.202 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.74 -28.76 70.1 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.379 -1.451 . . . . 0.0 113.489 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -67.67 -11.24 57.82 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 171.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.8 t -101.29 -44.19 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.977 1.311 . . . . 0.0 111.455 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -75.48 -17.51 60.11 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.0 -110.21 3.84 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 117.772 -1.571 . . . . 0.0 115.506 159.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.83 -28.23 4.22 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.677 2.918 . . . . 0.0 116.487 -148.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -134.81 164.36 27.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.887 1.221 . . . . 0.0 112.391 -170.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.4 tt -78.55 -7.13 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.327 -0.858 . . . . 0.0 113.183 -166.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.35 -1.48 53.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.684 1.594 . . . . 0.0 114.568 161.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 111.31 -127.72 8.33 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.303 1.43 . . . . 0.0 113.334 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -64.81 -19.37 65.81 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.31 1.844 . . . . 0.0 114.238 -171.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -147.68 150.47 34.41 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.932 1.693 . . . . 0.0 109.429 -172.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.83 112.94 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.365 0.666 . . . . 0.0 109.484 164.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.3 p -140.25 -164.66 1.75 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.362 1.065 . . . . 0.0 110.9 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.63 -24.2 2.09 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -167.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.83 -43.11 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 120.234 1.379 . . . . 0.0 112.142 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.83 -44.81 96.45 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.031 -1.043 . . . . 0.0 112.187 169.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.4 -19.36 61.82 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.533 0.733 . . . . 0.0 112.841 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.9 m -95.44 -36.26 11.4 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.339 1.456 . . . . 0.0 113.115 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 48.5 mt -111.8 -36.07 5.54 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -165.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.48 -46.13 98.24 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -168.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.02 -20.38 19.41 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 120.662 1.272 . . . . 0.0 114.371 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -70.51 -32.77 70.38 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.834 -1.166 . . . . 0.0 111.77 170.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.91 -35.67 74.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.346 0.659 . . . . 0.0 112.597 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -65.39 -43.12 91.66 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.729 0.776 . . . . 0.0 112.378 169.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -68.0 -28.8 67.74 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.15 -0.969 . . . . 0.0 113.184 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.42 -56.3 15.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.482 1.113 . . . . 0.0 110.935 169.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -58.31 -46.18 86.62 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.511 1.124 . . . . 0.0 111.93 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.3 t -82.88 -52.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.13 -55.28 5.58 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.527 -0.733 . . . . 0.0 111.789 -167.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.36 -29.45 69.63 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.034 -0.416 . . . . 0.0 111.691 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.08 -21.31 38.19 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.04 1.305 . . . . 0.0 116.046 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -68.62 -19.34 64.43 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -131.17 -34.24 1.45 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -146.88 91.08 1.97 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.745 1.618 . . . . 0.0 109.335 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -66.58 90.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.666 0.786 . . . . 0.0 110.198 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -84.73 113.64 50.6 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.621 1.168 . . . . 0.0 111.143 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.36 136.82 22.38 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.295 1.997 . . . . 0.0 111.523 -175.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 97.0 mt -86.16 101.06 1.63 Allowed Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 161.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -70.16 160.86 48.09 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.014 1.81 . . . . 0.0 112.522 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.95 -21.54 58.55 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -172.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -61.4 -29.48 69.95 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.398 -0.814 . . . . 0.0 113.15 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.45 53.22 2.25 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.877 2.071 . . . . 0.0 111.064 171.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -21.67 63.34 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.318 1.047 . . . . 0.0 113.589 -160.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -75.05 -54.88 6.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.816 1.189 . . . . 0.0 109.823 165.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.82 -36.63 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 119.022 0.828 . . . . 0.0 112.476 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.9 tp -64.47 -32.42 74.04 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.879 -1.138 . . . . 0.0 112.957 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -81.09 -24.92 37.4 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.752 -1.218 . . . . 0.0 113.219 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -67.16 -31.62 72.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.12 0.968 . . . . 0.0 112.908 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 36.4 mm -56.28 -40.1 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 120.996 -1.065 . . . . 0.0 111.705 168.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -71.39 -22.4 61.88 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.473 -1.392 . . . . 0.0 112.288 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.76 -22.5 59.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 117.795 -1.098 . . . . 0.0 113.458 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.82 -27.03 68.48 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 120.212 1.369 . . . . 0.0 112.907 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.73 12.51 8.8 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.181 1.792 . . . . 0.0 113.463 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.9 p -137.78 178.24 7.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.832 1.653 . . . . 0.0 113.821 -167.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 56.61 -171.41 0.08 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.402 1.481 . . . . 0.0 111.351 -163.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 190' ' ' GLU . 4.4 mp0 -78.28 -44.01 26.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.009 0.924 . . . . 0.0 109.435 156.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 59.5 p -70.01 -36.05 74.82 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 126.018 1.727 . . . . 0.0 115.456 -161.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -85.06 -50.57 7.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.278 0.945 . . . . 0.0 111.547 165.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -59.76 -34.84 73.51 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -73.09 -19.5 61.15 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.387 0.994 . . . . 0.0 113.181 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.1 p -94.7 -8.8 36.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -53.18 107.64 0.25 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.108 1.363 . . . . 0.0 110.188 167.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.62 145.4 34.7 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.565 0.746 . . . . 0.0 111.826 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.54 127.1 30.36 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.732 0.813 . . . . 0.0 111.158 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -69.26 -42.19 75.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.473 1.109 . . . . 0.0 113.889 -149.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -61.41 -33.67 74.08 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.693 1.197 . . . . 0.0 112.328 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -79.81 -12.78 59.75 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.21 -48.52 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 119.247 0.931 . . . . 0.0 109.591 163.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.0 mt -63.5 -55.31 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.703 1.201 . . . . 0.0 111.8 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.67 -29.14 67.53 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -78.74 -27.8 56.12 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.709 -1.244 . . . . 0.0 113.211 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -75.43 -33.41 60.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.194 1.398 . . . . 0.0 113.929 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -48.21 -52.01 45.14 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.8 -20.41 58.73 Favored 'Trans proline' 0 C--N 1.354 0.823 0 CA-C-N 121.57 1.596 . . . . 0.0 113.552 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -93.65 9.88 35.07 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.575 1.95 . . . . 0.0 114.408 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 50.0 t -68.27 -25.12 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.681 -0.637 . . . . 0.0 110.364 148.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -96.59 -50.01 4.89 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 117.833 -1.08 . . . . 0.0 113.762 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.894 0 C-N-CA 125.843 1.657 . . . . 0.0 114.539 -175.625 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.5 mtp . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 118.372 -0.823 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.94 -167.3 0.06 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.346 1.058 . . . . 0.0 112.704 -170.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.8 mt -73.16 118.31 15.95 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.945 -1.097 . . . . 0.0 111.521 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -122.3 122.21 38.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.635 1.174 . . . . 0.0 109.806 166.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mt -109.43 129.23 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.004 1.322 . . . . 0.0 108.29 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.3 m -113.27 117.52 32.09 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.79 142.76 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.222 1.009 . . . . 0.0 110.198 -161.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.699 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.8 tttm -64.32 128.78 37.25 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.451 170.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.07 174.08 9.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.996 1.719 . . . . 0.0 112.176 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.24 136.1 43.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.9 0.88 . . . . 0.0 111.107 164.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 68.1 t -57.85 122.85 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.75 -0.594 . . . . 0.0 109.763 172.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.04 -10.81 61.94 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 118.21 -1.328 . . . . 0.0 116.07 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.46 83.89 24.69 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 120.078 1.939 . . . . 0.0 112.293 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.83 -14.05 42.77 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.552 2.835 . . . . 0.0 116.525 -171.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -81.8 -7.03 59.56 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.2 pt -141.83 161.88 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.868 1.267 . . . . 0.0 111.957 -166.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.5 mt -77.37 -46.13 23.8 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.37 -123.89 7.39 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.829 1.204 . . . . 0.0 114.398 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -63.4 16.97 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.802 2.841 . . . . 0.0 116.894 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -116.26 71.16 4.41 Favored Pre-proline 0 C--O 1.26 1.635 0 O-C-N 119.494 -2.004 . . . . 0.0 110.945 -162.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -69.28 -21.38 35.8 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.425 2.75 . . . . 0.0 112.42 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -69.1 -42.51 76.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.441 1.496 . . . . 0.0 112.627 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.699 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -60.74 -42.48 97.46 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 119.364 -2.085 . . . . 0.0 111.014 168.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -63.1 -27.46 69.4 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 117.59 -1.195 . . . . 0.0 113.106 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -55.75 -44.96 78.12 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 120.139 1.336 . . . . 0.0 112.536 172.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -72.03 -40.09 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.904 1.281 . . . . 0.0 111.422 -171.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.43 -36.4 71.29 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.453 0.701 . . . . 0.0 111.493 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.71 -41.79 95.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.603 1.161 . . . . 0.0 113.698 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -70.42 -40.84 73.58 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.011 1.278 . . . . 0.0 112.527 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.2 -34.5 65.99 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.684 0.794 . . . . 0.0 113.036 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -78.28 -19.77 52.96 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -72.69 -40.88 65.88 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 120.709 -1.244 . . . . 0.0 112.008 162.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -74.07 -4.53 36.1 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.59 1.556 . . . . 0.0 114.775 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt 58.7 16.81 4.63 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.99 2.116 . . . . 0.0 115.197 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.5 mm -76.99 129.55 78.26 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.858 0.863 . . . . 0.0 110.317 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.95 145.76 45.88 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.462 2.108 . . . . 0.0 111.953 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -148.31 158.65 44.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.339 1.456 . . . . 0.0 110.489 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -96.8 100.93 12.44 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.387 1.075 . . . . 0.0 110.268 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.4 t -81.73 136.26 35.46 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -127.51 96.74 4.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.289 1.836 . . . . 0.0 110.165 168.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.7 mt -72.15 142.26 49.11 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.634 1.174 . . . . 0.0 111.433 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.4 mt -133.07 119.52 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.592 1.557 . . . . 0.0 110.683 -170.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -89.37 112.05 23.06 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.708 -0.62 . . . . 0.0 110.064 170.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.3 mt 51.29 22.18 1.32 Allowed 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.02 24.97 15.44 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 119.061 -0.855 . . . . 0.0 115.207 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -65.34 16.73 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -141.02 147.61 48.53 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 126.203 1.801 . . . . 0.0 110.517 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -62.99 171.66 5.84 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.475 2.116 . . . . 0.0 112.094 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -58.89 -17.67 26.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 116.919 -1.515 . . . . 0.0 115.045 -174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -57.35 -11.84 2.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.692 1.997 . . . . 0.0 116.261 169.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -116.32 3.4 13.35 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.352 1.861 . . . . 0.0 113.091 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.6 mt -131.96 -40.26 1.06 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.127 2.171 . . . . 0.0 112.594 -170.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.49 -8.78 2.02 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 128.531 2.732 . . . . 0.0 115.137 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.464 HD11 ' HE3' ' A' ' 64' ' ' LYS . 11.3 mt -68.31 -19.64 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 127.989 2.516 . . . . 0.0 111.16 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.7 p -110.56 148.07 37.71 Favored Pre-proline 0 N--CA 1.472 0.634 0 C-N-CA 124.671 1.188 . . . . 0.0 111.069 161.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.71 -20.94 59.18 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.907 2.405 . . . . 0.0 113.985 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -101.14 1.48 39.22 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.135 1.374 . . . . 0.0 114.038 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.54 11.69 80.24 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 119.219 0.918 . . . . 0.0 114.971 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -62.62 150.87 39.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.061 1.344 . . . . 0.0 110.673 171.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.42 150.33 75.3 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.224 1.41 . . . . 0.0 108.843 155.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.5 153.78 97.11 Favored 'Cis proline' 0 CA--C 1.542 0.888 0 N-CA-C 116.721 1.777 . . . . 0.0 116.721 14.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.8 m -157.13 167.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 127.964 2.506 . . . . 0.0 110.92 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.41 147.19 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.964 -1.085 . . . . 0.0 113.797 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HE3' HD11 ' A' ' 54' ' ' ILE . 87.6 mttt -100.09 115.55 30.04 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.063 1.745 . . . . 0.0 108.932 164.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.3 mt -95.05 77.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.645 1.178 . . . . 0.0 109.173 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.7 t70 58.39 60.41 2.62 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.418 -164.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.263 56.0 m-20 64.9 -10.84 0.15 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 127.591 2.356 . . . . 0.0 117.33 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -73.33 117.75 15.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.347 1.459 . . . . 0.0 109.928 171.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -68.75 144.49 54.35 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.0 t -141.83 131.84 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.278 1.831 . . . . 0.0 109.173 166.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.87 -149.58 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.27 1.828 . . . . 0.0 113.732 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -46.01 158.51 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.097 2.159 . . . . 0.0 116.766 -163.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.6 p -51.93 -30.52 24.83 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.624 -1.298 . . . . 0.0 113.83 168.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.65 -7.37 52.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -170.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.8 -22.13 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.282 1.033 . . . . 0.0 113.094 160.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mt -53.78 -37.79 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.694 1.598 . . . . 0.0 112.946 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.92 -11.08 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.7 -58.81 0.71 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.781 0.705 . . . . 0.0 112.341 154.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.15 -32.58 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.388 -1.066 . . . . 0.0 113.839 -161.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -77.28 -45.73 25.38 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.258 0.936 . . . . 0.0 111.752 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.31 -26.28 68.41 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.11 0.964 . . . . 0.0 113.511 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.51 -33.57 75.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.903 1.681 . . . . 0.0 114.264 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -116.28 -20.03 9.94 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.789 1.236 . . . . 0.0 113.629 -158.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -73.83 126.35 89.59 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.15 0.98 . . . . 0.0 108.701 158.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.18 -12.98 25.81 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.822 2.348 . . . . 0.0 115.333 -168.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -72.03 142.2 84.92 Favored Pre-proline 0 CA--C 1.547 0.864 0 CA-C-N 119.073 0.851 . . . . 0.0 109.637 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -57.83 134.6 63.67 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 CA-C-N 121.886 1.709 . . . . 0.0 114.939 -163.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.38 132.92 46.21 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.173 3.249 . . . . 0.0 113.578 -166.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 mt -86.45 2.61 47.15 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.171 1.388 . . . . 0.0 112.819 166.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.79 -31.85 73.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.75 1.62 . . . . 0.0 115.094 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.6 m -64.93 120.57 67.82 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.848 -164.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.34 125.98 10.06 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.192 1.928 . . . . 0.0 111.026 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -73.71 176.86 8.8 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.146 2.564 . . . . 0.0 110.765 164.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -58.56 -29.63 66.52 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.605 -1.309 . . . . 0.0 113.323 171.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -57.6 -23.96 53.78 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.022 1.329 . . . . 0.0 114.144 172.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.97 67.04 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.905 -1.122 . . . . 0.0 113.705 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.6 p -65.94 -14.23 61.18 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 171.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.61 -37.54 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.943 1.297 . . . . 0.0 111.343 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.18 -26.06 68.89 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.333 0.968 . . . . 0.0 114.897 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 p -70.15 -15.64 62.98 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -88.0 -41.07 13.37 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.281 1.432 . . . . 0.0 111.731 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.7 -31.34 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.599 1.159 . . . . 0.0 111.895 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.53 -54.65 53.85 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.612 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.66 -29.61 4.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.608 2.205 . . . . 0.0 113.874 170.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 p -70.4 -31.19 68.31 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 121.384 1.902 . . . . 0.0 113.356 -173.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.6 -34.8 74.63 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.077 -1.639 . . . . 0.0 113.517 165.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.2 t -67.02 -32.47 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.941 -1.1 . . . . 0.0 111.315 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -68.4 -44.87 74.14 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.521 1.529 . . . . 0.0 111.868 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -63.07 -37.98 89.37 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.89 1.276 . . . . 0.0 112.737 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 73.1 mt -74.82 13.67 0.61 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.815 1.646 . . . . 0.0 114.633 170.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -141.07 71.17 1.36 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.94 1.296 . . . . 0.0 111.047 160.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 m -61.15 23.26 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 130.46 3.504 . . . . 0.0 118.279 -163.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.73 -32.66 72.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.72 1.608 . . . . 0.0 111.498 167.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -79.04 113.78 38.77 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 117.821 -1.085 . . . . 0.0 108.547 160.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -58.16 128.5 28.93 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.777 1.651 . . . . 0.0 114.141 -160.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -55.24 -51.89 65.14 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.594 1.158 . . . . 0.0 113.677 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.16 -27.23 66.93 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.11 -40.18 8.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.551 1.072 . . . . 0.0 113.414 172.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.7 m -59.58 -35.11 73.64 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.988 0.915 . . . . 0.0 112.652 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.16 -29.5 70.4 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.975 1.31 . . . . 0.0 113.26 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -71.02 -38.79 72.61 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.31 -0.869 . . . . 0.0 111.705 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.84 -39.72 87.73 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.39 -0.819 . . . . 0.0 112.499 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.46 -41.13 93.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.977 0.511 . . . . 0.0 111.8 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.23 -37.09 74.92 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.885 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -65.85 -42.16 90.81 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.654 1.57 . . . . 0.0 112.525 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -62.91 -47.39 83.46 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.573 -0.704 . . . . 0.0 112.029 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.0 mt -70.68 -33.34 70.82 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.988 -1.07 . . . . 0.0 113.166 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -64.08 -43.28 95.9 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.294 1.406 . . . . 0.0 111.967 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.66 -32.58 74.31 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.75 -57.94 3.6 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.994 0.918 . . . . 0.0 112.17 174.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.88 -30.7 69.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.741 1.216 . . . . 0.0 113.946 -168.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -55.89 -30.93 57.84 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.081 -0.844 . . . . 0.0 113.787 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -100.0 -27.2 13.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.114 0.966 . . . . 0.0 113.526 174.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.43 -31.17 72.25 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 120.096 -1.627 . . . . 0.0 113.008 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -66.93 -9.83 42.38 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.3 t -97.31 -42.92 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.864 1.266 . . . . 0.0 111.362 171.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -80.88 -15.57 55.97 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.72 -107.21 2.86 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-O 117.398 -1.779 . . . . 0.0 115.719 157.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.41 -25.26 3.92 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.442 2.761 . . . . 0.0 116.832 -150.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -138.72 162.58 34.33 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.52 1.055 . . . . 0.0 112.225 -166.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.0 tt -77.74 -4.4 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.727 -1.233 . . . . 0.0 113.854 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.65 -4.01 38.27 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.435 1.494 . . . . 0.0 114.882 161.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.2 -127.88 7.98 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.12 1.343 . . . . 0.0 112.976 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -67.21 -21.49 65.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.187 1.795 . . . . 0.0 114.187 -170.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -144.82 150.08 36.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.236 1.815 . . . . 0.0 109.27 -173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 77.9 mt -60.33 111.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.682 0.793 . . . . 0.0 109.488 163.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 p -141.77 -159.86 1.02 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.623 1.169 . . . . 0.0 110.592 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.98 -24.89 7.21 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -166.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.04 -40.27 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 120.113 1.324 . . . . 0.0 112.409 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 -45.63 93.6 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.848 -1.157 . . . . 0.0 111.916 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.9 mt -61.41 -24.96 66.88 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.856 0.462 . . . . 0.0 112.154 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.0 m -85.63 -43.96 13.01 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.214 1.405 . . . . 0.0 113.337 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.6 mt -110.73 -33.07 6.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -161.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.51 99.67 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.22 -23.47 17.9 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 CA-C-N 120.578 1.242 . . . . 0.0 113.881 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.27 -35.29 73.66 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.032 -1.043 . . . . 0.0 111.85 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.39 -36.66 81.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.494 0.718 . . . . 0.0 112.743 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -66.84 -45.82 77.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.648 0.658 . . . . 0.0 112.427 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -62.76 -24.43 67.71 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.534 0.733 . . . . 0.0 112.633 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.8 tp -77.23 -52.51 9.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.401 1.08 . . . . 0.0 112.654 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.27 -34.3 76.28 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.319 0.648 . . . . 0.0 111.869 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.67 -61.32 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.01 -52.26 15.1 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.077 -1.014 . . . . 0.0 112.372 -164.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.9 tp -70.27 -26.91 64.03 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.888 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.83 -26.95 48.88 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.05 1.31 . . . . 0.0 115.408 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -65.23 -20.14 66.29 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -126.32 -33.95 2.55 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.226 1.01 . . . . 0.0 113.67 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -152.64 97.52 2.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.824 1.65 . . . . 0.0 109.009 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -68.44 82.17 0.26 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.42 0.688 . . . . 0.0 110.773 168.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -73.25 120.56 81.67 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.357 1.063 . . . . 0.0 111.059 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.9 128.48 12.43 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.065 1.843 . . . . 0.0 111.189 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 95.3 mt -75.94 103.21 0.96 Allowed Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 155.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -70.61 161.93 44.32 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.744 1.63 . . . . 0.0 112.521 -163.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.19 -24.78 63.4 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.901 1.68 . . . . 0.0 115.477 -170.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -62.13 -25.67 67.87 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.217 1.007 . . . . 0.0 113.367 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.8 mt -83.9 51.77 2.12 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.449 1.9 . . . . 0.0 111.06 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.48 -22.86 62.62 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.376 1.071 . . . . 0.0 113.654 -156.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -74.0 -53.49 9.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.108 1.322 . . . . 0.0 109.833 164.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.28 -37.17 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.204 0.911 . . . . 0.0 112.291 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.57 -35.2 79.65 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -74.9 -31.8 61.67 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.461 -0.774 . . . . 0.0 112.745 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -65.62 -28.74 69.34 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.616 1.167 . . . . 0.0 112.9 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.3 mm -53.86 -39.27 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.086 -1.008 . . . . 0.0 111.719 166.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -82.82 -14.56 54.14 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.658 -1.276 . . . . 0.0 112.625 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.94 -20.34 61.08 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 161.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -61.76 -23.99 66.54 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.366 1.439 . . . . 0.0 113.428 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -85.71 3.56 40.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.796 1.238 . . . . 0.0 112.501 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 p -121.9 177.14 5.41 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -162.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 56.08 -161.34 0.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.531 1.532 . . . . 0.0 110.576 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -87.08 -38.13 16.79 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 125.392 1.477 . . . . 0.0 108.902 156.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -51.62 63.29 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 129.258 3.023 . . . . 0.0 113.274 -168.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -91.31 -44.26 9.29 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -58.19 -32.6 68.41 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -77.9 -21.28 51.47 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 29.3 p -89.34 -15.59 33.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.388 1.075 . . . . 0.0 113.311 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -53.03 132.99 38.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.315 1.046 . . . . 0.0 109.414 163.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -127.56 149.65 50.05 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.53 1.132 . . . . 0.0 111.436 -171.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -54.5 124.84 17.38 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.971 0.908 . . . . 0.0 111.615 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -83.86 -34.3 24.65 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.751 -143.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -37.62 74.81 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.776 1.631 . . . . 0.0 113.022 161.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -79.55 -10.98 59.89 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.6 t -75.15 -48.2 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 120.21 1.368 . . . . 0.0 110.039 161.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.2 mt -63.03 -54.1 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.294 1.038 . . . . 0.0 111.622 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.93 -33.07 73.98 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -173.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -75.22 -23.91 72.67 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 120.843 -1.161 . . . . 0.0 113.399 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -82.61 -25.56 33.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -48.63 -51.47 52.57 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.52 -19.92 54.37 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.817 1.678 . . . . 0.0 113.594 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -87.0 -0.59 56.87 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.653 1.581 . . . . 0.0 114.746 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.14 -21.89 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.361 -0.837 . . . . 0.0 110.879 152.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -96.9 -23.46 16.33 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.863 2.065 . . . . 0.0 113.531 -173.464 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 118.288 -0.863 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.33 -166.19 0.09 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.88 0.872 . . . . 0.0 112.631 -168.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.2 mt -75.4 121.17 21.87 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.068 -1.02 . . . . 0.0 111.18 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.27 118.16 25.39 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.856 1.262 . . . . 0.0 109.64 168.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.8 mt -107.89 128.33 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.092 1.357 . . . . 0.0 108.626 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.4 m -113.24 116.61 30.04 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.29 142.2 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.705 1.202 . . . . 0.0 110.151 -162.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.688 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.1 tttm -63.13 127.69 32.42 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.078 169.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.71 176.16 9.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.431 1.892 . . . . 0.0 111.916 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.88 140.17 37.76 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.902 0.881 . . . . 0.0 111.436 164.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.97 124.61 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.07 0.462 . . . . 0.0 110.11 169.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.43 -13.4 22.1 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.03 1.3 . . . . 0.0 116.133 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.69 80.34 66.44 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 119.771 1.786 . . . . 0.0 112.203 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.22 -8.79 15.26 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.943 3.095 . . . . 0.0 116.087 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -79.48 -12.33 59.88 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.0 pt -142.03 162.17 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.675 1.19 . . . . 0.0 112.224 -167.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 mt -76.05 -43.18 45.05 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.59 -120.71 4.45 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.091 1.329 . . . . 0.0 114.211 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -66.03 12.85 0.05 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.579 2.351 . . . . 0.0 117.158 -170.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -115.68 77.07 6.03 Favored Pre-proline 0 C--O 1.27 2.179 0 O-C-N 119.634 -1.916 . . . . 0.0 110.938 -155.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.74 -24.2 25.48 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 124.483 3.455 . . . . 0.0 113.713 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -66.01 -42.62 89.47 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.433 1.093 . . . . 0.0 112.641 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.0 m -62.55 -42.92 99.84 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 119.144 -2.223 . . . . 0.0 111.022 170.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -65.06 -23.59 67.22 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 117.084 -1.436 . . . . 0.0 113.004 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -56.19 -47.23 78.74 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.36 1.436 . . . . 0.0 112.412 170.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.98 -41.13 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.09 1.356 . . . . 0.0 111.284 -171.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.88 -36.24 72.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.375 0.67 . . . . 0.0 111.289 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.21 -41.35 98.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.156 0.982 . . . . 0.0 113.63 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 p -69.1 -40.52 78.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.338 1.426 . . . . 0.0 112.487 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -75.84 -33.69 60.05 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -76.64 -19.77 57.43 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -76.18 -35.93 58.9 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.516 -1.365 . . . . 0.0 112.961 163.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -74.05 -2.27 23.6 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 167.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt 60.28 13.61 4.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 127.309 2.243 . . . . 0.0 115.286 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.2 mt -80.3 129.12 70.68 Favored Pre-proline 0 CA--C 1.541 0.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.963 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.0 148.71 51.62 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.555 2.17 . . . . 0.0 112.331 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -147.04 157.55 43.65 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.172 1.389 . . . . 0.0 111.428 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -90.85 97.59 11.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.424 1.09 . . . . 0.0 110.152 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.6 t -80.61 137.79 36.39 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -129.75 93.06 3.44 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.297 1.839 . . . . 0.0 110.563 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.1 mt -70.14 133.35 47.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.323 1.449 . . . . 0.0 111.015 170.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.39 118.74 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.884 1.673 . . . . 0.0 110.235 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -93.29 107.53 19.34 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.738 0.815 . . . . 0.0 109.92 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.6 mt 53.64 20.26 2.1 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 171.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.15 25.7 12.33 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 119.123 -0.821 . . . . 0.0 115.037 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.99 9.05 0.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.39 1.595 . . . . 0.0 115.19 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -140.19 143.6 34.32 Favored Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 126.518 1.927 . . . . 0.0 109.781 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.59 175.9 3.94 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.383 2.722 . . . . 0.0 113.129 -170.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -57.75 -20.64 36.36 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -174.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -59.19 -12.32 5.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.607 1.963 . . . . 0.0 116.099 171.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -111.83 -0.93 15.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.891 2.076 . . . . 0.0 113.029 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 mt -127.29 -39.27 1.9 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.241 2.217 . . . . 0.0 112.689 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -59.83 -12.0 6.54 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.328 2.651 . . . . 0.0 114.888 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.543 HD11 ' HE3' ' A' ' 64' ' ' LYS . 11.0 mt -65.51 -21.19 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 127.566 2.347 . . . . 0.0 111.43 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.1 p -106.54 147.63 35.32 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 121.626 -0.671 . . . . 0.0 110.606 157.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.78 -11.59 32.59 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.848 2.365 . . . . 0.0 113.856 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -103.42 7.17 38.02 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.014 1.326 . . . . 0.0 112.97 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.13 14.03 67.89 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.047 -1.033 . . . . 0.0 114.924 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -76.43 162.86 27.5 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.786 1.634 . . . . 0.0 112.141 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.23 151.29 73.12 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.775 2.03 . . . . 0.0 108.075 154.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.77 146.75 79.66 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 N-CA-C 116.848 1.826 . . . . 0.0 116.848 11.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -156.77 169.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 128.717 2.807 . . . . 0.0 110.735 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.5 150.39 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.635 -1.291 . . . . 0.0 114.267 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' HE3' HD11 ' A' ' 54' ' ' ILE . 86.3 mttt -102.79 123.78 47.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.976 1.71 . . . . 0.0 109.085 162.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.5 mt -104.8 84.87 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.182 1.393 . . . . 0.0 108.744 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 56.04 57.89 4.76 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.743 -164.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.267 61.7 m-20 64.55 -7.03 0.26 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 117.333 2.346 . . . . 0.0 117.333 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -79.86 119.23 22.45 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.684 -1.26 . . . . 0.0 110.16 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -70.98 146.59 49.34 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.0 t -142.68 130.74 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.484 1.913 . . . . 0.0 109.531 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.57 -155.92 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.692 1.997 . . . . 0.0 114.119 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -44.16 153.12 0.15 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.908 2.083 . . . . 0.0 115.707 -161.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.1 p -50.88 -26.48 5.89 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -86.95 -12.52 47.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.06 -19.82 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.128 0.971 . . . . 0.0 113.137 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -54.34 -38.11 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.201 1.4 . . . . 0.0 112.651 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.65 -8.23 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.32 -55.24 0.64 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.914 0.769 . . . . 0.0 113.005 156.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.0 mt -74.19 -30.26 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.402 1.101 . . . . 0.0 113.631 -163.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.1 tp -73.25 -44.49 59.32 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.743 -1.223 . . . . 0.0 110.611 167.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -67.47 -26.53 66.42 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.516 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 26.1 tt0 -67.66 -46.03 73.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.819 2.048 . . . . 0.0 112.978 167.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 94.3 mttt -93.82 -13.12 27.66 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.461 1.105 . . . . 0.0 113.507 -167.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -86.72 133.11 40.43 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.789 1.636 . . . . 0.0 109.907 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.1 -15.26 25.89 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.244 1.962 . . . . 0.0 115.602 -168.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -76.27 143.9 73.87 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 119.666 1.121 . . . . 0.0 111.341 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -55.85 130.42 40.24 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.787 2.325 . . . . 0.0 114.336 -171.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -61.13 134.41 52.48 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.592 2.861 . . . . 0.0 113.574 -165.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.4 mt -81.86 -0.12 42.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.724 1.61 . . . . 0.0 112.513 165.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.48 -27.53 67.1 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.858 1.663 . . . . 0.0 114.935 -174.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.3 m -66.05 122.16 79.73 Favored Pre-proline 0 N--CA 1.475 0.778 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.325 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.53 133.77 14.67 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.106 1.871 . . . . 0.0 111.451 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.93 175.14 11.22 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.924 2.416 . . . . 0.0 110.58 160.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -57.07 -31.56 65.33 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.552 -1.342 . . . . 0.0 113.344 171.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -63.18 -17.6 62.58 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.268 1.427 . . . . 0.0 113.812 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.64 -21.99 66.86 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.665 -1.272 . . . . 0.0 113.503 171.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.1 p -64.24 -12.65 43.01 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.9 t -119.27 -36.67 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.143 1.377 . . . . 0.0 111.475 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.8 -27.47 70.13 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 120.828 -1.17 . . . . 0.0 114.718 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.8 p -69.54 -18.76 63.68 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 170.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -84.22 -43.22 15.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.86 1.264 . . . . 0.0 111.501 168.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -66.9 -33.71 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.907 0.883 . . . . 0.0 111.855 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -59.46 -53.08 69.5 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.278 -1.344 . . . . 0.0 113.654 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.21 -29.86 4.69 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.8 2.333 . . . . 0.0 114.214 170.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 p -69.1 -29.93 68.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.992 1.724 . . . . 0.0 112.771 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -67.28 -38.64 85.38 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.798 -1.189 . . . . 0.0 113.739 164.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.39 -40.75 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-N 120.108 1.322 . . . . 0.0 110.806 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -65.8 -42.3 90.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.531 1.132 . . . . 0.0 112.416 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -65.94 -36.45 83.39 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.192 0.997 . . . . 0.0 113.09 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.0 mt -76.62 9.26 2.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.675 1.59 . . . . 0.0 113.7 168.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -130.5 55.74 1.8 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.402 1.881 . . . . 0.0 109.688 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 m -65.45 26.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 129.674 3.19 . . . . 0.0 117.532 -151.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.02 -22.65 39.22 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.516 1.526 . . . . 0.0 112.285 164.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.5 123.02 85.66 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 117.512 -1.232 . . . . 0.0 107.725 151.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -63.33 110.94 1.31 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 CA-C-N 121.126 1.438 . . . . 0.0 112.374 -171.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -50.08 -44.31 51.77 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -173.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -63.86 -20.62 65.96 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.42 -38.96 6.1 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.312 1.434 . . . . 0.0 113.356 167.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 m -57.44 -41.7 81.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.401 1.08 . . . . 0.0 111.956 174.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -62.37 -30.94 71.55 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.182 1.793 . . . . 0.0 113.251 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -67.5 -41.52 84.36 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.512 -0.743 . . . . 0.0 111.25 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.45 80.8 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.37 -0.832 . . . . 0.0 112.872 172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.47 -36.42 83.7 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.72 -0.613 . . . . 0.0 112.468 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.3 -38.48 81.67 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.448 1.022 . . . . 0.0 112.223 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -64.97 -41.3 95.56 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.194 1.361 . . . . 0.0 112.732 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -64.47 -50.48 67.32 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.585 -0.697 . . . . 0.0 112.066 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.03 -30.91 68.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.823 -1.173 . . . . 0.0 113.236 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -63.24 -43.98 96.51 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.613 1.551 . . . . 0.0 112.053 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.85 72.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -73.84 -57.97 3.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.218 1.007 . . . . 0.0 112.05 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -66.97 -33.73 76.21 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.493 1.517 . . . . 0.0 113.856 -169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -56.26 -30.18 57.67 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.956 -0.913 . . . . 0.0 114.042 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 100.0 m-70 -104.15 -24.09 13.2 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.53 -34.04 76.9 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.264 1.393 . . . . 0.0 113.025 171.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -62.6 -13.75 34.98 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.34 -30.98 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.863 1.265 . . . . 0.0 112.057 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -97.96 -11.46 23.06 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.02 -123.59 6.03 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-O 117.27 -1.85 . . . . 0.0 115.473 155.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.5 -20.4 8.18 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.876 3.051 . . . . 0.0 117.282 -153.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -131.42 160.04 36.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.915 1.234 . . . . 0.0 112.465 -167.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.9 tt -76.18 -1.43 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.814 -1.179 . . . . 0.0 113.486 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -105.13 -0.65 26.39 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 162.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 117.58 -127.61 7.44 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 120.163 1.347 . . . . 0.0 113.487 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.3 -26.06 62.7 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.488 1.515 . . . . 0.0 113.84 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -131.12 151.48 51.4 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.238 1.815 . . . . 0.0 109.947 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.74 113.36 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.713 0.805 . . . . 0.0 108.948 163.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -141.57 -158.52 0.87 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.843 0.857 . . . . 0.0 110.959 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.32 -23.6 24.55 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -165.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.23 -39.0 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.595 1.089 . . . . 0.0 112.234 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.77 -45.84 92.17 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.575 1.08 . . . . 0.0 112.177 167.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.89 -26.15 67.23 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.5 m -82.21 -54.68 5.06 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.613 1.165 . . . . 0.0 112.326 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 34.0 mt -98.54 -33.09 11.13 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -160.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.08 -47.99 97.69 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.14 -26.47 14.84 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 120.908 1.36 . . . . 0.0 113.272 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -69.7 -34.95 74.64 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.289 172.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.11 -39.29 89.84 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.955 0.902 . . . . 0.0 112.418 171.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -64.95 -45.61 85.01 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.596 0.634 . . . . 0.0 112.201 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -61.61 -27.5 68.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.444 0.697 . . . . 0.0 112.346 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.8 tp -79.44 -46.71 16.98 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.28 -32.19 72.02 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.817 0.735 . . . . 0.0 111.593 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.5 t -90.07 -61.84 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.9 -50.33 20.66 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.22 -0.925 . . . . 0.0 112.809 -164.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 40.7 tp -71.93 -30.68 65.59 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 119.219 -0.42 . . . . 0.0 111.574 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.6 -26.76 60.31 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -64.13 -18.85 64.83 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.229 1.412 . . . . 0.0 114.58 171.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -124.8 -36.95 2.52 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.67 1.188 . . . . 0.0 113.42 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -151.91 94.24 1.94 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.255 1.822 . . . . 0.0 108.834 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -68.08 88.65 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.996 -0.44 . . . . 0.0 111.048 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -69.37 117.54 53.52 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.59 1.156 . . . . 0.0 111.269 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.86 111.79 3.38 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.012 1.808 . . . . 0.0 110.878 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.6 108.6 2.26 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 159.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -69.17 161.52 45.51 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.601 1.534 . . . . 0.0 112.246 -169.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.94 -26.47 64.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.549 1.539 . . . . 0.0 114.236 -176.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -65.32 -23.6 67.06 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.3 mt -85.65 50.08 1.89 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.879 1.671 . . . . 0.0 111.342 171.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -27.23 65.3 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -156.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -73.01 -50.95 20.17 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.829 1.195 . . . . 0.0 110.198 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.37 -40.22 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.883 0.765 . . . . 0.0 111.985 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.5 -41.72 96.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.475 1.11 . . . . 0.0 113.227 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -69.28 -35.14 75.73 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.373 -0.829 . . . . 0.0 112.395 171.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -65.47 -25.5 67.52 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.497 1.119 . . . . 0.0 112.984 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.8 mm -55.26 -37.53 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.016 -1.052 . . . . 0.0 111.785 166.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -84.52 -15.04 47.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.418 -1.426 . . . . 0.0 113.161 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 94.2 mt -73.13 -16.59 61.45 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 163.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 54.5 mt -63.47 -21.09 66.11 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.652 1.114 . . . . 0.0 113.476 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -94.95 4.97 53.2 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.424 1.49 . . . . 0.0 111.966 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -108.31 172.71 6.68 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.154 1.382 . . . . 0.0 114.627 -168.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 53.57 -157.47 0.17 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.819 1.648 . . . . 0.0 110.8 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -88.4 -38.98 14.63 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 127.573 2.349 . . . . 0.0 108.551 161.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.86 -53.63 52.82 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 129.216 3.007 . . . . 0.0 113.432 -167.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -90.27 -42.15 11.15 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -57.75 -34.86 69.98 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -76.32 -22.79 54.53 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 30.1 p -85.38 -16.35 40.14 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.287 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -49.73 137.89 15.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.318 1.047 . . . . 0.0 109.767 165.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -135.97 146.43 47.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.678 0.791 . . . . 0.0 111.701 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -49.26 114.45 1.03 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.358 1.463 . . . . 0.0 111.809 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.82 -32.58 74.14 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -153.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -59.19 -38.99 81.19 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.98 1.312 . . . . 0.0 113.053 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -81.74 -10.17 59.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.7 t -76.01 -43.85 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.07 0.85 . . . . 0.0 109.796 163.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.8 mt -66.97 -57.12 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.207 1.403 . . . . 0.0 111.819 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.27 67.98 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -80.47 -24.16 59.31 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 120.736 -1.227 . . . . 0.0 113.627 171.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -75.22 -34.73 61.5 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.096 1.448 . . . . 0.0 113.225 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -43.6 -53.04 12.78 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -174.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.34 -28.1 55.04 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 121.838 1.692 . . . . 0.0 113.811 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -82.38 0.59 41.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.476 1.91 . . . . 0.0 114.504 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.81 -25.79 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.523 0.729 . . . . 0.0 110.776 156.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -115.68 -41.27 3.25 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.165 1.386 . . . . 0.0 114.273 174.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 CA-C-O 115.924 -1.988 . . . . 0.0 114.361 -173.596 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.73 -170.07 0.05 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.083 1.353 . . . . 0.0 112.934 -169.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.8 mt -71.28 117.07 12.34 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.047 -1.033 . . . . 0.0 111.126 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -120.36 121.91 39.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.852 1.261 . . . . 0.0 109.592 167.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 37' ' ' TYR . 38.0 mt -109.52 131.98 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.921 1.288 . . . . 0.0 108.126 -174.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.6 m -112.53 128.49 56.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 166.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.55 142.14 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.509 1.123 . . . . 0.0 109.697 -164.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.758 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 32.1 tttm -63.91 128.19 34.72 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.616 170.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.66 175.85 9.82 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.904 2.082 . . . . 0.0 112.041 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.48 141.49 30.79 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.818 0.847 . . . . 0.0 111.555 164.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.39 124.5 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 120.995 0.426 . . . . 0.0 110.157 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.19 -16.68 15.57 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.984 1.278 . . . . 0.0 116.056 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.53 84.57 61.32 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.834 1.817 . . . . 0.0 112.245 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.71 -11.57 27.2 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.008 3.139 . . . . 0.0 115.755 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -79.72 -13.61 59.34 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.1 pt -141.05 160.28 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.513 1.125 . . . . 0.0 112.22 -164.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.4 mt -72.22 -47.83 47.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.2 -124.82 5.54 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.967 1.27 . . . . 0.0 114.716 -171.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.04 10.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.67 2.788 . . . . 0.0 117.964 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -112.8 76.66 2.25 Favored Pre-proline 0 C--O 1.268 2.041 0 CA-C-N 121.182 1.81 . . . . 0.0 111.02 -155.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.69 -24.91 34.55 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 124.13 3.22 . . . . 0.0 113.193 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -67.34 -40.98 85.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.262 1.025 . . . . 0.0 112.746 171.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.758 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.4 m -59.75 -43.54 94.22 Favored 'General case' 0 C--N 1.376 1.729 0 O-C-N 119.688 -1.882 . . . . 0.0 111.031 168.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -66.26 -23.5 66.41 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 117.147 -1.406 . . . . 0.0 113.009 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -56.11 -46.06 79.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 120.359 1.436 . . . . 0.0 112.288 170.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.8 t -72.99 -40.45 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.164 1.386 . . . . 0.0 111.586 -172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.9 -37.95 72.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.681 0.792 . . . . 0.0 111.314 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.1 -43.52 95.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.808 1.243 . . . . 0.0 113.175 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 p -70.44 -40.64 73.64 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.533 1.06 . . . . 0.0 112.751 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.26 -32.04 64.46 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -78.23 -25.73 47.07 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 172.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -68.47 -39.02 81.56 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.569 -1.332 . . . . 0.0 111.829 165.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -74.04 -2.12 22.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.257 1.423 . . . . 0.0 114.826 168.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm 61.57 10.42 3.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 127.447 2.299 . . . . 0.0 115.798 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.458 ' CD1' HD21 ' A' ' 84' ' ' ASN . 42.4 mt -79.61 129.85 69.94 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 121.332 -0.855 . . . . 0.0 109.943 -170.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.67 145.21 51.3 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.371 2.047 . . . . 0.0 112.04 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.402 ' CD1' HD12 ' A' ' 5' ' ' ILE . 14.5 p90 -144.93 155.61 43.52 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.808 1.243 . . . . 0.0 111.492 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.43 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 46.0 tttt -89.63 94.1 9.73 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.065 1.346 . . . . 0.0 110.242 175.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.2 t -80.99 138.47 36.06 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.43 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 75.6 m-70 -129.47 94.15 3.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.328 1.851 . . . . 0.0 110.746 172.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.0 mt -70.5 134.98 48.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.733 1.213 . . . . 0.0 111.061 170.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.1 mt -130.89 117.54 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.973 1.709 . . . . 0.0 110.467 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -88.83 101.96 14.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.542 0.737 . . . . 0.0 109.638 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.8 mt 54.54 23.48 4.63 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 166.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.51 24.37 10.19 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.291 0.876 . . . . 0.0 115.291 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.48 -0.1 1.23 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.437 1.619 . . . . 0.0 114.868 171.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -130.55 142.21 44.69 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 125.57 1.548 . . . . 0.0 110.024 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.78 176.1 3.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.358 2.705 . . . . 0.0 112.967 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -57.96 -19.83 33.42 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 116.509 -1.71 . . . . 0.0 114.917 -174.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -57.61 -16.46 10.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.117 2.167 . . . . 0.0 116.022 170.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -111.93 1.01 16.27 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.738 2.015 . . . . 0.0 112.871 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.8 mt -126.24 -39.85 2.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.2 2.2 . . . . 0.0 112.626 -171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -57.12 -15.85 6.39 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 128.57 2.748 . . . . 0.0 114.725 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.524 HD11 ' HE3' ' A' ' 64' ' ' LYS . 8.8 mt -63.01 -21.54 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 127.696 2.398 . . . . 0.0 111.233 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.5 p -106.8 145.76 31.72 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.323 0.649 . . . . 0.0 110.736 153.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.73 -15.28 44.03 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.768 2.312 . . . . 0.0 113.467 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -89.85 -6.04 56.25 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.674 1.59 . . . . 0.0 113.263 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.61 11.11 72.35 Favored Glycine 0 CA--C 1.539 1.588 0 O-C-N 120.842 -1.161 . . . . 0.0 115.021 -175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -73.96 160.39 31.41 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.862 1.665 . . . . 0.0 111.641 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.39 148.31 63.6 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 126.604 1.962 . . . . 0.0 107.899 160.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.5 152.12 93.14 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 N-CA-C 116.717 1.776 . . . . 0.0 116.717 13.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.1 m -158.63 165.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 128.444 2.698 . . . . 0.0 110.289 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.19 150.82 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 120.661 -1.274 . . . . 0.0 114.229 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HE3' HD11 ' A' ' 54' ' ' ILE . 85.4 mttt -104.55 113.78 27.58 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.118 1.767 . . . . 0.0 109.092 164.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.1 mt -88.16 80.84 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.858 1.263 . . . . 0.0 108.654 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t70 58.59 58.83 3.16 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.753 0.787 . . . . 0.0 111.584 -168.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.256 49.0 m-20 65.69 -5.72 0.47 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.874 2.175 . . . . 0.0 116.874 -175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -84.61 114.54 22.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.931 1.292 . . . . 0.0 110.047 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -71.07 150.65 45.31 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -166.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.0 t -142.02 134.03 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.916 2.086 . . . . 0.0 109.132 165.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.78 -153.23 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.143 1.777 . . . . 0.0 113.467 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -33.91 156.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.826 2.05 . . . . 0.0 116.233 -170.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 p -48.95 -26.83 2.72 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.007 1.323 . . . . 0.0 114.224 160.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -94.35 -8.55 38.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.026 1.33 . . . . 0.0 113.142 -170.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.15 -21.32 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.43 1.092 . . . . 0.0 113.013 159.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mt -54.74 -38.82 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.598 1.559 . . . . 0.0 112.315 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.33 -6.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.45 -59.81 0.52 Allowed Glycine 0 CA--C 1.534 1.227 0 CA-C-N 119.037 0.835 . . . . 0.0 112.303 155.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.91 -35.76 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.443 -1.033 . . . . 0.0 113.648 -163.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.9 tp -72.64 -46.04 55.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.979 0.809 . . . . 0.0 111.075 172.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.94 -28.47 69.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.92 -36.33 81.99 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.133 1.373 . . . . 0.0 114.245 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -111.19 -15.42 13.66 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.866 1.266 . . . . 0.0 113.168 -160.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.458 HD21 ' CD1' ' A' ' 35' ' ' ILE . 27.9 t-20 -75.19 136.99 72.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.026 1.73 . . . . 0.0 109.698 164.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.04 -20.37 21.9 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.345 2.03 . . . . 0.0 115.113 -169.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -72.34 150.02 91.66 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.11 0.868 . . . . 0.0 111.246 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -55.52 130.86 42.81 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.681 2.254 . . . . 0.0 113.478 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.99 137.97 83.59 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.742 2.961 . . . . 0.0 112.775 -167.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -86.88 -3.61 59.09 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.689 0.795 . . . . 0.0 112.731 164.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.07 81.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.041 1.336 . . . . 0.0 114.042 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.4 m -63.14 114.53 12.93 Favored Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 123.447 0.699 . . . . 0.0 110.876 -166.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.3 136.81 14.55 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.009 1.806 . . . . 0.0 111.561 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.95 174.41 12.82 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.951 2.434 . . . . 0.0 110.43 156.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -27.0 62.86 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 168.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -54.57 -24.88 22.97 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.457 -1.402 . . . . 0.0 114.03 169.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.79 68.75 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.854 -1.154 . . . . 0.0 113.664 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.2 p -72.66 -3.42 24.86 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.007 1.276 . . . . 0.0 114.025 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.1 -38.46 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.166 1.386 . . . . 0.0 110.788 170.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.64 -28.55 68.06 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.254 0.93 . . . . 0.0 114.971 173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.6 p -67.79 -17.24 64.46 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.721 1.26 . . . . 0.0 114.144 173.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -91.44 -40.65 11.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.744 1.618 . . . . 0.0 111.758 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.4 mt -65.14 -32.28 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.251 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -57.06 -55.65 41.8 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.131 -1.414 . . . . 0.0 113.845 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -77.87 -29.62 4.24 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.626 2.217 . . . . 0.0 113.989 170.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.9 p -68.94 -32.65 72.41 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.723 1.602 . . . . 0.0 112.893 -173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -66.48 -37.78 85.86 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.901 -1.125 . . . . 0.0 113.619 166.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.57 -39.03 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.583 1.083 . . . . 0.0 110.982 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -68.13 -40.86 82.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.563 1.145 . . . . 0.0 112.542 174.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -66.5 -36.93 83.93 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.994 0.918 . . . . 0.0 112.626 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.3 mt -75.46 21.35 0.14 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.46 1.504 . . . . 0.0 113.621 166.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.8 tttt -144.43 54.71 1.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.599 2.36 . . . . 0.0 110.159 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.8 p -62.0 26.96 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 130.396 3.478 . . . . 0.0 118.203 -160.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -75.43 -25.56 57.62 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.295 -1.503 . . . . 0.0 112.093 157.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.04 120.84 79.12 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 117.485 -1.245 . . . . 0.0 107.88 155.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -63.06 115.56 3.03 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 121.029 1.403 . . . . 0.0 112.574 -169.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -46.45 -51.38 15.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.381 1.472 . . . . 0.0 114.351 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.07 -15.06 61.95 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -93.96 -42.77 4.0 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.456 1.503 . . . . 0.0 113.403 166.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.9 m -57.6 -40.3 78.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.617 1.167 . . . . 0.0 112.025 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.21 -30.25 70.32 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.498 1.919 . . . . 0.0 113.388 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -68.59 -39.72 80.79 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.366 -0.834 . . . . 0.0 111.343 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.72 -36.31 78.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.505 -0.747 . . . . 0.0 112.781 172.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.18 -38.27 88.45 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.776 -0.577 . . . . 0.0 112.197 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.38 -35.51 79.47 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.176 0.898 . . . . 0.0 112.667 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -66.67 -43.47 84.43 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.294 1.406 . . . . 0.0 112.559 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -64.82 -45.28 86.84 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.628 -0.67 . . . . 0.0 112.43 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.0 mt -72.42 -31.71 65.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.369 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -62.54 -42.85 99.79 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 120.771 1.623 . . . . 0.0 111.875 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.34 -26.81 68.2 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 tp -81.06 -54.53 5.47 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.203 1.001 . . . . 0.0 111.763 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.37 -33.85 75.0 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.869 1.268 . . . . 0.0 114.053 -168.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.19 -28.38 66.64 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.723 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -96.89 -29.83 13.48 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.176 0.991 . . . . 0.0 113.381 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.4 mt -62.65 -33.59 75.35 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.289 -1.507 . . . . 0.0 112.841 175.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -68.57 -1.25 6.33 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.82 -44.94 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.269 1.428 . . . . 0.0 111.458 165.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -93.99 5.48 51.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -168.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.11 -165.18 26.46 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 116.191 1.236 . . . . 0.0 116.191 158.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.35 -8.73 19.9 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.768 3.645 . . . . 0.0 117.808 -136.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -118.07 165.42 13.77 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.858 -1.151 . . . . 0.0 110.746 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.253 0.9 OUTLIER -75.75 -0.18 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 120.225 -1.547 . . . . 0.0 112.898 -172.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.54 9.43 29.49 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 128.006 2.522 . . . . 0.0 114.567 162.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.24 -128.36 9.36 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.939 1.256 . . . . 0.0 113.589 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -62.07 -23.93 66.79 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -136.61 148.06 47.27 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.393 1.477 . . . . 0.0 109.743 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.59 118.13 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.321 1.048 . . . . 0.0 109.555 163.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.5 p -142.55 -161.79 1.31 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.157 0.983 . . . . 0.0 111.544 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.4 -23.32 3.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.126 1.77 . . . . 0.0 115.319 -172.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.78 -43.79 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.824 1.193 . . . . 0.0 111.506 174.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.18 -43.21 98.87 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.92 -1.112 . . . . 0.0 111.97 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.3 mt -61.74 -24.61 66.92 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.1 m -85.76 -39.78 16.78 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.689 1.195 . . . . 0.0 113.174 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.0 mt -114.04 -34.6 5.34 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -164.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.34 -46.77 99.76 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -168.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.03 -21.88 15.34 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 120.723 1.294 . . . . 0.0 113.752 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -68.72 -36.45 78.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.926 -1.109 . . . . 0.0 111.628 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.11 -38.85 92.55 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.648 0.658 . . . . 0.0 112.343 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -65.21 -46.57 80.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 173.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -61.55 -31.12 71.14 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.267 0.627 . . . . 0.0 112.173 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.1 tp -76.66 -45.55 29.37 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.316 1.046 . . . . 0.0 113.418 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.62 -35.11 75.34 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.238 0.615 . . . . 0.0 111.635 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.4 t -89.08 -59.86 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.44 -48.55 22.26 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.294 -0.879 . . . . 0.0 113.11 -166.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.6 tp -73.74 -33.73 64.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.428 172.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.98 -26.05 60.34 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.888 -0.951 . . . . 0.0 115.345 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -62.92 -20.75 65.48 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.375 1.47 . . . . 0.0 114.599 170.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -123.87 -35.77 2.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.614 1.166 . . . . 0.0 113.432 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -150.79 98.91 2.67 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.444 1.898 . . . . 0.0 108.714 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -68.81 88.16 0.37 Allowed 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.972 -0.455 . . . . 0.0 110.504 168.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -70.04 116.64 46.22 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.194 0.997 . . . . 0.0 110.747 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.93 120.58 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.008 1.805 . . . . 0.0 111.035 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.25 109.21 4.46 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 155.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -69.24 166.01 28.42 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.676 1.584 . . . . 0.0 112.444 -170.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -26.89 63.75 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.736 1.615 . . . . 0.0 113.676 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -64.79 -26.46 68.36 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.615 1.166 . . . . 0.0 113.779 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.9 mt -89.86 50.24 1.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.293 1.837 . . . . 0.0 111.169 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -30.22 70.73 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.533 1.133 . . . . 0.0 113.504 -157.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -76.82 -45.39 28.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.535 1.061 . . . . 0.0 111.525 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 62.4 t -60.61 -38.76 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 118.851 0.75 . . . . 0.0 111.588 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.3 tp -64.65 -43.44 93.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.756 1.222 . . . . 0.0 113.187 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -68.48 -34.47 75.99 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.392 -0.817 . . . . 0.0 112.703 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.2 -28.4 70.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.174 0.99 . . . . 0.0 112.949 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 43.5 mm -54.21 -37.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.123 -0.985 . . . . 0.0 111.905 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -86.07 -11.79 51.86 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.565 -1.334 . . . . 0.0 113.831 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.5 mt -72.27 -21.6 61.34 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 117.89 -1.053 . . . . 0.0 113.35 162.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 58.4 mt -62.19 -23.16 66.46 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.566 1.076 . . . . 0.0 113.232 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -90.61 13.24 16.49 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.581 1.552 . . . . 0.0 112.83 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.1 p -132.64 176.59 8.32 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.228 1.411 . . . . 0.0 114.511 -167.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 53.62 -167.87 0.06 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.919 1.688 . . . . 0.0 110.846 -166.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -76.03 -42.83 46.63 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.085 1.354 . . . . 0.0 109.622 153.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -52.08 46.62 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 128.308 2.643 . . . . 0.0 113.081 -165.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -91.9 -44.84 8.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.746 0.419 . . . . 0.0 112.015 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -61.94 -28.12 69.31 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -172.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.86 -22.35 50.01 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.645 1.111 . . . . 0.0 113.619 171.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 26.8 p -89.32 -14.48 35.61 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.601 1.16 . . . . 0.0 113.595 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -51.86 130.92 30.3 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.573 1.149 . . . . 0.0 109.315 163.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -126.08 142.51 51.49 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.095 0.958 . . . . 0.0 111.418 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -52.43 120.27 5.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.537 1.135 . . . . 0.0 111.994 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.7 mp0 -67.91 -34.89 77.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.647 1.179 . . . . 0.0 113.883 -148.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -60.34 -37.18 79.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.832 1.253 . . . . 0.0 112.853 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -79.41 -9.82 59.68 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.604 -1.31 . . . . 0.0 114.03 174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 6.8 t -79.94 -44.0 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 118.912 0.778 . . . . 0.0 110.068 164.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.3 mt -65.93 -57.7 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.332 1.453 . . . . 0.0 111.633 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.08 -28.72 69.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.715 0.806 . . . . 0.0 112.994 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.53 -22.67 59.8 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 120.781 -1.199 . . . . 0.0 113.96 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -72.86 -35.95 67.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.654 1.727 . . . . 0.0 112.619 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -44.34 -53.12 14.95 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -171.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.77 -27.55 59.79 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 122.085 1.78 . . . . 0.0 113.691 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -85.16 1.12 49.39 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.247 1.819 . . . . 0.0 114.416 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.3 -24.44 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.428 0.691 . . . . 0.0 110.31 156.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -120.7 -37.15 3.04 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.928 1.291 . . . . 0.0 113.861 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 115.135 -2.364 . . . . 0.0 114.5 -179.716 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.45 -169.49 0.06 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.991 1.316 . . . . 0.0 112.815 -167.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.42 116.04 10.3 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.938 -1.101 . . . . 0.0 110.956 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -120.19 115.37 23.51 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.849 1.26 . . . . 0.0 109.756 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 mt -103.35 136.75 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.094 1.358 . . . . 0.0 108.378 -174.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.8 m -117.15 126.31 52.61 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 166.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.12 140.06 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.483 1.113 . . . . 0.0 109.98 -164.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.675 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.5 tttm -64.69 127.49 31.75 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.684 -0.635 . . . . 0.0 109.465 171.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.49 176.78 8.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.641 1.977 . . . . 0.0 112.223 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.72 140.49 29.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.924 0.89 . . . . 0.0 111.737 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.24 121.76 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.018 0.437 . . . . 0.0 109.952 167.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.54 -9.41 50.23 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.005 1.288 . . . . 0.0 116.307 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.31 84.36 24.15 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 119.999 1.899 . . . . 0.0 112.392 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.69 -10.68 27.47 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.237 2.625 . . . . 0.0 116.437 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -77.38 -11.51 59.85 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.2 pt -143.2 161.21 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.867 1.267 . . . . 0.0 112.197 -165.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.4 mt -76.19 -43.94 40.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.3 -126.18 8.93 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.761 1.172 . . . . 0.0 114.764 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.25 13.38 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.747 2.819 . . . . 0.0 117.461 -172.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -116.9 71.42 5.43 Favored Pre-proline 0 C--O 1.266 1.937 0 O-C-N 119.808 -1.808 . . . . 0.0 110.998 -156.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.0 -22.03 31.57 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.843 3.029 . . . . 0.0 113.365 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -67.64 -39.66 84.61 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.361 -0.837 . . . . 0.0 112.63 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.9 m -60.3 -42.72 96.1 Favored 'General case' 0 C--N 1.379 1.869 0 O-C-N 119.8 -1.812 . . . . 0.0 110.98 168.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -64.63 -25.7 68.08 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.182 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -55.3 -45.03 76.25 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 120.212 1.369 . . . . 0.0 112.545 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.5 t -73.22 -38.69 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.344 1.458 . . . . 0.0 111.727 -172.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.19 -38.46 69.07 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.663 0.785 . . . . 0.0 111.307 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.77 -43.32 98.19 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.146 1.379 . . . . 0.0 113.18 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 p -70.31 -40.58 74.12 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.627 1.103 . . . . 0.0 112.727 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.49 -32.64 68.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -78.74 -23.94 45.14 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -69.84 -37.77 76.27 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.404 -1.435 . . . . 0.0 112.184 164.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' A' ' 86' ' ' GLU . 76.7 mttt -74.58 -4.34 36.47 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.79 1.636 . . . . 0.0 114.46 168.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm 60.23 15.97 5.73 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 127.063 2.145 . . . . 0.0 115.356 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -81.56 132.08 56.24 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.142 -0.973 . . . . 0.0 110.31 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.58 142.22 43.8 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.513 2.142 . . . . 0.0 112.138 171.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -143.72 156.28 44.47 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.041 1.336 . . . . 0.0 111.559 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 43.6 tttt -90.76 99.72 12.7 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.807 1.243 . . . . 0.0 110.004 173.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -83.57 129.29 34.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.401 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 86.8 m-70 -111.87 98.86 7.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.945 1.698 . . . . 0.0 110.353 164.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.1 mt -74.02 132.54 42.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.099 0.96 . . . . 0.0 111.533 166.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 93.6 mt -129.45 115.87 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.117 1.767 . . . . 0.0 109.866 -170.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -82.4 109.0 16.25 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.428 -0.795 . . . . 0.0 109.765 169.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.7 mt 51.4 26.1 2.95 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 168.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.76 22.51 15.8 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.232 0.853 . . . . 0.0 115.232 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -66.44 18.78 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -138.8 148.82 59.72 Favored Pre-proline 0 N--CA 1.474 0.758 0 C-N-CA 126.005 1.722 . . . . 0.0 110.32 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.18 173.48 5.05 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.785 2.323 . . . . 0.0 112.472 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -57.1 -18.95 16.84 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -55.59 -15.49 2.97 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.241 2.217 . . . . 0.0 116.248 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -116.46 3.51 13.24 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.737 2.015 . . . . 0.0 113.375 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.1 mt -128.83 -39.26 1.61 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.558 2.343 . . . . 0.0 112.423 -171.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.76 -14.55 5.98 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 128.89 2.876 . . . . 0.0 114.769 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.552 HD11 ' HE3' ' A' ' 64' ' ' LYS . 12.5 mt -61.78 -21.7 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 128.016 2.526 . . . . 0.0 111.229 172.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.3 p -109.84 149.52 40.08 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 111.011 157.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.94 -9.85 26.98 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.264 2.643 . . . . 0.0 114.177 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 39.3 mt-10 -107.69 -1.33 21.16 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.84 1.656 . . . . 0.0 112.881 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.66 13.93 75.0 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 120.983 -1.073 . . . . 0.0 114.922 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HE2' ' HB2' ' A' ' 57' ' ' GLU . 52.4 mtmt -69.45 160.76 30.78 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.932 1.293 . . . . 0.0 111.941 173.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 m -136.96 149.33 66.23 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 126.491 1.916 . . . . 0.0 107.949 155.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.58 150.83 91.27 Favored 'Cis proline' 0 CA--C 1.538 0.722 0 N-CA-C 116.559 1.715 . . . . 0.0 116.559 13.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 m -158.05 167.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 128.231 2.613 . . . . 0.0 110.499 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.35 152.93 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.654 -1.279 . . . . 0.0 114.101 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.552 ' HE3' HD11 ' A' ' 54' ' ' ILE . 79.2 mttt -108.1 120.71 43.1 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.703 1.601 . . . . 0.0 109.377 162.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 54.8 mt -93.96 82.25 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.542 1.537 . . . . 0.0 108.6 175.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.3 t70 58.01 57.18 4.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.595 0.758 . . . . 0.0 111.941 -167.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.254 48.4 m-20 65.42 0.41 1.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -94.01 111.83 23.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.119 1.368 . . . . 0.0 110.21 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -73.76 152.22 40.41 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -161.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -140.67 134.09 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 127.038 2.135 . . . . 0.0 108.782 164.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.21 -149.57 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.29 1.836 . . . . 0.0 113.166 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -41.31 157.09 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.516 1.926 . . . . 0.0 115.232 -166.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.3 p -48.38 -29.75 4.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.421 1.488 . . . . 0.0 114.426 166.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.37 -7.41 50.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.336 1.054 . . . . 0.0 113.566 -170.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.08 -20.92 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.477 1.111 . . . . 0.0 112.974 159.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.6 mt -54.99 -39.87 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.849 1.26 . . . . 0.0 112.202 171.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 m -63.04 -3.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -117.36 -53.15 0.32 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.215 0.912 . . . . 0.0 113.111 156.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.4 mt -71.16 -30.81 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 121.238 -1.154 . . . . 0.0 113.263 -166.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 tp -74.42 -45.92 43.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.657 1.117 . . . . 0.0 110.646 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -61.23 -35.26 76.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.274 1.03 . . . . 0.0 113.679 -171.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -73.1 -31.11 64.14 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.257 1.423 . . . . 0.0 114.3 172.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -94.64 -11.96 28.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.803 1.241 . . . . 0.0 112.988 -171.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.24 144.08 53.43 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.12 1.768 . . . . 0.0 110.382 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.58 -19.23 19.17 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.281 1.987 . . . . 0.0 115.043 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB3' ' HE2' ' A' ' 33' ' ' LYS . 3.2 mm-40 -75.66 147.78 81.88 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.569 1.077 . . . . 0.0 109.942 165.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.21 145.84 63.5 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.519 2.813 . . . . 0.0 114.146 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -64.05 125.7 15.78 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.922 2.415 . . . . 0.0 112.212 -172.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.433 ' HG ' ' HE3' ' A' ' 33' ' ' LYS . 21.1 mt -73.31 -1.02 16.28 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.861 -1.15 . . . . 0.0 112.918 164.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.15 73.62 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.621 1.568 . . . . 0.0 113.654 174.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.5 m -61.54 113.12 7.3 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.434 0.693 . . . . 0.0 110.864 -169.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.11 135.62 11.1 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.97 1.78 . . . . 0.0 111.825 -166.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -75.06 172.43 16.38 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.809 2.339 . . . . 0.0 110.728 160.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -60.03 -26.51 66.16 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.647 -1.283 . . . . 0.0 113.399 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -58.05 -22.91 52.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.958 1.303 . . . . 0.0 114.021 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.59 -23.32 67.23 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.942 -1.099 . . . . 0.0 113.694 173.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.4 p -65.87 -14.5 61.58 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.4 t -116.33 -38.87 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.004 1.322 . . . . 0.0 111.663 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.47 -27.14 69.04 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.513 1.054 . . . . 0.0 114.892 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.1 p -67.97 -20.43 65.04 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 171.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -86.63 -39.88 15.68 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.307 1.443 . . . . 0.0 111.793 171.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.2 mt -66.88 -32.81 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.614 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.87 -51.67 80.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-O 117.438 -1.267 . . . . 0.0 113.987 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.81 -28.29 3.42 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.117 2.545 . . . . 0.0 114.333 169.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.6 p -69.24 -29.89 67.91 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.305 1.866 . . . . 0.0 112.841 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -65.39 -39.88 92.77 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.7 -1.25 . . . . 0.0 113.401 164.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.21 -38.76 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 119.974 1.261 . . . . 0.0 111.035 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -66.7 -42.67 86.03 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.418 1.087 . . . . 0.0 112.454 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -64.57 -39.95 94.66 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.839 0.856 . . . . 0.0 112.879 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.5 mt -70.99 5.95 1.79 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.475 1.51 . . . . 0.0 114.195 168.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -128.93 55.81 1.71 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.036 2.134 . . . . 0.0 109.577 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -61.77 20.94 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 129.733 3.213 . . . . 0.0 117.474 -159.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -73.07 -22.02 60.67 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.745 -1.222 . . . . 0.0 111.966 158.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -72.18 122.81 88.39 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.687 -1.149 . . . . 0.0 108.166 152.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -64.31 115.27 3.07 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.547 1.498 . . . . 0.0 112.656 -170.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -50.08 -44.62 51.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.48 -16.02 63.23 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -98.03 -38.23 4.15 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.259 1.409 . . . . 0.0 113.098 167.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.0 m -59.31 -39.48 83.21 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.34 1.07 . . . . 0.0 112.252 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -63.07 -26.35 68.79 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.009 1.724 . . . . 0.0 113.21 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -69.83 -41.04 75.48 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.316 -0.865 . . . . 0.0 111.269 173.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.4 87.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.336 -0.852 . . . . 0.0 112.503 171.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.1 mt -62.65 -40.37 96.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.273 0.488 . . . . 0.0 112.286 172.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.87 -42.3 94.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.221 0.919 . . . . 0.0 112.118 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -69.39 -36.19 76.54 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.892 1.224 . . . . 0.0 112.839 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -66.16 -46.25 78.11 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.298 -0.877 . . . . 0.0 112.326 171.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.69 -31.45 69.5 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.692 -1.147 . . . . 0.0 113.29 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -62.27 -45.99 90.82 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.591 1.541 . . . . 0.0 111.72 172.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.85 -29.62 70.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.501 0.72 . . . . 0.0 112.667 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -77.24 -57.66 3.71 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.117 0.967 . . . . 0.0 112.048 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.81 -33.0 74.64 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.425 1.49 . . . . 0.0 113.796 -170.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.03 -27.7 57.46 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.123 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -105.94 -20.15 13.52 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.34 -35.04 79.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.386 1.448 . . . . 0.0 112.376 171.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -65.21 -7.26 12.08 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.27 -38.53 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.796 1.238 . . . . 0.0 111.78 170.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -102.02 7.14 41.36 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.51 -141.27 15.51 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-O 117.41 -1.772 . . . . 0.0 115.891 157.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.84 -7.74 9.36 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.368 2.712 . . . . 0.0 118.072 -143.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -130.37 162.12 29.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.539 1.518 . . . . 0.0 111.633 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 tt -75.45 -4.42 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.428 -1.42 . . . . 0.0 113.541 -171.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.39 2.06 47.52 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 126.458 1.903 . . . . 0.0 115.206 161.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.47 -127.53 9.12 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.647 1.594 . . . . 0.0 113.133 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -62.2 -27.48 69.0 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -138.42 149.07 45.14 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.997 1.719 . . . . 0.0 109.598 -173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.9 mt -60.39 114.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.55 1.14 . . . . 0.0 109.936 164.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.9 p -143.38 -157.91 0.82 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.366 1.066 . . . . 0.0 111.044 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.71 -25.6 4.52 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -169.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.4 t -75.16 -40.83 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.863 1.21 . . . . 0.0 111.954 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.8 -44.54 96.65 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.047 -1.033 . . . . 0.0 112.179 167.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.35 -27.14 67.13 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.701 0.4 . . . . 0.0 112.068 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.4 m -83.67 -49.64 8.95 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.765 1.226 . . . . 0.0 112.638 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.5 mt -103.08 -33.85 9.1 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -162.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.4 99.02 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -171.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.24 -26.74 12.23 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 CA-C-N 120.758 1.306 . . . . 0.0 113.228 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -68.52 -34.82 76.55 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.14 -0.975 . . . . 0.0 112.235 172.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.51 -41.33 96.49 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.857 0.863 . . . . 0.0 112.571 172.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -65.26 -43.78 90.22 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.822 0.737 . . . . 0.0 112.508 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -63.2 -31.22 72.31 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.551 -0.718 . . . . 0.0 112.631 176.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.54 -49.5 26.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.482 1.513 . . . . 0.0 112.53 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -57.97 -35.81 71.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.338 1.055 . . . . 0.0 111.974 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.0 t -90.46 -63.33 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.625 0.77 . . . . 0.0 113.001 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.16 -47.74 23.1 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.055 -1.028 . . . . 0.0 113.558 -164.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.9 tt -76.35 -33.8 58.94 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.82 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.74 -27.31 66.29 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 118.681 -1.066 . . . . 0.0 115.702 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.03 -23.89 65.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.818 1.247 . . . . 0.0 114.218 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -116.73 -30.19 5.85 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.322 1.049 . . . . 0.0 113.34 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -150.7 96.38 2.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.755 1.622 . . . . 0.0 109.449 168.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.38 99.02 0.52 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.812 -0.555 . . . . 0.0 110.414 169.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.3 t90 -77.42 113.13 28.8 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.616 1.166 . . . . 0.0 110.991 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.9 112.56 3.59 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.107 1.871 . . . . 0.0 110.905 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 85.3 mt -65.49 114.06 14.18 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 164.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -67.43 159.04 54.24 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.801 1.667 . . . . 0.0 112.714 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.66 -27.48 64.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.016 1.727 . . . . 0.0 113.679 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -63.76 -24.89 67.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.677 1.191 . . . . 0.0 113.82 173.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.49 51.28 2.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.75 1.62 . . . . 0.0 111.183 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.41 -27.69 67.28 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.454 1.101 . . . . 0.0 113.781 -156.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -74.63 -51.68 13.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.883 1.22 . . . . 0.0 110.428 168.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.5 t -59.21 -37.79 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 118.959 0.8 . . . . 0.0 112.087 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.0 tp -62.34 -44.23 96.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.906 1.283 . . . . 0.0 113.136 174.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -71.44 -32.45 68.36 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.572 -0.705 . . . . 0.0 112.842 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.07 -29.63 70.75 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.445 1.098 . . . . 0.0 112.99 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.3 mm -54.18 -39.43 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.323 -0.861 . . . . 0.0 111.429 168.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -85.47 -5.35 59.3 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.472 -1.392 . . . . 0.0 114.238 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.3 mt -76.56 -18.51 58.63 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.609 159.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.68 -21.45 66.4 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.116 1.325 . . . . 0.0 113.318 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -89.34 8.59 29.84 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.631 1.572 . . . . 0.0 113.102 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.2 p -128.94 175.27 8.79 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -165.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 53.88 -164.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.265 1.826 . . . . 0.0 110.795 -166.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -80.62 -39.0 28.21 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.34 1.456 . . . . 0.0 109.426 158.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -49.67 75.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.151 2.58 . . . . 0.0 112.948 -165.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -96.0 -42.54 8.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 193' ' ' LYS . 33.7 ttpt -59.5 -33.82 71.82 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.03 -25.38 55.61 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.4 p -89.43 -10.57 45.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -55.32 122.83 12.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.407 1.083 . . . . 0.0 110.221 167.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -93.46 153.99 18.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.046 0.938 . . . . 0.0 112.56 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.8 128.95 38.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.893 0.877 . . . . 0.0 111.051 166.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -79.39 -35.18 41.1 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.455 1.502 . . . . 0.0 113.47 -147.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -39.09 80.86 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.608 1.563 . . . . 0.0 112.982 168.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -81.45 -8.16 59.69 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.12 -46.77 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 120.078 1.308 . . . . 0.0 110.205 160.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 26.6 mt -63.14 -56.34 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.776 1.23 . . . . 0.0 111.4 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.84 68.88 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -84.48 -19.84 59.55 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 120.95 -1.094 . . . . 0.0 114.017 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -75.82 -31.98 59.62 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.554 1.677 . . . . 0.0 113.199 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -43.27 -56.15 7.06 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.59 -29.51 52.3 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 121.968 1.739 . . . . 0.0 113.421 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -82.12 -3.24 54.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.941 1.696 . . . . 0.0 114.482 -175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.2 p -69.95 -13.93 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 118.707 0.685 . . . . 0.0 112.299 162.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -122.2 -40.63 2.48 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.451 1.5 . . . . 0.0 114.093 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.141 0 CA-C-O 116.215 -1.85 . . . . 0.0 114.362 -175.698 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.29 -164.05 0.07 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.973 0.909 . . . . 0.0 111.845 -163.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.96 105.04 5.03 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.074 -1.016 . . . . 0.0 111.231 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -112.91 118.75 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.056 0.942 . . . . 0.0 109.832 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.4 mt -102.67 142.35 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.322 1.449 . . . . 0.0 108.333 -176.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.9 m -121.93 135.16 54.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.841 0.746 . . . . 0.0 109.72 162.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.92 142.6 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.28 1.032 . . . . 0.0 110.06 -163.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.715 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 31.1 tttm -64.25 127.51 31.77 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.71 176.24 9.11 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.394 1.878 . . . . 0.0 111.916 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.82 140.32 30.52 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.542 -0.724 . . . . 0.0 111.934 167.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.5 t -54.12 121.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 121.061 0.457 . . . . 0.0 109.966 168.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.56 -9.12 51.96 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 118.26 -1.3 . . . . 0.0 116.265 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.3 84.27 24.43 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 120.106 1.953 . . . . 0.0 112.459 -172.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.59 -12.79 35.32 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.206 2.604 . . . . 0.0 116.476 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -74.51 -11.23 60.16 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 pt -145.74 163.37 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.117 1.367 . . . . 0.0 112.243 -164.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.8 mt -75.83 -43.64 44.9 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.84 -127.12 8.78 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.702 1.144 . . . . 0.0 115.001 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.416 ' OD2' ' HE3' ' A' ' 209' ' ' LYS . 7.9 p-10 -65.23 16.42 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.525 2.73 . . . . 0.0 117.026 -170.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.4 p -115.2 73.49 3.56 Favored Pre-proline 0 C--O 1.262 1.733 0 O-C-N 119.755 -1.841 . . . . 0.0 110.967 -158.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.81 -26.88 31.88 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.593 2.862 . . . . 0.0 112.76 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -63.03 -42.02 99.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.649 1.18 . . . . 0.0 112.661 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.715 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.4 m -61.34 -42.61 98.97 Favored 'General case' 0 C--N 1.376 1.746 0 O-C-N 119.543 -1.973 . . . . 0.0 111.02 170.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -65.5 -26.9 68.12 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 117.284 -1.341 . . . . 0.0 112.797 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -54.45 -44.12 72.23 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.772 1.169 . . . . 0.0 112.776 171.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.4 t -73.38 -38.39 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.261 1.424 . . . . 0.0 112.043 -172.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -74.85 -36.73 62.34 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.691 0.796 . . . . 0.0 111.432 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -59.25 -44.29 92.4 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.501 1.52 . . . . 0.0 113.271 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 p -70.06 -39.5 75.64 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.609 1.095 . . . . 0.0 112.998 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.78 -33.44 66.3 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -77.85 -25.37 48.69 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 173.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -67.04 -39.92 87.06 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.776 -1.202 . . . . 0.0 111.948 163.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -75.02 -1.79 24.33 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 169.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm 62.68 10.17 4.0 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.943 2.097 . . . . 0.0 115.6 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.403 ' CD1' HD21 ' A' ' 84' ' ' ASN . 59.8 mt -80.47 130.54 64.64 Favored Pre-proline 0 N--CA 1.472 0.648 0 O-C-N 121.159 -0.963 . . . . 0.0 110.374 -168.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.63 145.85 53.24 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.577 2.185 . . . . 0.0 112.195 171.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -146.64 161.17 41.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.956 1.702 . . . . 0.0 109.957 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -99.75 103.17 14.8 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.393 -0.817 . . . . 0.0 110.133 170.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.4 t -82.99 136.08 34.64 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.612 0.765 . . . . 0.0 112.364 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -119.63 95.12 4.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.557 1.543 . . . . 0.0 109.525 172.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.2 mt -70.94 136.46 48.53 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.56 0.744 . . . . 0.0 110.919 172.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.414 HD12 HG11 ' A' ' 60' ' ' VAL . 4.1 mt -132.12 117.43 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.471 1.508 . . . . 0.0 110.23 -174.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -83.05 107.56 15.72 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.452 -0.78 . . . . 0.0 109.546 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.0 mt 52.13 23.59 2.36 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 169.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.4 21.08 11.94 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 115.506 0.962 . . . . 0.0 115.506 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -66.41 23.17 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -140.93 150.84 60.79 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 125.729 1.612 . . . . 0.0 111.276 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -60.53 162.41 17.97 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.445 2.096 . . . . 0.0 111.674 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.67 -10.62 20.04 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -167.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -55.84 -24.25 35.39 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.106 2.162 . . . . 0.0 114.882 170.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -102.96 3.47 36.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.654 1.582 . . . . 0.0 113.454 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.6 mt -128.77 -39.55 1.61 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.204 2.202 . . . . 0.0 112.539 -169.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.22 -11.98 4.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 128.509 2.723 . . . . 0.0 114.669 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.7 mt -63.04 -21.0 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 127.039 2.136 . . . . 0.0 111.162 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -109.93 148.43 38.24 Favored Pre-proline 0 N--CA 1.472 0.647 0 C-N-CA 124.123 0.969 . . . . 0.0 111.104 157.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.61 -15.96 45.85 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.843 2.362 . . . . 0.0 113.426 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.71 -0.28 54.43 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.422 1.489 . . . . 0.0 113.01 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 12.57 63.86 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 120.907 -1.121 . . . . 0.0 114.847 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -76.62 164.29 26.05 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.931 1.692 . . . . 0.0 112.089 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.414 HG11 HD12 ' A' ' 42' ' ' ILE . 35.4 m -133.17 150.24 74.85 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.439 1.895 . . . . 0.0 108.129 154.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -76.94 151.89 94.54 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 N-CA-C 116.723 1.778 . . . . 0.0 116.723 13.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.4 m -158.09 165.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 128.528 2.731 . . . . 0.0 110.603 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.36 145.35 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 120.92 -1.113 . . . . 0.0 113.938 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -97.95 111.04 23.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.885 1.674 . . . . 0.0 109.067 161.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.34 83.99 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.619 1.168 . . . . 0.0 108.384 174.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.1 t70 55.94 51.38 12.21 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.276 1.03 . . . . 0.0 113.244 -166.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.68 25.2 14.12 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -175.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -113.93 111.74 22.19 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.034 1.333 . . . . 0.0 108.517 169.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -84.73 149.96 25.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.254 -151.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.05 132.36 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.761 1.624 . . . . 0.0 109.357 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.44 -149.45 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.054 1.742 . . . . 0.0 113.149 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -35.08 155.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.805 2.042 . . . . 0.0 116.411 -171.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.8 p -47.51 -30.47 3.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.181 1.392 . . . . 0.0 113.934 160.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -90.6 -8.44 50.15 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.623 1.169 . . . . 0.0 113.303 -171.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.75 -23.33 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.085 0.954 . . . . 0.0 113.01 158.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.4 mt -56.48 -40.06 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.023 1.329 . . . . 0.0 112.184 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -61.43 -9.39 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.82 -58.52 0.57 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.482 1.039 . . . . 0.0 112.935 158.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.0 -35.59 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.229 -1.16 . . . . 0.0 113.366 -164.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.63 -43.21 63.55 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.346 0.976 . . . . 0.0 110.922 171.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -64.9 -28.24 69.4 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -68.5 -37.19 79.85 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.249 1.419 . . . . 0.0 114.57 167.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -108.28 -12.35 15.08 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.959 1.303 . . . . 0.0 113.259 -161.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.403 HD21 ' CD1' ' A' ' 35' ' ' ILE . 25.6 t-20 -73.21 142.55 82.25 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.122 1.769 . . . . 0.0 109.99 163.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.05 -21.94 20.05 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.149 1.9 . . . . 0.0 114.656 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -74.58 146.67 83.84 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 119.154 0.888 . . . . 0.0 110.476 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -55.24 144.81 69.3 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.845 2.363 . . . . 0.0 114.08 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.83 133.6 51.91 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.315 2.676 . . . . 0.0 112.765 -171.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.4 mt -80.37 -0.92 39.0 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.533 -0.729 . . . . 0.0 112.915 160.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.06 -32.09 73.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.316 1.447 . . . . 0.0 114.057 175.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.0 m -62.71 115.38 16.55 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 123.577 0.751 . . . . 0.0 110.777 -168.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -80.17 134.72 10.52 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 121.889 1.726 . . . . 0.0 112.099 -168.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -75.63 175.13 11.69 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.971 2.447 . . . . 0.0 110.61 156.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -58.19 -29.18 65.45 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.578 -1.326 . . . . 0.0 113.458 173.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -57.69 -25.25 60.03 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.316 1.446 . . . . 0.0 114.4 173.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.38 -28.25 69.86 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.91 0.777 . . . . 0.0 113.05 175.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.3 p -61.91 -42.54 99.21 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.296 0.638 . . . . 0.0 112.226 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.57 -38.33 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.946 0.898 . . . . 0.0 112.11 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.11 -23.77 64.35 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.957 1.265 . . . . 0.0 114.368 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 p -62.66 -25.25 68.04 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 172.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -84.17 -41.57 16.88 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.853 1.261 . . . . 0.0 112.368 173.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.3 mt -68.34 -34.9 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.098 0.959 . . . . 0.0 111.316 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.32 -48.56 93.66 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 120.519 -1.363 . . . . 0.0 114.301 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.99 -31.5 2.27 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.289 2.659 . . . . 0.0 114.129 170.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.2 p -69.25 -26.41 64.77 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 121.207 1.821 . . . . 0.0 112.987 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -62.38 -42.03 99.1 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.358 -1.464 . . . . 0.0 113.531 161.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.48 -36.73 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 119.856 1.207 . . . . 0.0 110.821 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -66.65 -44.23 82.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.415 1.486 . . . . 0.0 112.306 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -66.78 -37.29 84.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.046 1.338 . . . . 0.0 113.295 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.6 mt -75.95 13.9 0.78 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.862 1.265 . . . . 0.0 113.627 168.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -140.02 60.25 1.56 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.02 2.128 . . . . 0.0 110.12 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -57.0 17.29 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 130.799 3.64 . . . . 0.0 119.237 -160.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.59 -30.42 64.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.294 1.838 . . . . 0.0 111.835 169.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -81.13 121.78 80.9 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 117.726 -1.13 . . . . 0.0 108.324 159.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -56.72 124.75 16.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.3 2.0 . . . . 0.0 114.056 -167.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -60.35 -43.69 96.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 117.791 -1.099 . . . . 0.0 113.538 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.86 -20.78 66.08 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.49 -39.76 6.63 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.025 -1.047 . . . . 0.0 113.227 170.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.5 m -67.89 -26.8 66.18 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.445 -1.032 . . . . 0.0 113.524 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -65.19 -36.9 85.64 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.93 1.292 . . . . 0.0 112.219 170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -68.11 -39.43 82.79 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.225 -0.922 . . . . 0.0 111.73 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.41 -42.95 92.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.075 0.55 . . . . 0.0 112.472 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -62.49 -39.3 93.04 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.014 0.926 . . . . 0.0 112.475 174.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.76 -37.23 86.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.756 1.162 . . . . 0.0 112.2 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.485 ' HA ' ' HE3' ' A' ' 128' ' ' LYS . 10.5 tp10 -69.9 -33.83 72.72 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.723 1.147 . . . . 0.0 113.11 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -70.88 -44.94 65.28 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.837 -1.165 . . . . 0.0 112.692 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.5 mt -73.52 -31.34 63.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.666 -1.159 . . . . 0.0 113.389 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 125' ' ' GLU . 39.5 mtmt -59.03 -43.06 91.57 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.381 1.446 . . . . 0.0 112.214 173.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.07 72.81 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.07 -54.23 8.28 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.66 0.784 . . . . 0.0 111.454 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.03 -35.79 81.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.688 1.595 . . . . 0.0 113.661 -172.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.14 -34.5 73.49 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.708 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -93.15 -27.55 16.84 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.7 mt -64.54 -36.89 85.67 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.306 1.412 . . . . 0.0 112.3 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -64.06 -9.21 14.91 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 172.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.5 t -98.48 -33.48 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.871 1.268 . . . . 0.0 112.334 171.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -95.42 -25.08 16.4 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.99 -167.83 16.43 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-O 118.478 -1.179 . . . . 0.0 114.751 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -81.77 -5.75 12.37 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.607 2.871 . . . . 0.0 117.107 -122.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -107.47 160.17 15.85 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.77 -1.206 . . . . 0.0 110.685 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.261 8.7 tt -76.71 -3.72 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 119.915 -1.741 . . . . 0.0 112.907 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.5 -1.29 44.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.158 1.783 . . . . 0.0 115.377 159.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.64 -125.87 7.79 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 120.411 1.46 . . . . 0.0 113.917 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -69.44 -20.7 63.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.687 1.195 . . . . 0.0 113.972 -171.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -138.87 150.68 46.26 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.312 1.845 . . . . 0.0 109.825 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.8 mt -66.67 111.71 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.613 0.765 . . . . 0.0 109.264 165.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.9 p -140.57 -162.64 1.39 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.476 1.11 . . . . 0.0 110.845 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.02 -25.52 3.46 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.37 -40.63 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 119.812 1.187 . . . . 0.0 112.101 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.67 -45.02 95.78 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.768 -1.207 . . . . 0.0 112.475 166.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.97 -24.99 64.86 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.9 m -86.61 -55.44 3.87 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.789 1.235 . . . . 0.0 112.35 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.15 -31.5 14.76 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -161.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.94 -50.74 84.99 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -169.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.86 -23.83 18.48 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 120.842 1.337 . . . . 0.0 112.799 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -72.82 -35.69 67.36 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.414 172.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 41.4 mt -63.7 -37.85 88.92 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.249 0.931 . . . . 0.0 112.726 169.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -64.34 -42.89 96.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.412 0.551 . . . . 0.0 112.27 172.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -68.19 -27.07 66.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.815 0.846 . . . . 0.0 113.117 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.03 -55.91 12.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.549 1.14 . . . . 0.0 111.466 166.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -60.0 -36.62 77.59 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.723 0.692 . . . . 0.0 112.042 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 78.2 t -86.78 -66.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.06 -50.32 15.05 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.125 -0.984 . . . . 0.0 113.251 -161.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 52.6 tp -79.65 -32.74 41.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.846 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.11 -25.88 65.05 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.554 1.073 . . . . 0.0 114.999 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -63.14 -24.17 67.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -115.46 -28.36 6.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.143 0.977 . . . . 0.0 113.553 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -148.76 101.87 3.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.211 1.404 . . . . 0.0 109.109 164.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -71.63 85.5 0.89 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.505 0.722 . . . . 0.0 110.092 170.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -68.55 113.86 18.39 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.802 1.241 . . . . 0.0 110.302 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.97 120.62 6.45 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.974 1.783 . . . . 0.0 110.907 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 52.9 mt -68.36 117.26 48.07 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 163.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -64.39 157.72 53.05 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.208 1.938 . . . . 0.0 112.826 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -27.94 66.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.599 1.56 . . . . 0.0 113.196 174.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -65.82 -27.01 67.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.473 1.109 . . . . 0.0 113.659 173.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.3 mt -85.79 52.32 2.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.073 1.349 . . . . 0.0 110.793 168.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.15 -29.71 71.01 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.46 1.104 . . . . 0.0 112.63 -161.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -76.66 -47.23 22.8 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.597 0.635 . . . . 0.0 111.604 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.03 -40.51 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.231 0.612 . . . . 0.0 111.16 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.67 -45.17 91.33 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.768 1.227 . . . . 0.0 113.245 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -67.1 -36.65 82.39 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.49 -0.756 . . . . 0.0 112.517 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -63.84 -27.46 69.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.943 0.897 . . . . 0.0 113.365 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 44.0 mm -54.14 -36.17 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 120.997 -1.064 . . . . 0.0 111.962 168.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -89.03 -8.69 53.52 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.537 -1.352 . . . . 0.0 114.054 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 78.3 mt -74.08 -19.08 60.72 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 116.645 -1.645 . . . . 0.0 113.611 158.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 56.2 mt -62.96 -22.41 66.79 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.369 1.44 . . . . 0.0 113.055 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -93.56 9.04 38.41 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.364 1.466 . . . . 0.0 112.982 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.3 p -123.44 176.46 6.15 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.008 1.723 . . . . 0.0 114.424 -166.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 52.7 -163.87 0.08 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.81 1.644 . . . . 0.0 110.763 -170.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 11.1 mp0 -78.68 -43.58 25.67 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 125.947 1.699 . . . . 0.0 110.275 154.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.02 -49.58 71.19 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 128.013 2.525 . . . . 0.0 112.916 -164.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -91.13 -44.92 8.97 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.79 -34.03 71.01 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -75.03 -24.53 58.32 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.419 1.009 . . . . 0.0 113.424 174.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 35.9 p -88.48 -12.29 43.44 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -53.56 110.55 0.58 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.14 1.376 . . . . 0.0 110.041 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.44 141.52 28.65 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.684 0.793 . . . . 0.0 112.005 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.61 119.47 5.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.703 1.201 . . . . 0.0 111.837 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -67.81 -38.01 82.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -149.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -59.15 -36.57 75.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.131 1.372 . . . . 0.0 112.502 174.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -82.35 -11.17 58.75 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.88 -43.97 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.921 0.782 . . . . 0.0 109.912 164.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.8 mt -62.28 -57.0 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.281 1.432 . . . . 0.0 111.364 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.53 70.38 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.37 -19.9 65.57 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.947 -1.096 . . . . 0.0 114.11 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -80.13 -27.57 39.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.586 1.193 . . . . 0.0 113.578 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -50.65 -49.94 75.8 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.47 -25.18 30.18 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 CA-C-N 121.881 1.707 . . . . 0.0 113.293 173.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.416 ' HE3' ' OD2' ' A' ' 19' ' ' ASP . 57.1 mttm -84.58 -12.92 53.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.989 1.716 . . . . 0.0 114.984 -175.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -22.29 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 118.634 0.652 . . . . 0.0 111.372 161.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -97.76 -53.18 3.5 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 117.414 -1.279 . . . . 0.0 114.01 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 C-N-CA 126.712 2.005 . . . . 0.0 114.026 -168.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.0 mtp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 119.113 -0.47 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.31 -164.73 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.51 1.124 . . . . 0.0 112.004 -169.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.4 mt -71.1 103.7 2.82 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.92 -1.112 . . . . 0.0 110.847 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -109.59 118.76 37.42 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.793 0.837 . . . . 0.0 109.654 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.1 mt -100.1 142.66 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.399 1.08 . . . . 0.0 108.17 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.1 m -123.6 132.32 53.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.634 0.652 . . . . 0.0 109.406 163.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.1 142.06 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.701 1.201 . . . . 0.0 109.775 -162.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.67 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 32.0 tttm -65.58 127.48 32.04 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.352 -0.843 . . . . 0.0 109.377 171.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.53 176.36 9.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.7 2.0 . . . . 0.0 111.767 170.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.25 141.79 34.08 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.434 -0.791 . . . . 0.0 111.621 166.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 81.5 t -54.46 121.36 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.941 -0.474 . . . . 0.0 109.88 168.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.31 -15.39 34.63 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.073 1.321 . . . . 0.0 116.085 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -132.53 90.35 33.59 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 119.768 1.784 . . . . 0.0 112.211 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.36 -13.44 39.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.396 2.731 . . . . 0.0 115.249 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -76.14 -12.38 60.1 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.6 pt -142.93 162.64 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.796 1.238 . . . . 0.0 112.113 -165.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.1 mt -74.4 -43.05 58.06 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.23 -125.94 7.17 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.907 1.241 . . . . 0.0 114.622 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.96 18.51 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 128.774 2.83 . . . . 0.0 117.178 -172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -119.23 68.78 9.99 Favored Pre-proline 0 C--O 1.262 1.749 0 O-C-N 120.558 -1.339 . . . . 0.0 110.965 -160.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.37 -22.11 39.97 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.975 3.117 . . . . 0.0 113.12 174.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -62.93 -42.22 99.73 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.405 -0.809 . . . . 0.0 112.786 167.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.2 m -61.57 -41.82 97.95 Favored 'General case' 0 C--N 1.369 1.447 0 O-C-N 120.015 -1.678 . . . . 0.0 111.006 170.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.04 -29.46 70.83 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 117.192 -1.385 . . . . 0.0 113.014 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -54.1 -43.19 70.2 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.141 1.337 . . . . 0.0 112.718 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.78 -36.72 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.369 1.468 . . . . 0.0 111.941 -173.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.31 -39.7 65.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.756 0.822 . . . . 0.0 111.279 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 191' ' ' SER . 16.7 tp -57.58 -44.79 85.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.975 1.71 . . . . 0.0 112.977 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -68.91 -43.13 75.82 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.48 1.037 . . . . 0.0 112.799 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.04 -32.44 69.17 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -77.73 -25.52 49.33 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 173.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -70.68 -36.04 73.11 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.441 -1.412 . . . . 0.0 112.106 164.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE3' ' HG ' ' A' ' 89' ' ' LEU . 65.2 mttt -73.21 -3.49 27.02 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 167.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm 60.93 12.55 3.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.241 2.217 . . . . 0.0 115.024 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.8 mt -80.14 131.01 63.99 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 124.223 1.009 . . . . 0.0 110.307 -172.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.75 147.06 44.12 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.791 2.328 . . . . 0.0 112.483 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -147.33 159.28 43.86 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.489 1.516 . . . . 0.0 110.972 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -96.89 95.08 7.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.368 1.067 . . . . 0.0 110.289 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.7 t -82.06 136.54 35.2 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -118.7 100.6 7.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.758 1.623 . . . . 0.0 109.5 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.0 mt -73.14 135.9 44.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.375 0.67 . . . . 0.0 110.717 170.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mt -129.5 117.35 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.41 1.484 . . . . 0.0 110.532 -172.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -86.77 101.16 13.06 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.697 -0.627 . . . . 0.0 109.964 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.2 mt 53.67 21.52 2.66 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 170.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.06 23.54 9.1 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-O 118.884 -0.954 . . . . 0.0 115.246 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -64.15 10.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -140.15 145.34 41.42 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 126.0 1.72 . . . . 0.0 110.305 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -63.5 167.67 12.78 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.084 2.523 . . . . 0.0 112.238 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -62.53 -13.95 36.5 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 116.268 -1.825 . . . . 0.0 115.627 -168.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -56.64 -17.68 9.56 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 167.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -108.58 6.43 25.95 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.82 1.648 . . . . 0.0 113.517 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.1 mt -130.8 -41.07 1.17 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.461 2.304 . . . . 0.0 112.702 -170.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.93 -6.58 3.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 128.286 2.635 . . . . 0.0 114.961 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.1 mt -63.39 -17.87 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 126.961 2.104 . . . . 0.0 111.123 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 p -115.43 149.95 43.74 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.426 1.09 . . . . 0.0 111.446 156.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.25 -27.0 56.27 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.801 2.334 . . . . 0.0 113.043 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -75.27 -10.36 59.39 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.504 1.522 . . . . 0.0 113.626 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.62 12.5 59.24 Favored Glycine 0 CA--C 1.54 1.608 0 O-C-N 120.431 -1.418 . . . . 0.0 114.39 -166.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -70.57 160.1 33.12 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.148 1.379 . . . . 0.0 111.295 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG12 HG22 ' A' ' 62' ' ' VAL . 35.4 m -135.09 149.39 70.09 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 125.965 1.706 . . . . 0.0 108.465 155.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -75.91 151.7 95.88 Favored 'Cis proline' 0 CA--C 1.541 0.855 0 N-CA-C 117.192 1.959 . . . . 0.0 117.192 15.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 60' ' ' VAL . 23.8 m -157.44 166.77 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 128.399 2.68 . . . . 0.0 111.023 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.78 144.83 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 171.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -96.14 111.0 23.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.703 2.001 . . . . 0.0 109.063 162.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.3 mt -89.55 79.75 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.052 0.941 . . . . 0.0 108.935 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.87 52.35 10.84 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.039 0.936 . . . . 0.0 112.207 -163.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.77 18.8 7.62 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -174.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -102.71 105.89 16.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.035 -1.041 . . . . 0.0 108.452 167.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -75.94 150.56 37.47 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -157.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.0 t -141.88 133.19 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.483 1.913 . . . . 0.0 108.829 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.63 -145.24 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.214 1.806 . . . . 0.0 113.341 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -38.3 154.19 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.395 1.878 . . . . 0.0 116.026 -170.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.0 p -48.9 -30.29 5.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.099 1.36 . . . . 0.0 113.831 164.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -92.13 -6.23 51.2 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.221 1.008 . . . . 0.0 113.341 -171.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.8 m -106.04 -22.07 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.195 0.998 . . . . 0.0 113.082 158.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.4 mt -56.24 -40.15 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.043 1.337 . . . . 0.0 112.136 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 m -62.12 -9.89 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 114.509 1.299 . . . . 0.0 114.509 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.05 -57.76 0.68 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.275 0.94 . . . . 0.0 113.038 159.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.2 mt -75.0 -30.3 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -163.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 tp -72.83 -43.31 62.82 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.671 -1.268 . . . . 0.0 110.612 167.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -65.96 -30.37 70.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.507 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 21.9 tt0 -65.09 -45.89 83.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.449 1.9 . . . . 0.0 113.013 168.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 94.8 mttt -92.73 -9.44 40.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.58 1.152 . . . . 0.0 113.728 -168.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.16 142.73 55.56 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.568 1.547 . . . . 0.0 110.494 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.12 -16.49 28.58 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.254 1.969 . . . . 0.0 115.263 -173.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -81.97 149.03 62.21 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 119.812 1.187 . . . . 0.0 110.957 165.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -53.03 146.16 38.76 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.262 2.641 . . . . 0.0 115.042 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.03 124.33 12.09 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.533 2.822 . . . . 0.0 113.57 -167.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HG ' ' HE3' ' A' ' 33' ' ' LYS . 19.4 mt -70.81 -5.72 32.36 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.328 -0.857 . . . . 0.0 113.186 163.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.26 -28.44 64.92 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.134 1.374 . . . . 0.0 113.513 170.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.3 m -61.88 113.59 8.87 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.134 0.973 . . . . 0.0 110.893 -166.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -80.21 125.08 5.66 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.156 1.904 . . . . 0.0 111.88 -171.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.49 170.97 18.69 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.378 2.052 . . . . 0.0 110.071 154.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.37 -23.98 64.72 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.847 -1.158 . . . . 0.0 113.79 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -54.9 -27.43 42.89 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.423 1.489 . . . . 0.0 114.247 170.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.04 -27.53 69.17 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.4 p -64.08 -42.38 96.98 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.861 0.755 . . . . 0.0 112.1 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 t -79.63 -38.82 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.52 1.128 . . . . 0.0 111.681 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.11 -23.28 61.63 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.038 1.304 . . . . 0.0 114.483 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.5 p -63.63 -24.85 67.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.868 1.267 . . . . 0.0 113.75 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -84.01 -45.32 13.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.688 1.195 . . . . 0.0 111.873 170.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.6 mt -68.23 -36.66 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.723 0.809 . . . . 0.0 111.466 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -61.17 -47.65 94.11 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 120.43 -1.419 . . . . 0.0 113.984 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.52 -31.78 2.49 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.087 2.525 . . . . 0.0 114.28 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 51.7 p -70.08 -24.0 63.15 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.147 1.794 . . . . 0.0 113.292 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -62.84 -40.2 96.71 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.057 -1.652 . . . . 0.0 113.575 161.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.8 t -66.12 -37.6 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.875 -1.141 . . . . 0.0 110.649 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -63.76 -45.56 89.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.317 1.447 . . . . 0.0 111.934 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -63.42 -41.37 98.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.178 1.391 . . . . 0.0 112.839 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.1 mt -69.89 -20.5 63.37 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 173.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -104.04 68.93 0.92 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.357 1.463 . . . . 0.0 110.436 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 m -64.91 27.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.61 2.764 . . . . 0.0 117.793 -162.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.628 ' HE3' ' HA ' ' A' ' 211' ' ' ASN . 93.3 mttt -70.63 -35.24 72.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.908 1.283 . . . . 0.0 112.447 163.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -78.08 116.71 60.94 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 117.494 -1.241 . . . . 0.0 107.793 164.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -53.43 125.27 17.94 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.674 2.25 . . . . 0.0 113.602 -164.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -55.92 -46.57 78.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.137 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.99 -27.68 68.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.54 -34.05 12.49 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.095 -1.003 . . . . 0.0 113.584 173.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.9 m -71.34 -26.72 62.95 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.451 -1.029 . . . . 0.0 113.103 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -64.01 -45.48 88.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.585 1.554 . . . . 0.0 111.57 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -63.72 -40.35 96.55 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.773 -0.58 . . . . 0.0 112.092 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.25 96.2 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.379 -0.826 . . . . 0.0 112.851 172.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.23 -32.05 73.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 117.891 -1.052 . . . . 0.0 112.873 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.25 -40.58 96.67 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.476 1.489 . . . . 0.0 111.718 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.78 -31.19 64.7 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.79 -47.59 62.3 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.205 -0.934 . . . . 0.0 112.28 169.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.8 mt -70.45 -31.11 68.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 117.957 -1.021 . . . . 0.0 113.122 -176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -56.72 -45.31 81.97 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.945 1.248 . . . . 0.0 112.264 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.7 -28.03 66.47 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.98 0.734 . . . . 0.0 112.98 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -78.01 -56.97 4.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.148 0.979 . . . . 0.0 111.222 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.85 -35.05 79.87 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.145 1.778 . . . . 0.0 113.794 -172.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.6 -33.34 66.78 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.895 -0.947 . . . . 0.0 113.903 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -97.08 -26.52 14.96 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.2 mt -61.46 -37.62 84.25 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.467 1.485 . . . . 0.0 112.217 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.93 -12.78 40.36 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.61 -33.66 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.039 1.335 . . . . 0.0 111.679 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -89.03 -50.21 6.3 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.95 -172.81 45.43 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 -167.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -96.34 -8.09 1.13 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.311 3.341 . . . . 0.0 114.487 -171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -100.6 156.71 17.15 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.07 0.948 . . . . 0.0 110.404 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.273 9.8 tt -77.49 0.73 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 120.517 -1.365 . . . . 0.0 113.407 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.26 5.68 37.66 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.626 1.97 . . . . 0.0 114.957 159.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.88 -122.0 7.44 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.56 1.552 . . . . 0.0 113.562 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -66.66 -25.15 66.43 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.751 2.02 . . . . 0.0 114.055 -170.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -143.53 151.54 40.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.021 1.728 . . . . 0.0 109.077 -178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.6 mt -57.84 112.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.248 1.019 . . . . 0.0 109.802 160.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.7 p -140.23 -162.88 1.41 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.924 1.69 . . . . 0.0 110.773 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.26 -25.42 2.32 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.39 -37.78 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 117.543 -1.217 . . . . 0.0 112.514 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.86 -44.34 96.38 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.753 -1.217 . . . . 0.0 112.296 163.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.0 mt -58.54 -27.61 64.71 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 175.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.5 m -83.97 -60.99 1.93 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.939 1.296 . . . . 0.0 112.55 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.96 -33.2 17.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -160.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.01 90.4 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -171.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -71.97 -27.6 17.25 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 CA-C-N 120.887 1.352 . . . . 0.0 112.676 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -72.6 -33.09 66.46 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 117.629 -1.177 . . . . 0.0 112.641 173.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.6 mt -64.6 -40.11 94.93 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.075 0.852 . . . . 0.0 112.604 168.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -63.33 -45.07 92.99 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.805 0.729 . . . . 0.0 112.245 173.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -65.24 -27.7 68.84 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.486 -0.758 . . . . 0.0 112.939 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.41 -50.06 20.01 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.772 1.229 . . . . 0.0 113.173 171.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -58.5 -36.76 74.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.231 0.923 . . . . 0.0 111.437 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -81.78 -70.05 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.512 0.725 . . . . 0.0 112.73 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.44 -43.79 31.27 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.957 -1.09 . . . . 0.0 113.623 -163.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.6 tp -79.48 -36.04 39.3 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.983 0.356 . . . . 0.0 111.387 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.56 -29.77 70.38 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.758 1.17 . . . . 0.0 114.638 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -60.81 -33.95 73.79 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 172.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -103.56 -26.31 12.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -152.69 103.69 2.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.048 1.339 . . . . 0.0 109.486 165.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -72.79 76.65 1.13 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.038 0.935 . . . . 0.0 111.754 173.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 41.0 t90 -64.4 111.49 5.69 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.245 1.418 . . . . 0.0 110.631 174.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.7 126.72 9.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.764 1.643 . . . . 0.0 110.21 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.92 117.44 45.51 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 166.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -64.64 159.35 45.4 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.074 1.85 . . . . 0.0 112.868 -174.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -27.31 65.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.68 1.592 . . . . 0.0 113.505 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -68.43 -24.55 64.75 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 73.2 mt -88.53 51.82 2.28 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.417 1.487 . . . . 0.0 110.922 168.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.65 -29.23 69.2 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.805 1.242 . . . . 0.0 113.235 -159.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -72.94 -53.02 12.35 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 119.384 0.993 . . . . 0.0 110.295 171.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.22 -35.15 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 118.909 0.777 . . . . 0.0 111.884 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.4 tp -61.68 -46.09 91.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.704 1.202 . . . . 0.0 113.269 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -69.11 -37.33 78.33 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.537 -0.727 . . . . 0.0 112.601 174.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -62.05 -27.48 68.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.194 1.398 . . . . 0.0 113.479 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 43.8 mm -50.99 -36.35 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.801 0.84 . . . . 0.0 112.163 168.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -85.08 -6.38 59.31 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.322 -1.487 . . . . 0.0 113.859 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 26.2 mt -75.5 -21.8 57.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 117.646 -1.169 . . . . 0.0 113.758 159.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 61.1 mt -62.65 -21.14 65.47 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.947 1.248 . . . . 0.0 113.331 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -95.0 11.28 32.52 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.457 1.503 . . . . 0.0 112.979 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.1 p -130.58 178.57 6.52 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -164.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 54.03 -161.68 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.925 1.69 . . . . 0.0 110.823 -170.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 190' ' ' GLU . 9.1 mp0 -82.28 -45.01 15.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 125.675 1.59 . . . . 0.0 109.312 157.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.4 ' HB2' HD12 ' A' ' 28' ' ' LEU . 54.4 p -55.34 -33.33 63.28 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.669 2.388 . . . . 0.0 115.78 -168.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -110.83 -40.24 4.6 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.299 0.954 . . . . 0.0 112.865 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -62.22 -29.36 70.33 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.447 -1.408 . . . . 0.0 113.817 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.75 -26.46 44.61 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 171.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 35.3 p -89.58 -9.04 51.25 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -50.65 114.99 1.29 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.781 1.633 . . . . 0.0 110.099 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -96.36 139.93 31.76 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.677 0.791 . . . . 0.0 111.934 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.35 117.29 3.41 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.785 1.234 . . . . 0.0 111.924 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -67.42 -36.92 82.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.98 1.312 . . . . 0.0 114.052 -149.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -62.06 -36.28 81.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.008 1.323 . . . . 0.0 112.454 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -83.15 -7.56 59.61 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 4.3 t -78.03 -43.31 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 119.352 0.978 . . . . 0.0 110.033 161.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.0 mt -63.49 -57.67 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.27 1.428 . . . . 0.0 111.394 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.14 69.31 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.27 -14.51 62.02 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 120.934 -1.104 . . . . 0.0 114.324 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -76.67 -37.72 55.72 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.15 1.475 . . . . 0.0 111.838 166.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -46.71 -56.43 11.53 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -168.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.44 -24.91 63.63 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 CA-C-N 122.116 1.791 . . . . 0.0 113.359 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -82.07 -3.66 55.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.225 1.41 . . . . 0.0 114.324 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.0 -20.03 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.248 0.931 . . . . 0.0 110.973 159.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.628 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 23.8 m-80 -105.91 -12.25 15.9 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 175.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.442 0 CA-C-O 115.505 -2.188 . . . . 0.0 115.264 -162.12 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.43 -166.36 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.841 0.856 . . . . 0.0 111.89 -166.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 mt -68.53 112.81 5.56 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.788 -1.195 . . . . 0.0 110.771 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -117.41 101.89 8.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.566 1.146 . . . . 0.0 109.049 167.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.9 mt -81.31 137.52 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.647 1.179 . . . . 0.0 108.656 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.6 m -121.29 132.55 54.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.315 0.507 . . . . 0.0 109.634 166.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.55 142.87 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.097 -1.002 . . . . 0.0 111.079 -158.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.704 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.8 tttm -66.28 128.49 36.33 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.623 -0.673 . . . . 0.0 109.331 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.25 176.13 8.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.017 1.727 . . . . 0.0 112.08 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.08 142.59 19.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.751 0.82 . . . . 0.0 111.951 167.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.4 t -54.45 121.59 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 120.965 0.412 . . . . 0.0 110.15 167.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.8 -8.6 42.22 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.042 1.306 . . . . 0.0 116.357 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.54 83.84 29.72 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 119.929 1.864 . . . . 0.0 112.278 -170.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.8 -13.7 40.8 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.582 2.855 . . . . 0.0 116.613 -172.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -81.84 -6.24 58.91 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.2 pt -142.97 160.01 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.179 1.392 . . . . 0.0 111.762 -167.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.5 mt -73.84 -43.28 59.18 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.83 -128.22 9.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.548 1.071 . . . . 0.0 114.593 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.04 15.56 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.426 2.69 . . . . 0.0 117.266 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -116.31 73.12 5.23 Favored Pre-proline 0 C--O 1.26 1.622 0 O-C-N 119.928 -1.732 . . . . 0.0 110.948 -158.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.23 -25.01 37.24 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 123.966 3.111 . . . . 0.0 113.098 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -66.97 -33.46 75.62 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.93 -1.106 . . . . 0.0 112.712 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.704 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.4 m -68.02 -43.47 78.7 Favored 'General case' 0 C--N 1.374 1.671 0 O-C-N 119.342 -2.099 . . . . 0.0 110.957 169.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.98 -36.12 76.47 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.799 0.84 . . . . 0.0 112.28 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -54.43 -39.8 67.7 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.582 1.553 . . . . 0.0 113.743 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.78 -36.93 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.843 0.857 . . . . 0.0 112.571 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.25 -39.11 82.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.157 0.583 . . . . 0.0 111.524 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.87 -41.41 95.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.358 1.463 . . . . 0.0 113.78 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 p -72.54 -38.8 67.89 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 119.822 1.192 . . . . 0.0 112.835 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -71.77 -36.8 70.47 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.94 0.896 . . . . 0.0 112.738 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -73.52 -28.81 62.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -69.58 -40.64 76.62 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.711 -1.243 . . . . 0.0 112.215 168.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -71.26 -4.2 24.5 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.23 1.412 . . . . 0.0 114.372 169.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' HE3' ' OE1' ' A' ' 190' ' ' GLU . 30.6 mmtm 60.58 14.91 5.25 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.891 2.076 . . . . 0.0 114.876 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.57 128.65 74.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.169 0.988 . . . . 0.0 109.964 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.7 149.4 54.64 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.709 2.273 . . . . 0.0 112.203 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -147.91 158.5 44.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.405 1.482 . . . . 0.0 110.246 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -85.29 146.72 26.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.076 0.951 . . . . 0.0 108.957 160.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 t -132.47 137.98 47.43 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.412 0.685 . . . . 0.0 112.008 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -126.08 88.18 2.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.531 1.932 . . . . 0.0 109.449 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.18 135.39 49.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.719 0.807 . . . . 0.0 110.889 171.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.8 mt -131.73 121.27 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.456 1.502 . . . . 0.0 110.048 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -87.85 111.78 21.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 168.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.7 mt 51.7 27.45 4.08 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 167.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.28 17.54 39.49 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -67.23 12.3 0.09 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -138.69 138.52 21.99 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 126.114 1.766 . . . . 0.0 108.503 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.75 170.11 7.65 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.817 2.345 . . . . 0.0 112.793 -165.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -57.87 -17.24 15.2 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -173.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -58.71 -16.19 15.38 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.295 -2.128 . . . . 0.0 116.235 166.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -107.97 7.01 27.7 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.597 1.559 . . . . 0.0 113.1 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.4 mt -132.36 -38.59 1.05 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.441 2.297 . . . . 0.0 112.941 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -57.58 -16.17 9.49 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 128.389 2.676 . . . . 0.0 113.932 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.6 mt -59.9 -19.7 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 126.804 2.042 . . . . 0.0 110.942 172.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -109.05 147.94 36.93 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.369 1.068 . . . . 0.0 110.723 153.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -66.57 -14.03 42.34 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.55 2.167 . . . . 0.0 112.939 170.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -84.05 -12.68 54.76 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.544 1.938 . . . . 0.0 112.717 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.5 15.06 65.58 Favored Glycine 0 CA--C 1.538 1.518 0 O-C-N 121.014 -1.054 . . . . 0.0 114.447 -168.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -82.63 167.47 18.24 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.407 1.483 . . . . 0.0 111.896 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.474 HG12 HG22 ' A' ' 62' ' ' VAL . 15.9 m -134.13 149.46 71.52 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 126.197 1.799 . . . . 0.0 108.504 152.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.16 151.29 95.02 Favored 'Cis proline' 0 CA--C 1.539 0.734 0 N-CA-C 116.765 1.794 . . . . 0.0 116.765 14.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 60' ' ' VAL . 30.3 m -157.45 168.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 128.16 2.584 . . . . 0.0 110.622 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.0 m -137.22 143.9 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 120.907 -1.121 . . . . 0.0 113.995 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -91.31 117.24 29.49 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.416 156.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.0 mt -92.33 76.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.25 1.02 . . . . 0.0 109.185 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 56.88 55.77 5.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.905 0.882 . . . . 0.0 112.089 -163.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.15 16.56 4.93 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -175.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -98.6 103.58 15.55 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.519 -1.363 . . . . 0.0 108.77 167.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -74.57 148.03 41.19 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -159.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.68 133.2 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.511 1.924 . . . . 0.0 109.074 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.99 -147.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.296 1.839 . . . . 0.0 113.202 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -38.85 153.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.891 2.077 . . . . 0.0 116.291 -168.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.3 p -49.73 -27.69 5.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.761 1.624 . . . . 0.0 114.22 168.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -95.11 -8.42 36.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.591 1.156 . . . . 0.0 113.422 -170.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -105.0 -20.5 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.235 1.014 . . . . 0.0 112.748 159.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.0 mt -55.46 -39.55 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.334 1.454 . . . . 0.0 112.286 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.83 -6.53 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.03 -55.62 0.56 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-N 119.034 0.834 . . . . 0.0 112.803 158.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.0 mt -74.38 -32.36 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 121.657 -0.908 . . . . 0.0 113.155 -164.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.5 tp -73.79 -43.62 58.36 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.54 167.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -64.31 -29.17 70.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 30.0 tt0 -69.38 -44.8 70.76 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.054 1.742 . . . . 0.0 113.425 168.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.502 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 92.0 mttt -96.76 -8.67 30.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.435 1.094 . . . . 0.0 113.545 -165.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -80.7 141.02 51.39 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 126.35 1.86 . . . . 0.0 109.862 170.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.26 -19.35 25.84 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.153 1.902 . . . . 0.0 115.03 -171.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -79.95 145.34 61.25 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.169 0.895 . . . . 0.0 110.804 171.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -54.86 145.61 60.85 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.939 2.426 . . . . 0.0 115.114 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.6 123.73 11.82 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.779 2.986 . . . . 0.0 113.28 -167.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.56 -5.67 30.82 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.359 -0.838 . . . . 0.0 113.246 164.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.23 -26.49 64.92 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.557 1.543 . . . . 0.0 113.742 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -63.04 114.25 11.89 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 124.044 0.938 . . . . 0.0 110.923 -169.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.5 127.35 6.47 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.084 1.856 . . . . 0.0 112.115 -169.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -73.58 171.94 16.75 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.945 1.763 . . . . 0.0 110.146 152.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -57.7 -28.29 63.7 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.931 -1.106 . . . . 0.0 113.627 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -55.74 -26.38 45.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.651 1.58 . . . . 0.0 114.511 173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.96 72.01 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.479 1.036 . . . . 0.0 112.671 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.6 p -64.9 -34.93 79.56 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.45 0.7 . . . . 0.0 112.453 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 31.4 t -86.76 -39.63 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.158 0.983 . . . . 0.0 112.055 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.79 60.45 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.142 1.353 . . . . 0.0 114.017 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.3 p -63.96 -24.44 67.72 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 171.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -82.44 -45.55 14.63 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.775 1.23 . . . . 0.0 111.873 170.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.9 mt -68.34 -35.16 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.123 0.969 . . . . 0.0 111.401 -172.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.6 -46.71 93.82 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.394 -1.441 . . . . 0.0 114.407 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.14 -31.24 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.193 2.595 . . . . 0.0 114.218 168.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.4 p -70.61 -23.54 62.58 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 121.279 1.854 . . . . 0.0 113.315 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -64.5 -39.09 93.14 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 119.97 -1.706 . . . . 0.0 113.544 161.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.81 -34.85 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 120.878 -1.139 . . . . 0.0 111.253 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -59.63 -52.2 66.54 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.024 1.33 . . . . 0.0 111.262 167.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -60.47 -38.29 83.73 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.703 1.201 . . . . 0.0 112.99 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.27 -24.23 57.53 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -94.48 61.11 2.7 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.325 1.45 . . . . 0.0 110.098 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.8 m -65.1 30.07 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.92 2.488 . . . . 0.0 117.517 -158.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -67.0 -38.28 85.72 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.147 1.379 . . . . 0.0 111.538 159.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -83.09 117.78 69.65 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.563 175.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -54.09 123.29 13.15 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.362 2.041 . . . . 0.0 114.419 -159.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -58.2 -46.62 85.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.276 1.03 . . . . 0.0 112.874 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.6 -23.79 67.53 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.43 -31.41 13.67 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 121.054 -1.029 . . . . 0.0 113.51 170.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 74.1 m -72.06 -28.89 63.63 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.45 1.1 . . . . 0.0 113.09 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 168' ' ' LYS . 79.0 mt-10 -61.65 -43.78 98.22 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.301 1.441 . . . . 0.0 111.817 168.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -66.3 -38.77 88.51 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.581 -0.699 . . . . 0.0 112.171 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.24 -41.84 93.94 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.44 -0.787 . . . . 0.0 112.684 171.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -66.49 -29.9 70.11 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 117.813 -1.089 . . . . 0.0 113.159 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.69 -43.53 97.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.562 1.528 . . . . 0.0 111.623 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -74.07 -31.78 62.99 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -67.97 -46.36 71.58 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.119 -0.988 . . . . 0.0 112.585 170.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.66 -29.73 62.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.845 -1.074 . . . . 0.0 113.026 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -57.21 -46.1 83.22 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.243 1.383 . . . . 0.0 112.195 171.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.1 70.65 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.375 0.67 . . . . 0.0 112.551 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.4 tp -75.73 -54.85 6.3 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.102 0.961 . . . . 0.0 111.278 173.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -66.63 -37.66 85.3 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.604 1.561 . . . . 0.0 113.94 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.38 -35.5 88.72 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.533 -0.593 . . . . 0.0 113.406 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -89.44 -29.42 19.03 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 173.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 21.5 mt -61.63 -38.67 88.51 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.409 1.459 . . . . 0.0 112.475 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -65.48 -5.65 8.39 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.26 -23.17 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.403 1.481 . . . . 0.0 112.292 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -108.45 -22.4 12.32 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -167.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.75 -163.63 34.78 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 121.023 1.738 . . . . 0.0 116.062 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -102.19 -11.0 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.493 3.462 . . . . 0.0 114.518 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -101.76 158.23 16.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.353 1.061 . . . . 0.0 110.833 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.272 6.1 tt -78.27 5.54 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.418 -1.426 . . . . 0.0 113.294 -171.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -106.95 3.46 26.15 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.01 2.124 . . . . 0.0 115.038 159.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.05 -129.77 9.98 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.683 1.611 . . . . 0.0 113.289 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -59.01 -34.98 72.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.542 1.537 . . . . 0.0 113.712 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -129.55 151.48 50.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.255 1.822 . . . . 0.0 109.603 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.46 118.7 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.697 0.799 . . . . 0.0 109.848 162.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.3 p -140.89 -164.44 1.74 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.134 0.974 . . . . 0.0 111.42 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.34 -22.25 1.75 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.77 -36.49 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 120.125 1.329 . . . . 0.0 112.594 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.65 -43.22 97.42 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.383 -1.448 . . . . 0.0 112.468 164.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.2 mt -59.82 -31.74 70.0 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.22 -0.3 . . . . 0.0 111.334 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.1 m -74.57 -57.57 3.84 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.786 0.834 . . . . 0.0 111.979 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.0 mt -96.37 -33.6 11.86 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -159.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.89 -49.93 89.03 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.78 -26.87 18.69 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 120.944 1.373 . . . . 0.0 112.492 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.66 -33.9 64.68 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.772 173.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.52 -40.5 95.74 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.034 0.933 . . . . 0.0 112.388 169.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -63.98 -44.58 92.28 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.438 0.563 . . . . 0.0 112.183 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -63.5 -28.36 69.9 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.486 -0.759 . . . . 0.0 112.804 174.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.5 mt -75.61 -48.76 20.86 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.794 1.238 . . . . 0.0 113.631 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -58.86 -34.5 71.68 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.744 1.156 . . . . 0.0 111.232 177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -86.27 -68.59 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.148 0.979 . . . . 0.0 113.112 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.75 -45.59 35.6 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.056 -1.027 . . . . 0.0 113.229 -166.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 10.8 tp -79.82 -35.36 38.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.167 0.44 . . . . 0.0 111.587 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.19 -25.96 65.31 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.856 1.217 . . . . 0.0 114.992 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -63.0 -34.94 78.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.385 1.074 . . . . 0.0 113.697 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -100.52 -28.88 12.67 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.495 ' HZ3' ' CD ' ' A' ' 120' ' ' GLU . 79.6 tttt -152.77 102.87 2.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.183 1.393 . . . . 0.0 109.641 168.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -72.19 85.56 1.05 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.584 0.754 . . . . 0.0 110.579 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.2 t90 -76.12 110.8 12.13 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.637 1.175 . . . . 0.0 110.477 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.45 130.35 14.88 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.008 1.805 . . . . 0.0 110.795 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 25.9 mt -68.87 119.03 66.74 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.93 157.68 55.53 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.129 1.886 . . . . 0.0 112.843 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.78 -25.59 65.03 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -65.85 -27.71 68.44 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.173 -0.955 . . . . 0.0 113.484 172.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.27 51.29 2.0 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.028 1.731 . . . . 0.0 110.932 170.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -31.93 73.4 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.148 1.379 . . . . 0.0 113.359 -160.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -74.98 -45.13 44.18 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.325 -0.86 . . . . 0.0 110.749 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.74 -39.43 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.358 0.981 . . . . 0.0 111.116 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.08 -49.4 74.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.294 1.437 . . . . 0.0 112.99 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -65.92 -37.09 85.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.513 -0.742 . . . . 0.0 112.826 177.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -63.06 -26.96 69.08 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.385 1.074 . . . . 0.0 113.294 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 42.8 mm -52.41 -37.86 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.794 0.838 . . . . 0.0 112.105 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -82.87 -6.04 59.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.361 -1.462 . . . . 0.0 113.497 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.47 -22.05 51.95 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 161.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.5 mt -62.73 -20.2 64.68 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.054 1.297 . . . . 0.0 113.466 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -91.52 7.25 42.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.05 1.34 . . . . 0.0 112.993 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.3 p -130.42 179.15 6.09 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -159.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 54.5 -160.25 0.16 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.152 1.781 . . . . 0.0 110.622 -167.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.442 ' OE1' ' HE3' ' A' ' 34' ' ' LYS . 16.1 mp0 -81.28 -40.19 24.08 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 125.92 1.688 . . . . 0.0 108.733 156.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -45.04 78.38 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 129.5 3.12 . . . . 0.0 113.908 -164.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -102.97 -38.45 7.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.475 0.71 . . . . 0.0 112.809 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -60.8 -31.33 70.72 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.472 -1.393 . . . . 0.0 113.389 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -78.22 -25.65 47.06 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 44.7 p -89.49 -8.37 53.01 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -52.71 115.65 1.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.252 1.421 . . . . 0.0 110.189 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -99.88 131.94 45.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.083 0.953 . . . . 0.0 111.421 -175.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -49.37 114.29 1.0 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.344 1.058 . . . . 0.0 112.354 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -62.46 -36.35 82.16 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -151.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -61.75 -36.2 80.3 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.073 1.349 . . . . 0.0 112.616 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -80.15 -11.65 59.73 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.42 -44.19 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.173 0.897 . . . . 0.0 109.812 165.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.3 mt -63.92 -57.16 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.146 1.379 . . . . 0.0 111.457 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.31 -28.14 67.74 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.32 -25.33 48.19 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 120.854 -1.154 . . . . 0.0 113.786 174.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -68.01 -37.96 82.05 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.13 1.465 . . . . 0.0 112.395 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -47.61 -55.07 18.26 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -166.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.34 -21.97 66.49 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 CA-C-N 122.352 1.876 . . . . 0.0 113.652 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -88.59 5.34 43.32 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.219 1.808 . . . . 0.0 114.383 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.11 -27.36 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.85 -0.531 . . . . 0.0 110.711 151.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -104.31 -40.4 6.12 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.622 -1.656 . . . . 0.0 113.926 -177.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 118.833 -0.603 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.25 -167.19 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.465 1.106 . . . . 0.0 112.036 -165.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.19 119.59 13.71 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.022 -1.049 . . . . 0.0 111.164 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.08 97.29 3.96 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.147 0.979 . . . . 0.0 109.328 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 mt -76.63 140.18 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.959 1.304 . . . . 0.0 108.715 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.6 m -118.01 137.39 52.91 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 159.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.81 142.38 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.36 1.064 . . . . 0.0 110.577 -161.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.694 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.9 tttm -66.54 129.14 38.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.62 -0.675 . . . . 0.0 109.271 169.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.63 173.62 8.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.54 1.936 . . . . 0.0 112.058 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.09 142.2 31.59 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.075 0.95 . . . . 0.0 111.847 169.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.36 120.98 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 121.007 0.432 . . . . 0.0 110.355 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.14 -10.08 22.59 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.945 1.26 . . . . 0.0 116.229 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.45 79.64 71.93 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 119.694 1.747 . . . . 0.0 111.66 -172.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.39 -11.65 29.31 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.849 3.033 . . . . 0.0 116.531 -170.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -84.69 -4.15 58.89 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.6 pt -143.08 161.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.325 1.45 . . . . 0.0 111.793 -169.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.4 -44.61 51.24 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.09 -123.67 5.84 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.849 1.214 . . . . 0.0 114.577 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.97 13.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.701 2.4 . . . . 0.0 117.192 -173.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.407 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.8 p -114.68 72.75 2.76 Favored Pre-proline 0 C--O 1.261 1.706 0 O-C-N 120.108 -1.62 . . . . 0.0 110.983 -159.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.18 -27.81 41.14 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.824 3.016 . . . . 0.0 112.303 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -63.64 -37.06 85.9 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.791 -1.193 . . . . 0.0 113.114 172.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.694 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -62.97 -41.78 99.64 Favored 'General case' 0 C--N 1.37 1.497 0 O-C-N 120.576 -1.327 . . . . 0.0 110.991 173.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -63.12 -27.99 69.76 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.453 1.101 . . . . 0.0 113.011 -176.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.522 HH12 ' CG ' ' A' ' 74' ' ' ASP . 75.4 mtp180 -58.13 -42.95 86.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.48 1.112 . . . . 0.0 113.145 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.1 t -74.04 -37.09 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.289 1.036 . . . . 0.0 111.441 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.09 -40.01 86.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.756 0.822 . . . . 0.0 111.141 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.23 -42.58 99.44 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -69.98 -41.81 73.94 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.312 1.415 . . . . 0.0 112.476 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.96 -36.19 69.78 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -76.13 -26.55 56.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -68.92 -41.95 77.48 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.585 -1.322 . . . . 0.0 111.87 167.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -70.73 -7.77 47.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.87 1.668 . . . . 0.0 114.243 170.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm 58.88 18.02 5.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.964 2.106 . . . . 0.0 114.707 -177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.7 mt -77.64 133.66 66.52 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.249 1.02 . . . . 0.0 110.13 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.31 146.15 44.81 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.801 2.334 . . . . 0.0 112.666 173.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -148.65 160.24 43.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.931 1.693 . . . . 0.0 110.335 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -85.24 151.6 23.95 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.24 -0.913 . . . . 0.0 109.576 158.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.2 t -134.15 130.53 37.45 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.76 0.824 . . . . 0.0 110.902 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -121.9 87.39 2.74 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.488 1.515 . . . . 0.0 109.508 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.5 mt -68.48 135.0 50.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.939 0.895 . . . . 0.0 111.072 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 60' ' ' VAL . 30.8 mt -131.62 121.83 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.355 1.462 . . . . 0.0 110.262 -174.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -88.1 111.12 21.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 168.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.2 mt 52.21 24.1 2.65 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 168.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.28 19.3 28.49 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.743 -1.032 . . . . 0.0 115.586 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -64.75 11.39 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -140.21 143.56 34.13 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 126.171 1.788 . . . . 0.0 110.504 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.04 161.48 22.33 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.081 2.521 . . . . 0.0 113.135 -167.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.14 -12.51 28.01 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -166.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -50.11 -31.42 13.29 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.107 1.763 . . . . 0.0 115.527 161.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -94.26 3.13 55.65 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.919 1.288 . . . . 0.0 113.901 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.4 mt -128.62 -40.2 1.59 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.121 2.168 . . . . 0.0 113.168 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.72 -16.66 11.69 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 127.961 2.504 . . . . 0.0 113.623 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.9 mt -58.92 -20.78 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 126.974 2.109 . . . . 0.0 111.063 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.5 p -109.56 147.8 36.82 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.921 1.288 . . . . 0.0 110.894 155.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -67.38 -17.62 49.39 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.592 2.195 . . . . 0.0 112.948 171.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.8 -8.91 59.12 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.527 1.531 . . . . 0.0 113.312 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.29 70.35 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 120.73 -1.231 . . . . 0.0 114.73 -172.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -83.46 174.52 10.56 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.405 1.882 . . . . 0.0 112.522 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 62' ' ' VAL . 12.3 m -138.09 152.51 72.01 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 126.565 1.946 . . . . 0.0 109.098 154.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.85 153.27 99.08 Favored 'Cis proline' 0 C--N 1.35 0.624 0 N-CA-C 116.535 1.706 . . . . 0.0 116.535 9.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 60' ' ' VAL . 26.9 m -156.5 167.67 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 128.783 2.833 . . . . 0.0 109.811 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -137.01 140.65 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 O-C-N 120.667 -1.271 . . . . 0.0 114.051 170.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -86.33 108.26 18.35 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.101 1.36 . . . . 0.0 108.739 156.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.9 mt -86.75 76.69 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.304 1.042 . . . . 0.0 109.151 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.6 t70 55.32 53.48 9.89 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.053 0.93 . . . . 0.0 111.819 -162.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.25 15.12 5.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -95.72 107.03 19.21 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.674 -1.266 . . . . 0.0 108.785 167.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -75.5 147.25 39.94 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -159.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -141.14 132.25 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.938 1.695 . . . . 0.0 109.816 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.2 -150.52 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.066 2.146 . . . . 0.0 114.295 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.12 154.1 0.61 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.757 2.023 . . . . 0.0 114.362 -171.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.6 p -54.72 -27.19 38.93 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 25' ' ' ARG . 39.5 m-20 -70.27 -20.19 63.06 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -97.58 -20.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.266 0.939 . . . . 0.0 112.973 167.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.2 mt -62.22 -42.9 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 O-C-N 121.121 -0.987 . . . . 0.0 111.652 170.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -63.48 -6.91 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.53 -58.43 0.55 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.515 1.055 . . . . 0.0 113.382 160.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.32 -31.61 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.404 1.082 . . . . 0.0 113.2 -165.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.05 -43.66 61.67 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.037 -1.039 . . . . 0.0 110.5 167.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -66.09 -27.83 68.36 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 25.0 tt0 -69.7 -45.83 67.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.84 1.656 . . . . 0.0 112.976 167.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.513 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.9 mttt -94.21 -8.36 39.51 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.354 1.062 . . . . 0.0 113.605 -166.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -80.45 141.25 52.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.071 1.748 . . . . 0.0 109.7 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.69 -15.45 27.05 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.018 1.812 . . . . 0.0 114.849 -172.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -84.06 141.15 40.2 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.901 171.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -49.98 142.27 27.31 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.921 3.081 . . . . 0.0 115.208 -173.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.89 118.09 5.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.29 2.66 . . . . 0.0 112.351 -169.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.56 -11.99 48.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.062 0.945 . . . . 0.0 112.774 165.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.01 -24.66 40.43 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.678 1.591 . . . . 0.0 113.645 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.2 m -65.29 116.13 27.91 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.821 0.848 . . . . 0.0 110.532 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.48 125.23 6.81 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.124 1.883 . . . . 0.0 112.513 -170.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.58 174.27 12.91 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.568 2.179 . . . . 0.0 110.288 154.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.23 -34.51 60.85 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.784 -1.198 . . . . 0.0 113.315 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -59.34 -22.88 61.96 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.894 1.678 . . . . 0.0 114.862 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.58 70.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.151 0.887 . . . . 0.0 112.899 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 85.4 p -64.57 -43.77 92.84 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.622 -0.673 . . . . 0.0 112.048 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.44 -39.8 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.265 1.026 . . . . 0.0 111.44 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.44 -24.51 67.7 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.52 1.533 . . . . 0.0 114.332 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.3 p -61.46 -26.02 67.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.451 1.125 . . . . 0.0 113.558 172.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -89.95 -39.98 12.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.638 1.175 . . . . 0.0 113.021 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.29 -32.74 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.587 0.755 . . . . 0.0 111.165 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.53 -49.26 93.09 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 120.551 -1.343 . . . . 0.0 114.015 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.31 -32.37 3.07 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.865 2.377 . . . . 0.0 113.699 168.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.8 p -71.96 -23.84 61.5 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 121.502 1.955 . . . . 0.0 114.043 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -64.94 -41.71 95.27 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 119.75 -1.844 . . . . 0.0 113.272 161.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.45 -33.88 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 121.063 -1.023 . . . . 0.0 111.126 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -61.37 -49.17 78.0 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.555 1.142 . . . . 0.0 111.634 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.13 -38.92 88.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.203 1.001 . . . . 0.0 112.156 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.2 mt -73.03 -7.61 52.03 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -116.91 58.73 0.77 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.797 2.039 . . . . 0.0 110.362 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.3 m -65.72 29.14 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.086 2.954 . . . . 0.0 117.572 -158.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 211' ' ' ASN . 93.0 mttt -64.98 -38.04 89.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.39 1.076 . . . . 0.0 111.959 161.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -90.4 131.27 38.85 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.772 -1.108 . . . . 0.0 108.324 170.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -58.13 135.52 68.94 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.263 1.975 . . . . 0.0 114.668 -161.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -61.72 -51.31 68.9 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.475 1.11 . . . . 0.0 112.591 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -23.24 64.71 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.97 -35.55 8.96 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 121.41 -0.806 . . . . 0.0 113.589 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.1 m -74.1 -26.22 60.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.404 -1.056 . . . . 0.0 112.847 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -62.19 -44.89 95.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.634 1.574 . . . . 0.0 111.545 164.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.41 -33.05 73.54 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.522 -0.737 . . . . 0.0 112.821 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.71 85.88 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.559 -0.713 . . . . 0.0 112.308 168.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.2 mt -64.64 -30.39 71.41 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.022 -0.989 . . . . 0.0 112.886 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.23 -35.19 76.55 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.336 1.425 . . . . 0.0 112.411 170.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -77.88 -38.87 44.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.484 1.038 . . . . 0.0 112.388 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -70.67 -41.44 72.07 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.602 -1.311 . . . . 0.0 113.167 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.5 mt -74.26 -25.94 59.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 117.416 -1.278 . . . . 0.0 112.532 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -58.84 -47.08 86.13 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 120.875 1.671 . . . . 0.0 112.262 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.92 66.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.838 0.855 . . . . 0.0 113.056 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 tp -83.8 -56.12 3.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.693 1.197 . . . . 0.0 111.445 174.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.07 -36.03 81.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.875 1.67 . . . . 0.0 113.992 -165.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.91 -34.64 89.49 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.681 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -90.36 -26.66 19.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.839 0.856 . . . . 0.0 113.15 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.2 mt -62.5 -38.86 91.56 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.245 0.93 . . . . 0.0 111.926 174.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -65.75 -2.05 3.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.13 -28.41 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.105 1.362 . . . . 0.0 112.491 171.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -86.6 -54.83 4.17 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 164.3 175.37 35.07 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.238 -0.914 . . . . 0.0 115.274 -169.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.89 -7.84 14.41 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.581 3.521 . . . . 0.0 115.783 -160.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -98.98 164.52 12.15 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.891 -1.131 . . . . 0.0 111.306 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.252 9.2 tt -78.78 -0.95 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 120.292 -1.505 . . . . 0.0 113.081 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -99.67 -4.92 29.81 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.49 1.916 . . . . 0.0 115.078 160.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.98 -129.76 9.55 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 120.287 1.403 . . . . 0.0 113.785 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.06 -24.23 65.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.65 1.58 . . . . 0.0 114.58 -172.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -130.73 151.77 50.81 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 126.588 1.955 . . . . 0.0 109.554 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 76.5 mt -67.38 119.66 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.997 0.919 . . . . 0.0 109.541 162.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.1 p -137.45 -166.66 1.98 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.168 1.387 . . . . 0.0 112.667 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.75 -20.34 3.11 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.834 1.654 . . . . 0.0 114.65 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.56 -38.1 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.062 1.301 . . . . 0.0 111.898 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.0 -42.58 94.36 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.332 -1.48 . . . . 0.0 112.045 165.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.9 mt -64.18 -15.81 60.64 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.0 m -95.53 -50.38 5.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.503 1.521 . . . . 0.0 112.491 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.5 mt -100.26 -34.15 10.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.299 1.44 . . . . 0.0 114.159 -164.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.63 90.08 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -170.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.93 -24.32 17.71 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 CA-C-N 120.714 1.291 . . . . 0.0 112.942 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.77 -33.46 66.32 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 117.775 -1.107 . . . . 0.0 112.334 173.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.78 -41.9 95.49 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.517 0.727 . . . . 0.0 112.637 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.66 -46.7 87.0 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.766 0.794 . . . . 0.0 111.929 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -64.81 -27.74 69.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.787 0.835 . . . . 0.0 112.889 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.31 -49.97 24.65 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.311 1.044 . . . . 0.0 113.33 170.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.96 -34.28 71.61 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.949 0.795 . . . . 0.0 111.694 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.32 -68.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.69 0.796 . . . . 0.0 112.86 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.73 -46.49 37.06 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.106 -0.996 . . . . 0.0 113.195 -161.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 19.5 tp -79.84 -32.34 40.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 119.247 -0.406 . . . . 0.0 111.649 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.89 -28.29 65.74 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.641 1.115 . . . . 0.0 114.946 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -61.11 -32.11 71.79 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.88 -28.91 11.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.975 0.91 . . . . 0.0 113.087 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -153.23 98.51 2.28 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.667 1.587 . . . . 0.0 109.612 169.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.41 84.14 0.8 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.548 0.739 . . . . 0.0 110.706 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 44.1 t90 -77.2 106.73 3.9 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.972 1.309 . . . . 0.0 110.169 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.23 134.6 25.25 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.649 1.566 . . . . 0.0 109.959 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.8 mm -65.49 117.2 38.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.078 -0.963 . . . . 0.0 108.652 166.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.69 159.35 45.64 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.068 1.846 . . . . 0.0 112.782 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -23.96 65.8 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.361 1.465 . . . . 0.0 114.439 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -66.12 -33.58 76.1 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.012 -1.055 . . . . 0.0 113.019 171.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.8 mt -86.85 48.42 1.64 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.595 1.958 . . . . 0.0 111.025 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -31.5 70.04 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.238 1.415 . . . . 0.0 112.613 -167.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -77.93 -42.04 34.4 Favored 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.643 -0.661 . . . . 0.0 112.366 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.1 -38.89 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.615 0.766 . . . . 0.0 110.734 174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.7 tp -61.19 -47.96 83.75 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.771 1.228 . . . . 0.0 113.182 172.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -68.86 -40.31 79.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.571 -0.706 . . . . 0.0 112.794 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -64.0 -31.21 72.32 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.589 1.156 . . . . 0.0 112.892 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.6 mt -55.47 -32.03 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 O-C-N 121.515 -0.74 . . . . 0.0 112.014 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -83.4 -10.61 58.32 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.089 -1.632 . . . . 0.0 114.243 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.79 -20.07 60.58 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.058 -1.026 . . . . 0.0 113.596 161.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.46 -16.41 62.38 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.623 1.102 . . . . 0.0 113.836 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -92.94 6.54 47.45 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.634 1.574 . . . . 0.0 112.577 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 p -131.7 -179.04 5.14 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -159.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 55.61 -162.01 0.16 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.066 1.746 . . . . 0.0 109.889 -166.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -80.48 -36.52 33.31 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.386 153.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -42.36 83.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 128.633 2.773 . . . . 0.0 114.327 -164.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -105.05 -34.97 7.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -55.51 -34.75 64.91 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.128 1.371 . . . . 0.0 113.359 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -79.75 -21.22 44.74 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 60.0 p -93.42 -12.67 29.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -51.05 117.67 2.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.883 1.273 . . . . 0.0 109.926 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -99.41 140.83 33.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.046 0.938 . . . . 0.0 111.59 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.4 119.92 6.34 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.978 1.311 . . . . 0.0 111.792 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -68.1 -41.57 81.61 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.265 1.426 . . . . 0.0 114.082 -149.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.1 -36.62 80.17 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.837 1.255 . . . . 0.0 112.926 171.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -78.2 -10.48 59.66 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.3 -47.28 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.9 1.227 . . . . 0.0 110.452 160.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.63 -57.15 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.017 1.327 . . . . 0.0 111.737 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.72 -25.7 64.89 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.75 -27.72 37.5 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.006 -1.059 . . . . 0.0 113.477 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 40.6 t90 -68.91 -39.8 79.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.901 1.351 . . . . 0.0 112.371 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -44.11 -56.32 7.97 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -166.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.35 -21.72 60.84 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 CA-C-N 122.206 1.823 . . . . 0.0 113.781 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -84.18 3.33 35.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.693 1.597 . . . . 0.0 114.187 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 2.2 p -60.22 -25.44 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.4 0.546 . . . . 0.0 111.226 154.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.509 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 17.5 m-80 -104.01 -37.0 7.54 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.359 -1.782 . . . . 0.0 115.277 -159.382 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.08 -160.61 0.1 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.564 0.745 . . . . 0.0 111.718 -168.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.1 123.56 22.4 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.327 -0.858 . . . . 0.0 110.629 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -130.78 103.2 6.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.375 1.07 . . . . 0.0 108.369 168.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.4 mt -75.03 139.83 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 m -118.37 137.33 53.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 158.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.25 142.39 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.911 -1.118 . . . . 0.0 110.542 -159.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.682 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 35.0 tttm -67.83 126.61 29.96 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.357 170.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.02 175.61 8.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.003 1.721 . . . . 0.0 111.845 170.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.39 141.96 28.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.852 0.861 . . . . 0.0 111.673 167.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.9 t -54.35 119.8 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.073 0.463 . . . . 0.0 110.15 168.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.65 -13.06 31.27 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 116.339 1.296 . . . . 0.0 116.339 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.35 83.15 63.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.902 1.851 . . . . 0.0 112.011 -172.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.21 -10.65 26.65 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.713 2.942 . . . . 0.0 116.266 -171.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -83.1 -6.9 59.66 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 pt -142.92 161.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.186 1.394 . . . . 0.0 111.578 -167.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.42 -41.0 61.63 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.01 -125.51 6.63 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.729 1.157 . . . . 0.0 114.622 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.43 14.29 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.118 2.567 . . . . 0.0 116.92 -171.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.459 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 68.7 m -115.02 76.39 4.44 Favored Pre-proline 0 C--O 1.257 1.476 0 O-C-N 120.052 -1.655 . . . . 0.0 110.974 -158.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.23 -28.15 40.5 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.535 2.824 . . . . 0.0 112.113 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -64.83 -37.36 87.34 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.231 -0.918 . . . . 0.0 113.159 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.3 m -62.45 -40.03 95.3 Favored 'General case' 0 C--N 1.364 1.205 0 O-C-N 119.659 -1.901 . . . . 0.0 110.986 172.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -66.01 -27.7 68.32 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.199 1.0 . . . . 0.0 112.753 -176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -58.01 -43.51 86.73 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.509 1.123 . . . . 0.0 112.761 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 t -73.92 -38.5 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.808 1.243 . . . . 0.0 111.826 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.0 mt -66.91 -39.59 87.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.57 0.748 . . . . 0.0 111.405 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.85 -41.45 99.37 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.052 0.941 . . . . 0.0 113.268 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 p -70.26 -43.66 70.04 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.772 1.169 . . . . 0.0 112.397 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.69 -35.01 72.57 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -77.59 -23.25 49.96 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 172.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -71.2 -43.04 68.19 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.472 -1.393 . . . . 0.0 112.005 166.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -70.69 -8.15 49.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.702 1.601 . . . . 0.0 114.291 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 59.09 16.14 4.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 127.065 2.146 . . . . 0.0 114.64 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.58 128.81 73.65 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.397 1.079 . . . . 0.0 109.799 -176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.58 155.74 44.97 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.981 2.454 . . . . 0.0 113.258 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -152.32 159.16 43.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.128 1.771 . . . . 0.0 110.165 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -77.41 151.06 34.95 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.991 -1.068 . . . . 0.0 109.482 152.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.9 t -127.81 126.61 42.03 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.772 0.829 . . . . 0.0 110.713 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -117.91 83.38 1.99 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.521 1.529 . . . . 0.0 109.161 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.7 mt -65.6 135.51 55.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.506 0.723 . . . . 0.0 110.804 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.459 HG22 ' H ' ' A' ' 45' ' ' GLY . 10.8 mt -130.12 120.13 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.533 1.533 . . . . 0.0 110.004 -174.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -84.47 103.58 13.74 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.606 -0.684 . . . . 0.0 109.394 167.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt 54.89 15.18 1.06 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 168.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.459 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 111.67 17.23 8.72 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.779 1.18 . . . . 0.0 115.343 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -65.4 12.19 0.05 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 120.036 1.918 . . . . 0.0 116.167 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -139.93 143.95 36.45 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 126.084 1.753 . . . . 0.0 109.909 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.88 163.29 19.49 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.889 2.393 . . . . 0.0 112.516 -167.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -64.43 -11.84 37.32 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 116.798 -1.572 . . . . 0.0 115.077 -167.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -55.53 -22.35 21.06 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 163.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -101.93 2.63 38.2 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.443 1.497 . . . . 0.0 113.302 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.8 mt -126.81 -38.08 2.08 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.112 2.165 . . . . 0.0 112.843 -171.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.25 -17.57 20.29 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.865 2.466 . . . . 0.0 113.324 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.78 -20.5 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 127.156 2.182 . . . . 0.0 111.322 171.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 93.9 p -116.14 137.41 23.42 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.142 1.377 . . . . 0.0 111.499 158.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.99 -25.22 38.49 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.582 2.188 . . . . 0.0 113.039 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.7 pm0 -71.99 -8.27 53.54 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.295 1.038 . . . . 0.0 113.7 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.64 51.29 48.65 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.832 1.196 . . . . 0.0 112.973 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -131.64 174.22 10.34 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.251 2.22 . . . . 0.0 110.877 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG12 HG22 ' A' ' 62' ' ' VAL . 23.5 m -140.57 152.6 66.68 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.752 1.621 . . . . 0.0 108.284 163.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -66.09 156.21 80.38 Favored 'Cis proline' 0 C--N 1.348 0.511 0 N-CA-C 116.845 1.825 . . . . 0.0 116.845 11.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG22 HG12 ' A' ' 60' ' ' VAL . 31.2 m -158.08 167.49 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 128.577 2.751 . . . . 0.0 109.027 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.05 148.67 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 120.92 -1.113 . . . . 0.0 113.293 166.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -90.54 140.86 29.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.476 153.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.9 mt -116.93 72.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 126.734 2.014 . . . . 0.0 108.039 170.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.2 t70 57.31 61.12 2.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.112 1.365 . . . . 0.0 112.19 -165.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.307 5.2 m-20 57.96 9.82 1.01 Allowed 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 -175.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -88.85 120.86 30.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.578 1.151 . . . . 0.0 108.316 163.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -87.99 152.18 22.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -164.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -143.34 133.84 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.888 2.075 . . . . 0.0 109.206 171.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.07 -147.9 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.857 2.063 . . . . 0.0 113.641 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -50.29 159.37 0.47 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -170.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 p -39.42 -40.71 0.86 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.849 2.06 . . . . 0.0 115.341 166.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -15.14 60.75 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.1 m -103.33 -22.52 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.75 0.704 . . . . 0.0 112.86 165.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.7 mt -59.55 -42.38 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.483 1.113 . . . . 0.0 111.872 170.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.2 m -62.68 -8.16 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.04 -58.38 0.56 Allowed Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.4 1.0 . . . . 0.0 113.297 159.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.55 -32.25 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.777 1.231 . . . . 0.0 113.313 -164.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 tp -73.39 -45.36 55.24 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.998 -1.064 . . . . 0.0 110.315 167.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.92 -30.33 71.43 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 18.8 tt0 -66.11 -46.2 78.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.128 1.771 . . . . 0.0 112.943 168.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.8 mttt -90.73 -9.35 47.02 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.716 1.206 . . . . 0.0 113.336 -169.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -76.06 140.59 70.14 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.011 1.724 . . . . 0.0 110.106 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.68 -11.99 22.17 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.946 1.764 . . . . 0.0 115.057 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -87.6 151.18 50.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.825 1.193 . . . . 0.0 111.056 164.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.48 144.42 18.67 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.652 2.902 . . . . 0.0 114.904 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.44 126.35 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.054 2.503 . . . . 0.0 112.285 -172.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.1 mt -67.02 -10.43 49.69 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 163.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.14 -21.57 47.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.697 1.599 . . . . 0.0 114.092 169.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.9 m -63.75 114.56 13.83 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 123.846 0.858 . . . . 0.0 110.245 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.17 127.44 7.58 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.014 1.809 . . . . 0.0 112.226 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.2 175.16 11.62 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.43 2.087 . . . . 0.0 110.143 154.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -56.12 -31.91 63.73 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.568 -1.333 . . . . 0.0 113.507 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -59.31 -21.09 59.21 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.445 1.498 . . . . 0.0 114.648 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.99 73.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.843 1.201 . . . . 0.0 112.593 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 79.9 p -64.48 -41.33 96.53 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.607 -0.683 . . . . 0.0 112.098 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.96 -42.0 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.812 1.245 . . . . 0.0 111.557 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.04 -23.29 65.78 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.725 1.631 . . . . 0.0 114.522 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -61.99 -24.55 67.1 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -85.8 -44.28 12.61 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.571 1.148 . . . . 0.0 112.427 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.1 mt -67.12 -37.75 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 111.262 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -58.94 -46.64 99.52 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.533 -1.223 . . . . 0.0 114.023 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.94 -29.96 1.9 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.8 2.333 . . . . 0.0 114.172 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.2 p -70.86 -28.65 64.73 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 121.673 2.033 . . . . 0.0 113.542 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -58.6 -39.64 80.97 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.58 -1.325 . . . . 0.0 112.847 162.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.3 -29.81 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.188 -0.945 . . . . 0.0 111.627 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -68.04 -43.8 77.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.768 0.827 . . . . 0.0 111.84 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -65.34 -31.44 72.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.286 1.034 . . . . 0.0 112.843 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.9 mt -82.21 6.79 15.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.44 1.896 . . . . 0.0 114.113 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -132.8 54.81 1.93 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.6 1.96 . . . . 0.0 110.422 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -61.65 16.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 129.768 3.227 . . . . 0.0 118.405 -155.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -62.32 -42.69 99.59 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.765 -1.209 . . . . 0.0 110.911 166.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 54.6 m-20 -84.6 128.7 60.19 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.93 -1.033 . . . . 0.0 108.469 174.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 89.4 Cg_exo -60.92 129.99 31.08 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 120.911 1.361 . . . . 0.0 115.511 -153.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -68.91 -39.7 79.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 117.542 -1.218 . . . . 0.0 113.785 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -59.72 -30.45 68.83 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.66 -34.22 11.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.145 0.879 . . . . 0.0 113.666 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 51.0 m -68.65 -27.58 66.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.216 1.006 . . . . 0.0 112.139 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -62.49 -41.17 98.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.136 1.374 . . . . 0.0 112.29 167.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -69.8 -36.09 75.39 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.268 -0.895 . . . . 0.0 112.261 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.2 97.71 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.244 -0.91 . . . . 0.0 112.149 171.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.0 mt -67.71 -31.88 72.13 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.728 -1.129 . . . . 0.0 113.001 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.27 -45.26 95.23 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.664 1.574 . . . . 0.0 111.553 172.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -72.12 -34.71 68.8 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.766 1.166 . . . . 0.0 113.086 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -68.71 -40.41 79.99 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.264 -0.898 . . . . 0.0 112.655 173.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.9 -27.6 39.96 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.061 -1.024 . . . . 0.0 113.47 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -59.29 -41.88 89.98 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.373 1.442 . . . . 0.0 111.935 171.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.78 -24.79 67.01 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -82.35 -54.54 5.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.032 1.333 . . . . 0.0 111.587 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.44 -36.42 76.62 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -158.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.28 -35.65 92.23 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.017 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -83.6 -27.44 29.19 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.816 0.846 . . . . 0.0 112.959 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.04 -40.55 98.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.007 0.822 . . . . 0.0 111.767 172.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -62.97 -9.53 10.27 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.62 -35.33 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.347 1.059 . . . . 0.0 112.328 171.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -86.54 -55.26 3.96 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.76 177.56 34.93 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 -171.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.69 -7.72 17.75 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.919 3.746 . . . . 0.0 116.172 -158.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.47 167.46 11.14 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.637 1.108 . . . . 0.0 111.506 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.25 9.6 tt -78.22 4.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.359 -1.463 . . . . 0.0 112.792 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -108.83 -0.1 20.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.316 2.246 . . . . 0.0 114.721 163.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.15 -130.94 10.39 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.915 1.234 . . . . 0.0 113.751 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -26.61 67.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.67 1.588 . . . . 0.0 114.395 -170.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -127.41 151.83 48.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.178 1.791 . . . . 0.0 110.142 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.75 129.39 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.676 -0.64 . . . . 0.0 109.908 161.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.6 p -137.8 -170.76 2.84 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.821 1.248 . . . . 0.0 112.005 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.13 -16.95 3.47 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 173.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.1 t -72.78 -41.01 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.598 1.09 . . . . 0.0 111.819 171.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.59 -42.51 95.53 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.589 -1.319 . . . . 0.0 112.392 166.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.0 mt -61.26 -18.0 56.25 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 175.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.2 m -99.44 -46.32 5.53 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.445 1.098 . . . . 0.0 112.371 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.3 mt -96.55 -36.01 10.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.17 -47.64 94.15 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -171.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.21 -24.75 16.53 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 121.024 1.401 . . . . 0.0 112.954 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -72.14 -33.85 68.08 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 117.905 -1.045 . . . . 0.0 112.308 172.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.7 mt -65.65 -41.27 92.75 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.803 0.841 . . . . 0.0 112.912 168.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -62.19 -47.02 86.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.867 0.758 . . . . 0.0 112.101 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -64.61 -27.58 69.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.86 0.864 . . . . 0.0 112.817 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.45 -51.02 22.06 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.535 1.134 . . . . 0.0 113.479 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.3 -32.16 70.96 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.269 0.94 . . . . 0.0 111.744 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.5 -68.76 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.633 0.773 . . . . 0.0 112.913 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.19 -47.05 38.17 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.098 -1.001 . . . . 0.0 113.435 -161.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 52.4 tp -81.82 -33.31 30.8 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.721 175.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.38 -26.81 64.67 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.41 1.005 . . . . 0.0 114.555 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -59.86 -33.73 72.19 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 169.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -102.93 -29.42 11.43 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.029 0.932 . . . . 0.0 113.394 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -152.03 98.77 2.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.286 1.434 . . . . 0.0 109.266 168.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -72.81 78.55 1.13 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.646 0.778 . . . . 0.0 110.78 171.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -70.4 115.55 36.02 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.012 0.925 . . . . 0.0 110.109 175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.53 124.6 10.45 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.639 1.559 . . . . 0.0 110.048 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.1 mt -62.27 115.15 14.38 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 163.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.28 157.23 55.23 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.547 1.498 . . . . 0.0 112.676 -170.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -25.1 62.22 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.714 1.606 . . . . 0.0 113.707 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -67.29 -36.38 81.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.19 1.396 . . . . 0.0 113.101 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.71 49.56 1.21 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.135 1.774 . . . . 0.0 110.824 164.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -37.12 70.53 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.032 1.733 . . . . 0.0 112.339 -166.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -80.73 -41.01 24.28 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.803 0.841 . . . . 0.0 111.961 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.67 -40.62 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.595 0.758 . . . . 0.0 110.753 171.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.0 tp -62.85 -49.13 76.08 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.872 1.269 . . . . 0.0 112.997 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -65.92 -37.12 85.23 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.545 -0.722 . . . . 0.0 112.715 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -62.17 -27.59 69.07 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.122 0.969 . . . . 0.0 113.266 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 42.0 mm -53.15 -37.61 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.319 -0.863 . . . . 0.0 111.994 170.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -83.24 -7.13 59.65 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.701 -1.249 . . . . 0.0 113.48 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 47.7 mt -75.67 -22.46 56.7 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 117.874 -1.06 . . . . 0.0 113.454 160.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.89 -19.76 66.08 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.956 1.253 . . . . 0.0 113.654 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -88.25 4.94 43.99 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.807 -1.183 . . . . 0.0 113.906 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -134.33 -176.63 4.27 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -158.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.4 mtp85 54.78 -161.64 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.637 1.575 . . . . 0.0 109.914 -162.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.42 -38.42 24.08 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.783 1.233 . . . . 0.0 108.468 156.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.89 -52.93 58.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 129.542 3.137 . . . . 0.0 113.531 -167.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -97.48 -35.03 10.78 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -57.63 -32.43 67.24 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.69 -1.256 . . . . 0.0 113.105 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -80.81 -21.68 40.67 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.1 p -89.08 -13.23 39.09 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -52.64 110.11 0.48 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.923 1.289 . . . . 0.0 110.523 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -92.45 136.41 33.23 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.866 0.866 . . . . 0.0 111.763 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.5 121.28 8.67 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.712 1.205 . . . . 0.0 112.36 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.5 mp0 -70.21 -39.95 74.84 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -144.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -60.91 -35.31 76.35 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.625 1.17 . . . . 0.0 112.355 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -79.58 -12.65 59.84 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.19 -44.09 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.897 166.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.1 mt -63.63 -57.68 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.955 1.302 . . . . 0.0 111.182 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.05 -24.85 66.03 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -86.34 -27.78 29.46 Favored Glycine 0 CA--C 1.536 1.356 0 O-C-N 120.938 -1.101 . . . . 0.0 113.562 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 50.5 t90 -69.97 -41.4 74.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.242 1.521 . . . . 0.0 112.471 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -43.05 -56.86 5.78 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -167.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.75 -23.07 56.25 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 CA-C-N 122.21 1.825 . . . . 0.0 113.92 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -81.87 4.47 22.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.344 1.458 . . . . 0.0 113.895 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.9 p -63.08 -19.5 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.253 0.478 . . . . 0.0 111.905 159.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -125.63 -31.06 3.0 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.083 1.353 . . . . 0.0 113.878 170.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 CA-C-O 115.75 -2.071 . . . . 0.0 114.321 176.158 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.72 -164.06 0.08 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.025 0.93 . . . . 0.0 111.872 -169.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 78.5 mt -69.67 119.27 13.66 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.723 -1.236 . . . . 0.0 111.132 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -128.5 91.58 3.27 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.539 1.161 . . . . 0.0 109.159 173.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 30' ' ' LEU . 54.9 mt -68.38 138.37 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 124.945 1.298 . . . . 0.0 108.312 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.0 m -123.98 133.47 53.68 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 165.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.53 141.93 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 121.011 -1.056 . . . . 0.0 110.977 -158.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.693 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.4 tttm -65.55 126.36 28.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 170.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.03 173.77 10.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.851 1.661 . . . . 0.0 111.663 169.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.07 142.48 19.95 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.616 0.766 . . . . 0.0 111.604 168.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.07 120.88 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 166.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.89 -16.62 31.2 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.069 1.319 . . . . 0.0 116.144 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.22 87.51 50.78 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 119.757 1.779 . . . . 0.0 112.095 -171.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.03 -4.78 10.84 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.022 3.148 . . . . 0.0 115.715 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -92.23 -6.84 49.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.929 1.291 . . . . 0.0 114.286 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.44 163.84 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.111 1.365 . . . . 0.0 111.701 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.11 -40.44 31.07 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -175.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.88 -124.59 6.07 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.912 1.244 . . . . 0.0 114.725 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -65.56 15.43 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.115 2.566 . . . . 0.0 116.67 -173.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.428 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 68.7 m -116.36 72.76 5.16 Favored Pre-proline 0 C--O 1.259 1.562 0 O-C-N 120.207 -1.558 . . . . 0.0 110.972 -160.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -66.08 -30.66 47.01 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.474 2.783 . . . . 0.0 111.935 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -61.81 -35.96 79.74 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.233 -0.917 . . . . 0.0 113.27 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.693 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.6 m -65.24 -41.9 93.86 Favored 'General case' 0 C--N 1.37 1.47 0 O-C-N 120.101 -1.624 . . . . 0.0 111.003 172.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -63.91 -27.88 69.45 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.274 1.03 . . . . 0.0 112.687 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.569 HH12 ' CG ' ' A' ' 74' ' ' ASP . 72.4 mtp180 -56.52 -43.2 79.59 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.717 1.207 . . . . 0.0 112.779 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 t -74.99 -35.78 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.889 1.276 . . . . 0.0 112.005 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.81 -40.35 83.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.306 0.642 . . . . 0.0 111.236 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.09 -44.56 96.4 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.5 p -71.66 -37.84 70.74 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.284 1.402 . . . . 0.0 112.877 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.401 HD12 HD11 ' A' ' 5' ' ' ILE . 91.5 mt -71.8 -32.16 67.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.629 0.772 . . . . 0.0 112.853 177.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -76.6 -29.8 56.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -42.79 77.64 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.285 -1.51 . . . . 0.0 111.652 167.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -69.68 -9.2 53.38 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.925 -1.109 . . . . 0.0 113.408 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 mttp 58.14 26.36 13.62 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.286 2.234 . . . . 0.0 113.107 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -85.51 133.96 41.09 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.823 1.649 . . . . 0.0 110.159 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.15 148.25 49.83 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.943 2.428 . . . . 0.0 113.161 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -148.59 162.78 38.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.371 1.468 . . . . 0.0 111.724 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -86.0 150.87 24.17 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.906 -1.121 . . . . 0.0 109.639 152.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.1 t -135.39 111.27 9.42 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.862 0.865 . . . . 0.0 110.558 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -100.69 86.72 3.17 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.033 1.733 . . . . 0.0 109.111 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.97 132.8 49.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.339 0.656 . . . . 0.0 110.664 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 45' ' ' GLY . 7.1 mt -128.0 117.49 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.588 1.555 . . . . 0.0 110.119 -174.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -81.97 99.85 9.35 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.493 -0.754 . . . . 0.0 109.217 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.9 mt 53.85 25.8 5.58 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 168.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 105.09 15.01 21.2 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-O 118.614 -1.103 . . . . 0.0 115.744 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.32 12.18 0.05 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -140.17 146.08 44.55 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 125.842 1.657 . . . . 0.0 110.609 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -60.78 157.58 37.18 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.975 2.45 . . . . 0.0 112.799 -168.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -64.12 -12.85 43.44 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -168.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -51.6 -26.77 9.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.61 1.964 . . . . 0.0 115.863 161.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -100.24 3.53 43.64 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.694 1.598 . . . . 0.0 113.874 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.5 mt -124.81 -41.07 2.14 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.304 2.242 . . . . 0.0 112.887 -171.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -58.76 -16.33 16.3 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.526 2.33 . . . . 0.0 113.608 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.8 mt -58.05 -21.65 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 127.044 2.137 . . . . 0.0 111.173 171.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.1 p -111.52 147.41 36.66 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.037 0.935 . . . . 0.0 111.338 155.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.26 -12.68 35.71 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.887 2.391 . . . . 0.0 113.065 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.4 -13.97 59.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.412 1.485 . . . . 0.0 113.339 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.38 13.86 61.14 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.002 -1.062 . . . . 0.0 114.195 -166.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -88.4 167.43 13.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.506 1.522 . . . . 0.0 111.402 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.547 HG12 HG22 ' A' ' 62' ' ' VAL . 25.0 m -133.49 152.33 78.97 Favored Pre-proline 0 N--CA 1.469 0.498 0 C-N-CA 125.915 1.686 . . . . 0.0 109.207 157.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.32 151.83 63.99 Favored 'Cis proline' 0 C--N 1.35 0.632 0 N-CA-C 117.378 2.03 . . . . 0.0 117.378 10.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.547 HG22 HG12 ' A' ' 60' ' ' VAL . 29.1 m -158.87 171.44 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 129.264 3.026 . . . . 0.0 110.196 174.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.61 141.64 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 120.791 -1.193 . . . . 0.0 113.514 165.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -84.58 121.38 27.53 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.903 0.881 . . . . 0.0 108.74 153.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.2 mt -98.82 79.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.737 1.215 . . . . 0.0 108.652 170.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 55.55 53.41 9.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.279 1.032 . . . . 0.0 112.152 -165.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.81 14.09 3.06 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -174.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -94.99 109.93 21.89 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.428 -1.42 . . . . 0.0 108.56 166.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -77.8 147.31 35.32 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -160.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.35 132.28 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.902 1.681 . . . . 0.0 108.846 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.57 -142.15 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.972 1.709 . . . . 0.0 113.029 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.43 169.05 2.43 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -164.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.0 p -50.45 -39.73 48.53 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.569 ' CG ' HH12 ' A' ' 25' ' ' ARG . 7.4 m-20 -72.87 -22.38 60.78 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.51 1.505 . . . . 0.0 113.156 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -92.49 -24.03 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.962 -1.086 . . . . 0.0 113.818 165.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.1 mt -61.8 -42.87 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.123 1.329 . . . . 0.0 111.487 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.93 -7.08 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.66 -59.56 0.63 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.637 1.113 . . . . 0.0 113.36 159.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.0 mt -75.18 -33.34 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.677 1.191 . . . . 0.0 113.476 -164.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.08 -42.58 66.01 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.827 -1.171 . . . . 0.0 110.207 168.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -65.28 -28.88 69.64 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 22.4 tt0 -69.41 -43.86 72.57 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.995 2.118 . . . . 0.0 113.088 168.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 95.5 mttt -94.03 -7.15 43.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.481 1.112 . . . . 0.0 113.695 -168.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -77.22 141.38 66.63 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.978 1.311 . . . . 0.0 110.082 171.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -68.21 -26.34 36.09 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 121.918 1.746 . . . . 0.0 113.815 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -82.24 142.64 47.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 118.941 0.791 . . . . 0.0 110.79 172.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -53.74 150.84 27.59 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.561 2.841 . . . . 0.0 116.325 -166.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.08 118.95 5.89 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.087 2.524 . . . . 0.0 112.523 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.1 mt -67.61 -10.91 56.34 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.85 1.26 . . . . 0.0 112.504 162.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.99 -21.87 33.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.75 1.62 . . . . 0.0 113.922 165.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -61.17 114.47 10.75 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 124.01 0.924 . . . . 0.0 110.226 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.05 125.58 7.33 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.159 1.906 . . . . 0.0 112.304 -168.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -76.34 174.64 12.49 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.505 2.137 . . . . 0.0 110.216 156.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -54.52 -34.93 62.59 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.862 -1.149 . . . . 0.0 113.235 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -58.26 -21.06 46.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.099 1.759 . . . . 0.0 114.844 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.82 -30.37 71.43 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 120.263 1.392 . . . . 0.0 112.87 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.9 p -67.5 -15.65 63.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.622 1.169 . . . . 0.0 114.061 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.0 t -111.91 -39.84 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.222 1.409 . . . . 0.0 111.679 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.82 -24.01 67.88 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.198 1.38 . . . . 0.0 114.434 175.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.5 p -66.11 -19.6 65.89 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -85.99 -43.03 13.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.478 1.111 . . . . 0.0 112.329 166.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.2 mt -68.55 -34.68 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.375 0.67 . . . . 0.0 111.544 -174.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.41 -45.77 97.46 Favored Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 120.319 -1.488 . . . . 0.0 114.068 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.59 -22.23 4.68 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.161 2.574 . . . . 0.0 114.712 168.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.1 p -75.6 -26.53 57.93 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.856 2.116 . . . . 0.0 114.289 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -60.65 -39.33 87.92 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.136 -0.978 . . . . 0.0 112.582 159.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.37 -38.86 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 119.516 1.053 . . . . 0.0 111.752 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -62.85 -45.77 91.01 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.159 0.891 . . . . 0.0 112.042 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -68.66 -30.12 68.74 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.251 1.02 . . . . 0.0 113.307 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.7 mt -82.82 -2.34 54.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.381 1.873 . . . . 0.0 114.082 168.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -122.32 56.95 1.09 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.937 1.695 . . . . 0.0 109.687 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 m -66.43 24.49 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.042 2.937 . . . . 0.0 116.301 -161.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -68.09 -29.78 68.8 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.282 1.033 . . . . 0.0 111.377 152.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.36 141.16 93.26 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.785 160.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -68.11 98.22 0.52 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.015 1.81 . . . . 0.0 112.687 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -51.85 -42.34 62.53 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -171.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -22.36 66.74 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.978 1.263 . . . . 0.0 114.189 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.01 -32.6 9.69 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.52 1.057 . . . . 0.0 113.599 168.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.8 m -62.25 -31.63 72.22 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.097 0.959 . . . . 0.0 112.182 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.451 ' CD ' ' HZ3' ' A' ' 168' ' ' LYS . 57.0 mt-10 -62.7 -44.29 96.61 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.117 1.767 . . . . 0.0 112.128 172.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -66.41 -36.81 83.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.509 -0.745 . . . . 0.0 112.157 175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.8 94.98 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.283 -0.885 . . . . 0.0 112.393 172.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.72 -33.07 75.04 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.065 -0.969 . . . . 0.0 112.874 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.7 mt -61.65 -43.37 98.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.458 1.481 . . . . 0.0 111.911 174.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -73.01 -31.87 64.75 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.516 1.053 . . . . 0.0 113.186 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -66.86 -43.78 82.72 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.264 -0.897 . . . . 0.0 112.279 170.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.44 -28.77 52.6 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.255 1.022 . . . . 0.0 113.525 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -59.85 -39.59 85.7 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 120.081 1.31 . . . . 0.0 112.51 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.99 -24.1 66.71 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 tp -85.15 -54.89 4.33 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.39 1.476 . . . . 0.0 111.635 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.27 -37.88 81.16 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -158.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.52 -34.32 88.79 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.217 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -84.5 -27.24 27.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.82 0.848 . . . . 0.0 112.883 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.48 -39.54 94.74 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.451 -0.781 . . . . 0.0 112.05 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -64.08 -6.07 5.8 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.41 -35.36 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.54 1.136 . . . . 0.0 112.368 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -82.64 -53.81 5.65 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 159.16 178.68 33.39 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 -170.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.63 -13.24 18.19 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.781 3.654 . . . . 0.0 115.986 -159.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -86.27 169.16 13.26 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.668 1.122 . . . . 0.0 111.559 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.255 9.9 tt -77.95 9.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.307 -1.496 . . . . 0.0 112.572 176.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.29 2.27 10.29 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.818 2.447 . . . . 0.0 114.173 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.15 -128.99 9.75 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 119.399 1.0 . . . . 0.0 113.86 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -67.12 -24.4 65.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.222 1.409 . . . . 0.0 114.119 -168.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -136.32 157.13 47.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.004 1.722 . . . . 0.0 110.274 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 81.1 mt -65.37 136.24 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.751 0.821 . . . . 0.0 109.597 164.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.4 p -138.9 -174.16 3.77 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.496 1.119 . . . . 0.0 111.77 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.71 -16.02 5.63 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 170.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.3 t -71.25 -43.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.499 1.045 . . . . 0.0 111.616 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.4 -42.44 96.1 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.227 -1.546 . . . . 0.0 112.643 166.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 37.4 mt -62.41 -16.6 55.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.6 m -98.27 -48.57 5.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.939 1.296 . . . . 0.0 112.331 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 28.3 mt -92.68 -37.35 12.45 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.77 1.228 . . . . 0.0 114.083 -168.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.73 -48.53 89.41 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -169.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.62 -27.11 15.69 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 120.859 1.342 . . . . 0.0 112.83 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.1 -33.98 74.35 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 117.3 -1.333 . . . . 0.0 112.39 171.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.06 -42.21 94.43 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.379 0.991 . . . . 0.0 112.641 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -64.83 -44.69 88.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.311 0.959 . . . . 0.0 112.174 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -62.3 -32.19 72.89 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.665 -0.647 . . . . 0.0 112.496 175.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 22.3 tp -74.01 -45.31 50.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.421 1.488 . . . . 0.0 113.427 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.6 -37.7 73.68 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.937 1.295 . . . . 0.0 111.44 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.65 -59.4 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.8 -51.03 17.72 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.169 -0.957 . . . . 0.0 113.507 -166.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.0 tp -75.9 -36.3 59.5 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.202 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.17 -26.53 63.79 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.955 -0.914 . . . . 0.0 114.972 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -60.11 -32.69 71.23 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 170.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.21 -30.22 9.34 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.141 0.977 . . . . 0.0 113.626 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.451 ' HZ3' ' CD ' ' A' ' 120' ' ' GLU . 80.8 tttt -150.58 96.72 2.41 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.534 1.534 . . . . 0.0 109.548 168.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.9 75.13 0.89 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.862 0.865 . . . . 0.0 111.008 168.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -67.55 117.46 47.59 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 123.926 0.89 . . . . 0.0 110.339 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.83 121.8 8.24 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.744 1.629 . . . . 0.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 37.6 mt -61.3 112.76 6.42 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 161.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.8 156.28 62.67 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.567 1.512 . . . . 0.0 112.528 -169.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -21.77 63.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.125 1.37 . . . . 0.0 114.258 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -64.89 -37.47 87.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.182 0.993 . . . . 0.0 112.847 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 83.7 mt -81.23 49.09 1.21 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.288 1.835 . . . . 0.0 111.253 166.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -32.84 70.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.313 1.445 . . . . 0.0 112.306 -166.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -81.41 -39.54 24.8 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.499 0.72 . . . . 0.0 112.18 -176.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.93 -40.86 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.427 0.691 . . . . 0.0 110.647 170.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 67.7 tp -64.59 -43.69 93.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.678 1.191 . . . . 0.0 113.333 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -69.33 -36.49 77.0 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.457 -0.777 . . . . 0.0 112.943 175.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -62.4 -26.68 68.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.964 0.906 . . . . 0.0 113.21 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 43.0 mm -51.36 -37.6 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.147 0.979 . . . . 0.0 112.16 168.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -78.8 -13.25 59.91 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.411 -1.431 . . . . 0.0 113.279 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 33.9 mt -74.81 -24.7 58.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.984 -1.007 . . . . 0.0 113.172 165.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.49 -23.78 67.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.361 0.982 . . . . 0.0 112.797 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -88.47 3.55 49.73 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.996 -1.065 . . . . 0.0 113.829 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.5 p -130.27 178.03 6.88 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -157.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 56.71 -170.36 0.09 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.154 1.781 . . . . 0.0 110.993 -173.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -72.8 -37.88 67.39 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.829 -1.17 . . . . 0.0 111.645 156.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -48.83 74.57 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.535 1.134 . . . . 0.0 113.679 -162.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -95.83 -35.03 11.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.01 -30.06 70.08 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.692 -1.255 . . . . 0.0 113.205 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.13 -24.87 51.64 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 63.3 p -90.25 -11.22 41.56 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -56.25 105.43 0.2 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.083 1.353 . . . . 0.0 110.512 171.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -76.12 151.63 36.95 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.998 0.919 . . . . 0.0 112.37 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.62 130.31 45.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.18 0.992 . . . . 0.0 111.303 166.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.56 -37.47 21.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.326 1.45 . . . . 0.0 112.902 -144.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -39.95 82.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.826 1.65 . . . . 0.0 113.037 167.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -79.99 -8.89 59.59 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.78 -47.77 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 120.103 1.319 . . . . 0.0 109.939 160.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.1 mt -65.14 -56.65 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.5 1.12 . . . . 0.0 111.204 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.45 -24.61 65.64 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.092 0.957 . . . . 0.0 113.45 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -85.13 -30.4 25.63 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.08 -1.012 . . . . 0.0 113.424 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -70.69 -36.56 73.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.127 1.464 . . . . 0.0 113.01 174.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -42.37 -56.51 5.5 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -164.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.64 -23.57 42.53 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 CA-C-N 122.359 1.878 . . . . 0.0 114.12 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -77.17 2.68 14.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.226 1.81 . . . . 0.0 113.904 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.38 -19.77 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.856 0.862 . . . . 0.0 112.377 156.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.44 -30.68 2.1 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 174.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 116.073 -1.918 . . . . 0.0 113.799 -179.616 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.02 -157.53 0.11 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.717 0.807 . . . . 0.0 112.002 -173.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.4 mt -73.07 119.51 17.42 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.358 -0.839 . . . . 0.0 111.182 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -123.94 98.51 5.83 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.833 1.253 . . . . 0.0 108.127 166.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.442 HD11 HD12 ' A' ' 30' ' ' LEU . 45.9 mt -74.22 135.02 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.2 m -120.53 129.89 54.0 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.1 140.2 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.99 -1.069 . . . . 0.0 110.737 -156.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.644 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.8 tttm -65.74 125.53 25.58 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 170.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.76 174.65 10.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.914 1.686 . . . . 0.0 111.76 169.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.55 140.85 21.8 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.884 0.874 . . . . 0.0 111.691 166.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.5 t -53.76 121.07 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.943 0.401 . . . . 0.0 110.091 167.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.3 -11.95 34.88 Favored Glycine 0 CA--C 1.536 1.403 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.91 83.93 55.37 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.979 1.89 . . . . 0.0 111.93 -172.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.24 -8.75 19.55 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.765 2.976 . . . . 0.0 116.742 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -91.63 -1.91 57.28 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.4 pt -142.56 163.09 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.253 1.421 . . . . 0.0 111.566 -170.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 mt -77.39 -41.75 38.95 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 45.28 -125.06 6.79 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.74 1.162 . . . . 0.0 114.961 -176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -65.1 13.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.318 2.647 . . . . 0.0 116.605 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.464 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 69.2 m -115.4 73.91 4.05 Favored Pre-proline 0 C--O 1.256 1.417 0 O-C-N 120.559 -1.338 . . . . 0.0 110.942 -160.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.77 -29.49 42.41 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 123.549 2.833 . . . . 0.0 111.804 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -61.19 -39.44 90.19 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.217 -0.927 . . . . 0.0 112.789 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.8 m -63.34 -42.43 98.94 Favored 'General case' 0 C--N 1.373 1.612 0 O-C-N 120.343 -1.473 . . . . 0.0 110.987 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -60.86 -32.92 72.32 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.878 0.871 . . . . 0.0 112.776 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.49 HH12 ' CG ' ' A' ' 74' ' ' ASP . 73.0 mtp180 -52.5 -43.55 65.12 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.783 1.233 . . . . 0.0 113.027 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -77.61 -32.2 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.058 1.343 . . . . 0.0 112.364 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.83 -37.47 76.21 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.074 -0.391 . . . . 0.0 111.27 168.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.59 -42.18 98.29 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.574 0.954 . . . . 0.0 113.574 -163.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.9 p -74.92 -38.57 61.77 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.953 0.797 . . . . 0.0 112.937 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.442 HD12 HD11 ' A' ' 5' ' ' ILE . 88.1 mt -67.89 -34.8 77.36 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.235 0.614 . . . . 0.0 112.609 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -77.66 -24.5 49.4 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -73.86 -42.65 60.48 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.691 -1.256 . . . . 0.0 112.283 169.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -66.52 -13.3 60.75 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.66 1.984 . . . . 0.0 112.846 167.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.8 mttm 61.86 21.47 12.28 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 127.827 2.451 . . . . 0.0 113.905 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.51 127.04 72.19 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.152 1.381 . . . . 0.0 109.66 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.3 152.46 49.93 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.93 2.42 . . . . 0.0 113.033 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -146.93 166.42 26.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.866 1.666 . . . . 0.0 111.13 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -89.8 148.87 22.96 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.04 -1.037 . . . . 0.0 109.813 156.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.1 t -131.98 108.73 9.55 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.868 0.867 . . . . 0.0 110.493 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -100.11 83.34 2.67 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.855 1.662 . . . . 0.0 108.494 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -69.23 130.5 42.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.418 0.687 . . . . 0.0 110.449 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 45' ' ' GLY . 9.3 mt -127.75 119.13 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.603 1.561 . . . . 0.0 110.266 -172.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -82.63 98.14 8.86 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 168.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt 53.72 30.11 10.58 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 167.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 99.55 16.19 29.91 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.79 8.53 0.18 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.089 1.945 . . . . 0.0 115.812 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -140.88 145.44 39.59 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 126.522 1.929 . . . . 0.0 110.02 -177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -62.46 161.26 28.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.153 2.569 . . . . 0.0 113.497 -164.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.95 -10.66 41.17 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -170.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -52.13 -21.71 3.54 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.284 1.834 . . . . 0.0 115.745 158.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -108.56 5.22 24.88 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.365 1.466 . . . . 0.0 113.516 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.7 mt -125.59 -40.76 2.05 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.969 2.108 . . . . 0.0 113.034 -171.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -61.09 -13.81 19.71 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 126.811 2.044 . . . . 0.0 113.641 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.5 mt -58.62 -21.39 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 126.816 2.046 . . . . 0.0 111.167 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 84.1 p -110.84 147.16 35.91 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.616 1.166 . . . . 0.0 111.203 155.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -69.05 -17.13 40.91 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.542 2.161 . . . . 0.0 113.025 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.12 -10.35 59.58 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.688 1.595 . . . . 0.0 112.997 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.91 13.69 62.03 Favored Glycine 0 CA--C 1.537 1.469 0 O-C-N 120.658 -1.276 . . . . 0.0 114.358 -169.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -81.35 168.72 18.09 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.465 1.906 . . . . 0.0 112.109 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 62' ' ' VAL . 15.3 m -136.71 151.05 71.87 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 113.211 -1.813 . . . . 0.0 108.769 153.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.9 151.07 91.46 Favored 'Cis proline' 0 C--N 1.349 0.562 0 N-CA-C 117.245 1.979 . . . . 0.0 117.245 11.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.523 HG22 HG12 ' A' ' 60' ' ' VAL . 35.8 m -154.58 170.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 128.779 2.832 . . . . 0.0 109.468 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.35 145.42 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 120.777 -1.202 . . . . 0.0 113.085 165.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -86.94 139.78 30.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.882 151.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.4 mt -118.52 81.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.249 1.42 . . . . 0.0 108.222 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.3 t70 55.53 55.38 7.35 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.171 1.388 . . . . 0.0 112.807 -164.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.72 20.29 3.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.746 2.018 . . . . 0.0 116.098 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -100.77 112.42 24.83 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.987 -1.071 . . . . 0.0 108.649 165.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -80.24 150.59 29.99 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -160.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.67 127.9 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.556 1.943 . . . . 0.0 109.029 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.93 -150.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.58 1.952 . . . . 0.0 113.825 -174.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.16 157.55 0.44 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -169.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.4 p -54.97 -28.26 50.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -173.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.49 ' CG ' HH12 ' A' ' 25' ' ' ARG . 3.3 m-20 -72.56 -21.41 61.16 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.076 1.351 . . . . 0.0 114.076 177.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 m -93.94 -23.59 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.729 1.149 . . . . 0.0 112.925 165.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.3 -42.34 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.276 0.944 . . . . 0.0 112.077 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -63.9 -6.17 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.43 -58.21 0.62 Allowed Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.602 1.096 . . . . 0.0 113.311 158.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -76.46 -31.08 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.602 1.161 . . . . 0.0 113.584 -163.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.6 tp -73.66 -40.28 63.83 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.526 -1.359 . . . . 0.0 110.746 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -65.14 -30.68 71.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.797 0.839 . . . . 0.0 113.11 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 25.3 tt0 -67.43 -42.26 83.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.384 1.874 . . . . 0.0 113.071 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.528 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.0 mttt -97.4 -7.33 32.01 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.537 1.135 . . . . 0.0 113.879 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.03 141.68 58.86 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.782 1.233 . . . . 0.0 110.015 169.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.23 -23.84 32.76 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.922 1.748 . . . . 0.0 114.252 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.33 139.57 60.09 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 117.734 -1.127 . . . . 0.0 110.343 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.53 146.73 18.87 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.869 3.046 . . . . 0.0 115.812 -171.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.47 120.24 7.4 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.875 2.383 . . . . 0.0 112.246 -173.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.4 mt -68.68 -8.6 43.97 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.042 0.937 . . . . 0.0 112.786 165.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.52 53.08 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.697 1.599 . . . . 0.0 113.717 164.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -61.58 112.11 5.49 Favored Pre-proline 0 N--CA 1.472 0.637 0 C-N-CA 124.072 0.949 . . . . 0.0 110.182 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.01 129.23 12.13 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.977 1.785 . . . . 0.0 112.246 -165.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -76.97 175.67 11.1 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.675 2.25 . . . . 0.0 110.401 157.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -53.56 -36.86 62.31 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.904 -1.123 . . . . 0.0 112.88 171.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -60.95 -15.93 36.9 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.063 1.745 . . . . 0.0 114.815 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.92 -30.29 70.11 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 120.321 1.419 . . . . 0.0 112.73 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.1 p -71.35 -8.62 54.96 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.179 1.392 . . . . 0.0 114.561 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.59 -41.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.735 1.214 . . . . 0.0 111.651 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.57 -22.92 68.31 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.106 1.336 . . . . 0.0 114.308 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.1 p -67.39 -18.16 65.02 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 168.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -87.91 -43.03 12.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.658 1.183 . . . . 0.0 112.15 165.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.57 -33.83 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.261 0.625 . . . . 0.0 111.721 -173.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.41 -48.78 92.86 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 120.387 -1.445 . . . . 0.0 113.743 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -79.89 -22.09 7.77 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.937 2.425 . . . . 0.0 114.998 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.0 p -73.85 -29.97 62.41 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 121.882 2.128 . . . . 0.0 113.363 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -62.85 -34.23 76.91 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.903 -1.123 . . . . 0.0 113.168 161.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.35 -41.93 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.056 1.298 . . . . 0.0 111.484 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -64.32 -43.66 93.99 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.337 0.971 . . . . 0.0 112.313 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.5 -30.19 70.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.053 0.941 . . . . 0.0 112.345 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.5 mt -91.97 20.94 5.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.79 1.636 . . . . 0.0 113.583 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -138.03 62.85 1.56 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.013 1.725 . . . . 0.0 110.33 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -60.46 13.08 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 129.158 2.983 . . . . 0.0 117.636 -164.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -68.3 -35.93 78.58 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.007 -1.058 . . . . 0.0 111.364 160.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -76.63 148.96 80.48 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.68 0.392 . . . . 0.0 110.128 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.23 106.48 1.57 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.083 1.856 . . . . 0.0 110.77 -175.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -62.04 -38.11 87.49 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.537 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.96 -27.65 68.99 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.383 -1.448 . . . . 0.0 114.455 173.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.27 -31.16 20.39 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.023 -1.048 . . . . 0.0 113.521 171.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.2 m -69.31 -29.91 67.86 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.626 1.171 . . . . 0.0 112.091 173.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.53 -44.21 96.92 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.177 1.791 . . . . 0.0 111.802 169.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -66.69 -37.14 84.14 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.3 -0.875 . . . . 0.0 112.534 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.38 93.73 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.381 -0.824 . . . . 0.0 112.461 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.5 tp -64.88 -36.49 84.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.916 1.286 . . . . 0.0 112.382 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -60.3 -40.2 89.65 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.521 1.055 . . . . 0.0 112.473 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -74.06 -27.7 61.04 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.953 0.797 . . . . 0.0 112.899 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -69.65 -44.66 70.12 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.186 -0.947 . . . . 0.0 112.097 168.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -72.18 -28.65 63.35 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -60.9 -38.09 84.51 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.911 1.232 . . . . 0.0 112.937 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.25 64.96 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 174.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 tp -87.53 -57.76 2.83 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.477 1.511 . . . . 0.0 112.011 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.36 -37.55 85.55 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -159.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.74 -34.05 88.9 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.708 -0.62 . . . . 0.0 113.657 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -89.78 -24.29 21.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.845 0.858 . . . . 0.0 112.997 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.6 -39.76 95.2 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.23 -0.919 . . . . 0.0 111.924 166.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -64.81 -5.54 6.16 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 172.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.2 t -101.15 -37.13 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.841 1.256 . . . . 0.0 112.31 168.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -82.13 -49.24 10.39 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 155.26 177.22 28.31 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 121.05 -1.031 . . . . 0.0 115.642 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.29 -13.65 20.76 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.933 3.755 . . . . 0.0 116.132 -161.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -82.93 170.02 15.39 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.515 1.052 . . . . 0.0 111.7 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.6 tt -78.74 10.85 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.503 -1.373 . . . . 0.0 112.532 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.65 5.32 6.14 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.798 2.439 . . . . 0.0 114.08 169.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.46 -120.87 6.97 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 119.08 0.855 . . . . 0.0 113.892 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -70.1 -22.31 63.04 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.229 1.012 . . . . 0.0 113.631 -164.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.0 pttt -144.2 168.54 19.79 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.542 1.937 . . . . 0.0 111.858 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.5 mt -67.77 131.72 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 161.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.2 p -130.3 -176.97 4.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.984 1.313 . . . . 0.0 111.219 173.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -56.19 -16.93 6.03 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 170.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.51 -46.58 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.714 0.806 . . . . 0.0 111.442 168.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.97 -41.25 99.49 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.442 -1.411 . . . . 0.0 112.936 168.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.8 mt -64.78 0.33 1.2 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.3 m -121.8 -43.0 2.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.625 1.17 . . . . 0.0 112.012 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.37 -40.09 13.82 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.778 1.231 . . . . 0.0 113.977 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.58 97.65 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -170.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.67 -25.43 12.6 Favored 'Trans proline' 0 C--N 1.35 0.632 0 CA-C-N 120.752 1.304 . . . . 0.0 112.8 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -68.88 -35.33 76.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 117.526 -1.226 . . . . 0.0 112.172 170.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.4 mt -64.84 -41.4 95.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 118.358 -0.829 . . . . 0.0 112.821 170.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -65.38 -42.08 93.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.321 0.964 . . . . 0.0 112.509 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -64.64 -30.07 71.09 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.304 -0.873 . . . . 0.0 112.435 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.2 tp -75.29 -44.48 45.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.001 1.321 . . . . 0.0 113.292 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -58.87 -36.41 74.57 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.696 1.198 . . . . 0.0 111.52 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.69 -57.07 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.69 -51.64 15.96 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.197 -0.939 . . . . 0.0 113.235 -166.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 60.6 tp -75.79 -33.4 60.16 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.564 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.22 -27.84 60.79 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.964 -0.909 . . . . 0.0 114.967 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -60.87 -27.27 68.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.182 1.393 . . . . 0.0 114.539 170.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -114.35 -33.07 5.74 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.604 1.162 . . . . 0.0 113.236 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -149.77 94.95 2.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.014 1.726 . . . . 0.0 109.091 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -71.17 76.53 0.7 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.65 0.78 . . . . 0.0 111.096 168.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -68.44 118.75 62.86 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 123.729 0.812 . . . . 0.0 110.234 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.96 128.63 14.27 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.644 1.563 . . . . 0.0 110.226 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.52 114.77 14.25 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 158.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -64.1 154.34 71.1 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.424 1.416 . . . . 0.0 113.29 -169.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -26.27 61.82 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.65 1.98 . . . . 0.0 113.489 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -62.95 -36.95 85.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.962 1.305 . . . . 0.0 112.607 172.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 87.2 mt -88.48 49.66 1.83 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.106 1.762 . . . . 0.0 111.239 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -28.96 69.62 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.283 1.433 . . . . 0.0 112.225 -166.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -80.15 -38.21 31.88 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.43 -0.794 . . . . 0.0 112.492 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.8 t -65.44 -39.17 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.773 0.829 . . . . 0.0 110.828 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 68.4 tp -65.02 -44.54 88.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.094 0.957 . . . . 0.0 113.117 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -67.3 -34.44 77.38 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.289 -0.882 . . . . 0.0 112.999 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -62.68 -26.94 68.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.838 0.855 . . . . 0.0 113.246 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.3 mm -53.7 -36.53 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 121.331 -0.856 . . . . 0.0 111.789 168.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -82.76 -7.43 59.65 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.418 -1.426 . . . . 0.0 113.713 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.27 -18.51 52.59 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 117.658 -1.163 . . . . 0.0 113.787 160.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.77 -17.49 63.11 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.117 1.326 . . . . 0.0 113.602 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -93.11 3.79 55.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.707 1.603 . . . . 0.0 113.749 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.6 p -123.17 178.77 4.95 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -159.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.7 mtp85 57.54 -165.57 0.16 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.335 1.854 . . . . 0.0 112.022 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -80.6 -38.31 29.62 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.62 1.168 . . . . 0.0 110.146 165.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.5 p -62.97 -81.13 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.484 2.314 . . . . 0.0 113.673 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -61.11 -39.82 91.44 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.172 -0.955 . . . . 0.0 113.507 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.35 -31.1 68.88 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.184 1.394 . . . . 0.0 113.736 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.31 -29.39 31.13 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.101 0.864 . . . . 0.0 113.22 172.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 81.5 p -75.8 -16.91 60.03 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 174.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -60.46 99.36 0.08 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.3 1.44 . . . . 0.0 112.125 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.61 150.42 41.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.37 123.16 18.02 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.008 1.323 . . . . 0.0 111.849 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -64.11 -47.04 81.57 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.956 1.702 . . . . 0.0 115.326 -153.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -61.71 -35.01 76.79 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.851 0.86 . . . . 0.0 112.258 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -77.97 -12.33 59.98 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.59 -45.54 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.406 1.003 . . . . 0.0 109.946 165.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.7 mt -67.16 -58.0 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.985 1.314 . . . . 0.0 111.585 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.06 -27.94 67.79 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.72 -21.01 62.47 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 120.848 -1.157 . . . . 0.0 113.782 171.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -80.2 -25.45 39.66 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.409 1.605 . . . . 0.0 113.841 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -47.27 -53.99 24.62 Favored Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -173.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.64 -18.5 37.53 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 122.295 1.855 . . . . 0.0 114.024 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -81.73 4.96 20.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.006 1.723 . . . . 0.0 114.11 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.32 -18.61 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 120.972 -1.08 . . . . 0.0 112.012 154.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -124.08 -35.64 2.8 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.12 1.368 . . . . 0.0 113.695 174.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 115.713 -2.089 . . . . 0.0 113.904 177.736 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.8 ttm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.63 -159.77 0.1 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.94 0.896 . . . . 0.0 111.514 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.0 mt -69.92 119.9 14.83 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.302 -0.873 . . . . 0.0 110.94 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -130.4 93.09 3.38 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 30' ' ' LEU . 55.6 mt -74.05 139.14 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.599 1.159 . . . . 0.0 108.642 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.8 m -119.98 135.86 54.75 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 167.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.32 141.72 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.936 -1.103 . . . . 0.0 110.292 -162.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.708 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.2 tttm -66.4 127.66 33.16 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 170.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.24 172.92 12.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.488 1.515 . . . . 0.0 111.732 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.54 139.82 36.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.186 0.994 . . . . 0.0 111.438 168.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 120.44 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.191 0.52 . . . . 0.0 110.05 169.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.66 -12.1 42.77 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 118.274 -1.292 . . . . 0.0 116.254 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.85 85.16 58.74 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 120.011 1.906 . . . . 0.0 111.891 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.82 -6.37 13.97 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.429 3.419 . . . . 0.0 117.179 -168.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -101.78 0.75 36.33 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.9 pt -141.81 162.59 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.61 1.564 . . . . 0.0 111.118 -172.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.07 -48.28 30.85 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.71 -126.71 13.42 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.338 0.97 . . . . 0.0 114.398 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.95 23.25 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 128.189 2.596 . . . . 0.0 117.009 -172.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.495 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.8 p -121.63 71.09 27.11 Favored Pre-proline 0 C--O 1.257 1.459 0 O-C-N 120.191 -1.568 . . . . 0.0 110.962 -159.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.75 -29.4 42.68 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.754 2.969 . . . . 0.0 112.424 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -61.96 -39.13 91.07 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.6 m -63.09 -45.81 90.37 Favored 'General case' 0 C--N 1.376 1.739 0 CA-C-N 120.2 1.364 . . . . 0.0 111.018 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -57.56 -33.09 67.77 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.712 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' A' ' 74' ' ' ASP . 74.7 mtp180 -53.72 -43.82 69.35 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.756 1.223 . . . . 0.0 112.883 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -76.74 -27.25 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.394 1.477 . . . . 0.0 112.098 -170.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.59 -42.36 52.18 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.704 0.802 . . . . 0.0 111.076 169.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.64 -39.07 83.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -161.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 p -72.8 -43.45 62.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.121 0.873 . . . . 0.0 112.661 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.485 HD12 HD11 ' A' ' 5' ' ' ILE . 99.4 mt -66.32 -32.39 73.77 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.058 0.943 . . . . 0.0 112.08 177.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -79.55 -26.98 41.27 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -75.29 -39.05 60.04 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.064 0.847 . . . . 0.0 112.33 168.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -68.99 -9.62 53.29 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.931 1.693 . . . . 0.0 113.063 167.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 83.4 mttt 58.62 21.52 8.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.812 2.445 . . . . 0.0 114.746 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.98 123.53 83.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.497 1.119 . . . . 0.0 109.31 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.54 152.64 54.38 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.77 2.313 . . . . 0.0 112.519 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.434 ' CD1' HD12 ' A' ' 5' ' ' ILE . 35.4 p90 -150.78 160.32 43.95 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.462 1.505 . . . . 0.0 110.94 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -81.74 146.78 29.79 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.136 -0.978 . . . . 0.0 109.636 159.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -123.2 126.84 47.71 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.715 0.806 . . . . 0.0 111.319 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -115.09 80.72 1.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.748 1.619 . . . . 0.0 108.972 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.04 130.66 43.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.136 0.974 . . . . 0.0 110.368 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -129.74 120.34 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.772 1.229 . . . . 0.0 110.587 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -86.86 101.09 13.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.46 0.704 . . . . 0.0 109.246 168.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.5 mt 53.21 28.17 6.81 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 167.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.41 16.64 24.26 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -65.97 3.49 0.82 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 120.227 2.014 . . . . 0.0 115.698 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -140.15 146.92 48.25 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 126.541 1.936 . . . . 0.0 110.029 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.25 160.23 31.75 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.013 2.475 . . . . 0.0 113.772 -163.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.29 -10.38 23.57 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -55.35 -20.08 10.69 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.41 1.884 . . . . 0.0 114.902 164.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -108.39 9.84 27.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.37 1.868 . . . . 0.0 113.173 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.3 mt -132.68 -41.57 0.94 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.406 2.282 . . . . 0.0 112.637 -171.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.41 -13.53 20.88 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.905 2.482 . . . . 0.0 113.578 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mt -59.81 -21.93 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 127.162 2.185 . . . . 0.0 111.045 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 94.6 p -106.85 149.67 38.79 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.403 1.481 . . . . 0.0 110.998 156.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -68.52 -17.4 43.5 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.519 2.146 . . . . 0.0 112.975 170.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -82.09 -9.78 59.42 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.515 1.526 . . . . 0.0 113.443 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.5 23.09 73.56 Favored Glycine 0 CA--C 1.539 1.565 0 O-C-N 121.041 -1.037 . . . . 0.0 114.118 -171.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -89.63 172.69 8.77 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.497 1.919 . . . . 0.0 113.598 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.08 153.53 81.78 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 112.945 -1.934 . . . . 0.0 108.619 152.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.15 152.14 80.06 Favored 'Cis proline' 0 CA--C 1.536 0.587 0 N-CA-C 115.108 1.157 . . . . 0.0 115.108 5.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.1 m -155.19 164.65 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 128.141 2.577 . . . . 0.0 109.06 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.59 144.42 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 120.157 -1.589 . . . . 0.0 114.028 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -88.88 132.14 34.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.899 155.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.7 mt -109.27 79.64 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.829 1.252 . . . . 0.0 108.326 168.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 55.76 57.09 5.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.718 1.207 . . . . 0.0 112.865 -165.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.8 14.19 3.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -98.37 107.23 19.64 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.409 -1.432 . . . . 0.0 108.36 168.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -76.73 148.81 36.5 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.532 1.133 . . . . 0.0 113.712 -160.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -141.8 127.94 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.415 1.886 . . . . 0.0 109.34 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.53 -152.46 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.393 1.877 . . . . 0.0 113.828 -174.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.92 159.25 0.59 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.398 1.879 . . . . 0.0 115.211 -167.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.0 p -54.48 -29.06 48.78 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 25' ' ' ARG . 41.6 m-20 -73.41 -15.53 61.35 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 m -100.2 -22.23 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.296 0.953 . . . . 0.0 113.007 163.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.1 mt -61.01 -40.82 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.449 1.022 . . . . 0.0 111.928 173.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.1 m -62.01 -7.39 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.17 -56.73 0.52 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.679 1.133 . . . . 0.0 113.346 161.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.1 mt -75.77 -31.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.648 1.179 . . . . 0.0 113.327 -164.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.5 tp -71.7 -42.7 67.07 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.83 -1.169 . . . . 0.0 110.51 168.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -65.26 -30.69 71.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 33.2 tt0 -66.25 -42.61 88.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.245 1.818 . . . . 0.0 112.996 169.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.532 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 94.5 mttt -99.78 -4.8 29.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.675 1.19 . . . . 0.0 113.621 -167.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -79.2 142.34 59.0 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.49 1.516 . . . . 0.0 110.188 170.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.7 -22.26 20.83 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.875 1.717 . . . . 0.0 114.004 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -80.08 145.43 60.88 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.043 169.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.52 149.09 24.89 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.632 2.888 . . . . 0.0 115.684 -172.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.13 120.47 7.62 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.939 2.426 . . . . 0.0 112.334 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.5 -10.13 53.55 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.436 -0.79 . . . . 0.0 112.593 164.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.58 -19.48 49.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.957 1.703 . . . . 0.0 114.211 166.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.5 m -59.91 112.88 6.02 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 123.712 0.805 . . . . 0.0 109.909 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.63 126.34 10.76 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.718 1.612 . . . . 0.0 111.852 -165.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.74 164.5 33.06 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.457 2.105 . . . . 0.0 110.788 159.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -51.97 -33.84 39.67 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.289 1.436 . . . . 0.0 112.961 160.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -60.63 -18.6 54.37 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 172.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.45 -29.9 70.85 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.505 -1.372 . . . . 0.0 113.182 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 94.3 p -67.61 -15.16 63.51 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.73 -38.79 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.419 1.488 . . . . 0.0 111.271 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.18 -27.8 71.16 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.31 0.957 . . . . 0.0 114.151 173.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.6 p -66.87 -19.49 65.74 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 171.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -87.91 -43.93 11.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.301 1.04 . . . . 0.0 112.837 167.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.8 mt -65.28 -32.79 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 122.605 0.362 . . . . 0.0 110.827 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.17 -49.57 90.16 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.238 -1.363 . . . . 0.0 114.449 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.32 -23.19 10.37 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.56 2.84 . . . . 0.0 114.128 167.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.493 ' HA ' ' CE ' ' A' ' 108' ' ' LYS . 17.2 m -66.88 -31.78 72.61 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.955 1.707 . . . . 0.0 114.147 171.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -67.73 -27.78 67.09 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 164.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.29 -42.27 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.313 1.415 . . . . 0.0 111.331 173.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.493 ' CE ' ' HA ' ' A' ' 105' ' ' SER . 53.3 mtmt -59.94 -47.87 84.03 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.035 0.834 . . . . 0.0 111.473 171.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -32.5 73.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.48 0.712 . . . . 0.0 112.333 -173.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.6 mt -88.01 17.03 5.26 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.537 1.535 . . . . 0.0 113.423 170.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -134.68 64.04 1.61 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.948 1.699 . . . . 0.0 110.335 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -60.39 10.22 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.351 2.66 . . . . 0.0 117.262 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -63.72 -33.33 75.42 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.012 -1.055 . . . . 0.0 111.605 156.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -82.23 149.1 61.38 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.044 0.938 . . . . 0.0 110.637 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.24 98.37 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.622 2.214 . . . . 0.0 110.913 -174.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -61.79 -31.81 72.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 116.925 -1.512 . . . . 0.0 114.394 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.34 -29.03 70.17 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.666 -1.272 . . . . 0.0 113.695 172.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.54 -27.63 32.07 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 120.891 -1.131 . . . . 0.0 113.656 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.1 m -70.93 -31.39 67.97 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.548 -0.972 . . . . 0.0 112.336 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.28 -44.09 96.08 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.879 1.672 . . . . 0.0 111.486 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -64.23 -41.46 97.0 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.466 -0.771 . . . . 0.0 112.788 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.4 95.02 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.382 -0.824 . . . . 0.0 112.66 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.9 tp -66.84 -36.58 82.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.738 1.215 . . . . 0.0 112.068 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.59 -38.1 83.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.809 1.186 . . . . 0.0 112.743 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.91 -29.22 62.97 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.063 0.847 . . . . 0.0 112.681 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -74.85 -37.6 62.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.201 1.0 . . . . 0.0 112.311 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.4 mt -71.9 -32.89 67.86 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.794 -1.191 . . . . 0.0 113.104 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -61.51 -39.45 91.03 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 120.014 1.279 . . . . 0.0 112.54 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.8 -25.46 67.25 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 174.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -86.29 -57.7 2.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.207 1.403 . . . . 0.0 112.46 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.71 -44.54 89.93 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -157.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.49 -24.79 69.64 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.637 -0.535 . . . . 0.0 113.312 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -89.23 -29.78 19.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.06 -0.972 . . . . 0.0 112.91 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.13 -39.4 86.14 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.32 1.418 . . . . 0.0 111.826 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 178' ' ' HIS . 86.0 mttt -60.77 -12.42 10.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.692 1.597 . . . . 0.0 114.778 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 99.4 t -96.58 -31.02 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.087 1.355 . . . . 0.0 112.663 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -103.93 -27.72 12.0 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -167.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.22 177.43 19.09 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 120.095 1.316 . . . . 0.0 115.459 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.11 -11.39 23.23 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.761 3.64 . . . . 0.0 116.131 -163.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -84.6 173.29 10.9 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.522 1.055 . . . . 0.0 112.222 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.2 tt -79.65 13.15 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 120.874 -1.141 . . . . 0.0 112.411 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.72 24.87 2.4 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.161 2.584 . . . . 0.0 112.783 169.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.94 -117.55 4.44 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.733 -1.229 . . . . 0.0 113.408 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -64.56 -23.92 67.43 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -165.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -152.84 166.4 32.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.929 1.291 . . . . 0.0 112.617 -168.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.1 mt -66.16 128.95 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.5 0.72 . . . . 0.0 109.193 161.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.9 p -127.74 -178.69 4.59 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.069 1.748 . . . . 0.0 110.55 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.14 -15.31 13.76 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.374 -1.454 . . . . 0.0 114.823 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.37 -45.94 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.971 0.805 . . . . 0.0 111.178 167.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.98 -41.85 98.48 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.745 -1.222 . . . . 0.0 112.678 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.9 -0.88 1.69 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 172.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.1 m -121.53 -37.79 2.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.652 1.181 . . . . 0.0 112.061 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.8 mt -94.16 -38.22 11.19 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.854 1.262 . . . . 0.0 114.042 -176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.56 -47.7 92.25 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -169.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -74.27 -23.82 15.09 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.967 1.381 . . . . 0.0 113.046 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -70.3 -35.19 73.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.469 -1.253 . . . . 0.0 112.28 170.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 24.3 mt -64.7 -40.97 96.29 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.347 0.976 . . . . 0.0 112.585 168.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -62.21 -48.54 79.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.723 0.773 . . . . 0.0 112.188 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -64.6 -25.16 67.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.867 0.867 . . . . 0.0 112.573 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 32.1 tp -79.41 -43.28 23.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.802 1.241 . . . . 0.0 113.793 175.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -60.72 -32.86 72.1 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.739 0.815 . . . . 0.0 111.544 174.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 80.5 t -92.93 -62.44 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.029 0.931 . . . . 0.0 113.243 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.29 -51.89 27.03 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.323 0.965 . . . . 0.0 113.19 -166.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 53.8 tp -76.3 -35.69 58.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.542 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.87 -26.54 60.7 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.024 -0.876 . . . . 0.0 114.897 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -60.11 -32.07 70.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.962 1.305 . . . . 0.0 114.332 169.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -107.38 -32.0 7.93 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.439 1.095 . . . . 0.0 113.311 -178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -149.58 96.34 2.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.79 1.636 . . . . 0.0 108.963 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -71.81 77.33 0.87 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.858 0.863 . . . . 0.0 110.712 169.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 87.0 t90 -75.83 114.85 40.78 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.91 0.884 . . . . 0.0 109.947 172.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -72.74 138.92 29.87 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.731 1.62 . . . . 0.0 110.4 177.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.6 mt -65.48 120.1 65.27 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 155.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -60.88 154.86 53.1 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.235 1.956 . . . . 0.0 113.154 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -22.35 64.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.446 1.499 . . . . 0.0 114.188 178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -59.91 -42.74 94.53 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 112.157 168.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 78.4 mt -87.91 45.78 1.31 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.382 2.273 . . . . 0.0 111.326 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -29.26 67.72 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.658 1.583 . . . . 0.0 113.331 -168.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 135' ' ' LYS . 43.7 t-80 -79.69 -38.42 33.54 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.417 -0.802 . . . . 0.0 112.138 -175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.7 t -69.87 -36.08 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.888 -0.508 . . . . 0.0 111.077 170.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 64.6 tp -61.55 -42.93 99.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.116 0.966 . . . . 0.0 112.926 170.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -70.82 -32.2 69.18 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.284 -0.885 . . . . 0.0 113.264 174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -63.02 -29.9 71.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.017 0.826 . . . . 0.0 112.932 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.47 -36.25 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.553 0.741 . . . . 0.0 111.503 169.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -81.78 -5.41 58.15 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.302 -1.499 . . . . 0.0 114.179 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.47 -22.74 54.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 117.989 -1.005 . . . . 0.0 113.357 159.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.34 -16.35 63.51 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.893 1.224 . . . . 0.0 114.17 -170.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -93.11 4.97 53.1 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.844 -1.16 . . . . 0.0 114.125 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.4 p -131.82 -174.68 3.49 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -158.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 59.31 -172.92 0.11 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.343 1.857 . . . . 0.0 111.809 -170.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -71.55 -34.87 70.38 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.918 163.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.4 p -76.7 -80.85 0.09 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.723 2.009 . . . . 0.0 112.558 -172.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -55.64 -40.49 72.26 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.206 -0.934 . . . . 0.0 113.258 -168.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.99 -38.52 67.95 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.105 1.762 . . . . 0.0 114.57 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -79.96 -33.36 39.58 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.178 0.899 . . . . 0.0 112.295 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 12.2 p -72.2 -7.44 49.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 171.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 199' ' ' GLU . 33.5 ttt180 -60.4 109.84 1.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.072 1.305 . . . . 0.0 110.162 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -84.77 142.1 30.05 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.616 0.766 . . . . 0.0 111.833 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.11 125.95 25.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.722 1.209 . . . . 0.0 111.995 177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 196' ' ' ARG . 1.0 OUTLIER -75.79 -34.96 60.22 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -151.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -39.02 92.8 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.85 -1.156 . . . . 0.0 112.757 169.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -76.86 -19.52 57.38 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.943 -1.098 . . . . 0.0 113.92 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 45.8 t -69.15 -46.11 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.082 0.855 . . . . 0.0 110.657 166.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mt -67.49 -55.63 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.028 0.931 . . . . 0.0 111.275 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.92 76.71 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -78.68 -18.18 75.98 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.846 -1.158 . . . . 0.0 113.721 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 58.2 t90 -82.43 -21.24 35.78 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.681 1.74 . . . . 0.0 114.069 173.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -45.83 -51.29 30.98 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.96 -18.39 24.32 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.179 1.919 . . . . 0.0 114.467 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -77.87 0.24 24.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.452 1.501 . . . . 0.0 114.345 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.3 m -60.48 -20.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.244 -0.91 . . . . 0.0 112.426 155.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -122.54 -33.48 3.42 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.592 1.557 . . . . 0.0 113.18 173.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -178.663 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.15 -161.14 0.08 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.178 0.991 . . . . 0.0 111.826 -169.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.5 mt -72.5 124.93 26.21 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.938 -1.102 . . . . 0.0 111.45 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -137.41 101.03 4.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.136 0.975 . . . . 0.0 108.777 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.652 HD11 HD12 ' A' ' 30' ' ' LEU . 64.3 mt -87.04 130.6 36.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 125.125 1.37 . . . . 0.0 108.605 -173.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 m -110.59 134.44 52.41 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.658 0.783 . . . . 0.0 109.418 169.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.04 140.66 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 121.114 -0.991 . . . . 0.0 110.8 -164.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.735 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 33.6 tttm -66.53 126.84 30.14 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 170.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.21 173.15 11.26 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.776 1.63 . . . . 0.0 111.657 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.07 139.56 34.52 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.245 1.018 . . . . 0.0 111.372 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.4 t -54.67 118.3 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.006 0.431 . . . . 0.0 109.976 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.55 -10.22 65.25 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.471 1.349 . . . . 0.0 116.471 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.7 84.93 43.39 Favored Pre-proline 0 CA--C 1.552 1.019 0 CA-C-N 120.325 2.063 . . . . 0.0 112.397 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.5 5.24 1.01 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 125.281 3.987 . . . . 0.0 117.82 -168.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.74 6.11 10.98 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.704 1.201 . . . . 0.0 113.551 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.1 pt -140.36 160.84 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.906 1.682 . . . . 0.0 110.563 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 mt -74.64 -48.68 24.9 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 47.29 -125.44 10.21 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.318 0.961 . . . . 0.0 114.539 -174.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.2 21.16 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.084 2.554 . . . . 0.0 116.886 -171.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.463 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 89.4 p -121.13 70.18 20.3 Favored Pre-proline 0 C--O 1.255 1.36 0 O-C-N 120.241 -1.537 . . . . 0.0 111.006 -158.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -68.42 -29.24 31.61 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.431 2.754 . . . . 0.0 112.067 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -59.85 -38.65 82.71 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.704 0.802 . . . . 0.0 113.109 168.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.735 ' SG ' ' N ' ' A' ' 8' ' ' LYS . 83.6 m -64.87 -45.96 83.82 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 119.995 1.271 . . . . 0.0 111.0 173.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -55.85 -36.09 67.17 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.089 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.528 HH12 ' CG ' ' A' ' 74' ' ' ASP . 76.1 mtp180 -52.02 -45.94 64.79 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.689 1.196 . . . . 0.0 113.305 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.77 -32.57 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.337 1.455 . . . . 0.0 111.792 -169.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.14 -42.15 72.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.731 0.813 . . . . 0.0 111.027 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.0 tp -60.16 -39.26 85.78 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 p -71.63 -44.47 64.32 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.187 0.903 . . . . 0.0 112.753 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.652 HD12 HD11 ' A' ' 5' ' ' ILE . 96.9 mt -72.76 -31.46 64.94 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.917 0.887 . . . . 0.0 112.251 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -79.08 -23.51 44.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -74.85 -41.23 60.25 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.218 0.917 . . . . 0.0 112.066 167.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -69.22 -8.58 47.16 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.135 1.374 . . . . 0.0 113.372 167.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HE2' ' HG3' ' A' ' 190' ' ' GLU . 66.9 mttt 58.88 18.37 6.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.783 2.433 . . . . 0.0 115.22 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.8 mt -76.04 125.74 87.66 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.062 0.945 . . . . 0.0 109.462 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.7 150.01 68.02 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.617 2.211 . . . . 0.0 112.463 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.497 ' CD1' HD12 ' A' ' 5' ' ' ILE . 45.8 p90 -150.5 160.13 43.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.585 1.554 . . . . 0.0 110.718 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -84.95 131.46 34.48 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.957 -1.089 . . . . 0.0 110.085 163.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.2 t -93.25 131.65 38.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.29 0.636 . . . . 0.0 112.136 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -125.77 74.33 1.41 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.853 1.661 . . . . 0.0 109.665 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.8 mt -65.94 134.36 52.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.912 0.885 . . . . 0.0 110.561 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 mt -135.27 125.89 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.001 1.32 . . . . 0.0 110.667 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -88.26 100.27 12.86 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.328 -0.857 . . . . 0.0 109.684 166.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.3 mt 54.88 24.52 5.86 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 165.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.71 17.43 21.33 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.731 1.052 . . . . 0.0 115.731 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' OD2' ' HE3' ' A' ' 47' ' ' LYS . 4.1 p-10 -65.4 -7.31 13.25 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.852 1.826 . . . . 0.0 114.661 174.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HE3' ' OD2' ' A' ' 46' ' ' ASP . 71.9 mttt -133.9 143.04 45.78 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.944 2.098 . . . . 0.0 108.565 -178.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.69 165.05 21.89 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.359 2.706 . . . . 0.0 114.657 -155.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -59.14 -15.09 12.56 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -56.29 -18.01 9.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.322 1.849 . . . . 0.0 115.199 168.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -112.66 11.54 19.57 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.103 2.161 . . . . 0.0 113.026 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.9 mt -137.86 -38.62 0.57 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.274 2.23 . . . . 0.0 112.507 -169.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.32 -14.71 19.87 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 128.165 2.586 . . . . 0.0 113.61 171.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.83 -21.15 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 127.022 2.129 . . . . 0.0 111.074 168.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.2 p -105.83 149.25 37.77 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.167 1.387 . . . . 0.0 110.9 153.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.92 -12.46 35.38 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.569 2.179 . . . . 0.0 113.213 169.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 2.0 mm-40 -87.02 -10.88 52.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.204 1.802 . . . . 0.0 113.369 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.03 27.88 72.44 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-N 119.061 0.846 . . . . 0.0 114.335 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' A' ' 57' ' ' GLU . 36.1 mtmt -102.08 169.98 8.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.827 1.651 . . . . 0.0 113.297 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.49 155.61 68.74 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 126.535 1.934 . . . . 0.0 108.719 154.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -82.2 148.87 69.77 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 119.995 1.034 . . . . 0.0 114.754 2.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.6 m -156.13 159.79 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 128.081 2.552 . . . . 0.0 109.391 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.34 147.05 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.172 -1.58 . . . . 0.0 114.691 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -95.41 124.03 39.23 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.344 1.458 . . . . 0.0 109.771 162.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.1 mt -100.31 79.02 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.989 1.315 . . . . 0.0 108.353 168.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.97 54.67 6.79 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.475 1.11 . . . . 0.0 112.755 -165.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.264 0.5 OUTLIER 58.67 17.56 5.18 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.171 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -100.37 114.51 28.09 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.061 1.344 . . . . 0.0 108.178 167.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -83.36 148.28 27.41 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -157.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -140.12 129.16 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.402 1.881 . . . . 0.0 109.392 172.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.45 -148.06 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.4 1.88 . . . . 0.0 113.533 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -44.09 159.29 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 -168.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.4 p -54.34 -32.22 56.23 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.528 ' CG ' HH12 ' A' ' 25' ' ' ARG . 41.1 m-20 -74.51 -17.81 60.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 176.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 m -96.27 -25.02 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.46 1.027 . . . . 0.0 112.687 164.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.5 mt -60.62 -41.96 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.973 0.909 . . . . 0.0 112.076 173.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -62.28 -8.76 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.92 -62.03 0.58 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.392 0.996 . . . . 0.0 112.888 159.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.96 -32.94 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.035 1.334 . . . . 0.0 113.613 -163.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.8 tp -70.61 -46.18 63.87 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.955 -1.09 . . . . 0.0 110.55 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -65.31 -34.79 79.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.504 1.121 . . . . 0.0 113.086 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 5.4 tt0 -58.88 -41.38 86.97 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.033 2.133 . . . . 0.0 112.785 169.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 93.7 mttt -101.93 6.24 41.23 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.925 1.29 . . . . 0.0 113.358 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -89.77 144.34 31.56 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.19 1.396 . . . . 0.0 111.014 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.88 -22.34 23.51 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.027 1.818 . . . . 0.0 114.385 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -82.66 144.08 48.23 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 119.223 0.92 . . . . 0.0 109.806 164.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -54.36 149.47 37.59 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.221 2.614 . . . . 0.0 115.18 -175.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.13 124.22 13.12 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.43 2.753 . . . . 0.0 112.849 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.2 mt -68.63 -11.48 60.13 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.309 -0.87 . . . . 0.0 112.293 161.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.24 -13.19 35.17 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.784 1.634 . . . . 0.0 114.73 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 m -60.49 116.63 18.88 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.859 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.17 123.86 7.5 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 121.927 1.751 . . . . 0.0 112.132 -166.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.04 172.06 17.11 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.757 2.305 . . . . 0.0 110.499 161.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.58 -33.4 68.14 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.458 -1.401 . . . . 0.0 112.682 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -60.99 -13.82 18.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.042 1.737 . . . . 0.0 114.983 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.67 69.99 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.111 1.323 . . . . 0.0 112.547 172.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.5 p -70.88 -13.18 61.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.15 -42.63 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.807 1.243 . . . . 0.0 111.267 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.34 -26.53 72.66 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 121.014 -1.054 . . . . 0.0 114.292 174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.7 p -68.84 -17.38 63.99 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.59 -47.03 10.96 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.541 1.064 . . . . 0.0 112.646 163.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 75.9 mt -65.78 -30.16 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.689 0.396 . . . . 0.0 111.12 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.09 -50.64 85.29 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 117.117 -1.42 . . . . 0.0 114.139 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.76 -27.38 8.87 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.301 2.667 . . . . 0.0 114.559 168.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.6 m -63.95 -35.09 79.54 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.035 1.743 . . . . 0.0 112.825 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -65.57 -29.03 69.58 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.723 -1.235 . . . . 0.0 113.912 166.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.9 t -66.68 -42.43 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.324 1.42 . . . . 0.0 110.539 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.73 -44.95 92.04 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.397 0.679 . . . . 0.0 112.78 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.81 -21.8 63.36 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.2 0.524 . . . . 0.0 112.104 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.7 mt -96.22 20.46 10.3 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.257 1.823 . . . . 0.0 113.402 167.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -140.23 69.21 1.35 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.512 1.525 . . . . 0.0 109.608 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.26 8.6 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.976 2.51 . . . . 0.0 116.608 -169.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -70.11 -33.6 72.05 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.82 1.248 . . . . 0.0 112.494 158.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -69.52 149.71 97.01 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.217 0.607 . . . . 0.0 109.971 159.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.17 101.43 0.97 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.339 2.026 . . . . 0.0 110.3 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.18 -39.65 79.47 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.64 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.49 -18.11 63.66 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.7 -28.99 14.38 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 121.196 -0.94 . . . . 0.0 113.355 168.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 60.8 m -69.53 -32.55 71.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.494 1.118 . . . . 0.0 111.907 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -58.23 -45.23 88.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.016 2.126 . . . . 0.0 111.887 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.19 -41.47 97.08 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.497 -0.752 . . . . 0.0 112.513 175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.87 -42.71 94.61 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.706 -0.621 . . . . 0.0 112.646 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.18 -37.4 87.23 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.548 1.139 . . . . 0.0 112.582 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.6 mt -60.88 -37.41 82.08 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.96 0.8 . . . . 0.0 112.658 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -71.22 -33.44 69.89 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.295 0.952 . . . . 0.0 112.605 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -71.19 -35.3 71.52 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.262 -0.899 . . . . 0.0 112.389 174.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -71.73 -31.64 66.91 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.855 0.862 . . . . 0.0 113.315 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -63.69 -36.3 83.38 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.029 1.286 . . . . 0.0 112.697 173.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.6 -28.69 68.7 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.02 -58.12 3.0 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.257 1.423 . . . . 0.0 112.911 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.16 -40.88 90.86 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -155.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.58 -26.68 72.03 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.679 -0.512 . . . . 0.0 113.729 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -89.98 -25.91 20.63 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.005 0.922 . . . . 0.0 113.06 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.67 -40.53 97.35 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.123 -0.986 . . . . 0.0 112.099 165.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -61.12 -14.19 22.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.018 1.327 . . . . 0.0 114.455 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.4 -34.48 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.733 1.213 . . . . 0.0 112.461 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -88.49 -53.49 4.63 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -174.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 161.54 177.41 34.6 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.646 1.019 . . . . 0.0 115.646 -169.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.07 -8.94 19.15 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.902 3.735 . . . . 0.0 116.503 -160.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -92.01 173.47 7.82 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.846 1.203 . . . . 0.0 112.199 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.258 8.5 tt -80.04 12.59 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.525 -1.36 . . . . 0.0 112.677 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.22 11.12 3.86 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.312 2.245 . . . . 0.0 113.543 168.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.99 -128.95 9.73 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 119.14 0.882 . . . . 0.0 113.748 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.92 -22.71 65.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.365 1.466 . . . . 0.0 114.541 -168.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -136.11 157.08 47.68 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.217 1.407 . . . . 0.0 112.04 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.35 131.64 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.875 1.27 . . . . 0.0 109.893 159.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.1 p -130.75 -176.08 3.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.304 1.842 . . . . 0.0 111.335 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.92 -14.52 22.97 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.125 -1.609 . . . . 0.0 114.787 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.66 -46.53 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.953 0.797 . . . . 0.0 110.874 167.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.7 -42.22 98.64 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.71 -1.244 . . . . 0.0 112.931 169.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.0 mt -64.48 -3.54 3.13 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.8 m -117.85 -39.46 3.11 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 120.892 -1.13 . . . . 0.0 112.055 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 21.8 mt -91.26 -38.97 12.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.593 1.157 . . . . 0.0 114.044 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.2 98.4 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.8 -22.66 13.25 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 121.07 1.418 . . . . 0.0 113.269 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -72.27 -33.92 67.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 117.544 -1.217 . . . . 0.0 112.319 170.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 30.2 mt -63.85 -41.27 97.85 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.036 0.835 . . . . 0.0 112.524 167.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -62.36 -45.31 93.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.575 0.625 . . . . 0.0 112.369 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -66.23 -25.91 67.12 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.536 0.734 . . . . 0.0 112.604 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.5 tp -77.37 -44.99 27.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.661 1.184 . . . . 0.0 113.137 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -61.39 -36.28 79.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.912 0.885 . . . . 0.0 111.498 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.71 -60.89 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.09 -47.98 15.16 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.148 -0.97 . . . . 0.0 113.332 -165.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.51 -37.13 79.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.382 0.537 . . . . 0.0 111.029 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.13 -27.86 60.56 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 115.636 1.014 . . . . 0.0 115.636 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -62.52 -30.25 71.15 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 171.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.41 -30.55 7.62 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.364 1.066 . . . . 0.0 113.149 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -149.43 101.07 3.07 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.243 1.817 . . . . 0.0 108.806 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -69.04 88.94 0.41 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.143 0.577 . . . . 0.0 110.495 168.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -82.78 111.33 28.69 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.605 1.162 . . . . 0.0 110.395 172.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.99 136.82 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.72 1.613 . . . . 0.0 109.812 170.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.1 mt -65.39 119.42 59.42 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 161.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -59.5 152.69 59.86 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.305 2.003 . . . . 0.0 113.339 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -23.1 64.79 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -63.72 -40.6 97.15 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.924 -1.11 . . . . 0.0 112.358 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.08 44.82 1.11 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.698 2.399 . . . . 0.0 111.187 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -28.39 69.23 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.356 1.462 . . . . 0.0 113.063 -167.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -77.28 -41.61 40.22 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.348 -0.845 . . . . 0.0 112.103 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 20.2 t -71.0 -32.9 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 118.908 -0.567 . . . . 0.0 111.368 171.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.39 -43.83 98.2 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.882 0.873 . . . . 0.0 112.826 168.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -69.1 -32.78 72.43 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.284 -0.885 . . . . 0.0 112.85 173.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -63.87 -27.5 69.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.721 0.809 . . . . 0.0 113.066 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.3 mt -53.16 -39.77 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.269 -0.895 . . . . 0.0 111.243 167.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -79.37 -10.27 59.77 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.262 -1.524 . . . . 0.0 113.488 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.22 -21.75 53.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 117.602 -1.19 . . . . 0.0 113.594 162.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.57 -21.77 65.85 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.115 1.325 . . . . 0.0 113.687 -177.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -89.3 5.13 46.37 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.803 -1.186 . . . . 0.0 114.071 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.2 p -129.68 -175.22 3.53 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -159.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 59.52 -169.8 0.14 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.339 1.856 . . . . 0.0 112.164 -172.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.402 ' HG3' ' HE2' ' A' ' 34' ' ' LYS . 70.3 mm-40 -70.28 -49.79 46.1 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.086 160.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -61.5 -78.19 0.04 OUTLIER 'General case' 0 C--O 1.231 0.113 0 C-N-CA 127.572 2.349 . . . . 0.0 113.267 -169.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -57.41 -40.39 78.19 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.737 0.699 . . . . 0.0 112.362 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.56 -40.38 91.4 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.14 1.376 . . . . 0.0 114.458 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.25 -35.95 74.15 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 120.114 1.324 . . . . 0.0 111.868 174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.1 p -76.16 -1.61 27.08 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -64.71 99.14 0.3 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.273 1.397 . . . . 0.0 110.772 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.72 134.56 45.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.363 0.665 . . . . 0.0 111.736 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.65 122.78 13.6 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.026 0.93 . . . . 0.0 111.931 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 36.0 mp0 -68.51 -40.68 80.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.013 1.325 . . . . 0.0 113.962 -148.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -61.7 -33.98 74.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.339 1.056 . . . . 0.0 112.442 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -79.01 -15.05 58.78 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.973 -1.079 . . . . 0.0 113.778 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.44 -46.11 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 119.038 0.836 . . . . 0.0 109.829 166.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -63.83 -54.5 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.81 1.244 . . . . 0.0 111.272 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.52 -34.33 77.99 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.58 -15.74 72.72 Favored Glycine 0 CA--C 1.537 1.406 0 O-C-N 120.975 -1.078 . . . . 0.0 114.116 173.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -82.22 -21.96 36.13 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.804 1.802 . . . . 0.0 113.891 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -48.68 -47.36 71.58 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.98 -23.77 15.82 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 CA-C-N 122.16 1.807 . . . . 0.0 114.168 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.0 -1.82 30.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.862 1.665 . . . . 0.0 114.557 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 m -61.2 -20.47 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.48 -0.763 . . . . 0.0 112.239 158.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -118.86 -32.33 4.53 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.057 1.343 . . . . 0.0 114.461 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.25 0 CA-C-O 116.447 -1.74 . . . . 0.0 114.689 -174.855 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' UU3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_